data_2loe_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2loe _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 70.4 t -98.22 130.78 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.333 -0.854 . . . . 0.0 109.871 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -71.07 121.94 19.16 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.201 -0.937 . . . . 0.0 108.483 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.2 164.86 31.04 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.403 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 7.2 t -105.71 133.34 50.61 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.396 -1.061 . . . . 0.0 109.862 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.512 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 39.8 t0 -110.92 109.39 19.52 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.211 -0.931 . . . . 0.0 109.462 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -87.0 3.75 44.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.135 -0.978 . . . . 0.0 108.872 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.4 m -109.83 -16.61 13.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.473 -0.767 . . . . 0.0 110.623 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.5 m -151.14 117.24 5.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.804 -1.185 . . . . 0.0 110.186 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.7 m -59.93 -32.22 70.57 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -111.49 75.48 0.92 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.512 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 1.3 m -74.18 115.11 13.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.354 -0.842 . . . . 0.0 110.365 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.9 t -67.75 3.25 1.51 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.502 ' H ' ' C ' ' A' ' 13' ' ' SER . 8.0 pt -124.02 -40.8 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.473 -0.767 . . . . 0.0 110.184 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -100.32 142.08 32.28 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.919 -1.113 . . . . 0.0 109.806 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.6 t -72.24 -23.79 61.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.414 -0.804 . . . . 0.0 110.915 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -119.2 129.78 55.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.715 -1.24 . . . . 0.0 110.417 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -141.41 154.73 24.82 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.403 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 33.0 m-85 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.252 -1.146 . . . . 0.0 109.575 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.448 HG21 HD12 ' A' ' 36' ' ' ILE . 38.2 mm . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -119.3 129.42 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.062 -1.024 . . . . 0.0 110.25 -179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 74.4 m -102.77 101.91 12.02 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.0 m -94.12 120.63 34.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -0.958 . . . . 0.0 109.722 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 m -138.58 158.58 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.42 -0.8 . . . . 0.0 109.041 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -100.85 122.45 43.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -0.895 . . . . 0.0 109.509 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.49 164.41 13.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -0.847 . . . . 0.0 109.546 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -138.1 153.07 49.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 0.0 109.715 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 100' ' ' PRO . . . -54.63 -26.29 32.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 0.0 109.783 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -100.99 -24.77 14.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.148 -0.97 . . . . 0.0 109.572 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -72.77 138.5 46.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.827 . . . . 0.0 109.893 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.3 mt -80.31 144.88 32.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 108.741 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.9 pt -122.12 143.85 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.927 -1.108 . . . . 0.0 110.014 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.04 -175.82 47.69 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.464 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 50.2 p90 -167.71 169.49 11.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.024 -1.28 . . . . 0.0 109.751 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -148.43 146.38 28.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.955 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 63.1 m -126.33 152.21 73.52 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.459 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.21 153.93 8.75 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.449 2.099 . . . . 0.0 111.923 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.8 p -72.64 -10.99 60.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.709 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.514 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 80.8 m-20 -92.02 -3.31 55.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.937 -1.102 . . . . 0.0 110.083 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.459 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 15.8 m-85 -106.61 161.44 14.63 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.9 -1.125 . . . . 0.0 110.168 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.474 ' OG ' ' NZ ' ' A' ' 115' ' ' LYS . 7.1 m -99.89 138.39 37.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.363 -0.835 . . . . 0.0 109.389 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.522 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.8 m -94.38 117.08 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.977 -1.077 . . . . 0.0 110.454 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -126.18 127.67 24.61 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.97 111.11 3.03 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.614 1.543 . . . . 0.0 112.224 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -90.96 -26.99 18.99 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.3 t0 -166.37 42.22 0.06 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.594 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 84.5 m -67.74 -157.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 109.836 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.9 p90 -112.16 -49.53 2.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.874 -1.141 . . . . 0.0 111.425 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 55.7 t -58.41 -48.75 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.495 -1.378 . . . . 0.0 108.922 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.1 t -156.84 128.94 7.32 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.594 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.62 -178.16 1.57 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.872 -1.142 . . . . 0.0 110.475 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 9.2 m-85 -94.14 127.54 40.03 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -70.16 -175.77 1.03 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.964 -1.085 . . . . 0.0 109.879 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.8 mt -61.95 -24.35 66.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.337 -0.852 . . . . 0.0 108.968 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 67.1 m -82.43 -5.07 58.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.316 -0.865 . . . . 0.0 108.804 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.41 19.03 65.13 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -100.23 141.41 33.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -1.136 . . . . 0.0 109.145 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -82.69 110.35 17.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.149 -0.969 . . . . 0.0 110.016 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -146.1 140.95 27.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.328 -0.857 . . . . 0.0 109.56 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -61.25 145.92 49.61 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.3 tp -96.61 5.89 49.83 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.175 -0.953 . . . . 0.0 109.892 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.463 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.3 OUTLIER -70.73 -41.66 71.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.1 -1.0 . . . . 0.0 109.789 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.415 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 41.0 t30 -59.8 -27.22 66.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.146 -0.971 . . . . 0.0 109.037 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -82.15 -45.46 15.1 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.246 -0.909 . . . . 0.0 109.353 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.0 tp -139.13 133.64 31.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.431 -0.793 . . . . 0.0 109.187 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.65 86.09 7.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.079 -1.013 . . . . 0.0 109.433 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.37 148.33 43.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.898 . . . . 0.0 109.842 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.1 p -127.29 162.74 25.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.409 -0.807 . . . . 0.0 109.391 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 54.32 51.88 13.51 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.062 -1.023 . . . . 0.0 109.529 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.414 HG23 HD11 ' A' ' 86' ' ' ILE . 96.6 mt -80.2 131.07 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.353 -0.842 . . . . 0.0 110.093 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.8 mm -123.87 122.42 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.434 -0.791 . . . . 0.0 109.238 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 87.9 mtp -123.48 107.79 11.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.953 -1.092 . . . . 0.0 110.019 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -114.7 101.49 9.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.21 -0.931 . . . . 0.0 108.983 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.469 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 95.9 m-70 -73.27 -34.69 65.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.052 -1.03 . . . . 0.0 110.645 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -60.34 -45.7 92.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.896 -1.127 . . . . 0.0 109.61 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -89.43 -4.71 57.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.087 -1.008 . . . . 0.0 109.053 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 96.7 m-20 55.39 47.8 20.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 110.151 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.573 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.3 t -132.33 136.45 46.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.98 -1.075 . . . . 0.0 109.516 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.464 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 79.3 m-85 -126.29 139.53 53.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.019 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.573 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 80.1 m-85 -135.03 146.45 49.0 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.199 -0.938 . . . . 0.0 109.434 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.554 ' C ' ' HE ' ' A' ' 98' ' ' ARG . 39.7 t -145.74 144.95 30.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.095 -1.003 . . . . 0.0 109.212 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.554 ' HE ' ' C ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -100.46 128.75 46.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.072 -1.017 . . . . 0.0 109.435 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.523 ' O ' ' O ' ' A' ' 100' ' ' PRO . 94.8 mt -89.86 138.27 27.91 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.25 -0.906 . . . . 0.0 109.636 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 99' ' ' LEU . 75.7 Cg_exo -46.17 -177.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.896 1.731 . . . . 0.0 110.984 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 95.3 p -90.45 -8.35 50.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.968 -1.082 . . . . 0.0 109.748 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.7 tp -135.49 129.76 33.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.125 -0.984 . . . . 0.0 110.445 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.478 HD13 HG22 ' A' ' 103' ' ' ILE . 48.1 mt -150.92 108.3 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.367 -0.833 . . . . 0.0 108.838 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 99.8 p -110.41 0.11 17.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.124 -0.985 . . . . 0.0 109.678 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 127' ' ' ALA . 73.7 m-20 -82.57 152.79 25.81 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.062 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -99.15 32.5 2.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.375 -0.828 . . . . 0.0 109.082 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 17.7 p-90 -65.88 151.09 47.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 110.553 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -134.91 156.3 49.2 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.627 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 36.9 p90 -156.06 158.13 37.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.079 -1.013 . . . . 0.0 108.954 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 17.5 p90 -151.83 156.27 39.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.756 -1.215 . . . . 0.0 111.588 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 90.7 m -121.38 158.51 28.14 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 76.7 t -132.8 150.15 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.612 -1.305 . . . . 0.0 111.684 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.5 m -127.88 134.12 49.37 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.8 p -167.58 176.83 6.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.336 -1.478 . . . . 0.0 111.743 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.514 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 50.0 mttm -155.86 168.35 27.48 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 117' ' ' ASN . 90.8 m-20 -57.67 148.29 24.98 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.917 -1.114 . . . . 0.0 109.331 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.494 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 65.9 t30 40.9 60.93 1.84 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.264 -0.897 . . . . 0.0 109.771 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 48.9 mm-40 -157.31 136.67 12.01 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.978 -1.076 . . . . 0.0 110.187 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -56.33 133.44 52.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.262 -0.899 . . . . 0.0 109.019 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -85.28 143.28 28.8 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.114 -0.991 . . . . 0.0 110.404 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 68.4 mt -111.33 124.33 52.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.446 -0.784 . . . . 0.0 109.154 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.4 t -109.45 130.98 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.986 -1.071 . . . . 0.0 110.711 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -109.98 120.62 43.04 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.4 t -137.05 143.95 42.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.475 -1.391 . . . . 0.0 112.008 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.627 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 2.9 m -136.53 159.94 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -134.31 150.11 50.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.836 -1.165 . . . . 0.0 110.13 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.338 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.6 t -88.16 136.39 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.372 -0.83 . . . . 0.0 110.36 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -68.84 125.22 25.92 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.054 -1.029 . . . . 0.0 108.615 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.81 179.11 45.18 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -118.56 132.4 56.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.619 -0.93 . . . . 0.0 109.369 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -109.07 109.07 19.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.542 -0.724 . . . . 0.0 109.272 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.458 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 78.0 m-85 -88.76 -0.54 57.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.171 -0.956 . . . . 0.0 108.912 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.0 m -98.55 -18.18 18.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.468 -0.77 . . . . 0.0 110.537 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.0 m -158.2 127.07 5.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.836 -1.165 . . . . 0.0 110.361 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.1 p -64.59 -26.6 68.47 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.611 -0.836 . . . . 0.0 108.985 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -113.04 73.89 0.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.501 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 95.0 p -69.67 151.39 45.94 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.226 -0.921 . . . . 0.0 110.159 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 t -101.25 0.85 38.14 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 pt -124.76 -20.86 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.672 -0.643 . . . . 0.0 110.496 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.501 ' O ' ' OG ' ' A' ' 13' ' ' SER . 57.4 m-85 -115.93 144.52 43.94 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.401 -0.812 . . . . 0.0 110.325 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.0 m -72.28 -17.58 61.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.502 -0.749 . . . . 0.0 110.542 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -135.0 145.53 48.18 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.96 -1.088 . . . . 0.0 110.762 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -159.53 173.37 36.29 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.394 -1.062 . . . . 0.0 109.614 -179.845 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.9 mm . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.2 t -120.78 130.21 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.411 -0.806 . . . . 0.0 110.42 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.458 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 89.6 m -101.05 100.67 11.29 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 58.5 m -96.06 120.73 36.86 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.182 -0.949 . . . . 0.0 109.513 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.2 m -141.66 153.51 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.492 -0.755 . . . . 0.0 109.306 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -94.03 132.75 38.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.005 -1.059 . . . . 0.0 109.149 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.02 146.78 27.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.22 -0.925 . . . . 0.0 109.626 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.467 ' HD1' ' CG ' ' A' ' 45' ' ' ASN . 21.0 t-80 -116.43 150.73 37.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.429 -0.794 . . . . 0.0 109.507 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.99 -25.38 43.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.415 -0.803 . . . . 0.0 109.883 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.554 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 30.5 p30 -98.22 -22.99 15.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 109.684 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.554 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 82.2 m-20 -76.4 136.78 39.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.449 -0.782 . . . . 0.0 110.165 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.47 146.5 38.48 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.43 HD11 HG21 ' A' ' 48' ' ' ILE . 38.3 pt -120.4 141.89 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.113 -0.992 . . . . 0.0 110.307 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.93 -173.75 46.25 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -170.18 169.55 7.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.11 -1.229 . . . . 0.0 109.685 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -144.74 143.64 30.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.235 -0.916 . . . . 0.0 110.015 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 90.1 m -124.0 151.87 65.83 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.406 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.74 147.53 24.34 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.337 2.025 . . . . 0.0 111.976 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.1 m -70.6 -12.1 61.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.424 -0.798 . . . . 0.0 110.545 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.615 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.8 m-20 -91.6 0.49 57.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.051 -1.031 . . . . 0.0 110.084 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.406 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.4 m-85 -109.86 165.73 11.48 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.124 -0.985 . . . . 0.0 110.353 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -103.65 130.76 51.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.34 -0.85 . . . . 0.0 109.05 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.504 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.8 m -89.5 118.74 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.004 -1.06 . . . . 0.0 110.104 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -124.73 126.78 25.31 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.13 114.57 3.6 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.777 1.651 . . . . 0.0 112.051 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.491 ' O ' ' O ' ' A' ' 68' ' ' PHE . 17.0 t-80 -93.56 -24.0 18.11 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.8 t0 -170.19 40.59 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.485 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 89.9 m -64.28 -154.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.422 -0.799 . . . . 0.0 109.887 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.6 p90 -109.29 -58.69 2.0 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.155 -0.966 . . . . 0.0 111.483 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 64' ' ' PHE . 31.2 t -46.05 -70.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.58 -1.325 . . . . 0.0 108.804 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.2 t -141.38 132.45 26.23 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.485 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -170.97 175.86 4.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.97 -1.081 . . . . 0.0 110.464 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.1 m-85 -92.39 142.36 27.53 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -83.26 -170.86 3.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.879 -1.138 . . . . 0.0 109.895 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.56 -15.03 63.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.325 -0.86 . . . . 0.0 108.98 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 65.7 m -86.55 -8.61 57.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.38 -0.825 . . . . 0.0 108.806 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.93 20.07 64.01 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -106.73 139.84 40.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.318 -1.107 . . . . 0.0 109.246 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -66.78 125.68 26.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.28 -0.888 . . . . 0.0 109.844 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -145.47 165.26 29.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.408 -0.808 . . . . 0.0 109.644 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.442 ' ND2' ' CD ' ' A' ' 78' ' ' GLU . 37.8 t-20 -105.96 136.94 44.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.337 -0.852 . . . . 0.0 109.472 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 tp -93.26 -8.28 42.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 0.0 110.194 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.488 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 20.7 pt-20 -58.94 -46.63 87.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.044 -1.035 . . . . 0.0 109.523 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.488 ' N ' ' CG ' ' A' ' 78' ' ' GLU . 92.5 m-20 -64.87 -34.52 78.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 108.972 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -69.24 -52.41 27.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.499 -0.751 . . . . 0.0 109.61 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.418 HD21 ' CZ2' ' A' ' 107' ' ' TRP . 31.5 tp -129.13 126.51 39.45 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -76.63 108.54 9.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.015 -1.053 . . . . 0.0 109.018 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.3 mt -105.18 137.86 42.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 110.088 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.9 p -124.46 162.69 23.4 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.493 -0.754 . . . . 0.0 109.287 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.6 ' O ' ' NH1' ' A' ' 98' ' ' ARG . 98.9 m-20 55.0 51.46 13.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.573 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 86' ' ' ILE . 96.7 mt -78.92 130.62 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.185 -0.947 . . . . 0.0 110.152 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.5 mm -120.19 119.79 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.482 -0.761 . . . . 0.0 109.225 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 78.8 mtp -124.56 109.59 13.41 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.295 -0.878 . . . . 0.0 109.835 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -111.73 100.74 9.18 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.38 -0.825 . . . . 0.0 108.938 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.486 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 97.1 m-70 -71.76 -36.48 70.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.859 -1.15 . . . . 0.0 110.632 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -61.13 -46.76 89.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.963 -1.085 . . . . 0.0 109.556 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -87.17 -4.96 59.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.07 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.4 m-20 54.93 47.32 22.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.556 -0.715 . . . . 0.0 110.209 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.593 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.3 t -133.84 139.73 46.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.03 -1.043 . . . . 0.0 109.325 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 49.5 m-85 -128.52 140.14 51.96 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.429 -0.794 . . . . 0.0 109.982 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.593 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 67.2 m-85 -138.23 148.7 45.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.289 -0.882 . . . . 0.0 109.16 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.703 ' N ' ' NH2' ' A' ' 98' ' ' ARG . 57.6 m -157.3 159.4 37.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.099 -1.001 . . . . 0.0 109.336 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.703 ' NH2' ' N ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -103.59 139.72 38.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.236 -0.915 . . . . 0.0 109.679 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.4 mt -91.98 138.54 24.64 Favored Pre-proline 0 C--N 1.304 -1.396 0 O-C-N 121.619 -0.676 . . . . 0.0 109.597 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -46.93 158.28 0.44 Allowed 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.734 1.622 . . . . 0.0 111.265 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.6 t -69.6 -17.98 63.58 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.179 -0.95 . . . . 0.0 109.916 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 44.9 tp -125.41 129.32 49.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.258 -0.901 . . . . 0.0 110.639 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.454 HD13 HG21 ' A' ' 103' ' ' ILE . 83.1 mt -149.29 102.86 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.3 m -113.25 3.1 15.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.352 -0.842 . . . . 0.0 109.834 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 53.2 t0 -89.28 155.28 19.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.976 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.584 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 98.9 m-20 -96.54 34.15 1.69 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.417 -0.802 . . . . 0.0 108.914 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.468 ' CZ3' ' CD1' ' A' ' 109' ' ' PHE . 13.0 p-90 -62.69 154.06 30.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.165 -0.959 . . . . 0.0 110.42 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.607 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 21.2 tttp -141.07 149.13 41.24 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.641 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 29.2 p90 -155.09 163.31 40.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.188 -0.945 . . . . 0.0 108.731 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 10.7 p90 -154.84 160.06 40.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.86 -1.15 . . . . 0.0 111.872 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 75.1 m -122.92 155.43 36.73 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.4 t -128.78 139.05 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.848 -1.158 . . . . 0.0 111.933 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 96.4 m -122.9 131.94 53.96 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 62.9 p -171.54 178.7 3.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.306 -1.496 . . . . 0.0 111.608 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.615 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 50.6 mtmt -150.7 163.62 38.1 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 55.4 p-10 -59.44 154.27 17.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.907 -1.121 . . . . 0.0 109.114 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.511 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 64.7 t30 44.26 59.69 3.13 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.211 -0.931 . . . . 0.0 109.642 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 38.8 mt-10 -165.28 146.19 7.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.256 -0.902 . . . . 0.0 110.154 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -58.03 142.16 47.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 109.193 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -88.95 140.09 29.79 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.077 -1.015 . . . . 0.0 110.414 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 86.6 mt -108.89 120.8 43.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.417 -0.802 . . . . 0.0 108.965 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.6 t -109.36 130.1 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.049 -1.032 . . . . 0.0 110.54 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -107.81 118.62 37.23 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.607 ' OG1' ' NZ ' ' A' ' 108' ' ' LYS . 7.3 t -136.94 141.88 42.65 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.918 -1.114 . . . . 0.0 112.3 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.3 m -134.55 158.48 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -132.31 152.66 51.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.229 -0.919 . . . . 0.0 110.278 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.333 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.2 t -96.55 133.17 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 109.795 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.8 mmtp -69.86 122.11 18.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.126 -0.984 . . . . 0.0 108.706 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.4 ' HA3' ' CD1' ' A' ' 16' ' ' PHE . . . 178.3 176.41 46.22 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.543 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 4.7 t -116.28 128.54 55.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.471 -1.017 . . . . 0.0 109.296 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -103.45 111.18 23.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.59 -0.694 . . . . 0.0 109.375 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -91.59 -0.88 57.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.186 -0.947 . . . . 0.0 108.826 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.5 m -103.72 -16.67 15.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.486 -0.759 . . . . 0.0 110.632 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 m -156.35 125.02 5.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.883 -1.136 . . . . 0.0 110.278 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.505 ' OG ' ' OE1' ' A' ' 12' ' ' GLU . 74.0 p -65.47 -26.36 67.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.184 -0.948 . . . . 0.0 108.981 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.505 ' OE1' ' OG ' ' A' ' 11' ' ' SER . 55.5 mp0 -113.67 72.96 0.8 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.2 t -67.7 150.62 48.46 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.134 -0.979 . . . . 0.0 110.352 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.77 0.6 41.99 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.419 HD12 HG23 ' A' ' 15' ' ' ILE . 24.2 pt -125.04 -27.19 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.749 -0.594 . . . . 0.0 110.199 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.4 ' CD1' ' HA3' ' A' ' 5' ' ' GLY . 52.1 m-85 -110.27 133.74 52.95 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.041 -1.037 . . . . 0.0 109.87 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.9 t -67.95 -18.53 64.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.641 -0.662 . . . . 0.0 110.858 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -125.09 136.73 53.94 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.027 -1.046 . . . . 0.0 110.67 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -146.86 158.81 27.84 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.543 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 21.4 m-85 . . . . . 0 N--CA 1.495 1.795 0 O-C-N 121.323 -1.104 . . . . 0.0 109.589 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 122' ' ' VAL . 20.8 mm . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 79.5 t -115.68 127.85 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.114 -0.991 . . . . 0.0 110.604 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.505 ' O ' ' O ' ' A' ' 124' ' ' THR . 66.8 m -102.07 101.49 11.86 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.1 m -92.46 119.53 32.05 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.822 -1.174 . . . . 0.0 109.848 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.8 m -136.23 155.76 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -99.03 121.88 41.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 109.504 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.86 163.56 13.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.574 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.4 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 37.1 t60 -136.64 155.61 49.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.203 -0.936 . . . . 0.0 109.656 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 100' ' ' PRO . . . -55.24 -26.47 39.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.325 -0.86 . . . . 0.0 109.711 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -101.46 -22.44 14.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.166 -0.959 . . . . 0.0 109.632 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.4 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 85.8 m-20 -75.08 137.49 41.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.419 -0.8 . . . . 0.0 109.942 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.8 mt -80.73 147.46 30.55 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.7 pt -122.12 144.26 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.144 -0.972 . . . . 0.0 110.294 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.9 -173.06 45.7 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.474 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 50.5 p90 -169.68 168.81 8.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.056 -1.261 . . . . 0.0 109.725 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -143.42 142.6 31.29 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.319 -0.863 . . . . 0.0 109.636 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 61.4 m -123.77 152.31 65.66 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 108.662 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.444 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.3 Cg_endo -51.7 150.98 15.71 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.431 2.087 . . . . 0.0 111.905 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.1 m -71.32 -13.2 61.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.459 -0.775 . . . . 0.0 110.726 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.491 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 80.2 m-20 -91.04 -1.04 57.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.867 -1.146 . . . . 0.0 110.214 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.444 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 16.5 m-85 -107.67 162.49 13.92 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.514 -0.741 . . . . 0.0 110.099 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.432 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 6.2 t -102.91 134.04 47.0 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.333 -0.855 . . . . 0.0 109.334 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.515 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 3.5 m -90.45 115.25 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.092 -1.005 . . . . 0.0 110.389 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.492 ' N ' ' OE1' ' A' ' 59' ' ' GLU . 15.8 mp0 -121.24 126.56 26.52 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.08 112.71 3.29 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.617 1.545 . . . . 0.0 112.265 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -94.05 -25.24 17.28 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.7 t0 -168.34 39.51 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 80.5 m -65.08 -153.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.579 -0.701 . . . . 0.0 109.729 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.9 p90 -111.26 -59.15 2.01 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.179 -0.95 . . . . 0.0 111.347 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.449 ' C ' ' O ' ' A' ' 64' ' ' PHE . 24.1 t -45.72 -73.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.682 -1.261 . . . . 0.0 108.757 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.3 t -136.44 132.61 35.65 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -173.71 -178.67 1.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.908 -1.12 . . . . 0.0 110.446 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 7.6 m-85 -93.07 124.21 36.88 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -69.74 -175.03 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.07 -1.019 . . . . 0.0 109.869 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.527 ' CD1' ' HZ1' ' A' ' 108' ' ' LYS . 58.8 mt -62.3 -23.66 66.86 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.29 -0.881 . . . . 0.0 108.905 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.6 p -81.92 -7.17 59.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 108.819 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.64 15.63 70.35 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -95.75 138.51 33.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.394 -1.062 . . . . 0.0 109.137 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -81.91 108.35 15.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.249 -0.907 . . . . 0.0 110.143 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -145.35 143.58 30.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 110.063 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.0 m-20 -64.54 149.59 48.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.913 -1.117 . . . . 0.0 109.512 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.409 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 13.9 tp -99.22 6.7 46.24 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.465 -0.772 . . . . 0.0 109.941 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -69.38 -41.06 76.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.13 -0.981 . . . . 0.0 109.923 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 48.4 p-10 -62.58 -26.08 68.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.197 -0.939 . . . . 0.0 109.071 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.5 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 88.0 tttt -84.79 -46.29 11.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.45 -0.781 . . . . 0.0 109.442 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.403 HD22 ' CZ2' ' A' ' 107' ' ' TRP . 41.0 tp -131.64 127.35 36.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.405 -0.809 . . . . 0.0 109.234 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -83.29 83.77 7.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.066 -1.021 . . . . 0.0 109.297 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.9 mt -75.73 146.71 39.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.888 . . . . 0.0 110.121 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.3 p -127.94 160.61 31.33 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.606 -0.684 . . . . 0.0 109.318 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.679 HD21 ' NE ' ' A' ' 98' ' ' ARG . 96.8 m-20 54.72 50.78 15.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.278 -0.889 . . . . 0.0 109.546 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.2 mt -77.61 128.54 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 109.879 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.0 mm -118.92 119.19 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.489 -0.757 . . . . 0.0 109.229 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 85.4 mtp -123.44 108.03 12.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.214 -0.929 . . . . 0.0 109.806 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -114.19 101.75 9.49 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.411 -0.806 . . . . 0.0 108.873 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.472 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 95.4 m-70 -71.63 -36.22 70.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.995 -1.066 . . . . 0.0 110.592 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -60.91 -45.15 95.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.974 -1.079 . . . . 0.0 109.462 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -88.89 -5.21 58.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.953 . . . . 0.0 109.07 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.7 m-20 54.4 47.95 21.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.49 -0.756 . . . . 0.0 110.139 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.608 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 2.6 t -132.37 137.16 47.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.987 -1.071 . . . . 0.0 109.606 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.474 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 79.4 m-85 -126.68 138.88 53.47 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.402 -0.811 . . . . 0.0 109.977 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.608 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 71.4 m-85 -135.61 146.1 47.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.239 -0.913 . . . . 0.0 109.437 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.5 t -150.87 150.99 31.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.959 . . . . 0.0 109.242 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.679 ' NE ' HD21 ' A' ' 85' ' ' ASN . 60.3 mtt-85 -101.29 133.1 46.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.16 -0.962 . . . . 0.0 109.434 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 100' ' ' PRO . 38.5 mt -91.54 137.9 25.59 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.461 -0.774 . . . . 0.0 109.789 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.493 ' O ' ' O ' ' A' ' 44' ' ' ALA . 77.5 Cg_exo -45.68 177.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.876 1.717 . . . . 0.0 111.163 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 99.9 p -89.36 -9.87 48.76 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.113 -0.992 . . . . 0.0 109.847 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.7 tp -133.68 128.15 34.39 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.208 -0.932 . . . . 0.0 110.254 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.43 HG23 HD13 ' A' ' 103' ' ' ILE . 68.3 mt -150.12 106.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.945 . . . . 0.0 108.677 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 96.3 p -107.78 0.33 22.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.088 -1.007 . . . . 0.0 109.772 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 127' ' ' ALA . 82.6 m-20 -84.64 154.54 22.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.038 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -102.38 31.5 4.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.493 -0.754 . . . . 0.0 109.12 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.403 ' CZ2' HD22 ' A' ' 81' ' ' LEU . 16.5 p-90 -66.68 160.07 26.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.205 -0.934 . . . . 0.0 110.507 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.527 ' HZ1' ' CD1' ' A' ' 70' ' ' LEU . 26.6 pttm -142.0 159.05 43.01 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.553 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 20.9 p90 -154.04 162.66 41.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.929 -1.107 . . . . 0.0 108.661 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 7.3 p90 -153.59 160.4 42.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.67 -1.269 . . . . 0.0 111.836 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 94.7 m -124.83 156.68 37.43 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.0 t -127.9 138.91 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.867 -1.145 . . . . 0.0 111.792 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.1 m -120.11 130.77 54.79 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.2 p -168.93 174.84 6.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.322 -1.486 . . . . 0.0 111.601 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.491 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 52.4 mttm -152.72 168.1 26.79 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 117' ' ' ASN . 90.1 m-20 -58.54 148.34 28.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.835 -1.166 . . . . 0.0 108.845 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.456 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 66.2 t30 43.86 60.67 2.6 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.26 -0.9 . . . . 0.0 109.395 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 58.2 mm-40 -158.01 137.44 11.88 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.19 -0.944 . . . . 0.0 110.455 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -54.77 131.57 44.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.083 -1.011 . . . . 0.0 108.962 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -79.81 139.25 37.28 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.21 -0.931 . . . . 0.0 110.249 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.6 mt -111.26 124.43 52.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.644 -0.66 . . . . 0.0 109.389 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 36' ' ' ILE . 39.2 t -110.39 132.04 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.979 -1.076 . . . . 0.0 110.71 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.419 ' O ' ' CB ' ' A' ' 110' ' ' PHE . 26.4 t80 -110.43 123.0 49.06 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.505 ' O ' ' O ' ' A' ' 38' ' ' CYS . 6.6 t -137.88 143.73 41.01 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.005 -1.059 . . . . 0.0 112.145 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.553 ' CG2' ' CE2' ' A' ' 109' ' ' PHE . 2.8 m -136.71 159.52 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -133.16 150.64 52.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.071 -1.018 . . . . 0.0 110.31 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.4 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.9 t -103.63 135.29 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.054 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -69.46 125.12 25.75 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.583 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.61 176.02 43.51 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -115.85 132.47 56.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.493 -1.004 . . . . 0.0 109.246 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.496 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 36.9 t0 -110.21 109.18 19.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.595 -0.691 . . . . 0.0 109.333 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -88.17 -1.17 57.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.298 -0.876 . . . . 0.0 108.982 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.5 m -100.93 -18.64 16.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.515 -0.741 . . . . 0.0 110.577 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.7 m -156.19 125.06 5.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.878 -1.139 . . . . 0.0 110.367 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 t -65.99 -27.0 67.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.413 -0.804 . . . . 0.0 108.957 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 58.7 mp0 -112.92 73.98 0.84 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.496 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 12.5 m -70.78 152.85 43.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.875 . . . . 0.0 110.225 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.93 -0.04 40.28 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.7 pt -125.9 -22.28 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.71 -0.619 . . . . 0.0 110.25 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -113.05 140.28 47.98 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.255 -0.903 . . . . 0.0 110.133 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.9 m -73.43 -17.08 61.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.603 -0.686 . . . . 0.0 110.691 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -132.87 144.04 49.92 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.998 -1.064 . . . . 0.0 110.563 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.416 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -160.7 171.32 36.81 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.423 -1.045 . . . . 0.0 109.666 179.935 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.9 mm . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.9 t -121.44 126.86 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.392 -0.818 . . . . 0.0 110.009 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.3 m -102.45 102.16 12.43 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 75.8 m -98.78 122.37 41.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.076 -1.015 . . . . 0.0 109.397 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.1 m -140.96 155.22 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.562 -0.711 . . . . 0.0 109.257 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -96.12 132.5 41.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.084 -1.01 . . . . 0.0 109.405 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.76 160.45 14.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.405 -0.81 . . . . 0.0 109.591 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.8 t60 -133.0 153.81 51.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.245 -0.909 . . . . 0.0 109.55 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 100' ' ' PRO . . . -54.01 -25.28 20.34 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.384 -0.822 . . . . 0.0 109.788 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -101.53 -26.06 13.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.704 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -71.67 132.02 43.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.336 -0.852 . . . . 0.0 110.069 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.3 mt -77.28 145.89 37.19 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.423 HG21 HD11 ' A' ' 48' ' ' ILE . 44.9 pt -123.11 145.85 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.766 0.793 . . . . 0.0 110.479 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.48 -173.98 46.58 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -169.54 170.01 8.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.095 -1.239 . . . . 0.0 109.697 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -147.71 145.4 28.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.9 . . . . 0.0 109.907 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 92.6 m -124.83 151.65 68.61 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.413 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.6 Cg_endo -51.7 150.1 17.65 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.334 2.023 . . . . 0.0 112.044 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 m -69.68 -11.74 61.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.398 -0.813 . . . . 0.0 110.528 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -90.94 -2.67 57.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.023 -1.048 . . . . 0.0 110.223 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.413 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.4 m-85 -109.17 164.28 12.59 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.219 -0.925 . . . . 0.0 110.426 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.7 t -105.96 133.93 49.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.448 -0.783 . . . . 0.0 108.919 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.499 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 3.1 m -89.8 118.92 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.032 -1.043 . . . . 0.0 110.364 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 112' ' ' VAL . 10.0 mt-10 -123.1 126.67 25.91 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.14 114.11 3.51 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.66 1.573 . . . . 0.0 112.12 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.505 ' O ' ' O ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -93.63 -24.14 18.01 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 110' ' ' PHE . 66.9 t0 -169.9 43.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.462 ' H ' ' CB ' ' A' ' 67' ' ' ALA . 97.3 m -67.55 -153.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.748 . . . . 0.0 109.844 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.8 p90 -110.1 -57.88 2.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.141 -0.975 . . . . 0.0 111.455 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 64' ' ' PHE . 24.9 t -46.76 -71.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.601 -1.312 . . . . 0.0 108.863 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.8 t -140.91 131.3 25.18 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.462 ' CB ' ' H ' ' A' ' 63' ' ' CYS . . . -170.76 175.74 4.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.975 -1.078 . . . . 0.0 110.425 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 2.5 m-85 -92.86 140.67 29.26 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -81.81 -170.35 2.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.835 -1.165 . . . . 0.0 109.829 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.0 mp -66.42 -15.31 63.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.305 -0.872 . . . . 0.0 109.087 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 69.5 m -86.6 -7.94 57.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 108.883 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.7 20.9 64.93 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -106.98 138.26 43.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.273 -1.134 . . . . 0.0 109.114 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -65.62 124.32 22.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.257 -0.902 . . . . 0.0 109.754 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -143.71 165.09 28.61 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.396 -0.815 . . . . 0.0 109.704 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -106.51 137.83 43.8 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.353 -0.842 . . . . 0.0 109.371 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.8 tp -95.39 -11.03 28.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.192 -0.942 . . . . 0.0 109.988 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.497 ' CD ' ' N ' ' A' ' 79' ' ' ASN . 2.3 pp20? -61.35 -43.82 98.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.978 -1.076 . . . . 0.0 109.557 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 49.1 p30 -64.17 -20.43 66.0 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.096 -1.003 . . . . 0.0 108.856 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.54 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 84.7 tttt -88.95 -43.97 10.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.0 109.67 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.0 tp -133.35 123.24 25.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.423 -0.798 . . . . 0.0 109.305 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -79.3 85.25 5.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.117 -0.989 . . . . 0.0 109.409 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.7 mt -74.23 147.03 42.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.322 -0.861 . . . . 0.0 110.036 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 47.3 p -127.42 161.23 29.18 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.527 -0.733 . . . . 0.0 109.339 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 53.58 51.16 15.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.172 -0.955 . . . . 0.0 109.553 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.1 mt -79.05 130.61 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.075 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.7 mm -118.62 119.09 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.509 -0.744 . . . . 0.0 109.117 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 83.0 mtp -121.42 103.78 9.2 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.257 -0.902 . . . . 0.0 109.731 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -113.52 101.45 9.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.425 -0.797 . . . . 0.0 109.085 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -76.46 -32.89 58.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.03 -1.044 . . . . 0.0 110.471 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -59.45 -47.07 86.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.011 -1.055 . . . . 0.0 109.579 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -89.53 2.96 53.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.184 -0.947 . . . . 0.0 109.044 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 50.78 46.58 25.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.543 -0.723 . . . . 0.0 109.904 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.544 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.7 t -131.5 135.31 46.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.027 -1.046 . . . . 0.0 109.427 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -128.23 140.07 52.1 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.421 -0.799 . . . . 0.0 109.977 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.544 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 70.8 m-85 -135.68 147.25 48.46 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.167 -0.958 . . . . 0.0 109.319 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.8 t -146.11 143.48 29.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.116 -0.99 . . . . 0.0 109.115 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -99.35 133.15 44.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.235 -0.916 . . . . 0.0 109.355 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 100' ' ' PRO . 88.4 mt -92.0 139.08 24.39 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.486 -0.759 . . . . 0.0 109.763 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.481 ' O ' ' O ' ' A' ' 44' ' ' ALA . 77.7 Cg_exo -45.87 176.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.867 1.711 . . . . 0.0 111.118 178.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.2 m -86.03 -11.91 51.63 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.195 -0.941 . . . . 0.0 109.772 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.4 tp -138.66 130.5 27.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.107 -0.996 . . . . 0.0 110.536 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.412 HD11 HG23 ' A' ' 103' ' ' ILE . 96.8 mt -141.78 123.6 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.303 -0.873 . . . . 0.0 108.651 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.488 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 12.9 t -119.87 50.5 1.27 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.221 -0.924 . . . . 0.0 109.781 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.489 ' O ' ' OXT' ' A' ' 127' ' ' ALA . 87.8 m-20 -144.26 153.16 41.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.975 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -101.92 33.47 3.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.363 -0.836 . . . . 0.0 109.266 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.44 ' CB ' ' HZ3' ' A' ' 80' ' ' LYS . 15.1 p-90 -64.64 157.05 28.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.096 -1.002 . . . . 0.0 110.332 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -138.15 150.28 46.65 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.615 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 30.0 p90 -153.55 164.58 37.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.969 . . . . 0.0 108.785 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 11.8 p90 -155.11 161.83 41.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.803 -1.186 . . . . 0.0 111.783 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 98.7 m -126.09 157.15 38.76 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 59' ' ' GLU . 49.8 t -129.67 141.07 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.88 -1.137 . . . . 0.0 111.738 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 46.8 m -121.89 131.98 54.32 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 93.7 p -170.88 178.88 3.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.297 -1.502 . . . . 0.0 111.57 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.586 ' NZ ' ' OE1' ' A' ' 118' ' ' GLU . 26.1 mtmm -154.34 164.92 37.86 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.49 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 50.1 p30 -58.87 152.75 18.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.842 -1.161 . . . . 0.0 109.173 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.504 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 53.4 t-20 44.5 59.66 3.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.282 -0.886 . . . . 0.0 109.567 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.586 ' OE1' ' NZ ' ' A' ' 115' ' ' LYS . 41.2 mt-10 -164.97 145.44 7.32 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.158 -0.964 . . . . 0.0 110.241 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -63.58 135.74 57.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.871 . . . . 0.0 108.729 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.534 ' HE2' ' H ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -84.3 146.43 27.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.075 -1.016 . . . . 0.0 110.42 -179.405 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 57.2 mt -111.58 124.23 51.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.184 -0.948 . . . . 0.0 109.287 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 51.3 t -108.22 129.99 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.942 -1.099 . . . . 0.0 110.593 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -109.64 121.48 45.3 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.5 t -137.2 142.1 42.12 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.866 -1.146 . . . . 0.0 112.193 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.615 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.0 m -136.78 156.73 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -133.95 157.13 46.82 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.157 -0.965 . . . . 0.0 110.385 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.489 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.907 -1.044 . . . . 0.0 109.314 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.4 t -104.28 133.75 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.315 -0.866 . . . . 0.0 109.901 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -67.73 119.83 13.09 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.095 -1.003 . . . . 0.0 108.715 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.97 176.04 47.09 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.7 t -120.51 132.1 55.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.374 -1.074 . . . . 0.0 109.35 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.417 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 43.3 t0 -107.42 108.86 20.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.556 -0.715 . . . . 0.0 109.485 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -86.2 -0.92 56.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 108.929 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.3 m -101.81 -15.88 16.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.56 -0.712 . . . . 0.0 110.54 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 m -158.54 127.67 5.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.883 -1.136 . . . . 0.0 110.258 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.514 ' OG ' ' OE1' ' A' ' 12' ' ' GLU . 64.6 p -68.16 -24.1 64.94 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.911 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 57.0 mp0 -114.58 74.05 0.86 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.481 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 23.5 p -71.33 153.87 42.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.464 -0.772 . . . . 0.0 110.241 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.46 0.82 37.45 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.1 pt -124.05 -25.65 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.628 -0.67 . . . . 0.0 110.219 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.481 ' O ' ' OG ' ' A' ' 13' ' ' SER . 71.4 m-85 -113.13 139.4 48.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.168 -0.957 . . . . 0.0 110.012 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.6 p -69.37 -16.46 63.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.719 . . . . 0.0 110.766 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -135.05 146.1 48.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.956 -1.09 . . . . 0.0 110.847 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.417 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -163.01 173.37 39.2 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.41 -1.053 . . . . 0.0 109.564 -179.809 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.2 mm . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.6 t -117.86 126.5 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.362 -0.836 . . . . 0.0 110.383 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.427 ' O ' ' O ' ' A' ' 124' ' ' THR . 96.9 m -101.96 101.11 11.47 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.1 m -93.54 119.77 33.0 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.928 . . . . 0.0 109.624 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.6 m -139.88 139.48 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.498 -0.751 . . . . 0.0 109.238 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -82.22 127.41 33.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.117 -0.989 . . . . 0.0 109.301 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.01 154.79 17.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 109.45 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.712 ' HD1' ' H ' ' A' ' 45' ' ' ASN . 45.8 t-80 -128.32 152.62 47.93 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.385 -0.822 . . . . 0.0 109.593 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 100' ' ' PRO . . . -56.03 -25.61 45.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 109.766 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.712 ' H ' ' HD1' ' A' ' 43' ' ' HIS . 99.1 m-20 -97.14 -24.38 15.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 109.497 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -77.35 136.86 38.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.465 -0.772 . . . . 0.0 109.888 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.1 mt -79.6 149.18 31.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.933 . . . . 0.0 108.595 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.1 pt -120.83 142.35 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.11 -0.994 . . . . 0.0 110.086 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.13 -173.27 45.79 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -172.79 172.12 4.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.081 -1.246 . . . . 0.0 109.864 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -146.02 144.55 30.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.271 -0.893 . . . . 0.0 109.861 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 47.1 m -125.24 153.99 71.88 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.127 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.429 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.66 146.96 25.3 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.647 2.232 . . . . 0.0 112.027 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.3 t -68.4 -13.16 62.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.462 -0.773 . . . . 0.0 110.71 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.47 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 80.0 m-20 -90.37 -0.61 57.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.942 -1.099 . . . . 0.0 110.213 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.429 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 18.8 m-85 -109.5 164.03 12.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.216 -0.928 . . . . 0.0 110.207 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.4 133.88 48.54 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.416 -0.802 . . . . 0.0 108.984 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.544 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 3.2 m -91.47 112.95 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.994 -1.066 . . . . 0.0 110.508 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -121.42 129.53 25.19 Favored Pre-proline 0 N--CA 1.49 1.526 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.08 113.53 3.43 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.593 1.529 . . . . 0.0 112.243 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -88.96 -24.81 22.33 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.1 t0 -170.17 37.32 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.415 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 79.6 m -60.78 -154.05 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.628 -0.67 . . . . 0.0 109.696 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.1 p90 -110.14 -57.81 2.15 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.12 -0.987 . . . . 0.0 111.206 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 64' ' ' PHE . 6.2 t -46.68 -72.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.385 -1.447 . . . . 0.0 108.965 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.7 t -137.65 133.2 34.02 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.415 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.27 -178.75 2.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.986 -1.071 . . . . 0.0 110.483 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 6.3 m-85 -93.13 128.46 39.06 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -71.76 -173.69 1.03 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.076 -1.015 . . . . 0.0 109.724 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.67 -19.69 65.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.099 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.5 p -84.09 -9.17 58.81 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.365 -0.835 . . . . 0.0 108.92 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.97 19.69 58.94 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -105.2 140.59 38.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.319 -1.106 . . . . 0.0 109.075 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -74.12 123.0 23.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 110.167 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -155.31 132.2 10.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.93 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -61.76 146.18 50.2 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.171 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 tp -100.47 6.05 44.28 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.229 -0.919 . . . . 0.0 109.669 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.452 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.3 OUTLIER -72.57 -38.57 67.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.883 -1.136 . . . . 0.0 110.072 -179.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.94 -15.91 25.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.163 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -102.79 -35.2 8.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 109.312 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.7 tp -131.9 123.36 27.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -82.0 83.72 7.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.919 -1.113 . . . . 0.0 109.248 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.3 mt -76.86 140.99 40.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.061 -1.024 . . . . 0.0 110.144 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.4 p -128.32 158.07 39.23 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.509 -0.744 . . . . 0.0 109.303 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 54.74 50.14 16.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 0.0 109.656 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.7 mt -78.48 132.63 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 109.818 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.5 mm -116.02 118.3 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.43 -0.794 . . . . 0.0 109.386 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 41.7 mtp -124.72 109.8 13.57 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.146 -0.971 . . . . 0.0 109.804 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.68 101.85 9.71 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.365 -0.835 . . . . 0.0 108.839 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.485 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 52.1 m170 -70.02 -38.63 75.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.022 -1.049 . . . . 0.0 110.628 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -60.53 -45.39 94.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.971 -1.081 . . . . 0.0 109.513 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -86.19 -6.11 59.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 0.0 109.135 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.485 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.6 m-20 54.72 47.89 21.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.388 -0.82 . . . . 0.0 110.237 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.6 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 1.9 t -133.87 139.45 46.21 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.983 -1.073 . . . . 0.0 109.409 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -128.05 140.13 52.14 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.49 -0.756 . . . . 0.0 110.055 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.6 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 73.5 m-85 -136.32 146.64 46.82 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.261 -0.9 . . . . 0.0 109.249 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 64.0 m -149.6 151.66 34.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.072 -1.018 . . . . 0.0 109.223 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 -101.35 132.52 46.87 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.038 -1.039 . . . . 0.0 109.341 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.4 mt -90.51 137.45 27.34 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.379 -0.826 . . . . 0.0 109.599 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.466 ' O ' ' CB ' ' A' ' 44' ' ' ALA . 76.7 Cg_exo -46.24 163.89 0.1 OUTLIER 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.816 1.678 . . . . 0.0 111.296 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 93.4 p -73.68 -12.1 60.62 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.089 -1.007 . . . . 0.0 109.65 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.9 tp -137.31 130.27 30.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.086 -1.009 . . . . 0.0 110.609 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.2 mt -145.01 102.34 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.3 m -97.11 -6.51 34.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 0.0 109.847 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -83.69 154.74 23.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.999 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -105.55 33.35 3.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.35 -0.844 . . . . 0.0 109.241 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 23.6 p-90 -65.31 153.54 40.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.142 -0.974 . . . . 0.0 110.505 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -132.45 154.38 49.93 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.641 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 33.4 p90 -152.69 159.34 43.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.113 -0.992 . . . . 0.0 108.666 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 4.2 p90 -150.7 159.05 44.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.779 -1.2 . . . . 0.0 111.742 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 88.9 m -123.22 155.66 36.68 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.9 t -129.97 141.97 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.759 -1.213 . . . . 0.0 111.768 -178.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 76.3 m -120.49 131.39 54.7 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.9 p -169.56 171.84 7.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.272 -1.518 . . . . 0.0 111.653 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.47 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 51.9 mttm -148.59 165.23 31.88 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 54.4 p-10 -57.62 150.48 19.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.854 -1.154 . . . . 0.0 109.067 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 116' ' ' ASP . 64.3 t30 42.71 60.62 2.36 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.203 -0.935 . . . . 0.0 109.763 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 44.6 mt-10 -161.74 141.8 10.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.221 -0.924 . . . . 0.0 110.305 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -54.58 147.07 14.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.161 -0.962 . . . . 0.0 108.953 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.7 pttt -98.81 140.44 33.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.211 -0.93 . . . . 0.0 110.36 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.7 mt -111.27 124.51 52.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.567 -0.708 . . . . 0.0 109.251 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.4 t -109.56 130.72 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.947 -1.095 . . . . 0.0 110.469 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -109.33 121.76 45.88 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 38' ' ' CYS . 7.2 t -136.97 141.81 42.6 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.927 -1.108 . . . . 0.0 112.123 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -135.74 159.1 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -123.58 142.91 50.58 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.129 -0.982 . . . . 0.0 110.389 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.319 179.748 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.6 mttp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.0 t -86.2 135.78 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.915 . . . . 0.0 110.031 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -71.05 129.51 39.15 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.571 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 168.11 -163.25 37.0 Favored Glycine 0 N--CA 1.483 1.798 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.98 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -129.08 135.09 48.44 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.461 -1.023 . . . . 0.0 109.779 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -114.51 109.41 18.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.447 -0.783 . . . . 0.0 109.302 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -89.23 3.26 52.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.161 -0.962 . . . . 0.0 108.807 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.6 m -98.21 -20.7 17.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.409 -0.807 . . . . 0.0 110.586 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.2 m -156.65 126.64 6.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.881 -1.137 . . . . 0.0 110.263 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 t -59.08 -31.88 69.29 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -112.64 73.89 0.84 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -66.62 148.57 51.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.34 -0.85 . . . . 0.0 110.29 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.6 t -98.35 0.55 45.67 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.6 pt -123.86 -20.73 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.658 -0.651 . . . . 0.0 110.243 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.448 ' CZ ' ' N ' ' A' ' 50' ' ' PHE . 56.6 m-85 -119.59 137.81 53.62 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.304 -0.872 . . . . 0.0 109.999 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.1 t -65.99 -16.81 64.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.635 -0.666 . . . . 0.0 110.819 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -132.71 144.11 50.07 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.04 -1.038 . . . . 0.0 110.68 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -159.38 171.72 35.9 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.382 -1.07 . . . . 0.0 109.682 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.458 HD12 HG22 ' A' ' 36' ' ' ILE . 46.1 mm . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.8 t -116.21 128.33 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.469 -0.77 . . . . 0.0 110.13 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 74.8 m -101.99 101.82 12.27 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.5 m -93.61 119.84 33.14 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.266 -0.896 . . . . 0.0 109.673 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.0 m -141.12 153.77 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.544 -0.723 . . . . 0.0 109.12 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -99.79 134.95 41.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.989 -1.069 . . . . 0.0 109.488 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.68 159.58 14.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.324 -0.86 . . . . 0.0 109.549 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -133.11 150.88 52.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.908 . . . . 0.0 109.445 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.98 -23.95 5.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.256 -0.903 . . . . 0.0 109.805 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -104.03 -25.87 12.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -0.925 . . . . 0.0 109.732 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -73.03 134.58 44.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.324 -0.86 . . . . 0.0 109.954 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -80.42 147.93 30.77 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.9 pt -120.34 142.31 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.219 -0.926 . . . . 0.0 110.128 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.58 -172.65 45.39 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.448 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 45.7 p90 -172.42 172.08 4.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.965 -1.314 . . . . 0.0 109.724 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -146.15 144.82 30.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.207 -0.933 . . . . 0.0 109.864 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 85.3 m -123.2 151.94 62.97 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.4 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.45 146.95 23.8 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.287 1.992 . . . . 0.0 111.929 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.3 t -68.47 -13.21 62.15 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.463 -0.773 . . . . 0.0 110.838 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -91.24 -1.48 57.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.935 -1.103 . . . . 0.0 110.324 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.4 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 20.0 m-85 -108.95 164.36 12.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.251 -0.906 . . . . 0.0 110.422 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.9 t -104.72 134.95 47.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.35 -0.844 . . . . 0.0 108.996 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.474 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.8 m -90.44 123.36 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.958 -1.089 . . . . 0.0 110.223 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 112' ' ' VAL . 26.3 mt-10 -127.81 126.22 23.82 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.06 114.32 3.57 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 121.688 1.592 . . . . 0.0 112.16 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 68' ' ' PHE . 7.3 t-160 -93.07 -24.84 18.17 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.6 t0 -170.21 39.76 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 98.6 m -63.02 -153.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.44 -0.788 . . . . 0.0 109.733 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.9 p90 -111.17 -56.42 2.37 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.246 -0.909 . . . . 0.0 111.359 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' ' 64' ' ' PHE . 16.2 t -48.51 -72.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.362 -1.461 . . . . 0.0 108.848 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.3 t -138.89 131.29 28.58 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -173.42 -179.42 1.88 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.999 -1.063 . . . . 0.0 110.483 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 6.2 m-85 -93.45 127.65 39.18 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -73.95 -172.36 1.31 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.115 -0.99 . . . . 0.0 109.671 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.8 mt -63.62 -22.53 66.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 109.122 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.0 p -82.5 -7.41 59.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 108.875 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.93 18.47 67.53 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -101.48 140.72 35.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.253 -1.145 . . . . 0.0 108.989 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -80.6 115.9 20.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.297 -0.877 . . . . 0.0 110.133 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -152.65 139.64 19.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 109.767 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -63.3 148.56 47.94 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.156 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.0 tp -97.59 7.94 45.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.306 -0.871 . . . . 0.0 109.817 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -68.65 -40.47 80.2 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.845 -1.159 . . . . 0.0 110.049 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 79' ' ' ASN . 52.0 t-20 -62.39 -33.99 75.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.019 -1.051 . . . . 0.0 109.108 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -74.42 -48.87 25.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.888 . . . . 0.0 109.56 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.5 tp -139.29 124.74 19.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.459 -0.776 . . . . 0.0 109.161 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -81.19 90.13 6.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.046 -1.033 . . . . 0.0 109.734 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.2 mt -75.26 149.96 38.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 109.972 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.9 p -127.24 159.97 32.72 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.469 -0.769 . . . . 0.0 109.203 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.725 HD21 HH11 ' A' ' 98' ' ' ARG . 82.3 m-20 55.69 52.77 10.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.92 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -81.77 132.98 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.379 -0.826 . . . . 0.0 110.009 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.3 mm -122.48 122.65 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.521 -0.737 . . . . 0.0 109.21 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 91.0 mtp -122.24 102.91 8.41 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.154 -0.966 . . . . 0.0 109.757 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -111.98 100.62 9.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.304 -0.873 . . . . 0.0 109.037 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.491 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 76.3 m80 -73.28 -35.02 66.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.002 -1.061 . . . . 0.0 110.64 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -60.67 -46.59 89.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.009 -1.057 . . . . 0.0 109.646 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -88.48 -3.89 58.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.138 -0.976 . . . . 0.0 109.07 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 97.3 m-20 54.57 47.28 23.04 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 0.0 110.144 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.594 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 2.3 t -132.65 138.0 47.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.229 -0.919 . . . . 0.0 109.36 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -127.91 139.71 52.44 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.392 -0.818 . . . . 0.0 110.103 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.594 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 58.3 m-85 -136.2 146.88 47.3 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.279 -0.888 . . . . 0.0 109.245 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.4 t -151.46 152.92 33.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.978 . . . . 0.0 109.143 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.725 HH11 HD21 ' A' ' 85' ' ' ASN . 53.9 mtp180 -108.37 137.43 46.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.341 -0.849 . . . . 0.0 109.36 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.8 mt -93.24 141.1 23.57 Favored Pre-proline 0 N--CA 1.491 1.624 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.603 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -46.54 159.49 0.29 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.781 1.654 . . . . 0.0 111.206 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.2 p -68.71 -16.52 63.84 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.254 -0.904 . . . . 0.0 109.772 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.2 tp -123.37 131.44 53.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.408 -0.808 . . . . 0.0 110.502 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 64.6 mt -143.07 126.03 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.4 m -139.16 52.99 1.75 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.955 -1.091 . . . . 0.0 109.782 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.519 ' O ' ' OXT' ' A' ' 127' ' ' ALA . 54.6 t0 -145.99 153.33 40.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.957 . . . . 0.0 110.026 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.491 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 99.0 m-20 -91.93 33.03 1.07 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.39 -0.819 . . . . 0.0 108.912 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.432 ' CD1' ' OXT' ' A' ' 127' ' ' ALA . 7.8 p-90 -64.57 154.33 36.53 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.135 -0.978 . . . . 0.0 110.494 -178.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.559 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 53.7 tttp -145.39 151.42 38.23 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.611 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 30.2 p90 -155.45 164.48 38.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.077 -1.014 . . . . 0.0 108.621 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 8.0 p90 -154.63 159.07 40.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.717 -1.239 . . . . 0.0 111.861 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 80.7 m -123.25 156.24 35.59 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 59' ' ' GLU . 46.4 t -129.3 141.21 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 120.874 -1.141 . . . . 0.0 111.693 -178.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 35.1 m -122.25 131.73 54.07 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.0 p -172.12 179.04 2.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.243 -1.536 . . . . 0.0 111.565 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.504 ' CB ' ' HZ2' ' A' ' 115' ' ' LYS . 6.3 mtmp? -153.09 167.32 29.63 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 117' ' ' ASN . 99.9 m-20 -58.84 152.14 19.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.782 -1.199 . . . . 0.0 109.001 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.461 ' C ' ' O ' ' A' ' 116' ' ' ASP . 56.8 t-20 39.77 59.53 1.86 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.462 -0.774 . . . . 0.0 109.683 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 54.0 mm-40 -158.46 139.9 13.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.374 -0.829 . . . . 0.0 110.551 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -52.98 140.43 24.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 0.0 108.873 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -92.88 139.12 30.86 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.462 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.3 mt -110.04 122.77 48.35 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.6 t -107.25 129.47 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.049 -1.032 . . . . 0.0 110.625 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -106.95 119.07 38.35 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.559 ' OG1' ' NZ ' ' A' ' 108' ' ' LYS . 6.3 t -136.11 140.21 43.54 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.997 -1.064 . . . . 0.0 112.119 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.611 ' CG2' ' CE2' ' A' ' 109' ' ' PHE . 3.0 m -136.06 156.81 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -136.18 155.47 50.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.088 -1.007 . . . . 0.0 110.291 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.519 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.355 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.526 ' CB ' ' HG ' ' A' ' 17' ' ' SER . 98.8 mttt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.7 t -95.19 134.88 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.279 -0.888 . . . . 0.0 110.061 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -68.96 123.09 20.07 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.017 -1.052 . . . . 0.0 108.617 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.54 179.66 47.83 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.9 t -119.15 130.04 55.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.523 -0.986 . . . . 0.0 109.318 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -106.3 109.12 20.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.572 -0.705 . . . . 0.0 109.326 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -89.62 1.51 55.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.322 -0.861 . . . . 0.0 108.939 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.3 m -103.29 -17.03 15.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.477 -0.765 . . . . 0.0 110.514 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.8 m -156.93 126.02 5.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.814 -1.179 . . . . 0.0 110.387 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.6 t -64.1 -28.19 69.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.37 -0.831 . . . . 0.0 108.937 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -112.68 73.77 0.83 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.1 t -68.15 150.43 48.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.806 . . . . 0.0 110.211 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.52 -0.08 41.34 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 pt -125.14 -22.03 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.712 -0.618 . . . . 0.0 110.312 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -114.19 141.47 47.48 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.279 -0.888 . . . . 0.0 110.156 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.526 ' HG ' ' CB ' ' A' ' 2' ' ' LYS . 5.9 m -74.98 -18.8 60.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.552 -0.718 . . . . 0.0 110.894 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.55 ' NZ ' ' CE1' ' A' ' 20' ' ' TYR . 61.5 tttm -129.43 140.22 51.39 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.018 -1.051 . . . . 0.0 110.577 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.98 164.88 32.49 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.55 ' CE1' ' NZ ' ' A' ' 18' ' ' LYS . 36.5 m-85 . . . . . 0 N--CA 1.495 1.795 0 O-C-N 121.446 -1.032 . . . . 0.0 109.745 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.456 HG22 HD12 ' A' ' 36' ' ' ILE . 21.7 mm . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.4 t -115.33 124.48 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 110.147 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 71.3 m -102.64 101.97 12.14 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.6 m -95.81 121.13 37.21 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.164 -0.96 . . . . 0.0 109.693 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.8 m -141.04 153.91 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.578 -0.701 . . . . 0.0 109.218 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -97.99 133.96 41.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.008 -1.058 . . . . 0.0 109.37 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.81 160.57 14.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 0.0 109.641 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -135.28 151.88 50.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.327 -0.858 . . . . 0.0 109.487 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.77 -25.23 7.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 109.635 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -101.48 -27.04 13.35 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.291 -0.881 . . . . 0.0 109.817 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -73.64 134.4 43.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.298 -0.876 . . . . 0.0 109.989 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.92 148.31 31.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 108.545 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.5 pt -120.4 141.5 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.24 -0.913 . . . . 0.0 109.969 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' A' ' 95' ' ' PHE . . . 176.86 -173.28 46.18 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -171.66 173.05 4.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.001 -1.293 . . . . 0.0 109.791 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -146.05 144.78 30.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 0.0 109.892 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 80.0 m -123.79 152.45 65.96 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.405 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.53 148.33 20.77 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.28 1.987 . . . . 0.0 112.005 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.4 m -71.5 -12.96 61.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.431 -0.793 . . . . 0.0 110.647 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -91.84 1.9 56.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.016 -1.053 . . . . 0.0 110.119 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.446 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 18.1 m-85 -110.09 165.26 11.88 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.266 -0.896 . . . . 0.0 110.354 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.5 t -102.92 139.75 38.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 109.012 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.448 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.6 m -97.92 125.86 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.991 -1.068 . . . . 0.0 110.199 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -132.14 129.86 21.85 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.3 113.12 3.32 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.664 1.576 . . . . 0.0 112.095 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -92.01 -27.98 17.48 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -166.81 38.42 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.587 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 79.0 m -62.85 -157.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.544 -0.722 . . . . 0.0 109.77 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.2 p90 -111.27 -49.07 3.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.226 -0.921 . . . . 0.0 111.629 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.6 t -59.22 -48.45 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.343 -1.473 . . . . 0.0 109.286 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.5 t -157.78 128.73 6.53 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.587 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.7 -178.93 1.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.092 -1.005 . . . . 0.0 110.499 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 9.9 m-85 -93.1 124.75 37.3 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -69.28 -174.91 0.71 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.011 . . . . 0.0 109.847 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.404 HD23 ' HZ2' ' A' ' 108' ' ' LYS . 54.5 mt -62.92 -23.01 67.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.316 -0.865 . . . . 0.0 108.95 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.8 m -82.36 -6.34 59.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.327 -0.858 . . . . 0.0 108.761 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.18 19.88 63.88 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -101.71 138.95 38.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.318 -1.107 . . . . 0.0 109.101 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -82.46 110.25 17.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.21 -0.931 . . . . 0.0 109.964 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -147.01 141.91 26.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.499 -0.751 . . . . 0.0 110.011 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -59.86 144.02 49.78 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.274 -0.891 . . . . 0.0 109.32 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.3 tp -97.09 8.03 45.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.202 -0.936 . . . . 0.0 109.735 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -69.67 -38.74 77.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.179 -0.951 . . . . 0.0 110.065 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 41.7 p-10 -62.43 -32.85 73.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.125 -0.984 . . . . 0.0 109.217 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.555 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 37.3 ttmt -71.86 -50.79 26.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.345 -0.847 . . . . 0.0 109.663 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 39.0 tp -140.74 128.2 21.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.479 -0.763 . . . . 0.0 109.166 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -81.05 87.73 6.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.035 -1.041 . . . . 0.0 109.487 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.7 mt -71.66 152.99 42.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 0.0 109.928 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.6 p -128.19 163.92 23.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.562 -0.711 . . . . 0.0 109.323 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 55.44 52.24 11.59 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.265 -0.897 . . . . 0.0 109.94 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.45 128.26 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.337 -0.852 . . . . 0.0 109.985 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.1 mm -123.47 122.44 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.554 -0.716 . . . . 0.0 109.136 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 83.2 mtp -123.59 104.81 9.26 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.197 -0.94 . . . . 0.0 109.793 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -113.37 101.85 9.78 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.342 -0.849 . . . . 0.0 109.013 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.487 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 96.6 m-70 -73.14 -36.14 66.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.97 -1.081 . . . . 0.0 110.652 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -60.21 -46.32 90.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.891 -1.131 . . . . 0.0 109.623 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -89.79 -5.09 57.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.172 -0.955 . . . . 0.0 109.032 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.487 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.6 m-20 54.66 47.66 22.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.551 -0.718 . . . . 0.0 110.25 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.593 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 2.5 t -131.94 135.8 46.88 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.21 -0.931 . . . . 0.0 109.291 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.416 ' O ' ' CA ' ' A' ' 49' ' ' GLY . 76.0 m-85 -126.63 139.28 53.29 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.388 -0.82 . . . . 0.0 109.951 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.593 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 72.3 m-85 -136.15 147.3 47.66 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.349 -0.844 . . . . 0.0 109.264 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.5 t -152.9 152.59 31.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.063 -1.023 . . . . 0.0 109.189 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -107.41 139.29 42.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.26 -0.9 . . . . 0.0 109.856 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 100' ' ' PRO . 38.2 mt -94.88 141.47 23.35 Favored Pre-proline 0 N--CA 1.49 1.548 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.853 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 99' ' ' LEU . 77.3 Cg_exo -45.9 179.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.912 1.741 . . . . 0.0 111.162 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.7 m -86.08 -14.17 45.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.088 -1.008 . . . . 0.0 110.001 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.7 tp -120.99 130.22 53.72 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.276 -0.89 . . . . 0.0 110.442 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 7.6 mt -150.23 102.38 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 84.2 p -115.49 -0.69 13.0 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.168 -0.957 . . . . 0.0 109.748 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 52.4 t0 -87.38 158.01 19.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.564 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 92.9 m-20 -99.42 32.2 2.86 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.451 -0.781 . . . . 0.0 109.071 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 10.3 p-90 -65.97 157.18 31.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.145 -0.972 . . . . 0.0 110.509 -178.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.404 ' HZ2' HD23 ' A' ' 70' ' ' LEU . 22.4 pttp -146.4 157.96 43.83 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.568 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 39.6 p90 -155.68 163.54 39.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.155 -0.966 . . . . 0.0 108.718 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -153.73 163.07 40.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.83 -1.169 . . . . 0.0 111.877 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 95.1 m -127.73 158.93 36.3 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.0 t -130.44 143.34 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.93 -1.106 . . . . 0.0 111.856 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 86.1 m -124.8 132.92 53.3 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.0 p -171.49 179.14 2.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.306 -1.496 . . . . 0.0 111.669 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.58 ' NZ ' ' OE2' ' A' ' 118' ' ' GLU . 6.4 mtmp? -153.09 166.15 33.36 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.62 151.7 20.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.867 -1.146 . . . . 0.0 109.245 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.49 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 64.8 t30 44.7 61.2 2.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.219 -0.926 . . . . 0.0 109.667 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.58 ' OE2' ' NZ ' ' A' ' 115' ' ' LYS . 42.5 mt-10 -164.61 145.38 7.85 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.226 -0.921 . . . . 0.0 110.26 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -60.47 146.79 43.45 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.228 -0.92 . . . . 0.0 108.937 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -93.72 141.71 28.18 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.111 -0.993 . . . . 0.0 110.394 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.1 mt -108.84 121.0 44.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.313 -0.867 . . . . 0.0 108.899 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.4 t -108.96 130.3 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.092 -1.005 . . . . 0.0 110.577 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -110.65 122.65 48.3 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.0 t -137.68 143.94 41.56 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.029 -1.044 . . . . 0.0 112.378 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.568 ' CG2' ' CE2' ' A' ' 109' ' ' PHE . 3.0 m -135.42 158.77 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -136.83 153.91 50.66 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.058 -1.026 . . . . 0.0 110.282 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.512 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.354 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.6 t -95.06 133.36 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.97 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.416 ' N ' ' CD ' ' A' ' 4' ' ' LYS . 13.6 mptt -70.59 125.18 26.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.104 -0.998 . . . . 0.0 108.663 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.21 -179.95 42.71 Favored Glycine 0 N--CA 1.484 1.844 0 C-N-CA 119.479 -1.343 . . . . 0.0 109.79 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.9 t -116.92 134.72 54.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.402 -1.057 . . . . 0.0 109.712 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.683 ' CB ' ' HG ' ' A' ' 13' ' ' SER . 68.1 t0 -115.81 110.66 19.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.499 -0.751 . . . . 0.0 109.332 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -87.17 3.26 47.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.94 . . . . 0.0 108.916 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.4 m -102.96 -18.85 14.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.434 -0.791 . . . . 0.0 110.549 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.4 m -157.42 127.52 6.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.887 -1.133 . . . . 0.0 110.289 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.3 m -66.49 -27.0 67.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.408 -0.807 . . . . 0.0 109.001 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.583 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 57.9 mp0 -113.81 74.87 0.89 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.683 ' HG ' ' CB ' ' A' ' 7' ' ' ASP . 26.6 m -75.97 115.87 16.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.423 -0.798 . . . . 0.0 110.578 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.7 t -65.39 3.2 0.71 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.555 ' H ' ' C ' ' A' ' 13' ' ' SER . 15.1 pt -122.83 -36.57 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.712 -0.618 . . . . 0.0 110.333 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.416 ' CZ ' ' CE1' ' A' ' 96' ' ' TYR . 50.9 m-85 -108.21 137.11 46.75 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.185 -0.947 . . . . 0.0 109.816 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.2 t -68.28 -18.4 64.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.593 -0.692 . . . . 0.0 111.003 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -130.58 141.42 50.46 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.953 -1.092 . . . . 0.0 110.521 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.449 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -161.83 173.55 38.2 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.38 -1.07 . . . . 0.0 109.568 -179.859 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 36' ' ' ILE . 40.2 mm . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 50.0 t -121.03 129.62 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.303 -0.873 . . . . 0.0 110.157 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 124' ' ' THR . 84.5 m -101.26 100.12 10.59 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.8 m -95.53 120.64 36.13 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.089 -1.007 . . . . 0.0 109.412 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 m -139.05 159.44 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.526 -0.734 . . . . 0.0 109.176 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -97.77 123.71 41.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.151 -0.968 . . . . 0.0 109.594 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.55 155.03 19.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -0.87 . . . . 0.0 109.531 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.735 ' HD1' ' H ' ' A' ' 45' ' ' ASN . 35.4 t-80 -133.33 152.13 51.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -0.898 . . . . 0.0 109.553 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.34 -29.61 64.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.335 -0.853 . . . . 0.0 109.827 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.735 ' H ' ' HD1' ' A' ' 43' ' ' HIS . 49.3 t30 -93.6 -26.89 16.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 109.725 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -76.68 135.6 39.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.523 -0.735 . . . . 0.0 110.043 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.1 mt -78.36 148.64 33.63 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.5 pt -122.36 144.83 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.331 -0.856 . . . . 0.0 110.308 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.5 -171.2 44.16 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -172.73 171.57 4.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.136 -1.214 . . . . 0.0 109.71 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -146.82 144.84 29.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 0.0 109.9 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 86.0 m -125.37 152.17 70.96 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.929 . . . . 0.0 108.54 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.447 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.4 Cg_endo -51.63 149.82 17.9 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.3 2.0 . . . . 0.0 111.944 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.0 m -70.84 -12.1 61.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -0.83 . . . . 0.0 110.682 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.448 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 82.4 m-20 -92.78 0.23 57.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.94 -1.1 . . . . 0.0 110.182 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.447 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 16.3 m-85 -108.28 164.2 12.53 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.202 -0.936 . . . . 0.0 110.364 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.9 m -103.85 128.08 51.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 109.087 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.537 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 3.2 m -88.3 114.38 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.959 -1.088 . . . . 0.0 110.151 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -120.37 126.8 26.62 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.06 113.53 3.43 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 121.545 1.496 . . . . 0.0 112.106 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.491 ' O ' ' O ' ' A' ' 68' ' ' PHE . 2.8 t-80 -93.59 -23.63 18.23 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -172.26 51.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.647 ' H ' ' CB ' ' A' ' 67' ' ' ALA . 76.4 m -76.47 -151.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.63 -0.668 . . . . 0.0 109.799 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 6.5 p90 -110.18 -58.33 2.08 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.098 -1.001 . . . . 0.0 111.373 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.454 ' C ' ' O ' ' A' ' 64' ' ' PHE . 24.0 t -45.27 -70.35 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.627 -1.296 . . . . 0.0 108.809 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.4 t -145.58 129.36 17.23 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.647 ' CB ' ' H ' ' A' ' 63' ' ' CYS . . . -167.84 -179.78 4.38 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.373 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.3 m-85 -93.98 141.2 28.79 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.656 HD22 ' CB ' ' A' ' 75' ' ' GLU . 75.8 m-20 -80.88 -169.7 2.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.955 -1.091 . . . . 0.0 109.652 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.2 mp -67.91 -13.8 62.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 108.913 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.4 t -90.73 -7.14 53.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -0.856 . . . . 0.0 108.982 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.07 23.87 56.26 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -107.73 136.44 47.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.213 -1.169 . . . . 0.0 109.095 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -67.42 135.02 52.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.216 -0.927 . . . . 0.0 109.984 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.656 ' CB ' HD22 ' A' ' 69' ' ' ASN . 80.3 tt0 -155.42 166.0 34.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.437 -0.789 . . . . 0.0 109.548 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.437 ' N ' ' HG2' ' A' ' 75' ' ' GLU . 5.3 m120 -106.94 139.1 41.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.33 -0.856 . . . . 0.0 109.531 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.7 tp -95.79 -10.27 29.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.0 . . . . 0.0 110.027 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.481 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 20.5 pt-20 -62.67 -44.86 95.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.99 -1.069 . . . . 0.0 109.476 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.563 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 48.7 p30 -66.72 -22.09 66.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.138 -0.976 . . . . 0.0 108.94 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.563 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 52.6 tptt -86.74 -48.09 8.55 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.359 -0.838 . . . . 0.0 109.415 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.403 HD22 ' CZ2' ' A' ' 107' ' ' TRP . 30.8 tp -122.89 129.95 52.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.412 -0.805 . . . . 0.0 109.174 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -78.66 82.68 4.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.032 -1.043 . . . . 0.0 109.244 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.8 mt -81.53 137.69 35.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.873 . . . . 0.0 110.112 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 48.1 p -127.44 163.31 24.36 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.513 -0.742 . . . . 0.0 109.278 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.511 HD21 ' NE ' ' A' ' 98' ' ' ARG . 97.8 m-20 55.04 51.05 14.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.623 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.2 131.53 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.353 -0.842 . . . . 0.0 110.039 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.425 HG22 HD13 ' A' ' 87' ' ' ILE . 45.6 mm -121.85 121.17 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.503 -0.748 . . . . 0.0 109.277 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 79.6 mtp -123.73 107.4 11.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.21 -0.931 . . . . 0.0 109.785 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -112.57 101.27 9.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.374 -0.829 . . . . 0.0 109.082 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.448 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 76.4 m80 -71.55 -36.8 71.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.917 -1.114 . . . . 0.0 110.651 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -60.61 -45.74 92.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.022 -1.049 . . . . 0.0 109.557 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -87.91 -5.28 58.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.117 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 99.7 m-20 54.37 47.61 22.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.504 -0.747 . . . . 0.0 110.332 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.606 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 2.6 t -132.99 138.19 46.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.028 -1.045 . . . . 0.0 109.333 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -126.38 138.9 53.61 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.512 -0.742 . . . . 0.0 109.809 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.606 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 77.9 m-85 -135.41 146.15 48.0 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.115 -0.991 . . . . 0.0 109.336 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.5 p -153.03 155.69 37.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.097 -1.002 . . . . 0.0 108.986 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.511 ' NE ' HD21 ' A' ' 85' ' ' ASN . 59.2 mtt-85 -105.11 136.68 44.16 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.264 -0.897 . . . . 0.0 109.65 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 100' ' ' PRO . 78.1 mt -91.83 138.41 24.91 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.459 -0.776 . . . . 0.0 109.706 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 99' ' ' LEU . 76.4 Cg_exo -45.74 175.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.83 1.686 . . . . 0.0 111.305 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.6 m -83.92 -12.93 54.66 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.077 -1.014 . . . . 0.0 109.844 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.3 tp -134.13 130.0 36.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.131 -0.981 . . . . 0.0 110.511 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 91.3 mt -147.37 102.48 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.865 . . . . 0.0 108.806 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.3 m -104.1 -6.96 20.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.072 -1.017 . . . . 0.0 109.794 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 127' ' ' ALA . 78.6 m-20 -78.41 151.65 32.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 110.022 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -100.15 31.79 3.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.391 -0.818 . . . . 0.0 109.205 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.403 ' CZ2' HD22 ' A' ' 81' ' ' LEU . 20.4 p-90 -65.4 159.88 23.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.117 -0.99 . . . . 0.0 110.465 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -142.23 156.97 45.34 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.643 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 36.4 p90 -154.08 158.62 40.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.088 -1.007 . . . . 0.0 108.692 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 18.5 p90 -150.66 156.33 41.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.804 -1.185 . . . . 0.0 111.937 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 96.5 m -121.78 156.19 33.71 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -127.71 138.43 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.77 -1.206 . . . . 0.0 111.872 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 67.0 m -123.34 132.0 53.84 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 97.5 p -165.6 171.5 13.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.121 -1.612 . . . . 0.0 111.652 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.448 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 47.6 mtpt -136.87 158.58 44.14 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -60.29 143.21 53.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.933 -1.105 . . . . 0.0 108.813 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.513 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 59.6 t-20 49.82 62.63 2.55 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.395 -0.816 . . . . 0.0 109.09 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 63.3 mm-40 -165.11 149.66 9.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.177 -0.952 . . . . 0.0 110.71 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -55.18 136.92 48.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.251 -0.905 . . . . 0.0 108.974 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -88.41 140.41 29.5 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.18 -0.95 . . . . 0.0 110.322 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 70.8 mt -109.16 122.03 46.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.432 -0.793 . . . . 0.0 109.136 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.2 t -111.02 131.36 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.075 -1.016 . . . . 0.0 110.492 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -107.58 118.59 37.12 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 38' ' ' CYS . 7.3 t -136.6 141.43 43.27 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.868 -1.145 . . . . 0.0 111.967 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.643 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 2.8 m -137.37 160.34 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -128.81 149.04 50.9 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.094 -1.004 . . . . 0.0 110.264 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.353 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.8 t -95.32 135.36 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.324 -0.86 . . . . 0.0 109.89 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -67.99 121.31 15.81 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.0 108.6 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.71 175.04 45.45 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.425 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 5.0 t -116.08 130.02 56.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.415 -1.05 . . . . 0.0 109.465 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -104.82 108.51 20.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.533 -0.729 . . . . 0.0 109.214 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -89.29 0.24 56.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.889 . . . . 0.0 108.93 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.4 m -102.33 -17.17 16.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.568 -0.707 . . . . 0.0 110.414 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.0 m -156.87 126.7 6.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.801 -1.187 . . . . 0.0 110.229 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.2 p -64.06 -27.63 69.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 108.858 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -114.77 76.87 1.02 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 88.1 p -71.75 153.37 42.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.395 -0.815 . . . . 0.0 110.224 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.15 1.1 35.72 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.6 pt -123.61 -24.03 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.632 -0.667 . . . . 0.0 110.29 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.507 ' O ' ' OG ' ' A' ' 13' ' ' SER . 63.3 m-85 -114.91 140.87 48.63 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.093 -1.005 . . . . 0.0 110.093 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.1 p -69.04 -17.81 63.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.403 -0.811 . . . . 0.0 110.614 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -129.58 139.86 51.36 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.921 -1.112 . . . . 0.0 110.458 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.37 162.95 29.43 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.425 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 36.5 m-85 . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.371 -1.076 . . . . 0.0 109.568 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 mm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.1 t -123.29 129.17 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.364 -0.835 . . . . 0.0 110.31 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 85.1 m -102.08 101.61 11.98 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.4 m -97.03 122.31 39.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.057 -1.027 . . . . 0.0 109.649 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.0 m -138.91 158.02 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.437 -0.789 . . . . 0.0 109.079 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -97.06 119.95 36.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.135 -0.978 . . . . 0.0 109.517 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.41 156.43 17.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.362 -0.836 . . . . 0.0 109.592 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -131.26 152.37 50.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.464 ' CB ' ' O ' ' A' ' 100' ' ' PRO . . . -56.02 -26.18 47.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.282 -0.886 . . . . 0.0 109.797 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -99.06 -24.75 14.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -0.95 . . . . 0.0 109.626 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -74.67 137.17 42.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.512 -0.743 . . . . 0.0 110.002 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.9 mt -78.83 146.53 33.64 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 48' ' ' ILE . 45.4 pt -121.83 144.3 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.095 -1.003 . . . . 0.0 110.28 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.17 -173.46 46.26 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -171.18 170.94 5.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.038 -1.272 . . . . 0.0 109.794 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -147.04 145.44 29.68 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.343 -0.848 . . . . 0.0 109.864 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 86.4 m -125.22 151.4 69.45 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 108.815 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.449 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.48 154.1 9.3 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.43 2.086 . . . . 0.0 111.977 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.7 m -72.24 -10.5 59.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.496 -0.753 . . . . 0.0 110.711 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.536 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 78.7 m-20 -93.29 -3.68 53.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.95 -1.094 . . . . 0.0 110.245 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.449 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 15.4 m-85 -105.92 160.63 15.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.246 -0.909 . . . . 0.0 110.08 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -101.33 132.69 46.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.47 -0.768 . . . . 0.0 109.328 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.511 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.6 m -88.59 118.31 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.109 -0.994 . . . . 0.0 110.219 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -126.93 127.04 24.47 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.13 113.51 3.42 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 121.631 1.554 . . . . 0.0 112.131 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.484 ' O ' ' O ' ' A' ' 68' ' ' PHE . 9.6 t-160 -91.4 -25.57 19.29 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.475 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.3 t0 -169.48 38.94 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.422 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 81.8 m -62.56 -154.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.601 -0.687 . . . . 0.0 109.717 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.1 p90 -109.96 -59.28 1.95 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.061 -1.024 . . . . 0.0 111.359 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.464 ' C ' ' O ' ' A' ' 64' ' ' PHE . 25.3 t -44.75 -73.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.67 -1.269 . . . . 0.0 108.788 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.0 t -138.2 131.13 29.84 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.422 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -171.98 179.1 2.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.876 -1.14 . . . . 0.0 110.458 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 5.2 m-85 -93.84 126.18 38.89 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -71.74 -170.79 0.59 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.976 -1.078 . . . . 0.0 109.823 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.401 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 10.8 mp -65.07 -19.72 66.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.191 -0.943 . . . . 0.0 109.038 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.6 m -83.49 -7.97 59.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.343 -0.848 . . . . 0.0 108.843 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.5 19.15 66.9 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -103.79 137.05 42.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.342 -1.093 . . . . 0.0 109.139 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -76.38 113.85 14.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.279 -0.888 . . . . 0.0 110.073 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -144.56 131.56 20.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.333 -0.855 . . . . 0.0 110.04 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -59.98 145.18 47.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.145 -0.972 . . . . 0.0 109.303 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.3 tp -100.2 -0.9 37.82 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.588 -0.695 . . . . 0.0 110.088 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -67.03 -42.35 85.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.222 -0.924 . . . . 0.0 109.85 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -63.77 -21.94 66.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.995 . . . . 0.0 109.023 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -86.86 -46.82 9.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.46 -0.775 . . . . 0.0 109.342 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.8 tp -124.62 127.89 48.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.492 -0.755 . . . . 0.0 109.171 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -77.17 83.48 3.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.966 -1.084 . . . . 0.0 109.235 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.1 mt -81.22 139.37 35.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.414 -0.804 . . . . 0.0 110.027 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.8 p -128.0 160.76 30.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.558 -0.714 . . . . 0.0 109.247 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 55.02 50.1 16.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.302 -0.874 . . . . 0.0 109.472 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.4 mt -78.91 131.97 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 110.093 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.3 mm -119.6 120.08 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.456 -0.778 . . . . 0.0 109.329 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 93.8 mtp -122.09 105.06 9.93 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.058 -1.026 . . . . 0.0 109.785 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -112.5 101.16 9.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.337 -0.852 . . . . 0.0 109.067 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -76.68 -31.72 57.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.217 -0.927 . . . . 0.0 110.49 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -59.97 -46.96 87.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.799 -1.188 . . . . 0.0 109.645 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -90.23 3.01 54.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.157 -0.965 . . . . 0.0 109.1 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 51.96 46.8 25.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.479 -0.763 . . . . 0.0 110.13 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.475 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 3.5 t -132.6 137.73 47.15 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.997 -1.064 . . . . 0.0 109.475 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -128.91 140.02 51.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.477 -0.764 . . . . 0.0 109.974 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.475 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 78.4 m-85 -135.14 146.71 49.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.154 -0.966 . . . . 0.0 109.477 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.4 t -149.82 149.39 30.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.024 -1.047 . . . . 0.0 109.157 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.402 HH11 ' HG2' ' A' ' 98' ' ' ARG . 60.3 mtt-85 -102.17 134.48 45.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.074 -1.016 . . . . 0.0 109.5 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.5 mt -92.69 139.21 23.49 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.486 -0.759 . . . . 0.0 109.625 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.464 ' O ' ' CB ' ' A' ' 44' ' ' ALA . 78.2 Cg_exo -45.81 170.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.851 1.701 . . . . 0.0 111.284 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.9 m -79.93 -12.24 59.74 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.098 -1.001 . . . . 0.0 109.778 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.3 tp -135.39 131.17 35.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.256 -0.902 . . . . 0.0 110.573 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.447 HD11 HG22 ' A' ' 103' ' ' ILE . 87.0 mt -147.54 102.27 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.8 t -99.73 -3.88 31.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.861 -1.149 . . . . 0.0 109.897 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 127' ' ' ALA . 84.7 m-20 -83.7 154.63 23.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.958 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -104.21 33.17 3.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.389 -0.819 . . . . 0.0 109.161 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 18.4 p-90 -65.33 152.06 44.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.932 . . . . 0.0 110.462 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -130.82 150.97 51.74 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.644 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 25.2 p90 -150.17 159.66 44.25 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.042 -1.036 . . . . 0.0 108.693 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 6.0 p90 -152.87 159.06 43.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.773 -1.205 . . . . 0.0 111.819 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 99.4 m -123.18 156.02 35.92 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 42.4 t -129.19 140.86 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.866 -1.147 . . . . 0.0 111.794 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 70.2 m -121.65 131.46 54.11 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.6 p -170.82 176.11 4.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.232 -1.542 . . . . 0.0 111.704 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.536 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 51.5 mttm -151.57 166.46 31.11 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 117' ' ' ASN . 98.6 m-20 -57.59 151.54 16.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.757 -1.214 . . . . 0.0 109.17 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 116' ' ' ASP . 66.7 t30 42.43 61.47 2.01 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.209 -0.932 . . . . 0.0 109.816 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 43.6 mt-10 -161.76 140.84 9.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.103 -0.998 . . . . 0.0 110.21 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -55.02 138.75 43.17 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.171 -0.955 . . . . 0.0 109.326 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -87.35 139.93 30.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.302 -0.874 . . . . 0.0 110.387 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.3 mt -110.12 122.27 47.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.473 -0.767 . . . . 0.0 109.024 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 51.6 t -110.69 131.76 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.04 -1.038 . . . . 0.0 110.664 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.405 ' CZ ' ' CG1' ' A' ' 125' ' ' VAL . 23.9 t80 -110.22 122.53 47.87 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.0 t -137.54 142.45 41.4 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 119.059 -1.057 . . . . 0.0 111.969 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.644 ' CG2' ' CE2' ' A' ' 109' ' ' PHE . 3.0 m -137.53 154.52 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -122.87 147.6 46.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.201 -0.937 . . . . 0.0 110.366 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.329 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.473 ' CB ' ' HG ' ' A' ' 17' ' ' SER . 22.7 mmtp . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.8 t -97.64 132.19 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.256 -0.903 . . . . 0.0 109.873 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -68.01 121.42 16.05 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.175 -0.953 . . . . 0.0 108.648 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.29 172.4 43.45 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.9 t -113.66 129.36 56.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.384 -1.068 . . . . 0.0 109.329 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -101.97 108.67 20.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.508 -0.745 . . . . 0.0 109.252 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.476 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 96.8 m-85 -89.75 -1.29 57.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.018 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.1 m -103.0 -16.0 15.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.594 -0.691 . . . . 0.0 110.511 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.0 m -157.9 126.25 5.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.756 -1.215 . . . . 0.0 110.152 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.9 p -66.07 -26.01 67.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.97 . . . . 0.0 108.921 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -114.07 74.16 0.86 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.8 p -71.25 154.15 41.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 110.24 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -101.86 0.96 36.43 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.404 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 5.5 pt -125.28 -26.47 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.643 -0.661 . . . . 0.0 110.243 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.404 ' CE2' ' CD1' ' A' ' 15' ' ' ILE . 72.3 m-85 -105.37 143.53 33.41 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.028 -1.045 . . . . 0.0 109.887 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.473 ' HG ' ' CB ' ' A' ' 2' ' ' LYS . 12.9 m -70.37 -18.09 63.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.542 -0.724 . . . . 0.0 110.765 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -144.33 156.52 44.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.75 -1.219 . . . . 0.0 110.775 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -158.78 169.24 35.09 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.199 -1.177 . . . . 0.0 109.646 -179.754 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 36' ' ' ILE . 37.7 mm . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.0 t -117.07 127.83 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.153 -0.967 . . . . 0.0 110.182 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.476 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 96.7 m -102.45 100.62 10.76 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 65.6 m -94.4 120.24 34.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.016 -1.053 . . . . 0.0 109.645 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.3 156.11 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.161 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -98.11 133.96 41.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.171 -0.955 . . . . 0.0 109.445 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.0 150.35 23.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.052 -1.03 . . . . 0.0 109.63 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.42 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 29.8 t60 -120.0 152.52 37.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.363 -0.836 . . . . 0.0 109.551 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.34 -25.59 35.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 109.917 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -99.78 -21.63 15.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.118 -0.989 . . . . 0.0 109.714 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.42 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 81.4 m-20 -77.85 138.02 38.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.501 -0.749 . . . . 0.0 109.998 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.2 mt -79.39 148.9 31.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 108.703 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.46 HD11 HG21 ' A' ' 48' ' ' ILE . 42.6 pt -120.4 141.73 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.969 -1.082 . . . . 0.0 110.214 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.67 -178.3 47.96 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.43 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 55.2 p90 -164.0 170.08 17.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.118 -1.224 . . . . 0.0 109.736 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -144.08 142.87 30.87 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.354 -0.841 . . . . 0.0 109.772 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 82.4 m -122.79 151.83 61.34 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.425 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.46 145.75 27.71 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.289 1.993 . . . . 0.0 111.893 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.3 t -67.88 -14.57 63.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.464 -0.772 . . . . 0.0 110.624 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.608 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.4 m-20 -90.2 1.5 56.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.889 -1.132 . . . . 0.0 110.087 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.454 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 19.1 m-85 -111.11 166.75 10.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.6 m -103.6 139.98 38.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.398 -0.814 . . . . 0.0 109.315 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.5 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.7 m -97.55 120.35 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.94 -1.1 . . . . 0.0 110.311 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -127.19 126.68 24.29 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.0 113.81 3.49 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.732 1.622 . . . . 0.0 112.235 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -93.1 -24.8 18.15 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.7 t0 -168.89 36.26 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.412 ' O ' ' O ' ' A' ' 62' ' ' ASP . 88.7 m -59.44 -155.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.499 -0.751 . . . . 0.0 109.893 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.466 ' O ' ' C ' ' A' ' 65' ' ' VAL . 3.9 p90 -110.0 -59.07 1.98 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.953 -1.092 . . . . 0.0 111.246 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.483 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 36.6 t -43.95 -73.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.678 -1.264 . . . . 0.0 108.858 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.2 t -139.25 131.98 29.05 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -172.94 -178.48 1.83 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.879 -1.138 . . . . 0.0 110.457 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 6.6 m-85 -92.27 126.25 37.27 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -73.34 -172.49 1.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.136 -0.978 . . . . 0.0 109.763 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' A' ' 70' ' ' LEU . 3.8 mm? -64.22 -22.16 66.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.33 -0.856 . . . . 0.0 109.102 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 89.4 p -82.57 -7.37 59.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.889 . . . . 0.0 108.83 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.69 17.95 66.97 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -100.43 139.68 35.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -1.18 . . . . 0.0 109.184 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -82.07 109.46 16.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.174 -0.954 . . . . 0.0 109.934 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -143.88 137.57 27.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.863 . . . . 0.0 110.004 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 77' ' ' LEU . 62.0 t-20 -60.12 145.85 45.31 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.171 -0.956 . . . . 0.0 109.403 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.512 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 14.0 tp -99.07 6.56 46.51 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.359 -0.838 . . . . 0.0 109.829 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.44 ' CD ' ' N ' ' A' ' 79' ' ' ASN . 2.3 pp20? -69.69 -40.33 76.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.104 -0.997 . . . . 0.0 109.896 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.605 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 43.4 p30 -63.37 -27.69 69.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.155 -0.966 . . . . 0.0 109.12 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.605 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 50.9 tptt -78.26 -50.44 11.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.458 -0.776 . . . . 0.0 109.343 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.0 tp -130.39 130.53 44.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.512 -0.742 . . . . 0.0 109.191 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -81.32 84.53 6.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.13 -0.981 . . . . 0.0 109.408 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 86.4 mt -76.67 143.68 39.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -0.828 . . . . 0.0 109.888 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.1 p -127.67 161.81 28.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.509 -0.745 . . . . 0.0 109.299 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.486 ' ND2' HH11 ' A' ' 98' ' ' ARG . 10.9 m-20 55.44 51.83 12.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -0.952 . . . . 0.0 109.652 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.4 mt -80.39 130.59 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.397 -0.815 . . . . 0.0 110.047 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.5 mm -118.68 120.26 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.447 -0.783 . . . . 0.0 109.139 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 84.2 mtp -121.15 101.26 7.54 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.082 -1.011 . . . . 0.0 109.834 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -110.29 100.22 9.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.264 -0.898 . . . . 0.0 108.896 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.479 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 93.0 m-70 -72.34 -36.49 68.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.971 -1.081 . . . . 0.0 110.655 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -60.4 -46.18 90.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.94 -1.1 . . . . 0.0 109.631 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -88.59 -4.98 58.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -0.923 . . . . 0.0 109.119 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.7 m-20 54.37 47.94 21.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.517 -0.739 . . . . 0.0 110.283 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.598 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 1.8 t -133.41 140.01 47.08 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.025 -1.047 . . . . 0.0 109.463 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 66.4 m-85 -129.04 140.03 51.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.463 -0.773 . . . . 0.0 109.959 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.598 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 82.1 m-85 -138.08 148.89 45.48 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.261 -0.899 . . . . 0.0 109.479 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.3 p -154.54 158.02 39.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.142 -0.974 . . . . 0.0 109.215 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.486 HH11 ' ND2' ' A' ' 85' ' ' ASN . 68.6 mtp180 -104.01 136.37 43.78 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.166 -0.959 . . . . 0.0 109.399 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 100' ' ' PRO . 36.4 mt -89.69 136.66 29.21 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 109.635 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 99' ' ' LEU . 77.6 Cg_exo -45.75 177.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.863 1.708 . . . . 0.0 111.211 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 87.7 p -87.39 -15.3 38.23 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.064 -1.022 . . . . 0.0 109.839 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.2 tp -127.37 128.85 46.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.156 -0.965 . . . . 0.0 110.311 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.456 HG22 HD13 ' A' ' 103' ' ' ILE . 72.8 mt -150.22 107.77 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.206 -0.934 . . . . 0.0 108.676 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 81.5 p -118.44 -1.56 11.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.06 -1.025 . . . . 0.0 109.773 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 9.0 p30 -82.67 154.5 24.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.052 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -95.61 34.08 1.54 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.504 -0.748 . . . . 0.0 109.037 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.464 ' CZ3' ' CD1' ' A' ' 109' ' ' PHE . 10.0 p-90 -63.21 154.16 32.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 110.379 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -142.69 149.65 39.11 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.62 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 33.5 p90 -154.46 163.74 39.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.125 -0.984 . . . . 0.0 108.784 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 7.3 p90 -154.44 160.04 41.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.846 -1.159 . . . . 0.0 111.705 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 67.8 m -123.35 155.99 36.25 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.0 t -129.36 140.87 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.878 -1.139 . . . . 0.0 111.756 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 98.4 m -124.66 133.37 53.25 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 72.6 p -170.49 179.23 3.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.239 -1.538 . . . . 0.0 111.665 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.608 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 49.7 mtmt -151.61 162.59 40.73 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 117' ' ' ASN . 97.9 m-20 -57.81 152.19 16.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.816 -1.178 . . . . 0.0 109.173 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.53 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 57.3 t-20 45.24 61.33 2.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.104 -0.997 . . . . 0.0 109.681 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 38.0 mt-10 -166.15 146.69 6.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.141 -0.974 . . . . 0.0 110.174 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.38 139.32 57.73 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.133 -0.979 . . . . 0.0 109.021 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -85.95 142.09 29.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.169 -0.957 . . . . 0.0 110.326 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 68.6 mt -109.21 120.8 43.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.402 -0.812 . . . . 0.0 109.045 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.8 t -109.42 131.21 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 120.951 -1.093 . . . . 0.0 110.774 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -109.66 121.03 44.3 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.4 t -137.16 142.63 42.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.776 -1.202 . . . . 0.0 112.008 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.62 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 2.9 m -136.26 156.37 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -133.88 155.97 48.92 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.226 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.51 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.432 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.3 mttp . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.7 t -80.81 134.19 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.35 -0.844 . . . . 0.0 110.119 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -72.18 129.93 39.64 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.017 -1.052 . . . . 0.0 108.642 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.97 -154.35 24.29 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.378 -1.392 . . . . 0.0 109.914 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.4 t -133.93 131.64 39.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -1.111 . . . . 0.0 109.656 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.513 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 38.6 t0 -109.51 109.25 20.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.539 -0.726 . . . . 0.0 109.15 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.4 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 91.0 m-85 -89.78 3.38 53.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 108.819 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 91.9 m -100.54 -19.59 16.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.386 -0.821 . . . . 0.0 110.515 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.6 m -157.75 127.49 6.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.791 -1.193 . . . . 0.0 110.535 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.1 p -64.17 -27.22 68.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.232 -0.917 . . . . 0.0 108.996 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -114.02 74.36 0.87 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.513 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 8.6 m -69.29 150.61 47.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.269 -0.894 . . . . 0.0 110.304 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.27 -1.05 34.62 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.9 pt -125.59 -10.35 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.676 -0.64 . . . . 0.0 110.491 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -125.7 141.0 52.23 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.201 -0.937 . . . . 0.0 110.191 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.8 t -69.18 -20.73 64.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.668 -0.645 . . . . 0.0 110.995 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -132.57 142.65 49.26 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.106 -0.997 . . . . 0.0 110.668 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.74 169.61 32.97 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.474 -1.015 . . . . 0.0 109.647 -179.963 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.0 mm . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.7 t -118.98 131.97 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.371 -0.831 . . . . 0.0 110.565 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.417 ' O ' ' O ' ' A' ' 124' ' ' THR . 89.0 m -102.1 102.65 13.15 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.5 m -93.07 119.97 32.87 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.081 -1.012 . . . . 0.0 109.574 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.8 m -140.33 141.03 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.656 -0.653 . . . . 0.0 109.344 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -87.02 129.89 34.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.078 -1.014 . . . . 0.0 109.452 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.58 159.64 14.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 109.504 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -134.77 154.05 51.76 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.282 -0.886 . . . . 0.0 109.568 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.55 -26.48 32.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.373 -0.829 . . . . 0.0 109.762 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -99.49 -27.04 13.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.904 . . . . 0.0 109.866 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -69.91 132.79 46.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.199 -0.938 . . . . 0.0 110.152 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.2 mt -77.81 145.09 36.57 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.7 pt -117.37 137.45 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.169 -0.957 . . . . 0.0 110.15 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.1 154.08 11.61 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -142.45 173.55 11.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.022 -1.281 . . . . 0.0 109.879 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -146.65 144.72 29.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.356 -0.84 . . . . 0.0 109.87 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 88.7 m -123.34 152.11 63.76 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.424 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.8 Cg_endo -51.55 151.52 14.02 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.321 2.014 . . . . 0.0 112.043 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.3 m -71.7 -13.62 61.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.456 -0.777 . . . . 0.0 110.59 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.609 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 82.4 m-20 -90.84 -1.34 57.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.961 -1.087 . . . . 0.0 110.196 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.424 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.3 m-85 -108.11 164.13 12.56 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.306 -0.871 . . . . 0.0 110.492 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.1 t -104.72 137.55 42.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.295 -0.878 . . . . 0.0 108.982 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.495 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.8 m -93.13 121.86 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.066 -1.021 . . . . 0.0 110.212 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.414 ' O ' ' O ' ' A' ' 112' ' ' VAL . 10.4 mt-10 -126.19 124.61 24.57 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.15 113.51 3.41 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.623 1.548 . . . . 0.0 112.097 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 68' ' ' PHE . 12.6 t-80 -93.51 -24.0 18.15 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 110' ' ' PHE . 68.0 t0 -171.0 48.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.654 ' H ' ' CB ' ' A' ' 67' ' ' ALA . 91.0 m -71.59 -154.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.518 -0.739 . . . . 0.0 109.774 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.6 p90 -112.17 -49.26 2.98 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.299 -0.876 . . . . 0.0 111.649 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.5 t -59.47 -48.27 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.291 -1.506 . . . . 0.0 109.43 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.3 t -161.16 130.8 4.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.654 ' CB ' ' H ' ' A' ' 63' ' ' CYS . . . -173.93 -178.49 1.54 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.129 -0.982 . . . . 0.0 110.414 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 6.1 m-85 -93.06 125.59 37.73 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -70.86 -173.92 0.86 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.107 -0.995 . . . . 0.0 109.871 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.45 -21.37 66.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.301 -0.874 . . . . 0.0 109.037 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.8 m -82.35 -8.27 59.63 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.306 -0.871 . . . . 0.0 108.943 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.35 17.72 63.91 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -104.91 145.02 30.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.327 -1.102 . . . . 0.0 109.213 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -83.63 117.8 23.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.486 -0.759 . . . . 0.0 110.149 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -149.73 136.36 19.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.836 . . . . 0.0 110.211 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -59.73 142.96 52.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.5 tp -95.45 7.07 47.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.227 -0.921 . . . . 0.0 109.775 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' A' ' 79' ' ' ASN . 0.3 OUTLIER -68.82 -39.9 79.79 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.269 -0.894 . . . . 0.0 109.991 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.448 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 91.3 m-20 -62.04 -36.03 80.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.017 . . . . 0.0 109.121 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -72.53 -48.72 38.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.514 -0.741 . . . . 0.0 109.657 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.449 ' CD2' ' CZ2' ' A' ' 107' ' ' TRP . 42.6 tp -148.79 120.84 8.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.468 -0.77 . . . . 0.0 108.997 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.48 113.1 19.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.968 . . . . 0.0 109.502 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.2 mt -90.5 159.27 16.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.857 . . . . 0.0 109.917 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 46.7 p -127.14 160.79 30.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.464 -0.773 . . . . 0.0 109.223 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 55.5 52.11 11.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -0.947 . . . . 0.0 109.814 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.2 mt -79.03 127.81 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.922 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.6 mm -122.18 121.51 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.49 -0.756 . . . . 0.0 109.174 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 86.6 mtp -121.84 103.18 8.67 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.222 -0.924 . . . . 0.0 109.569 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -112.24 100.76 9.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.377 -0.827 . . . . 0.0 109.033 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.476 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 77.5 m80 -71.18 -37.41 72.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.006 -1.059 . . . . 0.0 110.596 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -60.7 -46.03 91.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.972 -1.08 . . . . 0.0 109.704 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -88.71 -4.73 58.46 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.092 -1.005 . . . . 0.0 109.112 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.6 m-20 53.36 47.72 23.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.417 -0.802 . . . . 0.0 110.04 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.607 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.0 t -132.63 137.04 46.87 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.024 -1.047 . . . . 0.0 109.403 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -126.86 139.37 53.13 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.068 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.607 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 72.3 m-85 -136.42 146.31 46.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.27 -0.893 . . . . 0.0 109.259 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.9 m -151.18 151.53 32.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.175 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -102.32 131.87 48.65 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.351 -0.843 . . . . 0.0 109.576 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' A' ' 100' ' ' PRO . 92.6 mt -86.43 137.16 34.58 Favored Pre-proline 0 N--CA 1.489 1.479 0 C-N-CA 120.431 -0.508 . . . . 0.0 109.717 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 99' ' ' LEU . 77.7 Cg_exo -45.86 -177.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.954 1.77 . . . . 0.0 111.204 178.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.6 t -88.88 -19.23 26.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.963 -1.085 . . . . 0.0 110.107 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.7 tp -124.42 128.47 49.08 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.283 -0.886 . . . . 0.0 110.516 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.421 HD12 HG23 ' A' ' 103' ' ' ILE . 78.5 mt -149.74 102.72 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 92.4 p -113.08 1.0 15.16 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.316 -0.865 . . . . 0.0 109.89 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.601 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 49.3 t0 -83.51 153.23 24.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 110.114 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.601 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 95.5 m-20 -96.23 33.36 1.77 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.453 -0.779 . . . . 0.0 108.938 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.516 ' CD1' ' OXT' ' A' ' 127' ' ' ALA . 11.9 p-90 -63.99 154.24 34.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 110.628 -178.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -140.06 150.13 43.99 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.637 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 32.5 p90 -154.5 161.86 41.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.096 -1.002 . . . . 0.0 108.595 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.42 ' O ' ' C ' ' A' ' 62' ' ' ASP . 13.3 p90 -153.58 158.44 41.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.738 -1.226 . . . . 0.0 111.906 -178.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 90.8 m -123.61 156.79 35.13 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 59' ' ' GLU . 50.7 t -127.91 137.66 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 120.96 -1.088 . . . . 0.0 111.736 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.2 m -119.22 130.52 55.52 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.0 p -171.54 178.73 3.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.41 -1.431 . . . . 0.0 111.577 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.609 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 49.3 mtmt -150.06 164.38 35.7 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 117' ' ' ASN . 88.3 m-20 -58.21 151.39 19.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.863 -1.148 . . . . 0.0 109.175 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.481 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 54.3 t-20 43.69 61.94 2.09 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.172 -0.955 . . . . 0.0 109.772 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.481 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 36.1 mt-10 -164.46 144.13 7.53 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.136 -0.978 . . . . 0.0 110.145 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -55.1 135.26 49.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.326 -0.859 . . . . 0.0 109.216 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -85.27 140.97 30.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.165 -0.96 . . . . 0.0 110.327 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.7 mt -110.17 123.67 50.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.554 -0.716 . . . . 0.0 109.187 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.7 t -108.69 130.05 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.032 -1.042 . . . . 0.0 110.387 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -108.03 118.68 37.38 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 38' ' ' CYS . 6.1 t -136.74 142.52 43.05 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.496 1.141 . . . . 0.0 112.109 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.637 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -137.05 160.23 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -131.03 147.83 52.68 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.263 -0.898 . . . . 0.0 110.409 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.516 ' OXT' ' CD1' ' A' ' 107' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.432 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.4 t -87.59 135.51 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.93 . . . . 0.0 110.117 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -66.55 124.53 23.06 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.662 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.97 166.93 34.71 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.2 t -107.04 129.89 54.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.455 -1.026 . . . . 0.0 109.192 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -108.49 109.28 20.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.529 -0.732 . . . . 0.0 109.461 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.416 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 86.2 m-85 -89.49 1.7 55.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 108.948 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.415 ' HG1' ' N ' ' A' ' 53' ' ' PRO . 20.5 m -101.99 -18.36 15.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.516 -0.74 . . . . 0.0 110.62 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.5 m -156.86 126.5 6.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.761 -1.212 . . . . 0.0 110.383 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.6 m -67.06 -26.38 66.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.443 -0.785 . . . . 0.0 109.138 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -113.59 73.91 0.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 20.7 p -71.73 153.27 42.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.385 -0.822 . . . . 0.0 110.221 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.38 -1.27 31.19 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.3 pt -125.67 -13.45 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.661 -0.649 . . . . 0.0 110.443 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.461 ' O ' ' OG ' ' A' ' 13' ' ' SER . 76.5 m-85 -121.63 137.13 54.87 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.283 -0.886 . . . . 0.0 109.925 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.8 t -68.12 -20.04 64.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.578 -0.701 . . . . 0.0 110.669 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -131.95 142.55 49.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.95 -1.094 . . . . 0.0 110.745 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.88 168.36 32.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.334 -1.098 . . . . 0.0 109.586 179.867 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.404 HG23 HD11 ' A' ' 36' ' ' ILE . 36.8 mm . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -118.77 131.42 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.314 -0.867 . . . . 0.0 110.526 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 124' ' ' THR . 95.1 m -101.57 101.06 11.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.1 m -94.35 120.09 34.07 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.143 -0.973 . . . . 0.0 109.852 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.3 m -141.12 155.8 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.499 -0.751 . . . . 0.0 109.184 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -97.07 131.07 44.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.371 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.27 162.92 12.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.595 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.584 ' HD1' ' H ' ' A' ' 45' ' ' ASN . 34.3 t-80 -132.59 148.97 52.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.307 -0.871 . . . . 0.0 109.454 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.48 -26.94 14.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 109.889 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.584 ' H ' ' HD1' ' A' ' 43' ' ' HIS . 50.3 t30 -99.71 -23.15 15.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 109.786 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -74.18 136.83 42.84 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.415 -0.803 . . . . 0.0 110.156 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.417 HD23 ' NE ' ' A' ' 98' ' ' ARG . 15.1 mt -75.52 143.37 42.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 108.826 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.449 HD12 HG21 ' A' ' 48' ' ' ILE . 46.0 pt -121.14 142.8 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.288 -0.883 . . . . 0.0 110.091 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.47 -175.39 47.21 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.484 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 48.9 p90 -164.12 169.01 18.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.059 -1.259 . . . . 0.0 109.639 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -146.03 144.14 29.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.762 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 84.1 m -125.58 152.17 71.51 Favored Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.415 ' N ' ' HG1' ' A' ' 9' ' ' THR . 8.5 Cg_endo -51.52 151.3 14.26 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.273 1.982 . . . . 0.0 111.952 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.9 m -71.23 -11.01 60.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.379 -0.826 . . . . 0.0 110.673 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.623 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 83.6 m-20 -90.69 -1.71 57.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.938 -1.101 . . . . 0.0 110.092 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.413 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 20.5 m-85 -109.61 164.04 12.9 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.149 -0.97 . . . . 0.0 110.315 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 m -102.81 146.21 28.6 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.374 -0.829 . . . . 0.0 109.043 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.472 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.6 m -101.02 124.19 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.99 -1.069 . . . . 0.0 110.087 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -130.63 127.25 22.26 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.09 113.79 3.47 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.657 1.571 . . . . 0.0 112.146 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.495 ' O ' ' O ' ' A' ' 68' ' ' PHE . 27.1 t-80 -93.88 -26.4 16.91 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.7 t0 -168.26 38.35 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.459 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 81.8 m -62.75 -155.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.735 . . . . 0.0 109.836 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 4.8 p90 -107.95 -54.54 2.48 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.195 -0.941 . . . . 0.0 111.475 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.0 t -49.13 -71.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.67 -1.269 . . . . 0.0 108.728 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.7 t -142.4 131.36 23.04 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.459 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -168.94 -179.57 3.72 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.364 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.4 m-85 -94.61 145.1 25.06 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.404 HD22 ' HG2' ' A' ' 75' ' ' GLU . 99.6 m-20 -86.59 -172.89 4.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.93 -1.106 . . . . 0.0 109.695 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.0 mt -64.65 -15.37 61.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -0.881 . . . . 0.0 109.16 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.3 m -86.92 -6.42 58.78 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.361 -0.837 . . . . 0.0 108.948 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.34 20.47 69.36 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -107.55 142.46 37.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.291 -1.123 . . . . 0.0 109.207 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -66.05 131.66 46.74 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.212 -0.93 . . . . 0.0 109.899 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.404 ' HG2' HD22 ' A' ' 69' ' ' ASN . 30.7 tp10 -152.21 163.26 39.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.364 -0.835 . . . . 0.0 109.405 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.402 ' H ' ' HG3' ' A' ' 75' ' ' GLU . 16.9 t-20 -107.01 138.06 43.89 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.175 -0.953 . . . . 0.0 109.553 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.1 tp -88.03 -8.83 55.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.105 -0.997 . . . . 0.0 109.921 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.586 ' OE1' ' N ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -60.0 -45.99 90.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.869 -1.144 . . . . 0.0 109.532 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.592 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 28.7 p30 -63.8 -34.8 78.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.073 -1.017 . . . . 0.0 108.951 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.592 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 9.1 tppt? -69.91 -51.67 31.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 109.112 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.7 tp -151.76 121.42 6.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.448 -0.783 . . . . 0.0 108.958 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -78.17 113.78 16.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.018 -1.051 . . . . 0.0 109.573 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.72 162.3 17.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.412 -0.805 . . . . 0.0 109.974 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 70.4 p -129.55 162.0 29.21 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.349 -0.845 . . . . 0.0 109.331 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.444 HD21 ' HG3' ' A' ' 98' ' ' ARG . 73.6 m-80 55.36 51.23 13.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 109.691 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.5 mt -81.13 131.44 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.327 -0.858 . . . . 0.0 110.264 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.3 mm -127.58 123.5 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.456 -0.777 . . . . 0.0 109.073 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 72.6 mtp -122.59 104.09 9.11 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.21 -0.932 . . . . 0.0 109.761 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -111.9 100.7 9.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.327 -0.858 . . . . 0.0 109.039 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.488 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 97.5 m-70 -72.32 -36.41 68.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.882 -1.136 . . . . 0.0 110.642 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -60.51 -46.16 91.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.999 -1.063 . . . . 0.0 109.528 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -88.91 -4.83 58.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.071 -1.018 . . . . 0.0 109.149 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.5 m-20 54.48 48.17 21.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.468 -0.77 . . . . 0.0 110.273 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.606 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.9 t -134.02 139.46 46.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.994 -1.066 . . . . 0.0 109.296 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.484 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 75.2 m-85 -128.4 140.33 51.9 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.483 -0.761 . . . . 0.0 110.071 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.606 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 72.0 m-85 -137.99 147.96 44.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.323 -0.861 . . . . 0.0 109.13 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.4 p -156.33 157.98 36.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.08 -1.012 . . . . 0.0 109.21 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.444 ' HG3' HD21 ' A' ' 85' ' ' ASN . 18.7 mmt180 -104.08 137.65 41.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.324 -0.86 . . . . 0.0 109.613 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.8 mt -87.81 137.5 31.74 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.65 -0.656 . . . . 0.0 109.62 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -46.88 154.04 1.21 Allowed 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.745 1.63 . . . . 0.0 111.212 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 54.0 m -62.56 -36.86 84.01 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.118 -0.989 . . . . 0.0 109.93 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.4 tp -111.34 130.63 55.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.26 -0.9 . . . . 0.0 110.55 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.401 HG23 HD13 ' A' ' 103' ' ' ILE . 95.3 mt -145.71 103.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.401 -0.812 . . . . 0.0 108.857 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.459 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 7.1 m -111.18 53.58 0.7 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.179 -0.951 . . . . 0.0 109.647 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.479 ' O ' ' OXT' ' A' ' 127' ' ' ALA . 83.1 m-20 -144.86 156.5 44.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 110.029 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -102.89 33.06 3.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.426 -0.796 . . . . 0.0 109.09 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 19.3 p-90 -65.15 150.8 47.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.411 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -132.38 151.08 52.01 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.625 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 32.2 p90 -151.62 161.0 43.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.196 -0.94 . . . . 0.0 108.665 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 8.1 p90 -154.19 164.33 38.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.741 -1.225 . . . . 0.0 111.912 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 85.2 m -127.72 157.96 38.91 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.2 t -127.72 137.88 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.802 -1.186 . . . . 0.0 111.929 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 70.9 m -119.24 130.04 55.25 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.7 p -169.29 179.33 3.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.281 -1.512 . . . . 0.0 111.658 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.623 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 42.2 mtmt -158.78 167.67 28.86 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 117' ' ' ASN . 54.1 p-10 -58.56 151.55 20.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.766 -1.209 . . . . 0.0 109.008 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 116' ' ' ASP . 58.9 t-20 41.42 58.71 2.6 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.329 -0.857 . . . . 0.0 109.6 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 66.5 mm-40 -157.87 137.5 12.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.394 -0.817 . . . . 0.0 110.503 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -54.69 136.5 45.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.366 -0.834 . . . . 0.0 109.12 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.4 pttm -85.36 139.08 31.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.217 -0.927 . . . . 0.0 110.49 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.9 mt -111.77 125.48 54.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.556 -0.715 . . . . 0.0 109.354 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.4 t -110.98 131.25 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.036 -1.04 . . . . 0.0 110.561 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -108.73 119.46 39.61 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 38' ' ' CYS . 6.8 t -136.83 141.52 42.86 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.957 -1.089 . . . . 0.0 111.989 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.625 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -136.41 156.55 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -127.13 151.01 49.22 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.179 -0.951 . . . . 0.0 110.265 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.479 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.365 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.3 mttp . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.6 t -91.66 135.63 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 110.267 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -69.55 123.2 20.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.9 -1.125 . . . . 0.0 108.543 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.76 174.87 46.07 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.656 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 7.7 t -114.8 128.19 56.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.441 -1.035 . . . . 0.0 109.292 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.442 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 51.8 t0 -106.05 109.05 20.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.505 -0.747 . . . . 0.0 109.359 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 97.6 m-85 -88.05 -0.12 56.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.226 -0.921 . . . . 0.0 108.961 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.5 m -101.47 -15.67 17.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.42 -0.8 . . . . 0.0 110.578 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.5 m -159.89 129.24 5.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.88 -1.137 . . . . 0.0 110.316 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.501 ' OG ' ' OE1' ' A' ' 12' ' ' GLU . 78.2 p -70.76 -22.78 62.36 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.587 -0.845 . . . . 0.0 108.852 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.501 ' OE1' ' OG ' ' A' ' 11' ' ' SER . 57.9 mp0 -114.16 74.12 0.86 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.442 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 6.4 m -70.77 151.32 44.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.371 -0.83 . . . . 0.0 110.241 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.0 -0.72 35.99 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.7 pt -125.91 -22.8 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.612 -0.68 . . . . 0.0 110.34 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -112.15 141.97 45.18 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.261 -0.9 . . . . 0.0 110.015 -178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.3 p -75.59 -21.14 58.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.519 -0.738 . . . . 0.0 110.958 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -118.66 127.89 54.0 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.138 -0.976 . . . . 0.0 110.449 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.94 153.84 20.69 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.656 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 20.4 m-85 . . . . . 0 N--CA 1.495 1.783 0 O-C-N 121.479 -1.013 . . . . 0.0 109.557 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.436 HG23 HD12 ' A' ' 36' ' ' ILE . 36.6 mm . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 50.9 t -119.96 129.86 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.334 -0.854 . . . . 0.0 110.277 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.44 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 76.6 m -102.61 101.87 12.05 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.8 m -95.19 120.51 35.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.16 -0.962 . . . . 0.0 109.84 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.1 m -140.43 157.45 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.467 -0.771 . . . . 0.0 109.146 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -99.99 133.74 43.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.114 -0.991 . . . . 0.0 109.398 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.22 160.7 14.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 0.0 109.52 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -134.58 152.38 51.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.19 -27.57 35.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.363 -0.835 . . . . 0.0 109.823 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -99.05 -25.46 14.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.934 . . . . 0.0 109.647 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -75.14 133.29 41.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.363 -0.836 . . . . 0.0 110.074 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.6 mt -77.94 148.41 34.51 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.2 pt -120.94 142.78 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.272 -0.892 . . . . 0.0 110.048 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 95' ' ' PHE . . . 176.78 -172.6 45.56 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.466 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 51.4 p90 -170.14 170.17 7.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -1.218 . . . . 0.0 109.79 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -145.06 143.43 30.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.289 -0.882 . . . . 0.0 109.703 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.2 m -125.57 154.28 72.75 Favored Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -51.53 143.35 36.33 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.213 1.942 . . . . 0.0 111.991 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.1 t -67.28 -12.84 61.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.387 -0.821 . . . . 0.0 110.595 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -89.46 3.33 52.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.941 -1.1 . . . . 0.0 110.197 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.572 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 20.7 m-85 -113.29 167.73 10.32 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.157 -0.965 . . . . 0.0 110.324 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.8 t -103.35 138.47 40.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.328 -0.858 . . . . 0.0 108.903 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.525 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.4 m -97.29 118.05 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.987 -1.07 . . . . 0.0 110.386 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -126.76 129.53 24.03 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.97 114.34 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.628 1.552 . . . . 0.0 111.959 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.447 ' O ' ' O ' ' A' ' 68' ' ' PHE . 10.9 t-80 -87.76 -24.38 23.81 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.1 t0 -172.93 38.91 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.452 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 71.1 m -60.92 -152.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.549 -0.719 . . . . 0.0 109.762 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.445 ' O ' ' C ' ' A' ' 65' ' ' VAL . 3.9 p90 -109.42 -58.7 2.0 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.216 -0.928 . . . . 0.0 111.354 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.445 ' C ' ' O ' ' A' ' 64' ' ' PHE . 13.4 t -46.67 -74.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.436 -1.415 . . . . 0.0 108.927 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.4 t -135.96 132.02 35.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.452 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.84 179.89 2.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.01 . . . . 0.0 110.459 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.4 m-85 -93.69 128.2 39.78 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -73.61 -176.51 2.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.953 -1.092 . . . . 0.0 109.844 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.59 -20.4 65.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.932 . . . . 0.0 109.035 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.5 m -83.92 -6.43 59.42 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.74 19.05 64.36 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -100.18 139.06 36.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -1.149 . . . . 0.0 109.019 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -85.4 108.77 18.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.205 -0.934 . . . . 0.0 109.994 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -146.06 140.48 26.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.435 -0.791 . . . . 0.0 109.91 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 -62.15 148.95 42.83 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.475 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.42 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 13.0 tp -96.51 7.53 46.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.209 -0.932 . . . . 0.0 109.724 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -69.07 -40.6 78.39 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.949 -1.094 . . . . 0.0 109.878 -179.583 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.501 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 95.2 m-20 -64.31 -38.85 92.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.173 -0.955 . . . . 0.0 109.122 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -67.81 -53.23 28.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.216 -0.927 . . . . 0.0 109.389 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.513 ' CD2' ' CZ2' ' A' ' 107' ' ' TRP . 35.7 tp -143.23 121.57 12.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.413 -0.805 . . . . 0.0 109.049 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -81.03 104.88 11.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 109.371 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.9 mt -84.3 163.03 19.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 109.949 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 46.6 p -129.95 162.94 27.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.438 -0.789 . . . . 0.0 109.384 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 54.39 51.85 13.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.159 -0.963 . . . . 0.0 109.775 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 86' ' ' ILE . 96.6 mt -81.31 128.76 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 110.117 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.5 mm -125.91 123.67 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.528 -0.733 . . . . 0.0 109.206 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 91.3 mtp -123.45 104.93 9.38 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.164 -0.96 . . . . 0.0 109.829 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -110.19 100.24 9.17 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.382 -0.824 . . . . 0.0 109.014 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.509 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 98.7 m-70 -73.0 -34.75 66.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.978 -1.076 . . . . 0.0 110.643 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -61.58 -44.91 96.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.964 -1.085 . . . . 0.0 109.647 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -88.65 -4.72 58.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.955 . . . . 0.0 109.104 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.509 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 1.6 m-20 56.5 45.57 22.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.492 -0.755 . . . . 0.0 109.995 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.579 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.7 t -132.26 138.73 48.0 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.04 -1.037 . . . . 0.0 109.385 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.466 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 69.5 m-85 -127.62 139.74 52.54 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.406 -0.809 . . . . 0.0 109.986 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.592 ' CB ' HH12 ' A' ' 98' ' ' ARG . 82.5 m-85 -136.45 147.03 46.99 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.293 -0.879 . . . . 0.0 109.278 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.583 ' N ' ' NH1' ' A' ' 98' ' ' ARG . 38.2 t -153.41 150.72 29.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.114 -0.991 . . . . 0.0 109.357 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.592 HH12 ' CB ' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -105.88 139.27 40.69 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.222 -0.924 . . . . 0.0 109.541 -179.726 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.9 mt -93.65 142.38 25.06 Favored Pre-proline 0 N--CA 1.491 1.613 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.69 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -46.83 157.47 0.52 Allowed 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.713 1.608 . . . . 0.0 111.226 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.1 t -67.27 -17.25 64.71 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.157 -0.965 . . . . 0.0 109.702 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 45.9 tp -122.2 130.84 53.57 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.281 -0.887 . . . . 0.0 110.555 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 24.2 mt -144.39 124.5 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.6 m -133.3 15.75 4.12 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.042 -1.036 . . . . 0.0 109.855 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -109.02 154.15 22.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.329 -0.857 . . . . 0.0 110.014 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -95.99 32.13 1.98 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.471 -0.768 . . . . 0.0 108.997 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.513 ' CZ2' ' CD2' ' A' ' 81' ' ' LEU . 18.2 p-90 -66.33 156.86 33.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.899 . . . . 0.0 110.636 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -143.78 155.42 44.15 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.632 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 38.3 p90 -151.88 161.46 42.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.208 -0.933 . . . . 0.0 108.785 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 5.5 p90 -152.24 161.17 43.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.77 -1.206 . . . . 0.0 111.813 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 91.7 m -127.97 157.45 40.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.8 t -130.22 142.22 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.836 -1.165 . . . . 0.0 111.712 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 75.1 m -119.86 131.1 55.17 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.4 p -170.8 179.06 3.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.215 -1.553 . . . . 0.0 111.616 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.401 ' NZ ' ' OE2' ' A' ' 118' ' ' GLU . 5.6 mtmp? -158.11 167.34 30.12 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 117' ' ' ASN . 91.3 m-20 -58.13 150.5 21.12 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.818 -1.176 . . . . 0.0 109.119 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.437 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 66.5 t30 44.38 59.99 3.03 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.172 -0.955 . . . . 0.0 109.809 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.572 ' OE1' ' CE2' ' A' ' 56' ' ' TYR . 49.7 mt-10 -162.06 140.77 9.3 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.18 -0.95 . . . . 0.0 110.21 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -56.63 144.47 31.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 109.209 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -93.54 141.0 28.96 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.123 -0.986 . . . . 0.0 110.315 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 75.0 mt -112.3 125.73 54.48 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.546 -0.721 . . . . 0.0 109.151 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.5 t -110.92 131.27 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.036 -1.04 . . . . 0.0 110.63 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -109.65 121.17 44.62 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.7 t -137.24 141.82 42.04 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.953 -1.092 . . . . 0.0 112.114 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.632 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.1 m -135.49 157.77 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -128.25 150.94 49.82 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.208 -0.932 . . . . 0.0 110.263 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.498 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.253 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 66.9 t -99.31 133.84 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.306 -0.871 . . . . 0.0 109.831 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -67.48 122.91 19.0 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.134 -0.979 . . . . 0.0 108.544 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.82 162.99 26.58 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.7 t -103.5 135.25 45.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.477 -1.014 . . . . 0.0 110.084 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.509 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 67.7 t0 -111.98 109.43 19.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.371 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -87.4 -0.92 57.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 108.985 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.3 m -98.89 -17.67 18.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.645 -0.659 . . . . 0.0 110.505 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.2 m -160.41 131.08 5.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.764 -1.21 . . . . 0.0 110.223 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.1 p -64.17 -26.18 68.41 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.697 -0.801 . . . . 0.0 108.851 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -114.37 102.12 9.8 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.551 ' C ' ' H ' ' A' ' 15' ' ' ILE . 23.6 m -102.8 113.28 26.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -0.803 . . . . 0.0 110.372 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.5 t -65.64 2.88 0.85 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.551 ' H ' ' C ' ' A' ' 13' ' ' SER . 6.8 pt -123.56 -32.6 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.482 -0.761 . . . . 0.0 110.325 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.5 ' CZ ' ' CE2' ' A' ' 96' ' ' TYR . 53.8 m-85 -113.07 146.76 38.58 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.954 -1.091 . . . . 0.0 109.854 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 m -79.85 -20.82 45.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.38 -0.825 . . . . 0.0 110.956 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -119.9 131.18 55.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.708 -1.245 . . . . 0.0 110.86 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.51 158.66 27.78 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.201 -1.176 . . . . 0.0 109.609 -179.927 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.416 HD12 HG21 ' A' ' 36' ' ' ILE . 7.8 mm . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.7 t -114.9 127.73 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.1 -1.0 . . . . 0.0 110.268 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 81.3 m -102.51 102.49 12.77 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.6 m -95.07 120.19 34.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -0.981 . . . . 0.0 109.763 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 m -139.78 156.74 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.395 -0.816 . . . . 0.0 108.996 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.3 130.7 45.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.203 -0.936 . . . . 0.0 109.341 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.88 161.71 14.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 109.635 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.688 ' HD1' ' H ' ' A' ' 45' ' ' ASN . 41.9 t-80 -139.0 150.31 45.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 109.586 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.46 -25.2 50.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 109.818 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.688 ' H ' ' HD1' ' A' ' 43' ' ' HIS . 66.7 t30 -98.98 -26.29 14.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.162 -0.961 . . . . 0.0 109.667 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -78.97 134.97 36.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.531 -0.73 . . . . 0.0 110.013 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.7 mt -78.13 149.88 33.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 108.554 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.0 pt -120.82 142.42 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.887 -1.133 . . . . 0.0 110.027 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.2 -170.66 43.34 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -172.9 171.17 4.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.063 -1.257 . . . . 0.0 109.684 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -146.42 145.01 30.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.317 -0.865 . . . . 0.0 109.866 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.6 m -125.03 152.26 70.2 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.415 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.33 145.58 27.13 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.328 2.019 . . . . 0.0 112.026 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.9 m -68.65 -11.97 60.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.428 -0.795 . . . . 0.0 110.606 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.627 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 79.4 m-20 -91.44 1.03 57.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.928 -1.107 . . . . 0.0 110.039 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.51 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 19.4 m-85 -111.59 166.53 11.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.919 -1.113 . . . . 0.0 110.162 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -104.53 131.26 52.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.302 -0.874 . . . . 0.0 109.339 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.5 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.6 m -89.14 121.12 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.006 -1.059 . . . . 0.0 110.203 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -125.81 129.15 24.41 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.21 114.42 3.55 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.664 1.576 . . . . 0.0 112.088 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.465 ' O ' ' O ' ' A' ' 68' ' ' PHE . 10.8 t-80 -92.93 -25.29 18.1 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.474 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.8 t0 -171.43 40.44 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.508 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 70.8 m -63.7 -152.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.604 -0.685 . . . . 0.0 109.84 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.6 p90 -110.95 -58.9 2.04 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.863 -1.148 . . . . 0.0 111.151 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.442 ' C ' ' O ' ' A' ' 64' ' ' PHE . 25.3 t -45.97 -70.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.442 -1.411 . . . . 0.0 108.897 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.3 t -140.44 130.76 25.16 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.508 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.22 178.48 2.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.926 -1.109 . . . . 0.0 110.425 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 6.5 m-85 -93.12 124.94 37.45 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -69.6 -176.36 1.01 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.936 -1.103 . . . . 0.0 109.759 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.425 ' CD1' ' HZ1' ' A' ' 108' ' ' LYS . 17.5 mt -63.29 -21.73 66.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.857 . . . . 0.0 109.044 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.6 m -81.63 -5.81 58.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.352 -0.842 . . . . 0.0 108.858 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.41 19.94 65.38 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -105.25 141.56 36.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -1.145 . . . . 0.0 109.187 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -83.89 112.83 20.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.115 -0.99 . . . . 0.0 109.944 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -148.13 136.26 21.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.783 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -58.33 144.87 40.03 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.073 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.6 tp -97.12 7.4 46.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.186 -0.946 . . . . 0.0 109.691 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.46 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -69.7 -38.74 77.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 109.913 -179.374 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.586 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 49.3 p-10 -61.26 -31.15 70.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.164 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.586 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 37.4 ttmt -74.87 -48.37 25.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.374 -0.828 . . . . 0.0 109.392 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.417 HD22 ' CZ2' ' A' ' 107' ' ' TRP . 31.9 tp -136.74 127.27 26.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.38 -0.825 . . . . 0.0 109.205 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -74.68 85.44 2.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.119 -0.988 . . . . 0.0 109.12 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.0 mt -77.73 138.23 38.92 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.283 -0.885 . . . . 0.0 109.927 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.3 p -126.39 166.52 17.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.543 -0.723 . . . . 0.0 109.315 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 55.51 50.46 14.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.883 . . . . 0.0 109.559 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 86' ' ' ILE . 96.8 mt -79.89 130.86 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 0.0 110.094 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -120.72 120.3 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.349 -0.844 . . . . 0.0 109.201 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 81.5 mtp -122.53 104.72 9.55 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.987 -1.071 . . . . 0.0 109.98 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -108.52 99.35 8.75 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.248 -0.907 . . . . 0.0 108.805 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.477 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 97.4 m-70 -72.53 -36.89 68.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.985 -1.072 . . . . 0.0 110.686 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -60.54 -45.75 92.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.005 -1.059 . . . . 0.0 109.515 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -87.68 -4.83 58.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.142 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.3 m-20 54.93 47.46 22.17 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 110.348 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.562 ' OG1' ' CE1' ' A' ' 96' ' ' TYR . 2.6 t -134.66 141.94 46.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.956 -1.09 . . . . 0.0 109.387 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -129.44 140.34 51.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.42 -0.8 . . . . 0.0 110.01 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.562 ' CE1' ' OG1' ' A' ' 94' ' ' THR . 82.7 m-85 -135.38 146.14 48.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.23 -0.919 . . . . 0.0 109.483 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.4 m -151.43 153.27 34.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 109.231 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.4 mtt-85 -107.9 138.4 44.23 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.071 -1.018 . . . . 0.0 109.419 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 100' ' ' PRO . 60.3 mt -96.0 141.17 22.78 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.828 . . . . 0.0 109.727 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 99' ' ' LEU . 77.9 Cg_exo -45.64 178.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.901 1.734 . . . . 0.0 111.187 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.9 m -85.46 -11.73 53.59 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.035 -1.041 . . . . 0.0 109.689 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.3 tp -124.3 131.14 53.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.007 . . . . 0.0 110.54 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 41.3 mt -147.48 103.82 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 97.4 p -114.0 -0.41 14.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.028 -1.045 . . . . 0.0 109.748 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.556 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 0.4 OUTLIER -89.46 153.66 20.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 0.0 110.071 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -98.43 31.98 2.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.459 -0.776 . . . . 0.0 109.127 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.417 ' CZ2' HD22 ' A' ' 81' ' ' LEU . 16.1 p-90 -65.65 159.21 25.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -0.848 . . . . 0.0 110.493 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.425 ' HZ1' ' CD1' ' A' ' 70' ' ' LEU . 25.4 pttm -146.7 156.82 43.47 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.57 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 43.5 p90 -153.47 163.67 39.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.085 -1.01 . . . . 0.0 108.9 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 6.8 p90 -152.71 163.04 40.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.672 -1.268 . . . . 0.0 111.681 -178.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 87.0 m -130.04 158.64 39.06 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 42.9 t -130.74 143.36 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.66 -1.275 . . . . 0.0 111.774 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 87.8 m -123.36 132.61 54.04 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.3 p -170.76 178.69 3.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.298 -1.501 . . . . 0.0 111.743 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.627 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 46.2 mtmt -154.06 165.55 35.82 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.6 150.89 21.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.78 -1.2 . . . . 0.0 109.123 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.527 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 61.8 t-20 46.47 61.27 2.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.266 -0.897 . . . . 0.0 109.52 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 44.4 mt-10 -165.1 145.43 7.16 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.956 -1.09 . . . . 0.0 110.127 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -60.66 147.73 40.98 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.204 -0.935 . . . . 0.0 109.003 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -93.26 140.8 29.14 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.066 -1.021 . . . . 0.0 110.355 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.2 mt -110.17 122.35 47.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.412 -0.805 . . . . 0.0 109.093 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.96 130.79 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.938 -1.101 . . . . 0.0 110.833 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -109.57 121.46 45.24 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.0 t -137.37 142.15 41.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.666 -1.271 . . . . 0.0 112.029 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.57 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.1 m -135.09 158.04 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -137.12 157.88 45.71 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.89 -1.131 . . . . 0.0 110.128 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.408 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.4 t -103.3 132.81 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -0.893 . . . . 0.0 109.955 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -62.76 117.5 6.41 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.363 -0.935 . . . . 0.0 108.574 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.44 155.7 15.72 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.422 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 4.9 t -100.08 132.01 45.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.562 -0.963 . . . . 0.0 109.493 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.418 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 47.2 t0 -105.05 108.4 19.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.448 -0.783 . . . . 0.0 109.302 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -88.27 -0.99 57.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 108.854 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.421 ' HG1' ' HD3' ' A' ' 53' ' ' PRO . 9.5 m -101.19 -16.56 16.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.492 -0.755 . . . . 0.0 110.434 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.6 m -157.13 124.88 5.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.859 -1.15 . . . . 0.0 110.182 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.493 ' OG ' ' OE1' ' A' ' 12' ' ' GLU . 78.0 p -67.16 -26.9 66.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.369 -0.832 . . . . 0.0 108.98 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.496 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 57.5 mp0 -109.07 72.61 0.82 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 t -74.11 158.59 33.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.407 -0.808 . . . . 0.0 110.137 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -103.23 -48.7 3.94 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.131 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.444 ' H ' HG22 ' A' ' 14' ' ' THR . 24.0 pt -86.78 -12.92 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.574 -0.704 . . . . 0.0 110.16 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.402 ' CD2' HG13 ' A' ' 15' ' ' ILE . 68.0 m-85 -110.4 136.93 48.81 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.153 -0.967 . . . . 0.0 109.606 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 t -74.24 -26.7 60.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.431 -0.793 . . . . 0.0 111.157 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -123.3 134.51 54.05 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.07 -1.019 . . . . 0.0 110.787 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.418 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -144.47 156.13 26.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.422 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 22.5 m-85 . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.333 -1.098 . . . . 0.0 109.647 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.418 HG21 HD12 ' A' ' 36' ' ' ILE . 9.0 mm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.4 t -121.06 126.5 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.0 110.337 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 96.8 m -103.16 102.47 12.46 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.8 m -94.85 120.77 35.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.13 -0.981 . . . . 0.0 109.848 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.82 156.73 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.364 -0.835 . . . . 0.0 109.013 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -100.16 131.84 45.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 109.415 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.07 158.09 15.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 109.57 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 31.5 t60 -134.05 153.25 51.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.207 -0.933 . . . . 0.0 109.53 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.24 -25.03 20.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.349 -0.844 . . . . 0.0 109.772 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -99.74 -25.93 14.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.068 -1.02 . . . . 0.0 109.662 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -75.47 134.57 40.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.88 . . . . 0.0 110.034 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.1 mt -76.24 147.39 38.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 108.661 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.0 pt -116.93 136.57 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.159 -0.963 . . . . 0.0 109.847 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.26 -176.94 47.86 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.438 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 55.6 p90 -164.57 169.77 16.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.087 -1.243 . . . . 0.0 109.858 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -144.17 143.16 30.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.255 -0.903 . . . . 0.0 109.908 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 68.6 m -126.6 152.37 74.47 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.421 ' HD3' ' HG1' ' A' ' 9' ' ' THR . 8.7 Cg_endo -51.4 149.16 17.93 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.404 2.069 . . . . 0.0 112.122 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.4 p -71.73 -11.27 60.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.435 -0.791 . . . . 0.0 110.649 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -90.67 0.24 57.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.9 -1.125 . . . . 0.0 110.129 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.404 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 20.7 m-85 -110.36 165.99 11.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.199 -0.938 . . . . 0.0 110.252 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -102.87 133.45 47.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 0.0 109.107 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.493 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.1 m -91.13 123.53 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.969 -1.082 . . . . 0.0 110.335 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -130.68 129.16 22.64 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.05 113.53 3.44 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.71 1.607 . . . . 0.0 112.046 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.47 ' O ' ' O ' ' A' ' 68' ' ' PHE . 15.9 t-160 -91.06 -26.66 19.05 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.503 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.5 t0 -169.72 37.13 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.541 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 75.9 m -60.38 -155.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.472 -0.767 . . . . 0.0 109.724 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.3 p90 -111.47 -56.66 2.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.141 -0.974 . . . . 0.0 111.316 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 64' ' ' PHE . 78.0 t -47.36 -54.7 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 120.479 -1.388 . . . . 0.0 109.062 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -158.08 129.8 6.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.541 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.01 -179.34 1.99 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.957 -1.09 . . . . 0.0 110.442 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 6.3 m-85 -93.16 123.58 36.53 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -70.66 -173.74 0.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 109.787 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.61 -21.49 66.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.272 -0.892 . . . . 0.0 109.018 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.7 m -82.44 -7.05 59.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.347 -0.846 . . . . 0.0 108.885 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.41 19.83 65.62 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -102.86 138.78 39.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.212 -1.169 . . . . 0.0 108.999 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -83.7 108.33 16.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 110.004 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -144.2 138.74 28.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.852 . . . . 0.0 109.85 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 77' ' ' LEU . 55.1 t-20 -59.78 145.55 44.87 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.298 -0.876 . . . . 0.0 108.954 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.467 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 13.4 tp -97.32 7.44 46.55 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.292 -0.88 . . . . 0.0 109.845 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.449 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -70.12 -37.99 75.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.065 -1.022 . . . . 0.0 110.058 -179.539 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -62.72 -32.73 73.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.044 -1.035 . . . . 0.0 109.156 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt -72.41 -50.21 28.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.853 . . . . 0.0 109.634 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.406 HD21 ' CZ2' ' A' ' 107' ' ' TRP . 19.2 tp -139.3 128.81 24.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.487 -0.758 . . . . 0.0 109.074 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -78.99 88.28 4.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.988 . . . . 0.0 109.639 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.21 150.82 41.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.357 -0.839 . . . . 0.0 109.936 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.2 p -127.14 164.33 21.86 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.512 -0.742 . . . . 0.0 109.176 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.424 HD21 ' HG3' ' A' ' 98' ' ' ARG . 78.7 m-20 56.1 53.15 9.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 0.0 109.942 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.5 mt -79.68 125.17 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -0.825 . . . . 0.0 109.918 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.4 HG23 HD13 ' A' ' 87' ' ' ILE . 44.7 mm -123.14 121.99 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.5 -0.75 . . . . 0.0 109.265 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 84.6 mtp -123.25 103.37 8.49 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.108 -0.995 . . . . 0.0 109.696 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -110.98 101.36 9.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.378 -0.826 . . . . 0.0 109.037 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.499 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 91.8 m-70 -72.96 -35.78 66.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.876 -1.14 . . . . 0.0 110.686 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -60.19 -45.91 91.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.942 -1.099 . . . . 0.0 109.572 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -89.87 -4.35 57.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.925 . . . . 0.0 109.064 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.499 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 97.7 m-20 54.52 47.91 21.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.424 -0.798 . . . . 0.0 110.167 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.574 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 2.5 t -133.35 138.64 46.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.171 -0.956 . . . . 0.0 109.451 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.438 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 65.2 m-85 -129.06 140.64 51.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.402 -0.811 . . . . 0.0 109.915 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.574 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 72.1 m-85 -137.74 148.89 46.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.45 -0.781 . . . . 0.0 109.383 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 63.8 m -152.49 155.1 36.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.092 -1.005 . . . . 0.0 109.172 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.424 ' HG3' HD21 ' A' ' 85' ' ' ASN . 16.6 mmt180 -102.53 136.08 42.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.188 -0.945 . . . . 0.0 109.732 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 100' ' ' PRO . 68.2 mt -89.92 136.78 28.72 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.803 -0.56 . . . . 0.0 109.699 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 99' ' ' LEU . 77.9 Cg_exo -45.87 176.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 121.848 1.699 . . . . 0.0 111.188 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.2 m -85.63 -14.66 44.93 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.099 -1.0 . . . . 0.0 109.925 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 47.6 tp -121.04 130.43 53.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.189 -0.945 . . . . 0.0 110.523 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 43.9 mt -149.84 102.88 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.5 p -120.01 3.68 10.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.202 -0.936 . . . . 0.0 109.722 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.518 ' O ' ' OXT' ' A' ' 127' ' ' ALA . 27.9 t70 -93.72 158.97 15.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.97 . . . . 0.0 109.933 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -96.15 33.8 1.68 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.455 -0.778 . . . . 0.0 109.045 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.406 ' CZ2' HD21 ' A' ' 81' ' ' LEU . 12.4 p-90 -65.21 154.27 38.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 110.635 -178.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -145.86 155.46 42.91 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.602 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 42.0 p90 -154.35 162.63 41.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.133 -0.979 . . . . 0.0 108.753 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 6.1 p90 -152.79 162.32 41.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.69 -1.256 . . . . 0.0 111.833 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 95.2 m -127.63 157.66 39.64 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 42.2 t -130.01 142.62 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.768 -1.208 . . . . 0.0 111.789 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 72.2 m -123.39 132.44 53.97 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.0 p -171.19 178.63 3.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.239 -1.538 . . . . 0.0 111.691 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.59 ' NZ ' ' OE2' ' A' ' 118' ' ' GLU . 7.3 mtmp? -153.41 164.75 37.61 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 117' ' ' ASN . 99.7 m-20 -57.76 152.28 15.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.771 -1.206 . . . . 0.0 109.195 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.515 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 66.8 t30 44.68 60.73 2.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.217 -0.927 . . . . 0.0 109.669 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.59 ' OE2' ' NZ ' ' A' ' 115' ' ' LYS . 36.8 mt-10 -165.37 145.71 6.97 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.136 -0.977 . . . . 0.0 110.178 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -63.67 136.2 57.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.25 -0.906 . . . . 0.0 109.038 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -85.26 146.12 27.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.226 -0.922 . . . . 0.0 110.406 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.1 mt -111.16 123.71 50.74 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.498 -0.751 . . . . 0.0 109.177 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.0 t -109.03 130.34 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.022 -1.049 . . . . 0.0 110.617 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -110.69 122.62 48.24 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.9 t -137.84 143.28 40.9 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.835 -1.166 . . . . 0.0 112.208 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.602 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.1 m -134.75 156.9 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -134.79 155.58 50.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.982 -1.074 . . . . 0.0 110.272 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.518 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.086 -0.959 . . . . 0.0 109.393 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 mmtp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.92 133.54 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.708 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.61 ' NZ ' ' OD2' ' A' ' 46' ' ' ASP . 2.0 mptm? -74.72 125.49 28.85 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.047 -1.033 . . . . 0.0 108.95 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.95 179.05 44.33 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.436 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 4.8 t -115.97 132.23 56.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.483 -1.01 . . . . 0.0 109.316 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.461 ' CG ' ' OG ' ' A' ' 13' ' ' SER . 29.5 t70 -108.19 109.63 21.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.496 -0.752 . . . . 0.0 109.422 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 91.0 m-85 -89.83 0.05 57.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.227 -0.921 . . . . 0.0 108.857 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.0 m -101.88 -17.88 15.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.566 -0.709 . . . . 0.0 110.505 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.8 m -156.87 125.22 5.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.878 -1.139 . . . . 0.0 110.249 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.0 p -66.85 -24.84 66.19 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.629 -0.829 . . . . 0.0 108.97 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -115.0 74.59 0.89 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.461 ' OG ' ' CG ' ' A' ' 7' ' ' ASP . 20.0 m -71.81 152.39 42.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.83 . . . . 0.0 110.398 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.77 0.29 38.54 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.8 pt -125.27 -23.83 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.646 -0.659 . . . . 0.0 110.292 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -111.78 140.99 45.96 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.243 -0.911 . . . . 0.0 109.92 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.1 p -72.54 -18.42 61.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.589 -0.694 . . . . 0.0 111.045 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -132.14 143.14 49.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.015 -1.053 . . . . 0.0 110.847 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.81 159.91 28.73 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.436 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 32.4 m-85 . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.442 -1.034 . . . . 0.0 109.594 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.413 ' O ' ' N ' ' A' ' 122' ' ' VAL . 20.2 mm . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.1 t -121.68 126.52 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.277 -0.889 . . . . 0.0 110.173 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.44 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 84.3 m -102.18 100.8 11.05 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.8 m -93.87 119.58 32.99 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.141 -0.974 . . . . 0.0 109.659 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.0 m -141.95 153.86 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.49 -0.756 . . . . 0.0 109.232 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -95.25 133.88 38.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.116 -0.99 . . . . 0.0 109.142 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.47 124.06 50.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.457 -0.777 . . . . 0.0 109.734 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.429 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 28.2 t60 -86.72 148.2 25.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.84 . . . . 0.0 109.542 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 100' ' ' PRO . . . -50.17 -34.26 21.9 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.22 -0.925 . . . . 0.0 109.779 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -89.88 -17.63 27.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.273 -0.892 . . . . 0.0 109.423 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.61 ' OD2' ' NZ ' ' A' ' 4' ' ' LYS . 76.4 m-20 -75.7 136.83 40.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.432 -0.793 . . . . 0.0 110.07 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.3 mt -77.31 145.41 37.41 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.0 pt -121.32 143.21 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.264 -0.898 . . . . 0.0 110.191 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.21 -174.07 46.07 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.613 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 50.8 p90 -170.52 169.62 7.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -1.225 . . . . 0.0 109.831 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -146.17 144.54 30.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.306 -0.871 . . . . 0.0 109.861 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 40.8 m -125.01 153.93 71.29 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.403 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 9.0 Cg_endo -51.51 144.78 31.27 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.337 2.025 . . . . 0.0 112.167 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.6 t -68.3 -13.85 62.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.453 -0.779 . . . . 0.0 110.636 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.632 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.9 m-20 -89.95 1.73 55.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.89 -1.131 . . . . 0.0 110.039 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.403 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 18.9 m-85 -110.79 165.93 11.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.099 -1.001 . . . . 0.0 110.446 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.506 ' OG ' ' OE2' ' A' ' 59' ' ' GLU . 39.5 t -102.7 132.92 48.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.344 -0.847 . . . . 0.0 108.96 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.506 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.4 m -89.73 120.31 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.992 -1.067 . . . . 0.0 110.346 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 59' ' ' GLU . 35.0 mp0 -127.69 128.08 23.95 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.22 114.3 3.53 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.683 1.588 . . . . 0.0 112.106 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.493 ' O ' ' O ' ' A' ' 68' ' ' PHE . 9.3 t-80 -91.17 -25.33 19.61 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 63' ' ' CYS . 67.4 t0 -171.85 36.43 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.495 ' O ' ' O ' ' A' ' 62' ' ' ASP . 96.5 m -57.13 -155.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.548 -0.72 . . . . 0.0 109.651 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 4.0 p90 -108.77 -56.27 2.29 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.037 -1.04 . . . . 0.0 111.173 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 64' ' ' PHE . 53.2 t -46.49 -73.42 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.479 -1.388 . . . . 0.0 108.865 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.2 t -140.21 130.71 25.47 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.424 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.19 -178.41 2.07 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.464 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 5.0 m-85 -93.82 128.84 40.28 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -76.45 -174.57 2.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.953 -1.092 . . . . 0.0 109.741 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.4 -20.55 65.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.275 -0.891 . . . . 0.0 109.21 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.9 m -83.38 -6.85 59.59 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.32 19.61 66.3 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -101.43 136.74 40.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -1.167 . . . . 0.0 109.145 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -84.94 112.98 21.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.122 -0.986 . . . . 0.0 110.097 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -150.12 141.55 23.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.41 -0.806 . . . . 0.0 109.983 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 77' ' ' LEU . 56.0 t-20 -61.61 146.71 48.07 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.4 -0.812 . . . . 0.0 109.215 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.539 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 6.6 tp -99.69 6.11 45.63 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.288 -0.882 . . . . 0.0 109.8 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.439 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.8 OUTLIER -75.52 -39.02 58.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.97 -1.081 . . . . 0.0 109.983 -179.449 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 56.5 p30 -59.26 -14.21 10.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.131 -0.981 . . . . 0.0 109.165 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 31.0 ttpt -107.0 -36.17 6.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.382 -0.824 . . . . 0.0 109.327 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.1 tp -123.92 129.5 51.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.42 -0.8 . . . . 0.0 109.339 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -73.31 83.46 1.4 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.039 -1.038 . . . . 0.0 109.285 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.3 mt -69.32 130.11 41.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.224 -0.923 . . . . 0.0 109.959 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.3 p -133.86 151.71 51.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.397 -0.814 . . . . 0.0 109.302 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 52.82 50.69 17.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.098 -1.001 . . . . 0.0 109.58 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.6 mt -78.73 130.37 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.327 -0.858 . . . . 0.0 110.085 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mm -117.85 118.84 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.473 -0.767 . . . . 0.0 109.276 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 81.0 mtp -124.17 108.09 11.92 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.286 -0.884 . . . . 0.0 109.822 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -113.93 102.17 9.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.362 -0.836 . . . . 0.0 109.05 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.501 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 70.2 m80 -72.33 -35.74 68.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.898 -1.126 . . . . 0.0 110.488 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -60.7 -44.86 96.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.874 -1.141 . . . . 0.0 109.457 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -89.41 -5.72 57.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.134 -0.979 . . . . 0.0 109.129 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.501 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.3 m-20 55.36 47.47 21.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.576 -0.702 . . . . 0.0 110.392 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.594 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 2.8 t -132.3 137.5 47.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.146 -0.971 . . . . 0.0 109.404 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.613 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 23.8 m-85 -127.28 139.41 52.92 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.372 -0.83 . . . . 0.0 109.818 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.594 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 81.2 m-85 -135.9 147.01 47.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.21 -0.932 . . . . 0.0 109.358 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.6 t -150.86 150.9 31.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.953 -1.092 . . . . 0.0 109.174 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.405 HH11 ' HG2' ' A' ' 98' ' ' ARG . 60.7 mtt-85 -101.68 134.41 44.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.044 -1.035 . . . . 0.0 109.476 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 94.7 mt -93.39 139.22 22.86 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.436 -0.79 . . . . 0.0 109.5 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.433 ' O ' ' CB ' ' A' ' 44' ' ' ALA . 77.0 Cg_exo -46.36 163.22 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.853 1.702 . . . . 0.0 111.222 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 m -76.34 -10.15 59.19 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.1 -1.0 . . . . 0.0 109.696 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.8 tp -136.42 129.29 30.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.152 -0.968 . . . . 0.0 110.339 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.473 HD11 HG21 ' A' ' 103' ' ' ILE . 88.7 mt -145.69 106.92 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 108.893 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.3 p -100.53 -2.81 32.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.048 -1.032 . . . . 0.0 109.899 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -88.45 156.13 19.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.99 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -105.02 33.2 3.75 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.452 -0.78 . . . . 0.0 109.135 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 24.4 p-90 -65.77 161.53 20.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.141 -0.974 . . . . 0.0 110.625 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -143.54 160.68 40.19 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.622 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 36.4 p90 -155.09 160.65 41.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.17 -0.956 . . . . 0.0 108.674 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.518 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 5.0 p90 -151.67 159.93 43.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.778 -1.201 . . . . 0.0 111.892 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 96.7 m -125.0 156.5 38.01 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.8 t -130.58 143.65 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.839 -1.163 . . . . 0.0 111.764 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 63.4 m -124.66 132.95 53.38 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.6 p -167.62 178.08 5.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.25 -1.531 . . . . 0.0 111.694 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.632 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 46.5 mtmt -155.31 165.04 37.88 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 117' ' ' ASN . 98.2 m-20 -58.69 150.95 22.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.827 -1.171 . . . . 0.0 109.116 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.492 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 64.5 t30 44.53 60.95 2.62 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.232 -0.917 . . . . 0.0 109.639 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 40.4 mt-10 -164.48 144.72 7.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.132 -0.98 . . . . 0.0 110.216 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -63.28 136.66 57.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.197 -0.939 . . . . 0.0 109.111 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.3 pttm -84.26 144.8 28.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.249 -0.907 . . . . 0.0 110.575 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 72.7 mt -110.92 123.67 50.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.583 -0.698 . . . . 0.0 109.181 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' A' ' 36' ' ' ILE . 45.3 t -109.9 130.94 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.01 -1.056 . . . . 0.0 110.679 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -110.37 122.53 47.92 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 38' ' ' CYS . 7.6 t -137.86 142.85 40.71 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.795 -1.191 . . . . 0.0 112.163 -178.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.622 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -136.12 158.18 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -124.01 145.21 49.35 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.106 -0.996 . . . . 0.0 110.415 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.279 179.792 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 69.4 t -106.12 134.32 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.162 -0.962 . . . . 0.0 110.042 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -70.47 124.04 23.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.065 -1.022 . . . . 0.0 108.371 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.18 164.79 30.39 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.471 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 4.4 t -107.59 138.04 44.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.621 -0.929 . . . . 0.0 109.386 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.445 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 67.3 t0 -114.81 109.01 17.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.446 -0.784 . . . . 0.0 109.36 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -86.32 -0.73 56.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 108.928 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.427 ' OG1' ' N ' ' A' ' 53' ' ' PRO . 17.1 m -99.66 -17.92 17.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.638 -0.663 . . . . 0.0 110.5 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.3 m -158.24 127.64 5.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.769 -1.207 . . . . 0.0 110.263 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.7 p -62.5 -28.08 69.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -0.953 . . . . 0.0 108.973 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -109.24 108.4 18.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 15' ' ' ILE . 74.4 m -107.63 109.5 21.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 110.376 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.84 2.58 1.35 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.524 ' H ' ' C ' ' A' ' 13' ' ' SER . 6.9 pt -124.48 -30.28 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.598 -0.689 . . . . 0.0 110.374 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.484 ' CZ ' ' CE2' ' A' ' 96' ' ' TYR . 54.5 m-85 -112.67 144.63 41.86 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.129 -0.982 . . . . 0.0 110.145 -179.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.0 p -75.11 -22.34 58.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.567 -0.708 . . . . 0.0 110.837 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -119.96 129.22 54.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.869 -1.144 . . . . 0.0 110.644 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -140.7 154.23 24.15 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.471 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 24.2 m-85 . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.354 -1.086 . . . . 0.0 109.53 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.461 HG21 HD12 ' A' ' 36' ' ' ILE . 46.3 mm . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.4 t -121.51 130.37 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.121 -0.987 . . . . 0.0 110.445 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.434 ' O ' ' O ' ' A' ' 124' ' ' THR . 61.1 m -101.79 101.39 11.86 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.8 m -94.08 119.18 32.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.848 -1.157 . . . . 0.0 109.649 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.4 156.54 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.475 -0.766 . . . . 0.0 109.118 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -99.05 131.59 44.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.929 . . . . 0.0 109.561 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.56 152.48 21.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.553 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.652 ' HD1' ' H ' ' A' ' 45' ' ' ASN . 47.4 t-80 -124.1 153.53 41.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.358 -0.839 . . . . 0.0 109.515 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.05 -26.1 47.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.368 -0.832 . . . . 0.0 109.772 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.652 ' H ' ' HD1' ' A' ' 43' ' ' HIS . 66.9 t30 -96.91 -23.67 16.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.954 . . . . 0.0 109.61 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -78.96 136.74 37.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.948 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.9 mt -78.78 150.36 32.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 0.0 108.669 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.9 pt -121.66 143.55 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.06 -1.025 . . . . 0.0 110.111 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.5 -172.72 45.49 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -170.49 169.9 7.16 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.007 -1.29 . . . . 0.0 109.713 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -145.11 144.03 30.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.296 -0.878 . . . . 0.0 109.816 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 86.0 m -123.45 151.99 63.97 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.427 ' N ' ' OG1' ' A' ' 9' ' ' THR . 8.6 Cg_endo -51.59 144.41 33.19 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.363 2.042 . . . . 0.0 111.949 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -66.64 -13.82 61.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.52 -0.738 . . . . 0.0 110.535 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.608 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 82.3 m-20 -89.93 0.66 56.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.922 -1.111 . . . . 0.0 110.161 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.409 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 19.0 m-85 -110.97 165.73 11.62 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.267 -0.896 . . . . 0.0 110.187 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.7 m -102.28 140.46 36.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.388 -0.82 . . . . 0.0 109.294 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.506 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.8 m -97.21 118.42 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.002 -1.061 . . . . 0.0 110.369 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.446 ' N ' ' OE1' ' A' ' 59' ' ' GLU . 5.6 mp0 -125.09 126.77 25.18 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.17 114.39 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.658 1.572 . . . . 0.0 112.142 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -93.66 -24.32 17.92 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.2 t0 -170.94 40.07 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.451 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 88.5 m -63.97 -152.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.608 -0.682 . . . . 0.0 109.89 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.3 p90 -110.3 -58.19 2.11 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.118 -0.989 . . . . 0.0 111.252 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.447 ' C ' ' O ' ' A' ' 64' ' ' PHE . 27.6 t -45.82 -70.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.568 -1.332 . . . . 0.0 108.807 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.4 t -142.54 132.48 24.33 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.451 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -171.83 179.59 2.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.929 -1.107 . . . . 0.0 110.419 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.7 m-85 -93.76 140.44 29.66 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.402 HD22 ' HG2' ' A' ' 75' ' ' GLU . 99.8 m-20 -80.7 -171.12 2.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.895 -1.128 . . . . 0.0 109.9 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.2 mt -65.99 -15.8 63.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.353 -0.842 . . . . 0.0 109.134 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.496 ' OG ' ' NZ ' ' A' ' 73' ' ' LYS . 32.5 t -86.47 -7.15 58.65 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.322 -0.861 . . . . 0.0 108.878 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.57 20.2 66.81 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.496 ' NZ ' ' OG ' ' A' ' 71' ' ' SER . 64.6 mttp -107.28 140.47 40.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -1.147 . . . . 0.0 109.068 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -63.66 134.15 54.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.135 -0.978 . . . . 0.0 109.933 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.402 ' HG2' HD22 ' A' ' 69' ' ' ASN . 34.5 tp10 -154.19 163.81 39.53 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.313 -0.867 . . . . 0.0 109.446 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.401 ' H ' ' HG3' ' A' ' 75' ' ' GLU . 4.4 m120 -107.35 138.79 42.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.251 -0.906 . . . . 0.0 109.52 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 tp -97.06 -16.01 20.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.079 -1.013 . . . . 0.0 109.828 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -61.1 -43.65 98.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.894 -1.129 . . . . 0.0 109.521 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -65.09 -13.51 58.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.042 -1.036 . . . . 0.0 108.887 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -100.41 -41.66 6.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.384 -0.823 . . . . 0.0 109.162 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.403 HD23 ' CZ2' ' A' ' 107' ' ' TRP . 37.1 tp -125.83 126.39 44.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 109.133 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -81.03 83.83 6.63 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.081 -1.012 . . . . 0.0 109.378 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.1 mt -77.21 143.93 38.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.312 -0.868 . . . . 0.0 109.955 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.7 p -127.78 158.23 38.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.554 -0.716 . . . . 0.0 109.308 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.817 HD21 HH11 ' A' ' 98' ' ' ARG . 88.4 m-20 55.22 51.54 13.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.95 . . . . 0.0 109.699 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.75 129.84 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 110.107 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.2 mm -118.22 118.8 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.447 -0.783 . . . . 0.0 109.271 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 80.2 mtp -120.52 103.34 9.08 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.28 -0.887 . . . . 0.0 109.74 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -110.6 99.63 8.57 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.252 -0.905 . . . . 0.0 109.041 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.482 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 61.8 m80 -72.3 -35.99 68.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.107 -0.996 . . . . 0.0 110.549 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -60.32 -45.02 94.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.912 -1.117 . . . . 0.0 109.516 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -89.5 -4.94 57.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 109.031 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.482 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.0 m-20 54.82 48.46 20.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.495 -0.753 . . . . 0.0 110.17 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.543 ' OG1' ' CE1' ' A' ' 96' ' ' TYR . 3.3 t -134.22 140.14 46.28 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.026 -1.046 . . . . 0.0 109.343 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -129.43 140.72 51.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.489 -0.757 . . . . 0.0 110.206 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.543 ' CE1' ' OG1' ' A' ' 94' ' ' THR . 83.6 m-85 -136.18 146.85 47.3 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.417 -0.802 . . . . 0.0 109.537 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.1 p -152.64 159.44 43.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.981 -1.074 . . . . 0.0 109.172 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.817 HH11 HD21 ' A' ' 85' ' ' ASN . 71.0 mtp180 -108.44 137.9 45.64 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.096 -1.003 . . . . 0.0 109.339 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.3 mt -92.86 137.54 23.91 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.405 -0.809 . . . . 0.0 109.543 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -45.86 170.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.836 1.69 . . . . 0.0 111.309 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.3 m -79.69 -10.61 59.81 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.101 -1.0 . . . . 0.0 109.754 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.6 tp -136.11 129.93 32.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.225 -0.922 . . . . 0.0 110.432 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.6 mt -147.37 102.37 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.235 -0.916 . . . . 0.0 108.643 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.7 m -102.83 -6.91 22.04 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.017 -1.052 . . . . 0.0 109.8 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 127' ' ' ALA . 84.7 m-20 -81.42 154.36 26.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.169 -0.957 . . . . 0.0 110.013 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -103.51 33.74 3.24 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.417 -0.802 . . . . 0.0 109.091 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.403 ' CZ2' HD23 ' A' ' 81' ' ' LEU . 23.5 p-90 -64.98 152.66 42.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 110.452 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.24 153.96 51.09 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.639 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 30.6 p90 -152.4 162.35 41.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.999 -1.063 . . . . 0.0 108.698 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 8.2 p90 -154.1 160.77 42.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.729 -1.232 . . . . 0.0 111.792 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 97.5 m -125.61 156.45 39.16 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.45 139.1 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.881 -1.137 . . . . 0.0 111.79 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 93.5 m -122.15 131.87 54.17 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.5 p -170.2 178.55 3.79 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.176 -1.578 . . . . 0.0 111.663 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.608 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 50.0 mtmt -151.7 163.38 39.25 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -58.55 151.25 20.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.775 -1.203 . . . . 0.0 109.078 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.52 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 60.5 t-20 46.35 61.19 2.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.228 -0.92 . . . . 0.0 109.47 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 37.3 mt-10 -165.73 146.3 6.79 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.127 -0.983 . . . . 0.0 110.233 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -61.84 134.75 57.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.168 -0.958 . . . . 0.0 109.089 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -81.57 143.31 32.08 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.118 -0.989 . . . . 0.0 110.328 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 58.7 mt -110.75 122.87 48.89 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 52.6 t -110.07 131.14 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.883 -1.135 . . . . 0.0 110.79 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -109.0 120.52 42.79 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 38' ' ' CYS . 7.2 t -137.08 141.25 42.37 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.933 -1.105 . . . . 0.0 111.892 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.639 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -135.92 159.47 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -124.9 146.68 49.21 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.161 -0.962 . . . . 0.0 110.423 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.31 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.2 t -93.91 133.05 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 109.983 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.58 ' NZ ' ' OD2' ' A' ' 46' ' ' ASP . 96.7 mttt -72.85 127.18 31.8 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.735 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.77 166.18 32.26 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.442 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 5.2 t -104.96 131.9 51.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.422 -1.046 . . . . 0.0 109.471 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -110.88 109.44 19.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.494 -0.754 . . . . 0.0 109.424 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -87.17 1.1 54.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 108.942 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.4 m -105.24 -17.17 14.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.561 -0.712 . . . . 0.0 110.461 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.9 m -153.7 121.23 5.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.823 -1.173 . . . . 0.0 110.311 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.6 p -62.87 -29.79 71.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 108.911 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -109.98 73.02 0.82 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 19.8 p -71.9 111.84 7.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.261 -0.899 . . . . 0.0 110.315 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.0 t -69.4 2.86 2.65 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.481 ' H ' ' C ' ' A' ' 13' ' ' SER . 4.8 pt -123.61 -32.24 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.711 -0.618 . . . . 0.0 110.394 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.483 ' O ' ' OG ' ' A' ' 13' ' ' SER . 86.6 m-85 -106.6 145.67 31.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.212 -0.93 . . . . 0.0 109.812 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.1 m -71.34 -25.29 62.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.511 -0.743 . . . . 0.0 110.886 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -125.19 136.03 53.18 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.925 -1.109 . . . . 0.0 110.52 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -142.89 158.33 27.1 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.442 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 22.6 m-85 . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.346 -1.091 . . . . 0.0 109.648 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.1 mm . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.2 t -114.36 124.89 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.348 -0.845 . . . . 0.0 110.213 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 83.1 m -102.26 101.92 12.26 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.8 m -97.4 121.96 39.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.072 -1.017 . . . . 0.0 109.588 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.1 m -139.38 155.5 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.408 -0.807 . . . . 0.0 109.024 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -95.94 123.76 39.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.324 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.99 161.99 17.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.7 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.621 ' HD1' ' H ' ' A' ' 45' ' ' ASN . 30.4 t-80 -139.99 148.4 41.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.908 . . . . 0.0 109.6 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.71 -24.2 33.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.362 -0.837 . . . . 0.0 109.745 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.621 ' H ' ' HD1' ' A' ' 43' ' ' HIS . 63.1 t-20 -98.96 -27.72 13.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.05 -1.031 . . . . 0.0 109.704 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.58 ' OD2' ' NZ ' ' A' ' 4' ' ' LYS . 88.3 m-20 -77.41 137.12 38.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.531 -0.731 . . . . 0.0 110.099 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.6 mt -78.23 148.28 34.03 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.448 HG23 HD13 ' A' ' 48' ' ' ILE . 47.2 pt -121.59 143.3 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.06 -1.025 . . . . 0.0 110.126 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.22 -176.14 47.22 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 50.5 p90 -164.9 170.37 15.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.126 -1.22 . . . . 0.0 109.75 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -148.33 146.08 28.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 109.936 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.4 m -126.21 152.17 73.16 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.415 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.3 Cg_endo -51.44 153.53 10.14 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.322 2.014 . . . . 0.0 111.867 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.5 m -72.5 -10.64 60.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.449 -0.782 . . . . 0.0 110.7 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.62 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.9 m-20 -92.4 -2.26 56.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.993 -1.067 . . . . 0.0 110.173 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.415 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 18.6 m-85 -108.69 164.58 12.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.158 -0.964 . . . . 0.0 110.346 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 t -105.11 135.13 47.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.331 -0.855 . . . . 0.0 109.119 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.493 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 3.0 m -92.6 119.87 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.993 -1.067 . . . . 0.0 110.316 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -123.36 126.4 25.88 Favored Pre-proline 0 N--CA 1.489 1.522 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.13 114.25 3.54 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.721 1.614 . . . . 0.0 112.144 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 68' ' ' PHE . 16.5 t-80 -93.71 -24.26 17.91 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.0 t0 -170.18 40.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.453 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 89.1 m -63.6 -154.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.524 -0.735 . . . . 0.0 109.887 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 4.3 p90 -110.56 -57.28 2.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.122 -0.986 . . . . 0.0 111.388 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 64' ' ' PHE . 34.7 t -46.12 -59.12 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.562 -1.336 . . . . 0.0 108.963 -179.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.1 t -156.85 133.86 10.36 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.453 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.0 -178.14 2.07 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.396 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.3 m-85 -93.63 143.25 26.48 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . 0.678 HD22 ' CB ' ' A' ' 75' ' ' GLU . 82.9 m-20 -84.77 -169.2 2.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.112 -0.993 . . . . 0.0 109.828 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.2 mp -66.85 -15.32 63.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.362 -0.836 . . . . 0.0 108.936 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.8 p -89.62 -8.35 52.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.916 . . . . 0.0 108.693 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.25 22.25 57.29 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -107.16 138.9 42.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.278 -1.13 . . . . 0.0 109.126 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -67.97 136.42 53.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.419 -0.8 . . . . 0.0 109.988 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.678 ' CB ' HD22 ' A' ' 69' ' ' ASN . 68.1 tt0 -155.33 165.84 35.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 109.594 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -103.93 135.6 45.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.448 -0.782 . . . . 0.0 109.452 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.7 tp -97.61 -10.04 25.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.115 -0.99 . . . . 0.0 109.98 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -60.28 -44.57 95.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.944 -1.097 . . . . 0.0 109.638 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -64.83 -21.8 66.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.101 -1.0 . . . . 0.0 108.927 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -81.0 -48.42 12.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.437 -0.79 . . . . 0.0 109.283 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 44.0 tp -127.06 128.69 46.68 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.522 -0.737 . . . . 0.0 109.111 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -73.91 83.96 1.71 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.031 -1.043 . . . . 0.0 109.198 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.6 mt -80.37 135.25 36.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -0.828 . . . . 0.0 110.026 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.9 p -126.78 162.21 26.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.601 -0.687 . . . . 0.0 109.201 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 54.82 50.95 14.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 109.574 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.53 131.33 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.331 -0.856 . . . . 0.0 110.124 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -119.49 120.01 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.461 -0.774 . . . . 0.0 109.246 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 71.9 mtp -122.51 105.33 10.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.111 -0.993 . . . . 0.0 109.745 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -110.81 100.79 9.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.367 -0.833 . . . . 0.0 109.0 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.453 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 95.5 m-70 -73.25 -34.61 65.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.964 -1.085 . . . . 0.0 110.583 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -60.47 -45.8 92.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.862 -1.149 . . . . 0.0 109.63 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -89.64 -3.89 58.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.129 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 97.5 m-20 55.06 48.07 20.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.585 -0.697 . . . . 0.0 110.326 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.597 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 1.9 t -133.43 138.89 46.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.99 -1.068 . . . . 0.0 109.458 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 75.3 m-85 -126.93 139.06 53.34 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.323 -0.861 . . . . 0.0 109.93 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.597 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 73.4 m-85 -135.39 146.23 48.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.257 -0.902 . . . . 0.0 109.427 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 53.9 m -150.05 151.95 34.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.094 -1.004 . . . . 0.0 109.189 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' ' 98' ' ' ARG . 59.0 mtt-85 -103.55 135.64 44.76 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.062 -1.024 . . . . 0.0 109.415 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.8 mt -89.81 137.18 28.53 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.478 -0.764 . . . . 0.0 109.607 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -46.39 162.09 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.777 1.651 . . . . 0.0 111.329 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.0 m -71.36 -17.43 62.43 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.115 -0.991 . . . . 0.0 109.713 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.2 tp -132.46 130.71 40.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.236 -0.915 . . . . 0.0 110.39 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.7 mt -142.78 125.56 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.321 -0.862 . . . . 0.0 108.713 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.9 p -131.5 54.28 1.93 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.041 -1.037 . . . . 0.0 109.755 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.603 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 7.1 t0 -145.24 151.06 37.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 109.954 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.603 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 99.8 m-20 -91.33 33.66 0.98 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.492 -0.755 . . . . 0.0 109.039 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.589 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 12.8 p-90 -64.86 150.19 48.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.167 -0.958 . . . . 0.0 110.514 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.6 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 12.9 tttp -139.85 151.95 46.09 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.637 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 32.1 p90 -156.07 162.61 40.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.028 -1.045 . . . . 0.0 108.72 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 10.1 p90 -153.89 158.62 41.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.679 -1.263 . . . . 0.0 111.785 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 98.1 m -123.15 156.49 34.94 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.5 139.19 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 120.955 -1.09 . . . . 0.0 111.678 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 23.2 m -122.14 131.61 54.05 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 71.6 p -172.01 179.18 2.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.325 -1.484 . . . . 0.0 111.573 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.62 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 49.8 mtmt -150.72 163.17 39.21 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 117' ' ' ASN . 55.2 p-10 -58.13 154.38 13.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.751 -1.218 . . . . 0.0 109.214 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.508 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 66.3 t30 43.43 60.33 2.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.208 -0.932 . . . . 0.0 109.641 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 36.8 mt-10 -165.31 146.01 7.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.14 -0.975 . . . . 0.0 110.205 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -57.41 144.27 37.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.232 -0.918 . . . . 0.0 108.904 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -91.9 139.74 30.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.175 -0.953 . . . . 0.0 110.382 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.5 mt -108.04 120.43 42.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.374 -0.828 . . . . 0.0 109.043 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.9 t -109.01 129.88 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.968 -1.083 . . . . 0.0 110.493 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -108.27 120.42 42.33 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.6 ' OG1' ' NZ ' ' A' ' 108' ' ' LYS . 12.9 t -136.26 140.93 43.82 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.889 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.637 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.1 m -134.88 156.47 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -129.97 150.5 51.22 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.158 -0.964 . . . . 0.0 110.3 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.51 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.277 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 51.7 t -104.48 130.82 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.236 -0.915 . . . . 0.0 109.904 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.461 ' N ' ' CD ' ' A' ' 4' ' ' LYS . 3.6 mptp? -68.54 122.96 19.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.159 -0.963 . . . . 0.0 108.791 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.52 175.39 44.71 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -116.11 130.78 56.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.453 -1.028 . . . . 0.0 109.479 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.512 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 40.5 t0 -108.23 109.47 20.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.447 -0.783 . . . . 0.0 109.269 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.47 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 91.8 m-85 -88.29 0.89 55.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.151 -0.968 . . . . 0.0 108.977 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.2 m -102.12 -17.02 16.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.592 -0.692 . . . . 0.0 110.685 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.4 m -158.08 128.38 6.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.868 -1.145 . . . . 0.0 110.292 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.443 ' OG ' ' C ' ' A' ' 20' ' ' TYR . 13.7 m -68.11 -25.45 65.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.895 . . . . 0.0 108.934 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -114.35 74.28 0.87 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 108.928 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.512 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 7.8 m -70.01 151.94 44.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 110.248 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.03 -0.08 39.91 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.8 pt -125.25 -25.01 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.7 -0.625 . . . . 0.0 110.176 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -111.58 139.64 46.85 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.033 -1.042 . . . . 0.0 109.912 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.2 m -71.85 -18.09 62.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.555 -0.716 . . . . 0.0 110.649 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -131.22 142.13 50.13 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.789 -1.194 . . . . 0.0 110.636 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -162.33 166.35 36.45 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.443 ' C ' ' OG ' ' A' ' 11' ' ' SER . 70.8 m-85 . . . . . 0 N--CA 1.495 1.779 0 O-C-N 121.316 -1.108 . . . . 0.0 109.586 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.7 mm . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.1 t -120.97 129.84 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.061 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.47 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 91.1 m -100.8 99.56 10.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.0 m -95.87 121.07 37.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.933 -1.104 . . . . 0.0 109.489 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.8 m -141.34 155.84 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.401 -0.812 . . . . 0.0 109.246 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -96.08 129.52 43.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.945 . . . . 0.0 109.387 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.02 154.53 18.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.304 -0.872 . . . . 0.0 109.626 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.606 ' HD1' ' H ' ' A' ' 45' ' ' ASN . 32.4 t-80 -126.56 151.84 47.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.336 -0.852 . . . . 0.0 109.558 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.17 -25.11 30.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.883 . . . . 0.0 109.789 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.606 ' H ' ' HD1' ' A' ' 43' ' ' HIS . 98.9 m-20 -98.99 -24.97 14.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.926 . . . . 0.0 109.655 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -74.4 135.66 42.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.428 -0.795 . . . . 0.0 110.161 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.413 HD23 ' HE ' ' A' ' 98' ' ' ARG . 69.7 mt -76.86 145.59 38.26 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.455 HD11 HG22 ' A' ' 48' ' ' ILE . 39.1 pt -120.17 141.92 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.019 -1.05 . . . . 0.0 110.392 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.29 -174.57 46.83 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -170.16 169.95 7.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.049 -1.265 . . . . 0.0 109.739 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -146.96 145.03 29.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.315 -0.865 . . . . 0.0 109.762 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.7 m -124.49 153.4 69.43 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.258 -0.902 . . . . 0.0 108.626 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.431 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.51 147.69 22.31 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.307 2.004 . . . . 0.0 111.98 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.1 t -68.1 -13.84 62.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.465 -0.772 . . . . 0.0 110.621 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.641 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.7 m-20 -89.71 -0.77 57.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.834 -1.166 . . . . 0.0 110.224 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.431 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.5 m-85 -109.63 164.8 12.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.961 . . . . 0.0 110.186 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 m -105.24 135.51 46.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.387 -0.821 . . . . 0.0 109.298 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.515 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.8 m -90.16 118.4 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.074 -1.016 . . . . 0.0 110.393 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -123.84 127.84 25.31 Favored Pre-proline 0 N--CA 1.491 1.609 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.29 114.04 3.47 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.662 1.574 . . . . 0.0 112.16 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 68' ' ' PHE . 12.1 t-80 -91.22 -25.41 19.53 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.3 t0 -172.7 39.27 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.458 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 77.0 m -60.87 -153.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.538 -0.726 . . . . 0.0 109.842 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 4.3 p90 -108.97 -56.1 2.32 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.004 -1.06 . . . . 0.0 111.256 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 64' ' ' PHE . 13.1 t -48.79 -74.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.559 -1.338 . . . . 0.0 108.876 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.6 t -137.16 131.2 32.22 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.458 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.11 179.92 2.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.992 -1.068 . . . . 0.0 110.428 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 5.4 m-85 -93.46 130.31 39.33 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -76.63 -174.03 2.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.931 -1.106 . . . . 0.0 109.904 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.4 mt -64.27 -20.85 66.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 109.103 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.7 p -83.42 -6.36 59.44 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.12 19.74 66.45 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -100.82 139.14 36.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.233 -1.157 . . . . 0.0 109.193 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -84.38 112.38 20.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.928 . . . . 0.0 110.08 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -150.57 140.99 22.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.355 -0.841 . . . . 0.0 109.964 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -63.24 149.46 45.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.114 -0.991 . . . . 0.0 109.49 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.408 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 14.7 tp -96.55 7.39 46.66 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.359 -0.838 . . . . 0.0 109.691 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -69.02 -40.39 78.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.053 -1.029 . . . . 0.0 109.952 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.607 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 51.5 p-10 -61.95 -31.44 71.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 0.0 109.106 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.607 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 29.1 tptp -75.56 -48.17 23.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.514 -0.741 . . . . 0.0 109.255 178.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.6 tp -149.13 123.67 9.74 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -80.46 99.54 8.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.054 -1.029 . . . . 0.0 109.644 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.2 mt -76.08 158.97 31.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.435 -0.79 . . . . 0.0 109.784 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.2 p -129.51 160.17 34.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.264 -0.898 . . . . 0.0 109.346 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 54.59 51.29 14.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.072 -1.018 . . . . 0.0 109.723 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.9 mt -80.74 130.79 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.331 -0.856 . . . . 0.0 109.996 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.412 HG22 HD13 ' A' ' 87' ' ' ILE . 46.9 mm -123.06 121.82 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.516 -0.74 . . . . 0.0 109.192 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 87.1 mtp -121.87 104.14 9.34 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.021 -1.05 . . . . 0.0 109.884 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -112.07 100.76 9.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.296 -0.878 . . . . 0.0 108.904 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.48 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 93.5 m-70 -72.88 -35.94 67.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.873 -1.142 . . . . 0.0 110.657 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -60.4 -46.55 89.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.964 -1.085 . . . . 0.0 109.434 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -88.13 -4.92 58.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 0.0 109.107 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.48 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.3 m-20 54.71 47.72 21.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.522 -0.736 . . . . 0.0 110.173 178.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.59 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 4.8 t -132.62 137.87 47.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.009 -1.057 . . . . 0.0 109.359 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -126.89 139.24 53.22 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.385 -0.822 . . . . 0.0 109.979 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.59 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 80.4 m-85 -136.24 146.79 47.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.162 -0.961 . . . . 0.0 109.569 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.548 ' C ' ' CZ ' ' A' ' 98' ' ' ARG . 20.0 p -154.28 153.18 31.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.199 -0.938 . . . . 0.0 109.167 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.548 ' CZ ' ' C ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -100.64 137.01 39.61 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.112 -0.993 . . . . 0.0 109.687 -179.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.8 mt -88.84 134.74 33.06 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.467 -0.771 . . . . 0.0 109.518 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -46.48 155.78 0.68 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.68 1.586 . . . . 0.0 111.32 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.5 t -63.98 -43.36 95.96 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.172 -0.955 . . . . 0.0 109.862 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.7 tp -105.18 126.25 51.87 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.163 -0.961 . . . . 0.0 110.209 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 91.9 mt -151.33 104.06 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.134 -0.979 . . . . 0.0 108.847 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 90.7 p -108.25 0.9 21.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.967 . . . . 0.0 109.757 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -79.93 151.6 30.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 109.994 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -98.85 32.6 2.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.462 -0.774 . . . . 0.0 108.969 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 19.7 p-90 -65.89 158.41 28.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 110.587 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.3 157.46 44.79 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.63 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 35.8 p90 -155.31 160.47 40.78 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.939 -1.101 . . . . 0.0 108.769 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 5.6 p90 -151.49 158.99 44.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.664 -1.273 . . . . 0.0 111.766 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 90.0 m -124.62 156.3 37.71 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.7 t -129.64 141.66 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.89 -1.132 . . . . 0.0 111.72 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 91.4 m -120.37 131.44 54.84 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.8 p -168.38 178.86 4.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.264 -1.523 . . . . 0.0 111.643 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.641 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 42.5 mtmt -159.11 167.94 27.91 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.508 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 48.5 p30 -58.72 151.44 21.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.823 -1.173 . . . . 0.0 109.009 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.463 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 60.1 t-20 40.89 58.91 2.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.237 -0.914 . . . . 0.0 109.385 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 54.5 mm-40 -157.57 137.54 12.45 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.089 -1.007 . . . . 0.0 110.521 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -54.3 140.89 31.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.059 -1.025 . . . . 0.0 109.141 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -89.11 138.75 31.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.189 -0.944 . . . . 0.0 110.307 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.5 mt -111.24 123.11 49.55 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.4 t -108.58 130.45 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.878 -1.139 . . . . 0.0 110.621 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -108.91 119.76 40.5 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.6 t -137.14 143.51 42.52 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.876 -1.14 . . . . 0.0 111.946 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.63 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.4 m -136.79 159.55 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 126' ' ' GLU . 57.2 mp0 -128.51 147.83 50.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.055 -1.028 . . . . 0.0 110.217 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.299 179.762 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 77.5 t -97.76 134.84 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.262 -0.899 . . . . 0.0 110.079 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -68.89 125.91 28.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.949 -1.095 . . . . 0.0 108.618 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.82 -170.95 44.12 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.461 -1.352 . . . . 0.0 109.736 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.7 t -126.49 132.66 51.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -1.087 . . . . 0.0 109.612 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -107.86 108.71 20.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.557 -0.714 . . . . 0.0 109.283 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -88.28 1.23 55.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 108.756 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 83.0 m -102.28 -16.97 16.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.503 -0.748 . . . . 0.0 110.477 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.6 m -158.08 127.37 5.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.884 -1.135 . . . . 0.0 110.409 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 t -65.2 -26.01 67.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 108.826 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -114.33 74.06 0.85 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -69.91 150.8 46.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 110.37 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.89 0.89 39.29 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.9 pt -123.91 -23.63 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.666 -0.647 . . . . 0.0 110.184 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -115.26 136.85 52.67 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.304 -0.873 . . . . 0.0 110.023 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.1 t -67.28 -17.79 64.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.571 -0.706 . . . . 0.0 110.864 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -129.95 140.97 50.84 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.039 -1.038 . . . . 0.0 110.523 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.43 161.16 29.99 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 . . . . . 0 N--CA 1.495 1.782 0 O-C-N 121.481 -1.011 . . . . 0.0 109.636 -179.794 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.435 HD11 HG21 ' A' ' 36' ' ' ILE . 38.5 mm . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.6 t -115.98 127.05 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.345 -0.847 . . . . 0.0 110.482 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.42 ' O ' ' O ' ' A' ' 124' ' ' THR . 97.5 m -102.62 101.43 11.57 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.2 m -94.22 120.69 34.84 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.055 -1.028 . . . . 0.0 109.58 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 m -141.36 149.34 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.528 -0.733 . . . . 0.0 109.349 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -90.52 130.65 36.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.971 -1.081 . . . . 0.0 109.24 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.25 151.27 22.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.906 . . . . 0.0 109.288 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.619 ' HD1' ' H ' ' A' ' 45' ' ' ASN . 38.2 t-80 -122.92 152.63 40.63 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.322 -0.861 . . . . 0.0 109.483 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 100' ' ' PRO . . . -55.69 -25.73 41.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.409 -0.807 . . . . 0.0 109.762 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.619 ' H ' ' HD1' ' A' ' 43' ' ' HIS . 53.6 t30 -98.81 -25.72 14.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 0.0 109.764 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -73.37 135.51 44.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.361 -0.837 . . . . 0.0 110.026 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 75.3 mt -77.21 145.87 37.35 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.428 HG22 HD12 ' A' ' 48' ' ' ILE . 46.1 pt -123.05 145.04 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.204 -0.935 . . . . 0.0 110.207 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.52 -172.52 45.28 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 49.9 p90 -171.3 170.11 6.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.075 -1.25 . . . . 0.0 109.785 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -146.38 144.67 29.9 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.243 -0.911 . . . . 0.0 109.79 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 70.4 m -123.0 153.15 64.08 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 9.3 Cg_endo -51.81 145.06 32.86 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.292 1.995 . . . . 0.0 112.138 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 t -68.02 -14.83 63.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.481 -0.762 . . . . 0.0 110.628 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -89.6 1.64 55.72 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.931 -1.106 . . . . 0.0 110.233 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.438 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 19.0 m-85 -110.55 166.43 11.0 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.398 -0.814 . . . . 0.0 110.482 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.431 ' OG ' ' OE2' ' A' ' 59' ' ' GLU . 35.2 t -103.01 133.88 47.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -0.837 . . . . 0.0 108.828 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.476 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.1 m -91.05 124.49 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.042 -1.037 . . . . 0.0 110.198 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.431 ' OE2' ' OG ' ' A' ' 57' ' ' SER . 10.5 mp0 -131.28 125.82 21.08 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.07 114.47 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.644 1.562 . . . . 0.0 112.047 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.497 ' O ' ' O ' ' A' ' 68' ' ' PHE . 17.3 t-80 -91.57 -23.26 19.96 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.2 t0 -173.5 39.15 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.425 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 81.5 m -60.34 -152.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.577 -0.702 . . . . 0.0 109.533 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.3 p90 -110.88 -58.03 2.15 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.245 -0.909 . . . . 0.0 111.318 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 64' ' ' PHE . 23.5 t -45.95 -72.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.298 -1.501 . . . . 0.0 108.893 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.4 t -139.98 130.31 25.31 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.425 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.24 -178.79 1.8 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.121 -0.987 . . . . 0.0 110.524 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.2 m-85 -93.55 123.45 36.87 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -71.9 -175.84 1.54 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.044 -1.035 . . . . 0.0 109.754 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.6 mt -62.79 -22.86 66.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.181 -0.95 . . . . 0.0 109.112 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.6 t -79.85 -7.36 58.67 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.333 -0.855 . . . . 0.0 108.857 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.69 18.4 68.24 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -101.41 138.63 38.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -1.156 . . . . 0.0 109.072 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -86.08 110.12 19.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.202 -0.936 . . . . 0.0 110.165 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -146.72 143.35 28.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.364 -0.835 . . . . 0.0 109.914 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -64.65 149.64 48.61 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.503 -0.879 . . . . 0.0 109.51 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 13.1 tp -98.8 4.94 47.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.234 -0.916 . . . . 0.0 109.945 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -68.23 -41.31 81.42 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.038 -1.039 . . . . 0.0 110.013 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.593 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 43.4 p30 -64.46 -27.67 69.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.09 -1.006 . . . . 0.0 109.138 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.593 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 28.9 tptp -83.5 -47.73 11.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 109.361 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 43.3 tp -125.94 126.68 44.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.44 -0.787 . . . . 0.0 109.299 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -77.86 83.62 4.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.134 -0.979 . . . . 0.0 109.277 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.3 mt -82.6 136.04 34.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.393 -0.817 . . . . 0.0 110.083 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.3 p -126.16 160.79 29.24 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.572 HD21 ' CZ ' ' A' ' 98' ' ' ARG . 84.0 m-20 55.59 50.8 13.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.455 -0.778 . . . . 0.0 109.666 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.2 mt -78.33 131.53 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.997 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.2 mm -117.94 118.68 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.374 -0.829 . . . . 0.0 109.258 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 93.8 mtp -124.98 110.65 14.47 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.276 -0.89 . . . . 0.0 109.883 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -114.07 101.13 8.94 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.364 -0.835 . . . . 0.0 108.907 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.458 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 74.2 m80 -71.04 -36.74 72.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.079 -1.013 . . . . 0.0 110.677 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -60.14 -45.78 91.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.998 -1.064 . . . . 0.0 109.66 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -88.61 -5.23 58.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.161 -0.962 . . . . 0.0 109.152 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.3 m-20 54.72 48.28 20.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.573 -0.704 . . . . 0.0 110.338 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.603 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 2.9 t -132.38 137.04 47.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.013 -1.055 . . . . 0.0 109.313 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.563 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 47.1 m-85 -125.2 138.34 54.13 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.338 -0.851 . . . . 0.0 109.735 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' TYR . . . . . 0.603 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 81.3 m-85 -136.07 146.19 46.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.217 -0.927 . . . . 0.0 109.154 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 83.8 p -154.96 155.91 35.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.932 . . . . 0.0 109.015 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.596 HH11 ' CB ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -107.81 139.56 42.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.162 -0.961 . . . . 0.0 109.934 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 100' ' ' PRO . 94.6 mt -96.6 142.31 24.36 Favored Pre-proline 0 C--N 1.297 -1.685 0 O-C-N 121.65 -0.656 . . . . 0.0 109.756 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 44' ' ' ALA . 76.4 Cg_exo -45.56 177.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.779 1.653 . . . . 0.0 111.263 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 96.9 p -85.32 -9.23 57.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.022 -1.049 . . . . 0.0 109.747 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.2 tp -139.0 130.66 27.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.229 -0.919 . . . . 0.0 110.778 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.492 HG23 HD12 ' A' ' 103' ' ' ILE . 74.2 mt -147.37 102.57 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.225 -0.922 . . . . 0.0 108.885 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 97.1 p -100.0 -3.05 32.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.056 -1.027 . . . . 0.0 109.819 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 127' ' ' ALA . 84.4 m-20 -82.11 151.05 27.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.853 . . . . 0.0 110.165 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -99.22 31.34 3.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.525 -0.734 . . . . 0.0 109.126 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 18.8 p-90 -66.59 159.95 26.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 110.627 -178.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -144.24 158.83 43.51 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PHE . . . . . 0.539 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 25.5 p90 -152.13 161.96 41.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.942 -1.098 . . . . 0.0 108.655 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 7.3 p90 -152.56 158.48 42.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.794 -1.191 . . . . 0.0 111.746 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 84.9 m -124.74 156.55 37.49 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 59' ' ' GLU . 44.4 t -129.73 140.51 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.893 -1.129 . . . . 0.0 111.829 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 72.2 m -124.16 133.18 53.63 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.2 p -169.56 178.25 4.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.27 -1.518 . . . . 0.0 111.647 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.551 ' NZ ' ' OE2' ' A' ' 118' ' ' GLU . 6.1 mtmp? -153.59 163.29 40.23 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 178.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 117' ' ' ASN . 99.3 m-20 -58.22 153.22 15.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.851 -1.156 . . . . 0.0 109.109 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.506 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 66.7 t30 44.04 59.4 3.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.167 -0.958 . . . . 0.0 109.555 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.551 ' OE2' ' NZ ' ' A' ' 115' ' ' LYS . 41.6 mt-10 -165.23 145.96 7.24 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.189 -0.944 . . . . 0.0 110.164 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.2 134.07 52.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.115 -0.991 . . . . 0.0 109.003 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -83.37 147.86 27.65 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.038 -1.039 . . . . 0.0 110.337 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.6 mt -111.04 124.45 52.2 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.2 t -108.83 130.22 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.998 -1.064 . . . . 0.0 110.388 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -109.52 121.23 44.74 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.42 ' O ' ' O ' ' A' ' 38' ' ' CYS . 5.3 t -137.33 142.89 41.83 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.468 1.127 . . . . 0.0 112.323 -178.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.539 ' CG2' ' CE2' ' A' ' 109' ' ' PHE . 3.1 m -138.39 158.7 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.546 ' CD ' ' N ' ' A' ' 127' ' ' ALA . 12.4 tm-20 -134.34 155.7 49.79 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.185 -0.947 . . . . 0.0 110.317 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.546 ' N ' ' CD ' ' A' ' 126' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.386 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -73.09 156.41 38.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.155 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 70.4 t -98.22 130.78 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.333 -0.854 . . . . 0.0 109.871 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -71.07 121.94 19.16 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.201 -0.937 . . . . 0.0 108.483 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.2 164.86 31.04 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.403 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 7.2 t -105.71 133.34 50.61 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.396 -1.061 . . . . 0.0 109.862 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.512 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 39.8 t0 -110.92 109.39 19.52 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.211 -0.931 . . . . 0.0 109.462 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -87.0 3.75 44.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.135 -0.978 . . . . 0.0 108.872 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.4 m -109.83 -16.61 13.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.473 -0.767 . . . . 0.0 110.623 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.5 m -151.14 117.24 5.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.804 -1.185 . . . . 0.0 110.186 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.7 m -59.93 -32.22 70.57 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -111.49 75.48 0.92 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.512 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 1.3 m -74.18 115.11 13.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.354 -0.842 . . . . 0.0 110.365 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.9 t -67.75 3.25 1.51 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.502 ' H ' ' C ' ' A' ' 13' ' ' SER . 8.0 pt -124.02 -40.8 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.473 -0.767 . . . . 0.0 110.184 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -100.32 142.08 32.28 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.919 -1.113 . . . . 0.0 109.806 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.6 t -72.24 -23.79 61.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.414 -0.804 . . . . 0.0 110.915 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -119.2 129.78 55.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.715 -1.24 . . . . 0.0 110.417 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -141.41 154.73 24.82 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.403 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 33.0 m-85 -123.58 155.71 37.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -1.146 . . . . 0.0 109.575 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.8 t -94.81 157.44 15.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.127 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.8 pt -61.25 -23.67 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.101 -0.999 . . . . 0.0 109.481 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -79.47 -52.69 7.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 109.654 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.68 -39.55 37.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.361 -0.837 . . . . 0.0 109.969 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.4 pt -70.25 -12.64 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.919 -1.113 . . . . 0.0 109.526 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.2 p -101.96 -23.64 14.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.209 -0.932 . . . . 0.0 109.478 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.48 ' O ' ' N ' ' A' ' 29' ' ' SER . 56.3 t-20 -125.61 -78.97 0.6 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.246 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -66.34 66.98 0.05 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.513 -0.742 . . . . 0.0 109.434 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 33' ' ' GLN . 12.8 m -61.64 179.02 0.27 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 109.282 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.631 ' CB ' ' H ' ' A' ' 37' ' ' VAL . 16.1 m -72.18 -82.38 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.507 -0.746 . . . . 0.0 109.84 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -116.69 -59.05 2.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.195 -0.94 . . . . 0.0 109.573 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -63.39 -150.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.489 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.507 ' O ' ' OG ' ' A' ' 29' ' ' SER . 9.9 pt20 -102.96 -49.98 3.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.17 -0.956 . . . . 0.0 109.579 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.557 ' CG ' ' N ' ' A' ' 35' ' ' ASP . 11.0 pt20 -108.0 -47.0 3.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.061 -1.025 . . . . 0.0 109.429 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.579 ' OD1' ' NZ ' ' A' ' 120' ' ' LYS . 0.7 OUTLIER -50.23 117.85 2.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.259 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.448 HG21 HD12 ' A' ' 36' ' ' ILE . 38.2 mm -98.59 122.15 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.135 -0.978 . . . . 0.0 108.821 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.631 ' H ' ' CB ' ' A' ' 30' ' ' SER . 49.0 t -119.3 129.42 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.062 -1.024 . . . . 0.0 110.25 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 74.4 m -102.77 101.91 12.02 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.0 m -94.12 120.63 34.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -0.958 . . . . 0.0 109.722 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 m -138.58 158.58 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.42 -0.8 . . . . 0.0 109.041 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -100.85 122.45 43.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -0.895 . . . . 0.0 109.509 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.49 164.41 13.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -0.847 . . . . 0.0 109.546 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -138.1 153.07 49.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 0.0 109.715 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 100' ' ' PRO . . . -54.63 -26.29 32.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 0.0 109.783 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -100.99 -24.77 14.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.148 -0.97 . . . . 0.0 109.572 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -72.77 138.5 46.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.827 . . . . 0.0 109.893 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.3 mt -80.31 144.88 32.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 108.741 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.9 pt -122.12 143.85 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.927 -1.108 . . . . 0.0 110.014 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.04 -175.82 47.69 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.464 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 50.2 p90 -167.71 169.49 11.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.024 -1.28 . . . . 0.0 109.751 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -148.43 146.38 28.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.955 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 63.1 m -126.33 152.21 73.52 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.459 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.21 153.93 8.75 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.449 2.099 . . . . 0.0 111.923 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.8 p -72.64 -10.99 60.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.709 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.514 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 80.8 m-20 -92.02 -3.31 55.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.937 -1.102 . . . . 0.0 110.083 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.459 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 15.8 m-85 -106.61 161.44 14.63 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.9 -1.125 . . . . 0.0 110.168 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.474 ' OG ' ' NZ ' ' A' ' 115' ' ' LYS . 7.1 m -99.89 138.39 37.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.363 -0.835 . . . . 0.0 109.389 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.522 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.8 m -94.38 117.08 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.977 -1.077 . . . . 0.0 110.454 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -126.18 127.67 24.61 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.97 111.11 3.03 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.614 1.543 . . . . 0.0 112.224 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -90.96 -26.99 18.99 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.441 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.3 t0 -166.37 42.22 0.06 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.594 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 84.5 m -67.74 -157.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 109.836 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.9 p90 -112.16 -49.53 2.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.874 -1.141 . . . . 0.0 111.425 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 55.7 t -58.41 -48.75 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.495 -1.378 . . . . 0.0 108.922 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.1 t -156.84 128.94 7.32 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.594 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.62 -178.16 1.57 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.872 -1.142 . . . . 0.0 110.475 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 9.2 m-85 -94.14 127.54 40.03 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -70.16 -175.77 1.03 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.964 -1.085 . . . . 0.0 109.879 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.8 mt -61.95 -24.35 66.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.337 -0.852 . . . . 0.0 108.968 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 67.1 m -82.43 -5.07 58.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.316 -0.865 . . . . 0.0 108.804 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.41 19.03 65.13 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -100.23 141.41 33.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -1.136 . . . . 0.0 109.145 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -82.69 110.35 17.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.149 -0.969 . . . . 0.0 110.016 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -146.1 140.95 27.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.328 -0.857 . . . . 0.0 109.56 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -61.25 145.92 49.61 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.3 tp -96.61 5.89 49.83 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.175 -0.953 . . . . 0.0 109.892 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.463 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.3 OUTLIER -70.73 -41.66 71.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.1 -1.0 . . . . 0.0 109.789 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.415 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 41.0 t30 -59.8 -27.22 66.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.146 -0.971 . . . . 0.0 109.037 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -82.15 -45.46 15.1 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.246 -0.909 . . . . 0.0 109.353 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 51.0 tp -139.13 133.64 31.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.431 -0.793 . . . . 0.0 109.187 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.65 86.09 7.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.079 -1.013 . . . . 0.0 109.433 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.4 mt -73.37 148.33 43.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.898 . . . . 0.0 109.842 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.1 p -127.29 162.74 25.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.409 -0.807 . . . . 0.0 109.391 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 54.32 51.88 13.51 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.062 -1.023 . . . . 0.0 109.529 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.414 HG23 HD11 ' A' ' 86' ' ' ILE . 96.6 mt -80.2 131.07 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.353 -0.842 . . . . 0.0 110.093 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.8 mm -123.87 122.42 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.434 -0.791 . . . . 0.0 109.238 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 87.9 mtp -123.48 107.79 11.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.953 -1.092 . . . . 0.0 110.019 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -114.7 101.49 9.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.21 -0.931 . . . . 0.0 108.983 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.469 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 95.9 m-70 -73.27 -34.69 65.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.052 -1.03 . . . . 0.0 110.645 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -60.34 -45.7 92.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.896 -1.127 . . . . 0.0 109.61 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -89.43 -4.71 57.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.087 -1.008 . . . . 0.0 109.053 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 96.7 m-20 55.39 47.8 20.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 110.151 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.573 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.3 t -132.33 136.45 46.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.98 -1.075 . . . . 0.0 109.516 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.464 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 79.3 m-85 -126.29 139.53 53.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.019 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.573 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 80.1 m-85 -135.03 146.45 49.0 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.199 -0.938 . . . . 0.0 109.434 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.554 ' C ' ' HE ' ' A' ' 98' ' ' ARG . 39.7 t -145.74 144.95 30.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.095 -1.003 . . . . 0.0 109.212 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.554 ' HE ' ' C ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -100.46 128.75 46.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.072 -1.017 . . . . 0.0 109.435 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.523 ' O ' ' O ' ' A' ' 100' ' ' PRO . 94.8 mt -89.86 138.27 27.91 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.25 -0.906 . . . . 0.0 109.636 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 99' ' ' LEU . 75.7 Cg_exo -46.17 -177.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.896 1.731 . . . . 0.0 110.984 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 95.3 p -90.45 -8.35 50.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.968 -1.082 . . . . 0.0 109.748 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.7 tp -135.49 129.76 33.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.125 -0.984 . . . . 0.0 110.445 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.478 HD13 HG22 ' A' ' 103' ' ' ILE . 48.1 mt -150.92 108.3 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.367 -0.833 . . . . 0.0 108.838 178.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 99.8 p -110.41 0.11 17.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.124 -0.985 . . . . 0.0 109.678 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 127' ' ' ALA . 73.7 m-20 -82.57 152.79 25.81 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.062 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -99.15 32.5 2.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.375 -0.828 . . . . 0.0 109.082 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 17.7 p-90 -65.88 151.09 47.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 110.553 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -134.91 156.3 49.2 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.627 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 36.9 p90 -156.06 158.13 37.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.079 -1.013 . . . . 0.0 108.954 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.444 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 17.5 p90 -151.83 156.27 39.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.756 -1.215 . . . . 0.0 111.588 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 90.7 m -121.38 158.51 28.14 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 76.7 t -132.8 150.15 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.612 -1.305 . . . . 0.0 111.684 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.5 m -127.88 134.12 49.37 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.8 p -167.58 176.83 6.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.336 -1.478 . . . . 0.0 111.743 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.514 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 50.0 mttm -155.86 168.35 27.48 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 117' ' ' ASN . 90.8 m-20 -57.67 148.29 24.98 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.917 -1.114 . . . . 0.0 109.331 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.494 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 65.9 t30 40.9 60.93 1.84 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.264 -0.897 . . . . 0.0 109.771 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 48.9 mm-40 -157.31 136.67 12.01 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.978 -1.076 . . . . 0.0 110.187 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -56.33 133.44 52.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.262 -0.899 . . . . 0.0 109.019 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.579 ' NZ ' ' OD1' ' A' ' 35' ' ' ASP . 23.6 pttm -85.28 143.28 28.8 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.114 -0.991 . . . . 0.0 110.404 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 68.4 mt -111.33 124.33 52.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.446 -0.784 . . . . 0.0 109.154 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.4 t -109.45 130.98 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.986 -1.071 . . . . 0.0 110.711 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -109.98 120.62 43.04 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.4 t -137.05 143.95 42.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.475 -1.391 . . . . 0.0 112.008 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.627 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 2.9 m -136.53 159.94 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -134.31 150.11 50.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.836 -1.165 . . . . 0.0 110.13 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.338 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -142.1 152.23 43.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.359 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.6 t -88.16 136.39 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.372 -0.83 . . . . 0.0 110.36 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -68.84 125.22 25.92 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.054 -1.029 . . . . 0.0 108.615 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.81 179.11 45.18 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -118.56 132.4 56.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.619 -0.93 . . . . 0.0 109.369 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -109.07 109.07 19.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.542 -0.724 . . . . 0.0 109.272 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.458 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 78.0 m-85 -88.76 -0.54 57.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.171 -0.956 . . . . 0.0 108.912 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.0 m -98.55 -18.18 18.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.468 -0.77 . . . . 0.0 110.537 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.0 m -158.2 127.07 5.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.836 -1.165 . . . . 0.0 110.361 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.1 p -64.59 -26.6 68.47 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.611 -0.836 . . . . 0.0 108.985 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -113.04 73.89 0.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.501 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 95.0 p -69.67 151.39 45.94 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.226 -0.921 . . . . 0.0 110.159 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 t -101.25 0.85 38.14 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 pt -124.76 -20.86 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.672 -0.643 . . . . 0.0 110.496 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.501 ' O ' ' OG ' ' A' ' 13' ' ' SER . 57.4 m-85 -115.93 144.52 43.94 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.401 -0.812 . . . . 0.0 110.325 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.0 m -72.28 -17.58 61.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.502 -0.749 . . . . 0.0 110.542 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -135.0 145.53 48.18 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.96 -1.088 . . . . 0.0 110.762 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -159.53 173.37 36.29 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -131.47 164.22 26.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.394 -1.062 . . . . 0.0 109.614 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 t -95.43 151.8 18.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.321 -0.862 . . . . 0.0 109.122 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.458 ' O ' ' CB ' ' A' ' 26' ' ' SER . 42.9 pt -59.69 -31.92 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.41 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -65.95 -39.18 90.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 109.561 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.61 -43.4 89.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.42 -0.8 . . . . 0.0 110.229 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.5 pt -86.09 -19.29 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.0 -1.063 . . . . 0.0 109.704 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.68 ' O ' ' C ' ' A' ' 27' ' ' ASN . 48.0 t -85.11 -76.96 0.3 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.236 -0.915 . . . . 0.0 109.224 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.68 ' C ' ' O ' ' A' ' 26' ' ' SER . 63.6 t30 0.47 96.51 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 121.337 0.589 . . . . 0.0 109.445 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 30' ' ' SER . 44.1 mmtm -66.13 34.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.56 -0.712 . . . . 0.0 109.741 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.625 ' H ' ' C ' ' A' ' 27' ' ' ASN . 44.3 t -63.11 70.78 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.507 -0.746 . . . . 0.0 109.282 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.575 ' C ' ' H ' ' A' ' 32' ' ' ASN . 15.1 m -36.89 -26.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.304 0.573 . . . . 0.0 109.621 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.605 ' N ' ' O ' ' A' ' 29' ' ' SER . 99.0 m-20 -68.58 33.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.561 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.575 ' H ' ' C ' ' A' ' 30' ' ' SER . 51.6 t-20 -155.61 120.25 4.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.085 -1.009 . . . . 0.0 109.286 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.523 ' C ' ' H ' ' A' ' 35' ' ' ASP . 11.6 pt20 -35.06 121.72 0.55 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.542 0.687 . . . . 0.0 109.691 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -72.33 38.91 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.216 -0.928 . . . . 0.0 109.413 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' A' ' 33' ' ' GLN . 88.9 m-20 -130.72 108.2 9.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.718 -0.614 . . . . 0.0 109.689 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.9 mm -99.29 125.04 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.108 -0.995 . . . . 0.0 108.591 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 47.2 t -120.78 130.21 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.411 -0.806 . . . . 0.0 110.42 -179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.458 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 89.6 m -101.05 100.67 11.29 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 58.5 m -96.06 120.73 36.86 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.182 -0.949 . . . . 0.0 109.513 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.2 m -141.66 153.51 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.492 -0.755 . . . . 0.0 109.306 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -94.03 132.75 38.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.005 -1.059 . . . . 0.0 109.149 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.02 146.78 27.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.22 -0.925 . . . . 0.0 109.626 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.467 ' HD1' ' CG ' ' A' ' 45' ' ' ASN . 21.0 t-80 -116.43 150.73 37.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.429 -0.794 . . . . 0.0 109.507 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.99 -25.38 43.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.415 -0.803 . . . . 0.0 109.883 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.554 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 30.5 p30 -98.22 -22.99 15.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 109.684 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.554 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 82.2 m-20 -76.4 136.78 39.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.449 -0.782 . . . . 0.0 110.165 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.47 146.5 38.48 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.43 HD11 HG21 ' A' ' 48' ' ' ILE . 38.3 pt -120.4 141.89 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.113 -0.992 . . . . 0.0 110.307 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.93 -173.75 46.25 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -170.18 169.55 7.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.11 -1.229 . . . . 0.0 109.685 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -144.74 143.64 30.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.235 -0.916 . . . . 0.0 110.015 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 90.1 m -124.0 151.87 65.83 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.406 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.74 147.53 24.34 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.337 2.025 . . . . 0.0 111.976 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.1 m -70.6 -12.1 61.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.424 -0.798 . . . . 0.0 110.545 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.615 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.8 m-20 -91.6 0.49 57.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.051 -1.031 . . . . 0.0 110.084 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.406 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.4 m-85 -109.86 165.73 11.48 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.124 -0.985 . . . . 0.0 110.353 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -103.65 130.76 51.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.34 -0.85 . . . . 0.0 109.05 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.504 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.8 m -89.5 118.74 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.004 -1.06 . . . . 0.0 110.104 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -124.73 126.78 25.31 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.13 114.57 3.6 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.777 1.651 . . . . 0.0 112.051 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.491 ' O ' ' O ' ' A' ' 68' ' ' PHE . 17.0 t-80 -93.56 -24.0 18.11 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.8 t0 -170.19 40.59 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.485 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 89.9 m -64.28 -154.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.422 -0.799 . . . . 0.0 109.887 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.6 p90 -109.29 -58.69 2.0 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.155 -0.966 . . . . 0.0 111.483 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 64' ' ' PHE . 31.2 t -46.05 -70.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.58 -1.325 . . . . 0.0 108.804 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.2 t -141.38 132.45 26.23 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.485 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -170.97 175.86 4.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.97 -1.081 . . . . 0.0 110.464 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.1 m-85 -92.39 142.36 27.53 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -83.26 -170.86 3.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.879 -1.138 . . . . 0.0 109.895 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.3 mp -66.56 -15.03 63.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.325 -0.86 . . . . 0.0 108.98 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 65.7 m -86.55 -8.61 57.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.38 -0.825 . . . . 0.0 108.806 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.93 20.07 64.01 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -106.73 139.84 40.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.318 -1.107 . . . . 0.0 109.246 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -66.78 125.68 26.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.28 -0.888 . . . . 0.0 109.844 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -145.47 165.26 29.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.408 -0.808 . . . . 0.0 109.644 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.442 ' ND2' ' CD ' ' A' ' 78' ' ' GLU . 37.8 t-20 -105.96 136.94 44.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.337 -0.852 . . . . 0.0 109.472 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 tp -93.26 -8.28 42.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 0.0 110.194 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.488 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 20.7 pt-20 -58.94 -46.63 87.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.044 -1.035 . . . . 0.0 109.523 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.488 ' N ' ' CG ' ' A' ' 78' ' ' GLU . 92.5 m-20 -64.87 -34.52 78.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 108.972 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -69.24 -52.41 27.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.499 -0.751 . . . . 0.0 109.61 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.418 HD21 ' CZ2' ' A' ' 107' ' ' TRP . 31.5 tp -129.13 126.51 39.45 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -76.63 108.54 9.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.015 -1.053 . . . . 0.0 109.018 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.3 mt -105.18 137.86 42.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 110.088 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.9 p -124.46 162.69 23.4 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.493 -0.754 . . . . 0.0 109.287 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.6 ' O ' ' NH1' ' A' ' 98' ' ' ARG . 98.9 m-20 55.0 51.46 13.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.573 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 86' ' ' ILE . 96.7 mt -78.92 130.62 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.185 -0.947 . . . . 0.0 110.152 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.5 mm -120.19 119.79 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.482 -0.761 . . . . 0.0 109.225 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 78.8 mtp -124.56 109.59 13.41 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.295 -0.878 . . . . 0.0 109.835 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -111.73 100.74 9.18 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.38 -0.825 . . . . 0.0 108.938 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.486 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 97.1 m-70 -71.76 -36.48 70.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.859 -1.15 . . . . 0.0 110.632 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -61.13 -46.76 89.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.963 -1.085 . . . . 0.0 109.556 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -87.17 -4.96 59.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.07 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.4 m-20 54.93 47.32 22.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.556 -0.715 . . . . 0.0 110.209 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.593 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.3 t -133.84 139.73 46.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.03 -1.043 . . . . 0.0 109.325 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 49.5 m-85 -128.52 140.14 51.96 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.429 -0.794 . . . . 0.0 109.982 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.593 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 67.2 m-85 -138.23 148.7 45.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.289 -0.882 . . . . 0.0 109.16 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.703 ' N ' ' NH2' ' A' ' 98' ' ' ARG . 57.6 m -157.3 159.4 37.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.099 -1.001 . . . . 0.0 109.336 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.703 ' NH2' ' N ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -103.59 139.72 38.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.236 -0.915 . . . . 0.0 109.679 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 47.4 mt -91.98 138.54 24.64 Favored Pre-proline 0 C--N 1.304 -1.396 0 O-C-N 121.619 -0.676 . . . . 0.0 109.597 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -46.93 158.28 0.44 Allowed 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.734 1.622 . . . . 0.0 111.265 178.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.6 t -69.6 -17.98 63.58 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.179 -0.95 . . . . 0.0 109.916 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 44.9 tp -125.41 129.32 49.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.258 -0.901 . . . . 0.0 110.639 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.454 HD13 HG21 ' A' ' 103' ' ' ILE . 83.1 mt -149.29 102.86 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.3 m -113.25 3.1 15.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.352 -0.842 . . . . 0.0 109.834 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 53.2 t0 -89.28 155.28 19.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.976 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.584 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 98.9 m-20 -96.54 34.15 1.69 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.417 -0.802 . . . . 0.0 108.914 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.468 ' CZ3' ' CD1' ' A' ' 109' ' ' PHE . 13.0 p-90 -62.69 154.06 30.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.165 -0.959 . . . . 0.0 110.42 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.607 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 21.2 tttp -141.07 149.13 41.24 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.641 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 29.2 p90 -155.09 163.31 40.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.188 -0.945 . . . . 0.0 108.731 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 10.7 p90 -154.84 160.06 40.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.86 -1.15 . . . . 0.0 111.872 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 75.1 m -122.92 155.43 36.73 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.4 t -128.78 139.05 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.848 -1.158 . . . . 0.0 111.933 -178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 96.4 m -122.9 131.94 53.96 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 62.9 p -171.54 178.7 3.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.306 -1.496 . . . . 0.0 111.608 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.615 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 50.6 mtmt -150.7 163.62 38.1 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 55.4 p-10 -59.44 154.27 17.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.907 -1.121 . . . . 0.0 109.114 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.511 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 64.7 t30 44.26 59.69 3.13 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.211 -0.931 . . . . 0.0 109.642 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 38.8 mt-10 -165.28 146.19 7.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.256 -0.902 . . . . 0.0 110.154 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.59 ' NZ ' ' O ' ' A' ' 27' ' ' ASN . 98.8 mttt -58.03 142.16 47.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 109.193 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -88.95 140.09 29.79 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.077 -1.015 . . . . 0.0 110.414 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 86.6 mt -108.89 120.8 43.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.417 -0.802 . . . . 0.0 108.965 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.6 t -109.36 130.1 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.049 -1.032 . . . . 0.0 110.54 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -107.81 118.62 37.23 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.607 ' OG1' ' NZ ' ' A' ' 108' ' ' LYS . 7.3 t -136.94 141.88 42.65 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.918 -1.114 . . . . 0.0 112.3 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.3 m -134.55 158.48 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -132.31 152.66 51.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.229 -0.919 . . . . 0.0 110.278 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.333 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.558 ' OE1' ' N ' ' A' ' 1' ' ' GLU . 57.2 mp0 . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -75.29 155.12 36.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.231 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.2 t -96.55 133.17 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 109.795 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.8 mmtp -69.86 122.11 18.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.126 -0.984 . . . . 0.0 108.706 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.4 ' HA3' ' CD1' ' A' ' 16' ' ' PHE . . . 178.3 176.41 46.22 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.543 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 4.7 t -116.28 128.54 55.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.471 -1.017 . . . . 0.0 109.296 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 54.4 t0 -103.45 111.18 23.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.59 -0.694 . . . . 0.0 109.375 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -91.59 -0.88 57.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.186 -0.947 . . . . 0.0 108.826 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.5 m -103.72 -16.67 15.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.486 -0.759 . . . . 0.0 110.632 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.3 m -156.35 125.02 5.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.883 -1.136 . . . . 0.0 110.278 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.505 ' OG ' ' OE1' ' A' ' 12' ' ' GLU . 74.0 p -65.47 -26.36 67.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.184 -0.948 . . . . 0.0 108.981 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.505 ' OE1' ' OG ' ' A' ' 11' ' ' SER . 55.5 mp0 -113.67 72.96 0.8 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.2 t -67.7 150.62 48.46 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.134 -0.979 . . . . 0.0 110.352 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.77 0.6 41.99 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.419 HD12 HG23 ' A' ' 15' ' ' ILE . 24.2 pt -125.04 -27.19 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.749 -0.594 . . . . 0.0 110.199 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.4 ' CD1' ' HA3' ' A' ' 5' ' ' GLY . 52.1 m-85 -110.27 133.74 52.95 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.041 -1.037 . . . . 0.0 109.87 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.9 t -67.95 -18.53 64.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.641 -0.662 . . . . 0.0 110.858 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -125.09 136.73 53.94 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.027 -1.046 . . . . 0.0 110.67 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -146.86 158.81 27.84 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.543 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 21.4 m-85 -116.81 150.4 38.41 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.323 -1.104 . . . . 0.0 109.589 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.0 t -94.75 156.61 16.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.349 -0.844 . . . . 0.0 109.016 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.412 ' O ' ' CG1' ' A' ' 25' ' ' ILE . 45.3 pt -58.41 -20.5 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.925 . . . . 0.0 109.344 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -68.7 -43.61 75.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.115 -0.991 . . . . 0.0 109.186 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 28' ' ' LYS . 79.6 mm-40 -50.98 -49.72 59.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.098 -1.002 . . . . 0.0 110.082 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.491 ' O ' ' OG ' ' A' ' 29' ' ' SER . 19.6 pt -63.07 -43.79 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.044 -1.035 . . . . 0.0 109.632 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.493 ' O ' ' OG ' ' A' ' 30' ' ' SER . 58.2 m -59.67 -44.22 93.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 109.202 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.628 ' O ' ' N ' ' A' ' 29' ' ' SER . 41.9 t30 -79.48 -61.64 1.94 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.174 -0.954 . . . . 0.0 108.849 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.507 ' O ' ' O ' ' A' ' 32' ' ' ASN . 36.0 tptt -44.31 -12.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.225 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.628 ' N ' ' O ' ' A' ' 27' ' ' ASN . 86.4 p -109.71 -38.31 5.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.076 -1.015 . . . . 0.0 109.436 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.493 ' OG ' ' O ' ' A' ' 26' ' ' SER . 67.3 m -60.12 -44.95 94.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.529 -0.732 . . . . 0.0 109.709 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.417 ' OD1' ' C ' ' A' ' 31' ' ' ASN . 45.9 t-20 -86.65 -58.94 2.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.295 -0.878 . . . . 0.0 109.519 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 32' ' ' ASN . 8.7 p-10 -107.8 94.28 4.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.426 -0.796 . . . . 0.0 109.553 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -71.99 93.76 1.41 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 109.42 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -151.08 -166.76 2.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.945 -1.097 . . . . 0.0 109.514 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.603 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 0.4 OUTLIER -83.32 141.05 32.09 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.222 -0.924 . . . . 0.0 109.635 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 122' ' ' VAL . 20.8 mm -80.2 122.14 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 79.5 t -115.68 127.85 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.114 -0.991 . . . . 0.0 110.604 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.505 ' O ' ' O ' ' A' ' 124' ' ' THR . 66.8 m -102.07 101.49 11.86 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.1 m -92.46 119.53 32.05 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.822 -1.174 . . . . 0.0 109.848 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.8 m -136.23 155.76 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -99.03 121.88 41.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 109.504 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.86 163.56 13.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.574 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.4 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 37.1 t60 -136.64 155.61 49.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.203 -0.936 . . . . 0.0 109.656 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 100' ' ' PRO . . . -55.24 -26.47 39.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.325 -0.86 . . . . 0.0 109.711 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -101.46 -22.44 14.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.166 -0.959 . . . . 0.0 109.632 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.4 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 85.8 m-20 -75.08 137.49 41.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.419 -0.8 . . . . 0.0 109.942 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.8 mt -80.73 147.46 30.55 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 43.7 pt -122.12 144.26 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.144 -0.972 . . . . 0.0 110.294 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.9 -173.06 45.7 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.474 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 50.5 p90 -169.68 168.81 8.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.056 -1.261 . . . . 0.0 109.725 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -143.42 142.6 31.29 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.319 -0.863 . . . . 0.0 109.636 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 61.4 m -123.77 152.31 65.66 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 108.662 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.444 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.3 Cg_endo -51.7 150.98 15.71 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.431 2.087 . . . . 0.0 111.905 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.1 m -71.32 -13.2 61.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.459 -0.775 . . . . 0.0 110.726 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.491 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 80.2 m-20 -91.04 -1.04 57.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.867 -1.146 . . . . 0.0 110.214 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.444 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 16.5 m-85 -107.67 162.49 13.92 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.514 -0.741 . . . . 0.0 110.099 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.432 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 6.2 t -102.91 134.04 47.0 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.333 -0.855 . . . . 0.0 109.334 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.515 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 3.5 m -90.45 115.25 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.092 -1.005 . . . . 0.0 110.389 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.492 ' N ' ' OE1' ' A' ' 59' ' ' GLU . 15.8 mp0 -121.24 126.56 26.52 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.08 112.71 3.29 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.617 1.545 . . . . 0.0 112.265 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -94.05 -25.24 17.28 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.7 t0 -168.34 39.51 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 80.5 m -65.08 -153.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.579 -0.701 . . . . 0.0 109.729 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.9 p90 -111.26 -59.15 2.01 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.179 -0.95 . . . . 0.0 111.347 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.449 ' C ' ' O ' ' A' ' 64' ' ' PHE . 24.1 t -45.72 -73.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.682 -1.261 . . . . 0.0 108.757 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.3 t -136.44 132.61 35.65 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -173.71 -178.67 1.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.908 -1.12 . . . . 0.0 110.446 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 7.6 m-85 -93.07 124.21 36.88 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -69.74 -175.03 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.07 -1.019 . . . . 0.0 109.869 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.527 ' CD1' ' HZ1' ' A' ' 108' ' ' LYS . 58.8 mt -62.3 -23.66 66.86 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.29 -0.881 . . . . 0.0 108.905 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.6 p -81.92 -7.17 59.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 108.819 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.64 15.63 70.35 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -95.75 138.51 33.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.394 -1.062 . . . . 0.0 109.137 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -81.91 108.35 15.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.249 -0.907 . . . . 0.0 110.143 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -145.35 143.58 30.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 110.063 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.0 m-20 -64.54 149.59 48.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.913 -1.117 . . . . 0.0 109.512 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.409 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 13.9 tp -99.22 6.7 46.24 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.465 -0.772 . . . . 0.0 109.941 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -69.38 -41.06 76.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.13 -0.981 . . . . 0.0 109.923 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 48.4 p-10 -62.58 -26.08 68.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.197 -0.939 . . . . 0.0 109.071 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.5 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 88.0 tttt -84.79 -46.29 11.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.45 -0.781 . . . . 0.0 109.442 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.403 HD22 ' CZ2' ' A' ' 107' ' ' TRP . 41.0 tp -131.64 127.35 36.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.405 -0.809 . . . . 0.0 109.234 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -83.29 83.77 7.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.066 -1.021 . . . . 0.0 109.297 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.9 mt -75.73 146.71 39.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.888 . . . . 0.0 110.121 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.3 p -127.94 160.61 31.33 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.606 -0.684 . . . . 0.0 109.318 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.679 HD21 ' NE ' ' A' ' 98' ' ' ARG . 96.8 m-20 54.72 50.78 15.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.278 -0.889 . . . . 0.0 109.546 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.2 mt -77.61 128.54 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 109.879 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.0 mm -118.92 119.19 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.489 -0.757 . . . . 0.0 109.229 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 85.4 mtp -123.44 108.03 12.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.214 -0.929 . . . . 0.0 109.806 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -114.19 101.75 9.49 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.411 -0.806 . . . . 0.0 108.873 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.472 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 95.4 m-70 -71.63 -36.22 70.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.995 -1.066 . . . . 0.0 110.592 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -60.91 -45.15 95.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.974 -1.079 . . . . 0.0 109.462 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -88.89 -5.21 58.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.953 . . . . 0.0 109.07 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.7 m-20 54.4 47.95 21.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.49 -0.756 . . . . 0.0 110.139 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.608 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 2.6 t -132.37 137.16 47.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.987 -1.071 . . . . 0.0 109.606 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.474 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 79.4 m-85 -126.68 138.88 53.47 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.402 -0.811 . . . . 0.0 109.977 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.608 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 71.4 m-85 -135.61 146.1 47.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.239 -0.913 . . . . 0.0 109.437 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.5 t -150.87 150.99 31.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.959 . . . . 0.0 109.242 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.679 ' NE ' HD21 ' A' ' 85' ' ' ASN . 60.3 mtt-85 -101.29 133.1 46.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.16 -0.962 . . . . 0.0 109.434 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' A' ' 100' ' ' PRO . 38.5 mt -91.54 137.9 25.59 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.461 -0.774 . . . . 0.0 109.789 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.493 ' O ' ' O ' ' A' ' 44' ' ' ALA . 77.5 Cg_exo -45.68 177.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.876 1.717 . . . . 0.0 111.163 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 99.9 p -89.36 -9.87 48.76 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.113 -0.992 . . . . 0.0 109.847 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.7 tp -133.68 128.15 34.39 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.208 -0.932 . . . . 0.0 110.254 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.43 HG23 HD13 ' A' ' 103' ' ' ILE . 68.3 mt -150.12 106.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.945 . . . . 0.0 108.677 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 96.3 p -107.78 0.33 22.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.088 -1.007 . . . . 0.0 109.772 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 127' ' ' ALA . 82.6 m-20 -84.64 154.54 22.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.038 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -102.38 31.5 4.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.493 -0.754 . . . . 0.0 109.12 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.403 ' CZ2' HD22 ' A' ' 81' ' ' LEU . 16.5 p-90 -66.68 160.07 26.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.205 -0.934 . . . . 0.0 110.507 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.527 ' HZ1' ' CD1' ' A' ' 70' ' ' LEU . 26.6 pttm -142.0 159.05 43.01 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.553 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 20.9 p90 -154.04 162.66 41.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.929 -1.107 . . . . 0.0 108.661 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 7.3 p90 -153.59 160.4 42.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.67 -1.269 . . . . 0.0 111.836 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 94.7 m -124.83 156.68 37.43 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.0 t -127.9 138.91 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.867 -1.145 . . . . 0.0 111.792 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.1 m -120.11 130.77 54.79 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.2 p -168.93 174.84 6.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.322 -1.486 . . . . 0.0 111.601 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.491 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 52.4 mttm -152.72 168.1 26.79 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 117' ' ' ASN . 90.1 m-20 -58.54 148.34 28.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.835 -1.166 . . . . 0.0 108.845 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.456 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 66.2 t30 43.86 60.67 2.6 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.26 -0.9 . . . . 0.0 109.395 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 58.2 mm-40 -158.01 137.44 11.88 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.19 -0.944 . . . . 0.0 110.455 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -54.77 131.57 44.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.083 -1.011 . . . . 0.0 108.962 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -79.81 139.25 37.28 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.21 -0.931 . . . . 0.0 110.249 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.6 mt -111.26 124.43 52.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.644 -0.66 . . . . 0.0 109.389 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 36' ' ' ILE . 39.2 t -110.39 132.04 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.979 -1.076 . . . . 0.0 110.71 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.419 ' O ' ' CB ' ' A' ' 110' ' ' PHE . 26.4 t80 -110.43 123.0 49.06 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.505 ' O ' ' O ' ' A' ' 38' ' ' CYS . 6.6 t -137.88 143.73 41.01 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.005 -1.059 . . . . 0.0 112.145 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.553 ' CG2' ' CE2' ' A' ' 109' ' ' PHE . 2.8 m -136.71 159.52 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -133.16 150.64 52.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.071 -1.018 . . . . 0.0 110.31 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.4 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -78.45 162.03 26.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.9 t -103.63 135.29 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.054 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -69.46 125.12 25.75 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.583 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.61 176.02 43.51 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -115.85 132.47 56.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.493 -1.004 . . . . 0.0 109.246 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.496 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 36.9 t0 -110.21 109.18 19.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.595 -0.691 . . . . 0.0 109.333 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -88.17 -1.17 57.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.298 -0.876 . . . . 0.0 108.982 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.5 m -100.93 -18.64 16.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.515 -0.741 . . . . 0.0 110.577 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.7 m -156.19 125.06 5.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.878 -1.139 . . . . 0.0 110.367 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 t -65.99 -27.0 67.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.413 -0.804 . . . . 0.0 108.957 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 58.7 mp0 -112.92 73.98 0.84 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.496 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 12.5 m -70.78 152.85 43.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.875 . . . . 0.0 110.225 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.93 -0.04 40.28 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.7 pt -125.9 -22.28 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.71 -0.619 . . . . 0.0 110.25 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -113.05 140.28 47.98 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.255 -0.903 . . . . 0.0 110.133 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.9 m -73.43 -17.08 61.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.603 -0.686 . . . . 0.0 110.691 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -132.87 144.04 49.92 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.998 -1.064 . . . . 0.0 110.563 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.416 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -160.7 171.32 36.81 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -122.93 158.95 29.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.423 -1.045 . . . . 0.0 109.666 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.4 t -96.22 151.71 19.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 0.0 109.058 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.7 pt -55.59 -33.08 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.347 -0.846 . . . . 0.0 109.372 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -65.25 -38.6 90.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.113 -0.992 . . . . 0.0 109.505 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.09 -41.78 94.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.814 . . . . 0.0 110.159 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.622 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 14.9 pt -85.63 -15.08 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.006 -1.059 . . . . 0.0 109.653 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.693 ' O ' ' C ' ' A' ' 27' ' ' ASN . 39.7 t -89.86 -78.05 0.38 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.175 -0.953 . . . . 0.0 109.169 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.693 ' C ' ' O ' ' A' ' 26' ' ' SER . 6.1 p30 -1.97 88.75 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 121.371 0.605 . . . . 0.0 109.541 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -77.21 22.28 0.22 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.489 -0.757 . . . . 0.0 109.455 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.448 ' H ' ' C ' ' A' ' 27' ' ' ASN . 40.6 t -90.17 -71.53 0.61 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.341 -0.849 . . . . 0.0 109.577 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 29' ' ' SER . 18.7 m -41.39 141.42 0.72 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.526 -0.733 . . . . 0.0 109.482 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -103.58 41.51 1.27 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.292 -0.88 . . . . 0.0 109.49 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -137.97 -22.91 1.05 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.966 . . . . 0.0 109.628 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.628 ' O ' ' N ' ' A' ' 35' ' ' ASP . 2.3 pt20 -57.08 -31.71 65.52 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.158 -0.964 . . . . 0.0 109.622 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.572 ' C ' ' O ' ' A' ' 33' ' ' GLN . 14.9 pt20 -28.15 -37.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.628 ' N ' ' O ' ' A' ' 33' ' ' GLN . 14.7 m-20 -125.05 107.97 11.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.683 -0.636 . . . . 0.0 110.15 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.9 mm -99.38 125.51 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.006 -1.059 . . . . 0.0 108.632 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.9 t -121.44 126.86 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.392 -0.818 . . . . 0.0 110.009 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.3 m -102.45 102.16 12.43 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 75.8 m -98.78 122.37 41.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.076 -1.015 . . . . 0.0 109.397 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.1 m -140.96 155.22 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.562 -0.711 . . . . 0.0 109.257 179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -96.12 132.5 41.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.084 -1.01 . . . . 0.0 109.405 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.76 160.45 14.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.405 -0.81 . . . . 0.0 109.591 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.8 t60 -133.0 153.81 51.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.245 -0.909 . . . . 0.0 109.55 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 100' ' ' PRO . . . -54.01 -25.28 20.34 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.384 -0.822 . . . . 0.0 109.788 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -101.53 -26.06 13.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.704 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -71.67 132.02 43.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.336 -0.852 . . . . 0.0 110.069 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 11.3 mt -77.28 145.89 37.19 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.423 HG21 HD11 ' A' ' 48' ' ' ILE . 44.9 pt -123.11 145.85 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.766 0.793 . . . . 0.0 110.479 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.48 -173.98 46.58 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -169.54 170.01 8.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.095 -1.239 . . . . 0.0 109.697 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -147.71 145.4 28.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.9 . . . . 0.0 109.907 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 92.6 m -124.83 151.65 68.61 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.413 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.6 Cg_endo -51.7 150.1 17.65 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.334 2.023 . . . . 0.0 112.044 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 m -69.68 -11.74 61.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.398 -0.813 . . . . 0.0 110.528 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -90.94 -2.67 57.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.023 -1.048 . . . . 0.0 110.223 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.413 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.4 m-85 -109.17 164.28 12.59 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.219 -0.925 . . . . 0.0 110.426 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.7 t -105.96 133.93 49.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.448 -0.783 . . . . 0.0 108.919 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.499 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 3.1 m -89.8 118.92 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.032 -1.043 . . . . 0.0 110.364 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 112' ' ' VAL . 10.0 mt-10 -123.1 126.67 25.91 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.14 114.11 3.51 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.66 1.573 . . . . 0.0 112.12 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.505 ' O ' ' O ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -93.63 -24.14 18.01 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 110' ' ' PHE . 66.9 t0 -169.9 43.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.462 ' H ' ' CB ' ' A' ' 67' ' ' ALA . 97.3 m -67.55 -153.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.748 . . . . 0.0 109.844 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.8 p90 -110.1 -57.88 2.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.141 -0.975 . . . . 0.0 111.455 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 64' ' ' PHE . 24.9 t -46.76 -71.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.601 -1.312 . . . . 0.0 108.863 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.8 t -140.91 131.3 25.18 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.462 ' CB ' ' H ' ' A' ' 63' ' ' CYS . . . -170.76 175.74 4.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.975 -1.078 . . . . 0.0 110.425 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 2.5 m-85 -92.86 140.67 29.26 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -81.81 -170.35 2.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.835 -1.165 . . . . 0.0 109.829 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.0 mp -66.42 -15.31 63.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.305 -0.872 . . . . 0.0 109.087 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 69.5 m -86.6 -7.94 57.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 108.883 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.7 20.9 64.93 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -106.98 138.26 43.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.273 -1.134 . . . . 0.0 109.114 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -65.62 124.32 22.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.257 -0.902 . . . . 0.0 109.754 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -143.71 165.09 28.61 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.396 -0.815 . . . . 0.0 109.704 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -106.51 137.83 43.8 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.353 -0.842 . . . . 0.0 109.371 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.8 tp -95.39 -11.03 28.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.192 -0.942 . . . . 0.0 109.988 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.497 ' CD ' ' N ' ' A' ' 79' ' ' ASN . 2.3 pp20? -61.35 -43.82 98.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.978 -1.076 . . . . 0.0 109.557 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 49.1 p30 -64.17 -20.43 66.0 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.096 -1.003 . . . . 0.0 108.856 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.54 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 84.7 tttt -88.95 -43.97 10.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.0 109.67 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.0 tp -133.35 123.24 25.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.423 -0.798 . . . . 0.0 109.305 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -79.3 85.25 5.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.117 -0.989 . . . . 0.0 109.409 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.7 mt -74.23 147.03 42.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.322 -0.861 . . . . 0.0 110.036 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 47.3 p -127.42 161.23 29.18 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.527 -0.733 . . . . 0.0 109.339 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 53.58 51.16 15.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.172 -0.955 . . . . 0.0 109.553 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.1 mt -79.05 130.61 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.075 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.7 mm -118.62 119.09 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.509 -0.744 . . . . 0.0 109.117 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 83.0 mtp -121.42 103.78 9.2 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.257 -0.902 . . . . 0.0 109.731 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -113.52 101.45 9.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.425 -0.797 . . . . 0.0 109.085 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -76.46 -32.89 58.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.03 -1.044 . . . . 0.0 110.471 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -59.45 -47.07 86.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.011 -1.055 . . . . 0.0 109.579 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -89.53 2.96 53.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.184 -0.947 . . . . 0.0 109.044 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 50.78 46.58 25.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.543 -0.723 . . . . 0.0 109.904 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.544 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.7 t -131.5 135.31 46.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.027 -1.046 . . . . 0.0 109.427 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -128.23 140.07 52.1 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.421 -0.799 . . . . 0.0 109.977 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.544 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 70.8 m-85 -135.68 147.25 48.46 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.167 -0.958 . . . . 0.0 109.319 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 45.8 t -146.11 143.48 29.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.116 -0.99 . . . . 0.0 109.115 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -99.35 133.15 44.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.235 -0.916 . . . . 0.0 109.355 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 100' ' ' PRO . 88.4 mt -92.0 139.08 24.39 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.486 -0.759 . . . . 0.0 109.763 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.481 ' O ' ' O ' ' A' ' 44' ' ' ALA . 77.7 Cg_exo -45.87 176.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.867 1.711 . . . . 0.0 111.118 178.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.2 m -86.03 -11.91 51.63 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.195 -0.941 . . . . 0.0 109.772 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.4 tp -138.66 130.5 27.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.107 -0.996 . . . . 0.0 110.536 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.412 HD11 HG23 ' A' ' 103' ' ' ILE . 96.8 mt -141.78 123.6 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.303 -0.873 . . . . 0.0 108.651 178.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.488 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 12.9 t -119.87 50.5 1.27 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.221 -0.924 . . . . 0.0 109.781 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.489 ' O ' ' OXT' ' A' ' 127' ' ' ALA . 87.8 m-20 -144.26 153.16 41.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.975 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -101.92 33.47 3.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.363 -0.836 . . . . 0.0 109.266 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.44 ' CB ' ' HZ3' ' A' ' 80' ' ' LYS . 15.1 p-90 -64.64 157.05 28.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.096 -1.002 . . . . 0.0 110.332 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -138.15 150.28 46.65 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.615 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 30.0 p90 -153.55 164.58 37.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.969 . . . . 0.0 108.785 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 11.8 p90 -155.11 161.83 41.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.803 -1.186 . . . . 0.0 111.783 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 98.7 m -126.09 157.15 38.76 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.439 ' O ' ' O ' ' A' ' 59' ' ' GLU . 49.8 t -129.67 141.07 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.88 -1.137 . . . . 0.0 111.738 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 46.8 m -121.89 131.98 54.32 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 93.7 p -170.88 178.88 3.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.297 -1.502 . . . . 0.0 111.57 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.586 ' NZ ' ' OE1' ' A' ' 118' ' ' GLU . 26.1 mtmm -154.34 164.92 37.86 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.49 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 50.1 p30 -58.87 152.75 18.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.842 -1.161 . . . . 0.0 109.173 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.504 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 53.4 t-20 44.5 59.66 3.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.282 -0.886 . . . . 0.0 109.567 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.586 ' OE1' ' NZ ' ' A' ' 115' ' ' LYS . 41.2 mt-10 -164.97 145.44 7.32 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.158 -0.964 . . . . 0.0 110.241 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.622 ' NZ ' ' O ' ' A' ' 25' ' ' ILE . 51.0 mtmt -63.58 135.74 57.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.871 . . . . 0.0 108.729 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.534 ' HE2' ' H ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -84.3 146.43 27.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.075 -1.016 . . . . 0.0 110.42 -179.405 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 57.2 mt -111.58 124.23 51.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.184 -0.948 . . . . 0.0 109.287 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 51.3 t -108.22 129.99 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.942 -1.099 . . . . 0.0 110.593 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -109.64 121.48 45.3 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.5 t -137.2 142.1 42.12 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.866 -1.146 . . . . 0.0 112.193 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.615 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.0 m -136.78 156.73 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -133.95 157.13 46.82 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.157 -0.965 . . . . 0.0 110.385 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.489 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.907 -1.044 . . . . 0.0 109.314 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.315 0.579 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -74.41 159.13 32.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.092 -1.005 . . . . 0.0 109.277 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.4 t -104.28 133.75 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.315 -0.866 . . . . 0.0 109.901 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -67.73 119.83 13.09 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.095 -1.003 . . . . 0.0 108.715 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.97 176.04 47.09 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.7 t -120.51 132.1 55.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.374 -1.074 . . . . 0.0 109.35 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.417 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 43.3 t0 -107.42 108.86 20.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.556 -0.715 . . . . 0.0 109.485 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -86.2 -0.92 56.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 108.929 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.3 m -101.81 -15.88 16.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.56 -0.712 . . . . 0.0 110.54 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.9 m -158.54 127.67 5.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.883 -1.136 . . . . 0.0 110.258 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.514 ' OG ' ' OE1' ' A' ' 12' ' ' GLU . 64.6 p -68.16 -24.1 64.94 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.911 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 57.0 mp0 -114.58 74.05 0.86 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.481 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 23.5 p -71.33 153.87 42.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.464 -0.772 . . . . 0.0 110.241 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.46 0.82 37.45 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.1 pt -124.05 -25.65 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.628 -0.67 . . . . 0.0 110.219 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.481 ' O ' ' OG ' ' A' ' 13' ' ' SER . 71.4 m-85 -113.13 139.4 48.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.168 -0.957 . . . . 0.0 110.012 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.6 p -69.37 -16.46 63.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.719 . . . . 0.0 110.766 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -135.05 146.1 48.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.956 -1.09 . . . . 0.0 110.847 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.417 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -163.01 173.37 39.2 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -125.95 161.85 26.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.41 -1.053 . . . . 0.0 109.564 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 t -96.21 154.39 17.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.36 -0.837 . . . . 0.0 109.206 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.4 pt -55.31 -33.91 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.271 -0.893 . . . . 0.0 109.329 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.431 ' OD1' ' OD1' ' A' ' 27' ' ' ASN . 37.9 t30 -66.14 -40.23 90.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.895 -1.128 . . . . 0.0 109.679 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -60.94 -45.49 94.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 0.0 110.283 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.4 pt -77.7 -15.45 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.104 -0.998 . . . . 0.0 109.587 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.704 ' O ' ' C ' ' A' ' 27' ' ' ASN . 20.6 p -93.6 -61.59 1.52 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.292 -0.88 . . . . 0.0 109.21 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.704 ' C ' ' O ' ' A' ' 26' ' ' SER . 99.0 m-20 0.21 84.06 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 26' ' ' SER . 63.9 pttt -63.92 22.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.573 -0.705 . . . . 0.0 109.745 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.669 ' H ' ' C ' ' A' ' 27' ' ' ASN . 87.3 p -103.5 -68.45 0.84 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.171 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.0 p -51.46 107.27 0.18 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.465 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -64.67 -37.19 86.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 0.0 109.761 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -58.02 -9.3 1.32 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.465 -0.772 . . . . 0.0 109.535 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.582 ' O ' ' N ' ' A' ' 35' ' ' ASP . 23.1 pt20 -58.07 -44.78 87.71 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.215 -0.928 . . . . 0.0 109.446 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.544 ' C ' ' O ' ' A' ' 33' ' ' GLN . 6.4 pt20 -31.45 -35.84 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.411 0.624 . . . . 0.0 109.749 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 33' ' ' GLN . 10.6 m-20 -119.63 102.26 8.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.376 -0.827 . . . . 0.0 110.181 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.438 ' CD1' ' O ' ' A' ' 33' ' ' GLN . 15.2 mm -97.56 121.64 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.999 -1.063 . . . . 0.0 108.337 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.6 t -117.86 126.5 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.362 -0.836 . . . . 0.0 110.383 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.427 ' O ' ' O ' ' A' ' 124' ' ' THR . 96.9 m -101.96 101.11 11.47 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.1 m -93.54 119.77 33.0 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.928 . . . . 0.0 109.624 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 14.6 m -139.88 139.48 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.498 -0.751 . . . . 0.0 109.238 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -82.22 127.41 33.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.117 -0.989 . . . . 0.0 109.301 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.01 154.79 17.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 109.45 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.712 ' HD1' ' H ' ' A' ' 45' ' ' ASN . 45.8 t-80 -128.32 152.62 47.93 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.385 -0.822 . . . . 0.0 109.593 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.466 ' CB ' ' O ' ' A' ' 100' ' ' PRO . . . -56.03 -25.61 45.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 109.766 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.712 ' H ' ' HD1' ' A' ' 43' ' ' HIS . 99.1 m-20 -97.14 -24.38 15.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 109.497 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -77.35 136.86 38.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.465 -0.772 . . . . 0.0 109.888 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.1 mt -79.6 149.18 31.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.933 . . . . 0.0 108.595 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 22.1 pt -120.83 142.35 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.11 -0.994 . . . . 0.0 110.086 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.13 -173.27 45.79 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -172.79 172.12 4.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.081 -1.246 . . . . 0.0 109.864 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -146.02 144.55 30.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.271 -0.893 . . . . 0.0 109.861 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 47.1 m -125.24 153.99 71.88 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.127 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.429 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.66 146.96 25.3 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.647 2.232 . . . . 0.0 112.027 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.3 t -68.4 -13.16 62.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.462 -0.773 . . . . 0.0 110.71 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.47 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 80.0 m-20 -90.37 -0.61 57.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.942 -1.099 . . . . 0.0 110.213 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.429 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 18.8 m-85 -109.5 164.03 12.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.216 -0.928 . . . . 0.0 110.207 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.4 133.88 48.54 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.416 -0.802 . . . . 0.0 108.984 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.544 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 3.2 m -91.47 112.95 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.994 -1.066 . . . . 0.0 110.508 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -121.42 129.53 25.19 Favored Pre-proline 0 N--CA 1.49 1.526 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.08 113.53 3.43 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.593 1.529 . . . . 0.0 112.243 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -88.96 -24.81 22.33 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.1 t0 -170.17 37.32 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.415 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 79.6 m -60.78 -154.05 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.628 -0.67 . . . . 0.0 109.696 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.1 p90 -110.14 -57.81 2.15 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.12 -0.987 . . . . 0.0 111.206 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 64' ' ' PHE . 6.2 t -46.68 -72.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.385 -1.447 . . . . 0.0 108.965 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.7 t -137.65 133.2 34.02 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.415 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.27 -178.75 2.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.986 -1.071 . . . . 0.0 110.483 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 6.3 m-85 -93.13 128.46 39.06 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -71.76 -173.69 1.03 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.076 -1.015 . . . . 0.0 109.724 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.67 -19.69 65.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.099 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.5 p -84.09 -9.17 58.81 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.365 -0.835 . . . . 0.0 108.92 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.97 19.69 58.94 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -105.2 140.59 38.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.319 -1.106 . . . . 0.0 109.075 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -74.12 123.0 23.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 110.167 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -155.31 132.2 10.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.93 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -61.76 146.18 50.2 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.171 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 tp -100.47 6.05 44.28 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.229 -0.919 . . . . 0.0 109.669 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.452 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.3 OUTLIER -72.57 -38.57 67.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.883 -1.136 . . . . 0.0 110.072 -179.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.94 -15.91 25.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.163 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.2 ttpt -102.79 -35.2 8.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 109.312 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 41.7 tp -131.9 123.36 27.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -82.0 83.72 7.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.919 -1.113 . . . . 0.0 109.248 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.3 mt -76.86 140.99 40.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.061 -1.024 . . . . 0.0 110.144 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.4 p -128.32 158.07 39.23 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.509 -0.744 . . . . 0.0 109.303 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 54.74 50.14 16.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 0.0 109.656 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.7 mt -78.48 132.63 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 109.818 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.5 mm -116.02 118.3 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.43 -0.794 . . . . 0.0 109.386 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 41.7 mtp -124.72 109.8 13.57 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.146 -0.971 . . . . 0.0 109.804 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.68 101.85 9.71 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.365 -0.835 . . . . 0.0 108.839 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.485 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 52.1 m170 -70.02 -38.63 75.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.022 -1.049 . . . . 0.0 110.628 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -60.53 -45.39 94.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.971 -1.081 . . . . 0.0 109.513 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -86.19 -6.11 59.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 0.0 109.135 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.485 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.6 m-20 54.72 47.89 21.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.388 -0.82 . . . . 0.0 110.237 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.6 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 1.9 t -133.87 139.45 46.21 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.983 -1.073 . . . . 0.0 109.409 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -128.05 140.13 52.14 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.49 -0.756 . . . . 0.0 110.055 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.6 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 73.5 m-85 -136.32 146.64 46.82 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.261 -0.9 . . . . 0.0 109.249 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 64.0 m -149.6 151.66 34.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.072 -1.018 . . . . 0.0 109.223 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 -101.35 132.52 46.87 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.038 -1.039 . . . . 0.0 109.341 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 86.4 mt -90.51 137.45 27.34 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.379 -0.826 . . . . 0.0 109.599 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.466 ' O ' ' CB ' ' A' ' 44' ' ' ALA . 76.7 Cg_exo -46.24 163.89 0.1 OUTLIER 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.816 1.678 . . . . 0.0 111.296 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 93.4 p -73.68 -12.1 60.62 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.089 -1.007 . . . . 0.0 109.65 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.9 tp -137.31 130.27 30.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.086 -1.009 . . . . 0.0 110.609 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.2 mt -145.01 102.34 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.3 m -97.11 -6.51 34.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 0.0 109.847 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -83.69 154.74 23.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.999 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -105.55 33.35 3.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.35 -0.844 . . . . 0.0 109.241 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 23.6 p-90 -65.31 153.54 40.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.142 -0.974 . . . . 0.0 110.505 -178.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -132.45 154.38 49.93 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.641 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 33.4 p90 -152.69 159.34 43.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.113 -0.992 . . . . 0.0 108.666 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 4.2 p90 -150.7 159.05 44.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.779 -1.2 . . . . 0.0 111.742 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 88.9 m -123.22 155.66 36.68 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.9 t -129.97 141.97 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.759 -1.213 . . . . 0.0 111.768 -178.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 76.3 m -120.49 131.39 54.7 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.9 p -169.56 171.84 7.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.272 -1.518 . . . . 0.0 111.653 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.47 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 51.9 mttm -148.59 165.23 31.88 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 54.4 p-10 -57.62 150.48 19.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.854 -1.154 . . . . 0.0 109.067 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 116' ' ' ASP . 64.3 t30 42.71 60.62 2.36 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.203 -0.935 . . . . 0.0 109.763 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 44.6 mt-10 -161.74 141.8 10.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.221 -0.924 . . . . 0.0 110.305 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.583 ' NZ ' ' O ' ' A' ' 26' ' ' SER . 99.1 mttt -54.58 147.07 14.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.161 -0.962 . . . . 0.0 108.953 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.7 pttt -98.81 140.44 33.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.211 -0.93 . . . . 0.0 110.36 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.7 mt -111.27 124.51 52.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.567 -0.708 . . . . 0.0 109.251 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.4 t -109.56 130.72 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.947 -1.095 . . . . 0.0 110.469 -179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -109.33 121.76 45.88 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 38' ' ' CYS . 7.2 t -136.97 141.81 42.6 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.927 -1.108 . . . . 0.0 112.123 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -135.74 159.1 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -123.58 142.91 50.58 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.129 -0.982 . . . . 0.0 110.389 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.319 179.748 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -83.98 151.76 24.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -0.855 . . . . 0.0 109.372 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.0 t -86.2 135.78 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.915 . . . . 0.0 110.031 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -71.05 129.51 39.15 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.571 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 168.11 -163.25 37.0 Favored Glycine 0 N--CA 1.483 1.798 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.98 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -129.08 135.09 48.44 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.461 -1.023 . . . . 0.0 109.779 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -114.51 109.41 18.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.447 -0.783 . . . . 0.0 109.302 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -89.23 3.26 52.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.161 -0.962 . . . . 0.0 108.807 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.6 m -98.21 -20.7 17.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.409 -0.807 . . . . 0.0 110.586 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.2 m -156.65 126.64 6.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.881 -1.137 . . . . 0.0 110.263 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 t -59.08 -31.88 69.29 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -112.64 73.89 0.84 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -66.62 148.57 51.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.34 -0.85 . . . . 0.0 110.29 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.6 t -98.35 0.55 45.67 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.6 pt -123.86 -20.73 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.658 -0.651 . . . . 0.0 110.243 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.448 ' CZ ' ' N ' ' A' ' 50' ' ' PHE . 56.6 m-85 -119.59 137.81 53.62 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.304 -0.872 . . . . 0.0 109.999 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.1 t -65.99 -16.81 64.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.635 -0.666 . . . . 0.0 110.819 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -132.71 144.11 50.07 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.04 -1.038 . . . . 0.0 110.68 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -159.38 171.72 35.9 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -130.37 165.14 23.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.382 -1.07 . . . . 0.0 109.682 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.5 ' HG ' ' H ' ' A' ' 23' ' ' ASN . 6.9 t -95.46 153.81 17.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.38 -0.825 . . . . 0.0 109.17 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.459 ' N ' ' HG ' ' A' ' 21' ' ' SER . 41.1 pt -57.5 -32.22 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.24 -0.913 . . . . 0.0 109.379 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.5 ' H ' ' HG ' ' A' ' 21' ' ' SER . 14.9 t-20 -65.94 -39.45 90.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.113 -0.992 . . . . 0.0 109.533 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -65.16 -39.77 93.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.404 -0.81 . . . . 0.0 110.147 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.3 pt -86.29 -13.6 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.969 . . . . 0.0 109.703 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.527 ' HG ' ' CD ' ' A' ' 28' ' ' LYS . 88.0 p -66.69 -134.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.932 . . . . 0.0 109.33 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -104.52 28.36 7.05 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.244 -0.91 . . . . 0.0 109.11 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.527 ' CD ' ' HG ' ' A' ' 26' ' ' SER . 8.8 mptt -126.87 15.02 7.45 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.536 -0.727 . . . . 0.0 109.651 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.493 ' O ' ' C ' ' A' ' 30' ' ' SER . 16.8 m -40.99 143.39 0.38 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.499 -0.751 . . . . 0.0 109.406 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.493 ' C ' ' O ' ' A' ' 29' ' ' SER . 44.6 t -37.59 -81.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.473 -0.767 . . . . 0.0 109.676 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -143.21 -4.72 0.89 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.944 . . . . 0.0 109.69 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.529 ' O ' ' O ' ' A' ' 33' ' ' GLN . 98.9 m-20 -61.61 122.49 15.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.963 . . . . 0.0 109.385 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.529 ' O ' ' O ' ' A' ' 32' ' ' ASN . 0.4 OUTLIER -35.12 -95.91 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.864 -0.523 . . . . 0.0 109.816 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.461 ' H ' ' CG ' ' A' ' 33' ' ' GLN . 7.3 pt20 -139.67 34.0 2.01 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.781 -1.2 . . . . 0.0 109.213 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -134.42 106.17 6.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.408 -0.807 . . . . 0.0 109.721 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.458 HD12 HG22 ' A' ' 36' ' ' ILE . 46.1 mm -91.77 120.8 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 108.669 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.8 t -116.21 128.33 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.469 -0.77 . . . . 0.0 110.13 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 74.8 m -101.99 101.82 12.27 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.5 m -93.61 119.84 33.14 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.266 -0.896 . . . . 0.0 109.673 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.0 m -141.12 153.77 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.544 -0.723 . . . . 0.0 109.12 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -99.79 134.95 41.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.989 -1.069 . . . . 0.0 109.488 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.68 159.58 14.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.324 -0.86 . . . . 0.0 109.549 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -133.11 150.88 52.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.908 . . . . 0.0 109.445 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.98 -23.95 5.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.256 -0.903 . . . . 0.0 109.805 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -104.03 -25.87 12.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -0.925 . . . . 0.0 109.732 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -73.03 134.58 44.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.324 -0.86 . . . . 0.0 109.954 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -80.42 147.93 30.77 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 45.9 pt -120.34 142.31 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.219 -0.926 . . . . 0.0 110.128 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.58 -172.65 45.39 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.448 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 45.7 p90 -172.42 172.08 4.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.965 -1.314 . . . . 0.0 109.724 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -146.15 144.82 30.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.207 -0.933 . . . . 0.0 109.864 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 85.3 m -123.2 151.94 62.97 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.4 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.45 146.95 23.8 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.287 1.992 . . . . 0.0 111.929 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.3 t -68.47 -13.21 62.15 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.463 -0.773 . . . . 0.0 110.838 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -91.24 -1.48 57.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.935 -1.103 . . . . 0.0 110.324 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.4 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 20.0 m-85 -108.95 164.36 12.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.251 -0.906 . . . . 0.0 110.422 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.9 t -104.72 134.95 47.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.35 -0.844 . . . . 0.0 108.996 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.474 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.8 m -90.44 123.36 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.958 -1.089 . . . . 0.0 110.223 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 112' ' ' VAL . 26.3 mt-10 -127.81 126.22 23.82 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.06 114.32 3.57 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 121.688 1.592 . . . . 0.0 112.16 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 68' ' ' PHE . 7.3 t-160 -93.07 -24.84 18.17 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.6 t0 -170.21 39.76 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 98.6 m -63.02 -153.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.44 -0.788 . . . . 0.0 109.733 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.9 p90 -111.17 -56.42 2.37 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.246 -0.909 . . . . 0.0 111.359 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' ' 64' ' ' PHE . 16.2 t -48.51 -72.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.362 -1.461 . . . . 0.0 108.848 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.3 t -138.89 131.29 28.58 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -173.42 -179.42 1.88 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.999 -1.063 . . . . 0.0 110.483 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 6.2 m-85 -93.45 127.65 39.18 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -73.95 -172.36 1.31 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.115 -0.99 . . . . 0.0 109.671 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.8 mt -63.62 -22.53 66.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 109.122 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.0 p -82.5 -7.41 59.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 108.875 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.93 18.47 67.53 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -101.48 140.72 35.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.253 -1.145 . . . . 0.0 108.989 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -80.6 115.9 20.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.297 -0.877 . . . . 0.0 110.133 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -152.65 139.64 19.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 109.767 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -63.3 148.56 47.94 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.156 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.0 tp -97.59 7.94 45.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.306 -0.871 . . . . 0.0 109.817 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -68.65 -40.47 80.2 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.845 -1.159 . . . . 0.0 110.049 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 79' ' ' ASN . 52.0 t-20 -62.39 -33.99 75.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.019 -1.051 . . . . 0.0 109.108 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -74.42 -48.87 25.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.888 . . . . 0.0 109.56 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 48.5 tp -139.29 124.74 19.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.459 -0.776 . . . . 0.0 109.161 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -81.19 90.13 6.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.046 -1.033 . . . . 0.0 109.734 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.2 mt -75.26 149.96 38.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 109.972 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.9 p -127.24 159.97 32.72 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.469 -0.769 . . . . 0.0 109.203 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.725 HD21 HH11 ' A' ' 98' ' ' ARG . 82.3 m-20 55.69 52.77 10.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.92 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -81.77 132.98 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.379 -0.826 . . . . 0.0 110.009 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.3 mm -122.48 122.65 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.521 -0.737 . . . . 0.0 109.21 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 91.0 mtp -122.24 102.91 8.41 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.154 -0.966 . . . . 0.0 109.757 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -111.98 100.62 9.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.304 -0.873 . . . . 0.0 109.037 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.491 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 76.3 m80 -73.28 -35.02 66.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.002 -1.061 . . . . 0.0 110.64 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -60.67 -46.59 89.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.009 -1.057 . . . . 0.0 109.646 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -88.48 -3.89 58.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.138 -0.976 . . . . 0.0 109.07 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 97.3 m-20 54.57 47.28 23.04 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 0.0 110.144 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.594 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 2.3 t -132.65 138.0 47.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.229 -0.919 . . . . 0.0 109.36 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -127.91 139.71 52.44 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.392 -0.818 . . . . 0.0 110.103 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.594 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 58.3 m-85 -136.2 146.88 47.3 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.279 -0.888 . . . . 0.0 109.245 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.4 t -151.46 152.92 33.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.978 . . . . 0.0 109.143 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.725 HH11 HD21 ' A' ' 85' ' ' ASN . 53.9 mtp180 -108.37 137.43 46.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.341 -0.849 . . . . 0.0 109.36 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 40.8 mt -93.24 141.1 23.57 Favored Pre-proline 0 N--CA 1.491 1.624 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.603 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -46.54 159.49 0.29 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.781 1.654 . . . . 0.0 111.206 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.2 p -68.71 -16.52 63.84 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.254 -0.904 . . . . 0.0 109.772 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.2 tp -123.37 131.44 53.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.408 -0.808 . . . . 0.0 110.502 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 64.6 mt -143.07 126.03 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.4 m -139.16 52.99 1.75 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.955 -1.091 . . . . 0.0 109.782 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.519 ' O ' ' OXT' ' A' ' 127' ' ' ALA . 54.6 t0 -145.99 153.33 40.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.957 . . . . 0.0 110.026 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.491 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 99.0 m-20 -91.93 33.03 1.07 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.39 -0.819 . . . . 0.0 108.912 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.432 ' CD1' ' OXT' ' A' ' 127' ' ' ALA . 7.8 p-90 -64.57 154.33 36.53 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.135 -0.978 . . . . 0.0 110.494 -178.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.559 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 53.7 tttp -145.39 151.42 38.23 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.611 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 30.2 p90 -155.45 164.48 38.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.077 -1.014 . . . . 0.0 108.621 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 8.0 p90 -154.63 159.07 40.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.717 -1.239 . . . . 0.0 111.861 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 80.7 m -123.25 156.24 35.59 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 59' ' ' GLU . 46.4 t -129.3 141.21 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 120.874 -1.141 . . . . 0.0 111.693 -178.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 35.1 m -122.25 131.73 54.07 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.0 p -172.12 179.04 2.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.243 -1.536 . . . . 0.0 111.565 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.504 ' CB ' ' HZ2' ' A' ' 115' ' ' LYS . 6.3 mtmp? -153.09 167.32 29.63 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 117' ' ' ASN . 99.9 m-20 -58.84 152.14 19.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.782 -1.199 . . . . 0.0 109.001 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.461 ' C ' ' O ' ' A' ' 116' ' ' ASP . 56.8 t-20 39.77 59.53 1.86 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.462 -0.774 . . . . 0.0 109.683 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 54.0 mm-40 -158.46 139.9 13.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.374 -0.829 . . . . 0.0 110.551 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -52.98 140.43 24.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 0.0 108.873 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -92.88 139.12 30.86 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.462 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.3 mt -110.04 122.77 48.35 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 43.6 t -107.25 129.47 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.049 -1.032 . . . . 0.0 110.625 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -106.95 119.07 38.35 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.559 ' OG1' ' NZ ' ' A' ' 108' ' ' LYS . 6.3 t -136.11 140.21 43.54 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.997 -1.064 . . . . 0.0 112.119 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.611 ' CG2' ' CE2' ' A' ' 109' ' ' PHE . 3.0 m -136.06 156.81 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -136.18 155.47 50.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.088 -1.007 . . . . 0.0 110.291 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.519 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.355 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.526 ' CB ' ' HG ' ' A' ' 17' ' ' SER . 98.8 mttt -138.53 157.4 46.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.904 . . . . 0.0 109.393 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.7 t -95.19 134.88 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.279 -0.888 . . . . 0.0 110.061 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -68.96 123.09 20.07 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.017 -1.052 . . . . 0.0 108.617 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.54 179.66 47.83 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.9 t -119.15 130.04 55.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.523 -0.986 . . . . 0.0 109.318 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -106.3 109.12 20.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.572 -0.705 . . . . 0.0 109.326 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -89.62 1.51 55.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.322 -0.861 . . . . 0.0 108.939 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.3 m -103.29 -17.03 15.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.477 -0.765 . . . . 0.0 110.514 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.8 m -156.93 126.02 5.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.814 -1.179 . . . . 0.0 110.387 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.6 t -64.1 -28.19 69.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.37 -0.831 . . . . 0.0 108.937 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -112.68 73.77 0.83 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.1 t -68.15 150.43 48.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.806 . . . . 0.0 110.211 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.52 -0.08 41.34 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 pt -125.14 -22.03 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.712 -0.618 . . . . 0.0 110.312 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -114.19 141.47 47.48 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.279 -0.888 . . . . 0.0 110.156 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.526 ' HG ' ' CB ' ' A' ' 2' ' ' LYS . 5.9 m -74.98 -18.8 60.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.552 -0.718 . . . . 0.0 110.894 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.55 ' NZ ' ' CE1' ' A' ' 20' ' ' TYR . 61.5 tttm -129.43 140.22 51.39 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.018 -1.051 . . . . 0.0 110.577 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.98 164.88 32.49 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.55 ' CE1' ' NZ ' ' A' ' 18' ' ' LYS . 36.5 m-85 -118.28 155.18 31.04 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.446 -1.032 . . . . 0.0 109.745 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.7 t -94.17 152.08 18.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.443 -0.786 . . . . 0.0 109.024 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.4 pt -59.01 -28.27 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.761 -0.775 . . . . 0.0 109.478 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.47 ' O ' ' OG ' ' A' ' 26' ' ' SER . 66.6 t30 -69.72 -41.01 75.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.049 -1.032 . . . . 0.0 109.633 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -59.67 -45.92 90.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -0.89 . . . . 0.0 110.103 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 35.6 pt -67.17 -5.34 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.117 -0.989 . . . . 0.0 109.57 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.696 ' O ' ' N ' ' A' ' 28' ' ' LYS . 79.2 p -108.8 -36.47 6.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.261 -0.9 . . . . 0.0 109.231 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 29' ' ' SER . 98.8 m-20 -53.65 73.17 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.696 ' N ' ' O ' ' A' ' 26' ' ' SER . 98.3 mttt -52.27 93.05 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.43 -0.794 . . . . 0.0 109.689 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -140.92 -85.55 0.19 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.938 . . . . 0.0 109.212 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.524 ' N ' ' OG ' ' A' ' 29' ' ' SER . 7.0 p -69.21 177.19 2.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.57 -0.706 . . . . 0.0 109.587 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.527 ' C ' ' H ' ' A' ' 33' ' ' GLN . 56.8 p30 -51.46 -14.68 0.32 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.116 -0.99 . . . . 0.0 109.467 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.515 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 91.3 m-20 -69.05 10.48 0.29 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.148 -0.97 . . . . 0.0 109.332 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.61 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 15.2 pt20 -91.44 -7.82 49.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.036 . . . . 0.0 109.568 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.479 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 15.3 pt20 -138.28 -33.1 0.69 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.338 -0.851 . . . . 0.0 109.802 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.479 ' OD1' ' O ' ' A' ' 34' ' ' GLN . 78.8 m-20 -136.59 113.71 10.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.446 -0.784 . . . . 0.0 109.559 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.456 HG22 HD12 ' A' ' 36' ' ' ILE . 21.7 mm -92.72 120.1 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.061 -1.024 . . . . 0.0 108.58 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.4 t -115.33 124.48 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 110.147 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 71.3 m -102.64 101.97 12.14 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.6 m -95.81 121.13 37.21 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.164 -0.96 . . . . 0.0 109.693 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.8 m -141.04 153.91 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.578 -0.701 . . . . 0.0 109.218 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -97.99 133.96 41.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.008 -1.058 . . . . 0.0 109.37 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.81 160.57 14.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 0.0 109.641 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 32.2 t60 -135.28 151.88 50.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.327 -0.858 . . . . 0.0 109.487 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.77 -25.23 7.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 109.635 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -101.48 -27.04 13.35 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.291 -0.881 . . . . 0.0 109.817 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -73.64 134.4 43.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.298 -0.876 . . . . 0.0 109.989 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 97.3 mt -79.92 148.31 31.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 108.545 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.5 pt -120.4 141.5 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.24 -0.913 . . . . 0.0 109.969 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' A' ' 95' ' ' PHE . . . 176.86 -173.28 46.18 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -171.66 173.05 4.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.001 -1.293 . . . . 0.0 109.791 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -146.05 144.78 30.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 0.0 109.892 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 80.0 m -123.79 152.45 65.96 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.405 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.53 148.33 20.77 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.28 1.987 . . . . 0.0 112.005 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.4 m -71.5 -12.96 61.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.431 -0.793 . . . . 0.0 110.647 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -91.84 1.9 56.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.016 -1.053 . . . . 0.0 110.119 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.446 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 18.1 m-85 -110.09 165.26 11.88 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.266 -0.896 . . . . 0.0 110.354 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.5 t -102.92 139.75 38.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 109.012 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.448 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.6 m -97.92 125.86 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.991 -1.068 . . . . 0.0 110.199 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -132.14 129.86 21.85 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.3 113.12 3.32 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.664 1.576 . . . . 0.0 112.095 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -92.01 -27.98 17.48 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -166.81 38.42 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.587 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 79.0 m -62.85 -157.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.544 -0.722 . . . . 0.0 109.77 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.2 p90 -111.27 -49.07 3.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.226 -0.921 . . . . 0.0 111.629 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.6 t -59.22 -48.45 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.343 -1.473 . . . . 0.0 109.286 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.5 t -157.78 128.73 6.53 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.587 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.7 -178.93 1.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.092 -1.005 . . . . 0.0 110.499 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 9.9 m-85 -93.1 124.75 37.3 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -69.28 -174.91 0.71 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.011 . . . . 0.0 109.847 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.404 HD23 ' HZ2' ' A' ' 108' ' ' LYS . 54.5 mt -62.92 -23.01 67.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.316 -0.865 . . . . 0.0 108.95 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.8 m -82.36 -6.34 59.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.327 -0.858 . . . . 0.0 108.761 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.18 19.88 63.88 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -101.71 138.95 38.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.318 -1.107 . . . . 0.0 109.101 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -82.46 110.25 17.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.21 -0.931 . . . . 0.0 109.964 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -147.01 141.91 26.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.499 -0.751 . . . . 0.0 110.011 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -59.86 144.02 49.78 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.274 -0.891 . . . . 0.0 109.32 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.3 tp -97.09 8.03 45.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.202 -0.936 . . . . 0.0 109.735 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -69.67 -38.74 77.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.179 -0.951 . . . . 0.0 110.065 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 41.7 p-10 -62.43 -32.85 73.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.125 -0.984 . . . . 0.0 109.217 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.555 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 37.3 ttmt -71.86 -50.79 26.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.345 -0.847 . . . . 0.0 109.663 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 39.0 tp -140.74 128.2 21.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.479 -0.763 . . . . 0.0 109.166 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -81.05 87.73 6.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.035 -1.041 . . . . 0.0 109.487 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.7 mt -71.66 152.99 42.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 0.0 109.928 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.6 p -128.19 163.92 23.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.562 -0.711 . . . . 0.0 109.323 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 55.44 52.24 11.59 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.265 -0.897 . . . . 0.0 109.94 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.45 128.26 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.337 -0.852 . . . . 0.0 109.985 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.1 mm -123.47 122.44 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.554 -0.716 . . . . 0.0 109.136 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 83.2 mtp -123.59 104.81 9.26 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.197 -0.94 . . . . 0.0 109.793 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -113.37 101.85 9.78 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.342 -0.849 . . . . 0.0 109.013 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.487 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 96.6 m-70 -73.14 -36.14 66.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.97 -1.081 . . . . 0.0 110.652 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -60.21 -46.32 90.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.891 -1.131 . . . . 0.0 109.623 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -89.79 -5.09 57.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.172 -0.955 . . . . 0.0 109.032 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.487 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.6 m-20 54.66 47.66 22.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.551 -0.718 . . . . 0.0 110.25 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.593 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 2.5 t -131.94 135.8 46.88 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.21 -0.931 . . . . 0.0 109.291 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.416 ' O ' ' CA ' ' A' ' 49' ' ' GLY . 76.0 m-85 -126.63 139.28 53.29 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.388 -0.82 . . . . 0.0 109.951 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.593 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 72.3 m-85 -136.15 147.3 47.66 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.349 -0.844 . . . . 0.0 109.264 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.5 t -152.9 152.59 31.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.063 -1.023 . . . . 0.0 109.189 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -107.41 139.29 42.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.26 -0.9 . . . . 0.0 109.856 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.482 ' O ' ' O ' ' A' ' 100' ' ' PRO . 38.2 mt -94.88 141.47 23.35 Favored Pre-proline 0 N--CA 1.49 1.548 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.853 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.482 ' O ' ' O ' ' A' ' 99' ' ' LEU . 77.3 Cg_exo -45.9 179.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.912 1.741 . . . . 0.0 111.162 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.7 m -86.08 -14.17 45.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.088 -1.008 . . . . 0.0 110.001 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.7 tp -120.99 130.22 53.72 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.276 -0.89 . . . . 0.0 110.442 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 7.6 mt -150.23 102.38 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 84.2 p -115.49 -0.69 13.0 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.168 -0.957 . . . . 0.0 109.748 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 52.4 t0 -87.38 158.01 19.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.564 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 92.9 m-20 -99.42 32.2 2.86 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.451 -0.781 . . . . 0.0 109.071 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 10.3 p-90 -65.97 157.18 31.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.145 -0.972 . . . . 0.0 110.509 -178.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.404 ' HZ2' HD23 ' A' ' 70' ' ' LEU . 22.4 pttp -146.4 157.96 43.83 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.568 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 39.6 p90 -155.68 163.54 39.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.155 -0.966 . . . . 0.0 108.718 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -153.73 163.07 40.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.83 -1.169 . . . . 0.0 111.877 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 95.1 m -127.73 158.93 36.3 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.0 t -130.44 143.34 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.93 -1.106 . . . . 0.0 111.856 -178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 86.1 m -124.8 132.92 53.3 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.0 p -171.49 179.14 2.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.306 -1.496 . . . . 0.0 111.669 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.58 ' NZ ' ' OE2' ' A' ' 118' ' ' GLU . 6.4 mtmp? -153.09 166.15 33.36 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.62 151.7 20.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.867 -1.146 . . . . 0.0 109.245 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.49 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 64.8 t30 44.7 61.2 2.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.219 -0.926 . . . . 0.0 109.667 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.58 ' OE2' ' NZ ' ' A' ' 115' ' ' LYS . 42.5 mt-10 -164.61 145.38 7.85 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.226 -0.921 . . . . 0.0 110.26 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.61 ' NZ ' ' O ' ' A' ' 33' ' ' GLN . 67.6 mttm -60.47 146.79 43.45 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.228 -0.92 . . . . 0.0 108.937 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -93.72 141.71 28.18 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.111 -0.993 . . . . 0.0 110.394 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.1 mt -108.84 121.0 44.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.313 -0.867 . . . . 0.0 108.899 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 55.4 t -108.96 130.3 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.092 -1.005 . . . . 0.0 110.577 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -110.65 122.65 48.3 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.0 t -137.68 143.94 41.56 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.029 -1.044 . . . . 0.0 112.378 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.568 ' CG2' ' CE2' ' A' ' 109' ' ' PHE . 3.0 m -135.42 158.77 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -136.83 153.91 50.66 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.058 -1.026 . . . . 0.0 110.282 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.512 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.354 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.282 0.563 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -77.84 156.65 30.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.238 -0.914 . . . . 0.0 109.251 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.6 t -95.06 133.36 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.97 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.416 ' N ' ' CD ' ' A' ' 4' ' ' LYS . 13.6 mptt -70.59 125.18 26.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.104 -0.998 . . . . 0.0 108.663 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.21 -179.95 42.71 Favored Glycine 0 N--CA 1.484 1.844 0 C-N-CA 119.479 -1.343 . . . . 0.0 109.79 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.9 t -116.92 134.72 54.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.402 -1.057 . . . . 0.0 109.712 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.683 ' CB ' ' HG ' ' A' ' 13' ' ' SER . 68.1 t0 -115.81 110.66 19.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.499 -0.751 . . . . 0.0 109.332 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -87.17 3.26 47.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.94 . . . . 0.0 108.916 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.4 m -102.96 -18.85 14.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.434 -0.791 . . . . 0.0 110.549 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.4 m -157.42 127.52 6.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.887 -1.133 . . . . 0.0 110.289 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 21' ' ' SER . 37.3 m -66.49 -27.0 67.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.408 -0.807 . . . . 0.0 109.001 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.583 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 57.9 mp0 -113.81 74.87 0.89 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.683 ' HG ' ' CB ' ' A' ' 7' ' ' ASP . 26.6 m -75.97 115.87 16.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.423 -0.798 . . . . 0.0 110.578 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.7 t -65.39 3.2 0.71 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.555 ' H ' ' C ' ' A' ' 13' ' ' SER . 15.1 pt -122.83 -36.57 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.712 -0.618 . . . . 0.0 110.333 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.416 ' CZ ' ' CE1' ' A' ' 96' ' ' TYR . 50.9 m-85 -108.21 137.11 46.75 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.185 -0.947 . . . . 0.0 109.816 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.2 t -68.28 -18.4 64.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.593 -0.692 . . . . 0.0 111.003 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -130.58 141.42 50.46 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.953 -1.092 . . . . 0.0 110.521 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.449 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -161.83 173.55 38.2 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -128.44 162.23 27.63 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.38 -1.07 . . . . 0.0 109.568 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.509 ' N ' ' OG ' ' A' ' 11' ' ' SER . 10.7 t -97.05 157.37 15.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.392 -0.817 . . . . 0.0 109.182 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.479 ' O ' ' OG ' ' A' ' 26' ' ' SER . 44.1 pt -57.97 -30.38 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.308 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -65.9 -40.42 91.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.153 -0.967 . . . . 0.0 109.59 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -66.11 -41.53 90.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 110.219 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 25' ' ' ILE . 21.1 pt -86.85 -17.61 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.003 -1.061 . . . . 0.0 109.739 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.594 ' O ' ' N ' ' A' ' 28' ' ' LYS . 37.8 m -93.65 -73.27 0.57 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 0.0 109.342 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 29' ' ' SER . 58.7 t30 -50.36 87.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 0.0 109.147 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' A' ' 26' ' ' SER . 35.2 pttt -45.63 95.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.555 -0.715 . . . . 0.0 109.54 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 27' ' ' ASN . 20.3 m -157.17 21.42 0.3 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.335 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.5 t -78.23 155.43 30.31 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.881 -0.727 . . . . 0.0 109.929 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.409 ' CG ' ' H ' ' A' ' 32' ' ' ASN . 26.3 p-10 -52.03 -54.35 31.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.157 -0.964 . . . . 0.0 109.468 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.589 ' ND2' ' O ' ' A' ' 35' ' ' ASP . 25.1 p30 -71.94 177.29 4.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.168 -0.957 . . . . 0.0 109.341 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.547 ' C ' ' H ' ' A' ' 35' ' ' ASP . 21.0 pt20 -75.97 -148.42 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.595 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.72 ' H ' ' NE2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -69.65 40.0 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.471 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.589 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 86.3 m-20 -131.78 109.24 10.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.498 -0.751 . . . . 0.0 109.518 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 36' ' ' ILE . 40.2 mm -97.31 124.49 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.995 -1.066 . . . . 0.0 108.775 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 50.0 t -121.03 129.62 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.303 -0.873 . . . . 0.0 110.157 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 124' ' ' THR . 84.5 m -101.26 100.12 10.59 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.8 m -95.53 120.64 36.13 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.089 -1.007 . . . . 0.0 109.412 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.1 m -139.05 159.44 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.526 -0.734 . . . . 0.0 109.176 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -97.77 123.71 41.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.151 -0.968 . . . . 0.0 109.594 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.55 155.03 19.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -0.87 . . . . 0.0 109.531 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.735 ' HD1' ' H ' ' A' ' 45' ' ' ASN . 35.4 t-80 -133.33 152.13 51.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -0.898 . . . . 0.0 109.553 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.34 -29.61 64.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.335 -0.853 . . . . 0.0 109.827 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.735 ' H ' ' HD1' ' A' ' 43' ' ' HIS . 49.3 t30 -93.6 -26.89 16.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 109.725 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -76.68 135.6 39.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.523 -0.735 . . . . 0.0 110.043 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.1 mt -78.36 148.64 33.63 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 47.5 pt -122.36 144.83 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.331 -0.856 . . . . 0.0 110.308 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.5 -171.2 44.16 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -172.73 171.57 4.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.136 -1.214 . . . . 0.0 109.71 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -146.82 144.84 29.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 0.0 109.9 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 86.0 m -125.37 152.17 70.96 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.929 . . . . 0.0 108.54 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.447 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.4 Cg_endo -51.63 149.82 17.9 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.3 2.0 . . . . 0.0 111.944 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.0 m -70.84 -12.1 61.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -0.83 . . . . 0.0 110.682 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.448 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 82.4 m-20 -92.78 0.23 57.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.94 -1.1 . . . . 0.0 110.182 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.447 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 16.3 m-85 -108.28 164.2 12.53 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.202 -0.936 . . . . 0.0 110.364 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.9 m -103.85 128.08 51.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 109.087 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.537 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 3.2 m -88.3 114.38 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.959 -1.088 . . . . 0.0 110.151 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -120.37 126.8 26.62 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.06 113.53 3.43 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 121.545 1.496 . . . . 0.0 112.106 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.491 ' O ' ' O ' ' A' ' 68' ' ' PHE . 2.8 t-80 -93.59 -23.63 18.23 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -172.26 51.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.647 ' H ' ' CB ' ' A' ' 67' ' ' ALA . 76.4 m -76.47 -151.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.63 -0.668 . . . . 0.0 109.799 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 6.5 p90 -110.18 -58.33 2.08 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.098 -1.001 . . . . 0.0 111.373 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.454 ' C ' ' O ' ' A' ' 64' ' ' PHE . 24.0 t -45.27 -70.35 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.627 -1.296 . . . . 0.0 108.809 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.4 t -145.58 129.36 17.23 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.647 ' CB ' ' H ' ' A' ' 63' ' ' CYS . . . -167.84 -179.78 4.38 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.373 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.3 m-85 -93.98 141.2 28.79 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.656 HD22 ' CB ' ' A' ' 75' ' ' GLU . 75.8 m-20 -80.88 -169.7 2.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.955 -1.091 . . . . 0.0 109.652 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.2 mp -67.91 -13.8 62.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 108.913 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.4 t -90.73 -7.14 53.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -0.856 . . . . 0.0 108.982 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.07 23.87 56.26 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -107.73 136.44 47.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.213 -1.169 . . . . 0.0 109.095 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -67.42 135.02 52.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.216 -0.927 . . . . 0.0 109.984 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.656 ' CB ' HD22 ' A' ' 69' ' ' ASN . 80.3 tt0 -155.42 166.0 34.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.437 -0.789 . . . . 0.0 109.548 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.437 ' N ' ' HG2' ' A' ' 75' ' ' GLU . 5.3 m120 -106.94 139.1 41.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.33 -0.856 . . . . 0.0 109.531 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.7 tp -95.79 -10.27 29.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.0 . . . . 0.0 110.027 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.481 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 20.5 pt-20 -62.67 -44.86 95.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.99 -1.069 . . . . 0.0 109.476 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.563 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 48.7 p30 -66.72 -22.09 66.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.138 -0.976 . . . . 0.0 108.94 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.563 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 52.6 tptt -86.74 -48.09 8.55 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.359 -0.838 . . . . 0.0 109.415 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.403 HD22 ' CZ2' ' A' ' 107' ' ' TRP . 30.8 tp -122.89 129.95 52.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.412 -0.805 . . . . 0.0 109.174 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -78.66 82.68 4.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.032 -1.043 . . . . 0.0 109.244 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.8 mt -81.53 137.69 35.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.873 . . . . 0.0 110.112 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 48.1 p -127.44 163.31 24.36 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.513 -0.742 . . . . 0.0 109.278 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.511 HD21 ' NE ' ' A' ' 98' ' ' ARG . 97.8 m-20 55.04 51.05 14.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.623 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.2 131.53 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.353 -0.842 . . . . 0.0 110.039 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.425 HG22 HD13 ' A' ' 87' ' ' ILE . 45.6 mm -121.85 121.17 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.503 -0.748 . . . . 0.0 109.277 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 79.6 mtp -123.73 107.4 11.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.21 -0.931 . . . . 0.0 109.785 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -112.57 101.27 9.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.374 -0.829 . . . . 0.0 109.082 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.448 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 76.4 m80 -71.55 -36.8 71.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.917 -1.114 . . . . 0.0 110.651 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -60.61 -45.74 92.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.022 -1.049 . . . . 0.0 109.557 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -87.91 -5.28 58.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.117 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 99.7 m-20 54.37 47.61 22.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.504 -0.747 . . . . 0.0 110.332 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.606 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 2.6 t -132.99 138.19 46.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.028 -1.045 . . . . 0.0 109.333 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -126.38 138.9 53.61 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.512 -0.742 . . . . 0.0 109.809 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.606 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 77.9 m-85 -135.41 146.15 48.0 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.115 -0.991 . . . . 0.0 109.336 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.5 p -153.03 155.69 37.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.097 -1.002 . . . . 0.0 108.986 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.511 ' NE ' HD21 ' A' ' 85' ' ' ASN . 59.2 mtt-85 -105.11 136.68 44.16 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.264 -0.897 . . . . 0.0 109.65 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 100' ' ' PRO . 78.1 mt -91.83 138.41 24.91 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.459 -0.776 . . . . 0.0 109.706 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 99' ' ' LEU . 76.4 Cg_exo -45.74 175.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.83 1.686 . . . . 0.0 111.305 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.6 m -83.92 -12.93 54.66 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.077 -1.014 . . . . 0.0 109.844 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.3 tp -134.13 130.0 36.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.131 -0.981 . . . . 0.0 110.511 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 91.3 mt -147.37 102.48 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.865 . . . . 0.0 108.806 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.3 m -104.1 -6.96 20.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.072 -1.017 . . . . 0.0 109.794 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 127' ' ' ALA . 78.6 m-20 -78.41 151.65 32.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 110.022 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -100.15 31.79 3.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.391 -0.818 . . . . 0.0 109.205 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.403 ' CZ2' HD22 ' A' ' 81' ' ' LEU . 20.4 p-90 -65.4 159.88 23.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.117 -0.99 . . . . 0.0 110.465 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -142.23 156.97 45.34 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.643 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 36.4 p90 -154.08 158.62 40.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.088 -1.007 . . . . 0.0 108.692 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 18.5 p90 -150.66 156.33 41.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.804 -1.185 . . . . 0.0 111.937 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 96.5 m -121.78 156.19 33.71 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -127.71 138.43 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.77 -1.206 . . . . 0.0 111.872 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 67.0 m -123.34 132.0 53.84 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 97.5 p -165.6 171.5 13.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.121 -1.612 . . . . 0.0 111.652 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.448 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 47.6 mtpt -136.87 158.58 44.14 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -60.29 143.21 53.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.933 -1.105 . . . . 0.0 108.813 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.513 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 59.6 t-20 49.82 62.63 2.55 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.395 -0.816 . . . . 0.0 109.09 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 63.3 mm-40 -165.11 149.66 9.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.177 -0.952 . . . . 0.0 110.71 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -55.18 136.92 48.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.251 -0.905 . . . . 0.0 108.974 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -88.41 140.41 29.5 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.18 -0.95 . . . . 0.0 110.322 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 70.8 mt -109.16 122.03 46.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.432 -0.793 . . . . 0.0 109.136 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 47.2 t -111.02 131.36 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.075 -1.016 . . . . 0.0 110.492 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -107.58 118.59 37.12 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 38' ' ' CYS . 7.3 t -136.6 141.43 43.27 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.868 -1.145 . . . . 0.0 111.967 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.643 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 2.8 m -137.37 160.34 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -128.81 149.04 50.9 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.094 -1.004 . . . . 0.0 110.264 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.353 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -77.07 152.66 34.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.307 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.8 t -95.32 135.36 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.324 -0.86 . . . . 0.0 109.89 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -67.99 121.31 15.81 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.0 108.6 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.71 175.04 45.45 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.425 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 5.0 t -116.08 130.02 56.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.415 -1.05 . . . . 0.0 109.465 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -104.82 108.51 20.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.533 -0.729 . . . . 0.0 109.214 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -89.29 0.24 56.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.889 . . . . 0.0 108.93 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.4 m -102.33 -17.17 16.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.568 -0.707 . . . . 0.0 110.414 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.0 m -156.87 126.7 6.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.801 -1.187 . . . . 0.0 110.229 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.2 p -64.06 -27.63 69.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 108.858 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -114.77 76.87 1.02 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 88.1 p -71.75 153.37 42.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.395 -0.815 . . . . 0.0 110.224 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.15 1.1 35.72 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.6 pt -123.61 -24.03 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.632 -0.667 . . . . 0.0 110.29 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.507 ' O ' ' OG ' ' A' ' 13' ' ' SER . 63.3 m-85 -114.91 140.87 48.63 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.093 -1.005 . . . . 0.0 110.093 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.1 p -69.04 -17.81 63.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.403 -0.811 . . . . 0.0 110.614 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -129.58 139.86 51.36 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.921 -1.112 . . . . 0.0 110.458 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.37 162.95 29.43 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.425 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 36.5 m-85 -127.14 159.21 34.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.371 -1.076 . . . . 0.0 109.568 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.9 t -89.76 149.89 22.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.366 -0.834 . . . . 0.0 109.145 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.2 pt -64.38 -30.03 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.216 -0.927 . . . . 0.0 109.58 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -70.63 -41.01 72.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.151 -0.968 . . . . 0.0 109.786 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.05 -45.65 92.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 110.247 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.3 pt -69.97 -42.82 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.11 -0.994 . . . . 0.0 109.585 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.61 ' O ' ' N ' ' A' ' 28' ' ' LYS . 4.4 t -66.33 -54.85 19.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.169 -0.957 . . . . 0.0 109.32 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.682 ' O ' ' C ' ' A' ' 28' ' ' LYS . 62.5 t30 -46.57 88.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.342 -0.849 . . . . 0.0 109.22 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.682 ' C ' ' O ' ' A' ' 27' ' ' ASN . 44.2 tptt -13.3 115.58 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 121.349 0.595 . . . . 0.0 109.663 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.47 ' OG ' ' NZ ' ' A' ' 119' ' ' LYS . 74.5 m -46.96 123.5 5.31 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.467 -178.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 p -98.73 -8.12 26.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 109.316 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 56.1 p30 -104.7 -1.63 26.03 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.21 -0.931 . . . . 0.0 109.658 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.551 ' CG ' ' H ' ' A' ' 33' ' ' GLN . 66.5 t30 -162.56 -168.66 1.88 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.152 -0.967 . . . . 0.0 109.412 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.551 ' H ' ' CG ' ' A' ' 32' ' ' ASN . 18.5 pt20 -77.52 -172.46 2.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.611 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.491 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 13.8 pt20 -76.04 50.43 0.6 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.955 . . . . 0.0 109.575 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 34' ' ' GLN . 98.6 m-20 -141.68 116.77 9.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.393 -0.817 . . . . 0.0 109.521 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 mm -93.64 126.85 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.928 -1.107 . . . . 0.0 108.726 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.1 t -123.29 129.17 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.364 -0.835 . . . . 0.0 110.31 -179.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 85.1 m -102.08 101.61 11.98 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.4 m -97.03 122.31 39.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.057 -1.027 . . . . 0.0 109.649 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.0 m -138.91 158.02 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.437 -0.789 . . . . 0.0 109.079 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -97.06 119.95 36.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.135 -0.978 . . . . 0.0 109.517 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.41 156.43 17.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.362 -0.836 . . . . 0.0 109.592 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 39.9 t60 -131.26 152.37 50.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.464 ' CB ' ' O ' ' A' ' 100' ' ' PRO . . . -56.02 -26.18 47.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.282 -0.886 . . . . 0.0 109.797 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -99.06 -24.75 14.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -0.95 . . . . 0.0 109.626 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -74.67 137.17 42.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.512 -0.743 . . . . 0.0 110.002 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.9 mt -78.83 146.53 33.64 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 48' ' ' ILE . 45.4 pt -121.83 144.3 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.095 -1.003 . . . . 0.0 110.28 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.17 -173.46 46.26 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -171.18 170.94 5.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.038 -1.272 . . . . 0.0 109.794 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -147.04 145.44 29.68 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.343 -0.848 . . . . 0.0 109.864 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 86.4 m -125.22 151.4 69.45 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 108.815 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.449 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.48 154.1 9.3 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.43 2.086 . . . . 0.0 111.977 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.7 m -72.24 -10.5 59.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.496 -0.753 . . . . 0.0 110.711 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.536 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 78.7 m-20 -93.29 -3.68 53.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.95 -1.094 . . . . 0.0 110.245 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.449 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 15.4 m-85 -105.92 160.63 15.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.246 -0.909 . . . . 0.0 110.08 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -101.33 132.69 46.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.47 -0.768 . . . . 0.0 109.328 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.511 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.6 m -88.59 118.31 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.109 -0.994 . . . . 0.0 110.219 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -126.93 127.04 24.47 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.13 113.51 3.42 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 121.631 1.554 . . . . 0.0 112.131 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.484 ' O ' ' O ' ' A' ' 68' ' ' PHE . 9.6 t-160 -91.4 -25.57 19.29 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.475 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.3 t0 -169.48 38.94 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.422 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 81.8 m -62.56 -154.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.601 -0.687 . . . . 0.0 109.717 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.1 p90 -109.96 -59.28 1.95 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.061 -1.024 . . . . 0.0 111.359 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.464 ' C ' ' O ' ' A' ' 64' ' ' PHE . 25.3 t -44.75 -73.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.67 -1.269 . . . . 0.0 108.788 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.0 t -138.2 131.13 29.84 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.422 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -171.98 179.1 2.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.876 -1.14 . . . . 0.0 110.458 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 5.2 m-85 -93.84 126.18 38.89 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -71.74 -170.79 0.59 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.976 -1.078 . . . . 0.0 109.823 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.401 ' N ' ' CD1' ' A' ' 70' ' ' LEU . 10.8 mp -65.07 -19.72 66.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.191 -0.943 . . . . 0.0 109.038 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.6 m -83.49 -7.97 59.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.343 -0.848 . . . . 0.0 108.843 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.5 19.15 66.9 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -103.79 137.05 42.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.342 -1.093 . . . . 0.0 109.139 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -76.38 113.85 14.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.279 -0.888 . . . . 0.0 110.073 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -144.56 131.56 20.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.333 -0.855 . . . . 0.0 110.04 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -59.98 145.18 47.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.145 -0.972 . . . . 0.0 109.303 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.3 tp -100.2 -0.9 37.82 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.588 -0.695 . . . . 0.0 110.088 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -67.03 -42.35 85.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.222 -0.924 . . . . 0.0 109.85 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -63.77 -21.94 66.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.995 . . . . 0.0 109.023 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -86.86 -46.82 9.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.46 -0.775 . . . . 0.0 109.342 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.8 tp -124.62 127.89 48.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.492 -0.755 . . . . 0.0 109.171 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -77.17 83.48 3.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.966 -1.084 . . . . 0.0 109.235 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.1 mt -81.22 139.37 35.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.414 -0.804 . . . . 0.0 110.027 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.8 p -128.0 160.76 30.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.558 -0.714 . . . . 0.0 109.247 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 55.02 50.1 16.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.302 -0.874 . . . . 0.0 109.472 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.4 mt -78.91 131.97 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 110.093 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.3 mm -119.6 120.08 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.456 -0.778 . . . . 0.0 109.329 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 93.8 mtp -122.09 105.06 9.93 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.058 -1.026 . . . . 0.0 109.785 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -112.5 101.16 9.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.337 -0.852 . . . . 0.0 109.067 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -76.68 -31.72 57.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.217 -0.927 . . . . 0.0 110.49 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -59.97 -46.96 87.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.799 -1.188 . . . . 0.0 109.645 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -90.23 3.01 54.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.157 -0.965 . . . . 0.0 109.1 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 51.96 46.8 25.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.479 -0.763 . . . . 0.0 110.13 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.475 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 3.5 t -132.6 137.73 47.15 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.997 -1.064 . . . . 0.0 109.475 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -128.91 140.02 51.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.477 -0.764 . . . . 0.0 109.974 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.475 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 78.4 m-85 -135.14 146.71 49.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.154 -0.966 . . . . 0.0 109.477 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 32.4 t -149.82 149.39 30.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.024 -1.047 . . . . 0.0 109.157 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.402 HH11 ' HG2' ' A' ' 98' ' ' ARG . 60.3 mtt-85 -102.17 134.48 45.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.074 -1.016 . . . . 0.0 109.5 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 87.5 mt -92.69 139.21 23.49 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.486 -0.759 . . . . 0.0 109.625 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.464 ' O ' ' CB ' ' A' ' 44' ' ' ALA . 78.2 Cg_exo -45.81 170.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.851 1.701 . . . . 0.0 111.284 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.9 m -79.93 -12.24 59.74 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.098 -1.001 . . . . 0.0 109.778 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.3 tp -135.39 131.17 35.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.256 -0.902 . . . . 0.0 110.573 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.447 HD11 HG22 ' A' ' 103' ' ' ILE . 87.0 mt -147.54 102.27 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.8 t -99.73 -3.88 31.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.861 -1.149 . . . . 0.0 109.897 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 127' ' ' ALA . 84.7 m-20 -83.7 154.63 23.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.958 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -104.21 33.17 3.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.389 -0.819 . . . . 0.0 109.161 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 18.4 p-90 -65.33 152.06 44.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.932 . . . . 0.0 110.462 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -130.82 150.97 51.74 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.644 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 25.2 p90 -150.17 159.66 44.25 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.042 -1.036 . . . . 0.0 108.693 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 6.0 p90 -152.87 159.06 43.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.773 -1.205 . . . . 0.0 111.819 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 99.4 m -123.18 156.02 35.92 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 42.4 t -129.19 140.86 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.866 -1.147 . . . . 0.0 111.794 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 70.2 m -121.65 131.46 54.11 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.6 p -170.82 176.11 4.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.232 -1.542 . . . . 0.0 111.704 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.536 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 51.5 mttm -151.57 166.46 31.11 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 117' ' ' ASN . 98.6 m-20 -57.59 151.54 16.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.757 -1.214 . . . . 0.0 109.17 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 116' ' ' ASP . 66.7 t30 42.43 61.47 2.01 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.209 -0.932 . . . . 0.0 109.816 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 43.6 mt-10 -161.76 140.84 9.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.103 -0.998 . . . . 0.0 110.21 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.47 ' NZ ' ' OG ' ' A' ' 29' ' ' SER . 6.2 mmmt -55.02 138.75 43.17 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.171 -0.955 . . . . 0.0 109.326 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -87.35 139.93 30.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.302 -0.874 . . . . 0.0 110.387 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.3 mt -110.12 122.27 47.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.473 -0.767 . . . . 0.0 109.024 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 51.6 t -110.69 131.76 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.04 -1.038 . . . . 0.0 110.664 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.405 ' CZ ' ' CG1' ' A' ' 125' ' ' VAL . 23.9 t80 -110.22 122.53 47.87 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.0 t -137.54 142.45 41.4 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 119.059 -1.057 . . . . 0.0 111.969 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.644 ' CG2' ' CE2' ' A' ' 109' ' ' PHE . 3.0 m -137.53 154.52 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -122.87 147.6 46.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.201 -0.937 . . . . 0.0 110.366 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.329 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.473 ' CB ' ' HG ' ' A' ' 17' ' ' SER . 22.7 mmtp -134.24 157.0 47.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.324 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.8 t -97.64 132.19 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.256 -0.903 . . . . 0.0 109.873 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -68.01 121.42 16.05 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.175 -0.953 . . . . 0.0 108.648 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.29 172.4 43.45 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.9 t -113.66 129.36 56.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.384 -1.068 . . . . 0.0 109.329 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -101.97 108.67 20.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.508 -0.745 . . . . 0.0 109.252 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.476 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 96.8 m-85 -89.75 -1.29 57.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.018 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.1 m -103.0 -16.0 15.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.594 -0.691 . . . . 0.0 110.511 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.0 m -157.9 126.25 5.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.756 -1.215 . . . . 0.0 110.152 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.9 p -66.07 -26.01 67.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.97 . . . . 0.0 108.921 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -114.07 74.16 0.86 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.8 p -71.25 154.15 41.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 110.24 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -101.86 0.96 36.43 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.404 ' CD1' ' CE2' ' A' ' 16' ' ' PHE . 5.5 pt -125.28 -26.47 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.643 -0.661 . . . . 0.0 110.243 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.404 ' CE2' ' CD1' ' A' ' 15' ' ' ILE . 72.3 m-85 -105.37 143.53 33.41 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.028 -1.045 . . . . 0.0 109.887 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.473 ' HG ' ' CB ' ' A' ' 2' ' ' LYS . 12.9 m -70.37 -18.09 63.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.542 -0.724 . . . . 0.0 110.765 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -144.33 156.52 44.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.75 -1.219 . . . . 0.0 110.775 -178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -158.78 169.24 35.09 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -117.6 151.66 36.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.199 -1.177 . . . . 0.0 109.646 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.1 t -94.45 156.45 16.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.348 -0.845 . . . . 0.0 109.069 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.444 HD13 HG23 ' A' ' 22' ' ' ILE . 46.4 pt -60.0 -24.05 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.104 -0.998 . . . . 0.0 109.554 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -77.23 -51.37 11.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.126 -0.983 . . . . 0.0 109.587 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.482 ' O ' ' OG ' ' A' ' 29' ' ' SER . 74.8 mm-40 -51.73 -40.26 59.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.003 . . . . 0.0 110.229 -179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.5 pt -78.88 -5.89 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.976 -1.078 . . . . 0.0 109.781 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.5 m -96.81 -65.31 0.97 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.189 -0.945 . . . . 0.0 109.549 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.663 ' O ' ' N ' ' A' ' 29' ' ' SER . 98.5 m-20 -109.48 -70.94 0.78 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.901 . . . . 0.0 109.342 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -57.9 69.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.825 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.663 ' N ' ' O ' ' A' ' 27' ' ' ASN . 66.9 m -116.05 85.04 2.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.842 . . . . 0.0 108.916 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.9 m -88.61 70.11 8.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.821 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.49 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 11.1 p30 -152.68 -51.25 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 0.0 109.673 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 31' ' ' ASN . 73.6 m-20 -166.12 176.64 7.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.336 -0.853 . . . . 0.0 109.62 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.492 ' C ' ' H ' ' A' ' 35' ' ' ASP . 3.9 pt20 -60.56 -129.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.962 . . . . 0.0 109.458 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.504 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 15.4 pt20 -71.1 43.05 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.001 -1.062 . . . . 0.0 109.232 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.504 ' OD1' ' O ' ' A' ' 34' ' ' GLN . 53.9 m-20 -136.71 116.51 13.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.404 -0.81 . . . . 0.0 109.666 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 36' ' ' ILE . 37.7 mm -98.16 121.24 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.922 . . . . 0.0 108.72 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.0 t -117.07 127.83 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.153 -0.967 . . . . 0.0 110.182 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.476 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 96.7 m -102.45 100.62 10.76 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 65.6 m -94.4 120.24 34.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.016 -1.053 . . . . 0.0 109.645 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.3 156.11 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.161 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -98.11 133.96 41.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.171 -0.955 . . . . 0.0 109.445 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.0 150.35 23.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.052 -1.03 . . . . 0.0 109.63 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.42 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 29.8 t60 -120.0 152.52 37.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.363 -0.836 . . . . 0.0 109.551 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.34 -25.59 35.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 109.917 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -99.78 -21.63 15.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.118 -0.989 . . . . 0.0 109.714 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.42 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 81.4 m-20 -77.85 138.02 38.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.501 -0.749 . . . . 0.0 109.998 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.2 mt -79.39 148.9 31.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 108.703 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.46 HD11 HG21 ' A' ' 48' ' ' ILE . 42.6 pt -120.4 141.73 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.969 -1.082 . . . . 0.0 110.214 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.67 -178.3 47.96 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.43 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 55.2 p90 -164.0 170.08 17.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.118 -1.224 . . . . 0.0 109.736 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -144.08 142.87 30.87 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.354 -0.841 . . . . 0.0 109.772 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 82.4 m -122.79 151.83 61.34 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.425 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.46 145.75 27.71 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.289 1.993 . . . . 0.0 111.893 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.3 t -67.88 -14.57 63.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.464 -0.772 . . . . 0.0 110.624 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.608 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.4 m-20 -90.2 1.5 56.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.889 -1.132 . . . . 0.0 110.087 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.454 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 19.1 m-85 -111.11 166.75 10.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.6 m -103.6 139.98 38.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.398 -0.814 . . . . 0.0 109.315 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.5 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.7 m -97.55 120.35 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.94 -1.1 . . . . 0.0 110.311 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -127.19 126.68 24.29 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.0 113.81 3.49 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.732 1.622 . . . . 0.0 112.235 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -93.1 -24.8 18.15 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.7 t0 -168.89 36.26 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.412 ' O ' ' O ' ' A' ' 62' ' ' ASP . 88.7 m -59.44 -155.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.499 -0.751 . . . . 0.0 109.893 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.466 ' O ' ' C ' ' A' ' 65' ' ' VAL . 3.9 p90 -110.0 -59.07 1.98 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.953 -1.092 . . . . 0.0 111.246 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.483 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 36.6 t -43.95 -73.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.678 -1.264 . . . . 0.0 108.858 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.2 t -139.25 131.98 29.05 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -172.94 -178.48 1.83 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.879 -1.138 . . . . 0.0 110.457 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 6.6 m-85 -92.27 126.25 37.27 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -73.34 -172.49 1.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.136 -0.978 . . . . 0.0 109.763 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.508 ' CD2' ' N ' ' A' ' 70' ' ' LEU . 3.8 mm? -64.22 -22.16 66.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.33 -0.856 . . . . 0.0 109.102 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 89.4 p -82.57 -7.37 59.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.889 . . . . 0.0 108.83 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.69 17.95 66.97 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -100.43 139.68 35.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -1.18 . . . . 0.0 109.184 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -82.07 109.46 16.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.174 -0.954 . . . . 0.0 109.934 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -143.88 137.57 27.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.863 . . . . 0.0 110.004 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 77' ' ' LEU . 62.0 t-20 -60.12 145.85 45.31 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.171 -0.956 . . . . 0.0 109.403 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.512 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 14.0 tp -99.07 6.56 46.51 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.359 -0.838 . . . . 0.0 109.829 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.44 ' CD ' ' N ' ' A' ' 79' ' ' ASN . 2.3 pp20? -69.69 -40.33 76.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.104 -0.997 . . . . 0.0 109.896 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.605 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 43.4 p30 -63.37 -27.69 69.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.155 -0.966 . . . . 0.0 109.12 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.605 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 50.9 tptt -78.26 -50.44 11.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.458 -0.776 . . . . 0.0 109.343 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.0 tp -130.39 130.53 44.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.512 -0.742 . . . . 0.0 109.191 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -81.32 84.53 6.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.13 -0.981 . . . . 0.0 109.408 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 86.4 mt -76.67 143.68 39.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -0.828 . . . . 0.0 109.888 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.1 p -127.67 161.81 28.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.509 -0.745 . . . . 0.0 109.299 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.486 ' ND2' HH11 ' A' ' 98' ' ' ARG . 10.9 m-20 55.44 51.83 12.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -0.952 . . . . 0.0 109.652 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.4 mt -80.39 130.59 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.397 -0.815 . . . . 0.0 110.047 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.5 mm -118.68 120.26 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.447 -0.783 . . . . 0.0 109.139 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 84.2 mtp -121.15 101.26 7.54 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.082 -1.011 . . . . 0.0 109.834 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -110.29 100.22 9.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.264 -0.898 . . . . 0.0 108.896 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.479 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 93.0 m-70 -72.34 -36.49 68.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.971 -1.081 . . . . 0.0 110.655 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -60.4 -46.18 90.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.94 -1.1 . . . . 0.0 109.631 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -88.59 -4.98 58.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -0.923 . . . . 0.0 109.119 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.7 m-20 54.37 47.94 21.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.517 -0.739 . . . . 0.0 110.283 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.598 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 1.8 t -133.41 140.01 47.08 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.025 -1.047 . . . . 0.0 109.463 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 66.4 m-85 -129.04 140.03 51.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.463 -0.773 . . . . 0.0 109.959 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.598 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 82.1 m-85 -138.08 148.89 45.48 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.261 -0.899 . . . . 0.0 109.479 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.3 p -154.54 158.02 39.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.142 -0.974 . . . . 0.0 109.215 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.486 HH11 ' ND2' ' A' ' 85' ' ' ASN . 68.6 mtp180 -104.01 136.37 43.78 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.166 -0.959 . . . . 0.0 109.399 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 100' ' ' PRO . 36.4 mt -89.69 136.66 29.21 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 109.635 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 99' ' ' LEU . 77.6 Cg_exo -45.75 177.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.863 1.708 . . . . 0.0 111.211 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 87.7 p -87.39 -15.3 38.23 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.064 -1.022 . . . . 0.0 109.839 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.2 tp -127.37 128.85 46.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.156 -0.965 . . . . 0.0 110.311 -179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.456 HG22 HD13 ' A' ' 103' ' ' ILE . 72.8 mt -150.22 107.77 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.206 -0.934 . . . . 0.0 108.676 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 81.5 p -118.44 -1.56 11.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.06 -1.025 . . . . 0.0 109.773 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 9.0 p30 -82.67 154.5 24.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.052 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -95.61 34.08 1.54 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.504 -0.748 . . . . 0.0 109.037 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.464 ' CZ3' ' CD1' ' A' ' 109' ' ' PHE . 10.0 p-90 -63.21 154.16 32.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 110.379 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -142.69 149.65 39.11 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.62 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 33.5 p90 -154.46 163.74 39.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.125 -0.984 . . . . 0.0 108.784 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 7.3 p90 -154.44 160.04 41.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.846 -1.159 . . . . 0.0 111.705 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 67.8 m -123.35 155.99 36.25 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.0 t -129.36 140.87 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.878 -1.139 . . . . 0.0 111.756 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 98.4 m -124.66 133.37 53.25 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 72.6 p -170.49 179.23 3.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.239 -1.538 . . . . 0.0 111.665 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.608 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 49.7 mtmt -151.61 162.59 40.73 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 117' ' ' ASN . 97.9 m-20 -57.81 152.19 16.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.816 -1.178 . . . . 0.0 109.173 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.53 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 57.3 t-20 45.24 61.33 2.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.104 -0.997 . . . . 0.0 109.681 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 38.0 mt-10 -166.15 146.69 6.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.141 -0.974 . . . . 0.0 110.174 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.38 139.32 57.73 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.133 -0.979 . . . . 0.0 109.021 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -85.95 142.09 29.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.169 -0.957 . . . . 0.0 110.326 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 68.6 mt -109.21 120.8 43.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.402 -0.812 . . . . 0.0 109.045 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.8 t -109.42 131.21 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 120.951 -1.093 . . . . 0.0 110.774 -179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -109.66 121.03 44.3 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.4 t -137.16 142.63 42.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.776 -1.202 . . . . 0.0 112.008 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.62 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 2.9 m -136.26 156.37 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -133.88 155.97 48.92 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.226 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.51 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.432 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -83.96 148.11 27.09 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.24 -0.913 . . . . 0.0 109.328 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.7 t -80.81 134.19 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.35 -0.844 . . . . 0.0 110.119 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -72.18 129.93 39.64 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.017 -1.052 . . . . 0.0 108.642 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.97 -154.35 24.29 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.378 -1.392 . . . . 0.0 109.914 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.4 t -133.93 131.64 39.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -1.111 . . . . 0.0 109.656 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.513 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 38.6 t0 -109.51 109.25 20.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.539 -0.726 . . . . 0.0 109.15 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.4 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 91.0 m-85 -89.78 3.38 53.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 108.819 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 91.9 m -100.54 -19.59 16.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.386 -0.821 . . . . 0.0 110.515 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.6 m -157.75 127.49 6.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.791 -1.193 . . . . 0.0 110.535 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.1 p -64.17 -27.22 68.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.232 -0.917 . . . . 0.0 108.996 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -114.02 74.36 0.87 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.513 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 8.6 m -69.29 150.61 47.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.269 -0.894 . . . . 0.0 110.304 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.27 -1.05 34.62 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.9 pt -125.59 -10.35 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.676 -0.64 . . . . 0.0 110.491 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -125.7 141.0 52.23 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.201 -0.937 . . . . 0.0 110.191 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.8 t -69.18 -20.73 64.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.668 -0.645 . . . . 0.0 110.995 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -132.57 142.65 49.26 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.106 -0.997 . . . . 0.0 110.668 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.74 169.61 32.97 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -128.81 159.77 34.69 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.474 -1.015 . . . . 0.0 109.647 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.0 t -90.82 148.77 22.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.393 -0.817 . . . . 0.0 109.187 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.4 pt -58.39 -33.38 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.12 -0.987 . . . . 0.0 109.476 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.481 ' O ' ' OD1' ' A' ' 27' ' ' ASN . 49.0 t-20 -65.86 -37.8 87.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 109.793 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -66.45 -41.23 89.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.611 -0.681 . . . . 0.0 110.464 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.0 pt -83.1 -15.75 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.944 -1.097 . . . . 0.0 109.767 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 28' ' ' LYS . 53.2 p -89.46 -73.14 0.52 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.937 . . . . 0.0 109.287 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.569 ' N ' ' OG ' ' A' ' 26' ' ' SER . 48.5 p-10 -38.0 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.524 0.678 . . . . 0.0 109.206 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 26' ' ' SER . 59.1 pttt -90.99 49.23 1.61 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.468 -0.77 . . . . 0.0 109.775 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.0 m -157.28 18.11 0.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.415 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.9 t -75.42 -103.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.462 -0.773 . . . . 0.0 109.533 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.55 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 98.0 m-20 -110.34 -61.89 1.6 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.149 -0.969 . . . . 0.0 109.242 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.525 HD22 HE21 ' A' ' 34' ' ' GLN . 59.0 t30 -94.89 106.53 18.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.289 -0.882 . . . . 0.0 109.44 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.55 ' NE2' ' O ' ' A' ' 31' ' ' ASN . 1.2 pm0 -104.07 82.32 1.95 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.216 -0.928 . . . . 0.0 109.698 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.525 HE21 HD22 ' A' ' 32' ' ' ASN . 17.3 pt20 -162.34 -162.77 0.85 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.544 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -59.69 139.82 56.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.215 -0.928 . . . . 0.0 109.247 -179.193 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.0 mm -97.33 122.77 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.106 -0.996 . . . . 0.0 108.508 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.7 t -118.98 131.97 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.371 -0.831 . . . . 0.0 110.565 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.417 ' O ' ' O ' ' A' ' 124' ' ' THR . 89.0 m -102.1 102.65 13.15 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.5 m -93.07 119.97 32.87 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.081 -1.012 . . . . 0.0 109.574 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 11.8 m -140.33 141.03 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.656 -0.653 . . . . 0.0 109.344 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -87.02 129.89 34.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.078 -1.014 . . . . 0.0 109.452 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.58 159.64 14.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 109.504 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -134.77 154.05 51.76 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.282 -0.886 . . . . 0.0 109.568 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.55 -26.48 32.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.373 -0.829 . . . . 0.0 109.762 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -99.49 -27.04 13.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.904 . . . . 0.0 109.866 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -69.91 132.79 46.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.199 -0.938 . . . . 0.0 110.152 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.2 mt -77.81 145.09 36.57 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.7 pt -117.37 137.45 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.169 -0.957 . . . . 0.0 110.15 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.1 154.08 11.61 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -142.45 173.55 11.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.022 -1.281 . . . . 0.0 109.879 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -146.65 144.72 29.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.356 -0.84 . . . . 0.0 109.87 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 88.7 m -123.34 152.11 63.76 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.424 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.8 Cg_endo -51.55 151.52 14.02 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.321 2.014 . . . . 0.0 112.043 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.3 m -71.7 -13.62 61.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.456 -0.777 . . . . 0.0 110.59 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.609 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 82.4 m-20 -90.84 -1.34 57.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.961 -1.087 . . . . 0.0 110.196 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.424 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.3 m-85 -108.11 164.13 12.56 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.306 -0.871 . . . . 0.0 110.492 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.1 t -104.72 137.55 42.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.295 -0.878 . . . . 0.0 108.982 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.495 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.8 m -93.13 121.86 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.066 -1.021 . . . . 0.0 110.212 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.414 ' O ' ' O ' ' A' ' 112' ' ' VAL . 10.4 mt-10 -126.19 124.61 24.57 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.15 113.51 3.41 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.623 1.548 . . . . 0.0 112.097 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 68' ' ' PHE . 12.6 t-80 -93.51 -24.0 18.15 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 110' ' ' PHE . 68.0 t0 -171.0 48.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.654 ' H ' ' CB ' ' A' ' 67' ' ' ALA . 91.0 m -71.59 -154.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.518 -0.739 . . . . 0.0 109.774 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.6 p90 -112.17 -49.26 2.98 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.299 -0.876 . . . . 0.0 111.649 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.5 t -59.47 -48.27 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.291 -1.506 . . . . 0.0 109.43 -178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.3 t -161.16 130.8 4.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.654 ' CB ' ' H ' ' A' ' 63' ' ' CYS . . . -173.93 -178.49 1.54 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.129 -0.982 . . . . 0.0 110.414 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 6.1 m-85 -93.06 125.59 37.73 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -70.86 -173.92 0.86 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.107 -0.995 . . . . 0.0 109.871 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.45 -21.37 66.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.301 -0.874 . . . . 0.0 109.037 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.8 m -82.35 -8.27 59.63 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.306 -0.871 . . . . 0.0 108.943 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.35 17.72 63.91 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -104.91 145.02 30.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.327 -1.102 . . . . 0.0 109.213 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -83.63 117.8 23.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.486 -0.759 . . . . 0.0 110.149 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -149.73 136.36 19.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.836 . . . . 0.0 110.211 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -59.73 142.96 52.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.5 tp -95.45 7.07 47.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.227 -0.921 . . . . 0.0 109.775 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' A' ' 79' ' ' ASN . 0.3 OUTLIER -68.82 -39.9 79.79 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.269 -0.894 . . . . 0.0 109.991 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.448 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 91.3 m-20 -62.04 -36.03 80.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.017 . . . . 0.0 109.121 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -72.53 -48.72 38.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.514 -0.741 . . . . 0.0 109.657 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.449 ' CD2' ' CZ2' ' A' ' 107' ' ' TRP . 42.6 tp -148.79 120.84 8.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.468 -0.77 . . . . 0.0 108.997 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.48 113.1 19.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.968 . . . . 0.0 109.502 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.2 mt -90.5 159.27 16.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.857 . . . . 0.0 109.917 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 46.7 p -127.14 160.79 30.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.464 -0.773 . . . . 0.0 109.223 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 55.5 52.11 11.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -0.947 . . . . 0.0 109.814 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.2 mt -79.03 127.81 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.922 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.6 mm -122.18 121.51 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.49 -0.756 . . . . 0.0 109.174 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 86.6 mtp -121.84 103.18 8.67 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.222 -0.924 . . . . 0.0 109.569 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -112.24 100.76 9.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.377 -0.827 . . . . 0.0 109.033 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.476 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 77.5 m80 -71.18 -37.41 72.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.006 -1.059 . . . . 0.0 110.596 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -60.7 -46.03 91.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.972 -1.08 . . . . 0.0 109.704 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -88.71 -4.73 58.46 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.092 -1.005 . . . . 0.0 109.112 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.6 m-20 53.36 47.72 23.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.417 -0.802 . . . . 0.0 110.04 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.607 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.0 t -132.63 137.04 46.87 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.024 -1.047 . . . . 0.0 109.403 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -126.86 139.37 53.13 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.068 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.607 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 72.3 m-85 -136.42 146.31 46.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.27 -0.893 . . . . 0.0 109.259 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.9 m -151.18 151.53 32.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.175 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -102.32 131.87 48.65 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.351 -0.843 . . . . 0.0 109.576 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.503 ' O ' ' O ' ' A' ' 100' ' ' PRO . 92.6 mt -86.43 137.16 34.58 Favored Pre-proline 0 N--CA 1.489 1.479 0 C-N-CA 120.431 -0.508 . . . . 0.0 109.717 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 99' ' ' LEU . 77.7 Cg_exo -45.86 -177.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.954 1.77 . . . . 0.0 111.204 178.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.6 t -88.88 -19.23 26.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.963 -1.085 . . . . 0.0 110.107 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.7 tp -124.42 128.47 49.08 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.283 -0.886 . . . . 0.0 110.516 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.421 HD12 HG23 ' A' ' 103' ' ' ILE . 78.5 mt -149.74 102.72 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 92.4 p -113.08 1.0 15.16 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.316 -0.865 . . . . 0.0 109.89 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.601 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 49.3 t0 -83.51 153.23 24.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 110.114 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.601 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 95.5 m-20 -96.23 33.36 1.77 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.453 -0.779 . . . . 0.0 108.938 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.516 ' CD1' ' OXT' ' A' ' 127' ' ' ALA . 11.9 p-90 -63.99 154.24 34.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 110.628 -178.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -140.06 150.13 43.99 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.637 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 32.5 p90 -154.5 161.86 41.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.096 -1.002 . . . . 0.0 108.595 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.42 ' O ' ' C ' ' A' ' 62' ' ' ASP . 13.3 p90 -153.58 158.44 41.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.738 -1.226 . . . . 0.0 111.906 -178.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 90.8 m -123.61 156.79 35.13 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 59' ' ' GLU . 50.7 t -127.91 137.66 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 120.96 -1.088 . . . . 0.0 111.736 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.2 m -119.22 130.52 55.52 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.0 p -171.54 178.73 3.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.41 -1.431 . . . . 0.0 111.577 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.609 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 49.3 mtmt -150.06 164.38 35.7 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 117' ' ' ASN . 88.3 m-20 -58.21 151.39 19.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.863 -1.148 . . . . 0.0 109.175 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.481 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 54.3 t-20 43.69 61.94 2.09 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.172 -0.955 . . . . 0.0 109.772 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.481 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 36.1 mt-10 -164.46 144.13 7.53 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.136 -0.978 . . . . 0.0 110.145 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.476 ' NZ ' ' N ' ' A' ' 34' ' ' GLN . 18.0 mmmt -55.1 135.26 49.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.326 -0.859 . . . . 0.0 109.216 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -85.27 140.97 30.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.165 -0.96 . . . . 0.0 110.327 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.7 mt -110.17 123.67 50.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.554 -0.716 . . . . 0.0 109.187 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.7 t -108.69 130.05 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.032 -1.042 . . . . 0.0 110.387 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -108.03 118.68 37.38 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 38' ' ' CYS . 6.1 t -136.74 142.52 43.05 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.496 1.141 . . . . 0.0 112.109 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.637 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -137.05 160.23 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -131.03 147.83 52.68 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.263 -0.898 . . . . 0.0 110.409 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.516 ' OXT' ' CD1' ' A' ' 107' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.432 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.55 ' OE1' ' N ' ' A' ' 1' ' ' GLU . 56.8 mp0 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -141.55 149.84 41.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.879 . . . . 0.0 109.317 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.4 t -87.59 135.51 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.93 . . . . 0.0 110.117 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -66.55 124.53 23.06 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.662 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.97 166.93 34.71 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.2 t -107.04 129.89 54.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.455 -1.026 . . . . 0.0 109.192 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -108.49 109.28 20.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.529 -0.732 . . . . 0.0 109.461 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.416 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 86.2 m-85 -89.49 1.7 55.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 108.948 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.415 ' HG1' ' N ' ' A' ' 53' ' ' PRO . 20.5 m -101.99 -18.36 15.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.516 -0.74 . . . . 0.0 110.62 -178.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.5 m -156.86 126.5 6.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.761 -1.212 . . . . 0.0 110.383 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.593 ' OG ' ' N ' ' A' ' 21' ' ' SER . 38.6 m -67.06 -26.38 66.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.443 -0.785 . . . . 0.0 109.138 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -113.59 73.91 0.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 20.7 p -71.73 153.27 42.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.385 -0.822 . . . . 0.0 110.221 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.38 -1.27 31.19 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.3 pt -125.67 -13.45 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.661 -0.649 . . . . 0.0 110.443 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.461 ' O ' ' OG ' ' A' ' 13' ' ' SER . 76.5 m-85 -121.63 137.13 54.87 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.283 -0.886 . . . . 0.0 109.925 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.8 t -68.12 -20.04 64.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.578 -0.701 . . . . 0.0 110.669 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -131.95 142.55 49.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.95 -1.094 . . . . 0.0 110.745 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.88 168.36 32.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -128.96 160.11 33.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.334 -1.098 . . . . 0.0 109.586 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.593 ' N ' ' OG ' ' A' ' 11' ' ' SER . 6.2 t -90.84 148.95 22.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 109.097 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.2 pt -58.43 -32.55 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.171 -0.956 . . . . 0.0 109.444 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.48 ' H ' ' HG ' ' A' ' 21' ' ' SER . 52.1 t-20 -68.85 -40.31 79.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 0.0 109.74 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -61.45 -45.03 95.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 110.319 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 9.7 pt -68.77 -45.03 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.045 -1.034 . . . . 0.0 109.702 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.702 ' O ' ' C ' ' A' ' 27' ' ' ASN . 5.9 t -65.99 -49.26 68.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -0.844 . . . . 0.0 109.336 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.702 ' C ' ' O ' ' A' ' 26' ' ' SER . 46.9 t30 -5.07 85.97 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.781 ' O ' ' N ' ' A' ' 30' ' ' SER . 2.0 mptm? -39.44 170.18 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.1 p -47.79 73.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.584 -0.698 . . . . 0.0 109.99 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.781 ' N ' ' O ' ' A' ' 28' ' ' LYS . 33.3 p -128.71 -39.9 1.59 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.431 -0.793 . . . . 0.0 109.373 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.4 ' CB ' ' ND2' ' A' ' 27' ' ' ASN . 62.1 t30 -119.38 -16.6 8.95 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.396 -0.815 . . . . 0.0 109.587 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.504 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 32.0 p30 -161.94 116.44 1.91 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 109.436 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -110.86 53.21 0.71 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.151 -0.968 . . . . 0.0 109.61 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -151.52 -169.05 3.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.076 -1.015 . . . . 0.0 109.462 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.613 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -73.65 141.64 46.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 109.484 -179.599 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.404 HG23 HD11 ' A' ' 36' ' ' ILE . 36.8 mm -88.19 122.66 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.948 . . . . 0.0 108.508 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -118.77 131.42 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.314 -0.867 . . . . 0.0 110.526 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 124' ' ' THR . 95.1 m -101.57 101.06 11.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.1 m -94.35 120.09 34.07 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.143 -0.973 . . . . 0.0 109.852 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 20.3 m -141.12 155.8 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.499 -0.751 . . . . 0.0 109.184 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -97.07 131.07 44.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.371 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.27 162.92 12.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.595 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.584 ' HD1' ' H ' ' A' ' 45' ' ' ASN . 34.3 t-80 -132.59 148.97 52.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.307 -0.871 . . . . 0.0 109.454 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.48 -26.94 14.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 109.889 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.584 ' H ' ' HD1' ' A' ' 43' ' ' HIS . 50.3 t30 -99.71 -23.15 15.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 109.786 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -74.18 136.83 42.84 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.415 -0.803 . . . . 0.0 110.156 -179.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.417 HD23 ' NE ' ' A' ' 98' ' ' ARG . 15.1 mt -75.52 143.37 42.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 108.826 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.449 HD12 HG21 ' A' ' 48' ' ' ILE . 46.0 pt -121.14 142.8 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.288 -0.883 . . . . 0.0 110.091 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.47 -175.39 47.21 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.484 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 48.9 p90 -164.12 169.01 18.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.059 -1.259 . . . . 0.0 109.639 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -146.03 144.14 29.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.762 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 84.1 m -125.58 152.17 71.51 Favored Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.415 ' N ' ' HG1' ' A' ' 9' ' ' THR . 8.5 Cg_endo -51.52 151.3 14.26 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.273 1.982 . . . . 0.0 111.952 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.9 m -71.23 -11.01 60.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.379 -0.826 . . . . 0.0 110.673 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.623 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 83.6 m-20 -90.69 -1.71 57.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.938 -1.101 . . . . 0.0 110.092 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.413 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 20.5 m-85 -109.61 164.04 12.9 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.149 -0.97 . . . . 0.0 110.315 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 m -102.81 146.21 28.6 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.374 -0.829 . . . . 0.0 109.043 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.472 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.6 m -101.02 124.19 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.99 -1.069 . . . . 0.0 110.087 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -130.63 127.25 22.26 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.09 113.79 3.47 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.657 1.571 . . . . 0.0 112.146 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.495 ' O ' ' O ' ' A' ' 68' ' ' PHE . 27.1 t-80 -93.88 -26.4 16.91 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.7 t0 -168.26 38.35 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.459 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 81.8 m -62.75 -155.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.735 . . . . 0.0 109.836 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 4.8 p90 -107.95 -54.54 2.48 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.195 -0.941 . . . . 0.0 111.475 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.0 t -49.13 -71.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.67 -1.269 . . . . 0.0 108.728 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.7 t -142.4 131.36 23.04 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.459 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -168.94 -179.57 3.72 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.364 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.4 m-85 -94.61 145.1 25.06 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.404 HD22 ' HG2' ' A' ' 75' ' ' GLU . 99.6 m-20 -86.59 -172.89 4.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.93 -1.106 . . . . 0.0 109.695 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.0 mt -64.65 -15.37 61.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -0.881 . . . . 0.0 109.16 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.3 m -86.92 -6.42 58.78 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.361 -0.837 . . . . 0.0 108.948 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.34 20.47 69.36 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -107.55 142.46 37.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.291 -1.123 . . . . 0.0 109.207 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -66.05 131.66 46.74 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.212 -0.93 . . . . 0.0 109.899 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.404 ' HG2' HD22 ' A' ' 69' ' ' ASN . 30.7 tp10 -152.21 163.26 39.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.364 -0.835 . . . . 0.0 109.405 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.402 ' H ' ' HG3' ' A' ' 75' ' ' GLU . 16.9 t-20 -107.01 138.06 43.89 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.175 -0.953 . . . . 0.0 109.553 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.1 tp -88.03 -8.83 55.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.105 -0.997 . . . . 0.0 109.921 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.586 ' OE1' ' N ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -60.0 -45.99 90.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.869 -1.144 . . . . 0.0 109.532 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.592 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 28.7 p30 -63.8 -34.8 78.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.073 -1.017 . . . . 0.0 108.951 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.592 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 9.1 tppt? -69.91 -51.67 31.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 109.112 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 20.7 tp -151.76 121.42 6.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.448 -0.783 . . . . 0.0 108.958 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -78.17 113.78 16.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.018 -1.051 . . . . 0.0 109.573 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.72 162.3 17.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.412 -0.805 . . . . 0.0 109.974 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 70.4 p -129.55 162.0 29.21 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.349 -0.845 . . . . 0.0 109.331 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.444 HD21 ' HG3' ' A' ' 98' ' ' ARG . 73.6 m-80 55.36 51.23 13.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 109.691 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.5 mt -81.13 131.44 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.327 -0.858 . . . . 0.0 110.264 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.3 mm -127.58 123.5 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.456 -0.777 . . . . 0.0 109.073 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 72.6 mtp -122.59 104.09 9.11 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.21 -0.932 . . . . 0.0 109.761 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -111.9 100.7 9.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.327 -0.858 . . . . 0.0 109.039 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.488 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 97.5 m-70 -72.32 -36.41 68.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.882 -1.136 . . . . 0.0 110.642 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -60.51 -46.16 91.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.999 -1.063 . . . . 0.0 109.528 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -88.91 -4.83 58.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.071 -1.018 . . . . 0.0 109.149 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.5 m-20 54.48 48.17 21.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.468 -0.77 . . . . 0.0 110.273 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.606 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.9 t -134.02 139.46 46.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.994 -1.066 . . . . 0.0 109.296 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.484 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 75.2 m-85 -128.4 140.33 51.9 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.483 -0.761 . . . . 0.0 110.071 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.606 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 72.0 m-85 -137.99 147.96 44.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.323 -0.861 . . . . 0.0 109.13 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.4 p -156.33 157.98 36.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.08 -1.012 . . . . 0.0 109.21 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.444 ' HG3' HD21 ' A' ' 85' ' ' ASN . 18.7 mmt180 -104.08 137.65 41.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.324 -0.86 . . . . 0.0 109.613 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.8 mt -87.81 137.5 31.74 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.65 -0.656 . . . . 0.0 109.62 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -46.88 154.04 1.21 Allowed 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.745 1.63 . . . . 0.0 111.212 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 54.0 m -62.56 -36.86 84.01 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.118 -0.989 . . . . 0.0 109.93 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.4 tp -111.34 130.63 55.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.26 -0.9 . . . . 0.0 110.55 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.401 HG23 HD13 ' A' ' 103' ' ' ILE . 95.3 mt -145.71 103.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.401 -0.812 . . . . 0.0 108.857 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.459 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 7.1 m -111.18 53.58 0.7 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.179 -0.951 . . . . 0.0 109.647 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.479 ' O ' ' OXT' ' A' ' 127' ' ' ALA . 83.1 m-20 -144.86 156.5 44.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 110.029 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -102.89 33.06 3.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.426 -0.796 . . . . 0.0 109.09 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 19.3 p-90 -65.15 150.8 47.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.411 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -132.38 151.08 52.01 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.625 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 32.2 p90 -151.62 161.0 43.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.196 -0.94 . . . . 0.0 108.665 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 8.1 p90 -154.19 164.33 38.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.741 -1.225 . . . . 0.0 111.912 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 85.2 m -127.72 157.96 38.91 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.2 t -127.72 137.88 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.802 -1.186 . . . . 0.0 111.929 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 70.9 m -119.24 130.04 55.25 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.7 p -169.29 179.33 3.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.281 -1.512 . . . . 0.0 111.658 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.623 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 42.2 mtmt -158.78 167.67 28.86 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 117' ' ' ASN . 54.1 p-10 -58.56 151.55 20.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.766 -1.209 . . . . 0.0 109.008 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 116' ' ' ASP . 58.9 t-20 41.42 58.71 2.6 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.329 -0.857 . . . . 0.0 109.6 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 66.5 mm-40 -157.87 137.5 12.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.394 -0.817 . . . . 0.0 110.503 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -54.69 136.5 45.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.366 -0.834 . . . . 0.0 109.12 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 4.4 pttm -85.36 139.08 31.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.217 -0.927 . . . . 0.0 110.49 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.9 mt -111.77 125.48 54.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.556 -0.715 . . . . 0.0 109.354 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 53.4 t -110.98 131.25 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.036 -1.04 . . . . 0.0 110.561 -179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -108.73 119.46 39.61 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 38' ' ' CYS . 6.8 t -136.83 141.52 42.86 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.957 -1.089 . . . . 0.0 111.989 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.625 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -136.41 156.55 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -127.13 151.01 49.22 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.179 -0.951 . . . . 0.0 110.265 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.479 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.365 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.364 0.602 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -77.46 150.12 34.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.155 -0.966 . . . . 0.0 109.242 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 84.6 t -91.66 135.63 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 110.267 -179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -69.55 123.2 20.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.9 -1.125 . . . . 0.0 108.543 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.76 174.87 46.07 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.656 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 7.7 t -114.8 128.19 56.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.441 -1.035 . . . . 0.0 109.292 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.442 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 51.8 t0 -106.05 109.05 20.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.505 -0.747 . . . . 0.0 109.359 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 97.6 m-85 -88.05 -0.12 56.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.226 -0.921 . . . . 0.0 108.961 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.5 m -101.47 -15.67 17.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.42 -0.8 . . . . 0.0 110.578 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.5 m -159.89 129.24 5.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.88 -1.137 . . . . 0.0 110.316 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.501 ' OG ' ' OE1' ' A' ' 12' ' ' GLU . 78.2 p -70.76 -22.78 62.36 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.587 -0.845 . . . . 0.0 108.852 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.501 ' OE1' ' OG ' ' A' ' 11' ' ' SER . 57.9 mp0 -114.16 74.12 0.86 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.442 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 6.4 m -70.77 151.32 44.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.371 -0.83 . . . . 0.0 110.241 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.0 -0.72 35.99 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.7 pt -125.91 -22.8 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.612 -0.68 . . . . 0.0 110.34 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -112.15 141.97 45.18 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.261 -0.9 . . . . 0.0 110.015 -178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.3 p -75.59 -21.14 58.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.519 -0.738 . . . . 0.0 110.958 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -118.66 127.89 54.0 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.138 -0.976 . . . . 0.0 110.449 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.94 153.84 20.69 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.656 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 20.4 m-85 -118.31 144.42 45.86 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.479 -1.013 . . . . 0.0 109.557 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.1 t -96.27 153.8 17.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 109.122 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.9 pt -48.2 -32.23 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.209 -0.932 . . . . 0.0 109.357 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -68.76 -47.55 65.95 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.9 -1.125 . . . . 0.0 109.707 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -51.12 -47.62 61.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.332 -0.855 . . . . 0.0 109.904 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.1 pt -67.12 -31.01 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.109 -0.995 . . . . 0.0 109.584 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 28' ' ' LYS . 68.3 p -82.39 -7.22 59.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 109.391 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.452 ' C ' ' H ' ' A' ' 29' ' ' SER . 65.8 t30 -68.05 54.04 0.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.364 -0.835 . . . . 0.0 108.959 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 26' ' ' SER . 22.6 pttp -75.93 37.61 0.15 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.272 -0.893 . . . . 0.0 109.772 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.452 ' H ' ' C ' ' A' ' 27' ' ' ASN . 5.7 t -78.92 -65.49 0.99 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 109.621 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.0 m -56.5 -174.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.454 -0.779 . . . . 0.0 109.5 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.616 ' O ' ' N ' ' A' ' 33' ' ' GLN . 90.3 m-20 -60.49 -41.17 93.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.441 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 53.2 p-10 -59.3 71.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.261 -0.899 . . . . 0.0 109.203 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.647 ' C ' ' H ' ' A' ' 35' ' ' ASP . 10.9 pt20 -70.17 -113.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.119 -0.988 . . . . 0.0 109.631 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -65.4 22.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.187 -0.945 . . . . 0.0 109.546 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.647 ' H ' ' C ' ' A' ' 33' ' ' GLN . 33.5 m-20 -118.07 101.66 8.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -0.838 . . . . 0.0 109.482 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.436 HG23 HD12 ' A' ' 36' ' ' ILE . 36.6 mm -102.07 124.58 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.198 -0.938 . . . . 0.0 108.646 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 50.9 t -119.96 129.86 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.334 -0.854 . . . . 0.0 110.277 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.44 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 76.6 m -102.61 101.87 12.05 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.8 m -95.19 120.51 35.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.16 -0.962 . . . . 0.0 109.84 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 26.1 m -140.43 157.45 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.467 -0.771 . . . . 0.0 109.146 179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -99.99 133.74 43.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.114 -0.991 . . . . 0.0 109.398 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.22 160.7 14.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 0.0 109.52 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -134.58 152.38 51.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.19 -27.57 35.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.363 -0.835 . . . . 0.0 109.823 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -99.05 -25.46 14.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.934 . . . . 0.0 109.647 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -75.14 133.29 41.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.363 -0.836 . . . . 0.0 110.074 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.6 mt -77.94 148.41 34.51 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.2 pt -120.94 142.78 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.272 -0.892 . . . . 0.0 110.048 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 95' ' ' PHE . . . 176.78 -172.6 45.56 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.466 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 51.4 p90 -170.14 170.17 7.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -1.218 . . . . 0.0 109.79 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -145.06 143.43 30.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.289 -0.882 . . . . 0.0 109.703 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.2 m -125.57 154.28 72.75 Favored Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -51.53 143.35 36.33 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.213 1.942 . . . . 0.0 111.991 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.1 t -67.28 -12.84 61.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.387 -0.821 . . . . 0.0 110.595 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -89.46 3.33 52.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.941 -1.1 . . . . 0.0 110.197 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.572 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 20.7 m-85 -113.29 167.73 10.32 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.157 -0.965 . . . . 0.0 110.324 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.8 t -103.35 138.47 40.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.328 -0.858 . . . . 0.0 108.903 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.525 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.4 m -97.29 118.05 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.987 -1.07 . . . . 0.0 110.386 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -126.76 129.53 24.03 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.97 114.34 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.628 1.552 . . . . 0.0 111.959 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.447 ' O ' ' O ' ' A' ' 68' ' ' PHE . 10.9 t-80 -87.76 -24.38 23.81 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.1 t0 -172.93 38.91 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.452 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 71.1 m -60.92 -152.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.549 -0.719 . . . . 0.0 109.762 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.445 ' O ' ' C ' ' A' ' 65' ' ' VAL . 3.9 p90 -109.42 -58.7 2.0 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.216 -0.928 . . . . 0.0 111.354 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.445 ' C ' ' O ' ' A' ' 64' ' ' PHE . 13.4 t -46.67 -74.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.436 -1.415 . . . . 0.0 108.927 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.4 t -135.96 132.02 35.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.452 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.84 179.89 2.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.01 . . . . 0.0 110.459 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.4 m-85 -93.69 128.2 39.78 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -73.61 -176.51 2.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.953 -1.092 . . . . 0.0 109.844 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.59 -20.4 65.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.932 . . . . 0.0 109.035 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.5 m -83.92 -6.43 59.42 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.74 19.05 64.36 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -100.18 139.06 36.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -1.149 . . . . 0.0 109.019 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -85.4 108.77 18.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.205 -0.934 . . . . 0.0 109.994 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -146.06 140.48 26.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.435 -0.791 . . . . 0.0 109.91 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 -62.15 148.95 42.83 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.475 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.42 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 13.0 tp -96.51 7.53 46.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.209 -0.932 . . . . 0.0 109.724 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -69.07 -40.6 78.39 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.949 -1.094 . . . . 0.0 109.878 -179.583 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.501 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 95.2 m-20 -64.31 -38.85 92.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.173 -0.955 . . . . 0.0 109.122 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -67.81 -53.23 28.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.216 -0.927 . . . . 0.0 109.389 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.513 ' CD2' ' CZ2' ' A' ' 107' ' ' TRP . 35.7 tp -143.23 121.57 12.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.413 -0.805 . . . . 0.0 109.049 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -81.03 104.88 11.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 109.371 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.9 mt -84.3 163.03 19.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 109.949 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 46.6 p -129.95 162.94 27.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.438 -0.789 . . . . 0.0 109.384 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 54.39 51.85 13.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.159 -0.963 . . . . 0.0 109.775 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 86' ' ' ILE . 96.6 mt -81.31 128.76 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 110.117 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.5 mm -125.91 123.67 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.528 -0.733 . . . . 0.0 109.206 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 91.3 mtp -123.45 104.93 9.38 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.164 -0.96 . . . . 0.0 109.829 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -110.19 100.24 9.17 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.382 -0.824 . . . . 0.0 109.014 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.509 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 98.7 m-70 -73.0 -34.75 66.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.978 -1.076 . . . . 0.0 110.643 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -61.58 -44.91 96.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.964 -1.085 . . . . 0.0 109.647 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -88.65 -4.72 58.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.955 . . . . 0.0 109.104 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.509 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 1.6 m-20 56.5 45.57 22.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.492 -0.755 . . . . 0.0 109.995 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.579 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.7 t -132.26 138.73 48.0 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.04 -1.037 . . . . 0.0 109.385 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.466 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 69.5 m-85 -127.62 139.74 52.54 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.406 -0.809 . . . . 0.0 109.986 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.592 ' CB ' HH12 ' A' ' 98' ' ' ARG . 82.5 m-85 -136.45 147.03 46.99 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.293 -0.879 . . . . 0.0 109.278 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.583 ' N ' ' NH1' ' A' ' 98' ' ' ARG . 38.2 t -153.41 150.72 29.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.114 -0.991 . . . . 0.0 109.357 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.592 HH12 ' CB ' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -105.88 139.27 40.69 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.222 -0.924 . . . . 0.0 109.541 -179.726 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 42.9 mt -93.65 142.38 25.06 Favored Pre-proline 0 N--CA 1.491 1.613 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.69 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -46.83 157.47 0.52 Allowed 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.713 1.608 . . . . 0.0 111.226 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.1 t -67.27 -17.25 64.71 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.157 -0.965 . . . . 0.0 109.702 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 45.9 tp -122.2 130.84 53.57 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.281 -0.887 . . . . 0.0 110.555 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 24.2 mt -144.39 124.5 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.6 m -133.3 15.75 4.12 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.042 -1.036 . . . . 0.0 109.855 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -109.02 154.15 22.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.329 -0.857 . . . . 0.0 110.014 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -95.99 32.13 1.98 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.471 -0.768 . . . . 0.0 108.997 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.513 ' CZ2' ' CD2' ' A' ' 81' ' ' LEU . 18.2 p-90 -66.33 156.86 33.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.899 . . . . 0.0 110.636 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -143.78 155.42 44.15 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.632 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 38.3 p90 -151.88 161.46 42.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.208 -0.933 . . . . 0.0 108.785 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 5.5 p90 -152.24 161.17 43.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.77 -1.206 . . . . 0.0 111.813 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 91.7 m -127.97 157.45 40.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.8 t -130.22 142.22 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.836 -1.165 . . . . 0.0 111.712 -178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 75.1 m -119.86 131.1 55.17 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.4 p -170.8 179.06 3.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.215 -1.553 . . . . 0.0 111.616 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.401 ' NZ ' ' OE2' ' A' ' 118' ' ' GLU . 5.6 mtmp? -158.11 167.34 30.12 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 117' ' ' ASN . 91.3 m-20 -58.13 150.5 21.12 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.818 -1.176 . . . . 0.0 109.119 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.437 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 66.5 t30 44.38 59.99 3.03 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.172 -0.955 . . . . 0.0 109.809 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.572 ' OE1' ' CE2' ' A' ' 56' ' ' TYR . 49.7 mt-10 -162.06 140.77 9.3 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.18 -0.95 . . . . 0.0 110.21 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -56.63 144.47 31.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 109.209 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -93.54 141.0 28.96 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.123 -0.986 . . . . 0.0 110.315 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 75.0 mt -112.3 125.73 54.48 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.546 -0.721 . . . . 0.0 109.151 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.5 t -110.92 131.27 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.036 -1.04 . . . . 0.0 110.63 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -109.65 121.17 44.62 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.7 t -137.24 141.82 42.04 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.953 -1.092 . . . . 0.0 112.114 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.632 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.1 m -135.49 157.77 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -128.25 150.94 49.82 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.208 -0.932 . . . . 0.0 110.263 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.498 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.253 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -76.62 157.35 31.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.905 . . . . 0.0 109.272 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 66.9 t -99.31 133.84 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.306 -0.871 . . . . 0.0 109.831 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -67.48 122.91 19.0 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.134 -0.979 . . . . 0.0 108.544 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.82 162.99 26.58 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.7 t -103.5 135.25 45.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.477 -1.014 . . . . 0.0 110.084 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.509 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 67.7 t0 -111.98 109.43 19.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.371 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -87.4 -0.92 57.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 108.985 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.3 m -98.89 -17.67 18.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.645 -0.659 . . . . 0.0 110.505 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.2 m -160.41 131.08 5.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.764 -1.21 . . . . 0.0 110.223 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.1 p -64.17 -26.18 68.41 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.697 -0.801 . . . . 0.0 108.851 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -114.37 102.12 9.8 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.551 ' C ' ' H ' ' A' ' 15' ' ' ILE . 23.6 m -102.8 113.28 26.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -0.803 . . . . 0.0 110.372 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.5 t -65.64 2.88 0.85 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.551 ' H ' ' C ' ' A' ' 13' ' ' SER . 6.8 pt -123.56 -32.6 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.482 -0.761 . . . . 0.0 110.325 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.5 ' CZ ' ' CE2' ' A' ' 96' ' ' TYR . 53.8 m-85 -113.07 146.76 38.58 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.954 -1.091 . . . . 0.0 109.854 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 m -79.85 -20.82 45.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.38 -0.825 . . . . 0.0 110.956 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -119.9 131.18 55.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.708 -1.245 . . . . 0.0 110.86 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.51 158.66 27.78 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -118.03 153.22 34.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.201 -1.176 . . . . 0.0 109.609 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.8 t -89.77 148.87 22.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.327 -0.858 . . . . 0.0 109.265 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.1 pt -55.33 -31.22 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.12 -0.987 . . . . 0.0 109.536 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -68.31 -41.38 80.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.131 -0.981 . . . . 0.0 109.616 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.597 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 96.3 mt-10 -56.85 -48.63 77.63 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.236 -0.915 . . . . 0.0 110.395 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 26' ' ' SER . 15.0 pt -62.58 -44.19 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.036 -1.04 . . . . 0.0 109.619 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.7 ' O ' ' N ' ' A' ' 28' ' ' LYS . 78.1 p -72.0 -33.85 68.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.296 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 29' ' ' SER . 62.5 t-20 -54.56 73.38 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.53 -0.731 . . . . 0.0 109.307 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 26' ' ' SER . 42.5 tttp -62.79 78.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.431 -0.793 . . . . 0.0 109.287 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 27' ' ' ASN . 44.2 t -129.43 -87.44 0.53 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.126 -0.984 . . . . 0.0 109.595 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.4 t -129.79 -52.75 1.15 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.397 -0.814 . . . . 0.0 109.636 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.489 ' O ' ' CG ' ' A' ' 32' ' ' ASN . 57.8 t30 -65.0 -6.57 8.9 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.196 -0.94 . . . . 0.0 109.465 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.597 ' ND2' ' O ' ' A' ' 24' ' ' GLU . 75.7 m-80 -161.4 119.46 2.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.339 -0.85 . . . . 0.0 109.605 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.547 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 9.3 pt20 -136.01 -52.42 0.73 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.108 -0.995 . . . . 0.0 109.538 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.47 ' H ' ' HG3' ' A' ' 33' ' ' GLN . 29.5 pt20 -155.2 -20.63 0.11 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.317 -0.864 . . . . 0.0 109.621 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -131.24 108.31 9.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.375 -0.828 . . . . 0.0 109.422 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.416 HD12 HG21 ' A' ' 36' ' ' ILE . 7.8 mm -95.7 118.44 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.102 -0.999 . . . . 0.0 108.714 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.7 t -114.9 127.73 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.1 -1.0 . . . . 0.0 110.268 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 81.3 m -102.51 102.49 12.77 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.6 m -95.07 120.19 34.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -0.981 . . . . 0.0 109.763 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 21.7 m -139.78 156.74 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.395 -0.816 . . . . 0.0 108.996 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.3 130.7 45.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.203 -0.936 . . . . 0.0 109.341 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.88 161.71 14.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 109.635 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.688 ' HD1' ' H ' ' A' ' 45' ' ' ASN . 41.9 t-80 -139.0 150.31 45.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 109.586 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.46 -25.2 50.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 109.818 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.688 ' H ' ' HD1' ' A' ' 43' ' ' HIS . 66.7 t30 -98.98 -26.29 14.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.162 -0.961 . . . . 0.0 109.667 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -78.97 134.97 36.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.531 -0.73 . . . . 0.0 110.013 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.7 mt -78.13 149.88 33.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 108.554 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.0 pt -120.82 142.42 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.887 -1.133 . . . . 0.0 110.027 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.2 -170.66 43.34 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -172.9 171.17 4.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.063 -1.257 . . . . 0.0 109.684 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -146.42 145.01 30.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.317 -0.865 . . . . 0.0 109.866 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.6 m -125.03 152.26 70.2 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.415 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.33 145.58 27.13 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.328 2.019 . . . . 0.0 112.026 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.9 m -68.65 -11.97 60.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.428 -0.795 . . . . 0.0 110.606 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.627 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 79.4 m-20 -91.44 1.03 57.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.928 -1.107 . . . . 0.0 110.039 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.51 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 19.4 m-85 -111.59 166.53 11.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.919 -1.113 . . . . 0.0 110.162 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -104.53 131.26 52.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.302 -0.874 . . . . 0.0 109.339 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.5 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.6 m -89.14 121.12 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.006 -1.059 . . . . 0.0 110.203 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -125.81 129.15 24.41 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.21 114.42 3.55 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.664 1.576 . . . . 0.0 112.088 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.465 ' O ' ' O ' ' A' ' 68' ' ' PHE . 10.8 t-80 -92.93 -25.29 18.1 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.474 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.8 t0 -171.43 40.44 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.508 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 70.8 m -63.7 -152.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.604 -0.685 . . . . 0.0 109.84 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.6 p90 -110.95 -58.9 2.04 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.863 -1.148 . . . . 0.0 111.151 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.442 ' C ' ' O ' ' A' ' 64' ' ' PHE . 25.3 t -45.97 -70.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.442 -1.411 . . . . 0.0 108.897 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.3 t -140.44 130.76 25.16 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.508 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.22 178.48 2.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.926 -1.109 . . . . 0.0 110.425 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 6.5 m-85 -93.12 124.94 37.45 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -69.6 -176.36 1.01 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.936 -1.103 . . . . 0.0 109.759 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.425 ' CD1' ' HZ1' ' A' ' 108' ' ' LYS . 17.5 mt -63.29 -21.73 66.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.857 . . . . 0.0 109.044 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.6 m -81.63 -5.81 58.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.352 -0.842 . . . . 0.0 108.858 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.41 19.94 65.38 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -105.25 141.56 36.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -1.145 . . . . 0.0 109.187 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -83.89 112.83 20.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.115 -0.99 . . . . 0.0 109.944 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -148.13 136.26 21.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.783 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -58.33 144.87 40.03 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.073 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 14.6 tp -97.12 7.4 46.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.186 -0.946 . . . . 0.0 109.691 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.46 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -69.7 -38.74 77.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 109.913 -179.374 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.586 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 49.3 p-10 -61.26 -31.15 70.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.164 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.586 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 37.4 ttmt -74.87 -48.37 25.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.374 -0.828 . . . . 0.0 109.392 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.417 HD22 ' CZ2' ' A' ' 107' ' ' TRP . 31.9 tp -136.74 127.27 26.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.38 -0.825 . . . . 0.0 109.205 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -74.68 85.44 2.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.119 -0.988 . . . . 0.0 109.12 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.0 mt -77.73 138.23 38.92 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.283 -0.885 . . . . 0.0 109.927 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.3 p -126.39 166.52 17.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.543 -0.723 . . . . 0.0 109.315 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 55.51 50.46 14.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.883 . . . . 0.0 109.559 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.408 HD13 HG21 ' A' ' 86' ' ' ILE . 96.8 mt -79.89 130.86 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 0.0 110.094 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -120.72 120.3 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.349 -0.844 . . . . 0.0 109.201 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 81.5 mtp -122.53 104.72 9.55 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.987 -1.071 . . . . 0.0 109.98 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -108.52 99.35 8.75 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.248 -0.907 . . . . 0.0 108.805 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.477 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 97.4 m-70 -72.53 -36.89 68.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.985 -1.072 . . . . 0.0 110.686 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -60.54 -45.75 92.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.005 -1.059 . . . . 0.0 109.515 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -87.68 -4.83 58.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.142 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.3 m-20 54.93 47.46 22.17 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 110.348 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.562 ' OG1' ' CE1' ' A' ' 96' ' ' TYR . 2.6 t -134.66 141.94 46.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.956 -1.09 . . . . 0.0 109.387 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -129.44 140.34 51.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.42 -0.8 . . . . 0.0 110.01 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.562 ' CE1' ' OG1' ' A' ' 94' ' ' THR . 82.7 m-85 -135.38 146.14 48.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.23 -0.919 . . . . 0.0 109.483 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.4 m -151.43 153.27 34.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 109.231 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.4 mtt-85 -107.9 138.4 44.23 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.071 -1.018 . . . . 0.0 109.419 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 100' ' ' PRO . 60.3 mt -96.0 141.17 22.78 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.828 . . . . 0.0 109.727 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 99' ' ' LEU . 77.9 Cg_exo -45.64 178.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.901 1.734 . . . . 0.0 111.187 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.9 m -85.46 -11.73 53.59 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.035 -1.041 . . . . 0.0 109.689 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.3 tp -124.3 131.14 53.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.007 . . . . 0.0 110.54 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 41.3 mt -147.48 103.82 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 97.4 p -114.0 -0.41 14.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.028 -1.045 . . . . 0.0 109.748 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.556 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 0.4 OUTLIER -89.46 153.66 20.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 0.0 110.071 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -98.43 31.98 2.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.459 -0.776 . . . . 0.0 109.127 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.417 ' CZ2' HD22 ' A' ' 81' ' ' LEU . 16.1 p-90 -65.65 159.21 25.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -0.848 . . . . 0.0 110.493 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.425 ' HZ1' ' CD1' ' A' ' 70' ' ' LEU . 25.4 pttm -146.7 156.82 43.47 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.57 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 43.5 p90 -153.47 163.67 39.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.085 -1.01 . . . . 0.0 108.9 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 6.8 p90 -152.71 163.04 40.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.672 -1.268 . . . . 0.0 111.681 -178.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 87.0 m -130.04 158.64 39.06 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 42.9 t -130.74 143.36 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.66 -1.275 . . . . 0.0 111.774 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 87.8 m -123.36 132.61 54.04 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.3 p -170.76 178.69 3.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.298 -1.501 . . . . 0.0 111.743 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.627 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 46.2 mtmt -154.06 165.55 35.82 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.6 150.89 21.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.78 -1.2 . . . . 0.0 109.123 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.527 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 61.8 t-20 46.47 61.27 2.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.266 -0.897 . . . . 0.0 109.52 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 44.4 mt-10 -165.1 145.43 7.16 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.956 -1.09 . . . . 0.0 110.127 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -60.66 147.73 40.98 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.204 -0.935 . . . . 0.0 109.003 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -93.26 140.8 29.14 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.066 -1.021 . . . . 0.0 110.355 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.2 mt -110.17 122.35 47.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.412 -0.805 . . . . 0.0 109.093 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.96 130.79 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.938 -1.101 . . . . 0.0 110.833 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -109.57 121.46 45.24 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.0 t -137.37 142.15 41.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.666 -1.271 . . . . 0.0 112.029 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.57 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.1 m -135.09 158.04 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -137.12 157.88 45.71 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.89 -1.131 . . . . 0.0 110.128 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.408 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -74.76 157.98 34.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.167 -0.958 . . . . 0.0 109.198 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.4 t -103.3 132.81 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -0.893 . . . . 0.0 109.955 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -62.76 117.5 6.41 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.363 -0.935 . . . . 0.0 108.574 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.44 155.7 15.72 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.422 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 4.9 t -100.08 132.01 45.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.562 -0.963 . . . . 0.0 109.493 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.418 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 47.2 t0 -105.05 108.4 19.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.448 -0.783 . . . . 0.0 109.302 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -88.27 -0.99 57.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 108.854 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.421 ' HG1' ' HD3' ' A' ' 53' ' ' PRO . 9.5 m -101.19 -16.56 16.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.492 -0.755 . . . . 0.0 110.434 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.6 m -157.13 124.88 5.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.859 -1.15 . . . . 0.0 110.182 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.493 ' OG ' ' OE1' ' A' ' 12' ' ' GLU . 78.0 p -67.16 -26.9 66.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.369 -0.832 . . . . 0.0 108.98 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.496 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 57.5 mp0 -109.07 72.61 0.82 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 t -74.11 158.59 33.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.407 -0.808 . . . . 0.0 110.137 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -103.23 -48.7 3.94 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.131 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.444 ' H ' HG22 ' A' ' 14' ' ' THR . 24.0 pt -86.78 -12.92 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.574 -0.704 . . . . 0.0 110.16 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.402 ' CD2' HG13 ' A' ' 15' ' ' ILE . 68.0 m-85 -110.4 136.93 48.81 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.153 -0.967 . . . . 0.0 109.606 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 t -74.24 -26.7 60.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.431 -0.793 . . . . 0.0 111.157 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -123.3 134.51 54.05 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.07 -1.019 . . . . 0.0 110.787 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.418 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -144.47 156.13 26.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.422 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 22.5 m-85 -122.22 153.34 38.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.333 -1.098 . . . . 0.0 109.647 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 t -88.83 149.56 23.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.328 -0.857 . . . . 0.0 109.116 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.466 ' O ' ' OG ' ' A' ' 26' ' ' SER . 45.8 pt -58.55 -30.2 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.495 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -66.85 -40.65 87.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.929 . . . . 0.0 109.619 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.457 ' O ' ' CG ' ' A' ' 32' ' ' ASN . 76.5 mm-40 -64.44 -45.45 87.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.408 -0.808 . . . . 0.0 110.113 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.8 pt -80.57 -14.07 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.939 -1.101 . . . . 0.0 109.679 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 28' ' ' LYS . 49.2 m -96.01 -70.21 0.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 109.34 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 29' ' ' SER . 66.3 t30 -52.27 85.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 109.246 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 26' ' ' SER . 18.3 pttm -49.18 96.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.45 -0.781 . . . . 0.0 109.679 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.619 ' HG ' ' H ' ' A' ' 30' ' ' SER . 89.4 p -107.31 -100.54 0.36 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.08 -1.012 . . . . 0.0 109.74 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.634 ' C ' ' H ' ' A' ' 32' ' ' ASN . 78.3 p -125.61 -71.81 0.69 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.45 -0.781 . . . . 0.0 109.845 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -64.72 13.82 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.278 -0.889 . . . . 0.0 109.477 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.634 ' H ' ' C ' ' A' ' 30' ' ' SER . 15.6 p30 -169.12 81.84 0.13 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 0.0 109.604 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -138.96 -34.44 0.6 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.144 -0.973 . . . . 0.0 109.905 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.546 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 13.8 pt20 -117.09 -45.04 2.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.379 -0.826 . . . . 0.0 109.753 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.546 ' OD1' ' O ' ' A' ' 34' ' ' GLN . 1.8 m-20 -145.62 124.52 12.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.322 -0.861 . . . . 0.0 109.305 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.418 HG21 HD12 ' A' ' 36' ' ' ILE . 9.0 mm -90.29 122.71 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.135 -0.978 . . . . 0.0 108.439 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.4 t -121.06 126.5 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.0 110.337 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 96.8 m -103.16 102.47 12.46 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.8 m -94.85 120.77 35.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.13 -0.981 . . . . 0.0 109.848 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 27.3 m -139.82 156.73 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.364 -0.835 . . . . 0.0 109.013 179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -100.16 131.84 45.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 109.415 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -97.07 158.09 15.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 109.57 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 31.5 t60 -134.05 153.25 51.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.207 -0.933 . . . . 0.0 109.53 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.24 -25.03 20.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.349 -0.844 . . . . 0.0 109.772 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -99.74 -25.93 14.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.068 -1.02 . . . . 0.0 109.662 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -75.47 134.57 40.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.88 . . . . 0.0 110.034 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.1 mt -76.24 147.39 38.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 108.661 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.0 pt -116.93 136.57 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.159 -0.963 . . . . 0.0 109.847 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.26 -176.94 47.86 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.438 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 55.6 p90 -164.57 169.77 16.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.087 -1.243 . . . . 0.0 109.858 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -144.17 143.16 30.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.255 -0.903 . . . . 0.0 109.908 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 68.6 m -126.6 152.37 74.47 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.421 ' HD3' ' HG1' ' A' ' 9' ' ' THR . 8.7 Cg_endo -51.4 149.16 17.93 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.404 2.069 . . . . 0.0 112.122 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.4 p -71.73 -11.27 60.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.435 -0.791 . . . . 0.0 110.649 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -90.67 0.24 57.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.9 -1.125 . . . . 0.0 110.129 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.404 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 20.7 m-85 -110.36 165.99 11.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.199 -0.938 . . . . 0.0 110.252 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -102.87 133.45 47.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 0.0 109.107 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.493 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.1 m -91.13 123.53 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.969 -1.082 . . . . 0.0 110.335 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -130.68 129.16 22.64 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.05 113.53 3.44 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.71 1.607 . . . . 0.0 112.046 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.47 ' O ' ' O ' ' A' ' 68' ' ' PHE . 15.9 t-160 -91.06 -26.66 19.05 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.503 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.5 t0 -169.72 37.13 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.541 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 75.9 m -60.38 -155.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.472 -0.767 . . . . 0.0 109.724 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.3 p90 -111.47 -56.66 2.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.141 -0.974 . . . . 0.0 111.316 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.417 ' C ' ' O ' ' A' ' 64' ' ' PHE . 78.0 t -47.36 -54.7 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 120.479 -1.388 . . . . 0.0 109.062 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -158.08 129.8 6.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.541 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.01 -179.34 1.99 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.957 -1.09 . . . . 0.0 110.442 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 6.3 m-85 -93.16 123.58 36.53 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -70.66 -173.74 0.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 109.787 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.3 mp -63.61 -21.49 66.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.272 -0.892 . . . . 0.0 109.018 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.7 m -82.44 -7.05 59.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.347 -0.846 . . . . 0.0 108.885 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.41 19.83 65.62 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -102.86 138.78 39.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.212 -1.169 . . . . 0.0 108.999 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -83.7 108.33 16.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 110.004 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -144.2 138.74 28.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.852 . . . . 0.0 109.85 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 77' ' ' LEU . 55.1 t-20 -59.78 145.55 44.87 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.298 -0.876 . . . . 0.0 108.954 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.467 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 13.4 tp -97.32 7.44 46.55 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.292 -0.88 . . . . 0.0 109.845 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.449 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -70.12 -37.99 75.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.065 -1.022 . . . . 0.0 110.058 -179.539 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -62.72 -32.73 73.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.044 -1.035 . . . . 0.0 109.156 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.4 ttmt -72.41 -50.21 28.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.853 . . . . 0.0 109.634 179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.406 HD21 ' CZ2' ' A' ' 107' ' ' TRP . 19.2 tp -139.3 128.81 24.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.487 -0.758 . . . . 0.0 109.074 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -78.99 88.28 4.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.988 . . . . 0.0 109.639 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.21 150.82 41.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.357 -0.839 . . . . 0.0 109.936 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.2 p -127.14 164.33 21.86 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.512 -0.742 . . . . 0.0 109.176 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.424 HD21 ' HG3' ' A' ' 98' ' ' ARG . 78.7 m-20 56.1 53.15 9.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 0.0 109.942 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.5 mt -79.68 125.17 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -0.825 . . . . 0.0 109.918 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.4 HG23 HD13 ' A' ' 87' ' ' ILE . 44.7 mm -123.14 121.99 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.5 -0.75 . . . . 0.0 109.265 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 84.6 mtp -123.25 103.37 8.49 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.108 -0.995 . . . . 0.0 109.696 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -110.98 101.36 9.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.378 -0.826 . . . . 0.0 109.037 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.499 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 91.8 m-70 -72.96 -35.78 66.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.876 -1.14 . . . . 0.0 110.686 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -60.19 -45.91 91.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.942 -1.099 . . . . 0.0 109.572 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -89.87 -4.35 57.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.925 . . . . 0.0 109.064 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.499 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 97.7 m-20 54.52 47.91 21.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.424 -0.798 . . . . 0.0 110.167 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.574 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 2.5 t -133.35 138.64 46.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.171 -0.956 . . . . 0.0 109.451 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.438 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 65.2 m-85 -129.06 140.64 51.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.402 -0.811 . . . . 0.0 109.915 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.574 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 72.1 m-85 -137.74 148.89 46.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.45 -0.781 . . . . 0.0 109.383 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 63.8 m -152.49 155.1 36.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.092 -1.005 . . . . 0.0 109.172 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.424 ' HG3' HD21 ' A' ' 85' ' ' ASN . 16.6 mmt180 -102.53 136.08 42.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.188 -0.945 . . . . 0.0 109.732 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.461 ' O ' ' O ' ' A' ' 100' ' ' PRO . 68.2 mt -89.92 136.78 28.72 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.803 -0.56 . . . . 0.0 109.699 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 99' ' ' LEU . 77.9 Cg_exo -45.87 176.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 121.848 1.699 . . . . 0.0 111.188 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.2 m -85.63 -14.66 44.93 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.099 -1.0 . . . . 0.0 109.925 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 47.6 tp -121.04 130.43 53.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.189 -0.945 . . . . 0.0 110.523 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 43.9 mt -149.84 102.88 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.5 p -120.01 3.68 10.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.202 -0.936 . . . . 0.0 109.722 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.518 ' O ' ' OXT' ' A' ' 127' ' ' ALA . 27.9 t70 -93.72 158.97 15.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.97 . . . . 0.0 109.933 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -96.15 33.8 1.68 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.455 -0.778 . . . . 0.0 109.045 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.406 ' CZ2' HD21 ' A' ' 81' ' ' LEU . 12.4 p-90 -65.21 154.27 38.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 110.635 -178.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -145.86 155.46 42.91 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.602 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 42.0 p90 -154.35 162.63 41.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.133 -0.979 . . . . 0.0 108.753 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 6.1 p90 -152.79 162.32 41.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.69 -1.256 . . . . 0.0 111.833 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 95.2 m -127.63 157.66 39.64 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 42.2 t -130.01 142.62 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.768 -1.208 . . . . 0.0 111.789 -178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 72.2 m -123.39 132.44 53.97 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.0 p -171.19 178.63 3.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.239 -1.538 . . . . 0.0 111.691 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.59 ' NZ ' ' OE2' ' A' ' 118' ' ' GLU . 7.3 mtmp? -153.41 164.75 37.61 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 117' ' ' ASN . 99.7 m-20 -57.76 152.28 15.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.771 -1.206 . . . . 0.0 109.195 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.515 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 66.8 t30 44.68 60.73 2.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.217 -0.927 . . . . 0.0 109.669 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.59 ' OE2' ' NZ ' ' A' ' 115' ' ' LYS . 36.8 mt-10 -165.37 145.71 6.97 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.136 -0.977 . . . . 0.0 110.178 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.42 ' HZ2' ' C ' ' A' ' 32' ' ' ASN . 56.5 mtpt -63.67 136.2 57.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.25 -0.906 . . . . 0.0 109.038 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.408 ' CE ' ' OD1' ' A' ' 35' ' ' ASP . 52.8 pttt -85.26 146.12 27.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.226 -0.922 . . . . 0.0 110.406 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.1 mt -111.16 123.71 50.74 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.498 -0.751 . . . . 0.0 109.177 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 46.0 t -109.03 130.34 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.022 -1.049 . . . . 0.0 110.617 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -110.69 122.62 48.24 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.9 t -137.84 143.28 40.9 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.835 -1.166 . . . . 0.0 112.208 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.602 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.1 m -134.75 156.9 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.07 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -134.79 155.58 50.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.982 -1.074 . . . . 0.0 110.272 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.518 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.086 -0.959 . . . . 0.0 109.393 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.339 0.59 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 mmtp -76.31 142.71 41.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.1 -1.0 . . . . 0.0 109.188 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.92 133.54 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.708 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.61 ' NZ ' ' OD2' ' A' ' 46' ' ' ASP . 2.0 mptm? -74.72 125.49 28.85 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.047 -1.033 . . . . 0.0 108.95 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.95 179.05 44.33 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.436 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 4.8 t -115.97 132.23 56.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.483 -1.01 . . . . 0.0 109.316 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.461 ' CG ' ' OG ' ' A' ' 13' ' ' SER . 29.5 t70 -108.19 109.63 21.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.496 -0.752 . . . . 0.0 109.422 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 91.0 m-85 -89.83 0.05 57.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.227 -0.921 . . . . 0.0 108.857 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.0 m -101.88 -17.88 15.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.566 -0.709 . . . . 0.0 110.505 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.8 m -156.87 125.22 5.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.878 -1.139 . . . . 0.0 110.249 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.0 p -66.85 -24.84 66.19 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.629 -0.829 . . . . 0.0 108.97 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -115.0 74.59 0.89 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.461 ' OG ' ' CG ' ' A' ' 7' ' ' ASP . 20.0 m -71.81 152.39 42.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.83 . . . . 0.0 110.398 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.77 0.29 38.54 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.8 pt -125.27 -23.83 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.646 -0.659 . . . . 0.0 110.292 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -111.78 140.99 45.96 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.243 -0.911 . . . . 0.0 109.92 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.1 p -72.54 -18.42 61.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.589 -0.694 . . . . 0.0 111.045 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -132.14 143.14 49.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.015 -1.053 . . . . 0.0 110.847 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.81 159.91 28.73 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.436 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 32.4 m-85 -118.52 156.24 29.44 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.442 -1.034 . . . . 0.0 109.594 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.526 ' HG ' ' N ' ' A' ' 22' ' ' ILE . 27.3 t -96.66 158.45 15.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.37 -0.832 . . . . 0.0 109.148 179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.526 ' N ' ' HG ' ' A' ' 21' ' ' SER . 42.5 pt -61.47 -22.71 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.153 -0.967 . . . . 0.0 109.35 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -80.01 -52.85 7.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.137 -0.977 . . . . 0.0 109.778 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.458 ' O ' ' OD1' ' A' ' 27' ' ' ASN . 79.8 mm-40 -51.7 -36.88 48.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.852 . . . . 0.0 110.004 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.5 pt -76.34 -13.03 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.978 -1.076 . . . . 0.0 109.598 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.771 ' O ' ' N ' ' A' ' 28' ' ' LYS . 31.8 t -104.23 -28.55 11.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.261 -0.899 . . . . 0.0 109.375 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 29' ' ' SER . 46.8 p30 -42.49 77.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.499 0.666 . . . . 0.0 109.431 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.771 ' N ' ' O ' ' A' ' 26' ' ' SER . 68.6 mttm -54.97 86.0 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.377 -0.827 . . . . 0.0 109.585 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 27' ' ' ASN . 5.6 p -143.25 -84.1 0.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.893 . . . . 0.0 109.235 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 84.5 p -69.39 -179.26 1.6 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.465 -0.772 . . . . 0.0 109.449 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.562 ' OD1' ' NE2' ' A' ' 34' ' ' GLN . 34.5 t30 -51.18 -17.14 0.6 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.115 -0.99 . . . . 0.0 109.454 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.429 ' O ' ' CD1' ' A' ' 36' ' ' ILE . 98.9 m-20 -65.6 4.94 0.49 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -0.863 . . . . 0.0 109.2 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.514 ' H ' ' C ' ' A' ' 31' ' ' ASN . 20.4 pt20 -90.48 -12.38 37.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.944 -1.097 . . . . 0.0 109.573 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.562 ' NE2' ' OD1' ' A' ' 31' ' ' ASN . 29.5 pt20 -122.44 -34.75 3.22 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.517 -0.739 . . . . 0.0 109.672 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.539 ' OD2' ' CE ' ' A' ' 120' ' ' LYS . 1.4 m-20 -147.8 115.5 6.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.319 -0.863 . . . . 0.0 109.493 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.429 ' CD1' ' O ' ' A' ' 32' ' ' ASN . 20.2 mm -81.97 124.63 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.086 -1.009 . . . . 0.0 108.462 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.1 t -121.68 126.52 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.277 -0.889 . . . . 0.0 110.173 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.44 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 84.3 m -102.18 100.8 11.05 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.8 m -93.87 119.58 32.99 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.141 -0.974 . . . . 0.0 109.659 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 28.0 m -141.95 153.86 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.49 -0.756 . . . . 0.0 109.232 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -95.25 133.88 38.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.116 -0.99 . . . . 0.0 109.142 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.47 124.06 50.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.457 -0.777 . . . . 0.0 109.734 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.429 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 28.2 t60 -86.72 148.2 25.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.84 . . . . 0.0 109.542 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 100' ' ' PRO . . . -50.17 -34.26 21.9 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.22 -0.925 . . . . 0.0 109.779 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -89.88 -17.63 27.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.273 -0.892 . . . . 0.0 109.423 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.61 ' OD2' ' NZ ' ' A' ' 4' ' ' LYS . 76.4 m-20 -75.7 136.83 40.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.432 -0.793 . . . . 0.0 110.07 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.3 mt -77.31 145.41 37.41 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 21.0 pt -121.32 143.21 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.264 -0.898 . . . . 0.0 110.191 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.21 -174.07 46.07 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.613 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 50.8 p90 -170.52 169.62 7.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -1.225 . . . . 0.0 109.831 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -146.17 144.54 30.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.306 -0.871 . . . . 0.0 109.861 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 40.8 m -125.01 153.93 71.29 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.403 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 9.0 Cg_endo -51.51 144.78 31.27 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.337 2.025 . . . . 0.0 112.167 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.6 t -68.3 -13.85 62.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.453 -0.779 . . . . 0.0 110.636 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.632 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.9 m-20 -89.95 1.73 55.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.89 -1.131 . . . . 0.0 110.039 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.403 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 18.9 m-85 -110.79 165.93 11.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.099 -1.001 . . . . 0.0 110.446 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.506 ' OG ' ' OE2' ' A' ' 59' ' ' GLU . 39.5 t -102.7 132.92 48.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.344 -0.847 . . . . 0.0 108.96 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.506 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.4 m -89.73 120.31 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.992 -1.067 . . . . 0.0 110.346 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 59' ' ' GLU . 35.0 mp0 -127.69 128.08 23.95 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.22 114.3 3.53 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.683 1.588 . . . . 0.0 112.106 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.493 ' O ' ' O ' ' A' ' 68' ' ' PHE . 9.3 t-80 -91.17 -25.33 19.61 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 63' ' ' CYS . 67.4 t0 -171.85 36.43 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.495 ' O ' ' O ' ' A' ' 62' ' ' ASP . 96.5 m -57.13 -155.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.548 -0.72 . . . . 0.0 109.651 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 4.0 p90 -108.77 -56.27 2.29 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.037 -1.04 . . . . 0.0 111.173 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 64' ' ' PHE . 53.2 t -46.49 -73.42 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.479 -1.388 . . . . 0.0 108.865 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.2 t -140.21 130.71 25.47 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.424 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.19 -178.41 2.07 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.464 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 5.0 m-85 -93.82 128.84 40.28 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -76.45 -174.57 2.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.953 -1.092 . . . . 0.0 109.741 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.4 -20.55 65.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.275 -0.891 . . . . 0.0 109.21 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.9 m -83.38 -6.85 59.59 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.32 19.61 66.3 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -101.43 136.74 40.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -1.167 . . . . 0.0 109.145 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -84.94 112.98 21.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.122 -0.986 . . . . 0.0 110.097 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -150.12 141.55 23.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.41 -0.806 . . . . 0.0 109.983 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 77' ' ' LEU . 56.0 t-20 -61.61 146.71 48.07 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.4 -0.812 . . . . 0.0 109.215 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.539 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 6.6 tp -99.69 6.11 45.63 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.288 -0.882 . . . . 0.0 109.8 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.439 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.8 OUTLIER -75.52 -39.02 58.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.97 -1.081 . . . . 0.0 109.983 -179.449 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 56.5 p30 -59.26 -14.21 10.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.131 -0.981 . . . . 0.0 109.165 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 31.0 ttpt -107.0 -36.17 6.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.382 -0.824 . . . . 0.0 109.327 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 33.1 tp -123.92 129.5 51.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.42 -0.8 . . . . 0.0 109.339 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -73.31 83.46 1.4 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.039 -1.038 . . . . 0.0 109.285 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.3 mt -69.32 130.11 41.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.224 -0.923 . . . . 0.0 109.959 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.3 p -133.86 151.71 51.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.397 -0.814 . . . . 0.0 109.302 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 52.82 50.69 17.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.098 -1.001 . . . . 0.0 109.58 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.6 mt -78.73 130.37 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.327 -0.858 . . . . 0.0 110.085 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mm -117.85 118.84 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.473 -0.767 . . . . 0.0 109.276 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 81.0 mtp -124.17 108.09 11.92 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.286 -0.884 . . . . 0.0 109.822 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -113.93 102.17 9.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.362 -0.836 . . . . 0.0 109.05 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.501 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 70.2 m80 -72.33 -35.74 68.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.898 -1.126 . . . . 0.0 110.488 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -60.7 -44.86 96.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.874 -1.141 . . . . 0.0 109.457 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -89.41 -5.72 57.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.134 -0.979 . . . . 0.0 109.129 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.501 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.3 m-20 55.36 47.47 21.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.576 -0.702 . . . . 0.0 110.392 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.594 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 2.8 t -132.3 137.5 47.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.146 -0.971 . . . . 0.0 109.404 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.613 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 23.8 m-85 -127.28 139.41 52.92 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.372 -0.83 . . . . 0.0 109.818 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.594 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 81.2 m-85 -135.9 147.01 47.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.21 -0.932 . . . . 0.0 109.358 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.6 t -150.86 150.9 31.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.953 -1.092 . . . . 0.0 109.174 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.405 HH11 ' HG2' ' A' ' 98' ' ' ARG . 60.7 mtt-85 -101.68 134.41 44.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.044 -1.035 . . . . 0.0 109.476 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 94.7 mt -93.39 139.22 22.86 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.436 -0.79 . . . . 0.0 109.5 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.433 ' O ' ' CB ' ' A' ' 44' ' ' ALA . 77.0 Cg_exo -46.36 163.22 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.853 1.702 . . . . 0.0 111.222 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 m -76.34 -10.15 59.19 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.1 -1.0 . . . . 0.0 109.696 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.8 tp -136.42 129.29 30.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.152 -0.968 . . . . 0.0 110.339 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.473 HD11 HG21 ' A' ' 103' ' ' ILE . 88.7 mt -145.69 106.92 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 108.893 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.3 p -100.53 -2.81 32.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.048 -1.032 . . . . 0.0 109.899 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -88.45 156.13 19.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.99 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -105.02 33.2 3.75 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.452 -0.78 . . . . 0.0 109.135 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 24.4 p-90 -65.77 161.53 20.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.141 -0.974 . . . . 0.0 110.625 -178.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -143.54 160.68 40.19 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.622 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 36.4 p90 -155.09 160.65 41.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.17 -0.956 . . . . 0.0 108.674 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.518 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 5.0 p90 -151.67 159.93 43.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.778 -1.201 . . . . 0.0 111.892 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 96.7 m -125.0 156.5 38.01 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.8 t -130.58 143.65 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.839 -1.163 . . . . 0.0 111.764 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 63.4 m -124.66 132.95 53.38 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.6 p -167.62 178.08 5.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.25 -1.531 . . . . 0.0 111.694 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.632 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 46.5 mtmt -155.31 165.04 37.88 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 117' ' ' ASN . 98.2 m-20 -58.69 150.95 22.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.827 -1.171 . . . . 0.0 109.116 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.492 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 64.5 t30 44.53 60.95 2.62 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.232 -0.917 . . . . 0.0 109.639 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 40.4 mt-10 -164.48 144.72 7.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.132 -0.98 . . . . 0.0 110.216 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.539 ' CE ' ' NZ ' ' A' ' 28' ' ' LYS . 69.7 mmtt -63.28 136.66 57.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.197 -0.939 . . . . 0.0 109.111 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.539 ' CE ' ' OD2' ' A' ' 35' ' ' ASP . 4.3 pttm -84.26 144.8 28.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.249 -0.907 . . . . 0.0 110.575 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 72.7 mt -110.92 123.67 50.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.583 -0.698 . . . . 0.0 109.181 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.413 ' N ' ' O ' ' A' ' 36' ' ' ILE . 45.3 t -109.9 130.94 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.01 -1.056 . . . . 0.0 110.679 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -110.37 122.53 47.92 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 38' ' ' CYS . 7.6 t -137.86 142.85 40.71 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.795 -1.191 . . . . 0.0 112.163 -178.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.622 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -136.12 158.18 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -124.01 145.21 49.35 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.106 -0.996 . . . . 0.0 110.415 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.279 179.792 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -76.18 162.96 27.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.139 -0.976 . . . . 0.0 109.294 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 69.4 t -106.12 134.32 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.162 -0.962 . . . . 0.0 110.042 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -70.47 124.04 23.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.065 -1.022 . . . . 0.0 108.371 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.18 164.79 30.39 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.471 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 4.4 t -107.59 138.04 44.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.621 -0.929 . . . . 0.0 109.386 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.445 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 67.3 t0 -114.81 109.01 17.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.446 -0.784 . . . . 0.0 109.36 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -86.32 -0.73 56.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 108.928 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.427 ' OG1' ' N ' ' A' ' 53' ' ' PRO . 17.1 m -99.66 -17.92 17.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.638 -0.663 . . . . 0.0 110.5 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.3 m -158.24 127.64 5.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.769 -1.207 . . . . 0.0 110.263 -179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.7 p -62.5 -28.08 69.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -0.953 . . . . 0.0 108.973 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -109.24 108.4 18.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 15' ' ' ILE . 74.4 m -107.63 109.5 21.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 110.376 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.84 2.58 1.35 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.524 ' H ' ' C ' ' A' ' 13' ' ' SER . 6.9 pt -124.48 -30.28 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.598 -0.689 . . . . 0.0 110.374 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.484 ' CZ ' ' CE2' ' A' ' 96' ' ' TYR . 54.5 m-85 -112.67 144.63 41.86 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.129 -0.982 . . . . 0.0 110.145 -179.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.0 p -75.11 -22.34 58.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.567 -0.708 . . . . 0.0 110.837 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -119.96 129.22 54.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.869 -1.144 . . . . 0.0 110.644 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -140.7 154.23 24.15 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.471 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 24.2 m-85 -124.06 154.61 39.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.354 -1.086 . . . . 0.0 109.53 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.1 t -91.25 152.91 20.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.367 -0.833 . . . . 0.0 109.206 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.9 pt -51.6 -33.47 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 120.955 -1.09 . . . . 0.0 109.484 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -69.86 -46.44 65.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 109.674 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -56.44 -47.02 79.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 110.199 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.436 HG13 ' N ' ' A' ' 26' ' ' SER . 32.8 pt -66.65 -40.34 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.082 -1.011 . . . . 0.0 109.46 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.436 ' N ' HG13 ' A' ' 25' ' ' ILE . 22.4 t -132.65 84.35 2.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.927 . . . . 0.0 109.316 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -86.52 124.17 32.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 109.396 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.41 ' H ' ' HD2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -76.18 -14.93 60.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.437 -0.789 . . . . 0.0 109.582 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.463 ' O ' ' C ' ' A' ' 30' ' ' SER . 81.9 p -92.77 -77.1 0.45 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.203 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.49 ' OG ' ' OD1' ' A' ' 32' ' ' ASN . 15.8 t -39.48 153.66 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.607 -0.683 . . . . 0.0 109.556 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.615 ' O ' ' N ' ' A' ' 33' ' ' GLN . 32.5 p-10 -97.04 -46.74 6.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.973 . . . . 0.0 109.503 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.536 ' C ' ' O ' ' A' ' 31' ' ' ASN . 24.1 p-10 -33.14 90.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.598 -0.689 . . . . 0.0 109.923 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.615 ' N ' ' O ' ' A' ' 31' ' ' ASN . 10.9 pt20 -137.46 117.13 13.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.159 -0.963 . . . . 0.0 109.211 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.599 ' CG ' ' H ' ' A' ' 35' ' ' ASP . 10.3 pt20 -169.18 -60.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.101 -0.999 . . . . 0.0 109.618 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.599 ' H ' ' CG ' ' A' ' 34' ' ' GLN . 3.7 m-20 -151.76 116.62 5.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.373 -0.829 . . . . 0.0 109.549 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.461 HG21 HD12 ' A' ' 36' ' ' ILE . 46.3 mm -82.65 125.72 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.126 -0.984 . . . . 0.0 108.456 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.4 t -121.51 130.37 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.121 -0.987 . . . . 0.0 110.445 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.434 ' O ' ' O ' ' A' ' 124' ' ' THR . 61.1 m -101.79 101.39 11.86 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.8 m -94.08 119.18 32.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.848 -1.157 . . . . 0.0 109.649 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.4 156.54 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.475 -0.766 . . . . 0.0 109.118 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -99.05 131.59 44.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.929 . . . . 0.0 109.561 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.56 152.48 21.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.553 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.652 ' HD1' ' H ' ' A' ' 45' ' ' ASN . 47.4 t-80 -124.1 153.53 41.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.358 -0.839 . . . . 0.0 109.515 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.05 -26.1 47.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.368 -0.832 . . . . 0.0 109.772 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.652 ' H ' ' HD1' ' A' ' 43' ' ' HIS . 66.9 t30 -96.91 -23.67 16.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.954 . . . . 0.0 109.61 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -78.96 136.74 37.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.948 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.9 mt -78.78 150.36 32.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 0.0 108.669 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.9 pt -121.66 143.55 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.06 -1.025 . . . . 0.0 110.111 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.5 -172.72 45.49 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -170.49 169.9 7.16 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.007 -1.29 . . . . 0.0 109.713 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -145.11 144.03 30.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.296 -0.878 . . . . 0.0 109.816 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 86.0 m -123.45 151.99 63.97 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.427 ' N ' ' OG1' ' A' ' 9' ' ' THR . 8.6 Cg_endo -51.59 144.41 33.19 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.363 2.042 . . . . 0.0 111.949 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -66.64 -13.82 61.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.52 -0.738 . . . . 0.0 110.535 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.608 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 82.3 m-20 -89.93 0.66 56.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.922 -1.111 . . . . 0.0 110.161 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.409 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 19.0 m-85 -110.97 165.73 11.62 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.267 -0.896 . . . . 0.0 110.187 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.7 m -102.28 140.46 36.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.388 -0.82 . . . . 0.0 109.294 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.506 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.8 m -97.21 118.42 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.002 -1.061 . . . . 0.0 110.369 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.446 ' N ' ' OE1' ' A' ' 59' ' ' GLU . 5.6 mp0 -125.09 126.77 25.18 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.17 114.39 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.658 1.572 . . . . 0.0 112.142 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -93.66 -24.32 17.92 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.2 t0 -170.94 40.07 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.451 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 88.5 m -63.97 -152.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.608 -0.682 . . . . 0.0 109.89 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.3 p90 -110.3 -58.19 2.11 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.118 -0.989 . . . . 0.0 111.252 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.447 ' C ' ' O ' ' A' ' 64' ' ' PHE . 27.6 t -45.82 -70.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.568 -1.332 . . . . 0.0 108.807 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.4 t -142.54 132.48 24.33 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.451 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -171.83 179.59 2.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.929 -1.107 . . . . 0.0 110.419 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.7 m-85 -93.76 140.44 29.66 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.402 HD22 ' HG2' ' A' ' 75' ' ' GLU . 99.8 m-20 -80.7 -171.12 2.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.895 -1.128 . . . . 0.0 109.9 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.2 mt -65.99 -15.8 63.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.353 -0.842 . . . . 0.0 109.134 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.496 ' OG ' ' NZ ' ' A' ' 73' ' ' LYS . 32.5 t -86.47 -7.15 58.65 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.322 -0.861 . . . . 0.0 108.878 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.57 20.2 66.81 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.496 ' NZ ' ' OG ' ' A' ' 71' ' ' SER . 64.6 mttp -107.28 140.47 40.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -1.147 . . . . 0.0 109.068 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -63.66 134.15 54.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.135 -0.978 . . . . 0.0 109.933 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.402 ' HG2' HD22 ' A' ' 69' ' ' ASN . 34.5 tp10 -154.19 163.81 39.53 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.313 -0.867 . . . . 0.0 109.446 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.401 ' H ' ' HG3' ' A' ' 75' ' ' GLU . 4.4 m120 -107.35 138.79 42.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.251 -0.906 . . . . 0.0 109.52 179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 tp -97.06 -16.01 20.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.079 -1.013 . . . . 0.0 109.828 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -61.1 -43.65 98.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.894 -1.129 . . . . 0.0 109.521 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -65.09 -13.51 58.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.042 -1.036 . . . . 0.0 108.887 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -100.41 -41.66 6.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.384 -0.823 . . . . 0.0 109.162 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.403 HD23 ' CZ2' ' A' ' 107' ' ' TRP . 37.1 tp -125.83 126.39 44.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 109.133 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -81.03 83.83 6.63 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.081 -1.012 . . . . 0.0 109.378 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.1 mt -77.21 143.93 38.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.312 -0.868 . . . . 0.0 109.955 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.7 p -127.78 158.23 38.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.554 -0.716 . . . . 0.0 109.308 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.817 HD21 HH11 ' A' ' 98' ' ' ARG . 88.4 m-20 55.22 51.54 13.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.95 . . . . 0.0 109.699 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.75 129.84 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 110.107 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.2 mm -118.22 118.8 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.447 -0.783 . . . . 0.0 109.271 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 80.2 mtp -120.52 103.34 9.08 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.28 -0.887 . . . . 0.0 109.74 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -110.6 99.63 8.57 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.252 -0.905 . . . . 0.0 109.041 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.482 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 61.8 m80 -72.3 -35.99 68.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.107 -0.996 . . . . 0.0 110.549 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -60.32 -45.02 94.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.912 -1.117 . . . . 0.0 109.516 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -89.5 -4.94 57.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 109.031 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.482 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.0 m-20 54.82 48.46 20.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.495 -0.753 . . . . 0.0 110.17 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.543 ' OG1' ' CE1' ' A' ' 96' ' ' TYR . 3.3 t -134.22 140.14 46.28 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.026 -1.046 . . . . 0.0 109.343 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -129.43 140.72 51.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.489 -0.757 . . . . 0.0 110.206 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.543 ' CE1' ' OG1' ' A' ' 94' ' ' THR . 83.6 m-85 -136.18 146.85 47.3 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.417 -0.802 . . . . 0.0 109.537 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.1 p -152.64 159.44 43.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.981 -1.074 . . . . 0.0 109.172 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.817 HH11 HD21 ' A' ' 85' ' ' ASN . 71.0 mtp180 -108.44 137.9 45.64 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.096 -1.003 . . . . 0.0 109.339 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.3 mt -92.86 137.54 23.91 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.405 -0.809 . . . . 0.0 109.543 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -45.86 170.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.836 1.69 . . . . 0.0 111.309 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.3 m -79.69 -10.61 59.81 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.101 -1.0 . . . . 0.0 109.754 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.6 tp -136.11 129.93 32.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.225 -0.922 . . . . 0.0 110.432 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.6 mt -147.37 102.37 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.235 -0.916 . . . . 0.0 108.643 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.7 m -102.83 -6.91 22.04 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.017 -1.052 . . . . 0.0 109.8 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 127' ' ' ALA . 84.7 m-20 -81.42 154.36 26.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.169 -0.957 . . . . 0.0 110.013 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -103.51 33.74 3.24 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.417 -0.802 . . . . 0.0 109.091 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.403 ' CZ2' HD23 ' A' ' 81' ' ' LEU . 23.5 p-90 -64.98 152.66 42.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 110.452 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.24 153.96 51.09 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.639 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 30.6 p90 -152.4 162.35 41.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.999 -1.063 . . . . 0.0 108.698 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 8.2 p90 -154.1 160.77 42.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.729 -1.232 . . . . 0.0 111.792 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 97.5 m -125.61 156.45 39.16 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.45 139.1 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.881 -1.137 . . . . 0.0 111.79 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 93.5 m -122.15 131.87 54.17 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.5 p -170.2 178.55 3.79 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.176 -1.578 . . . . 0.0 111.663 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.608 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 50.0 mtmt -151.7 163.38 39.25 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -58.55 151.25 20.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.775 -1.203 . . . . 0.0 109.078 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.52 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 60.5 t-20 46.35 61.19 2.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.228 -0.92 . . . . 0.0 109.47 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 37.3 mt-10 -165.73 146.3 6.79 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.127 -0.983 . . . . 0.0 110.233 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -61.84 134.75 57.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.168 -0.958 . . . . 0.0 109.089 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -81.57 143.31 32.08 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.118 -0.989 . . . . 0.0 110.328 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 58.7 mt -110.75 122.87 48.89 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 52.6 t -110.07 131.14 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.883 -1.135 . . . . 0.0 110.79 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -109.0 120.52 42.79 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 38' ' ' CYS . 7.2 t -137.08 141.25 42.37 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.933 -1.105 . . . . 0.0 111.892 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.639 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -135.92 159.47 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -124.9 146.68 49.21 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.161 -0.962 . . . . 0.0 110.423 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.31 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.258 0.551 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -76.99 152.77 35.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.935 . . . . 0.0 109.201 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.2 t -93.91 133.05 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 109.983 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.58 ' NZ ' ' OD2' ' A' ' 46' ' ' ASP . 96.7 mttt -72.85 127.18 31.8 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.735 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.77 166.18 32.26 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.442 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 5.2 t -104.96 131.9 51.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.422 -1.046 . . . . 0.0 109.471 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -110.88 109.44 19.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.494 -0.754 . . . . 0.0 109.424 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -87.17 1.1 54.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 108.942 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.4 m -105.24 -17.17 14.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.561 -0.712 . . . . 0.0 110.461 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.9 m -153.7 121.23 5.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.823 -1.173 . . . . 0.0 110.311 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.6 p -62.87 -29.79 71.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 108.911 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -109.98 73.02 0.82 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.483 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 19.8 p -71.9 111.84 7.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.261 -0.899 . . . . 0.0 110.315 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.0 t -69.4 2.86 2.65 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.481 ' H ' ' C ' ' A' ' 13' ' ' SER . 4.8 pt -123.61 -32.24 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.711 -0.618 . . . . 0.0 110.394 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.483 ' O ' ' OG ' ' A' ' 13' ' ' SER . 86.6 m-85 -106.6 145.67 31.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.212 -0.93 . . . . 0.0 109.812 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.1 m -71.34 -25.29 62.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.511 -0.743 . . . . 0.0 110.886 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -125.19 136.03 53.18 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.925 -1.109 . . . . 0.0 110.52 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -142.89 158.33 27.1 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.442 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 22.6 m-85 -123.53 152.69 41.52 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.346 -1.091 . . . . 0.0 109.648 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.3 t -99.69 162.53 12.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.0 109.049 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.9 pt -56.23 -19.0 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.103 -0.998 . . . . 0.0 109.4 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.443 ' O ' ' N ' ' A' ' 26' ' ' SER . 46.5 t-20 -86.0 -54.75 4.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.187 -0.946 . . . . 0.0 109.402 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -46.34 -40.72 12.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.916 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 32' ' ' ASN . 39.5 pt -61.87 -25.58 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.019 -1.05 . . . . 0.0 109.518 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 27' ' ' ASN . 2.9 t -90.35 -106.65 0.09 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.161 -0.962 . . . . 0.0 108.927 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.542 ' N ' ' OG ' ' A' ' 26' ' ' SER . 97.6 m-20 -84.21 121.64 27.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.184 -0.948 . . . . 0.0 108.735 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -142.01 -71.44 0.34 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.195 -0.94 . . . . 0.0 109.83 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 t -159.59 -76.56 0.07 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.047 -1.033 . . . . 0.0 109.09 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.591 ' C ' ' H ' ' A' ' 32' ' ' ASN . 5.1 p -71.22 -166.81 0.19 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.572 ' C ' ' H ' ' A' ' 33' ' ' GLN . 95.1 m-20 -67.45 34.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.714 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.591 ' H ' ' C ' ' A' ' 30' ' ' SER . 99.3 m-20 -65.4 11.22 0.07 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.154 -0.966 . . . . 0.0 109.439 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.61 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 29.8 pt20 -94.14 -6.9 43.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.916 -1.115 . . . . 0.0 109.5 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.485 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 14.0 pt20 -136.44 -34.6 0.77 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.113 -0.992 . . . . 0.0 109.695 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 34' ' ' GLN . 74.6 m-20 -136.58 114.6 11.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.42 -0.8 . . . . 0.0 109.45 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.1 mm -93.97 118.86 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.898 -1.126 . . . . 0.0 108.446 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.2 t -114.36 124.89 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.348 -0.845 . . . . 0.0 110.213 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 83.1 m -102.26 101.92 12.26 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.8 m -97.4 121.96 39.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.072 -1.017 . . . . 0.0 109.588 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.1 m -139.38 155.5 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.408 -0.807 . . . . 0.0 109.024 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -95.94 123.76 39.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.324 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.99 161.99 17.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.7 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.621 ' HD1' ' H ' ' A' ' 45' ' ' ASN . 30.4 t-80 -139.99 148.4 41.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.908 . . . . 0.0 109.6 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.71 -24.2 33.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.362 -0.837 . . . . 0.0 109.745 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.621 ' H ' ' HD1' ' A' ' 43' ' ' HIS . 63.1 t-20 -98.96 -27.72 13.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.05 -1.031 . . . . 0.0 109.704 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.58 ' OD2' ' NZ ' ' A' ' 4' ' ' LYS . 88.3 m-20 -77.41 137.12 38.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.531 -0.731 . . . . 0.0 110.099 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.6 mt -78.23 148.28 34.03 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.448 HG23 HD13 ' A' ' 48' ' ' ILE . 47.2 pt -121.59 143.3 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.06 -1.025 . . . . 0.0 110.126 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.22 -176.14 47.22 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 50.5 p90 -164.9 170.37 15.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.126 -1.22 . . . . 0.0 109.75 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -148.33 146.08 28.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 109.936 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.4 m -126.21 152.17 73.16 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.415 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.3 Cg_endo -51.44 153.53 10.14 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.322 2.014 . . . . 0.0 111.867 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.5 m -72.5 -10.64 60.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.449 -0.782 . . . . 0.0 110.7 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.62 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.9 m-20 -92.4 -2.26 56.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.993 -1.067 . . . . 0.0 110.173 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.415 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 18.6 m-85 -108.69 164.58 12.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.158 -0.964 . . . . 0.0 110.346 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 t -105.11 135.13 47.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.331 -0.855 . . . . 0.0 109.119 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.493 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 3.0 m -92.6 119.87 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.993 -1.067 . . . . 0.0 110.316 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -123.36 126.4 25.88 Favored Pre-proline 0 N--CA 1.489 1.522 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.13 114.25 3.54 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.721 1.614 . . . . 0.0 112.144 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 68' ' ' PHE . 16.5 t-80 -93.71 -24.26 17.91 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.0 t0 -170.18 40.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.453 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 89.1 m -63.6 -154.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.524 -0.735 . . . . 0.0 109.887 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 4.3 p90 -110.56 -57.28 2.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.122 -0.986 . . . . 0.0 111.388 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 64' ' ' PHE . 34.7 t -46.12 -59.12 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.562 -1.336 . . . . 0.0 108.963 -179.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.1 t -156.85 133.86 10.36 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.453 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.0 -178.14 2.07 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.396 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.3 m-85 -93.63 143.25 26.48 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.678 HD22 ' CB ' ' A' ' 75' ' ' GLU . 82.9 m-20 -84.77 -169.2 2.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.112 -0.993 . . . . 0.0 109.828 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.2 mp -66.85 -15.32 63.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.362 -0.836 . . . . 0.0 108.936 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.8 p -89.62 -8.35 52.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.916 . . . . 0.0 108.693 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.25 22.25 57.29 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -107.16 138.9 42.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.278 -1.13 . . . . 0.0 109.126 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -67.97 136.42 53.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.419 -0.8 . . . . 0.0 109.988 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.678 ' CB ' HD22 ' A' ' 69' ' ' ASN . 68.1 tt0 -155.33 165.84 35.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 109.594 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -103.93 135.6 45.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.448 -0.782 . . . . 0.0 109.452 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.7 tp -97.61 -10.04 25.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.115 -0.99 . . . . 0.0 109.98 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -60.28 -44.57 95.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.944 -1.097 . . . . 0.0 109.638 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -64.83 -21.8 66.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.101 -1.0 . . . . 0.0 108.927 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -81.0 -48.42 12.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.437 -0.79 . . . . 0.0 109.283 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 44.0 tp -127.06 128.69 46.68 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.522 -0.737 . . . . 0.0 109.111 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -73.91 83.96 1.71 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.031 -1.043 . . . . 0.0 109.198 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.6 mt -80.37 135.25 36.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -0.828 . . . . 0.0 110.026 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.9 p -126.78 162.21 26.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.601 -0.687 . . . . 0.0 109.201 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 54.82 50.95 14.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 109.574 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.53 131.33 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.331 -0.856 . . . . 0.0 110.124 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -119.49 120.01 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.461 -0.774 . . . . 0.0 109.246 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 71.9 mtp -122.51 105.33 10.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.111 -0.993 . . . . 0.0 109.745 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -110.81 100.79 9.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.367 -0.833 . . . . 0.0 109.0 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.453 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 95.5 m-70 -73.25 -34.61 65.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.964 -1.085 . . . . 0.0 110.583 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -60.47 -45.8 92.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.862 -1.149 . . . . 0.0 109.63 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -89.64 -3.89 58.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.129 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 97.5 m-20 55.06 48.07 20.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.585 -0.697 . . . . 0.0 110.326 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.597 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 1.9 t -133.43 138.89 46.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.99 -1.068 . . . . 0.0 109.458 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 75.3 m-85 -126.93 139.06 53.34 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.323 -0.861 . . . . 0.0 109.93 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.597 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 73.4 m-85 -135.39 146.23 48.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.257 -0.902 . . . . 0.0 109.427 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 53.9 m -150.05 151.95 34.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.094 -1.004 . . . . 0.0 109.189 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' ' 98' ' ' ARG . 59.0 mtt-85 -103.55 135.64 44.76 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.062 -1.024 . . . . 0.0 109.415 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 67.8 mt -89.81 137.18 28.53 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.478 -0.764 . . . . 0.0 109.607 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -46.39 162.09 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.777 1.651 . . . . 0.0 111.329 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.0 m -71.36 -17.43 62.43 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.115 -0.991 . . . . 0.0 109.713 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.2 tp -132.46 130.71 40.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.236 -0.915 . . . . 0.0 110.39 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.7 mt -142.78 125.56 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.321 -0.862 . . . . 0.0 108.713 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.9 p -131.5 54.28 1.93 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.041 -1.037 . . . . 0.0 109.755 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.603 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 7.1 t0 -145.24 151.06 37.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 109.954 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.603 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 99.8 m-20 -91.33 33.66 0.98 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.492 -0.755 . . . . 0.0 109.039 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.589 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 12.8 p-90 -64.86 150.19 48.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.167 -0.958 . . . . 0.0 110.514 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.6 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 12.9 tttp -139.85 151.95 46.09 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.637 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 32.1 p90 -156.07 162.61 40.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.028 -1.045 . . . . 0.0 108.72 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 10.1 p90 -153.89 158.62 41.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.679 -1.263 . . . . 0.0 111.785 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 98.1 m -123.15 156.49 34.94 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.5 139.19 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 120.955 -1.09 . . . . 0.0 111.678 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 23.2 m -122.14 131.61 54.05 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 71.6 p -172.01 179.18 2.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.325 -1.484 . . . . 0.0 111.573 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.62 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 49.8 mtmt -150.72 163.17 39.21 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 117' ' ' ASN . 55.2 p-10 -58.13 154.38 13.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.751 -1.218 . . . . 0.0 109.214 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.508 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 66.3 t30 43.43 60.33 2.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.208 -0.932 . . . . 0.0 109.641 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 36.8 mt-10 -165.31 146.01 7.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.14 -0.975 . . . . 0.0 110.205 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.61 ' NZ ' ' O ' ' A' ' 33' ' ' GLN . 67.3 mttm -57.41 144.27 37.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.232 -0.918 . . . . 0.0 108.904 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -91.9 139.74 30.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.175 -0.953 . . . . 0.0 110.382 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 26.5 mt -108.04 120.43 42.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.374 -0.828 . . . . 0.0 109.043 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 49.9 t -109.01 129.88 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.968 -1.083 . . . . 0.0 110.493 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -108.27 120.42 42.33 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.6 ' OG1' ' NZ ' ' A' ' 108' ' ' LYS . 12.9 t -136.26 140.93 43.82 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.889 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.637 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.1 m -134.88 156.47 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -129.97 150.5 51.22 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.158 -0.964 . . . . 0.0 110.3 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.51 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.277 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -74.59 160.78 30.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.147 -0.971 . . . . 0.0 109.301 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 51.7 t -104.48 130.82 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.236 -0.915 . . . . 0.0 109.904 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.461 ' N ' ' CD ' ' A' ' 4' ' ' LYS . 3.6 mptp? -68.54 122.96 19.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.159 -0.963 . . . . 0.0 108.791 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.52 175.39 44.71 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -116.11 130.78 56.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.453 -1.028 . . . . 0.0 109.479 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.512 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 40.5 t0 -108.23 109.47 20.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.447 -0.783 . . . . 0.0 109.269 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.47 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 91.8 m-85 -88.29 0.89 55.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.151 -0.968 . . . . 0.0 108.977 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.2 m -102.12 -17.02 16.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.592 -0.692 . . . . 0.0 110.685 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.4 m -158.08 128.38 6.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.868 -1.145 . . . . 0.0 110.292 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.581 ' OG ' ' N ' ' A' ' 21' ' ' SER . 13.7 m -68.11 -25.45 65.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.895 . . . . 0.0 108.934 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -114.35 74.28 0.87 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 108.928 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.512 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 7.8 m -70.01 151.94 44.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 110.248 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.03 -0.08 39.91 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.8 pt -125.25 -25.01 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.7 -0.625 . . . . 0.0 110.176 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -111.58 139.64 46.85 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.033 -1.042 . . . . 0.0 109.912 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.2 m -71.85 -18.09 62.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.555 -0.716 . . . . 0.0 110.649 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -131.22 142.13 50.13 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.789 -1.194 . . . . 0.0 110.636 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -162.33 166.35 36.45 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.443 ' C ' ' OG ' ' A' ' 11' ' ' SER . 70.8 m-85 -125.65 168.24 14.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.316 -1.108 . . . . 0.0 109.586 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.581 ' N ' ' OG ' ' A' ' 11' ' ' SER . 4.9 t -103.4 164.69 11.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.466 -0.771 . . . . 0.0 109.072 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 26' ' ' SER . 44.9 pt -62.3 -20.82 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.078 -1.014 . . . . 0.0 109.512 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' A' ' 23' ' ' ASN . 49.0 t-20 -59.86 -35.41 74.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.342 -0.849 . . . . 0.0 109.338 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -69.01 -36.89 78.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.402 -0.811 . . . . 0.0 110.068 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 26' ' ' SER . 2.4 pt -100.48 -3.8 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.834 -1.166 . . . . 0.0 109.432 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 22' ' ' ILE . 48.9 m -54.31 -166.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.135 -0.978 . . . . 0.0 109.345 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.47 ' OD1' ' NZ ' ' A' ' 119' ' ' LYS . 89.8 m-20 -114.62 2.93 14.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.21 -0.931 . . . . 0.0 109.275 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -60.49 -98.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.522 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.3 t -144.45 69.85 1.27 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.108 -0.995 . . . . 0.0 109.183 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.7 p -73.62 139.74 45.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.37 -0.831 . . . . 0.0 109.616 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -67.05 -52.41 42.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.146 -0.971 . . . . 0.0 109.823 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.562 ' O ' ' O ' ' A' ' 33' ' ' GLN . 99.2 m-20 -65.7 121.38 14.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.019 -1.05 . . . . 0.0 109.605 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.744 ' C ' ' H ' ' A' ' 35' ' ' ASP . 2.8 pt20 -46.91 -178.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.512 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -58.62 16.48 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.483 -1.386 . . . . 0.0 109.961 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.744 ' H ' ' C ' ' A' ' 33' ' ' GLN . 97.4 m-20 -118.1 101.56 8.33 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.45 -0.781 . . . . 0.0 109.328 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.7 mm -102.2 126.13 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.037 -1.039 . . . . 0.0 108.895 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.1 t -120.97 129.84 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.061 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.47 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 91.1 m -100.8 99.56 10.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.0 m -95.87 121.07 37.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.933 -1.104 . . . . 0.0 109.489 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.8 m -141.34 155.84 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.401 -0.812 . . . . 0.0 109.246 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -96.08 129.52 43.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.945 . . . . 0.0 109.387 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.02 154.53 18.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.304 -0.872 . . . . 0.0 109.626 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.606 ' HD1' ' H ' ' A' ' 45' ' ' ASN . 32.4 t-80 -126.56 151.84 47.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.336 -0.852 . . . . 0.0 109.558 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.17 -25.11 30.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.883 . . . . 0.0 109.789 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.606 ' H ' ' HD1' ' A' ' 43' ' ' HIS . 98.9 m-20 -98.99 -24.97 14.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.926 . . . . 0.0 109.655 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -74.4 135.66 42.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.428 -0.795 . . . . 0.0 110.161 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.413 HD23 ' HE ' ' A' ' 98' ' ' ARG . 69.7 mt -76.86 145.59 38.26 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.455 HD11 HG22 ' A' ' 48' ' ' ILE . 39.1 pt -120.17 141.92 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.019 -1.05 . . . . 0.0 110.392 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.29 -174.57 46.83 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -170.16 169.95 7.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.049 -1.265 . . . . 0.0 109.739 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -146.96 145.03 29.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.315 -0.865 . . . . 0.0 109.762 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.7 m -124.49 153.4 69.43 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.258 -0.902 . . . . 0.0 108.626 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.431 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.51 147.69 22.31 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.307 2.004 . . . . 0.0 111.98 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.1 t -68.1 -13.84 62.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.465 -0.772 . . . . 0.0 110.621 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.641 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.7 m-20 -89.71 -0.77 57.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.834 -1.166 . . . . 0.0 110.224 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.431 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.5 m-85 -109.63 164.8 12.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.961 . . . . 0.0 110.186 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 m -105.24 135.51 46.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.387 -0.821 . . . . 0.0 109.298 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.515 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.8 m -90.16 118.4 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.074 -1.016 . . . . 0.0 110.393 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -123.84 127.84 25.31 Favored Pre-proline 0 N--CA 1.491 1.609 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.29 114.04 3.47 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.662 1.574 . . . . 0.0 112.16 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 68' ' ' PHE . 12.1 t-80 -91.22 -25.41 19.53 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.3 t0 -172.7 39.27 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.458 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 77.0 m -60.87 -153.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.538 -0.726 . . . . 0.0 109.842 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 4.3 p90 -108.97 -56.1 2.32 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.004 -1.06 . . . . 0.0 111.256 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 64' ' ' PHE . 13.1 t -48.79 -74.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.559 -1.338 . . . . 0.0 108.876 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 27.6 t -137.16 131.2 32.22 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.458 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.11 179.92 2.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.992 -1.068 . . . . 0.0 110.428 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 5.4 m-85 -93.46 130.31 39.33 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -76.63 -174.03 2.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.931 -1.106 . . . . 0.0 109.904 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.4 mt -64.27 -20.85 66.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 109.103 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.7 p -83.42 -6.36 59.44 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.12 19.74 66.45 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -100.82 139.14 36.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.233 -1.157 . . . . 0.0 109.193 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -84.38 112.38 20.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.928 . . . . 0.0 110.08 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -150.57 140.99 22.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.355 -0.841 . . . . 0.0 109.964 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -63.24 149.46 45.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.114 -0.991 . . . . 0.0 109.49 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.408 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 14.7 tp -96.55 7.39 46.66 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.359 -0.838 . . . . 0.0 109.691 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -69.02 -40.39 78.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.053 -1.029 . . . . 0.0 109.952 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.607 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 51.5 p-10 -61.95 -31.44 71.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 0.0 109.106 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.607 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 29.1 tptp -75.56 -48.17 23.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.514 -0.741 . . . . 0.0 109.255 178.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.6 tp -149.13 123.67 9.74 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -80.46 99.54 8.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.054 -1.029 . . . . 0.0 109.644 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.2 mt -76.08 158.97 31.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.435 -0.79 . . . . 0.0 109.784 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.2 p -129.51 160.17 34.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.264 -0.898 . . . . 0.0 109.346 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 54.59 51.29 14.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.072 -1.018 . . . . 0.0 109.723 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.9 mt -80.74 130.79 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.331 -0.856 . . . . 0.0 109.996 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.412 HG22 HD13 ' A' ' 87' ' ' ILE . 46.9 mm -123.06 121.82 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.516 -0.74 . . . . 0.0 109.192 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 87.1 mtp -121.87 104.14 9.34 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.021 -1.05 . . . . 0.0 109.884 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -112.07 100.76 9.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.296 -0.878 . . . . 0.0 108.904 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.48 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 93.5 m-70 -72.88 -35.94 67.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.873 -1.142 . . . . 0.0 110.657 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -60.4 -46.55 89.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.964 -1.085 . . . . 0.0 109.434 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -88.13 -4.92 58.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 0.0 109.107 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.48 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.3 m-20 54.71 47.72 21.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.522 -0.736 . . . . 0.0 110.173 178.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.59 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 4.8 t -132.62 137.87 47.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.009 -1.057 . . . . 0.0 109.359 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -126.89 139.24 53.22 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.385 -0.822 . . . . 0.0 109.979 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.59 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 80.4 m-85 -136.24 146.79 47.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.162 -0.961 . . . . 0.0 109.569 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.548 ' C ' ' CZ ' ' A' ' 98' ' ' ARG . 20.0 p -154.28 153.18 31.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.199 -0.938 . . . . 0.0 109.167 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.548 ' CZ ' ' C ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -100.64 137.01 39.61 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.112 -0.993 . . . . 0.0 109.687 -179.729 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 63.8 mt -88.84 134.74 33.06 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.467 -0.771 . . . . 0.0 109.518 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -46.48 155.78 0.68 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.68 1.586 . . . . 0.0 111.32 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.5 t -63.98 -43.36 95.96 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.172 -0.955 . . . . 0.0 109.862 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.7 tp -105.18 126.25 51.87 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.163 -0.961 . . . . 0.0 110.209 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 91.9 mt -151.33 104.06 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.134 -0.979 . . . . 0.0 108.847 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 90.7 p -108.25 0.9 21.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.967 . . . . 0.0 109.757 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -79.93 151.6 30.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 109.994 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -98.85 32.6 2.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.462 -0.774 . . . . 0.0 108.969 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 19.7 p-90 -65.89 158.41 28.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 110.587 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.3 157.46 44.79 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.63 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 35.8 p90 -155.31 160.47 40.78 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.939 -1.101 . . . . 0.0 108.769 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 5.6 p90 -151.49 158.99 44.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.664 -1.273 . . . . 0.0 111.766 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 90.0 m -124.62 156.3 37.71 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.7 t -129.64 141.66 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.89 -1.132 . . . . 0.0 111.72 -178.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 91.4 m -120.37 131.44 54.84 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.8 p -168.38 178.86 4.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.264 -1.523 . . . . 0.0 111.643 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.641 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 42.5 mtmt -159.11 167.94 27.91 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.508 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 48.5 p30 -58.72 151.44 21.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.823 -1.173 . . . . 0.0 109.009 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.463 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 60.1 t-20 40.89 58.91 2.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.237 -0.914 . . . . 0.0 109.385 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 54.5 mm-40 -157.57 137.54 12.45 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.089 -1.007 . . . . 0.0 110.521 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.47 ' NZ ' ' OD1' ' A' ' 27' ' ' ASN . 64.1 mttp -54.3 140.89 31.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.059 -1.025 . . . . 0.0 109.141 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -89.11 138.75 31.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.189 -0.944 . . . . 0.0 110.307 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.5 mt -111.24 123.11 49.55 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 39.4 t -108.58 130.45 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.878 -1.139 . . . . 0.0 110.621 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -108.91 119.76 40.5 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.6 t -137.14 143.51 42.52 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.876 -1.14 . . . . 0.0 111.946 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.63 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.4 m -136.79 159.55 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 126' ' ' GLU . 57.2 mp0 -128.51 147.83 50.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.055 -1.028 . . . . 0.0 110.217 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.299 179.762 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -80.39 160.03 25.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.19 -0.944 . . . . 0.0 109.327 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 77.5 t -97.76 134.84 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.262 -0.899 . . . . 0.0 110.079 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -68.89 125.91 28.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.949 -1.095 . . . . 0.0 108.618 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.82 -170.95 44.12 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.461 -1.352 . . . . 0.0 109.736 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.7 t -126.49 132.66 51.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -1.087 . . . . 0.0 109.612 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -107.86 108.71 20.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.557 -0.714 . . . . 0.0 109.283 179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -88.28 1.23 55.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 108.756 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 83.0 m -102.28 -16.97 16.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.503 -0.748 . . . . 0.0 110.477 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.6 m -158.08 127.37 5.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.884 -1.135 . . . . 0.0 110.409 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 t -65.2 -26.01 67.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 108.826 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -114.33 74.06 0.85 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -69.91 150.8 46.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 110.37 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.89 0.89 39.29 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.9 pt -123.91 -23.63 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.666 -0.647 . . . . 0.0 110.184 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -115.26 136.85 52.67 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.304 -0.873 . . . . 0.0 110.023 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.1 t -67.28 -17.79 64.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.571 -0.706 . . . . 0.0 110.864 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -129.95 140.97 50.84 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.039 -1.038 . . . . 0.0 110.523 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.43 161.16 29.99 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -119.37 155.6 31.63 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.481 -1.011 . . . . 0.0 109.636 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.3 t -90.59 152.16 21.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.806 . . . . 0.0 109.09 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.4 pt -54.52 -33.13 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -0.934 . . . . 0.0 109.376 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -68.31 -44.34 75.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.038 -1.039 . . . . 0.0 109.859 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -56.38 -42.69 78.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 110.101 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.468 ' C ' ' HG ' ' A' ' 26' ' ' SER . 41.6 pt -80.65 -15.77 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.87 -1.144 . . . . 0.0 109.598 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.468 ' HG ' ' C ' ' A' ' 25' ' ' ILE . 16.1 m -148.26 70.95 1.15 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.569 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.485 ' O ' ' C ' ' A' ' 28' ' ' LYS . 10.0 p30 -104.13 136.87 42.94 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.286 -0.884 . . . . 0.0 109.448 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 27' ' ' ASN . 99.3 mttt -39.35 -42.94 1.11 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.458 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.7 t -98.4 131.78 44.4 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.103 -0.998 . . . . 0.0 108.724 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.1 t -105.15 121.73 44.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.047 -1.033 . . . . 0.0 109.873 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.493 ' OD1' ' O ' ' A' ' 31' ' ' ASN . 61.2 t-20 -98.83 16.14 23.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.931 . . . . 0.0 109.203 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.448 ' CG ' ' H ' ' A' ' 33' ' ' GLN . 66.1 t30 -168.95 -178.55 3.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.917 . . . . 0.0 109.756 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.448 ' H ' ' CG ' ' A' ' 32' ' ' ASN . 16.9 pt20 -60.01 158.26 11.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 109.002 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.475 ' CG ' ' N ' ' A' ' 35' ' ' ASP . 11.7 pt20 -63.4 -41.72 98.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.032 -1.043 . . . . 0.0 109.444 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 0.7 OUTLIER -54.25 130.87 40.24 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.293 -0.879 . . . . 0.0 109.148 -179.312 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.435 HD11 HG21 ' A' ' 36' ' ' ILE . 38.5 mm -100.46 120.72 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.089 -1.007 . . . . 0.0 108.481 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.6 t -115.98 127.05 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.345 -0.847 . . . . 0.0 110.482 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.42 ' O ' ' O ' ' A' ' 124' ' ' THR . 97.5 m -102.62 101.43 11.57 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.2 m -94.22 120.69 34.84 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.055 -1.028 . . . . 0.0 109.58 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 15.9 m -141.36 149.34 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.528 -0.733 . . . . 0.0 109.349 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -90.52 130.65 36.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.971 -1.081 . . . . 0.0 109.24 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.25 151.27 22.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.906 . . . . 0.0 109.288 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.619 ' HD1' ' H ' ' A' ' 45' ' ' ASN . 38.2 t-80 -122.92 152.63 40.63 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.322 -0.861 . . . . 0.0 109.483 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 100' ' ' PRO . . . -55.69 -25.73 41.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.409 -0.807 . . . . 0.0 109.762 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.619 ' H ' ' HD1' ' A' ' 43' ' ' HIS . 53.6 t30 -98.81 -25.72 14.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 0.0 109.764 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -73.37 135.51 44.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.361 -0.837 . . . . 0.0 110.026 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 75.3 mt -77.21 145.87 37.35 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.428 HG22 HD12 ' A' ' 48' ' ' ILE . 46.1 pt -123.05 145.04 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.204 -0.935 . . . . 0.0 110.207 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.52 -172.52 45.28 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 49.9 p90 -171.3 170.11 6.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.075 -1.25 . . . . 0.0 109.785 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -146.38 144.67 29.9 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.243 -0.911 . . . . 0.0 109.79 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 70.4 m -123.0 153.15 64.08 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 9.3 Cg_endo -51.81 145.06 32.86 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.292 1.995 . . . . 0.0 112.138 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 t -68.02 -14.83 63.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.481 -0.762 . . . . 0.0 110.628 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -89.6 1.64 55.72 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.931 -1.106 . . . . 0.0 110.233 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.438 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 19.0 m-85 -110.55 166.43 11.0 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.398 -0.814 . . . . 0.0 110.482 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.431 ' OG ' ' OE2' ' A' ' 59' ' ' GLU . 35.2 t -103.01 133.88 47.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -0.837 . . . . 0.0 108.828 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.476 ' O ' ' CG2' ' A' ' 58' ' ' VAL . 2.1 m -91.05 124.49 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.042 -1.037 . . . . 0.0 110.198 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.431 ' OE2' ' OG ' ' A' ' 57' ' ' SER . 10.5 mp0 -131.28 125.82 21.08 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.07 114.47 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.644 1.562 . . . . 0.0 112.047 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.497 ' O ' ' O ' ' A' ' 68' ' ' PHE . 17.3 t-80 -91.57 -23.26 19.96 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.2 t0 -173.5 39.15 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.425 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 81.5 m -60.34 -152.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.577 -0.702 . . . . 0.0 109.533 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.3 p90 -110.88 -58.03 2.15 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.245 -0.909 . . . . 0.0 111.318 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 64' ' ' PHE . 23.5 t -45.95 -72.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.298 -1.501 . . . . 0.0 108.893 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.4 t -139.98 130.31 25.31 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.425 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.24 -178.79 1.8 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.121 -0.987 . . . . 0.0 110.524 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.2 m-85 -93.55 123.45 36.87 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -71.9 -175.84 1.54 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.044 -1.035 . . . . 0.0 109.754 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.6 mt -62.79 -22.86 66.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.181 -0.95 . . . . 0.0 109.112 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.6 t -79.85 -7.36 58.67 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.333 -0.855 . . . . 0.0 108.857 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.69 18.4 68.24 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -101.41 138.63 38.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -1.156 . . . . 0.0 109.072 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -86.08 110.12 19.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.202 -0.936 . . . . 0.0 110.165 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -146.72 143.35 28.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.364 -0.835 . . . . 0.0 109.914 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -64.65 149.64 48.61 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.503 -0.879 . . . . 0.0 109.51 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 13.1 tp -98.8 4.94 47.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.234 -0.916 . . . . 0.0 109.945 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -68.23 -41.31 81.42 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.038 -1.039 . . . . 0.0 110.013 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.593 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 43.4 p30 -64.46 -27.67 69.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.09 -1.006 . . . . 0.0 109.138 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.593 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 28.9 tptp -83.5 -47.73 11.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 109.361 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 43.3 tp -125.94 126.68 44.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.44 -0.787 . . . . 0.0 109.299 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -77.86 83.62 4.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.134 -0.979 . . . . 0.0 109.277 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.3 mt -82.6 136.04 34.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.393 -0.817 . . . . 0.0 110.083 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.3 p -126.16 160.79 29.24 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.572 HD21 ' CZ ' ' A' ' 98' ' ' ARG . 84.0 m-20 55.59 50.8 13.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.455 -0.778 . . . . 0.0 109.666 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.2 mt -78.33 131.53 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.997 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.2 mm -117.94 118.68 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.374 -0.829 . . . . 0.0 109.258 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 93.8 mtp -124.98 110.65 14.47 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.276 -0.89 . . . . 0.0 109.883 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -114.07 101.13 8.94 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.364 -0.835 . . . . 0.0 108.907 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.458 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 74.2 m80 -71.04 -36.74 72.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.079 -1.013 . . . . 0.0 110.677 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -60.14 -45.78 91.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.998 -1.064 . . . . 0.0 109.66 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -88.61 -5.23 58.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.161 -0.962 . . . . 0.0 109.152 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.3 m-20 54.72 48.28 20.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.573 -0.704 . . . . 0.0 110.338 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.603 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 2.9 t -132.38 137.04 47.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.013 -1.055 . . . . 0.0 109.313 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.563 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 47.1 m-85 -125.2 138.34 54.13 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.338 -0.851 . . . . 0.0 109.735 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TYR . . . . . 0.603 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 81.3 m-85 -136.07 146.19 46.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.217 -0.927 . . . . 0.0 109.154 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 83.8 p -154.96 155.91 35.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.932 . . . . 0.0 109.015 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.596 HH11 ' CB ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -107.81 139.56 42.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.162 -0.961 . . . . 0.0 109.934 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 100' ' ' PRO . 94.6 mt -96.6 142.31 24.36 Favored Pre-proline 0 C--N 1.297 -1.685 0 O-C-N 121.65 -0.656 . . . . 0.0 109.756 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 44' ' ' ALA . 76.4 Cg_exo -45.56 177.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.779 1.653 . . . . 0.0 111.263 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 96.9 p -85.32 -9.23 57.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.022 -1.049 . . . . 0.0 109.747 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.2 tp -139.0 130.66 27.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.229 -0.919 . . . . 0.0 110.778 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.492 HG23 HD12 ' A' ' 103' ' ' ILE . 74.2 mt -147.37 102.57 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.225 -0.922 . . . . 0.0 108.885 178.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 97.1 p -100.0 -3.05 32.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.056 -1.027 . . . . 0.0 109.819 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 127' ' ' ALA . 84.4 m-20 -82.11 151.05 27.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.853 . . . . 0.0 110.165 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -99.22 31.34 3.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.525 -0.734 . . . . 0.0 109.126 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 18.8 p-90 -66.59 159.95 26.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 110.627 -178.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -144.24 158.83 43.51 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PHE . . . . . 0.539 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 25.5 p90 -152.13 161.96 41.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.942 -1.098 . . . . 0.0 108.655 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 7.3 p90 -152.56 158.48 42.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.794 -1.191 . . . . 0.0 111.746 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 84.9 m -124.74 156.55 37.49 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 59' ' ' GLU . 44.4 t -129.73 140.51 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.893 -1.129 . . . . 0.0 111.829 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 72.2 m -124.16 133.18 53.63 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.2 p -169.56 178.25 4.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.27 -1.518 . . . . 0.0 111.647 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.551 ' NZ ' ' OE2' ' A' ' 118' ' ' GLU . 6.1 mtmp? -153.59 163.29 40.23 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 178.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 117' ' ' ASN . 99.3 m-20 -58.22 153.22 15.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.851 -1.156 . . . . 0.0 109.109 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.506 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 66.7 t30 44.04 59.4 3.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.167 -0.958 . . . . 0.0 109.555 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.551 ' OE2' ' NZ ' ' A' ' 115' ' ' LYS . 41.6 mt-10 -165.23 145.96 7.24 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.189 -0.944 . . . . 0.0 110.164 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.2 134.07 52.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.115 -0.991 . . . . 0.0 109.003 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -83.37 147.86 27.65 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.038 -1.039 . . . . 0.0 110.337 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.6 mt -111.04 124.45 52.2 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 42.2 t -108.83 130.22 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.998 -1.064 . . . . 0.0 110.388 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -109.52 121.23 44.74 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.42 ' O ' ' O ' ' A' ' 38' ' ' CYS . 5.3 t -137.33 142.89 41.83 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.468 1.127 . . . . 0.0 112.323 -178.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.539 ' CG2' ' CE2' ' A' ' 109' ' ' PHE . 3.1 m -138.39 158.7 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.546 ' CD ' ' N ' ' A' ' 127' ' ' ALA . 12.4 tm-20 -134.34 155.7 49.79 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.185 -0.947 . . . . 0.0 110.317 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.546 ' N ' ' CD ' ' A' ' 126' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.386 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 70.4 t -98.22 130.78 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.333 -0.854 . . . . 0.0 109.871 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -71.07 121.94 19.16 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.201 -0.937 . . . . 0.0 108.483 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.2 164.86 31.04 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.403 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 7.2 t -105.71 133.34 50.61 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.396 -1.061 . . . . 0.0 109.862 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.512 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 39.8 t0 -110.92 109.39 19.52 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.211 -0.931 . . . . 0.0 109.462 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.426 ' CG ' HD13 ' A' ' 121' ' ' LEU . 84.2 m-85 -87.0 3.75 44.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.135 -0.978 . . . . 0.0 108.872 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.4 m -109.83 -16.61 13.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.473 -0.767 . . . . 0.0 110.623 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.5 m -151.14 117.24 5.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.804 -1.185 . . . . 0.0 110.186 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.7 m -59.93 -32.22 70.57 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -111.49 75.48 0.92 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.512 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 1.3 m -74.18 115.11 13.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.354 -0.842 . . . . 0.0 110.365 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.9 t -67.75 3.25 1.51 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.478 ' H ' ' C ' ' A' ' 13' ' ' SER . 8.0 pt -124.02 -40.8 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.473 -0.767 . . . . 0.0 110.184 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.445 ' CE2' HD12 ' A' ' 15' ' ' ILE . 85.4 m-85 -100.32 142.08 32.28 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.919 -1.113 . . . . 0.0 109.806 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.6 t -72.24 -23.79 61.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.414 -0.804 . . . . 0.0 110.915 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -119.2 129.78 55.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.715 -1.24 . . . . 0.0 110.417 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -141.41 154.73 24.82 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.403 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 33.0 m-85 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.252 -1.146 . . . . 0.0 109.575 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.2 mm . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.515 HG22 ' HB ' ' A' ' 122' ' ' VAL . 49.0 t -119.3 129.42 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.062 -1.024 . . . . 0.0 110.25 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 74.4 m -102.77 101.91 12.02 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.0 m -94.12 120.63 34.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -0.958 . . . . 0.0 109.722 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.59 HG22 HG12 ' A' ' 125' ' ' VAL . 3.1 m -138.58 158.58 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.42 -0.8 . . . . 0.0 109.041 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -100.85 122.45 43.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -0.895 . . . . 0.0 109.509 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.49 164.41 13.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -0.847 . . . . 0.0 109.546 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.436 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 26.0 t60 -138.1 153.07 49.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 0.0 109.715 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 100' ' ' PRO . . . -54.63 -26.29 32.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 0.0 109.783 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -100.99 -24.77 14.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.148 -0.97 . . . . 0.0 109.572 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 98.0 m-20 -72.77 138.5 46.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.827 . . . . 0.0 109.893 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.538 HD22 ' CZ ' ' A' ' 98' ' ' ARG . 98.3 mt -80.31 144.88 32.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 108.741 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.9 pt -122.12 143.85 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.927 -1.108 . . . . 0.0 110.014 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.04 -175.82 47.69 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.464 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 50.2 p90 -167.71 169.49 11.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.024 -1.28 . . . . 0.0 109.751 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -148.43 146.38 28.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.955 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 63.1 m -126.33 152.21 73.52 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.21 153.93 8.75 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.449 2.099 . . . . 0.0 111.923 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.8 p -72.64 -10.99 60.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.709 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.514 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 80.8 m-20 -92.02 -3.31 55.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.937 -1.102 . . . . 0.0 110.083 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.476 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 15.8 m-85 -106.61 161.44 14.63 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.9 -1.125 . . . . 0.0 110.168 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.424 ' HG ' ' HZ3' ' A' ' 115' ' ' LYS . 7.1 m -99.89 138.39 37.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.363 -0.835 . . . . 0.0 109.389 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.8 m -94.38 117.08 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.977 -1.077 . . . . 0.0 110.454 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -126.18 127.67 24.61 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.97 111.11 3.03 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.614 1.543 . . . . 0.0 112.224 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -90.96 -26.99 18.99 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.461 ' HB3' ' H ' ' A' ' 110' ' ' PHE . 68.3 t0 -166.37 42.22 0.06 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.594 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 84.5 m -67.74 -157.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 109.836 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.541 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.9 p90 -112.16 -49.53 2.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.874 -1.141 . . . . 0.0 111.425 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 55.7 t -58.41 -48.75 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.495 -1.378 . . . . 0.0 108.922 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.1 t -156.84 128.94 7.32 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.594 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.62 -178.16 1.57 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.872 -1.142 . . . . 0.0 110.475 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.519 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 9.2 m-85 -94.14 127.54 40.03 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -70.16 -175.77 1.03 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.964 -1.085 . . . . 0.0 109.879 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.8 mt -61.95 -24.35 66.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.337 -0.852 . . . . 0.0 108.968 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 67.1 m -82.43 -5.07 58.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.316 -0.865 . . . . 0.0 108.804 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.41 19.03 65.13 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -100.23 141.41 33.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -1.136 . . . . 0.0 109.145 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -82.69 110.35 17.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.149 -0.969 . . . . 0.0 110.016 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -146.1 140.95 27.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.328 -0.857 . . . . 0.0 109.56 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -61.25 145.92 49.61 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.3 tp -96.61 5.89 49.83 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.175 -0.953 . . . . 0.0 109.892 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.463 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.3 OUTLIER -70.73 -41.66 71.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.1 -1.0 . . . . 0.0 109.789 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.415 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 41.0 t30 -59.8 -27.22 66.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.146 -0.971 . . . . 0.0 109.037 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -82.15 -45.46 15.1 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.246 -0.909 . . . . 0.0 109.353 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.548 HD22 ' CZ2' ' A' ' 107' ' ' TRP . 51.0 tp -139.13 133.64 31.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.431 -0.793 . . . . 0.0 109.187 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.65 86.09 7.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.079 -1.013 . . . . 0.0 109.433 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.432 HD21 HD23 ' A' ' 81' ' ' LEU . 96.4 mt -73.37 148.33 43.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.898 . . . . 0.0 109.842 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.1 p -127.29 162.74 25.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.409 -0.807 . . . . 0.0 109.391 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 54.32 51.88 13.51 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.062 -1.023 . . . . 0.0 109.529 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -80.2 131.07 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.353 -0.842 . . . . 0.0 110.093 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.8 mm -123.87 122.42 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.434 -0.791 . . . . 0.0 109.238 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 87.9 mtp -123.48 107.79 11.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.953 -1.092 . . . . 0.0 110.019 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -114.7 101.49 9.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.21 -0.931 . . . . 0.0 108.983 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.469 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 95.9 m-70 -73.27 -34.69 65.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.052 -1.03 . . . . 0.0 110.645 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -60.34 -45.7 92.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.896 -1.127 . . . . 0.0 109.61 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -89.43 -4.71 57.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.087 -1.008 . . . . 0.0 109.053 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 96.7 m-20 55.39 47.8 20.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 110.151 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.573 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.3 t -132.33 136.45 46.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.98 -1.075 . . . . 0.0 109.516 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.464 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 79.3 m-85 -126.29 139.53 53.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.019 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.573 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 80.1 m-85 -135.03 146.45 49.0 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.199 -0.938 . . . . 0.0 109.434 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.586 ' C ' ' HE ' ' A' ' 98' ' ' ARG . 39.7 t -145.74 144.95 30.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.095 -1.003 . . . . 0.0 109.212 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.586 ' HE ' ' C ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -100.46 128.75 46.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.072 -1.017 . . . . 0.0 109.435 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.523 ' O ' ' O ' ' A' ' 100' ' ' PRO . 94.8 mt -89.86 138.27 27.91 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.25 -0.906 . . . . 0.0 109.636 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 99' ' ' LEU . 75.7 Cg_exo -46.17 -177.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.896 1.731 . . . . 0.0 110.984 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 95.3 p -90.45 -8.35 50.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.968 -1.082 . . . . 0.0 109.748 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.7 tp -135.49 129.76 33.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.125 -0.984 . . . . 0.0 110.445 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.1 mt -150.92 108.3 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.367 -0.833 . . . . 0.0 108.838 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 99.8 p -110.41 0.11 17.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.124 -0.985 . . . . 0.0 109.678 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 127' ' ' ALA . 73.7 m-20 -82.57 152.79 25.81 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.062 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -99.15 32.5 2.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.375 -0.828 . . . . 0.0 109.082 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.548 ' CZ2' HD22 ' A' ' 81' ' ' LEU . 17.7 p-90 -65.88 151.09 47.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 110.553 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -134.91 156.3 49.2 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.627 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 36.9 p90 -156.06 158.13 37.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.079 -1.013 . . . . 0.0 108.954 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.461 ' H ' ' HB3' ' A' ' 62' ' ' ASP . 17.5 p90 -151.83 156.27 39.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.756 -1.215 . . . . 0.0 111.588 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 90.7 m -121.38 158.51 28.14 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 76.7 t -132.8 150.15 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.612 -1.305 . . . . 0.0 111.684 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.5 m -127.88 134.12 49.37 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.8 p -167.58 176.83 6.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.336 -1.478 . . . . 0.0 111.743 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.514 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 50.0 mttm -155.86 168.35 27.48 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 117' ' ' ASN . 90.8 m-20 -57.67 148.29 24.98 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.917 -1.114 . . . . 0.0 109.331 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.487 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 65.9 t30 40.9 60.93 1.84 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.264 -0.897 . . . . 0.0 109.771 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 48.9 mm-40 -157.31 136.67 12.01 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.978 -1.076 . . . . 0.0 110.187 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -56.33 133.44 52.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.262 -0.899 . . . . 0.0 109.019 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 120' ' ' LYS . 23.6 pttm -85.28 143.28 28.8 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.114 -0.991 . . . . 0.0 110.404 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.426 HD13 ' CG ' ' A' ' 8' ' ' PHE . 68.4 mt -111.33 124.33 52.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.446 -0.784 . . . . 0.0 109.154 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.515 ' HB ' HG22 ' A' ' 37' ' ' VAL . 46.4 t -109.45 130.98 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.986 -1.071 . . . . 0.0 110.711 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -109.98 120.62 43.04 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.4 t -137.05 143.95 42.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.475 -1.391 . . . . 0.0 112.008 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.627 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 2.9 m -136.53 159.94 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -134.31 150.11 50.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.836 -1.165 . . . . 0.0 110.13 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.338 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.6 t -88.16 136.39 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.372 -0.83 . . . . 0.0 110.36 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -68.84 125.22 25.92 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.054 -1.029 . . . . 0.0 108.615 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.81 179.11 45.18 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -118.56 132.4 56.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.619 -0.93 . . . . 0.0 109.369 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.483 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 36.0 t0 -109.07 109.07 19.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.542 -0.724 . . . . 0.0 109.272 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.458 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 78.0 m-85 -88.76 -0.54 57.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.171 -0.956 . . . . 0.0 108.912 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.0 m -98.55 -18.18 18.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.468 -0.77 . . . . 0.0 110.537 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.612 HG22 ' H ' ' A' ' 12' ' ' GLU . 65.0 m -158.2 127.07 5.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.836 -1.165 . . . . 0.0 110.361 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.1 p -64.59 -26.6 68.47 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.611 -0.836 . . . . 0.0 108.985 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.612 ' H ' HG22 ' A' ' 10' ' ' THR . 78.9 mm-40 -113.04 73.89 0.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.501 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 95.0 p -69.67 151.39 45.94 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.226 -0.921 . . . . 0.0 110.159 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 t -101.25 0.85 38.14 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 pt -124.76 -20.86 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.672 -0.643 . . . . 0.0 110.496 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.501 ' O ' ' OG ' ' A' ' 13' ' ' SER . 57.4 m-85 -115.93 144.52 43.94 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.401 -0.812 . . . . 0.0 110.325 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.0 m -72.28 -17.58 61.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.502 -0.749 . . . . 0.0 110.542 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -135.0 145.53 48.18 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.96 -1.088 . . . . 0.0 110.762 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.483 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -159.53 173.37 36.29 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.394 -1.062 . . . . 0.0 109.614 -179.845 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.9 mm . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.533 HG22 ' HB ' ' A' ' 122' ' ' VAL . 47.2 t -120.78 130.21 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.411 -0.806 . . . . 0.0 110.42 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.458 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 89.6 m -101.05 100.67 11.29 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 58.5 m -96.06 120.73 36.86 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.182 -0.949 . . . . 0.0 109.513 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.2 m -141.66 153.51 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.492 -0.755 . . . . 0.0 109.306 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -94.03 132.75 38.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.005 -1.059 . . . . 0.0 109.149 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.437 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -102.02 146.78 27.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.22 -0.925 . . . . 0.0 109.626 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.475 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 21.0 t-80 -116.43 150.73 37.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.429 -0.794 . . . . 0.0 109.507 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.667 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -55.99 -25.38 43.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.415 -0.803 . . . . 0.0 109.883 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.554 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 30.5 p30 -98.22 -22.99 15.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 109.684 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.554 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 82.2 m-20 -76.4 136.78 39.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.449 -0.782 . . . . 0.0 110.165 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.47 146.5 38.48 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.492 HD13 HD21 ' A' ' 99' ' ' LEU . 38.3 pt -120.4 141.89 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.113 -0.992 . . . . 0.0 110.307 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.93 -173.75 46.25 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -170.18 169.55 7.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.11 -1.229 . . . . 0.0 109.685 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -144.74 143.64 30.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.235 -0.916 . . . . 0.0 110.015 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 90.1 m -124.0 151.87 65.83 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.432 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.74 147.53 24.34 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.337 2.025 . . . . 0.0 111.976 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.1 m -70.6 -12.1 61.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.424 -0.798 . . . . 0.0 110.545 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.608 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.8 m-20 -91.6 0.49 57.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.051 -1.031 . . . . 0.0 110.084 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.4 m-85 -109.86 165.73 11.48 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.124 -0.985 . . . . 0.0 110.353 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -103.65 130.76 51.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.34 -0.85 . . . . 0.0 109.05 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.8 m -89.5 118.74 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.004 -1.06 . . . . 0.0 110.104 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -124.73 126.78 25.31 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.13 114.57 3.6 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.777 1.651 . . . . 0.0 112.051 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.491 ' O ' ' O ' ' A' ' 68' ' ' PHE . 17.0 t-80 -93.56 -24.0 18.11 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.8 t0 -170.19 40.59 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.485 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 89.9 m -64.28 -154.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.422 -0.799 . . . . 0.0 109.887 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 3.6 p90 -109.29 -58.69 2.0 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.155 -0.966 . . . . 0.0 111.483 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 64' ' ' PHE . 31.2 t -46.05 -70.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.58 -1.325 . . . . 0.0 108.804 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.2 t -141.38 132.45 26.23 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.485 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -170.97 175.86 4.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.97 -1.081 . . . . 0.0 110.464 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 4.1 m-85 -92.39 142.36 27.53 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -83.26 -170.86 3.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.879 -1.138 . . . . 0.0 109.895 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.558 ' N ' HD12 ' A' ' 70' ' ' LEU . 10.3 mp -66.56 -15.03 63.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.325 -0.86 . . . . 0.0 108.98 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 65.7 m -86.55 -8.61 57.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.38 -0.825 . . . . 0.0 108.806 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.93 20.07 64.01 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -106.73 139.84 40.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.318 -1.107 . . . . 0.0 109.246 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -66.78 125.68 26.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.28 -0.888 . . . . 0.0 109.844 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -145.47 165.26 29.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.408 -0.808 . . . . 0.0 109.644 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.442 ' ND2' ' CD ' ' A' ' 78' ' ' GLU . 37.8 t-20 -105.96 136.94 44.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.337 -0.852 . . . . 0.0 109.472 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 tp -93.26 -8.28 42.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 0.0 110.194 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.488 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 20.7 pt-20 -58.94 -46.63 87.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.044 -1.035 . . . . 0.0 109.523 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.488 ' N ' ' CG ' ' A' ' 78' ' ' GLU . 92.5 m-20 -64.87 -34.52 78.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 108.972 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -69.24 -52.41 27.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.499 -0.751 . . . . 0.0 109.61 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.565 HD23 HD21 ' A' ' 83' ' ' LEU . 31.5 tp -129.13 126.51 39.45 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -76.63 108.54 9.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.015 -1.053 . . . . 0.0 109.018 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.565 HD21 HD23 ' A' ' 81' ' ' LEU . 95.3 mt -105.18 137.86 42.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 110.088 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.9 p -124.46 162.69 23.4 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.493 -0.754 . . . . 0.0 109.287 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.6 ' O ' ' NH1' ' A' ' 98' ' ' ARG . 98.9 m-20 55.0 51.46 13.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.573 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -78.92 130.62 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.185 -0.947 . . . . 0.0 110.152 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.5 mm -120.19 119.79 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.482 -0.761 . . . . 0.0 109.225 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 78.8 mtp -124.56 109.59 13.41 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.295 -0.878 . . . . 0.0 109.835 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -111.73 100.74 9.18 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.38 -0.825 . . . . 0.0 108.938 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.486 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 97.1 m-70 -71.76 -36.48 70.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.859 -1.15 . . . . 0.0 110.632 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -61.13 -46.76 89.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.963 -1.085 . . . . 0.0 109.556 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -87.17 -4.96 59.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.07 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.4 m-20 54.93 47.32 22.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.556 -0.715 . . . . 0.0 110.209 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.592 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 3.3 t -133.84 139.73 46.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.03 -1.043 . . . . 0.0 109.325 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 49.5 m-85 -128.52 140.14 51.96 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.429 -0.794 . . . . 0.0 109.982 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.592 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 67.2 m-85 -138.23 148.7 45.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.289 -0.882 . . . . 0.0 109.16 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.703 ' N ' ' NH2' ' A' ' 98' ' ' ARG . 57.6 m -157.3 159.4 37.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.099 -1.001 . . . . 0.0 109.336 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.703 ' NH2' ' N ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -103.59 139.72 38.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.236 -0.915 . . . . 0.0 109.679 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.492 HD21 HD13 ' A' ' 48' ' ' ILE . 47.4 mt -91.98 138.54 24.64 Favored Pre-proline 0 C--N 1.304 -1.396 0 O-C-N 121.619 -0.676 . . . . 0.0 109.597 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.667 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 75.7 Cg_exo -46.93 158.28 0.44 Allowed 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.734 1.622 . . . . 0.0 111.265 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.6 t -69.6 -17.98 63.58 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.179 -0.95 . . . . 0.0 109.916 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 102' ' ' LEU . 44.9 tp -125.41 129.32 49.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.258 -0.901 . . . . 0.0 110.639 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 83.1 mt -149.29 102.86 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.3 m -113.25 3.1 15.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.352 -0.842 . . . . 0.0 109.834 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 53.2 t0 -89.28 155.28 19.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.976 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.584 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 98.9 m-20 -96.54 34.15 1.69 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.417 -0.802 . . . . 0.0 108.914 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.468 ' CZ3' ' CD1' ' A' ' 109' ' ' PHE . 13.0 p-90 -62.69 154.06 30.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.165 -0.959 . . . . 0.0 110.42 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.603 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 21.2 tttp -141.07 149.13 41.24 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.641 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 29.2 p90 -155.09 163.31 40.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.188 -0.945 . . . . 0.0 108.731 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.424 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 10.7 p90 -154.84 160.06 40.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.86 -1.15 . . . . 0.0 111.872 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 75.1 m -122.92 155.43 36.73 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 122' ' ' VAL . 44.4 t -128.78 139.05 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.848 -1.158 . . . . 0.0 111.933 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 96.4 m -122.9 131.94 53.96 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 62.9 p -171.54 178.7 3.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.306 -1.496 . . . . 0.0 111.608 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.608 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 50.6 mtmt -150.7 163.62 38.1 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 55.4 p-10 -59.44 154.27 17.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.907 -1.121 . . . . 0.0 109.114 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.511 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 64.7 t30 44.26 59.69 3.13 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.211 -0.931 . . . . 0.0 109.642 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 38.8 mt-10 -165.28 146.19 7.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.256 -0.902 . . . . 0.0 110.154 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -58.03 142.16 47.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 109.193 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -88.95 140.09 29.79 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.077 -1.015 . . . . 0.0 110.414 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 86.6 mt -108.89 120.8 43.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.417 -0.802 . . . . 0.0 108.965 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 112' ' ' VAL . 48.6 t -109.36 130.1 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.049 -1.032 . . . . 0.0 110.54 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -107.81 118.62 37.23 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.603 ' OG1' ' NZ ' ' A' ' 108' ' ' LYS . 7.3 t -136.94 141.88 42.65 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.918 -1.114 . . . . 0.0 112.3 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.3 m -134.55 158.48 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -132.31 152.66 51.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.229 -0.919 . . . . 0.0 110.278 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.333 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.2 t -96.55 133.17 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 109.795 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.8 mmtp -69.86 122.11 18.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.126 -0.984 . . . . 0.0 108.706 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.3 176.41 46.22 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.543 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 4.7 t -116.28 128.54 55.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.471 -1.017 . . . . 0.0 109.296 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.452 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 54.4 t0 -103.45 111.18 23.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.59 -0.694 . . . . 0.0 109.375 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -91.59 -0.88 57.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.186 -0.947 . . . . 0.0 108.826 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.5 m -103.72 -16.67 15.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.486 -0.759 . . . . 0.0 110.632 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 12' ' ' GLU . 23.3 m -156.35 125.02 5.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.883 -1.136 . . . . 0.0 110.278 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.505 ' OG ' ' OE1' ' A' ' 12' ' ' GLU . 74.0 p -65.47 -26.36 67.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.184 -0.948 . . . . 0.0 108.981 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.516 ' H ' HG22 ' A' ' 10' ' ' THR . 55.5 mp0 -113.67 72.96 0.8 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.2 t -67.7 150.62 48.46 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.134 -0.979 . . . . 0.0 110.352 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.77 0.6 41.99 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.411 HD12 ' OH ' ' A' ' 96' ' ' TYR . 24.2 pt -125.04 -27.19 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.749 -0.594 . . . . 0.0 110.199 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -110.27 133.74 52.95 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.041 -1.037 . . . . 0.0 109.87 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.9 t -67.95 -18.53 64.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.641 -0.662 . . . . 0.0 110.858 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -125.09 136.73 53.94 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.027 -1.046 . . . . 0.0 110.67 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.452 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -146.86 158.81 27.84 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.543 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 21.4 m-85 . . . . . 0 N--CA 1.495 1.795 0 O-C-N 121.323 -1.104 . . . . 0.0 109.589 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.449 ' O ' ' N ' ' A' ' 122' ' ' VAL . 20.8 mm . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 79.5 t -115.68 127.85 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.114 -0.991 . . . . 0.0 110.604 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.505 ' O ' ' O ' ' A' ' 124' ' ' THR . 66.8 m -102.07 101.49 11.86 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.1 m -92.46 119.53 32.05 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.822 -1.174 . . . . 0.0 109.848 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.558 ' CG2' HG12 ' A' ' 125' ' ' VAL . 19.8 m -136.23 155.76 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -99.03 121.88 41.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 109.504 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.86 163.56 13.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.574 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.474 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 37.1 t60 -136.64 155.61 49.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.203 -0.936 . . . . 0.0 109.656 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -55.24 -26.47 39.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.325 -0.86 . . . . 0.0 109.711 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -101.46 -22.44 14.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.166 -0.959 . . . . 0.0 109.632 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.474 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 85.8 m-20 -75.08 137.49 41.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.419 -0.8 . . . . 0.0 109.942 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.8 mt -80.73 147.46 30.55 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.407 HG21 HD11 ' A' ' 99' ' ' LEU . 43.7 pt -122.12 144.26 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.144 -0.972 . . . . 0.0 110.294 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.9 -173.06 45.7 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.474 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 50.5 p90 -169.68 168.81 8.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.056 -1.261 . . . . 0.0 109.725 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -143.42 142.6 31.29 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.319 -0.863 . . . . 0.0 109.636 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 61.4 m -123.77 152.31 65.66 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 108.662 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.467 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.3 Cg_endo -51.7 150.98 15.71 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.431 2.087 . . . . 0.0 111.905 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.1 m -71.32 -13.2 61.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.459 -0.775 . . . . 0.0 110.726 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.491 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 80.2 m-20 -91.04 -1.04 57.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.867 -1.146 . . . . 0.0 110.214 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.467 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 16.5 m-85 -107.67 162.49 13.92 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.514 -0.741 . . . . 0.0 110.099 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.432 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 6.2 t -102.91 134.04 47.0 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.333 -0.855 . . . . 0.0 109.334 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 58' ' ' VAL . 3.5 m -90.45 115.25 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.092 -1.005 . . . . 0.0 110.389 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' A' ' 59' ' ' GLU . 15.8 mp0 -121.24 126.56 26.52 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.08 112.71 3.29 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.617 1.545 . . . . 0.0 112.265 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -94.05 -25.24 17.28 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.7 t0 -168.34 39.51 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 80.5 m -65.08 -153.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.579 -0.701 . . . . 0.0 109.729 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.474 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 3.9 p90 -111.26 -59.15 2.01 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.179 -0.95 . . . . 0.0 111.347 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.449 ' C ' ' O ' ' A' ' 64' ' ' PHE . 24.1 t -45.72 -73.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.682 -1.261 . . . . 0.0 108.757 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.436 ' N ' HG12 ' A' ' 65' ' ' VAL . 33.3 t -136.44 132.61 35.65 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -173.71 -178.67 1.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.908 -1.12 . . . . 0.0 110.446 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 7.6 m-85 -93.07 124.21 36.88 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -69.74 -175.03 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.07 -1.019 . . . . 0.0 109.869 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.8 mt -62.3 -23.66 66.86 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.29 -0.881 . . . . 0.0 108.905 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.6 p -81.92 -7.17 59.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 108.819 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.64 15.63 70.35 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -95.75 138.51 33.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.394 -1.062 . . . . 0.0 109.137 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -81.91 108.35 15.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.249 -0.907 . . . . 0.0 110.143 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -145.35 143.58 30.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 110.063 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.0 m-20 -64.54 149.59 48.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.913 -1.117 . . . . 0.0 109.512 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.63 HD11 ' HD3' ' A' ' 80' ' ' LYS . 13.9 tp -99.22 6.7 46.24 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.465 -0.772 . . . . 0.0 109.941 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 79' ' ' ASN . 17.8 pt-20 -69.38 -41.06 76.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.13 -0.981 . . . . 0.0 109.923 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 48.4 p-10 -62.58 -26.08 68.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.197 -0.939 . . . . 0.0 109.071 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.63 ' HD3' HD11 ' A' ' 77' ' ' LEU . 88.0 tttt -84.79 -46.29 11.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.45 -0.781 . . . . 0.0 109.442 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.606 HD23 HD21 ' A' ' 83' ' ' LEU . 41.0 tp -131.64 127.35 36.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.405 -0.809 . . . . 0.0 109.234 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -83.29 83.77 7.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.066 -1.021 . . . . 0.0 109.297 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.606 HD21 HD23 ' A' ' 81' ' ' LEU . 95.9 mt -75.73 146.71 39.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.888 . . . . 0.0 110.121 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.3 p -127.94 160.61 31.33 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.606 -0.684 . . . . 0.0 109.318 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.6 m120 54.72 50.78 15.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.278 -0.889 . . . . 0.0 109.546 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.2 mt -77.61 128.54 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 109.879 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.0 mm -118.92 119.19 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.489 -0.757 . . . . 0.0 109.229 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 85.4 mtp -123.44 108.03 12.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.214 -0.929 . . . . 0.0 109.806 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -114.19 101.75 9.49 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.411 -0.806 . . . . 0.0 108.873 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.472 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 95.4 m-70 -71.63 -36.22 70.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.995 -1.066 . . . . 0.0 110.592 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -60.91 -45.15 95.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.974 -1.079 . . . . 0.0 109.462 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -88.89 -5.21 58.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.953 . . . . 0.0 109.07 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.7 m-20 54.4 47.95 21.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.49 -0.756 . . . . 0.0 110.139 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.608 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 2.6 t -132.37 137.16 47.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.987 -1.071 . . . . 0.0 109.606 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.474 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 79.4 m-85 -126.68 138.88 53.47 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.402 -0.811 . . . . 0.0 109.977 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.608 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 71.4 m-85 -135.61 146.1 47.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.239 -0.913 . . . . 0.0 109.437 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.521 ' OG ' HD22 ' A' ' 83' ' ' LEU . 35.5 t -150.87 150.99 31.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.959 . . . . 0.0 109.242 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.418 ' HG2' HH11 ' A' ' 98' ' ' ARG . 60.3 mtt-85 -101.29 133.1 46.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.16 -0.962 . . . . 0.0 109.434 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 99' ' ' LEU . 38.5 mt -91.54 137.9 25.59 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.461 -0.774 . . . . 0.0 109.789 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.542 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 77.5 Cg_exo -45.68 177.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.876 1.717 . . . . 0.0 111.163 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.483 ' C ' ' HB1' ' A' ' 44' ' ' ALA . 99.9 p -89.36 -9.87 48.76 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.113 -0.992 . . . . 0.0 109.847 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.7 tp -133.68 128.15 34.39 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.208 -0.932 . . . . 0.0 110.254 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.3 mt -150.12 106.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.945 . . . . 0.0 108.677 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 96.3 p -107.78 0.33 22.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.088 -1.007 . . . . 0.0 109.772 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 127' ' ' ALA . 82.6 m-20 -84.64 154.54 22.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.038 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -102.38 31.5 4.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.493 -0.754 . . . . 0.0 109.12 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.441 ' CH2' HD22 ' A' ' 81' ' ' LEU . 16.5 p-90 -66.68 160.07 26.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.205 -0.934 . . . . 0.0 110.507 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -142.0 159.05 43.01 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.553 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 20.9 p90 -154.04 162.66 41.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.929 -1.107 . . . . 0.0 108.661 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 7.3 p90 -153.59 160.4 42.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.67 -1.269 . . . . 0.0 111.836 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 94.7 m -124.83 156.68 37.43 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 122' ' ' VAL . 44.0 t -127.9 138.91 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.867 -1.145 . . . . 0.0 111.792 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.1 m -120.11 130.77 54.79 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.2 p -168.93 174.84 6.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.322 -1.486 . . . . 0.0 111.601 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.491 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 52.4 mttm -152.72 168.1 26.79 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 117' ' ' ASN . 90.1 m-20 -58.54 148.34 28.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.835 -1.166 . . . . 0.0 108.845 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 66.2 t30 43.86 60.67 2.6 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.26 -0.9 . . . . 0.0 109.395 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 58.2 mm-40 -158.01 137.44 11.88 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.19 -0.944 . . . . 0.0 110.455 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -54.77 131.57 44.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.083 -1.011 . . . . 0.0 108.962 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -79.81 139.25 37.28 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.21 -0.931 . . . . 0.0 110.249 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.6 mt -111.26 124.43 52.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.644 -0.66 . . . . 0.0 109.389 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 112' ' ' VAL . 39.2 t -110.39 132.04 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.979 -1.076 . . . . 0.0 110.71 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.419 ' O ' ' CB ' ' A' ' 110' ' ' PHE . 26.4 t80 -110.43 123.0 49.06 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.505 ' O ' ' O ' ' A' ' 38' ' ' CYS . 6.6 t -137.88 143.73 41.01 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.005 -1.059 . . . . 0.0 112.145 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.558 HG12 ' CG2' ' A' ' 40' ' ' VAL . 2.8 m -136.71 159.52 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -133.16 150.64 52.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.071 -1.018 . . . . 0.0 110.31 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.4 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.9 t -103.63 135.29 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.054 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -69.46 125.12 25.75 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.583 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.61 176.02 43.51 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -115.85 132.47 56.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.493 -1.004 . . . . 0.0 109.246 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.512 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 36.9 t0 -110.21 109.18 19.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.595 -0.691 . . . . 0.0 109.333 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -88.17 -1.17 57.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.298 -0.876 . . . . 0.0 108.982 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.5 m -100.93 -18.64 16.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.515 -0.741 . . . . 0.0 110.577 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 12' ' ' GLU . 25.7 m -156.19 125.06 5.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.878 -1.139 . . . . 0.0 110.367 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 t -65.99 -27.0 67.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.413 -0.804 . . . . 0.0 108.957 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 58.7 mp0 -112.92 73.98 0.84 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.496 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 12.5 m -70.78 152.85 43.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.875 . . . . 0.0 110.225 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.93 -0.04 40.28 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.7 pt -125.9 -22.28 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.71 -0.619 . . . . 0.0 110.25 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -113.05 140.28 47.98 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.255 -0.903 . . . . 0.0 110.133 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.9 m -73.43 -17.08 61.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.603 -0.686 . . . . 0.0 110.691 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -132.87 144.04 49.92 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.998 -1.064 . . . . 0.0 110.563 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.512 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -160.7 171.32 36.81 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.423 -1.045 . . . . 0.0 109.666 179.935 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.9 mm . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.438 HG22 ' HB ' ' A' ' 122' ' ' VAL . 54.9 t -121.44 126.86 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.392 -0.818 . . . . 0.0 110.009 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.3 m -102.45 102.16 12.43 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 75.8 m -98.78 122.37 41.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.076 -1.015 . . . . 0.0 109.397 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.513 ' CG2' HG12 ' A' ' 125' ' ' VAL . 24.1 m -140.96 155.22 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.562 -0.711 . . . . 0.0 109.257 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -96.12 132.5 41.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.084 -1.01 . . . . 0.0 109.405 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.76 160.45 14.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.405 -0.81 . . . . 0.0 109.591 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.489 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 34.8 t60 -133.0 153.81 51.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.245 -0.909 . . . . 0.0 109.55 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 100' ' ' PRO . . . -54.01 -25.28 20.34 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.384 -0.822 . . . . 0.0 109.788 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -101.53 -26.06 13.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.704 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.489 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 76.5 m-20 -71.67 132.02 43.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.336 -0.852 . . . . 0.0 110.069 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.636 HD22 HH11 ' A' ' 98' ' ' ARG . 11.3 mt -77.28 145.89 37.19 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.422 HG21 HD11 ' A' ' 99' ' ' LEU . 44.9 pt -123.11 145.85 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.766 0.793 . . . . 0.0 110.479 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.48 -173.98 46.58 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -169.54 170.01 8.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.095 -1.239 . . . . 0.0 109.697 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -147.71 145.4 28.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.9 . . . . 0.0 109.907 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 92.6 m -124.83 151.65 68.61 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.6 Cg_endo -51.7 150.1 17.65 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.334 2.023 . . . . 0.0 112.044 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 m -69.68 -11.74 61.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.398 -0.813 . . . . 0.0 110.528 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -90.94 -2.67 57.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.023 -1.048 . . . . 0.0 110.223 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.434 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.4 m-85 -109.17 164.28 12.59 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.219 -0.925 . . . . 0.0 110.426 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.7 t -105.96 133.93 49.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.448 -0.783 . . . . 0.0 108.919 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 58' ' ' VAL . 3.1 m -89.8 118.92 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.032 -1.043 . . . . 0.0 110.364 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 112' ' ' VAL . 10.0 mt-10 -123.1 126.67 25.91 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.14 114.11 3.51 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.66 1.573 . . . . 0.0 112.12 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.505 ' O ' ' O ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -93.63 -24.14 18.01 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.866 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 110' ' ' PHE . 66.9 t0 -169.9 43.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.478 ' H ' ' CB ' ' A' ' 67' ' ' ALA . 97.3 m -67.55 -153.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.748 . . . . 0.0 109.844 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.492 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 3.8 p90 -110.1 -57.88 2.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.141 -0.975 . . . . 0.0 111.455 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 64' ' ' PHE . 24.9 t -46.76 -71.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.601 -1.312 . . . . 0.0 108.863 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.8 t -140.91 131.3 25.18 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.478 ' CB ' ' H ' ' A' ' 63' ' ' CYS . . . -170.76 175.74 4.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.975 -1.078 . . . . 0.0 110.425 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.533 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 2.5 m-85 -92.86 140.67 29.26 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -81.81 -170.35 2.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.835 -1.165 . . . . 0.0 109.829 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 70' ' ' LEU . 10.0 mp -66.42 -15.31 63.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.305 -0.872 . . . . 0.0 109.087 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 69.5 m -86.6 -7.94 57.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 108.883 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.7 20.9 64.93 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -106.98 138.26 43.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.273 -1.134 . . . . 0.0 109.114 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -65.62 124.32 22.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.257 -0.902 . . . . 0.0 109.754 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -143.71 165.09 28.61 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.396 -0.815 . . . . 0.0 109.704 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -106.51 137.83 43.8 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.353 -0.842 . . . . 0.0 109.371 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.8 tp -95.39 -11.03 28.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.192 -0.942 . . . . 0.0 109.988 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.497 ' CD ' ' N ' ' A' ' 79' ' ' ASN . 2.3 pp20? -61.35 -43.82 98.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.978 -1.076 . . . . 0.0 109.557 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 49.1 p30 -64.17 -20.43 66.0 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.096 -1.003 . . . . 0.0 108.856 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.54 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 84.7 tttt -88.95 -43.97 10.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.0 109.67 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.437 HD23 HD21 ' A' ' 83' ' ' LEU . 45.0 tp -133.35 123.24 25.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.423 -0.798 . . . . 0.0 109.305 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -79.3 85.25 5.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.117 -0.989 . . . . 0.0 109.409 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.542 HD22 ' OG ' ' A' ' 97' ' ' SER . 92.7 mt -74.23 147.03 42.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.322 -0.861 . . . . 0.0 110.036 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 47.3 p -127.42 161.23 29.18 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.527 -0.733 . . . . 0.0 109.339 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 53.58 51.16 15.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.172 -0.955 . . . . 0.0 109.553 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.1 mt -79.05 130.61 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.075 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.7 mm -118.62 119.09 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.509 -0.744 . . . . 0.0 109.117 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 83.0 mtp -121.42 103.78 9.2 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.257 -0.902 . . . . 0.0 109.731 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -113.52 101.45 9.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.425 -0.797 . . . . 0.0 109.085 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -76.46 -32.89 58.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.03 -1.044 . . . . 0.0 110.471 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -59.45 -47.07 86.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.011 -1.055 . . . . 0.0 109.579 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -89.53 2.96 53.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.184 -0.947 . . . . 0.0 109.044 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 50.78 46.58 25.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.543 -0.723 . . . . 0.0 109.904 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.544 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.7 t -131.5 135.31 46.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.027 -1.046 . . . . 0.0 109.427 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -128.23 140.07 52.1 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.421 -0.799 . . . . 0.0 109.977 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.544 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 70.8 m-85 -135.68 147.25 48.46 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.167 -0.958 . . . . 0.0 109.319 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.542 ' OG ' HD22 ' A' ' 83' ' ' LEU . 45.8 t -146.11 143.48 29.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.116 -0.99 . . . . 0.0 109.115 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.636 HH11 HD22 ' A' ' 47' ' ' LEU . 21.4 mmt180 -99.35 133.15 44.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.235 -0.916 . . . . 0.0 109.355 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 100' ' ' PRO . 88.4 mt -92.0 139.08 24.39 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.486 -0.759 . . . . 0.0 109.763 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.481 ' O ' ' O ' ' A' ' 44' ' ' ALA . 77.7 Cg_exo -45.87 176.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.867 1.711 . . . . 0.0 111.118 178.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.447 ' C ' ' HB1' ' A' ' 44' ' ' ALA . 6.2 m -86.03 -11.91 51.63 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.195 -0.941 . . . . 0.0 109.772 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.4 tp -138.66 130.5 27.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.107 -0.996 . . . . 0.0 110.536 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.8 mt -141.78 123.6 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.303 -0.873 . . . . 0.0 108.651 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.488 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 12.9 t -119.87 50.5 1.27 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.221 -0.924 . . . . 0.0 109.781 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.489 ' O ' ' OXT' ' A' ' 127' ' ' ALA . 87.8 m-20 -144.26 153.16 41.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.975 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -101.92 33.47 3.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.363 -0.836 . . . . 0.0 109.266 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.419 ' HB2' ' NZ ' ' A' ' 80' ' ' LYS . 15.1 p-90 -64.64 157.05 28.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.096 -1.002 . . . . 0.0 110.332 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -138.15 150.28 46.65 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.615 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 30.0 p90 -153.55 164.58 37.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.969 . . . . 0.0 108.785 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 11.8 p90 -155.11 161.83 41.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.803 -1.186 . . . . 0.0 111.783 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 98.7 m -126.09 157.15 38.76 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 122' ' ' VAL . 49.8 t -129.67 141.07 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.88 -1.137 . . . . 0.0 111.738 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 46.8 m -121.89 131.98 54.32 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 93.7 p -170.88 178.88 3.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.297 -1.502 . . . . 0.0 111.57 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.586 ' NZ ' ' OE1' ' A' ' 118' ' ' GLU . 26.1 mtmm -154.34 164.92 37.86 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.49 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 50.1 p30 -58.87 152.75 18.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.842 -1.161 . . . . 0.0 109.173 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.504 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 53.4 t-20 44.5 59.66 3.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.282 -0.886 . . . . 0.0 109.567 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.586 ' OE1' ' NZ ' ' A' ' 115' ' ' LYS . 41.2 mt-10 -164.97 145.44 7.32 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.158 -0.964 . . . . 0.0 110.241 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -63.58 135.74 57.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.871 . . . . 0.0 108.729 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.591 ' HE2' ' H ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -84.3 146.43 27.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.075 -1.016 . . . . 0.0 110.42 -179.405 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 57.2 mt -111.58 124.23 51.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.184 -0.948 . . . . 0.0 109.287 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 112' ' ' VAL . 51.3 t -108.22 129.99 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.942 -1.099 . . . . 0.0 110.593 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -109.64 121.48 45.3 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.5 t -137.2 142.1 42.12 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.866 -1.146 . . . . 0.0 112.193 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.615 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.0 m -136.78 156.73 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -133.95 157.13 46.82 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.157 -0.965 . . . . 0.0 110.385 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.489 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.907 -1.044 . . . . 0.0 109.314 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.4 t -104.28 133.75 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.315 -0.866 . . . . 0.0 109.901 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -67.73 119.83 13.09 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.095 -1.003 . . . . 0.0 108.715 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.97 176.04 47.09 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.7 t -120.51 132.1 55.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.374 -1.074 . . . . 0.0 109.35 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.507 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 43.3 t0 -107.42 108.86 20.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.556 -0.715 . . . . 0.0 109.485 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -86.2 -0.92 56.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 108.929 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.3 m -101.81 -15.88 16.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.56 -0.712 . . . . 0.0 110.54 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 12' ' ' GLU . 5.9 m -158.54 127.67 5.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.883 -1.136 . . . . 0.0 110.258 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.514 ' OG ' ' OE1' ' A' ' 12' ' ' GLU . 64.6 p -68.16 -24.1 64.94 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.911 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 57.0 mp0 -114.58 74.05 0.86 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 23.5 p -71.33 153.87 42.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.464 -0.772 . . . . 0.0 110.241 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.46 0.82 37.45 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.1 pt -124.05 -25.65 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.628 -0.67 . . . . 0.0 110.219 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.48 ' O ' ' OG ' ' A' ' 13' ' ' SER . 71.4 m-85 -113.13 139.4 48.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.168 -0.957 . . . . 0.0 110.012 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.6 p -69.37 -16.46 63.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.719 . . . . 0.0 110.766 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -135.05 146.1 48.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.956 -1.09 . . . . 0.0 110.847 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.507 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -163.01 173.37 39.2 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.41 -1.053 . . . . 0.0 109.564 -179.809 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.2 mm . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.6 t -117.86 126.5 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.362 -0.836 . . . . 0.0 110.383 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.427 ' O ' ' O ' ' A' ' 124' ' ' THR . 96.9 m -101.96 101.11 11.47 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.1 m -93.54 119.77 33.0 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.928 . . . . 0.0 109.624 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.592 ' CG2' HG12 ' A' ' 125' ' ' VAL . 14.6 m -139.88 139.48 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.498 -0.751 . . . . 0.0 109.238 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -82.22 127.41 33.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.117 -0.989 . . . . 0.0 109.301 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.01 154.79 17.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 109.45 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.439 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 45.8 t-80 -128.32 152.62 47.93 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.385 -0.822 . . . . 0.0 109.593 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.842 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -56.03 -25.61 45.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 109.766 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -97.14 -24.38 15.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 109.497 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 81.9 m-20 -77.35 136.86 38.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.465 -0.772 . . . . 0.0 109.888 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.1 mt -79.6 149.18 31.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.933 . . . . 0.0 108.595 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.471 HD13 HD21 ' A' ' 99' ' ' LEU . 22.1 pt -120.83 142.35 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.11 -0.994 . . . . 0.0 110.086 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.13 -173.27 45.79 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -172.79 172.12 4.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.081 -1.246 . . . . 0.0 109.864 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -146.02 144.55 30.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.271 -0.893 . . . . 0.0 109.861 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 47.1 m -125.24 153.99 71.88 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.127 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.452 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.66 146.96 25.3 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.647 2.232 . . . . 0.0 112.027 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.3 t -68.4 -13.16 62.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.462 -0.773 . . . . 0.0 110.71 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.47 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 80.0 m-20 -90.37 -0.61 57.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.942 -1.099 . . . . 0.0 110.213 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.452 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 18.8 m-85 -109.5 164.03 12.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.216 -0.928 . . . . 0.0 110.207 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.4 133.88 48.54 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.416 -0.802 . . . . 0.0 108.984 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 58' ' ' VAL . 3.2 m -91.47 112.95 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.994 -1.066 . . . . 0.0 110.508 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -121.42 129.53 25.19 Favored Pre-proline 0 N--CA 1.49 1.526 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.08 113.53 3.43 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.593 1.529 . . . . 0.0 112.243 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -88.96 -24.81 22.33 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.1 t0 -170.17 37.32 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.415 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 79.6 m -60.78 -154.05 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.628 -0.67 . . . . 0.0 109.696 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.482 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 3.1 p90 -110.14 -57.81 2.15 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.12 -0.987 . . . . 0.0 111.206 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.459 HG23 ' CE2' ' A' ' 64' ' ' PHE . 6.2 t -46.68 -72.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.385 -1.447 . . . . 0.0 108.965 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.7 t -137.65 133.2 34.02 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.415 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.27 -178.75 2.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.986 -1.071 . . . . 0.0 110.483 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.517 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 6.3 m-85 -93.13 128.46 39.06 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -71.76 -173.69 1.03 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.076 -1.015 . . . . 0.0 109.724 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.67 -19.69 65.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.099 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.5 p -84.09 -9.17 58.81 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.365 -0.835 . . . . 0.0 108.92 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.97 19.69 58.94 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -105.2 140.59 38.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.319 -1.106 . . . . 0.0 109.075 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -74.12 123.0 23.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 110.167 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -155.31 132.2 10.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.93 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -61.76 146.18 50.2 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.171 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.473 HD11 ' CE ' ' A' ' 80' ' ' LYS . 6.9 tp -100.47 6.05 44.28 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.229 -0.919 . . . . 0.0 109.669 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.452 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.3 OUTLIER -72.57 -38.57 67.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.883 -1.136 . . . . 0.0 110.072 -179.178 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.94 -15.91 25.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.163 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.473 ' CE ' HD11 ' A' ' 77' ' ' LEU . 29.2 ttpt -102.79 -35.2 8.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 109.312 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.433 HD22 ' CH2' ' A' ' 107' ' ' TRP . 41.7 tp -131.9 123.36 27.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -82.0 83.72 7.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.919 -1.113 . . . . 0.0 109.248 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.3 mt -76.86 140.99 40.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.061 -1.024 . . . . 0.0 110.144 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.4 p -128.32 158.07 39.23 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.509 -0.744 . . . . 0.0 109.303 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 54.74 50.14 16.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 0.0 109.656 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.7 mt -78.48 132.63 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 109.818 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.5 mm -116.02 118.3 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.43 -0.794 . . . . 0.0 109.386 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 41.7 mtp -124.72 109.8 13.57 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.146 -0.971 . . . . 0.0 109.804 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.68 101.85 9.71 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.365 -0.835 . . . . 0.0 108.839 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.485 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 52.1 m170 -70.02 -38.63 75.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.022 -1.049 . . . . 0.0 110.628 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -60.53 -45.39 94.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.971 -1.081 . . . . 0.0 109.513 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -86.19 -6.11 59.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 0.0 109.135 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.485 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.6 m-20 54.72 47.89 21.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.388 -0.82 . . . . 0.0 110.237 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.593 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 1.9 t -133.87 139.45 46.21 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.983 -1.073 . . . . 0.0 109.409 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -128.05 140.13 52.14 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.49 -0.756 . . . . 0.0 110.055 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.593 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 73.5 m-85 -136.32 146.64 46.82 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.261 -0.9 . . . . 0.0 109.249 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 64.0 m -149.6 151.66 34.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.072 -1.018 . . . . 0.0 109.223 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 -101.35 132.52 46.87 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.038 -1.039 . . . . 0.0 109.341 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.471 HD21 HD13 ' A' ' 48' ' ' ILE . 86.4 mt -90.51 137.45 27.34 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.379 -0.826 . . . . 0.0 109.599 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.842 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 76.7 Cg_exo -46.24 163.89 0.1 OUTLIER 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.816 1.678 . . . . 0.0 111.296 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 93.4 p -73.68 -12.1 60.62 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.089 -1.007 . . . . 0.0 109.65 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.9 tp -137.31 130.27 30.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.086 -1.009 . . . . 0.0 110.609 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.2 mt -145.01 102.34 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.3 m -97.11 -6.51 34.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 0.0 109.847 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -83.69 154.74 23.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.999 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -105.55 33.35 3.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.35 -0.844 . . . . 0.0 109.241 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.433 ' CH2' HD22 ' A' ' 81' ' ' LEU . 23.6 p-90 -65.31 153.54 40.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.142 -0.974 . . . . 0.0 110.505 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -132.45 154.38 49.93 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.641 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 33.4 p90 -152.69 159.34 43.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.113 -0.992 . . . . 0.0 108.666 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 4.2 p90 -150.7 159.05 44.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.779 -1.2 . . . . 0.0 111.742 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 88.9 m -123.22 155.66 36.68 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 122' ' ' VAL . 41.9 t -129.97 141.97 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.759 -1.213 . . . . 0.0 111.768 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 76.3 m -120.49 131.39 54.7 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.9 p -169.56 171.84 7.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.272 -1.518 . . . . 0.0 111.653 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.47 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 51.9 mttm -148.59 165.23 31.88 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 54.4 p-10 -57.62 150.48 19.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.854 -1.154 . . . . 0.0 109.067 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 116' ' ' ASP . 64.3 t30 42.71 60.62 2.36 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.203 -0.935 . . . . 0.0 109.763 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 44.6 mt-10 -161.74 141.8 10.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.221 -0.924 . . . . 0.0 110.305 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -54.58 147.07 14.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.161 -0.962 . . . . 0.0 108.953 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.424 ' H ' ' HG2' ' A' ' 120' ' ' LYS . 15.7 pttt -98.81 140.44 33.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.211 -0.93 . . . . 0.0 110.36 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.7 mt -111.27 124.51 52.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.567 -0.708 . . . . 0.0 109.251 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 112' ' ' VAL . 42.4 t -109.56 130.72 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.947 -1.095 . . . . 0.0 110.469 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -109.33 121.76 45.88 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 38' ' ' CYS . 7.2 t -136.97 141.81 42.6 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.927 -1.108 . . . . 0.0 112.123 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -135.74 159.1 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -123.58 142.91 50.58 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.129 -0.982 . . . . 0.0 110.389 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.319 179.748 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.6 mttp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.0 t -86.2 135.78 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.915 . . . . 0.0 110.031 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -71.05 129.51 39.15 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.571 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 168.11 -163.25 37.0 Favored Glycine 0 N--CA 1.483 1.798 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.98 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -129.08 135.09 48.44 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.461 -1.023 . . . . 0.0 109.779 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.446 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 39.5 t0 -114.51 109.41 18.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.447 -0.783 . . . . 0.0 109.302 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -89.23 3.26 52.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.161 -0.962 . . . . 0.0 108.807 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.6 m -98.21 -20.7 17.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.409 -0.807 . . . . 0.0 110.586 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 12' ' ' GLU . 17.2 m -156.65 126.64 6.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.881 -1.137 . . . . 0.0 110.263 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 t -59.08 -31.88 69.29 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.459 ' H ' HG22 ' A' ' 10' ' ' THR . 97.1 mt-10 -112.64 73.89 0.84 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -66.62 148.57 51.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.34 -0.85 . . . . 0.0 110.29 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.6 t -98.35 0.55 45.67 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.6 pt -123.86 -20.73 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.658 -0.651 . . . . 0.0 110.243 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.448 ' CZ ' ' N ' ' A' ' 50' ' ' PHE . 56.6 m-85 -119.59 137.81 53.62 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.304 -0.872 . . . . 0.0 109.999 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.1 t -65.99 -16.81 64.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.635 -0.666 . . . . 0.0 110.819 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -132.71 144.11 50.07 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.04 -1.038 . . . . 0.0 110.68 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.446 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -159.38 171.72 35.9 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.382 -1.07 . . . . 0.0 109.682 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.1 mm . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.468 HG22 ' HB ' ' A' ' 122' ' ' VAL . 51.8 t -116.21 128.33 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.469 -0.77 . . . . 0.0 110.13 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 74.8 m -101.99 101.82 12.27 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.5 m -93.61 119.84 33.14 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.266 -0.896 . . . . 0.0 109.673 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.481 ' CG2' HG12 ' A' ' 125' ' ' VAL . 27.0 m -141.12 153.77 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.544 -0.723 . . . . 0.0 109.12 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -99.79 134.95 41.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.989 -1.069 . . . . 0.0 109.488 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.68 159.58 14.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.324 -0.86 . . . . 0.0 109.549 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.452 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 21.3 t-80 -133.11 150.88 52.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.908 . . . . 0.0 109.445 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.98 -23.95 5.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.256 -0.903 . . . . 0.0 109.805 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -104.03 -25.87 12.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -0.925 . . . . 0.0 109.732 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 84.6 m-20 -73.03 134.58 44.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.324 -0.86 . . . . 0.0 109.954 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -80.42 147.93 30.77 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.552 HD13 HD21 ' A' ' 99' ' ' LEU . 45.9 pt -120.34 142.31 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.219 -0.926 . . . . 0.0 110.128 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.58 -172.65 45.39 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.448 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 45.7 p90 -172.42 172.08 4.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.965 -1.314 . . . . 0.0 109.724 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -146.15 144.82 30.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.207 -0.933 . . . . 0.0 109.864 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 85.3 m -123.2 151.94 62.97 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.419 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.45 146.95 23.8 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.287 1.992 . . . . 0.0 111.929 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.3 t -68.47 -13.21 62.15 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.463 -0.773 . . . . 0.0 110.838 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -91.24 -1.48 57.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.935 -1.103 . . . . 0.0 110.324 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.419 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 20.0 m-85 -108.95 164.36 12.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.251 -0.906 . . . . 0.0 110.422 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.9 t -104.72 134.95 47.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.35 -0.844 . . . . 0.0 108.996 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.8 m -90.44 123.36 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.958 -1.089 . . . . 0.0 110.223 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 112' ' ' VAL . 26.3 mt-10 -127.81 126.22 23.82 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.06 114.32 3.57 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 121.688 1.592 . . . . 0.0 112.16 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 68' ' ' PHE . 7.3 t-160 -93.07 -24.84 18.17 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.6 t0 -170.21 39.76 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 98.6 m -63.02 -153.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.44 -0.788 . . . . 0.0 109.733 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.9 p90 -111.17 -56.42 2.37 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.246 -0.909 . . . . 0.0 111.359 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 66' ' ' SER . 16.2 t -48.51 -72.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.362 -1.461 . . . . 0.0 108.848 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.447 ' N ' HG12 ' A' ' 65' ' ' VAL . 33.3 t -138.89 131.29 28.58 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -173.42 -179.42 1.88 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.999 -1.063 . . . . 0.0 110.483 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.507 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 6.2 m-85 -93.45 127.65 39.18 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -73.95 -172.36 1.31 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.115 -0.99 . . . . 0.0 109.671 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.8 mt -63.62 -22.53 66.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 109.122 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.0 p -82.5 -7.41 59.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 108.875 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.93 18.47 67.53 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -101.48 140.72 35.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.253 -1.145 . . . . 0.0 108.989 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -80.6 115.9 20.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.297 -0.877 . . . . 0.0 110.133 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -152.65 139.64 19.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 109.767 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -63.3 148.56 47.94 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.156 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 77' ' ' LEU . 14.0 tp -97.59 7.94 45.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.306 -0.871 . . . . 0.0 109.817 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -68.65 -40.47 80.2 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.845 -1.159 . . . . 0.0 110.049 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 52.0 t-20 -62.39 -33.99 75.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.019 -1.051 . . . . 0.0 109.108 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -74.42 -48.87 25.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.888 . . . . 0.0 109.56 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.47 HD11 ' HG2' ' A' ' 100' ' ' PRO . 48.5 tp -139.29 124.74 19.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.459 -0.776 . . . . 0.0 109.161 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -81.19 90.13 6.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.046 -1.033 . . . . 0.0 109.734 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.2 mt -75.26 149.96 38.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 109.972 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.9 p -127.24 159.97 32.72 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.469 -0.769 . . . . 0.0 109.203 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 m120 55.69 52.77 10.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.92 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -81.77 132.98 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.379 -0.826 . . . . 0.0 110.009 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.3 mm -122.48 122.65 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.521 -0.737 . . . . 0.0 109.21 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 91.0 mtp -122.24 102.91 8.41 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.154 -0.966 . . . . 0.0 109.757 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -111.98 100.62 9.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.304 -0.873 . . . . 0.0 109.037 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.491 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 76.3 m80 -73.28 -35.02 66.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.002 -1.061 . . . . 0.0 110.64 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -60.67 -46.59 89.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.009 -1.057 . . . . 0.0 109.646 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -88.48 -3.89 58.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.138 -0.976 . . . . 0.0 109.07 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 97.3 m-20 54.57 47.28 23.04 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 0.0 110.144 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.594 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 2.3 t -132.65 138.0 47.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.229 -0.919 . . . . 0.0 109.36 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -127.91 139.71 52.44 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.392 -0.818 . . . . 0.0 110.103 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.594 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 58.3 m-85 -136.2 146.88 47.3 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.279 -0.888 . . . . 0.0 109.245 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.4 t -151.46 152.92 33.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.978 . . . . 0.0 109.143 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -108.37 137.43 46.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.341 -0.849 . . . . 0.0 109.36 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.61 ' HB3' HD11 ' A' ' 103' ' ' ILE . 40.8 mt -93.24 141.1 23.57 Favored Pre-proline 0 N--CA 1.491 1.624 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.603 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.47 ' HG2' HD11 ' A' ' 81' ' ' LEU . 78.3 Cg_exo -46.54 159.49 0.29 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.781 1.654 . . . . 0.0 111.206 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.2 p -68.71 -16.52 63.84 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.254 -0.904 . . . . 0.0 109.772 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.2 tp -123.37 131.44 53.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.408 -0.808 . . . . 0.0 110.502 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.61 HD11 ' HB3' ' A' ' 99' ' ' LEU . 64.6 mt -143.07 126.03 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.4 m -139.16 52.99 1.75 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.955 -1.091 . . . . 0.0 109.782 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.519 ' O ' ' OXT' ' A' ' 127' ' ' ALA . 54.6 t0 -145.99 153.33 40.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.957 . . . . 0.0 110.026 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.491 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 99.0 m-20 -91.93 33.03 1.07 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.39 -0.819 . . . . 0.0 108.912 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.52 ' NE1' ' HB3' ' A' ' 127' ' ' ALA . 7.8 p-90 -64.57 154.33 36.53 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.135 -0.978 . . . . 0.0 110.494 -178.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.52 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 53.7 tttp -145.39 151.42 38.23 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.611 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 30.2 p90 -155.45 164.48 38.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.077 -1.014 . . . . 0.0 108.621 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.501 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 8.0 p90 -154.63 159.07 40.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.717 -1.239 . . . . 0.0 111.861 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 80.7 m -123.25 156.24 35.59 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.483 HG22 HG22 ' A' ' 122' ' ' VAL . 46.4 t -129.3 141.21 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 120.874 -1.141 . . . . 0.0 111.693 -178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 35.1 m -122.25 131.73 54.07 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.0 p -172.12 179.04 2.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.243 -1.536 . . . . 0.0 111.565 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.468 ' HZ2' ' CB ' ' A' ' 115' ' ' LYS . 6.3 mtmp? -153.09 167.32 29.63 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 117' ' ' ASN . 99.9 m-20 -58.84 152.14 19.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.782 -1.199 . . . . 0.0 109.001 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.475 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 56.8 t-20 39.77 59.53 1.86 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.462 -0.774 . . . . 0.0 109.683 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 54.0 mm-40 -158.46 139.9 13.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.374 -0.829 . . . . 0.0 110.551 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -52.98 140.43 24.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 0.0 108.873 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -92.88 139.12 30.86 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.462 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.3 mt -110.04 122.77 48.35 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.483 HG22 HG22 ' A' ' 112' ' ' VAL . 43.6 t -107.25 129.47 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.049 -1.032 . . . . 0.0 110.625 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.412 ' CE1' ' HB3' ' A' ' 50' ' ' PHE . 21.5 t80 -106.95 119.07 38.35 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.52 ' OG1' ' NZ ' ' A' ' 108' ' ' LYS . 6.3 t -136.11 140.21 43.54 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.997 -1.064 . . . . 0.0 112.119 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.611 ' CG2' ' CE2' ' A' ' 109' ' ' PHE . 3.0 m -136.06 156.81 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -136.18 155.47 50.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.088 -1.007 . . . . 0.0 110.291 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.52 ' HB3' ' NE1' ' A' ' 107' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.355 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.7 t -95.19 134.88 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.279 -0.888 . . . . 0.0 110.061 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -68.96 123.09 20.07 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.017 -1.052 . . . . 0.0 108.617 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.54 179.66 47.83 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.9 t -119.15 130.04 55.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.523 -0.986 . . . . 0.0 109.318 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.419 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 40.2 t0 -106.3 109.12 20.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.572 -0.705 . . . . 0.0 109.326 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -89.62 1.51 55.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.322 -0.861 . . . . 0.0 108.939 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.3 m -103.29 -17.03 15.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.477 -0.765 . . . . 0.0 110.514 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.552 HG22 ' H ' ' A' ' 12' ' ' GLU . 74.8 m -156.93 126.02 5.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.814 -1.179 . . . . 0.0 110.387 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.6 t -64.1 -28.19 69.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.37 -0.831 . . . . 0.0 108.937 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.552 ' H ' HG22 ' A' ' 10' ' ' THR . 79.2 mm-40 -112.68 73.77 0.83 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.1 t -68.15 150.43 48.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.806 . . . . 0.0 110.211 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.52 -0.08 41.34 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 pt -125.14 -22.03 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.712 -0.618 . . . . 0.0 110.312 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -114.19 141.47 47.48 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.279 -0.888 . . . . 0.0 110.156 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 m -74.98 -18.8 60.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.552 -0.718 . . . . 0.0 110.894 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.55 ' NZ ' ' CE1' ' A' ' 20' ' ' TYR . 61.5 tttm -129.43 140.22 51.39 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.018 -1.051 . . . . 0.0 110.577 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.419 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -155.98 164.88 32.49 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.55 ' CE1' ' NZ ' ' A' ' 18' ' ' LYS . 36.5 m-85 . . . . . 0 N--CA 1.495 1.795 0 O-C-N 121.446 -1.032 . . . . 0.0 109.745 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.7 mm . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.4 t -115.33 124.48 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 110.147 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 71.3 m -102.64 101.97 12.14 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.6 m -95.81 121.13 37.21 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.164 -0.96 . . . . 0.0 109.693 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.443 ' CG2' HG12 ' A' ' 125' ' ' VAL . 26.8 m -141.04 153.91 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.578 -0.701 . . . . 0.0 109.218 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -97.99 133.96 41.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.008 -1.058 . . . . 0.0 109.37 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.81 160.57 14.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 0.0 109.641 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.446 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 32.2 t60 -135.28 151.88 50.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.327 -0.858 . . . . 0.0 109.487 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.571 ' HB1' ' HA ' ' A' ' 101' ' ' SER . . . -51.77 -25.23 7.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 109.635 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -101.48 -27.04 13.35 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.291 -0.881 . . . . 0.0 109.817 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.446 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 86.3 m-20 -73.64 134.4 43.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.298 -0.876 . . . . 0.0 109.989 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.523 HD21 ' CZ ' ' A' ' 98' ' ' ARG . 97.3 mt -79.92 148.31 31.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 108.545 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.485 HD13 HD21 ' A' ' 99' ' ' LEU . 9.5 pt -120.4 141.5 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.24 -0.913 . . . . 0.0 109.969 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' A' ' 95' ' ' PHE . . . 176.86 -173.28 46.18 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -171.66 173.05 4.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.001 -1.293 . . . . 0.0 109.791 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -146.05 144.78 30.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 0.0 109.892 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 80.0 m -123.79 152.45 65.96 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.429 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.53 148.33 20.77 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.28 1.987 . . . . 0.0 112.005 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.4 m -71.5 -12.96 61.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.431 -0.793 . . . . 0.0 110.647 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -91.84 1.9 56.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.016 -1.053 . . . . 0.0 110.119 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.446 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 18.1 m-85 -110.09 165.26 11.88 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.266 -0.896 . . . . 0.0 110.354 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.5 t -102.92 139.75 38.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 109.012 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.6 m -97.92 125.86 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.991 -1.068 . . . . 0.0 110.199 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -132.14 129.86 21.85 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.3 113.12 3.32 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.664 1.576 . . . . 0.0 112.095 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -92.01 -27.98 17.48 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 110' ' ' PHE . 54.3 t0 -166.81 38.42 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.587 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 79.0 m -62.85 -157.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.544 -0.722 . . . . 0.0 109.77 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 3.2 p90 -111.27 -49.07 3.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.226 -0.921 . . . . 0.0 111.629 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.409 HG23 ' CD2' ' A' ' 64' ' ' PHE . 53.6 t -59.22 -48.45 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.343 -1.473 . . . . 0.0 109.286 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.5 t -157.78 128.73 6.53 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.587 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.7 -178.93 1.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.092 -1.005 . . . . 0.0 110.499 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 9.9 m-85 -93.1 124.75 37.3 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -69.28 -174.91 0.71 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.011 . . . . 0.0 109.847 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.5 mt -62.92 -23.01 67.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.316 -0.865 . . . . 0.0 108.95 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.8 m -82.36 -6.34 59.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.327 -0.858 . . . . 0.0 108.761 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.18 19.88 63.88 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -101.71 138.95 38.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.318 -1.107 . . . . 0.0 109.101 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -82.46 110.25 17.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.21 -0.931 . . . . 0.0 109.964 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -147.01 141.91 26.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.499 -0.751 . . . . 0.0 110.011 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -59.86 144.02 49.78 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.274 -0.891 . . . . 0.0 109.32 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.571 HD11 ' HD2' ' A' ' 80' ' ' LYS . 14.3 tp -97.09 8.03 45.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.202 -0.936 . . . . 0.0 109.735 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -69.67 -38.74 77.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.179 -0.951 . . . . 0.0 110.065 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 41.7 p-10 -62.43 -32.85 73.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.125 -0.984 . . . . 0.0 109.217 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.571 ' HD2' HD11 ' A' ' 77' ' ' LEU . 37.3 ttmt -71.86 -50.79 26.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.345 -0.847 . . . . 0.0 109.663 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.595 HD22 ' CZ2' ' A' ' 107' ' ' TRP . 39.0 tp -140.74 128.2 21.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.479 -0.763 . . . . 0.0 109.166 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -81.05 87.73 6.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.035 -1.041 . . . . 0.0 109.487 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.7 mt -71.66 152.99 42.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 0.0 109.928 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.6 p -128.19 163.92 23.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.562 -0.711 . . . . 0.0 109.323 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 55.44 52.24 11.59 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.265 -0.897 . . . . 0.0 109.94 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.45 128.26 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.337 -0.852 . . . . 0.0 109.985 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.1 mm -123.47 122.44 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.554 -0.716 . . . . 0.0 109.136 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 83.2 mtp -123.59 104.81 9.26 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.197 -0.94 . . . . 0.0 109.793 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -113.37 101.85 9.78 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.342 -0.849 . . . . 0.0 109.013 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.487 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 96.6 m-70 -73.14 -36.14 66.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.97 -1.081 . . . . 0.0 110.652 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -60.21 -46.32 90.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.891 -1.131 . . . . 0.0 109.623 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -89.79 -5.09 57.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.172 -0.955 . . . . 0.0 109.032 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.487 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.6 m-20 54.66 47.66 22.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.551 -0.718 . . . . 0.0 110.25 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.586 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 2.5 t -131.94 135.8 46.88 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.21 -0.931 . . . . 0.0 109.291 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.416 ' O ' ' CA ' ' A' ' 49' ' ' GLY . 76.0 m-85 -126.63 139.28 53.29 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.388 -0.82 . . . . 0.0 109.951 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.586 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 72.3 m-85 -136.15 147.3 47.66 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.349 -0.844 . . . . 0.0 109.264 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.5 t -152.9 152.59 31.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.063 -1.023 . . . . 0.0 109.189 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.523 ' CZ ' HD21 ' A' ' 47' ' ' LEU . 9.0 mtt-85 -107.41 139.29 42.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.26 -0.9 . . . . 0.0 109.856 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.485 HD21 HD13 ' A' ' 48' ' ' ILE . 38.2 mt -94.88 141.47 23.35 Favored Pre-proline 0 N--CA 1.49 1.548 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.853 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.517 ' HG2' HD11 ' A' ' 81' ' ' LEU . 77.3 Cg_exo -45.9 179.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.912 1.741 . . . . 0.0 111.162 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.571 ' HA ' ' HB1' ' A' ' 44' ' ' ALA . 73.7 m -86.08 -14.17 45.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.088 -1.008 . . . . 0.0 110.001 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.7 tp -120.99 130.22 53.72 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.276 -0.89 . . . . 0.0 110.442 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.434 HD11 ' HB3' ' A' ' 99' ' ' LEU . 7.6 mt -150.23 102.38 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 84.2 p -115.49 -0.69 13.0 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.168 -0.957 . . . . 0.0 109.748 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 52.4 t0 -87.38 158.01 19.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.57 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 92.9 m-20 -99.42 32.2 2.86 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.451 -0.781 . . . . 0.0 109.071 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.595 ' CZ2' HD22 ' A' ' 81' ' ' LEU . 10.3 p-90 -65.97 157.18 31.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.145 -0.972 . . . . 0.0 110.509 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -146.4 157.96 43.83 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.568 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 39.6 p90 -155.68 163.54 39.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.155 -0.966 . . . . 0.0 108.718 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 62' ' ' ASP . 14.3 p90 -153.73 163.07 40.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.83 -1.169 . . . . 0.0 111.877 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 95.1 m -127.73 158.93 36.3 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 122' ' ' VAL . 44.0 t -130.44 143.34 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.93 -1.106 . . . . 0.0 111.856 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 86.1 m -124.8 132.92 53.3 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.0 p -171.49 179.14 2.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.306 -1.496 . . . . 0.0 111.669 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.575 ' NZ ' ' OE2' ' A' ' 118' ' ' GLU . 6.4 mtmp? -153.09 166.15 33.36 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.62 151.7 20.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.867 -1.146 . . . . 0.0 109.245 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.49 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 64.8 t30 44.7 61.2 2.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.219 -0.926 . . . . 0.0 109.667 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.575 ' OE2' ' NZ ' ' A' ' 115' ' ' LYS . 42.5 mt-10 -164.61 145.38 7.85 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.226 -0.921 . . . . 0.0 110.26 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -60.47 146.79 43.45 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.228 -0.92 . . . . 0.0 108.937 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -93.72 141.71 28.18 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.111 -0.993 . . . . 0.0 110.394 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.1 mt -108.84 121.0 44.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.313 -0.867 . . . . 0.0 108.899 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 112' ' ' VAL . 55.4 t -108.96 130.3 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.092 -1.005 . . . . 0.0 110.577 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -110.65 122.65 48.3 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.0 t -137.68 143.94 41.56 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.029 -1.044 . . . . 0.0 112.378 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.568 ' CG2' ' CE2' ' A' ' 109' ' ' PHE . 3.0 m -135.42 158.77 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -136.83 153.91 50.66 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.058 -1.026 . . . . 0.0 110.282 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.512 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.354 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.6 t -95.06 133.36 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.97 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.419 ' N ' ' HD2' ' A' ' 4' ' ' LYS . 13.6 mptt -70.59 125.18 26.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.104 -0.998 . . . . 0.0 108.663 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.21 -179.95 42.71 Favored Glycine 0 N--CA 1.484 1.844 0 C-N-CA 119.479 -1.343 . . . . 0.0 109.79 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.9 t -116.92 134.72 54.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.402 -1.057 . . . . 0.0 109.712 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.544 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 68.1 t0 -115.81 110.66 19.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.499 -0.751 . . . . 0.0 109.332 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -87.17 3.26 47.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.94 . . . . 0.0 108.916 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.4 m -102.96 -18.85 14.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.434 -0.791 . . . . 0.0 110.549 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 12' ' ' GLU . 10.4 m -157.42 127.52 6.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.887 -1.133 . . . . 0.0 110.289 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.3 m -66.49 -27.0 67.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.408 -0.807 . . . . 0.0 109.001 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.583 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 57.9 mp0 -113.81 74.87 0.89 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 15' ' ' ILE . 26.6 m -75.97 115.87 16.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.423 -0.798 . . . . 0.0 110.578 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.406 HG23 HG23 ' A' ' 15' ' ' ILE . 7.7 t -65.39 3.2 0.71 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.524 ' H ' ' C ' ' A' ' 13' ' ' SER . 15.1 pt -122.83 -36.57 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.712 -0.618 . . . . 0.0 110.333 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.416 ' CZ ' ' CE1' ' A' ' 96' ' ' TYR . 50.9 m-85 -108.21 137.11 46.75 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.185 -0.947 . . . . 0.0 109.816 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.2 t -68.28 -18.4 64.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.593 -0.692 . . . . 0.0 111.003 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -130.58 141.42 50.46 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.953 -1.092 . . . . 0.0 110.521 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.544 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -161.83 173.55 38.2 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.38 -1.07 . . . . 0.0 109.568 -179.859 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.2 mm . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.486 HG22 ' HB ' ' A' ' 122' ' ' VAL . 50.0 t -121.03 129.62 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.303 -0.873 . . . . 0.0 110.157 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 124' ' ' THR . 84.5 m -101.26 100.12 10.59 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.8 m -95.53 120.64 36.13 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.089 -1.007 . . . . 0.0 109.412 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.61 HG22 HG12 ' A' ' 125' ' ' VAL . 3.1 m -139.05 159.44 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.526 -0.734 . . . . 0.0 109.176 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -97.77 123.71 41.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.151 -0.968 . . . . 0.0 109.594 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.441 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -90.55 155.03 19.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -0.87 . . . . 0.0 109.531 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.431 ' O ' HD12 ' A' ' 99' ' ' LEU . 35.4 t-80 -133.33 152.13 51.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -0.898 . . . . 0.0 109.553 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.751 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -57.34 -29.61 64.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.335 -0.853 . . . . 0.0 109.827 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -93.6 -26.89 16.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 109.725 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -76.68 135.6 39.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.523 -0.735 . . . . 0.0 110.043 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.1 mt -78.36 148.64 33.63 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.468 HD13 HD21 ' A' ' 99' ' ' LEU . 47.5 pt -122.36 144.83 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.331 -0.856 . . . . 0.0 110.308 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.5 -171.2 44.16 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -172.73 171.57 4.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.136 -1.214 . . . . 0.0 109.71 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -146.82 144.84 29.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 0.0 109.9 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 86.0 m -125.37 152.17 70.96 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.929 . . . . 0.0 108.54 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.472 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.4 Cg_endo -51.63 149.82 17.9 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.3 2.0 . . . . 0.0 111.944 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.0 m -70.84 -12.1 61.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -0.83 . . . . 0.0 110.682 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.448 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 82.4 m-20 -92.78 0.23 57.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.94 -1.1 . . . . 0.0 110.182 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.472 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 16.3 m-85 -108.28 164.2 12.53 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.202 -0.936 . . . . 0.0 110.364 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.9 m -103.85 128.08 51.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 109.087 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 58' ' ' VAL . 3.2 m -88.3 114.38 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.959 -1.088 . . . . 0.0 110.151 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -120.37 126.8 26.62 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.06 113.53 3.43 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 121.545 1.496 . . . . 0.0 112.106 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.491 ' O ' ' O ' ' A' ' 68' ' ' PHE . 2.8 t-80 -93.59 -23.63 18.23 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -172.26 51.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.67 ' H ' ' CB ' ' A' ' 67' ' ' ALA . 76.4 m -76.47 -151.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.63 -0.668 . . . . 0.0 109.799 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.49 ' CE2' HG23 ' A' ' 65' ' ' VAL . 6.5 p90 -110.18 -58.33 2.08 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.098 -1.001 . . . . 0.0 111.373 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.49 HG23 ' CE2' ' A' ' 64' ' ' PHE . 24.0 t -45.27 -70.35 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.627 -1.296 . . . . 0.0 108.809 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.4 t -145.58 129.36 17.23 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.67 ' CB ' ' H ' ' A' ' 63' ' ' CYS . . . -167.84 -179.78 4.38 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.373 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.534 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 4.3 m-85 -93.98 141.2 28.79 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.461 ' OD1' ' OE1' ' A' ' 75' ' ' GLU . 33.2 m120 -80.88 -169.7 2.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.955 -1.091 . . . . 0.0 109.652 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 70' ' ' LEU . 10.2 mp -67.91 -13.8 62.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 108.913 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.4 t -90.73 -7.14 53.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -0.856 . . . . 0.0 108.982 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.07 23.87 56.26 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -107.73 136.44 47.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.213 -1.169 . . . . 0.0 109.095 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -67.42 135.02 52.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.216 -0.927 . . . . 0.0 109.984 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.461 ' OE1' ' OD1' ' A' ' 69' ' ' ASN . 80.3 tt0 -155.42 166.0 34.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.437 -0.789 . . . . 0.0 109.548 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.458 ' N ' ' HG2' ' A' ' 75' ' ' GLU . 5.3 m120 -106.94 139.1 41.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.33 -0.856 . . . . 0.0 109.531 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.7 tp -95.79 -10.27 29.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.0 . . . . 0.0 110.027 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.481 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 20.5 pt-20 -62.67 -44.86 95.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.99 -1.069 . . . . 0.0 109.476 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.563 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 48.7 p30 -66.72 -22.09 66.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.138 -0.976 . . . . 0.0 108.94 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.563 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 52.6 tptt -86.74 -48.09 8.55 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.359 -0.838 . . . . 0.0 109.415 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.649 HD23 HD21 ' A' ' 83' ' ' LEU . 30.8 tp -122.89 129.95 52.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.412 -0.805 . . . . 0.0 109.174 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -78.66 82.68 4.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.032 -1.043 . . . . 0.0 109.244 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.649 HD21 HD23 ' A' ' 81' ' ' LEU . 88.8 mt -81.53 137.69 35.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.873 . . . . 0.0 110.112 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 48.1 p -127.44 163.31 24.36 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.513 -0.742 . . . . 0.0 109.278 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.5 m120 55.04 51.05 14.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.623 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.2 131.53 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.353 -0.842 . . . . 0.0 110.039 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.6 mm -121.85 121.17 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.503 -0.748 . . . . 0.0 109.277 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 79.6 mtp -123.73 107.4 11.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.21 -0.931 . . . . 0.0 109.785 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -112.57 101.27 9.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.374 -0.829 . . . . 0.0 109.082 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.448 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 76.4 m80 -71.55 -36.8 71.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.917 -1.114 . . . . 0.0 110.651 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -60.61 -45.74 92.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.022 -1.049 . . . . 0.0 109.557 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -87.91 -5.28 58.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.117 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 99.7 m-20 54.37 47.61 22.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.504 -0.747 . . . . 0.0 110.332 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.597 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 2.6 t -132.99 138.19 46.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.028 -1.045 . . . . 0.0 109.333 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -126.38 138.9 53.61 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.512 -0.742 . . . . 0.0 109.809 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.597 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 77.9 m-85 -135.41 146.15 48.0 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.115 -0.991 . . . . 0.0 109.336 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.5 p -153.03 155.69 37.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.097 -1.002 . . . . 0.0 108.986 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 98' ' ' ARG . 59.2 mtt-85 -105.11 136.68 44.16 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.264 -0.897 . . . . 0.0 109.65 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.468 HD21 HD13 ' A' ' 48' ' ' ILE . 78.1 mt -91.83 138.41 24.91 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.459 -0.776 . . . . 0.0 109.706 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.751 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 76.4 Cg_exo -45.74 175.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.83 1.686 . . . . 0.0 111.305 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.6 m -83.92 -12.93 54.66 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.077 -1.014 . . . . 0.0 109.844 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.3 tp -134.13 130.0 36.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.131 -0.981 . . . . 0.0 110.511 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 91.3 mt -147.37 102.48 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.865 . . . . 0.0 108.806 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.3 m -104.1 -6.96 20.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.072 -1.017 . . . . 0.0 109.794 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 127' ' ' ALA . 78.6 m-20 -78.41 151.65 32.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 110.022 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -100.15 31.79 3.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.391 -0.818 . . . . 0.0 109.205 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.408 ' CH2' HD22 ' A' ' 81' ' ' LEU . 20.4 p-90 -65.4 159.88 23.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.117 -0.99 . . . . 0.0 110.465 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -142.23 156.97 45.34 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.643 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 36.4 p90 -154.08 158.62 40.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.088 -1.007 . . . . 0.0 108.692 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 18.5 p90 -150.66 156.33 41.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.804 -1.185 . . . . 0.0 111.937 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 96.5 m -121.78 156.19 33.71 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 122' ' ' VAL . 51.7 t -127.71 138.43 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.77 -1.206 . . . . 0.0 111.872 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 67.0 m -123.34 132.0 53.84 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 97.5 p -165.6 171.5 13.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.121 -1.612 . . . . 0.0 111.652 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.448 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 47.6 mtpt -136.87 158.58 44.14 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -60.29 143.21 53.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.933 -1.105 . . . . 0.0 108.813 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 59.6 t-20 49.82 62.63 2.55 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.395 -0.816 . . . . 0.0 109.09 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 63.3 mm-40 -165.11 149.66 9.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.177 -0.952 . . . . 0.0 110.71 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -55.18 136.92 48.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.251 -0.905 . . . . 0.0 108.974 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -88.41 140.41 29.5 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.18 -0.95 . . . . 0.0 110.322 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 70.8 mt -109.16 122.03 46.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.432 -0.793 . . . . 0.0 109.136 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 112' ' ' VAL . 47.2 t -111.02 131.36 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.075 -1.016 . . . . 0.0 110.492 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -107.58 118.59 37.12 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 38' ' ' CYS . 7.3 t -136.6 141.43 43.27 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.868 -1.145 . . . . 0.0 111.967 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.643 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 2.8 m -137.37 160.34 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -128.81 149.04 50.9 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.094 -1.004 . . . . 0.0 110.264 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.353 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.8 t -95.32 135.36 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.324 -0.86 . . . . 0.0 109.89 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -67.99 121.31 15.81 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.0 108.6 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.71 175.04 45.45 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.425 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 5.0 t -116.08 130.02 56.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.415 -1.05 . . . . 0.0 109.465 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.478 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 42.6 t0 -104.82 108.51 20.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.533 -0.729 . . . . 0.0 109.214 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -89.29 0.24 56.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.889 . . . . 0.0 108.93 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.4 m -102.33 -17.17 16.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.568 -0.707 . . . . 0.0 110.414 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.445 HG22 ' H ' ' A' ' 12' ' ' GLU . 8.0 m -156.87 126.7 6.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.801 -1.187 . . . . 0.0 110.229 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.2 p -64.06 -27.63 69.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 108.858 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.445 ' H ' HG22 ' A' ' 10' ' ' THR . 97.3 mt-10 -114.77 76.87 1.02 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 88.1 p -71.75 153.37 42.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.395 -0.815 . . . . 0.0 110.224 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.15 1.1 35.72 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.6 pt -123.61 -24.03 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.632 -0.667 . . . . 0.0 110.29 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.507 ' O ' ' OG ' ' A' ' 13' ' ' SER . 63.3 m-85 -114.91 140.87 48.63 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.093 -1.005 . . . . 0.0 110.093 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.1 p -69.04 -17.81 63.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.403 -0.811 . . . . 0.0 110.614 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -129.58 139.86 51.36 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.921 -1.112 . . . . 0.0 110.458 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.478 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -150.37 162.95 29.43 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.425 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 36.5 m-85 . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.371 -1.076 . . . . 0.0 109.568 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 mm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.453 HG22 ' HB ' ' A' ' 122' ' ' VAL . 56.1 t -123.29 129.17 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.364 -0.835 . . . . 0.0 110.31 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 85.1 m -102.08 101.61 11.98 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.4 m -97.03 122.31 39.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.057 -1.027 . . . . 0.0 109.649 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.619 ' CG2' HG12 ' A' ' 125' ' ' VAL . 19.0 m -138.91 158.02 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.437 -0.789 . . . . 0.0 109.079 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -97.06 119.95 36.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.135 -0.978 . . . . 0.0 109.517 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.41 156.43 17.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.362 -0.836 . . . . 0.0 109.592 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.413 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 39.9 t60 -131.26 152.37 50.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.829 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -56.02 -26.18 47.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.282 -0.886 . . . . 0.0 109.797 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -99.06 -24.75 14.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -0.95 . . . . 0.0 109.626 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 98.5 m-20 -74.67 137.17 42.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.512 -0.743 . . . . 0.0 110.002 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.9 mt -78.83 146.53 33.64 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 99' ' ' LEU . 45.4 pt -121.83 144.3 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.095 -1.003 . . . . 0.0 110.28 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.17 -173.46 46.26 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -171.18 170.94 5.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.038 -1.272 . . . . 0.0 109.794 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -147.04 145.44 29.68 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.343 -0.848 . . . . 0.0 109.864 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 86.4 m -125.22 151.4 69.45 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 108.815 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.48 154.1 9.3 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.43 2.086 . . . . 0.0 111.977 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.7 m -72.24 -10.5 59.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.496 -0.753 . . . . 0.0 110.711 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.536 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 78.7 m-20 -93.29 -3.68 53.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.95 -1.094 . . . . 0.0 110.245 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.476 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 15.4 m-85 -105.92 160.63 15.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.246 -0.909 . . . . 0.0 110.08 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -101.33 132.69 46.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.47 -0.768 . . . . 0.0 109.328 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.6 m -88.59 118.31 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.109 -0.994 . . . . 0.0 110.219 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -126.93 127.04 24.47 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.13 113.51 3.42 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 121.631 1.554 . . . . 0.0 112.131 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.484 ' O ' ' O ' ' A' ' 68' ' ' PHE . 9.6 t-160 -91.4 -25.57 19.29 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.475 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.3 t0 -169.48 38.94 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.422 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 81.8 m -62.56 -154.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.601 -0.687 . . . . 0.0 109.717 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.544 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.1 p90 -109.96 -59.28 1.95 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.061 -1.024 . . . . 0.0 111.359 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.464 ' C ' ' O ' ' A' ' 64' ' ' PHE . 25.3 t -44.75 -73.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.67 -1.269 . . . . 0.0 108.788 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.422 ' N ' HG12 ' A' ' 65' ' ' VAL . 43.0 t -138.2 131.13 29.84 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.422 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -171.98 179.1 2.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.876 -1.14 . . . . 0.0 110.458 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 5.2 m-85 -93.84 126.18 38.89 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -71.74 -170.79 0.59 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.976 -1.078 . . . . 0.0 109.823 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 70' ' ' LEU . 10.8 mp -65.07 -19.72 66.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.191 -0.943 . . . . 0.0 109.038 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.6 m -83.49 -7.97 59.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.343 -0.848 . . . . 0.0 108.843 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.5 19.15 66.9 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -103.79 137.05 42.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.342 -1.093 . . . . 0.0 109.139 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -76.38 113.85 14.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.279 -0.888 . . . . 0.0 110.073 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -144.56 131.56 20.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.333 -0.855 . . . . 0.0 110.04 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -59.98 145.18 47.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.145 -0.972 . . . . 0.0 109.303 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.3 tp -100.2 -0.9 37.82 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.588 -0.695 . . . . 0.0 110.088 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -67.03 -42.35 85.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.222 -0.924 . . . . 0.0 109.85 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -63.77 -21.94 66.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.995 . . . . 0.0 109.023 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -86.86 -46.82 9.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.46 -0.775 . . . . 0.0 109.342 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.542 HD23 HD21 ' A' ' 83' ' ' LEU . 38.8 tp -124.62 127.89 48.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.492 -0.755 . . . . 0.0 109.171 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -77.17 83.48 3.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.966 -1.084 . . . . 0.0 109.235 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.576 HD22 ' OG ' ' A' ' 97' ' ' SER . 83.1 mt -81.22 139.37 35.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.414 -0.804 . . . . 0.0 110.027 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.8 p -128.0 160.76 30.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.558 -0.714 . . . . 0.0 109.247 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 55.02 50.1 16.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.302 -0.874 . . . . 0.0 109.472 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.4 mt -78.91 131.97 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 110.093 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.3 mm -119.6 120.08 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.456 -0.778 . . . . 0.0 109.329 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 93.8 mtp -122.09 105.06 9.93 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.058 -1.026 . . . . 0.0 109.785 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -112.5 101.16 9.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.337 -0.852 . . . . 0.0 109.067 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -76.68 -31.72 57.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.217 -0.927 . . . . 0.0 110.49 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -59.97 -46.96 87.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.799 -1.188 . . . . 0.0 109.645 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -90.23 3.01 54.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.157 -0.965 . . . . 0.0 109.1 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 51.96 46.8 25.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.479 -0.763 . . . . 0.0 110.13 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.475 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 3.5 t -132.6 137.73 47.15 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.997 -1.064 . . . . 0.0 109.475 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -128.91 140.02 51.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.477 -0.764 . . . . 0.0 109.974 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.475 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 78.4 m-85 -135.14 146.71 49.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.154 -0.966 . . . . 0.0 109.477 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.576 ' OG ' HD22 ' A' ' 83' ' ' LEU . 32.4 t -149.82 149.39 30.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.024 -1.047 . . . . 0.0 109.157 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.412 ' HG2' HH11 ' A' ' 98' ' ' ARG . 60.3 mtt-85 -102.17 134.48 45.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.074 -1.016 . . . . 0.0 109.5 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 48' ' ' ILE . 87.5 mt -92.69 139.21 23.49 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.486 -0.759 . . . . 0.0 109.625 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.829 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 78.2 Cg_exo -45.81 170.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.851 1.701 . . . . 0.0 111.284 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.9 m -79.93 -12.24 59.74 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.098 -1.001 . . . . 0.0 109.778 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.3 tp -135.39 131.17 35.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.256 -0.902 . . . . 0.0 110.573 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 87.0 mt -147.54 102.27 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.8 t -99.73 -3.88 31.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.861 -1.149 . . . . 0.0 109.897 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 127' ' ' ALA . 84.7 m-20 -83.7 154.63 23.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.958 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -104.21 33.17 3.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.389 -0.819 . . . . 0.0 109.161 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 18.4 p-90 -65.33 152.06 44.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.932 . . . . 0.0 110.462 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -130.82 150.97 51.74 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.644 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 25.2 p90 -150.17 159.66 44.25 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.042 -1.036 . . . . 0.0 108.693 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.501 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 6.0 p90 -152.87 159.06 43.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.773 -1.205 . . . . 0.0 111.819 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 99.4 m -123.18 156.02 35.92 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.59 HG22 HG22 ' A' ' 122' ' ' VAL . 42.4 t -129.19 140.86 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.866 -1.147 . . . . 0.0 111.794 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 70.2 m -121.65 131.46 54.11 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.6 p -170.82 176.11 4.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.232 -1.542 . . . . 0.0 111.704 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.536 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 51.5 mttm -151.57 166.46 31.11 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 117' ' ' ASN . 98.6 m-20 -57.59 151.54 16.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.757 -1.214 . . . . 0.0 109.17 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 116' ' ' ASP . 66.7 t30 42.43 61.47 2.01 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.209 -0.932 . . . . 0.0 109.816 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 43.6 mt-10 -161.76 140.84 9.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.103 -0.998 . . . . 0.0 110.21 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -55.02 138.75 43.17 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.171 -0.955 . . . . 0.0 109.326 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -87.35 139.93 30.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.302 -0.874 . . . . 0.0 110.387 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.3 mt -110.12 122.27 47.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.473 -0.767 . . . . 0.0 109.024 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.59 HG22 HG22 ' A' ' 112' ' ' VAL . 51.6 t -110.69 131.76 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.04 -1.038 . . . . 0.0 110.664 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.405 ' CZ ' ' CG1' ' A' ' 125' ' ' VAL . 23.9 t80 -110.22 122.53 47.87 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.0 t -137.54 142.45 41.4 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 119.059 -1.057 . . . . 0.0 111.969 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.644 ' CG2' ' CE2' ' A' ' 109' ' ' PHE . 3.0 m -137.53 154.52 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -122.87 147.6 46.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.201 -0.937 . . . . 0.0 110.366 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.329 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 mmtp . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.8 t -97.64 132.19 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.256 -0.903 . . . . 0.0 109.873 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -68.01 121.42 16.05 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.175 -0.953 . . . . 0.0 108.648 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.29 172.4 43.45 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.9 t -113.66 129.36 56.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.384 -1.068 . . . . 0.0 109.329 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.441 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 40.3 t0 -101.97 108.67 20.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.508 -0.745 . . . . 0.0 109.252 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.476 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 96.8 m-85 -89.75 -1.29 57.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.018 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.1 m -103.0 -16.0 15.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.594 -0.691 . . . . 0.0 110.511 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.569 HG22 ' H ' ' A' ' 12' ' ' GLU . 39.0 m -157.9 126.25 5.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.756 -1.215 . . . . 0.0 110.152 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.9 p -66.07 -26.01 67.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.97 . . . . 0.0 108.921 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.569 ' H ' HG22 ' A' ' 10' ' ' THR . 79.4 mm-40 -114.07 74.16 0.86 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.8 p -71.25 154.15 41.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 110.24 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.407 HG23 HG23 ' A' ' 15' ' ' ILE . 14.8 t -101.86 0.96 36.43 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.407 HG23 HG23 ' A' ' 14' ' ' THR . 5.5 pt -125.28 -26.47 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.643 -0.661 . . . . 0.0 110.243 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.405 ' CD2' HG13 ' A' ' 15' ' ' ILE . 72.3 m-85 -105.37 143.53 33.41 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.028 -1.045 . . . . 0.0 109.887 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.9 m -70.37 -18.09 63.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.542 -0.724 . . . . 0.0 110.765 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' NZ ' HG12 ' A' ' 40' ' ' VAL . 53.3 mtmt -144.33 156.52 44.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.75 -1.219 . . . . 0.0 110.775 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.441 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -158.78 169.24 35.09 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.199 -1.177 . . . . 0.0 109.646 -179.754 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.7 mm . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.0 t -117.07 127.83 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.153 -0.967 . . . . 0.0 110.182 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.476 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 96.7 m -102.45 100.62 10.76 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 65.6 m -94.4 120.24 34.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.016 -1.053 . . . . 0.0 109.645 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.453 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 27.5 m -141.3 156.11 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.161 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -98.11 133.96 41.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.171 -0.955 . . . . 0.0 109.445 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.439 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -102.0 150.35 23.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.052 -1.03 . . . . 0.0 109.63 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.519 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 29.8 t60 -120.0 152.52 37.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.363 -0.836 . . . . 0.0 109.551 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.34 -25.59 35.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 109.917 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -99.78 -21.63 15.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.118 -0.989 . . . . 0.0 109.714 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.519 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 81.4 m-20 -77.85 138.02 38.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.501 -0.749 . . . . 0.0 109.998 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.2 mt -79.39 148.9 31.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 108.703 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.404 HG21 HD11 ' A' ' 99' ' ' LEU . 42.6 pt -120.4 141.73 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.969 -1.082 . . . . 0.0 110.214 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.67 -178.3 47.96 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.43 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 55.2 p90 -164.0 170.08 17.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.118 -1.224 . . . . 0.0 109.736 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -144.08 142.87 30.87 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.354 -0.841 . . . . 0.0 109.772 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 82.4 m -122.79 151.83 61.34 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.445 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.46 145.75 27.71 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.289 1.993 . . . . 0.0 111.893 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.3 t -67.88 -14.57 63.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.464 -0.772 . . . . 0.0 110.624 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.587 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.4 m-20 -90.2 1.5 56.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.889 -1.132 . . . . 0.0 110.087 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.454 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 19.1 m-85 -111.11 166.75 10.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.6 m -103.6 139.98 38.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.398 -0.814 . . . . 0.0 109.315 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.7 m -97.55 120.35 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.94 -1.1 . . . . 0.0 110.311 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -127.19 126.68 24.29 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.0 113.81 3.49 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.732 1.622 . . . . 0.0 112.235 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -93.1 -24.8 18.15 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.7 t0 -168.89 36.26 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.412 ' O ' ' O ' ' A' ' 62' ' ' ASP . 88.7 m -59.44 -155.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.499 -0.751 . . . . 0.0 109.893 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.466 ' O ' ' C ' ' A' ' 65' ' ' VAL . 3.9 p90 -110.0 -59.07 1.98 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.953 -1.092 . . . . 0.0 111.246 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.483 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 36.6 t -43.95 -73.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.678 -1.264 . . . . 0.0 108.858 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.2 t -139.25 131.98 29.05 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -172.94 -178.48 1.83 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.879 -1.138 . . . . 0.0 110.457 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.502 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 6.6 m-85 -92.27 126.25 37.27 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -73.34 -172.49 1.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.136 -0.978 . . . . 0.0 109.763 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.522 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.8 mm? -64.22 -22.16 66.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.33 -0.856 . . . . 0.0 109.102 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 89.4 p -82.57 -7.37 59.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.889 . . . . 0.0 108.83 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.69 17.95 66.97 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -100.43 139.68 35.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -1.18 . . . . 0.0 109.184 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -82.07 109.46 16.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.174 -0.954 . . . . 0.0 109.934 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -143.88 137.57 27.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.863 . . . . 0.0 110.004 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 77' ' ' LEU . 62.0 t-20 -60.12 145.85 45.31 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.171 -0.956 . . . . 0.0 109.403 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.512 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 14.0 tp -99.07 6.56 46.51 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.359 -0.838 . . . . 0.0 109.829 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.44 ' CD ' ' N ' ' A' ' 79' ' ' ASN . 2.3 pp20? -69.69 -40.33 76.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.104 -0.997 . . . . 0.0 109.896 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.605 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 43.4 p30 -63.37 -27.69 69.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.155 -0.966 . . . . 0.0 109.12 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.605 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 50.9 tptt -78.26 -50.44 11.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.458 -0.776 . . . . 0.0 109.343 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.538 HD11 ' HG2' ' A' ' 100' ' ' PRO . 38.0 tp -130.39 130.53 44.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.512 -0.742 . . . . 0.0 109.191 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -81.32 84.53 6.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.13 -0.981 . . . . 0.0 109.408 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 86.4 mt -76.67 143.68 39.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -0.828 . . . . 0.0 109.888 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.1 p -127.67 161.81 28.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.509 -0.745 . . . . 0.0 109.299 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 55.44 51.83 12.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -0.952 . . . . 0.0 109.652 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.4 mt -80.39 130.59 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.397 -0.815 . . . . 0.0 110.047 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.5 mm -118.68 120.26 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.447 -0.783 . . . . 0.0 109.139 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 84.2 mtp -121.15 101.26 7.54 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.082 -1.011 . . . . 0.0 109.834 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -110.29 100.22 9.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.264 -0.898 . . . . 0.0 108.896 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.479 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 93.0 m-70 -72.34 -36.49 68.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.971 -1.081 . . . . 0.0 110.655 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -60.4 -46.18 90.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.94 -1.1 . . . . 0.0 109.631 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -88.59 -4.98 58.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -0.923 . . . . 0.0 109.119 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.7 m-20 54.37 47.94 21.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.517 -0.739 . . . . 0.0 110.283 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.598 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 1.8 t -133.41 140.01 47.08 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.025 -1.047 . . . . 0.0 109.463 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 66.4 m-85 -129.04 140.03 51.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.463 -0.773 . . . . 0.0 109.959 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.598 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 82.1 m-85 -138.08 148.89 45.48 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.261 -0.899 . . . . 0.0 109.479 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.3 p -154.54 158.02 39.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.142 -0.974 . . . . 0.0 109.215 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -104.01 136.37 43.78 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.166 -0.959 . . . . 0.0 109.399 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 100' ' ' PRO . 36.4 mt -89.69 136.66 29.21 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 109.635 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.538 ' HG2' HD11 ' A' ' 81' ' ' LEU . 77.6 Cg_exo -45.75 177.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.863 1.708 . . . . 0.0 111.211 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 87.7 p -87.39 -15.3 38.23 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.064 -1.022 . . . . 0.0 109.839 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' A' ' 102' ' ' LEU . 52.2 tp -127.37 128.85 46.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.156 -0.965 . . . . 0.0 110.311 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.8 mt -150.22 107.77 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.206 -0.934 . . . . 0.0 108.676 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 81.5 p -118.44 -1.56 11.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.06 -1.025 . . . . 0.0 109.773 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 9.0 p30 -82.67 154.5 24.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.052 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -95.61 34.08 1.54 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.504 -0.748 . . . . 0.0 109.037 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.464 ' CZ3' ' CD1' ' A' ' 109' ' ' PHE . 10.0 p-90 -63.21 154.16 32.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 110.379 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -142.69 149.65 39.11 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.62 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 33.5 p90 -154.46 163.74 39.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.125 -0.984 . . . . 0.0 108.784 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 7.3 p90 -154.44 160.04 41.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.846 -1.159 . . . . 0.0 111.705 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 67.8 m -123.35 155.99 36.25 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.656 HG22 HG22 ' A' ' 122' ' ' VAL . 46.0 t -129.36 140.87 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.878 -1.139 . . . . 0.0 111.756 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 98.4 m -124.66 133.37 53.25 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 72.6 p -170.49 179.23 3.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.239 -1.538 . . . . 0.0 111.665 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.587 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 49.7 mtmt -151.61 162.59 40.73 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 117' ' ' ASN . 97.9 m-20 -57.81 152.19 16.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.816 -1.178 . . . . 0.0 109.173 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.53 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 57.3 t-20 45.24 61.33 2.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.104 -0.997 . . . . 0.0 109.681 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 38.0 mt-10 -166.15 146.69 6.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.141 -0.974 . . . . 0.0 110.174 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.38 139.32 57.73 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.133 -0.979 . . . . 0.0 109.021 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -85.95 142.09 29.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.169 -0.957 . . . . 0.0 110.326 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 68.6 mt -109.21 120.8 43.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.402 -0.812 . . . . 0.0 109.045 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.656 HG22 HG22 ' A' ' 112' ' ' VAL . 49.8 t -109.42 131.21 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 120.951 -1.093 . . . . 0.0 110.774 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -109.66 121.03 44.3 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.4 t -137.16 142.63 42.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.776 -1.202 . . . . 0.0 112.008 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.62 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 2.9 m -136.26 156.37 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -133.88 155.97 48.92 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.226 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.51 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.432 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.3 mttp . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.7 t -80.81 134.19 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.35 -0.844 . . . . 0.0 110.119 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -72.18 129.93 39.64 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.017 -1.052 . . . . 0.0 108.642 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.97 -154.35 24.29 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.378 -1.392 . . . . 0.0 109.914 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.4 t -133.93 131.64 39.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -1.111 . . . . 0.0 109.656 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.513 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 38.6 t0 -109.51 109.25 20.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.539 -0.726 . . . . 0.0 109.15 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.4 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 91.0 m-85 -89.78 3.38 53.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 108.819 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 91.9 m -100.54 -19.59 16.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.386 -0.821 . . . . 0.0 110.515 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.597 HG22 ' H ' ' A' ' 12' ' ' GLU . 32.6 m -157.75 127.49 6.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.791 -1.193 . . . . 0.0 110.535 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.1 p -64.17 -27.22 68.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.232 -0.917 . . . . 0.0 108.996 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.597 ' H ' HG22 ' A' ' 10' ' ' THR . 97.7 mt-10 -114.02 74.36 0.87 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.513 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 8.6 m -69.29 150.61 47.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.269 -0.894 . . . . 0.0 110.304 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.27 -1.05 34.62 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.9 pt -125.59 -10.35 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.676 -0.64 . . . . 0.0 110.491 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -125.7 141.0 52.23 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.201 -0.937 . . . . 0.0 110.191 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.8 t -69.18 -20.73 64.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.668 -0.645 . . . . 0.0 110.995 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -132.57 142.65 49.26 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.106 -0.997 . . . . 0.0 110.668 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.44 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -154.74 169.61 32.97 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.474 -1.015 . . . . 0.0 109.647 -179.963 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.0 mm . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.447 HG22 ' HB ' ' A' ' 122' ' ' VAL . 54.7 t -118.98 131.97 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.371 -0.831 . . . . 0.0 110.565 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.417 ' O ' ' O ' ' A' ' 124' ' ' THR . 89.0 m -102.1 102.65 13.15 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.5 m -93.07 119.97 32.87 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.081 -1.012 . . . . 0.0 109.574 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.586 ' CG2' HG12 ' A' ' 125' ' ' VAL . 11.8 m -140.33 141.03 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.656 -0.653 . . . . 0.0 109.344 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -87.02 129.89 34.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.078 -1.014 . . . . 0.0 109.452 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.434 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -98.58 159.64 14.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 109.504 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.48 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 24.9 t-80 -134.77 154.05 51.76 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.282 -0.886 . . . . 0.0 109.568 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.55 -26.48 32.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.373 -0.829 . . . . 0.0 109.762 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -99.49 -27.04 13.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.904 . . . . 0.0 109.866 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 83.9 m-20 -69.91 132.79 46.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.199 -0.938 . . . . 0.0 110.152 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.418 HD22 ' HD3' ' A' ' 98' ' ' ARG . 21.2 mt -77.81 145.09 36.57 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.549 HD13 HD21 ' A' ' 99' ' ' LEU . 21.7 pt -117.37 137.45 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.169 -0.957 . . . . 0.0 110.15 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.1 154.08 11.61 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -142.45 173.55 11.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.022 -1.281 . . . . 0.0 109.879 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -146.65 144.72 29.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.356 -0.84 . . . . 0.0 109.87 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 88.7 m -123.34 152.11 63.76 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.449 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.8 Cg_endo -51.55 151.52 14.02 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.321 2.014 . . . . 0.0 112.043 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.3 m -71.7 -13.62 61.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.456 -0.777 . . . . 0.0 110.59 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.609 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 82.4 m-20 -90.84 -1.34 57.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.961 -1.087 . . . . 0.0 110.196 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.449 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.3 m-85 -108.11 164.13 12.56 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.306 -0.871 . . . . 0.0 110.492 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.1 t -104.72 137.55 42.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.295 -0.878 . . . . 0.0 108.982 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.8 m -93.13 121.86 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.066 -1.021 . . . . 0.0 110.212 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.414 ' O ' ' O ' ' A' ' 112' ' ' VAL . 10.4 mt-10 -126.19 124.61 24.57 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.15 113.51 3.41 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.623 1.548 . . . . 0.0 112.097 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 68' ' ' PHE . 12.6 t-80 -93.51 -24.0 18.15 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 110' ' ' PHE . 68.0 t0 -171.0 48.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.668 ' H ' ' CB ' ' A' ' 67' ' ' ALA . 91.0 m -71.59 -154.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.518 -0.739 . . . . 0.0 109.774 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.474 ' CD2' HG23 ' A' ' 65' ' ' VAL . 3.6 p90 -112.17 -49.26 2.98 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.299 -0.876 . . . . 0.0 111.649 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.474 HG23 ' CD2' ' A' ' 64' ' ' PHE . 76.5 t -59.47 -48.27 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.291 -1.506 . . . . 0.0 109.43 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.3 t -161.16 130.8 4.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.668 ' CB ' ' H ' ' A' ' 63' ' ' CYS . . . -173.93 -178.49 1.54 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.129 -0.982 . . . . 0.0 110.414 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 6.1 m-85 -93.06 125.59 37.73 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -70.86 -173.92 0.86 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.107 -0.995 . . . . 0.0 109.871 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.526 ' N ' HD12 ' A' ' 70' ' ' LEU . 11.1 mp -64.45 -21.37 66.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.301 -0.874 . . . . 0.0 109.037 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.8 m -82.35 -8.27 59.63 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.306 -0.871 . . . . 0.0 108.943 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.35 17.72 63.91 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -104.91 145.02 30.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.327 -1.102 . . . . 0.0 109.213 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -83.63 117.8 23.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.486 -0.759 . . . . 0.0 110.149 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -149.73 136.36 19.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.836 . . . . 0.0 110.211 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -59.73 142.96 52.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.494 HD11 ' HD2' ' A' ' 80' ' ' LYS . 13.5 tp -95.45 7.07 47.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.227 -0.921 . . . . 0.0 109.775 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' A' ' 79' ' ' ASN . 0.3 OUTLIER -68.82 -39.9 79.79 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.269 -0.894 . . . . 0.0 109.991 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.448 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 91.3 m-20 -62.04 -36.03 80.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.017 . . . . 0.0 109.121 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.494 ' HD2' HD11 ' A' ' 77' ' ' LEU . 21.5 ttmt -72.53 -48.72 38.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.514 -0.741 . . . . 0.0 109.657 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.505 HD11 ' HG2' ' A' ' 100' ' ' PRO . 42.6 tp -148.79 120.84 8.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.468 -0.77 . . . . 0.0 108.997 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.48 113.1 19.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.968 . . . . 0.0 109.502 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.2 mt -90.5 159.27 16.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.857 . . . . 0.0 109.917 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 46.7 p -127.14 160.79 30.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.464 -0.773 . . . . 0.0 109.223 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.439 HD22 ' HG3' ' A' ' 98' ' ' ARG . 95.8 m-20 55.5 52.11 11.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -0.947 . . . . 0.0 109.814 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.2 mt -79.03 127.81 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.922 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.6 mm -122.18 121.51 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.49 -0.756 . . . . 0.0 109.174 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 86.6 mtp -121.84 103.18 8.67 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.222 -0.924 . . . . 0.0 109.569 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -112.24 100.76 9.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.377 -0.827 . . . . 0.0 109.033 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.476 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 77.5 m80 -71.18 -37.41 72.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.006 -1.059 . . . . 0.0 110.596 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -60.7 -46.03 91.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.972 -1.08 . . . . 0.0 109.704 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -88.71 -4.73 58.46 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.092 -1.005 . . . . 0.0 109.112 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.6 m-20 53.36 47.72 23.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.417 -0.802 . . . . 0.0 110.04 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.585 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.0 t -132.63 137.04 46.87 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.024 -1.047 . . . . 0.0 109.403 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -126.86 139.37 53.13 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.068 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.585 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 72.3 m-85 -136.42 146.31 46.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.27 -0.893 . . . . 0.0 109.259 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.9 m -151.18 151.53 32.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.175 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.439 ' HG3' HD22 ' A' ' 85' ' ' ASN . 7.5 mmm180 -102.32 131.87 48.65 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.351 -0.843 . . . . 0.0 109.576 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.549 HD21 HD13 ' A' ' 48' ' ' ILE . 92.6 mt -86.43 137.16 34.58 Favored Pre-proline 0 N--CA 1.489 1.479 0 C-N-CA 120.431 -0.508 . . . . 0.0 109.717 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.505 ' HG2' HD11 ' A' ' 81' ' ' LEU . 77.7 Cg_exo -45.86 -177.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.954 1.77 . . . . 0.0 111.204 178.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.6 t -88.88 -19.23 26.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.963 -1.085 . . . . 0.0 110.107 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.7 tp -124.42 128.47 49.08 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.283 -0.886 . . . . 0.0 110.516 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 78.5 mt -149.74 102.72 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 92.4 p -113.08 1.0 15.16 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.316 -0.865 . . . . 0.0 109.89 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.601 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 49.3 t0 -83.51 153.23 24.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 110.114 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.601 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 95.5 m-20 -96.23 33.36 1.77 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.453 -0.779 . . . . 0.0 108.938 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.516 ' CD1' ' OXT' ' A' ' 127' ' ' ALA . 11.9 p-90 -63.99 154.24 34.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 110.628 -178.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -140.06 150.13 43.99 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.637 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 32.5 p90 -154.5 161.86 41.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.096 -1.002 . . . . 0.0 108.595 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.42 ' O ' ' C ' ' A' ' 62' ' ' ASP . 13.3 p90 -153.58 158.44 41.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.738 -1.226 . . . . 0.0 111.906 -178.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 90.8 m -123.61 156.79 35.13 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 122' ' ' VAL . 50.7 t -127.91 137.66 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 120.96 -1.088 . . . . 0.0 111.736 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.2 m -119.22 130.52 55.52 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.0 p -171.54 178.73 3.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.41 -1.431 . . . . 0.0 111.577 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.609 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 49.3 mtmt -150.06 164.38 35.7 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 117' ' ' ASN . 88.3 m-20 -58.21 151.39 19.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.863 -1.148 . . . . 0.0 109.175 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.481 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 54.3 t-20 43.69 61.94 2.09 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.172 -0.955 . . . . 0.0 109.772 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.481 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 36.1 mt-10 -164.46 144.13 7.53 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.136 -0.978 . . . . 0.0 110.145 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -55.1 135.26 49.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.326 -0.859 . . . . 0.0 109.216 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -85.27 140.97 30.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.165 -0.96 . . . . 0.0 110.327 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.7 mt -110.17 123.67 50.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.554 -0.716 . . . . 0.0 109.187 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 112' ' ' VAL . 46.7 t -108.69 130.05 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.032 -1.042 . . . . 0.0 110.387 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -108.03 118.68 37.38 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 38' ' ' CYS . 6.1 t -136.74 142.52 43.05 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.496 1.141 . . . . 0.0 112.109 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.637 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -137.05 160.23 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -131.03 147.83 52.68 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.263 -0.898 . . . . 0.0 110.409 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.516 ' OXT' ' CD1' ' A' ' 107' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.432 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.456 HG13 ' CB ' ' A' ' 47' ' ' LEU . 85.4 t -87.59 135.51 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.93 . . . . 0.0 110.117 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -66.55 124.53 23.06 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.662 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.97 166.93 34.71 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.2 t -107.04 129.89 54.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.455 -1.026 . . . . 0.0 109.192 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.473 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 35.6 t0 -108.49 109.28 20.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.529 -0.732 . . . . 0.0 109.461 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.416 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 86.2 m-85 -89.49 1.7 55.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 108.948 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.5 m -101.99 -18.36 15.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.516 -0.74 . . . . 0.0 110.62 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 12' ' ' GLU . 8.5 m -156.86 126.5 6.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.761 -1.212 . . . . 0.0 110.383 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.6 m -67.06 -26.38 66.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.443 -0.785 . . . . 0.0 109.138 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.447 ' H ' HG22 ' A' ' 10' ' ' THR . 79.6 mm-40 -113.59 73.91 0.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 20.7 p -71.73 153.27 42.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.385 -0.822 . . . . 0.0 110.221 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.38 -1.27 31.19 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.3 pt -125.67 -13.45 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.661 -0.649 . . . . 0.0 110.443 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.461 ' O ' ' OG ' ' A' ' 13' ' ' SER . 76.5 m-85 -121.63 137.13 54.87 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.283 -0.886 . . . . 0.0 109.925 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.8 t -68.12 -20.04 64.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.578 -0.701 . . . . 0.0 110.669 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -131.95 142.55 49.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.95 -1.094 . . . . 0.0 110.745 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.473 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -154.88 168.36 32.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.334 -1.098 . . . . 0.0 109.586 179.867 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.8 mm . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -118.77 131.42 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.314 -0.867 . . . . 0.0 110.526 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 124' ' ' THR . 95.1 m -101.57 101.06 11.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.1 m -94.35 120.09 34.07 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.143 -0.973 . . . . 0.0 109.852 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.484 ' CG2' HG12 ' A' ' 125' ' ' VAL . 20.3 m -141.12 155.8 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.499 -0.751 . . . . 0.0 109.184 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -97.07 131.07 44.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.371 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.27 162.92 12.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.595 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.461 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 34.3 t-80 -132.59 148.97 52.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.307 -0.871 . . . . 0.0 109.454 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -52.48 -26.94 14.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 109.889 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -99.71 -23.15 15.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 109.786 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.461 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 92.1 m-20 -74.18 136.83 42.84 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.415 -0.803 . . . . 0.0 110.156 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.588 HD21 ' NE ' ' A' ' 98' ' ' ARG . 15.1 mt -75.52 143.37 42.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 108.826 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.0 pt -121.14 142.8 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.288 -0.883 . . . . 0.0 110.091 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.47 -175.39 47.21 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.484 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 48.9 p90 -164.12 169.01 18.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.059 -1.259 . . . . 0.0 109.639 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -146.03 144.14 29.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.762 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 84.1 m -125.58 152.17 71.51 Favored Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.52 151.3 14.26 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.273 1.982 . . . . 0.0 111.952 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.9 m -71.23 -11.01 60.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.379 -0.826 . . . . 0.0 110.673 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.618 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 83.6 m-20 -90.69 -1.71 57.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.938 -1.101 . . . . 0.0 110.092 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.434 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 20.5 m-85 -109.61 164.04 12.9 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.149 -0.97 . . . . 0.0 110.315 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 m -102.81 146.21 28.6 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.374 -0.829 . . . . 0.0 109.043 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.6 m -101.02 124.19 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.99 -1.069 . . . . 0.0 110.087 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -130.63 127.25 22.26 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.09 113.79 3.47 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.657 1.571 . . . . 0.0 112.146 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.495 ' O ' ' O ' ' A' ' 68' ' ' PHE . 27.1 t-80 -93.88 -26.4 16.91 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.7 t0 -168.26 38.35 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.459 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 81.8 m -62.75 -155.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.735 . . . . 0.0 109.836 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 4.8 p90 -107.95 -54.54 2.48 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.195 -0.941 . . . . 0.0 111.475 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.0 t -49.13 -71.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.67 -1.269 . . . . 0.0 108.728 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.7 t -142.4 131.36 23.04 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.459 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -168.94 -179.57 3.72 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.364 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.552 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 4.4 m-85 -94.61 145.1 25.06 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.431 HD21 ' HG2' ' A' ' 75' ' ' GLU . 99.6 m-20 -86.59 -172.89 4.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.93 -1.106 . . . . 0.0 109.695 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.0 mt -64.65 -15.37 61.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -0.881 . . . . 0.0 109.16 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.3 m -86.92 -6.42 58.78 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.361 -0.837 . . . . 0.0 108.948 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.34 20.47 69.36 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -107.55 142.46 37.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.291 -1.123 . . . . 0.0 109.207 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -66.05 131.66 46.74 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.212 -0.93 . . . . 0.0 109.899 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.431 ' HG2' HD21 ' A' ' 69' ' ' ASN . 30.7 tp10 -152.21 163.26 39.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.364 -0.835 . . . . 0.0 109.405 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -107.01 138.06 43.89 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.175 -0.953 . . . . 0.0 109.553 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.1 tp -88.03 -8.83 55.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.105 -0.997 . . . . 0.0 109.921 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.586 ' OE1' ' N ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -60.0 -45.99 90.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.869 -1.144 . . . . 0.0 109.532 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.592 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 28.7 p30 -63.8 -34.8 78.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.073 -1.017 . . . . 0.0 108.951 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.592 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 9.1 tppt? -69.91 -51.67 31.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 109.112 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.455 HD11 ' HG2' ' A' ' 100' ' ' PRO . 20.7 tp -151.76 121.42 6.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.448 -0.783 . . . . 0.0 108.958 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -78.17 113.78 16.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.018 -1.051 . . . . 0.0 109.573 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.72 162.3 17.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.412 -0.805 . . . . 0.0 109.974 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 70.4 p -129.55 162.0 29.21 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.349 -0.845 . . . . 0.0 109.331 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.1 m120 55.36 51.23 13.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 109.691 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.5 mt -81.13 131.44 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.327 -0.858 . . . . 0.0 110.264 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.3 mm -127.58 123.5 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.456 -0.777 . . . . 0.0 109.073 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 72.6 mtp -122.59 104.09 9.11 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.21 -0.932 . . . . 0.0 109.761 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -111.9 100.7 9.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.327 -0.858 . . . . 0.0 109.039 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.488 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 97.5 m-70 -72.32 -36.41 68.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.882 -1.136 . . . . 0.0 110.642 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -60.51 -46.16 91.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.999 -1.063 . . . . 0.0 109.528 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -88.91 -4.83 58.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.071 -1.018 . . . . 0.0 109.149 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.5 m-20 54.48 48.17 21.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.468 -0.77 . . . . 0.0 110.273 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.601 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.9 t -134.02 139.46 46.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.994 -1.066 . . . . 0.0 109.296 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.484 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 75.2 m-85 -128.4 140.33 51.9 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.483 -0.761 . . . . 0.0 110.071 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.601 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 72.0 m-85 -137.99 147.96 44.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.323 -0.861 . . . . 0.0 109.13 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.4 p -156.33 157.98 36.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.08 -1.012 . . . . 0.0 109.21 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.588 ' NE ' HD21 ' A' ' 47' ' ' LEU . 18.7 mmt180 -104.08 137.65 41.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.324 -0.86 . . . . 0.0 109.613 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.422 ' HB3' HD11 ' A' ' 103' ' ' ILE . 54.8 mt -87.81 137.5 31.74 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.65 -0.656 . . . . 0.0 109.62 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.493 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 77.5 Cg_exo -46.88 154.04 1.21 Allowed 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.745 1.63 . . . . 0.0 111.212 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 54.0 m -62.56 -36.86 84.01 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.118 -0.989 . . . . 0.0 109.93 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.4 tp -111.34 130.63 55.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.26 -0.9 . . . . 0.0 110.55 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.422 HD11 ' HB3' ' A' ' 99' ' ' LEU . 95.3 mt -145.71 103.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.401 -0.812 . . . . 0.0 108.857 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.459 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 7.1 m -111.18 53.58 0.7 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.179 -0.951 . . . . 0.0 109.647 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.479 ' O ' ' OXT' ' A' ' 127' ' ' ALA . 83.1 m-20 -144.86 156.5 44.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 110.029 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -102.89 33.06 3.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.426 -0.796 . . . . 0.0 109.09 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 19.3 p-90 -65.15 150.8 47.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.411 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -132.38 151.08 52.01 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.625 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 32.2 p90 -151.62 161.0 43.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.196 -0.94 . . . . 0.0 108.665 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 8.1 p90 -154.19 164.33 38.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.741 -1.225 . . . . 0.0 111.912 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 85.2 m -127.72 157.96 38.91 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.533 HG22 HG22 ' A' ' 122' ' ' VAL . 44.2 t -127.72 137.88 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.802 -1.186 . . . . 0.0 111.929 -178.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 70.9 m -119.24 130.04 55.25 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.7 p -169.29 179.33 3.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.281 -1.512 . . . . 0.0 111.658 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.618 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 42.2 mtmt -158.78 167.67 28.86 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 117' ' ' ASN . 54.1 p-10 -58.56 151.55 20.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.766 -1.209 . . . . 0.0 109.008 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.452 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 58.9 t-20 41.42 58.71 2.6 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.329 -0.857 . . . . 0.0 109.6 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 66.5 mm-40 -157.87 137.5 12.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.394 -0.817 . . . . 0.0 110.503 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -54.69 136.5 45.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.366 -0.834 . . . . 0.0 109.12 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.452 ' H ' ' HG2' ' A' ' 120' ' ' LYS . 4.4 pttm -85.36 139.08 31.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.217 -0.927 . . . . 0.0 110.49 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.9 mt -111.77 125.48 54.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.556 -0.715 . . . . 0.0 109.354 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.533 HG22 HG22 ' A' ' 112' ' ' VAL . 53.4 t -110.98 131.25 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.036 -1.04 . . . . 0.0 110.561 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -108.73 119.46 39.61 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 38' ' ' CYS . 6.8 t -136.83 141.52 42.86 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.957 -1.089 . . . . 0.0 111.989 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.625 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -136.41 156.55 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -127.13 151.01 49.22 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.179 -0.951 . . . . 0.0 110.265 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.479 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.365 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.3 mttp . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.438 HG13 ' HB2' ' A' ' 47' ' ' LEU . 84.6 t -91.66 135.63 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 110.267 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -69.55 123.2 20.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.9 -1.125 . . . . 0.0 108.543 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.76 174.87 46.07 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.656 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 7.7 t -114.8 128.19 56.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.441 -1.035 . . . . 0.0 109.292 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.442 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 51.8 t0 -106.05 109.05 20.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.505 -0.747 . . . . 0.0 109.359 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 97.6 m-85 -88.05 -0.12 56.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.226 -0.921 . . . . 0.0 108.961 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.5 m -101.47 -15.67 17.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.42 -0.8 . . . . 0.0 110.578 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 12' ' ' GLU . 6.5 m -159.89 129.24 5.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.88 -1.137 . . . . 0.0 110.316 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.501 ' OG ' ' OE1' ' A' ' 12' ' ' GLU . 78.2 p -70.76 -22.78 62.36 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.587 -0.845 . . . . 0.0 108.852 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.505 ' H ' HG22 ' A' ' 10' ' ' THR . 57.9 mp0 -114.16 74.12 0.86 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.442 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 6.4 m -70.77 151.32 44.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.371 -0.83 . . . . 0.0 110.241 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.0 -0.72 35.99 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.7 pt -125.91 -22.8 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.612 -0.68 . . . . 0.0 110.34 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -112.15 141.97 45.18 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.261 -0.9 . . . . 0.0 110.015 -178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.3 p -75.59 -21.14 58.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.519 -0.738 . . . . 0.0 110.958 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -118.66 127.89 54.0 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.138 -0.976 . . . . 0.0 110.449 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.94 153.84 20.69 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.656 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 20.4 m-85 . . . . . 0 N--CA 1.495 1.783 0 O-C-N 121.479 -1.013 . . . . 0.0 109.557 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.6 mm . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' A' ' 122' ' ' VAL . 50.9 t -119.96 129.86 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.334 -0.854 . . . . 0.0 110.277 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.44 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 76.6 m -102.61 101.87 12.05 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.8 m -95.19 120.51 35.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.16 -0.962 . . . . 0.0 109.84 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.549 ' CG2' HG12 ' A' ' 125' ' ' VAL . 26.1 m -140.43 157.45 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.467 -0.771 . . . . 0.0 109.146 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -99.99 133.74 43.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.114 -0.991 . . . . 0.0 109.398 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.22 160.7 14.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 0.0 109.52 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.403 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 20.8 t60 -134.58 152.38 51.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.19 -27.57 35.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.363 -0.835 . . . . 0.0 109.823 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -99.05 -25.46 14.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.934 . . . . 0.0 109.647 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 97.1 m-20 -75.14 133.29 41.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.363 -0.836 . . . . 0.0 110.074 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.438 ' HB2' HG13 ' A' ' 3' ' ' VAL . 49.6 mt -77.94 148.41 34.51 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.48 HD13 HD21 ' A' ' 99' ' ' LEU . 13.2 pt -120.94 142.78 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.272 -0.892 . . . . 0.0 110.048 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 95' ' ' PHE . . . 176.78 -172.6 45.56 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.466 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 51.4 p90 -170.14 170.17 7.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -1.218 . . . . 0.0 109.79 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -145.06 143.43 30.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.289 -0.882 . . . . 0.0 109.703 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.2 m -125.57 154.28 72.75 Favored Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.419 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.8 Cg_endo -51.53 143.35 36.33 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.213 1.942 . . . . 0.0 111.991 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.1 t -67.28 -12.84 61.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.387 -0.821 . . . . 0.0 110.595 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -89.46 3.33 52.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.941 -1.1 . . . . 0.0 110.197 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.572 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 20.7 m-85 -113.29 167.73 10.32 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.157 -0.965 . . . . 0.0 110.324 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.8 t -103.35 138.47 40.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.328 -0.858 . . . . 0.0 108.903 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.4 m -97.29 118.05 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.987 -1.07 . . . . 0.0 110.386 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -126.76 129.53 24.03 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.97 114.34 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.628 1.552 . . . . 0.0 111.959 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.447 ' O ' ' O ' ' A' ' 68' ' ' PHE . 10.9 t-80 -87.76 -24.38 23.81 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.1 t0 -172.93 38.91 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.452 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 71.1 m -60.92 -152.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.549 -0.719 . . . . 0.0 109.762 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.445 ' O ' ' C ' ' A' ' 65' ' ' VAL . 3.9 p90 -109.42 -58.7 2.0 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.216 -0.928 . . . . 0.0 111.354 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 66' ' ' SER . 13.4 t -46.67 -74.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.436 -1.415 . . . . 0.0 108.927 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.513 ' N ' HG12 ' A' ' 65' ' ' VAL . 32.4 t -135.96 132.02 35.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.452 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.84 179.89 2.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.01 . . . . 0.0 110.459 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.517 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 4.4 m-85 -93.69 128.2 39.78 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -73.61 -176.51 2.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.953 -1.092 . . . . 0.0 109.844 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.59 -20.4 65.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.932 . . . . 0.0 109.035 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.5 m -83.92 -6.43 59.42 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.74 19.05 64.36 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -100.18 139.06 36.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -1.149 . . . . 0.0 109.019 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -85.4 108.77 18.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.205 -0.934 . . . . 0.0 109.994 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -146.06 140.48 26.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.435 -0.791 . . . . 0.0 109.91 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 -62.15 148.95 42.83 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.475 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.42 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 13.0 tp -96.51 7.53 46.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.209 -0.932 . . . . 0.0 109.724 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -69.07 -40.6 78.39 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.949 -1.094 . . . . 0.0 109.878 -179.583 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.501 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 95.2 m-20 -64.31 -38.85 92.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.173 -0.955 . . . . 0.0 109.122 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -67.81 -53.23 28.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.216 -0.927 . . . . 0.0 109.389 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.523 HD22 ' CZ2' ' A' ' 107' ' ' TRP . 35.7 tp -143.23 121.57 12.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.413 -0.805 . . . . 0.0 109.049 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -81.03 104.88 11.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 109.371 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.537 HD13 ' OG ' ' A' ' 97' ' ' SER . 91.9 mt -84.3 163.03 19.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 109.949 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 46.6 p -129.95 162.94 27.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.438 -0.789 . . . . 0.0 109.384 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 54.39 51.85 13.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.159 -0.963 . . . . 0.0 109.775 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -81.31 128.76 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 110.117 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.5 mm -125.91 123.67 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.528 -0.733 . . . . 0.0 109.206 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 91.3 mtp -123.45 104.93 9.38 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.164 -0.96 . . . . 0.0 109.829 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -110.19 100.24 9.17 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.382 -0.824 . . . . 0.0 109.014 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.509 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 98.7 m-70 -73.0 -34.75 66.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.978 -1.076 . . . . 0.0 110.643 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -61.58 -44.91 96.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.964 -1.085 . . . . 0.0 109.647 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -88.65 -4.72 58.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.955 . . . . 0.0 109.104 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.509 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 1.6 m-20 56.5 45.57 22.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.492 -0.755 . . . . 0.0 109.995 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.575 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.7 t -132.26 138.73 48.0 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.04 -1.037 . . . . 0.0 109.385 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.466 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 69.5 m-85 -127.62 139.74 52.54 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.406 -0.809 . . . . 0.0 109.986 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.615 ' CB ' HH12 ' A' ' 98' ' ' ARG . 82.5 m-85 -136.45 147.03 46.99 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.293 -0.879 . . . . 0.0 109.278 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.583 ' N ' ' NH1' ' A' ' 98' ' ' ARG . 38.2 t -153.41 150.72 29.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.114 -0.991 . . . . 0.0 109.357 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.615 HH12 ' CB ' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -105.88 139.27 40.69 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.222 -0.924 . . . . 0.0 109.541 -179.726 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.523 ' HB3' HD11 ' A' ' 103' ' ' ILE . 42.9 mt -93.65 142.38 25.06 Favored Pre-proline 0 N--CA 1.491 1.613 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.69 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.489 ' HG2' HD11 ' A' ' 81' ' ' LEU . 78.0 Cg_exo -46.83 157.47 0.52 Allowed 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.713 1.608 . . . . 0.0 111.226 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.1 t -67.27 -17.25 64.71 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.157 -0.965 . . . . 0.0 109.702 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 45.9 tp -122.2 130.84 53.57 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.281 -0.887 . . . . 0.0 110.555 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.523 HD11 ' HB3' ' A' ' 99' ' ' LEU . 24.2 mt -144.39 124.5 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.6 m -133.3 15.75 4.12 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.042 -1.036 . . . . 0.0 109.855 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -109.02 154.15 22.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.329 -0.857 . . . . 0.0 110.014 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -95.99 32.13 1.98 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.471 -0.768 . . . . 0.0 108.997 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.523 ' CZ2' HD22 ' A' ' 81' ' ' LEU . 18.2 p-90 -66.33 156.86 33.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.899 . . . . 0.0 110.636 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -143.78 155.42 44.15 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.632 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 38.3 p90 -151.88 161.46 42.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.208 -0.933 . . . . 0.0 108.785 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.519 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 5.5 p90 -152.24 161.17 43.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.77 -1.206 . . . . 0.0 111.813 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 91.7 m -127.97 157.45 40.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.616 HG22 HG22 ' A' ' 122' ' ' VAL . 43.8 t -130.22 142.22 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.836 -1.165 . . . . 0.0 111.712 -178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 75.1 m -119.86 131.1 55.17 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.4 p -170.8 179.06 3.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.215 -1.553 . . . . 0.0 111.616 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.464 ' HZ2' ' HB3' ' A' ' 115' ' ' LYS . 5.6 mtmp? -158.11 167.34 30.12 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 117' ' ' ASN . 91.3 m-20 -58.13 150.5 21.12 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.818 -1.176 . . . . 0.0 109.119 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.437 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 66.5 t30 44.38 59.99 3.03 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.172 -0.955 . . . . 0.0 109.809 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.572 ' OE1' ' CE2' ' A' ' 56' ' ' TYR . 49.7 mt-10 -162.06 140.77 9.3 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.18 -0.95 . . . . 0.0 110.21 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -56.63 144.47 31.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 109.209 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -93.54 141.0 28.96 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.123 -0.986 . . . . 0.0 110.315 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.416 HD13 ' CG ' ' A' ' 8' ' ' PHE . 75.0 mt -112.3 125.73 54.48 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.546 -0.721 . . . . 0.0 109.151 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.616 HG22 HG22 ' A' ' 112' ' ' VAL . 49.5 t -110.92 131.27 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.036 -1.04 . . . . 0.0 110.63 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -109.65 121.17 44.62 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.7 t -137.24 141.82 42.04 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.953 -1.092 . . . . 0.0 112.114 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.632 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.1 m -135.49 157.77 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -128.25 150.94 49.82 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.208 -0.932 . . . . 0.0 110.263 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.498 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.253 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 66.9 t -99.31 133.84 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.306 -0.871 . . . . 0.0 109.831 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -67.48 122.91 19.0 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.134 -0.979 . . . . 0.0 108.544 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.82 162.99 26.58 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.7 t -103.5 135.25 45.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.477 -1.014 . . . . 0.0 110.084 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.509 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 67.7 t0 -111.98 109.43 19.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.371 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -87.4 -0.92 57.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 108.985 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.3 m -98.89 -17.67 18.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.645 -0.659 . . . . 0.0 110.505 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 12' ' ' GLU . 4.2 m -160.41 131.08 5.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.764 -1.21 . . . . 0.0 110.223 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.1 p -64.17 -26.18 68.41 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.697 -0.801 . . . . 0.0 108.851 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.438 ' H ' HG22 ' A' ' 10' ' ' THR . 98.4 mt-10 -114.37 102.12 9.8 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.517 ' C ' ' H ' ' A' ' 15' ' ' ILE . 23.6 m -102.8 113.28 26.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -0.803 . . . . 0.0 110.372 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.5 t -65.64 2.88 0.85 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.517 ' H ' ' C ' ' A' ' 13' ' ' SER . 6.8 pt -123.56 -32.6 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.482 -0.761 . . . . 0.0 110.325 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.5 ' CZ ' ' CE2' ' A' ' 96' ' ' TYR . 53.8 m-85 -113.07 146.76 38.58 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.954 -1.091 . . . . 0.0 109.854 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 m -79.85 -20.82 45.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.38 -0.825 . . . . 0.0 110.956 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -119.9 131.18 55.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.708 -1.245 . . . . 0.0 110.86 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.463 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -150.51 158.66 27.78 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.201 -1.176 . . . . 0.0 109.609 -179.927 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.8 mm . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.7 t -114.9 127.73 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.1 -1.0 . . . . 0.0 110.268 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 81.3 m -102.51 102.49 12.77 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.6 m -95.07 120.19 34.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -0.981 . . . . 0.0 109.763 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.524 ' CG2' HG12 ' A' ' 125' ' ' VAL . 21.7 m -139.78 156.74 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.395 -0.816 . . . . 0.0 108.996 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.3 130.7 45.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.203 -0.936 . . . . 0.0 109.341 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.88 161.71 14.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 109.635 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -139.0 150.31 45.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 109.586 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.46 -25.2 50.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 109.818 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -98.98 -26.29 14.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.162 -0.961 . . . . 0.0 109.667 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -78.97 134.97 36.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.531 -0.73 . . . . 0.0 110.013 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.7 mt -78.13 149.88 33.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 108.554 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.492 ' CD1' HD21 ' A' ' 99' ' ' LEU . 24.0 pt -120.82 142.42 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.887 -1.133 . . . . 0.0 110.027 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.2 -170.66 43.34 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -172.9 171.17 4.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.063 -1.257 . . . . 0.0 109.684 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -146.42 145.01 30.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.317 -0.865 . . . . 0.0 109.866 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.6 m -125.03 152.26 70.2 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.435 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.33 145.58 27.13 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.328 2.019 . . . . 0.0 112.026 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.9 m -68.65 -11.97 60.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.428 -0.795 . . . . 0.0 110.606 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.596 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 79.4 m-20 -91.44 1.03 57.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.928 -1.107 . . . . 0.0 110.039 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.51 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 19.4 m-85 -111.59 166.53 11.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.919 -1.113 . . . . 0.0 110.162 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -104.53 131.26 52.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.302 -0.874 . . . . 0.0 109.339 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.6 m -89.14 121.12 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.006 -1.059 . . . . 0.0 110.203 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -125.81 129.15 24.41 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.21 114.42 3.55 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.664 1.576 . . . . 0.0 112.088 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.465 ' O ' ' O ' ' A' ' 68' ' ' PHE . 10.8 t-80 -92.93 -25.29 18.1 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.474 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.8 t0 -171.43 40.44 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.508 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 70.8 m -63.7 -152.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.604 -0.685 . . . . 0.0 109.84 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.6 p90 -110.95 -58.9 2.04 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.863 -1.148 . . . . 0.0 111.151 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.442 ' C ' ' O ' ' A' ' 64' ' ' PHE . 25.3 t -45.97 -70.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.442 -1.411 . . . . 0.0 108.897 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.3 t -140.44 130.76 25.16 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.508 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.22 178.48 2.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.926 -1.109 . . . . 0.0 110.425 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.519 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 6.5 m-85 -93.12 124.94 37.45 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -69.6 -176.36 1.01 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.936 -1.103 . . . . 0.0 109.759 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 17.5 mt -63.29 -21.73 66.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.857 . . . . 0.0 109.044 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.6 m -81.63 -5.81 58.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.352 -0.842 . . . . 0.0 108.858 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.41 19.94 65.38 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -105.25 141.56 36.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -1.145 . . . . 0.0 109.187 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -83.89 112.83 20.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.115 -0.99 . . . . 0.0 109.944 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -148.13 136.26 21.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.783 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -58.33 144.87 40.03 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.073 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.568 HD11 ' HD2' ' A' ' 80' ' ' LYS . 14.6 tp -97.12 7.4 46.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.186 -0.946 . . . . 0.0 109.691 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.46 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -69.7 -38.74 77.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 109.913 -179.374 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.586 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 49.3 p-10 -61.26 -31.15 70.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.164 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.586 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 37.4 ttmt -74.87 -48.37 25.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.374 -0.828 . . . . 0.0 109.392 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.552 HD22 ' CZ2' ' A' ' 107' ' ' TRP . 31.9 tp -136.74 127.27 26.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.38 -0.825 . . . . 0.0 109.205 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -74.68 85.44 2.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.119 -0.988 . . . . 0.0 109.12 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.0 mt -77.73 138.23 38.92 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.283 -0.885 . . . . 0.0 109.927 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.3 p -126.39 166.52 17.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.543 -0.723 . . . . 0.0 109.315 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 55.51 50.46 14.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.883 . . . . 0.0 109.559 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.89 130.86 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 0.0 110.094 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -120.72 120.3 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.349 -0.844 . . . . 0.0 109.201 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 81.5 mtp -122.53 104.72 9.55 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.987 -1.071 . . . . 0.0 109.98 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -108.52 99.35 8.75 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.248 -0.907 . . . . 0.0 108.805 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.477 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 97.4 m-70 -72.53 -36.89 68.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.985 -1.072 . . . . 0.0 110.686 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -60.54 -45.75 92.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.005 -1.059 . . . . 0.0 109.515 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -87.68 -4.83 58.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.142 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.3 m-20 54.93 47.46 22.17 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 110.348 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.562 ' OG1' ' CE1' ' A' ' 96' ' ' TYR . 2.6 t -134.66 141.94 46.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.956 -1.09 . . . . 0.0 109.387 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -129.44 140.34 51.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.42 -0.8 . . . . 0.0 110.01 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.562 ' CE1' ' OG1' ' A' ' 94' ' ' THR . 82.7 m-85 -135.38 146.14 48.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.23 -0.919 . . . . 0.0 109.483 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.4 m -151.43 153.27 34.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 109.231 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.4 mtt-85 -107.9 138.4 44.23 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.071 -1.018 . . . . 0.0 109.419 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.634 ' HB3' HD11 ' A' ' 103' ' ' ILE . 60.3 mt -96.0 141.17 22.78 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.828 . . . . 0.0 109.727 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.499 ' HG2' HD11 ' A' ' 81' ' ' LEU . 77.9 Cg_exo -45.64 178.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.901 1.734 . . . . 0.0 111.187 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.9 m -85.46 -11.73 53.59 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.035 -1.041 . . . . 0.0 109.689 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.3 tp -124.3 131.14 53.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.007 . . . . 0.0 110.54 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.634 HD11 ' HB3' ' A' ' 99' ' ' LEU . 41.3 mt -147.48 103.82 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 97.4 p -114.0 -0.41 14.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.028 -1.045 . . . . 0.0 109.748 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 0.4 OUTLIER -89.46 153.66 20.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 0.0 110.071 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -98.43 31.98 2.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.459 -0.776 . . . . 0.0 109.127 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.552 ' CZ2' HD22 ' A' ' 81' ' ' LEU . 16.1 p-90 -65.65 159.21 25.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -0.848 . . . . 0.0 110.493 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -146.7 156.82 43.47 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.57 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 43.5 p90 -153.47 163.67 39.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.085 -1.01 . . . . 0.0 108.9 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 6.8 p90 -152.71 163.04 40.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.672 -1.268 . . . . 0.0 111.681 -178.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 87.0 m -130.04 158.64 39.06 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 122' ' ' VAL . 42.9 t -130.74 143.36 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.66 -1.275 . . . . 0.0 111.774 -178.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 87.8 m -123.36 132.61 54.04 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.3 p -170.76 178.69 3.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.298 -1.501 . . . . 0.0 111.743 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.596 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 46.2 mtmt -154.06 165.55 35.82 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.6 150.89 21.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.78 -1.2 . . . . 0.0 109.123 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.527 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 61.8 t-20 46.47 61.27 2.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.266 -0.897 . . . . 0.0 109.52 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 44.4 mt-10 -165.1 145.43 7.16 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.956 -1.09 . . . . 0.0 110.127 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -60.66 147.73 40.98 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.204 -0.935 . . . . 0.0 109.003 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -93.26 140.8 29.14 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.066 -1.021 . . . . 0.0 110.355 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.2 mt -110.17 122.35 47.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.412 -0.805 . . . . 0.0 109.093 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 112' ' ' VAL . 48.7 t -109.96 130.79 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.938 -1.101 . . . . 0.0 110.833 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -109.57 121.46 45.24 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.0 t -137.37 142.15 41.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.666 -1.271 . . . . 0.0 112.029 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.57 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.1 m -135.09 158.04 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -137.12 157.88 45.71 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.89 -1.131 . . . . 0.0 110.128 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.408 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.525 HG22 HD12 ' A' ' 47' ' ' LEU . 53.4 t -103.3 132.81 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -0.893 . . . . 0.0 109.955 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -62.76 117.5 6.41 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.363 -0.935 . . . . 0.0 108.574 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.44 155.7 15.72 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.422 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 4.9 t -100.08 132.01 45.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.562 -0.963 . . . . 0.0 109.493 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.511 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 47.2 t0 -105.05 108.4 19.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.448 -0.783 . . . . 0.0 109.302 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -88.27 -0.99 57.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 108.854 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 m -101.19 -16.56 16.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.492 -0.755 . . . . 0.0 110.434 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.6 m -157.13 124.88 5.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.859 -1.15 . . . . 0.0 110.182 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.493 ' OG ' ' OE1' ' A' ' 12' ' ' GLU . 78.0 p -67.16 -26.9 66.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.369 -0.832 . . . . 0.0 108.98 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 57.5 mp0 -109.07 72.61 0.82 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 t -74.11 158.59 33.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.407 -0.808 . . . . 0.0 110.137 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.433 HG23 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -103.23 -48.7 3.94 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.131 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.433 ' H ' HG23 ' A' ' 14' ' ' THR . 24.0 pt -86.78 -12.92 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.574 -0.704 . . . . 0.0 110.16 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.417 ' CD2' HG13 ' A' ' 15' ' ' ILE . 68.0 m-85 -110.4 136.93 48.81 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.153 -0.967 . . . . 0.0 109.606 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 t -74.24 -26.7 60.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.431 -0.793 . . . . 0.0 111.157 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -123.3 134.51 54.05 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.07 -1.019 . . . . 0.0 110.787 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.511 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -144.47 156.13 26.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.422 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 22.5 m-85 . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.333 -1.098 . . . . 0.0 109.647 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.0 mm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.4 t -121.06 126.5 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.0 110.337 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 96.8 m -103.16 102.47 12.46 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.8 m -94.85 120.77 35.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.13 -0.981 . . . . 0.0 109.848 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.518 ' CG2' HG12 ' A' ' 125' ' ' VAL . 27.3 m -139.82 156.73 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.364 -0.835 . . . . 0.0 109.013 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -100.16 131.84 45.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 109.415 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.449 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -97.07 158.09 15.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 109.57 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.428 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 31.5 t60 -134.05 153.25 51.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.207 -0.933 . . . . 0.0 109.53 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.24 -25.03 20.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.349 -0.844 . . . . 0.0 109.772 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -99.74 -25.93 14.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.068 -1.02 . . . . 0.0 109.662 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 77.8 m-20 -75.47 134.57 40.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.88 . . . . 0.0 110.034 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.525 HD12 HG22 ' A' ' 3' ' ' VAL . 83.1 mt -76.24 147.39 38.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 108.661 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.595 HD13 HD21 ' A' ' 99' ' ' LEU . 9.0 pt -116.93 136.57 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.159 -0.963 . . . . 0.0 109.847 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.26 -176.94 47.86 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.438 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 55.6 p90 -164.57 169.77 16.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.087 -1.243 . . . . 0.0 109.858 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -144.17 143.16 30.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.255 -0.903 . . . . 0.0 109.908 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 68.6 m -126.6 152.37 74.47 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.422 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.4 149.16 17.93 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.404 2.069 . . . . 0.0 112.122 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.4 p -71.73 -11.27 60.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.435 -0.791 . . . . 0.0 110.649 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -90.67 0.24 57.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.9 -1.125 . . . . 0.0 110.129 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.422 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 20.7 m-85 -110.36 165.99 11.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.199 -0.938 . . . . 0.0 110.252 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -102.87 133.45 47.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 0.0 109.107 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.1 m -91.13 123.53 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.969 -1.082 . . . . 0.0 110.335 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -130.68 129.16 22.64 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.05 113.53 3.44 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.71 1.607 . . . . 0.0 112.046 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.47 ' O ' ' O ' ' A' ' 68' ' ' PHE . 15.9 t-160 -91.06 -26.66 19.05 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.503 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.5 t0 -169.72 37.13 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.541 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 75.9 m -60.38 -155.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.472 -0.767 . . . . 0.0 109.724 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.471 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 3.3 p90 -111.47 -56.66 2.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.141 -0.974 . . . . 0.0 111.316 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.419 HG23 ' CE2' ' A' ' 64' ' ' PHE . 78.0 t -47.36 -54.7 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 120.479 -1.388 . . . . 0.0 109.062 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -158.08 129.8 6.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.541 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.01 -179.34 1.99 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.957 -1.09 . . . . 0.0 110.442 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 6.3 m-85 -93.16 123.58 36.53 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -70.66 -173.74 0.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 109.787 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 70' ' ' LEU . 10.3 mp -63.61 -21.49 66.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.272 -0.892 . . . . 0.0 109.018 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.7 m -82.44 -7.05 59.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.347 -0.846 . . . . 0.0 108.885 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.41 19.83 65.62 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -102.86 138.78 39.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.212 -1.169 . . . . 0.0 108.999 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -83.7 108.33 16.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 110.004 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -144.2 138.74 28.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.852 . . . . 0.0 109.85 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 77' ' ' LEU . 55.1 t-20 -59.78 145.55 44.87 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.298 -0.876 . . . . 0.0 108.954 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.54 HD11 ' HD2' ' A' ' 80' ' ' LYS . 13.4 tp -97.32 7.44 46.55 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.292 -0.88 . . . . 0.0 109.845 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.449 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -70.12 -37.99 75.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.065 -1.022 . . . . 0.0 110.058 -179.539 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -62.72 -32.73 73.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.044 -1.035 . . . . 0.0 109.156 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.54 ' HD2' HD11 ' A' ' 77' ' ' LEU . 23.4 ttmt -72.41 -50.21 28.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.853 . . . . 0.0 109.634 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.517 HD11 ' HG2' ' A' ' 100' ' ' PRO . 19.2 tp -139.3 128.81 24.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.487 -0.758 . . . . 0.0 109.074 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -78.99 88.28 4.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.988 . . . . 0.0 109.639 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.21 150.82 41.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.357 -0.839 . . . . 0.0 109.936 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.2 p -127.14 164.33 21.86 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.512 -0.742 . . . . 0.0 109.176 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.481 HD22 ' HG3' ' A' ' 98' ' ' ARG . 78.7 m-20 56.1 53.15 9.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 0.0 109.942 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.5 mt -79.68 125.17 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -0.825 . . . . 0.0 109.918 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -123.14 121.99 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.5 -0.75 . . . . 0.0 109.265 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 84.6 mtp -123.25 103.37 8.49 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.108 -0.995 . . . . 0.0 109.696 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -110.98 101.36 9.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.378 -0.826 . . . . 0.0 109.037 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.499 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 91.8 m-70 -72.96 -35.78 66.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.876 -1.14 . . . . 0.0 110.686 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -60.19 -45.91 91.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.942 -1.099 . . . . 0.0 109.572 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -89.87 -4.35 57.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.925 . . . . 0.0 109.064 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.499 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 97.7 m-20 54.52 47.91 21.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.424 -0.798 . . . . 0.0 110.167 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.574 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 2.5 t -133.35 138.64 46.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.171 -0.956 . . . . 0.0 109.451 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.438 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 65.2 m-85 -129.06 140.64 51.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.402 -0.811 . . . . 0.0 109.915 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.574 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 72.1 m-85 -137.74 148.89 46.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.45 -0.781 . . . . 0.0 109.383 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 63.8 m -152.49 155.1 36.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.092 -1.005 . . . . 0.0 109.172 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.489 ' CZ ' HD21 ' A' ' 47' ' ' LEU . 16.6 mmt180 -102.53 136.08 42.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.188 -0.945 . . . . 0.0 109.732 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.646 ' HB3' HD11 ' A' ' 103' ' ' ILE . 68.2 mt -89.92 136.78 28.72 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.803 -0.56 . . . . 0.0 109.699 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.517 ' HG2' HD11 ' A' ' 81' ' ' LEU . 77.9 Cg_exo -45.87 176.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 121.848 1.699 . . . . 0.0 111.188 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.2 m -85.63 -14.66 44.93 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.099 -1.0 . . . . 0.0 109.925 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 47.6 tp -121.04 130.43 53.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.189 -0.945 . . . . 0.0 110.523 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.646 HD11 ' HB3' ' A' ' 99' ' ' LEU . 43.9 mt -149.84 102.88 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.5 p -120.01 3.68 10.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.202 -0.936 . . . . 0.0 109.722 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.518 ' O ' ' OXT' ' A' ' 127' ' ' ALA . 27.9 t70 -93.72 158.97 15.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.97 . . . . 0.0 109.933 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -96.15 33.8 1.68 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.455 -0.778 . . . . 0.0 109.045 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 12.4 p-90 -65.21 154.27 38.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 110.635 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -145.86 155.46 42.91 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.602 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 42.0 p90 -154.35 162.63 41.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.133 -0.979 . . . . 0.0 108.753 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 6.1 p90 -152.79 162.32 41.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.69 -1.256 . . . . 0.0 111.833 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 95.2 m -127.63 157.66 39.64 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 122' ' ' VAL . 42.2 t -130.01 142.62 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.768 -1.208 . . . . 0.0 111.789 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 72.2 m -123.39 132.44 53.97 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.0 p -171.19 178.63 3.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.239 -1.538 . . . . 0.0 111.691 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.637 ' HZ2' ' CB ' ' A' ' 115' ' ' LYS . 7.3 mtmp? -153.41 164.75 37.61 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 117' ' ' ASN . 99.7 m-20 -57.76 152.28 15.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.771 -1.206 . . . . 0.0 109.195 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.515 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 66.8 t30 44.68 60.73 2.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.217 -0.927 . . . . 0.0 109.669 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.59 ' OE2' ' NZ ' ' A' ' 115' ' ' LYS . 36.8 mt-10 -165.37 145.71 6.97 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.136 -0.977 . . . . 0.0 110.178 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -63.67 136.2 57.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.25 -0.906 . . . . 0.0 109.038 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -85.26 146.12 27.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.226 -0.922 . . . . 0.0 110.406 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.1 mt -111.16 123.71 50.74 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.498 -0.751 . . . . 0.0 109.177 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 112' ' ' VAL . 46.0 t -109.03 130.34 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.022 -1.049 . . . . 0.0 110.617 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -110.69 122.62 48.24 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.9 t -137.84 143.28 40.9 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.835 -1.166 . . . . 0.0 112.208 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.602 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.1 m -134.75 156.9 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -134.79 155.58 50.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.982 -1.074 . . . . 0.0 110.272 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.518 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.086 -0.959 . . . . 0.0 109.393 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 mmtp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.92 133.54 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.708 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.61 ' NZ ' ' OD2' ' A' ' 46' ' ' ASP . 2.0 mptm? -74.72 125.49 28.85 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.047 -1.033 . . . . 0.0 108.95 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.95 179.05 44.33 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.436 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 4.8 t -115.97 132.23 56.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.483 -1.01 . . . . 0.0 109.316 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.472 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 29.5 t70 -108.19 109.63 21.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.496 -0.752 . . . . 0.0 109.422 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 91.0 m-85 -89.83 0.05 57.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.227 -0.921 . . . . 0.0 108.857 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.0 m -101.88 -17.88 15.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.566 -0.709 . . . . 0.0 110.505 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 12' ' ' GLU . 6.8 m -156.87 125.22 5.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.878 -1.139 . . . . 0.0 110.249 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.0 p -66.85 -24.84 66.19 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.629 -0.829 . . . . 0.0 108.97 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.441 ' H ' HG22 ' A' ' 10' ' ' THR . 79.0 mm-40 -115.0 74.59 0.89 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.461 ' OG ' ' CG ' ' A' ' 7' ' ' ASP . 20.0 m -71.81 152.39 42.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.83 . . . . 0.0 110.398 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.77 0.29 38.54 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.8 pt -125.27 -23.83 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.646 -0.659 . . . . 0.0 110.292 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -111.78 140.99 45.96 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.243 -0.911 . . . . 0.0 109.92 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.1 p -72.54 -18.42 61.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.589 -0.694 . . . . 0.0 111.045 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -132.14 143.14 49.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.015 -1.053 . . . . 0.0 110.847 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.472 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -152.81 159.91 28.73 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.436 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 32.4 m-85 . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.442 -1.034 . . . . 0.0 109.594 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.2 mm . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.1 t -121.68 126.52 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.277 -0.889 . . . . 0.0 110.173 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.44 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 84.3 m -102.18 100.8 11.05 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.8 m -93.87 119.58 32.99 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.141 -0.974 . . . . 0.0 109.659 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.434 ' CG2' HG12 ' A' ' 125' ' ' VAL . 28.0 m -141.95 153.86 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.49 -0.756 . . . . 0.0 109.232 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.419 ' HD3' ' H ' ' A' ' 41' ' ' LYS . 1.3 mppt? -95.25 133.88 38.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.116 -0.99 . . . . 0.0 109.142 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.435 ' HB1' ' CG2' ' A' ' 48' ' ' ILE . . . -109.47 124.06 50.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.457 -0.777 . . . . 0.0 109.734 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.509 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 28.2 t60 -86.72 148.2 25.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.84 . . . . 0.0 109.542 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.907 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -50.17 -34.26 21.9 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.22 -0.925 . . . . 0.0 109.779 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -89.88 -17.63 27.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.273 -0.892 . . . . 0.0 109.423 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.61 ' OD2' ' NZ ' ' A' ' 4' ' ' LYS . 76.4 m-20 -75.7 136.83 40.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.432 -0.793 . . . . 0.0 110.07 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.3 mt -77.31 145.41 37.41 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.435 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 21.0 pt -121.32 143.21 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.264 -0.898 . . . . 0.0 110.191 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.21 -174.07 46.07 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.613 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 50.8 p90 -170.52 169.62 7.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -1.225 . . . . 0.0 109.831 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -146.17 144.54 30.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.306 -0.871 . . . . 0.0 109.861 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 40.8 m -125.01 153.93 71.29 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.424 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 9.0 Cg_endo -51.51 144.78 31.27 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.337 2.025 . . . . 0.0 112.167 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.6 t -68.3 -13.85 62.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.453 -0.779 . . . . 0.0 110.636 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.623 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.9 m-20 -89.95 1.73 55.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.89 -1.131 . . . . 0.0 110.039 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.424 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 18.9 m-85 -110.79 165.93 11.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.099 -1.001 . . . . 0.0 110.446 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.416 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 39.5 t -102.7 132.92 48.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.344 -0.847 . . . . 0.0 108.96 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.4 m -89.73 120.31 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.992 -1.067 . . . . 0.0 110.346 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 59' ' ' GLU . 35.0 mp0 -127.69 128.08 23.95 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.22 114.3 3.53 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.683 1.588 . . . . 0.0 112.106 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.493 ' O ' ' O ' ' A' ' 68' ' ' PHE . 9.3 t-80 -91.17 -25.33 19.61 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 63' ' ' CYS . 67.4 t0 -171.85 36.43 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.495 ' O ' ' O ' ' A' ' 62' ' ' ASP . 96.5 m -57.13 -155.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.548 -0.72 . . . . 0.0 109.651 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.459 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 4.0 p90 -108.77 -56.27 2.29 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.037 -1.04 . . . . 0.0 111.173 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.44 HG23 ' CE2' ' A' ' 64' ' ' PHE . 53.2 t -46.49 -73.42 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.479 -1.388 . . . . 0.0 108.865 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.2 t -140.21 130.71 25.47 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.424 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.19 -178.41 2.07 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.464 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 5.0 m-85 -93.82 128.84 40.28 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -76.45 -174.57 2.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.953 -1.092 . . . . 0.0 109.741 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.4 -20.55 65.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.275 -0.891 . . . . 0.0 109.21 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.9 m -83.38 -6.85 59.59 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.32 19.61 66.3 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -101.43 136.74 40.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -1.167 . . . . 0.0 109.145 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -84.94 112.98 21.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.122 -0.986 . . . . 0.0 110.097 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -150.12 141.55 23.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.41 -0.806 . . . . 0.0 109.983 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 77' ' ' LEU . 56.0 t-20 -61.61 146.71 48.07 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.4 -0.812 . . . . 0.0 109.215 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.539 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 6.6 tp -99.69 6.11 45.63 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.288 -0.882 . . . . 0.0 109.8 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.439 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.8 OUTLIER -75.52 -39.02 58.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.97 -1.081 . . . . 0.0 109.983 -179.449 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 56.5 p30 -59.26 -14.21 10.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.131 -0.981 . . . . 0.0 109.165 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 31.0 ttpt -107.0 -36.17 6.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.382 -0.824 . . . . 0.0 109.327 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.662 HD22 ' CH2' ' A' ' 107' ' ' TRP . 33.1 tp -123.92 129.5 51.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.42 -0.8 . . . . 0.0 109.339 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -73.31 83.46 1.4 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.039 -1.038 . . . . 0.0 109.285 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.572 ' CB ' HD11 ' A' ' 86' ' ' ILE . 24.3 mt -69.32 130.11 41.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.224 -0.923 . . . . 0.0 109.959 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.3 p -133.86 151.71 51.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.397 -0.814 . . . . 0.0 109.302 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 52.82 50.69 17.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.098 -1.001 . . . . 0.0 109.58 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.572 HD11 ' CB ' ' A' ' 83' ' ' LEU . 97.6 mt -78.73 130.37 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.327 -0.858 . . . . 0.0 110.085 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mm -117.85 118.84 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.473 -0.767 . . . . 0.0 109.276 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 81.0 mtp -124.17 108.09 11.92 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.286 -0.884 . . . . 0.0 109.822 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -113.93 102.17 9.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.362 -0.836 . . . . 0.0 109.05 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.501 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 70.2 m80 -72.33 -35.74 68.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.898 -1.126 . . . . 0.0 110.488 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -60.7 -44.86 96.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.874 -1.141 . . . . 0.0 109.457 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -89.41 -5.72 57.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.134 -0.979 . . . . 0.0 109.129 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.501 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.3 m-20 55.36 47.47 21.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.576 -0.702 . . . . 0.0 110.392 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.589 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 2.8 t -132.3 137.5 47.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.146 -0.971 . . . . 0.0 109.404 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.613 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 23.8 m-85 -127.28 139.41 52.92 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.372 -0.83 . . . . 0.0 109.818 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.589 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 81.2 m-85 -135.9 147.01 47.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.21 -0.932 . . . . 0.0 109.358 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.6 t -150.86 150.9 31.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.953 -1.092 . . . . 0.0 109.174 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.413 ' HG2' HH11 ' A' ' 98' ' ' ARG . 60.7 mtt-85 -101.68 134.41 44.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.044 -1.035 . . . . 0.0 109.476 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.4 HD11 HG21 ' A' ' 48' ' ' ILE . 94.7 mt -93.39 139.22 22.86 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.436 -0.79 . . . . 0.0 109.5 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.907 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 77.0 Cg_exo -46.36 163.22 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.853 1.702 . . . . 0.0 111.222 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 m -76.34 -10.15 59.19 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.1 -1.0 . . . . 0.0 109.696 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.8 tp -136.42 129.29 30.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.152 -0.968 . . . . 0.0 110.339 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 88.7 mt -145.69 106.92 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 108.893 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.3 p -100.53 -2.81 32.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.048 -1.032 . . . . 0.0 109.899 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -88.45 156.13 19.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.99 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -105.02 33.2 3.75 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.452 -0.78 . . . . 0.0 109.135 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.662 ' CH2' HD22 ' A' ' 81' ' ' LEU . 24.4 p-90 -65.77 161.53 20.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.141 -0.974 . . . . 0.0 110.625 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -143.54 160.68 40.19 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.622 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 36.4 p90 -155.09 160.65 41.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.17 -0.956 . . . . 0.0 108.674 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 5.0 p90 -151.67 159.93 43.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.778 -1.201 . . . . 0.0 111.892 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 96.7 m -125.0 156.5 38.01 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.635 HG22 HG22 ' A' ' 122' ' ' VAL . 44.8 t -130.58 143.65 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.839 -1.163 . . . . 0.0 111.764 -178.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 63.4 m -124.66 132.95 53.38 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.6 p -167.62 178.08 5.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.25 -1.531 . . . . 0.0 111.694 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.623 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 46.5 mtmt -155.31 165.04 37.88 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 117' ' ' ASN . 98.2 m-20 -58.69 150.95 22.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.827 -1.171 . . . . 0.0 109.116 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.492 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 64.5 t30 44.53 60.95 2.62 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.232 -0.917 . . . . 0.0 109.639 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 40.4 mt-10 -164.48 144.72 7.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.132 -0.98 . . . . 0.0 110.216 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -63.28 136.66 57.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.197 -0.939 . . . . 0.0 109.111 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.432 ' HG2' ' H ' ' A' ' 120' ' ' LYS . 4.3 pttm -84.26 144.8 28.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.249 -0.907 . . . . 0.0 110.575 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 72.7 mt -110.92 123.67 50.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.583 -0.698 . . . . 0.0 109.181 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.635 HG22 HG22 ' A' ' 112' ' ' VAL . 45.3 t -109.9 130.94 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.01 -1.056 . . . . 0.0 110.679 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -110.37 122.53 47.92 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 38' ' ' CYS . 7.6 t -137.86 142.85 40.71 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.795 -1.191 . . . . 0.0 112.163 -178.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.622 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -136.12 158.18 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -124.01 145.21 49.35 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.106 -0.996 . . . . 0.0 110.415 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.279 179.792 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 69.4 t -106.12 134.32 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.162 -0.962 . . . . 0.0 110.042 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -70.47 124.04 23.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.065 -1.022 . . . . 0.0 108.371 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.18 164.79 30.39 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.471 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 4.4 t -107.59 138.04 44.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.621 -0.929 . . . . 0.0 109.386 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.445 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 67.3 t0 -114.81 109.01 17.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.446 -0.784 . . . . 0.0 109.36 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -86.32 -0.73 56.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 108.928 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.427 ' OG1' ' N ' ' A' ' 53' ' ' PRO . 17.1 m -99.66 -17.92 17.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.638 -0.663 . . . . 0.0 110.5 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.472 HG22 ' H ' ' A' ' 12' ' ' GLU . 9.3 m -158.24 127.64 5.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.769 -1.207 . . . . 0.0 110.263 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.7 p -62.5 -28.08 69.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -0.953 . . . . 0.0 108.973 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.472 ' H ' HG22 ' A' ' 10' ' ' THR . 97.8 mt-10 -109.24 108.4 18.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 15' ' ' ILE . 74.4 m -107.63 109.5 21.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 110.376 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 14' ' ' THR . 0.1 OUTLIER -66.84 2.58 1.35 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.489 ' H ' ' C ' ' A' ' 13' ' ' SER . 6.9 pt -124.48 -30.28 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.598 -0.689 . . . . 0.0 110.374 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.484 ' CZ ' ' CE2' ' A' ' 96' ' ' TYR . 54.5 m-85 -112.67 144.63 41.86 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.129 -0.982 . . . . 0.0 110.145 -179.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.0 p -75.11 -22.34 58.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.567 -0.708 . . . . 0.0 110.837 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -119.96 129.22 54.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.869 -1.144 . . . . 0.0 110.644 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -140.7 154.23 24.15 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.471 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 24.2 m-85 . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.354 -1.086 . . . . 0.0 109.53 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mm . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.4 t -121.51 130.37 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.121 -0.987 . . . . 0.0 110.445 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.434 ' O ' ' O ' ' A' ' 124' ' ' THR . 61.1 m -101.79 101.39 11.86 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.8 m -94.08 119.18 32.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.848 -1.157 . . . . 0.0 109.649 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.558 ' CG2' HG12 ' A' ' 125' ' ' VAL . 19.7 m -139.4 156.54 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.475 -0.766 . . . . 0.0 109.118 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -99.05 131.59 44.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.929 . . . . 0.0 109.561 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.56 152.48 21.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.553 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.477 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 47.4 t-80 -124.1 153.53 41.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.358 -0.839 . . . . 0.0 109.515 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.61 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -56.05 -26.1 47.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.368 -0.832 . . . . 0.0 109.772 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -96.91 -23.67 16.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.954 . . . . 0.0 109.61 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.477 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 82.4 m-20 -78.96 136.74 37.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.948 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.9 mt -78.78 150.36 32.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 0.0 108.669 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.9 pt -121.66 143.55 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.06 -1.025 . . . . 0.0 110.111 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.5 -172.72 45.49 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -170.49 169.9 7.16 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.007 -1.29 . . . . 0.0 109.713 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -145.11 144.03 30.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.296 -0.878 . . . . 0.0 109.816 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 86.0 m -123.45 151.99 63.97 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.427 ' N ' ' OG1' ' A' ' 9' ' ' THR . 8.6 Cg_endo -51.59 144.41 33.19 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.363 2.042 . . . . 0.0 111.949 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -66.64 -13.82 61.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.52 -0.738 . . . . 0.0 110.535 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.605 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 82.3 m-20 -89.93 0.66 56.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.922 -1.111 . . . . 0.0 110.161 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.423 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.0 m-85 -110.97 165.73 11.62 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.267 -0.896 . . . . 0.0 110.187 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.7 m -102.28 140.46 36.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.388 -0.82 . . . . 0.0 109.294 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.8 m -97.21 118.42 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.002 -1.061 . . . . 0.0 110.369 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.446 ' OE1' ' N ' ' A' ' 59' ' ' GLU . 5.6 mp0 -125.09 126.77 25.18 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.17 114.39 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.658 1.572 . . . . 0.0 112.142 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -93.66 -24.32 17.92 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.894 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.2 t0 -170.94 40.07 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.451 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 88.5 m -63.97 -152.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.608 -0.682 . . . . 0.0 109.89 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.519 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 3.3 p90 -110.3 -58.19 2.11 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.118 -0.989 . . . . 0.0 111.252 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.447 ' C ' ' O ' ' A' ' 64' ' ' PHE . 27.6 t -45.82 -70.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.568 -1.332 . . . . 0.0 108.807 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.4 t -142.54 132.48 24.33 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.451 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -171.83 179.59 2.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.929 -1.107 . . . . 0.0 110.419 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 4.7 m-85 -93.76 140.44 29.66 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.437 HD21 ' HG2' ' A' ' 75' ' ' GLU . 99.8 m-20 -80.7 -171.12 2.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.895 -1.128 . . . . 0.0 109.9 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.2 mt -65.99 -15.8 63.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.353 -0.842 . . . . 0.0 109.134 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.441 ' OG ' ' NZ ' ' A' ' 73' ' ' LYS . 32.5 t -86.47 -7.15 58.65 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.322 -0.861 . . . . 0.0 108.878 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.57 20.2 66.81 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.441 ' NZ ' ' OG ' ' A' ' 71' ' ' SER . 64.6 mttp -107.28 140.47 40.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -1.147 . . . . 0.0 109.068 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -63.66 134.15 54.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.135 -0.978 . . . . 0.0 109.933 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.437 ' HG2' HD21 ' A' ' 69' ' ' ASN . 34.5 tp10 -154.19 163.81 39.53 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.313 -0.867 . . . . 0.0 109.446 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -107.35 138.79 42.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.251 -0.906 . . . . 0.0 109.52 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 tp -97.06 -16.01 20.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.079 -1.013 . . . . 0.0 109.828 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -61.1 -43.65 98.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.894 -1.129 . . . . 0.0 109.521 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -65.09 -13.51 58.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.042 -1.036 . . . . 0.0 108.887 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -100.41 -41.66 6.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.384 -0.823 . . . . 0.0 109.162 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.521 HD23 HD21 ' A' ' 83' ' ' LEU . 37.1 tp -125.83 126.39 44.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 109.133 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -81.03 83.83 6.63 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.081 -1.012 . . . . 0.0 109.378 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.521 HD21 HD23 ' A' ' 81' ' ' LEU . 89.1 mt -77.21 143.93 38.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.312 -0.868 . . . . 0.0 109.955 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.7 p -127.78 158.23 38.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.554 -0.716 . . . . 0.0 109.308 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 m120 55.22 51.54 13.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.95 . . . . 0.0 109.699 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.75 129.84 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 110.107 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.2 mm -118.22 118.8 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.447 -0.783 . . . . 0.0 109.271 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 80.2 mtp -120.52 103.34 9.08 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.28 -0.887 . . . . 0.0 109.74 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -110.6 99.63 8.57 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.252 -0.905 . . . . 0.0 109.041 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.482 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 61.8 m80 -72.3 -35.99 68.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.107 -0.996 . . . . 0.0 110.549 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -60.32 -45.02 94.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.912 -1.117 . . . . 0.0 109.516 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -89.5 -4.94 57.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 109.031 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.482 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.0 m-20 54.82 48.46 20.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.495 -0.753 . . . . 0.0 110.17 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.543 ' OG1' ' CE1' ' A' ' 96' ' ' TYR . 3.3 t -134.22 140.14 46.28 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.026 -1.046 . . . . 0.0 109.343 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -129.43 140.72 51.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.489 -0.757 . . . . 0.0 110.206 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.543 ' CE1' ' OG1' ' A' ' 94' ' ' THR . 83.6 m-85 -136.18 146.85 47.3 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.417 -0.802 . . . . 0.0 109.537 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.1 p -152.64 159.44 43.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.981 -1.074 . . . . 0.0 109.172 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 -108.44 137.9 45.64 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.096 -1.003 . . . . 0.0 109.339 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 99' ' ' LEU . 46.3 mt -92.86 137.54 23.91 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.405 -0.809 . . . . 0.0 109.543 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.61 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 76.8 Cg_exo -45.86 170.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.836 1.69 . . . . 0.0 111.309 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.3 m -79.69 -10.61 59.81 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.101 -1.0 . . . . 0.0 109.754 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.6 tp -136.11 129.93 32.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.225 -0.922 . . . . 0.0 110.432 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.6 mt -147.37 102.37 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.235 -0.916 . . . . 0.0 108.643 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.7 m -102.83 -6.91 22.04 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.017 -1.052 . . . . 0.0 109.8 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 127' ' ' ALA . 84.7 m-20 -81.42 154.36 26.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.169 -0.957 . . . . 0.0 110.013 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -103.51 33.74 3.24 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.417 -0.802 . . . . 0.0 109.091 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.453 ' CH2' HD22 ' A' ' 81' ' ' LEU . 23.5 p-90 -64.98 152.66 42.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 110.452 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.24 153.96 51.09 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.639 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 30.6 p90 -152.4 162.35 41.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.999 -1.063 . . . . 0.0 108.698 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.491 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 8.2 p90 -154.1 160.77 42.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.729 -1.232 . . . . 0.0 111.792 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 97.5 m -125.61 156.45 39.16 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.587 HG22 HG22 ' A' ' 122' ' ' VAL . 42.8 t -128.45 139.1 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.881 -1.137 . . . . 0.0 111.79 -178.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 93.5 m -122.15 131.87 54.17 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.5 p -170.2 178.55 3.79 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.176 -1.578 . . . . 0.0 111.663 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.605 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 50.0 mtmt -151.7 163.38 39.25 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -58.55 151.25 20.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.775 -1.203 . . . . 0.0 109.078 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.52 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 60.5 t-20 46.35 61.19 2.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.228 -0.92 . . . . 0.0 109.47 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 37.3 mt-10 -165.73 146.3 6.79 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.127 -0.983 . . . . 0.0 110.233 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -61.84 134.75 57.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.168 -0.958 . . . . 0.0 109.089 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -81.57 143.31 32.08 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.118 -0.989 . . . . 0.0 110.328 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 58.7 mt -110.75 122.87 48.89 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.587 HG22 HG22 ' A' ' 112' ' ' VAL . 52.6 t -110.07 131.14 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.883 -1.135 . . . . 0.0 110.79 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -109.0 120.52 42.79 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 38' ' ' CYS . 7.2 t -137.08 141.25 42.37 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.933 -1.105 . . . . 0.0 111.892 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.639 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -135.92 159.47 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -124.9 146.68 49.21 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.161 -0.962 . . . . 0.0 110.423 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.31 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.2 t -93.91 133.05 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 109.983 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.548 ' NZ ' ' OD2' ' A' ' 46' ' ' ASP . 96.7 mttt -72.85 127.18 31.8 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.735 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.77 166.18 32.26 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.442 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 5.2 t -104.96 131.9 51.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.422 -1.046 . . . . 0.0 109.471 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -110.88 109.44 19.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.494 -0.754 . . . . 0.0 109.424 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.413 ' CD1' HD13 ' A' ' 121' ' ' LEU . 92.9 m-85 -87.17 1.1 54.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 108.942 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.4 m -105.24 -17.17 14.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.561 -0.712 . . . . 0.0 110.461 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.9 m -153.7 121.23 5.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.823 -1.173 . . . . 0.0 110.311 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.6 p -62.87 -29.79 71.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 108.911 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -109.98 73.02 0.82 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.491 ' HB2' ' H ' ' A' ' 16' ' ' PHE . 19.8 p -71.9 111.84 7.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.261 -0.899 . . . . 0.0 110.315 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.0 t -69.4 2.86 2.65 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.433 ' H ' ' C ' ' A' ' 13' ' ' SER . 4.8 pt -123.61 -32.24 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.711 -0.618 . . . . 0.0 110.394 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.491 ' H ' ' HB2' ' A' ' 13' ' ' SER . 86.6 m-85 -106.6 145.67 31.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.212 -0.93 . . . . 0.0 109.812 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.1 m -71.34 -25.29 62.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.511 -0.743 . . . . 0.0 110.886 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -125.19 136.03 53.18 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.925 -1.109 . . . . 0.0 110.52 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -142.89 158.33 27.1 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.442 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 22.6 m-85 . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.346 -1.091 . . . . 0.0 109.648 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.1 mm . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.2 t -114.36 124.89 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.348 -0.845 . . . . 0.0 110.213 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 83.1 m -102.26 101.92 12.26 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.8 m -97.4 121.96 39.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.072 -1.017 . . . . 0.0 109.588 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.413 ' CG2' HG12 ' A' ' 125' ' ' VAL . 24.1 m -139.38 155.5 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.408 -0.807 . . . . 0.0 109.024 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -95.94 123.76 39.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.324 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.542 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -87.99 161.99 17.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.7 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -139.99 148.4 41.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.908 . . . . 0.0 109.6 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.635 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -55.71 -24.2 33.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.362 -0.837 . . . . 0.0 109.745 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.485 ' OD1' ' O ' ' A' ' 45' ' ' ASN . 63.1 t-20 -98.96 -27.72 13.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.05 -1.031 . . . . 0.0 109.704 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.548 ' OD2' ' NZ ' ' A' ' 4' ' ' LYS . 88.3 m-20 -77.41 137.12 38.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.531 -0.731 . . . . 0.0 110.099 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.6 mt -78.23 148.28 34.03 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.431 HD13 HD21 ' A' ' 99' ' ' LEU . 47.2 pt -121.59 143.3 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.06 -1.025 . . . . 0.0 110.126 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.22 -176.14 47.22 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 50.5 p90 -164.9 170.37 15.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.126 -1.22 . . . . 0.0 109.75 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -148.33 146.08 28.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 109.936 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.4 m -126.21 152.17 73.16 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.3 Cg_endo -51.44 153.53 10.14 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.322 2.014 . . . . 0.0 111.867 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.5 m -72.5 -10.64 60.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.449 -0.782 . . . . 0.0 110.7 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.599 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.9 m-20 -92.4 -2.26 56.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.993 -1.067 . . . . 0.0 110.173 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.434 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 18.6 m-85 -108.69 164.58 12.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.158 -0.964 . . . . 0.0 110.346 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 t -105.11 135.13 47.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.331 -0.855 . . . . 0.0 109.119 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 58' ' ' VAL . 3.0 m -92.6 119.87 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.993 -1.067 . . . . 0.0 110.316 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -123.36 126.4 25.88 Favored Pre-proline 0 N--CA 1.489 1.522 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.13 114.25 3.54 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.721 1.614 . . . . 0.0 112.144 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 68' ' ' PHE . 16.5 t-80 -93.71 -24.26 17.91 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.0 t0 -170.18 40.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.453 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 89.1 m -63.6 -154.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.524 -0.735 . . . . 0.0 109.887 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 4.3 p90 -110.56 -57.28 2.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.122 -0.986 . . . . 0.0 111.388 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 64' ' ' PHE . 34.7 t -46.12 -59.12 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.562 -1.336 . . . . 0.0 108.963 -179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.1 t -156.85 133.86 10.36 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.453 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.0 -178.14 2.07 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.396 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 4.3 m-85 -93.63 143.25 26.48 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . 0.456 ' OD1' ' OE1' ' A' ' 75' ' ' GLU . 28.7 m120 -84.77 -169.2 2.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.112 -0.993 . . . . 0.0 109.828 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 70' ' ' LEU . 10.2 mp -66.85 -15.32 63.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.362 -0.836 . . . . 0.0 108.936 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.8 p -89.62 -8.35 52.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.916 . . . . 0.0 108.693 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.25 22.25 57.29 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -107.16 138.9 42.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.278 -1.13 . . . . 0.0 109.126 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -67.97 136.42 53.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.419 -0.8 . . . . 0.0 109.988 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.456 ' OE1' ' OD1' ' A' ' 69' ' ' ASN . 68.1 tt0 -155.33 165.84 35.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 109.594 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.416 ' N ' ' HG2' ' A' ' 75' ' ' GLU . 4.1 m120 -103.93 135.6 45.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.448 -0.782 . . . . 0.0 109.452 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.7 tp -97.61 -10.04 25.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.115 -0.99 . . . . 0.0 109.98 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -60.28 -44.57 95.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.944 -1.097 . . . . 0.0 109.638 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -64.83 -21.8 66.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.101 -1.0 . . . . 0.0 108.927 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -81.0 -48.42 12.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.437 -0.79 . . . . 0.0 109.283 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.673 HD23 HD21 ' A' ' 83' ' ' LEU . 44.0 tp -127.06 128.69 46.68 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.522 -0.737 . . . . 0.0 109.111 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -73.91 83.96 1.71 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.031 -1.043 . . . . 0.0 109.198 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.673 HD21 HD23 ' A' ' 81' ' ' LEU . 92.6 mt -80.37 135.25 36.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -0.828 . . . . 0.0 110.026 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.9 p -126.78 162.21 26.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.601 -0.687 . . . . 0.0 109.201 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.403 HD22 ' HD2' ' A' ' 98' ' ' ARG . 97.7 m-20 54.82 50.95 14.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 109.574 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.53 131.33 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.331 -0.856 . . . . 0.0 110.124 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -119.49 120.01 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.461 -0.774 . . . . 0.0 109.246 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 71.9 mtp -122.51 105.33 10.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.111 -0.993 . . . . 0.0 109.745 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -110.81 100.79 9.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.367 -0.833 . . . . 0.0 109.0 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.453 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 95.5 m-70 -73.25 -34.61 65.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.964 -1.085 . . . . 0.0 110.583 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -60.47 -45.8 92.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.862 -1.149 . . . . 0.0 109.63 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -89.64 -3.89 58.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.129 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 97.5 m-20 55.06 48.07 20.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.585 -0.697 . . . . 0.0 110.326 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.597 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 1.9 t -133.43 138.89 46.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.99 -1.068 . . . . 0.0 109.458 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 75.3 m-85 -126.93 139.06 53.34 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.323 -0.861 . . . . 0.0 109.93 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.597 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 73.4 m-85 -135.39 146.23 48.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.257 -0.902 . . . . 0.0 109.427 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 53.9 m -150.05 151.95 34.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.094 -1.004 . . . . 0.0 109.189 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.423 ' HG2' HH11 ' A' ' 98' ' ' ARG . 59.0 mtt-85 -103.55 135.64 44.76 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.062 -1.024 . . . . 0.0 109.415 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.542 HD11 ' HB1' ' A' ' 42' ' ' ALA . 67.8 mt -89.81 137.18 28.53 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.478 -0.764 . . . . 0.0 109.607 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.635 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 76.9 Cg_exo -46.39 162.09 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.777 1.651 . . . . 0.0 111.329 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.0 m -71.36 -17.43 62.43 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.115 -0.991 . . . . 0.0 109.713 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.2 tp -132.46 130.71 40.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.236 -0.915 . . . . 0.0 110.39 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.449 HD11 ' HB3' ' A' ' 99' ' ' LEU . 96.7 mt -142.78 125.56 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.321 -0.862 . . . . 0.0 108.713 178.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.9 p -131.5 54.28 1.93 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.041 -1.037 . . . . 0.0 109.755 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.603 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 7.1 t0 -145.24 151.06 37.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 109.954 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.603 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 99.8 m-20 -91.33 33.66 0.98 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.492 -0.755 . . . . 0.0 109.039 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.589 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 12.8 p-90 -64.86 150.19 48.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.167 -0.958 . . . . 0.0 110.514 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.6 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 12.9 tttp -139.85 151.95 46.09 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.637 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 32.1 p90 -156.07 162.61 40.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.028 -1.045 . . . . 0.0 108.72 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.464 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 10.1 p90 -153.89 158.62 41.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.679 -1.263 . . . . 0.0 111.785 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 98.1 m -123.15 156.49 34.94 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 122' ' ' VAL . 46.5 t -128.5 139.19 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 120.955 -1.09 . . . . 0.0 111.678 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 23.2 m -122.14 131.61 54.05 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 71.6 p -172.01 179.18 2.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.325 -1.484 . . . . 0.0 111.573 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.599 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 49.8 mtmt -150.72 163.17 39.21 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 117' ' ' ASN . 55.2 p-10 -58.13 154.38 13.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.751 -1.218 . . . . 0.0 109.214 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.508 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 66.3 t30 43.43 60.33 2.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.208 -0.932 . . . . 0.0 109.641 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 36.8 mt-10 -165.31 146.01 7.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.14 -0.975 . . . . 0.0 110.205 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -57.41 144.27 37.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.232 -0.918 . . . . 0.0 108.904 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -91.9 139.74 30.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.175 -0.953 . . . . 0.0 110.382 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.413 HD13 ' CD1' ' A' ' 8' ' ' PHE . 26.5 mt -108.04 120.43 42.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.374 -0.828 . . . . 0.0 109.043 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 112' ' ' VAL . 49.9 t -109.01 129.88 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.968 -1.083 . . . . 0.0 110.493 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -108.27 120.42 42.33 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.6 ' OG1' ' NZ ' ' A' ' 108' ' ' LYS . 12.9 t -136.26 140.93 43.82 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.889 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.637 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.1 m -134.88 156.47 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -129.97 150.5 51.22 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.158 -0.964 . . . . 0.0 110.3 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.519 ' HB3' ' NE1' ' A' ' 107' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.277 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 51.7 t -104.48 130.82 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.236 -0.915 . . . . 0.0 109.904 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.461 ' N ' ' CD ' ' A' ' 4' ' ' LYS . 3.6 mptp? -68.54 122.96 19.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.159 -0.963 . . . . 0.0 108.791 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.52 175.39 44.71 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -116.11 130.78 56.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.453 -1.028 . . . . 0.0 109.479 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.512 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 40.5 t0 -108.23 109.47 20.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.447 -0.783 . . . . 0.0 109.269 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.47 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 91.8 m-85 -88.29 0.89 55.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.151 -0.968 . . . . 0.0 108.977 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.2 m -102.12 -17.02 16.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.592 -0.692 . . . . 0.0 110.685 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.608 HG22 ' H ' ' A' ' 12' ' ' GLU . 69.4 m -158.08 128.38 6.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.868 -1.145 . . . . 0.0 110.292 -179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.443 ' OG ' ' C ' ' A' ' 20' ' ' TYR . 13.7 m -68.11 -25.45 65.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.895 . . . . 0.0 108.934 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.608 ' H ' HG22 ' A' ' 10' ' ' THR . 77.6 mt-10 -114.35 74.28 0.87 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 108.928 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.512 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 7.8 m -70.01 151.94 44.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 110.248 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -100.03 -0.08 39.91 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.8 pt -125.25 -25.01 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.7 -0.625 . . . . 0.0 110.176 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -111.58 139.64 46.85 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.033 -1.042 . . . . 0.0 109.912 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.2 m -71.85 -18.09 62.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.555 -0.716 . . . . 0.0 110.649 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -131.22 142.13 50.13 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.789 -1.194 . . . . 0.0 110.636 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.447 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -162.33 166.35 36.45 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.443 ' C ' ' OG ' ' A' ' 11' ' ' SER . 70.8 m-85 . . . . . 0 N--CA 1.495 1.779 0 O-C-N 121.316 -1.108 . . . . 0.0 109.586 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.7 mm . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.486 HG22 ' HB ' ' A' ' 122' ' ' VAL . 53.1 t -120.97 129.84 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.061 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.47 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 91.1 m -100.8 99.56 10.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.0 m -95.87 121.07 37.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.933 -1.104 . . . . 0.0 109.489 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.452 ' CG2' HG12 ' A' ' 125' ' ' VAL . 22.8 m -141.34 155.84 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.401 -0.812 . . . . 0.0 109.246 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -96.08 129.52 43.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.945 . . . . 0.0 109.387 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.491 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -100.02 154.53 18.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.304 -0.872 . . . . 0.0 109.626 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.48 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 32.4 t-80 -126.56 151.84 47.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.336 -0.852 . . . . 0.0 109.558 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.544 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -55.17 -25.11 30.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.883 . . . . 0.0 109.789 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -98.99 -24.97 14.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.926 . . . . 0.0 109.655 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 85.5 m-20 -74.4 135.66 42.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.428 -0.795 . . . . 0.0 110.161 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.404 ' HB3' HH21 ' A' ' 98' ' ' ARG . 69.7 mt -76.86 145.59 38.26 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.542 HD13 HD21 ' A' ' 99' ' ' LEU . 39.1 pt -120.17 141.92 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.019 -1.05 . . . . 0.0 110.392 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.29 -174.57 46.83 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -170.16 169.95 7.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.049 -1.265 . . . . 0.0 109.739 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -146.96 145.03 29.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.315 -0.865 . . . . 0.0 109.762 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.7 m -124.49 153.4 69.43 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.258 -0.902 . . . . 0.0 108.626 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.45 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.51 147.69 22.31 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.307 2.004 . . . . 0.0 111.98 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.1 t -68.1 -13.84 62.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.465 -0.772 . . . . 0.0 110.621 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.634 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.7 m-20 -89.71 -0.77 57.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.834 -1.166 . . . . 0.0 110.224 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.45 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.5 m-85 -109.63 164.8 12.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.961 . . . . 0.0 110.186 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 m -105.24 135.51 46.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.387 -0.821 . . . . 0.0 109.298 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.8 m -90.16 118.4 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.074 -1.016 . . . . 0.0 110.393 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -123.84 127.84 25.31 Favored Pre-proline 0 N--CA 1.491 1.609 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.29 114.04 3.47 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.662 1.574 . . . . 0.0 112.16 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 68' ' ' PHE . 12.1 t-80 -91.22 -25.41 19.53 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.3 t0 -172.7 39.27 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.458 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 77.0 m -60.87 -153.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.538 -0.726 . . . . 0.0 109.842 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 4.3 p90 -108.97 -56.1 2.32 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.004 -1.06 . . . . 0.0 111.256 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 66' ' ' SER . 13.1 t -48.79 -74.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.559 -1.338 . . . . 0.0 108.876 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.507 ' N ' HG12 ' A' ' 65' ' ' VAL . 27.6 t -137.16 131.2 32.22 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.458 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.11 179.92 2.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.992 -1.068 . . . . 0.0 110.428 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 5.4 m-85 -93.46 130.31 39.33 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -76.63 -174.03 2.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.931 -1.106 . . . . 0.0 109.904 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.4 mt -64.27 -20.85 66.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 109.103 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.7 p -83.42 -6.36 59.44 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.12 19.74 66.45 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -100.82 139.14 36.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.233 -1.157 . . . . 0.0 109.193 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -84.38 112.38 20.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.928 . . . . 0.0 110.08 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -150.57 140.99 22.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.355 -0.841 . . . . 0.0 109.964 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -63.24 149.46 45.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.114 -0.991 . . . . 0.0 109.49 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 77' ' ' LEU . 14.7 tp -96.55 7.39 46.66 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.359 -0.838 . . . . 0.0 109.691 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -69.02 -40.39 78.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.053 -1.029 . . . . 0.0 109.952 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.607 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 51.5 p-10 -61.95 -31.44 71.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 0.0 109.106 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.607 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 29.1 tptp -75.56 -48.17 23.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.514 -0.741 . . . . 0.0 109.255 178.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.465 HD11 ' HG2' ' A' ' 100' ' ' PRO . 15.6 tp -149.13 123.67 9.74 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -80.46 99.54 8.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.054 -1.029 . . . . 0.0 109.644 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.2 mt -76.08 158.97 31.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.435 -0.79 . . . . 0.0 109.784 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.2 p -129.51 160.17 34.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.264 -0.898 . . . . 0.0 109.346 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 54.59 51.29 14.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.072 -1.018 . . . . 0.0 109.723 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.9 mt -80.74 130.79 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.331 -0.856 . . . . 0.0 109.996 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.9 mm -123.06 121.82 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.516 -0.74 . . . . 0.0 109.192 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 87.1 mtp -121.87 104.14 9.34 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.021 -1.05 . . . . 0.0 109.884 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -112.07 100.76 9.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.296 -0.878 . . . . 0.0 108.904 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.48 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 93.5 m-70 -72.88 -35.94 67.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.873 -1.142 . . . . 0.0 110.657 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -60.4 -46.55 89.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.964 -1.085 . . . . 0.0 109.434 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -88.13 -4.92 58.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 0.0 109.107 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.48 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.3 m-20 54.71 47.72 21.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.522 -0.736 . . . . 0.0 110.173 178.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.584 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 4.8 t -132.62 137.87 47.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.009 -1.057 . . . . 0.0 109.359 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -126.89 139.24 53.22 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.385 -0.822 . . . . 0.0 109.979 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.584 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 80.4 m-85 -136.24 146.79 47.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.162 -0.961 . . . . 0.0 109.569 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.548 ' C ' ' CZ ' ' A' ' 98' ' ' ARG . 20.0 p -154.28 153.18 31.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.199 -0.938 . . . . 0.0 109.167 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.548 ' CZ ' ' C ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -100.64 137.01 39.61 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.112 -0.993 . . . . 0.0 109.687 -179.729 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.542 HD21 HD13 ' A' ' 48' ' ' ILE . 63.8 mt -88.84 134.74 33.06 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.467 -0.771 . . . . 0.0 109.518 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.586 ' HD2' HD11 ' A' ' 103' ' ' ILE . 78.1 Cg_exo -46.48 155.78 0.68 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.68 1.586 . . . . 0.0 111.32 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.5 t -63.98 -43.36 95.96 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.172 -0.955 . . . . 0.0 109.862 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.7 tp -105.18 126.25 51.87 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.163 -0.961 . . . . 0.0 110.209 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.586 HD11 ' HD2' ' A' ' 100' ' ' PRO . 91.9 mt -151.33 104.06 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.134 -0.979 . . . . 0.0 108.847 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 90.7 p -108.25 0.9 21.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.967 . . . . 0.0 109.757 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -79.93 151.6 30.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 109.994 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -98.85 32.6 2.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.462 -0.774 . . . . 0.0 108.969 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 19.7 p-90 -65.89 158.41 28.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 110.587 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.3 157.46 44.79 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.63 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 35.8 p90 -155.31 160.47 40.78 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.939 -1.101 . . . . 0.0 108.769 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.529 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 5.6 p90 -151.49 158.99 44.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.664 -1.273 . . . . 0.0 111.766 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 90.0 m -124.62 156.3 37.71 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 122' ' ' VAL . 41.7 t -129.64 141.66 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.89 -1.132 . . . . 0.0 111.72 -178.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 91.4 m -120.37 131.44 54.84 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.8 p -168.38 178.86 4.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.264 -1.523 . . . . 0.0 111.643 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.634 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 42.5 mtmt -159.11 167.94 27.91 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.508 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 48.5 p30 -58.72 151.44 21.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.823 -1.173 . . . . 0.0 109.009 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.47 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 60.1 t-20 40.89 58.91 2.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.237 -0.914 . . . . 0.0 109.385 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 54.5 mm-40 -157.57 137.54 12.45 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.089 -1.007 . . . . 0.0 110.521 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -54.3 140.89 31.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.059 -1.025 . . . . 0.0 109.141 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -89.11 138.75 31.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.189 -0.944 . . . . 0.0 110.307 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.5 mt -111.24 123.11 49.55 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 112' ' ' VAL . 39.4 t -108.58 130.45 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.878 -1.139 . . . . 0.0 110.621 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -108.91 119.76 40.5 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.6 t -137.14 143.51 42.52 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.876 -1.14 . . . . 0.0 111.946 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.63 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.4 m -136.79 159.55 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 126' ' ' GLU . 57.2 mp0 -128.51 147.83 50.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.055 -1.028 . . . . 0.0 110.217 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.299 179.762 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 77.5 t -97.76 134.84 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.262 -0.899 . . . . 0.0 110.079 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' A' ' 4' ' ' LYS . 14.2 mptt -68.89 125.91 28.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.949 -1.095 . . . . 0.0 108.618 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.82 -170.95 44.12 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.461 -1.352 . . . . 0.0 109.736 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.7 t -126.49 132.66 51.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -1.087 . . . . 0.0 109.612 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.453 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 51.6 t0 -107.86 108.71 20.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.557 -0.714 . . . . 0.0 109.283 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -88.28 1.23 55.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 108.756 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 83.0 m -102.28 -16.97 16.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.503 -0.748 . . . . 0.0 110.477 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.627 HG22 ' H ' ' A' ' 12' ' ' GLU . 48.6 m -158.08 127.37 5.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.884 -1.135 . . . . 0.0 110.409 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 t -65.2 -26.01 67.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 108.826 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.627 ' H ' HG22 ' A' ' 10' ' ' THR . 76.8 mm-40 -114.33 74.06 0.85 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -69.91 150.8 46.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 110.37 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.89 0.89 39.29 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.425 HD12 ' CE2' ' A' ' 16' ' ' PHE . 6.9 pt -123.91 -23.63 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.666 -0.647 . . . . 0.0 110.184 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.425 ' CE2' HD12 ' A' ' 15' ' ' ILE . 58.6 m-85 -115.26 136.85 52.67 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.304 -0.873 . . . . 0.0 110.023 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.1 t -67.28 -17.79 64.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.571 -0.706 . . . . 0.0 110.864 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -129.95 140.97 50.84 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.039 -1.038 . . . . 0.0 110.523 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.453 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -154.43 161.16 29.99 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 . . . . . 0 N--CA 1.495 1.782 0 O-C-N 121.481 -1.011 . . . . 0.0 109.636 -179.794 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.5 mm . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.6 t -115.98 127.05 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.345 -0.847 . . . . 0.0 110.482 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.42 ' O ' ' O ' ' A' ' 124' ' ' THR . 97.5 m -102.62 101.43 11.57 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.2 m -94.22 120.69 34.84 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.055 -1.028 . . . . 0.0 109.58 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.553 ' CG2' HG12 ' A' ' 125' ' ' VAL . 15.9 m -141.36 149.34 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.528 -0.733 . . . . 0.0 109.349 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -90.52 130.65 36.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.971 -1.081 . . . . 0.0 109.24 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.25 151.27 22.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.906 . . . . 0.0 109.288 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.494 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 38.2 t-80 -122.92 152.63 40.63 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.322 -0.861 . . . . 0.0 109.483 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.838 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -55.69 -25.73 41.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.409 -0.807 . . . . 0.0 109.762 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -98.81 -25.72 14.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 0.0 109.764 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.494 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 86.3 m-20 -73.37 135.51 44.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.361 -0.837 . . . . 0.0 110.026 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 75.3 mt -77.21 145.87 37.35 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.414 HG21 HD11 ' A' ' 99' ' ' LEU . 46.1 pt -123.05 145.04 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.204 -0.935 . . . . 0.0 110.207 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.52 -172.52 45.28 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 49.9 p90 -171.3 170.11 6.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.075 -1.25 . . . . 0.0 109.785 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -146.38 144.67 29.9 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.243 -0.911 . . . . 0.0 109.79 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 70.4 m -123.0 153.15 64.08 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.424 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 9.3 Cg_endo -51.81 145.06 32.86 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.292 1.995 . . . . 0.0 112.138 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 t -68.02 -14.83 63.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.481 -0.762 . . . . 0.0 110.628 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -89.6 1.64 55.72 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.931 -1.106 . . . . 0.0 110.233 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.438 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 19.0 m-85 -110.55 166.43 11.0 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.398 -0.814 . . . . 0.0 110.482 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.431 ' OG ' ' OE2' ' A' ' 59' ' ' GLU . 35.2 t -103.01 133.88 47.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -0.837 . . . . 0.0 108.828 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.1 m -91.05 124.49 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.042 -1.037 . . . . 0.0 110.198 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.431 ' OE2' ' OG ' ' A' ' 57' ' ' SER . 10.5 mp0 -131.28 125.82 21.08 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.07 114.47 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.644 1.562 . . . . 0.0 112.047 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.497 ' O ' ' O ' ' A' ' 68' ' ' PHE . 17.3 t-80 -91.57 -23.26 19.96 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.2 t0 -173.5 39.15 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.425 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 81.5 m -60.34 -152.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.577 -0.702 . . . . 0.0 109.533 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.502 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 3.3 p90 -110.88 -58.03 2.15 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.245 -0.909 . . . . 0.0 111.318 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 64' ' ' PHE . 23.5 t -45.95 -72.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.298 -1.501 . . . . 0.0 108.893 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.426 ' N ' HG12 ' A' ' 65' ' ' VAL . 38.4 t -139.98 130.31 25.31 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.425 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.24 -178.79 1.8 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.121 -0.987 . . . . 0.0 110.524 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.516 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 4.2 m-85 -93.55 123.45 36.87 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -71.9 -175.84 1.54 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.044 -1.035 . . . . 0.0 109.754 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.6 mt -62.79 -22.86 66.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.181 -0.95 . . . . 0.0 109.112 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.6 t -79.85 -7.36 58.67 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.333 -0.855 . . . . 0.0 108.857 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.69 18.4 68.24 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -101.41 138.63 38.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -1.156 . . . . 0.0 109.072 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -86.08 110.12 19.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.202 -0.936 . . . . 0.0 110.165 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -146.72 143.35 28.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.364 -0.835 . . . . 0.0 109.914 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -64.65 149.64 48.61 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.503 -0.879 . . . . 0.0 109.51 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 13.1 tp -98.8 4.94 47.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.234 -0.916 . . . . 0.0 109.945 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 79' ' ' ASN . 17.7 pt-20 -68.23 -41.31 81.42 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.038 -1.039 . . . . 0.0 110.013 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.593 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 43.4 p30 -64.46 -27.67 69.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.09 -1.006 . . . . 0.0 109.138 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.593 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 28.9 tptp -83.5 -47.73 11.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 109.361 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.582 HD23 HD21 ' A' ' 83' ' ' LEU . 43.3 tp -125.94 126.68 44.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.44 -0.787 . . . . 0.0 109.299 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -77.86 83.62 4.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.134 -0.979 . . . . 0.0 109.277 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.582 HD21 HD23 ' A' ' 81' ' ' LEU . 92.3 mt -82.6 136.04 34.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.393 -0.817 . . . . 0.0 110.083 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.3 p -126.16 160.79 29.24 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.418 ' HB2' ' NE ' ' A' ' 98' ' ' ARG . 26.5 m120 55.59 50.8 13.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.455 -0.778 . . . . 0.0 109.666 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.2 mt -78.33 131.53 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.997 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.2 mm -117.94 118.68 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.374 -0.829 . . . . 0.0 109.258 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 93.8 mtp -124.98 110.65 14.47 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.276 -0.89 . . . . 0.0 109.883 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -114.07 101.13 8.94 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.364 -0.835 . . . . 0.0 108.907 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.458 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 74.2 m80 -71.04 -36.74 72.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.079 -1.013 . . . . 0.0 110.677 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -60.14 -45.78 91.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.998 -1.064 . . . . 0.0 109.66 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -88.61 -5.23 58.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.161 -0.962 . . . . 0.0 109.152 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.3 m-20 54.72 48.28 20.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.573 -0.704 . . . . 0.0 110.338 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.603 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 2.9 t -132.38 137.04 47.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.013 -1.055 . . . . 0.0 109.313 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.563 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 47.1 m-85 -125.2 138.34 54.13 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.338 -0.851 . . . . 0.0 109.735 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' TYR . . . . . 0.603 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 81.3 m-85 -136.07 146.19 46.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.217 -0.927 . . . . 0.0 109.154 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 83.8 p -154.96 155.91 35.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.932 . . . . 0.0 109.015 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.614 ' CB ' HH11 ' A' ' 98' ' ' ARG . 0.0 OUTLIER -107.81 139.56 42.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.162 -0.961 . . . . 0.0 109.934 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 100' ' ' PRO . 94.6 mt -96.6 142.31 24.36 Favored Pre-proline 0 C--N 1.297 -1.685 0 O-C-N 121.65 -0.656 . . . . 0.0 109.756 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.838 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 76.4 Cg_exo -45.56 177.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.779 1.653 . . . . 0.0 111.263 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 96.9 p -85.32 -9.23 57.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.022 -1.049 . . . . 0.0 109.747 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.2 tp -139.0 130.66 27.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.229 -0.919 . . . . 0.0 110.778 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.2 mt -147.37 102.57 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.225 -0.922 . . . . 0.0 108.885 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 97.1 p -100.0 -3.05 32.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.056 -1.027 . . . . 0.0 109.819 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 127' ' ' ALA . 84.4 m-20 -82.11 151.05 27.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.853 . . . . 0.0 110.165 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -99.22 31.34 3.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.525 -0.734 . . . . 0.0 109.126 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.431 ' CH2' HD22 ' A' ' 81' ' ' LEU . 18.8 p-90 -66.59 159.95 26.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 110.627 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -144.24 158.83 43.51 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PHE . . . . . 0.539 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 25.5 p90 -152.13 161.96 41.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.942 -1.098 . . . . 0.0 108.655 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.521 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 7.3 p90 -152.56 158.48 42.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.794 -1.191 . . . . 0.0 111.746 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 84.9 m -124.74 156.55 37.49 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.588 HG22 HG22 ' A' ' 122' ' ' VAL . 44.4 t -129.73 140.51 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.893 -1.129 . . . . 0.0 111.829 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 72.2 m -124.16 133.18 53.63 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.2 p -169.56 178.25 4.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.27 -1.518 . . . . 0.0 111.647 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.546 ' NZ ' ' OE2' ' A' ' 118' ' ' GLU . 6.1 mtmp? -153.59 163.29 40.23 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 178.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 117' ' ' ASN . 99.3 m-20 -58.22 153.22 15.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.851 -1.156 . . . . 0.0 109.109 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.506 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 66.7 t30 44.04 59.4 3.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.167 -0.958 . . . . 0.0 109.555 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.546 ' OE2' ' NZ ' ' A' ' 115' ' ' LYS . 41.6 mt-10 -165.23 145.96 7.24 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.189 -0.944 . . . . 0.0 110.164 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.2 134.07 52.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.115 -0.991 . . . . 0.0 109.003 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -83.37 147.86 27.65 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.038 -1.039 . . . . 0.0 110.337 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.6 mt -111.04 124.45 52.2 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.588 HG22 HG22 ' A' ' 112' ' ' VAL . 42.2 t -108.83 130.22 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.998 -1.064 . . . . 0.0 110.388 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -109.52 121.23 44.74 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.42 ' O ' ' O ' ' A' ' 38' ' ' CYS . 5.3 t -137.33 142.89 41.83 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.468 1.127 . . . . 0.0 112.323 -178.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.553 HG12 ' CG2' ' A' ' 40' ' ' VAL . 3.1 m -138.39 158.7 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.546 ' CD ' ' N ' ' A' ' 127' ' ' ALA . 12.4 tm-20 -134.34 155.7 49.79 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.185 -0.947 . . . . 0.0 110.317 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.546 ' N ' ' CD ' ' A' ' 126' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.386 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -73.09 156.41 38.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.155 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 70.4 t -98.22 130.78 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.333 -0.854 . . . . 0.0 109.871 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -71.07 121.94 19.16 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.201 -0.937 . . . . 0.0 108.483 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.2 164.86 31.04 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.403 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 7.2 t -105.71 133.34 50.61 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.396 -1.061 . . . . 0.0 109.862 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.512 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 39.8 t0 -110.92 109.39 19.52 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.211 -0.931 . . . . 0.0 109.462 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.426 ' CG ' HD13 ' A' ' 121' ' ' LEU . 84.2 m-85 -87.0 3.75 44.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.135 -0.978 . . . . 0.0 108.872 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.4 m -109.83 -16.61 13.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.473 -0.767 . . . . 0.0 110.623 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.5 m -151.14 117.24 5.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.804 -1.185 . . . . 0.0 110.186 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.7 m -59.93 -32.22 70.57 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -111.49 75.48 0.92 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.512 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 1.3 m -74.18 115.11 13.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.354 -0.842 . . . . 0.0 110.365 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.9 t -67.75 3.25 1.51 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.478 ' H ' ' C ' ' A' ' 13' ' ' SER . 8.0 pt -124.02 -40.8 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.473 -0.767 . . . . 0.0 110.184 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.445 ' CE2' HD12 ' A' ' 15' ' ' ILE . 85.4 m-85 -100.32 142.08 32.28 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.919 -1.113 . . . . 0.0 109.806 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.6 t -72.24 -23.79 61.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.414 -0.804 . . . . 0.0 110.915 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -119.2 129.78 55.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.715 -1.24 . . . . 0.0 110.417 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -141.41 154.73 24.82 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.403 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 33.0 m-85 -123.58 155.71 37.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -1.146 . . . . 0.0 109.575 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.8 t -94.81 157.44 15.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.127 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.8 pt -61.25 -23.67 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.101 -0.999 . . . . 0.0 109.481 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -79.47 -52.69 7.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 109.654 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.68 -39.55 37.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.361 -0.837 . . . . 0.0 109.969 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.4 pt -70.25 -12.64 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.919 -1.113 . . . . 0.0 109.526 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.2 p -101.96 -23.64 14.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.209 -0.932 . . . . 0.0 109.478 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 29' ' ' SER . 56.3 t-20 -125.61 -78.97 0.6 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.246 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -66.34 66.98 0.05 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.513 -0.742 . . . . 0.0 109.434 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 27' ' ' ASN . 12.8 m -61.64 179.02 0.27 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 109.282 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.688 ' CB ' ' H ' ' A' ' 37' ' ' VAL . 16.1 m -72.18 -82.38 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.507 -0.746 . . . . 0.0 109.84 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -116.69 -59.05 2.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.195 -0.94 . . . . 0.0 109.573 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.413 HD22 ' HB2' ' A' ' 35' ' ' ASP . 89.0 m-20 -63.39 -150.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.489 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.465 ' HG3' ' H ' ' A' ' 34' ' ' GLN . 9.9 pt20 -102.96 -49.98 3.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.17 -0.956 . . . . 0.0 109.579 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.557 ' CG ' ' N ' ' A' ' 35' ' ' ASP . 2.3 pt20 -108.0 -47.0 3.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.061 -1.025 . . . . 0.0 109.429 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.557 ' N ' ' CG ' ' A' ' 34' ' ' GLN . 0.7 OUTLIER -50.23 117.85 2.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.259 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.2 mm -98.59 122.15 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.135 -0.978 . . . . 0.0 108.821 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.688 ' H ' ' CB ' ' A' ' 30' ' ' SER . 49.0 t -119.3 129.42 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.062 -1.024 . . . . 0.0 110.25 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 74.4 m -102.77 101.91 12.02 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.0 m -94.12 120.63 34.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -0.958 . . . . 0.0 109.722 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.59 HG22 HG12 ' A' ' 125' ' ' VAL . 3.1 m -138.58 158.58 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.42 -0.8 . . . . 0.0 109.041 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -100.85 122.45 43.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -0.895 . . . . 0.0 109.509 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.49 164.41 13.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -0.847 . . . . 0.0 109.546 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.436 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 26.0 t60 -138.1 153.07 49.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 0.0 109.715 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 100' ' ' PRO . . . -54.63 -26.29 32.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 0.0 109.783 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -100.99 -24.77 14.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.148 -0.97 . . . . 0.0 109.572 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 98.0 m-20 -72.77 138.5 46.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.827 . . . . 0.0 109.893 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.538 HD22 ' CZ ' ' A' ' 98' ' ' ARG . 98.3 mt -80.31 144.88 32.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 108.741 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.9 pt -122.12 143.85 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.927 -1.108 . . . . 0.0 110.014 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.04 -175.82 47.69 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.464 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 50.2 p90 -167.71 169.49 11.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.024 -1.28 . . . . 0.0 109.751 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -148.43 146.38 28.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.955 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 63.1 m -126.33 152.21 73.52 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.21 153.93 8.75 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.449 2.099 . . . . 0.0 111.923 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.8 p -72.64 -10.99 60.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.709 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.514 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 80.8 m-20 -92.02 -3.31 55.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.937 -1.102 . . . . 0.0 110.083 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.476 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 15.8 m-85 -106.61 161.44 14.63 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.9 -1.125 . . . . 0.0 110.168 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.424 ' HG ' ' HZ3' ' A' ' 115' ' ' LYS . 7.1 m -99.89 138.39 37.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.363 -0.835 . . . . 0.0 109.389 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.8 m -94.38 117.08 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.977 -1.077 . . . . 0.0 110.454 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -126.18 127.67 24.61 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.97 111.11 3.03 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.614 1.543 . . . . 0.0 112.224 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -90.96 -26.99 18.99 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.461 ' HB3' ' H ' ' A' ' 110' ' ' PHE . 68.3 t0 -166.37 42.22 0.06 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.594 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 84.5 m -67.74 -157.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 109.836 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.541 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 1.9 p90 -112.16 -49.53 2.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.874 -1.141 . . . . 0.0 111.425 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 55.7 t -58.41 -48.75 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.495 -1.378 . . . . 0.0 108.922 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.1 t -156.84 128.94 7.32 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.594 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.62 -178.16 1.57 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.872 -1.142 . . . . 0.0 110.475 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.519 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 9.2 m-85 -94.14 127.54 40.03 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -70.16 -175.77 1.03 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.964 -1.085 . . . . 0.0 109.879 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.8 mt -61.95 -24.35 66.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.337 -0.852 . . . . 0.0 108.968 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 67.1 m -82.43 -5.07 58.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.316 -0.865 . . . . 0.0 108.804 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.41 19.03 65.13 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -100.23 141.41 33.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -1.136 . . . . 0.0 109.145 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -82.69 110.35 17.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.149 -0.969 . . . . 0.0 110.016 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -146.1 140.95 27.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.328 -0.857 . . . . 0.0 109.56 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -61.25 145.92 49.61 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.3 tp -96.61 5.89 49.83 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.175 -0.953 . . . . 0.0 109.892 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.463 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.3 OUTLIER -70.73 -41.66 71.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.1 -1.0 . . . . 0.0 109.789 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.415 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 41.0 t30 -59.8 -27.22 66.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.146 -0.971 . . . . 0.0 109.037 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -82.15 -45.46 15.1 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.246 -0.909 . . . . 0.0 109.353 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.548 HD22 ' CZ2' ' A' ' 107' ' ' TRP . 51.0 tp -139.13 133.64 31.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.431 -0.793 . . . . 0.0 109.187 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.65 86.09 7.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.079 -1.013 . . . . 0.0 109.433 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.432 HD21 HD23 ' A' ' 81' ' ' LEU . 96.4 mt -73.37 148.33 43.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.898 . . . . 0.0 109.842 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.1 p -127.29 162.74 25.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.409 -0.807 . . . . 0.0 109.391 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 54.32 51.88 13.51 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.062 -1.023 . . . . 0.0 109.529 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -80.2 131.07 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.353 -0.842 . . . . 0.0 110.093 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.8 mm -123.87 122.42 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.434 -0.791 . . . . 0.0 109.238 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 87.9 mtp -123.48 107.79 11.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.953 -1.092 . . . . 0.0 110.019 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -114.7 101.49 9.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.21 -0.931 . . . . 0.0 108.983 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.469 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 95.9 m-70 -73.27 -34.69 65.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.052 -1.03 . . . . 0.0 110.645 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -60.34 -45.7 92.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.896 -1.127 . . . . 0.0 109.61 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -89.43 -4.71 57.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.087 -1.008 . . . . 0.0 109.053 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 96.7 m-20 55.39 47.8 20.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 110.151 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.573 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.3 t -132.33 136.45 46.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.98 -1.075 . . . . 0.0 109.516 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.464 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 79.3 m-85 -126.29 139.53 53.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.019 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.573 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 80.1 m-85 -135.03 146.45 49.0 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.199 -0.938 . . . . 0.0 109.434 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.586 ' C ' ' HE ' ' A' ' 98' ' ' ARG . 39.7 t -145.74 144.95 30.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.095 -1.003 . . . . 0.0 109.212 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.586 ' HE ' ' C ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -100.46 128.75 46.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.072 -1.017 . . . . 0.0 109.435 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.523 ' O ' ' O ' ' A' ' 100' ' ' PRO . 94.8 mt -89.86 138.27 27.91 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.25 -0.906 . . . . 0.0 109.636 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 99' ' ' LEU . 75.7 Cg_exo -46.17 -177.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.896 1.731 . . . . 0.0 110.984 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 95.3 p -90.45 -8.35 50.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.968 -1.082 . . . . 0.0 109.748 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.7 tp -135.49 129.76 33.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.125 -0.984 . . . . 0.0 110.445 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.1 mt -150.92 108.3 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.367 -0.833 . . . . 0.0 108.838 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 99.8 p -110.41 0.11 17.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.124 -0.985 . . . . 0.0 109.678 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 127' ' ' ALA . 73.7 m-20 -82.57 152.79 25.81 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.062 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -99.15 32.5 2.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.375 -0.828 . . . . 0.0 109.082 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.548 ' CZ2' HD22 ' A' ' 81' ' ' LEU . 17.7 p-90 -65.88 151.09 47.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 110.553 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -134.91 156.3 49.2 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.627 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 36.9 p90 -156.06 158.13 37.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.079 -1.013 . . . . 0.0 108.954 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.461 ' H ' ' HB3' ' A' ' 62' ' ' ASP . 17.5 p90 -151.83 156.27 39.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.756 -1.215 . . . . 0.0 111.588 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 90.7 m -121.38 158.51 28.14 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 76.7 t -132.8 150.15 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.612 -1.305 . . . . 0.0 111.684 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.5 m -127.88 134.12 49.37 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.8 p -167.58 176.83 6.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.336 -1.478 . . . . 0.0 111.743 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.514 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 50.0 mttm -155.86 168.35 27.48 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 117' ' ' ASN . 90.8 m-20 -57.67 148.29 24.98 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.917 -1.114 . . . . 0.0 109.331 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.487 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 65.9 t30 40.9 60.93 1.84 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.264 -0.897 . . . . 0.0 109.771 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 48.9 mm-40 -157.31 136.67 12.01 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.978 -1.076 . . . . 0.0 110.187 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -56.33 133.44 52.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.262 -0.899 . . . . 0.0 109.019 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.548 ' NZ ' ' OD1' ' A' ' 35' ' ' ASP . 23.6 pttm -85.28 143.28 28.8 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.114 -0.991 . . . . 0.0 110.404 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.426 HD13 ' CG ' ' A' ' 8' ' ' PHE . 68.4 mt -111.33 124.33 52.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.446 -0.784 . . . . 0.0 109.154 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.515 ' HB ' HG22 ' A' ' 37' ' ' VAL . 46.4 t -109.45 130.98 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.986 -1.071 . . . . 0.0 110.711 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -109.98 120.62 43.04 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.4 t -137.05 143.95 42.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.475 -1.391 . . . . 0.0 112.008 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.627 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 2.9 m -136.53 159.94 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -134.31 150.11 50.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.836 -1.165 . . . . 0.0 110.13 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.338 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -142.1 152.23 43.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.359 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.6 t -88.16 136.39 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.372 -0.83 . . . . 0.0 110.36 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -68.84 125.22 25.92 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.054 -1.029 . . . . 0.0 108.615 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.81 179.11 45.18 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -118.56 132.4 56.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.619 -0.93 . . . . 0.0 109.369 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.483 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 36.0 t0 -109.07 109.07 19.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.542 -0.724 . . . . 0.0 109.272 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.458 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 78.0 m-85 -88.76 -0.54 57.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.171 -0.956 . . . . 0.0 108.912 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.0 m -98.55 -18.18 18.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.468 -0.77 . . . . 0.0 110.537 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.612 HG22 ' H ' ' A' ' 12' ' ' GLU . 65.0 m -158.2 127.07 5.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.836 -1.165 . . . . 0.0 110.361 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.1 p -64.59 -26.6 68.47 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.611 -0.836 . . . . 0.0 108.985 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.612 ' H ' HG22 ' A' ' 10' ' ' THR . 78.9 mm-40 -113.04 73.89 0.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.501 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 95.0 p -69.67 151.39 45.94 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.226 -0.921 . . . . 0.0 110.159 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 t -101.25 0.85 38.14 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 pt -124.76 -20.86 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.672 -0.643 . . . . 0.0 110.496 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.501 ' O ' ' OG ' ' A' ' 13' ' ' SER . 57.4 m-85 -115.93 144.52 43.94 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.401 -0.812 . . . . 0.0 110.325 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.0 m -72.28 -17.58 61.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.502 -0.749 . . . . 0.0 110.542 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -135.0 145.53 48.18 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.96 -1.088 . . . . 0.0 110.762 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.483 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -159.53 173.37 36.29 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -131.47 164.22 26.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.394 -1.062 . . . . 0.0 109.614 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 t -95.43 151.8 18.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.321 -0.862 . . . . 0.0 109.122 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.458 ' O ' ' CB ' ' A' ' 26' ' ' SER . 42.9 pt -59.69 -31.92 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.41 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -65.95 -39.18 90.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 109.561 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.61 -43.4 89.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.42 -0.8 . . . . 0.0 110.229 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.5 pt -86.09 -19.29 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.0 -1.063 . . . . 0.0 109.704 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.68 ' O ' ' C ' ' A' ' 27' ' ' ASN . 48.0 t -85.11 -76.96 0.3 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.236 -0.915 . . . . 0.0 109.224 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.68 ' C ' ' O ' ' A' ' 26' ' ' SER . 63.6 t30 0.47 96.51 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 121.337 0.589 . . . . 0.0 109.445 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 30' ' ' SER . 44.1 mmtm -66.13 34.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.56 -0.712 . . . . 0.0 109.741 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.605 ' O ' ' N ' ' A' ' 31' ' ' ASN . 44.3 t -63.11 70.78 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.507 -0.746 . . . . 0.0 109.282 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 28' ' ' LYS . 15.1 m -36.89 -26.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.304 0.573 . . . . 0.0 109.621 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.605 ' N ' ' O ' ' A' ' 29' ' ' SER . 99.0 m-20 -68.58 33.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.561 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.546 ' H ' ' C ' ' A' ' 30' ' ' SER . 51.6 t-20 -155.61 120.25 4.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.085 -1.009 . . . . 0.0 109.286 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.498 ' C ' ' O ' ' A' ' 32' ' ' ASN . 11.6 pt20 -35.06 121.72 0.55 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.542 0.687 . . . . 0.0 109.691 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.405 ' HG2' ' H ' ' A' ' 34' ' ' GLN . 8.8 pt20 -72.33 38.91 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.216 -0.928 . . . . 0.0 109.413 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.479 ' H ' ' C ' ' A' ' 33' ' ' GLN . 88.9 m-20 -130.72 108.2 9.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.718 -0.614 . . . . 0.0 109.689 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.9 mm -99.29 125.04 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.108 -0.995 . . . . 0.0 108.591 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.533 HG22 ' HB ' ' A' ' 122' ' ' VAL . 47.2 t -120.78 130.21 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.411 -0.806 . . . . 0.0 110.42 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.458 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 89.6 m -101.05 100.67 11.29 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 58.5 m -96.06 120.73 36.86 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.182 -0.949 . . . . 0.0 109.513 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.2 m -141.66 153.51 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.492 -0.755 . . . . 0.0 109.306 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -94.03 132.75 38.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.005 -1.059 . . . . 0.0 109.149 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.437 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -102.02 146.78 27.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.22 -0.925 . . . . 0.0 109.626 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.475 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 21.0 t-80 -116.43 150.73 37.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.429 -0.794 . . . . 0.0 109.507 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.667 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -55.99 -25.38 43.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.415 -0.803 . . . . 0.0 109.883 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.554 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 30.5 p30 -98.22 -22.99 15.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 109.684 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.554 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 82.2 m-20 -76.4 136.78 39.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.449 -0.782 . . . . 0.0 110.165 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.47 146.5 38.48 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.492 HD13 HD21 ' A' ' 99' ' ' LEU . 38.3 pt -120.4 141.89 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.113 -0.992 . . . . 0.0 110.307 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.93 -173.75 46.25 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -170.18 169.55 7.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.11 -1.229 . . . . 0.0 109.685 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -144.74 143.64 30.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.235 -0.916 . . . . 0.0 110.015 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 90.1 m -124.0 151.87 65.83 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.432 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.74 147.53 24.34 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.337 2.025 . . . . 0.0 111.976 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.1 m -70.6 -12.1 61.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.424 -0.798 . . . . 0.0 110.545 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.608 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.8 m-20 -91.6 0.49 57.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.051 -1.031 . . . . 0.0 110.084 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.4 m-85 -109.86 165.73 11.48 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.124 -0.985 . . . . 0.0 110.353 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -103.65 130.76 51.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.34 -0.85 . . . . 0.0 109.05 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.8 m -89.5 118.74 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.004 -1.06 . . . . 0.0 110.104 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -124.73 126.78 25.31 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.13 114.57 3.6 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.777 1.651 . . . . 0.0 112.051 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.491 ' O ' ' O ' ' A' ' 68' ' ' PHE . 17.0 t-80 -93.56 -24.0 18.11 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.8 t0 -170.19 40.59 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.485 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 89.9 m -64.28 -154.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.422 -0.799 . . . . 0.0 109.887 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 3.6 p90 -109.29 -58.69 2.0 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.155 -0.966 . . . . 0.0 111.483 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 64' ' ' PHE . 31.2 t -46.05 -70.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.58 -1.325 . . . . 0.0 108.804 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.2 t -141.38 132.45 26.23 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.485 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -170.97 175.86 4.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.97 -1.081 . . . . 0.0 110.464 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 4.1 m-85 -92.39 142.36 27.53 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -83.26 -170.86 3.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.879 -1.138 . . . . 0.0 109.895 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.558 ' N ' HD12 ' A' ' 70' ' ' LEU . 10.3 mp -66.56 -15.03 63.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.325 -0.86 . . . . 0.0 108.98 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 65.7 m -86.55 -8.61 57.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.38 -0.825 . . . . 0.0 108.806 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.93 20.07 64.01 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -106.73 139.84 40.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.318 -1.107 . . . . 0.0 109.246 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -66.78 125.68 26.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.28 -0.888 . . . . 0.0 109.844 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -145.47 165.26 29.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.408 -0.808 . . . . 0.0 109.644 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.442 ' ND2' ' CD ' ' A' ' 78' ' ' GLU . 37.8 t-20 -105.96 136.94 44.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.337 -0.852 . . . . 0.0 109.472 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 tp -93.26 -8.28 42.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 0.0 110.194 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.488 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 20.7 pt-20 -58.94 -46.63 87.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.044 -1.035 . . . . 0.0 109.523 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.488 ' N ' ' CG ' ' A' ' 78' ' ' GLU . 92.5 m-20 -64.87 -34.52 78.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 108.972 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -69.24 -52.41 27.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.499 -0.751 . . . . 0.0 109.61 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.565 HD23 HD21 ' A' ' 83' ' ' LEU . 31.5 tp -129.13 126.51 39.45 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -76.63 108.54 9.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.015 -1.053 . . . . 0.0 109.018 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.565 HD21 HD23 ' A' ' 81' ' ' LEU . 95.3 mt -105.18 137.86 42.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 110.088 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.9 p -124.46 162.69 23.4 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.493 -0.754 . . . . 0.0 109.287 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.6 ' O ' ' NH1' ' A' ' 98' ' ' ARG . 98.9 m-20 55.0 51.46 13.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.573 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -78.92 130.62 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.185 -0.947 . . . . 0.0 110.152 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.5 mm -120.19 119.79 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.482 -0.761 . . . . 0.0 109.225 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 78.8 mtp -124.56 109.59 13.41 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.295 -0.878 . . . . 0.0 109.835 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -111.73 100.74 9.18 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.38 -0.825 . . . . 0.0 108.938 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.486 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 97.1 m-70 -71.76 -36.48 70.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.859 -1.15 . . . . 0.0 110.632 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -61.13 -46.76 89.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.963 -1.085 . . . . 0.0 109.556 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -87.17 -4.96 59.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.07 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.4 m-20 54.93 47.32 22.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.556 -0.715 . . . . 0.0 110.209 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.592 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 3.3 t -133.84 139.73 46.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.03 -1.043 . . . . 0.0 109.325 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 49.5 m-85 -128.52 140.14 51.96 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.429 -0.794 . . . . 0.0 109.982 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.592 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 67.2 m-85 -138.23 148.7 45.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.289 -0.882 . . . . 0.0 109.16 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.703 ' N ' ' NH2' ' A' ' 98' ' ' ARG . 57.6 m -157.3 159.4 37.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.099 -1.001 . . . . 0.0 109.336 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.703 ' NH2' ' N ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -103.59 139.72 38.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.236 -0.915 . . . . 0.0 109.679 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.492 HD21 HD13 ' A' ' 48' ' ' ILE . 47.4 mt -91.98 138.54 24.64 Favored Pre-proline 0 C--N 1.304 -1.396 0 O-C-N 121.619 -0.676 . . . . 0.0 109.597 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.667 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 75.7 Cg_exo -46.93 158.28 0.44 Allowed 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.734 1.622 . . . . 0.0 111.265 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.6 t -69.6 -17.98 63.58 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.179 -0.95 . . . . 0.0 109.916 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 102' ' ' LEU . 44.9 tp -125.41 129.32 49.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.258 -0.901 . . . . 0.0 110.639 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 83.1 mt -149.29 102.86 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.3 m -113.25 3.1 15.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.352 -0.842 . . . . 0.0 109.834 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 53.2 t0 -89.28 155.28 19.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.976 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.584 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 98.9 m-20 -96.54 34.15 1.69 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.417 -0.802 . . . . 0.0 108.914 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.468 ' CZ3' ' CD1' ' A' ' 109' ' ' PHE . 13.0 p-90 -62.69 154.06 30.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.165 -0.959 . . . . 0.0 110.42 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.603 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 21.2 tttp -141.07 149.13 41.24 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.641 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 29.2 p90 -155.09 163.31 40.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.188 -0.945 . . . . 0.0 108.731 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.424 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 10.7 p90 -154.84 160.06 40.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.86 -1.15 . . . . 0.0 111.872 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 75.1 m -122.92 155.43 36.73 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 122' ' ' VAL . 44.4 t -128.78 139.05 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.848 -1.158 . . . . 0.0 111.933 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 96.4 m -122.9 131.94 53.96 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 62.9 p -171.54 178.7 3.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.306 -1.496 . . . . 0.0 111.608 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.608 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 50.6 mtmt -150.7 163.62 38.1 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 55.4 p-10 -59.44 154.27 17.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.907 -1.121 . . . . 0.0 109.114 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.511 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 64.7 t30 44.26 59.69 3.13 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.211 -0.931 . . . . 0.0 109.642 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 38.8 mt-10 -165.28 146.19 7.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.256 -0.902 . . . . 0.0 110.154 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.587 ' NZ ' ' O ' ' A' ' 27' ' ' ASN . 98.8 mttt -58.03 142.16 47.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 109.193 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -88.95 140.09 29.79 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.077 -1.015 . . . . 0.0 110.414 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 86.6 mt -108.89 120.8 43.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.417 -0.802 . . . . 0.0 108.965 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 112' ' ' VAL . 48.6 t -109.36 130.1 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.049 -1.032 . . . . 0.0 110.54 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -107.81 118.62 37.23 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.603 ' OG1' ' NZ ' ' A' ' 108' ' ' LYS . 7.3 t -136.94 141.88 42.65 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.918 -1.114 . . . . 0.0 112.3 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.3 m -134.55 158.48 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -132.31 152.66 51.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.229 -0.919 . . . . 0.0 110.278 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.333 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.486 ' OE1' ' N ' ' A' ' 1' ' ' GLU . 57.2 mp0 . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -75.29 155.12 36.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.231 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.2 t -96.55 133.17 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 109.795 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.8 mmtp -69.86 122.11 18.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.126 -0.984 . . . . 0.0 108.706 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.3 176.41 46.22 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.543 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 4.7 t -116.28 128.54 55.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.471 -1.017 . . . . 0.0 109.296 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.452 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 54.4 t0 -103.45 111.18 23.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.59 -0.694 . . . . 0.0 109.375 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -91.59 -0.88 57.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.186 -0.947 . . . . 0.0 108.826 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.5 m -103.72 -16.67 15.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.486 -0.759 . . . . 0.0 110.632 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 12' ' ' GLU . 23.3 m -156.35 125.02 5.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.883 -1.136 . . . . 0.0 110.278 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.505 ' OG ' ' OE1' ' A' ' 12' ' ' GLU . 74.0 p -65.47 -26.36 67.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.184 -0.948 . . . . 0.0 108.981 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.516 ' H ' HG22 ' A' ' 10' ' ' THR . 55.5 mp0 -113.67 72.96 0.8 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.2 t -67.7 150.62 48.46 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.134 -0.979 . . . . 0.0 110.352 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.77 0.6 41.99 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.411 HD12 ' OH ' ' A' ' 96' ' ' TYR . 24.2 pt -125.04 -27.19 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.749 -0.594 . . . . 0.0 110.199 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -110.27 133.74 52.95 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.041 -1.037 . . . . 0.0 109.87 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.9 t -67.95 -18.53 64.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.641 -0.662 . . . . 0.0 110.858 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -125.09 136.73 53.94 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.027 -1.046 . . . . 0.0 110.67 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.452 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -146.86 158.81 27.84 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.543 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 21.4 m-85 -116.81 150.4 38.41 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.323 -1.104 . . . . 0.0 109.589 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.0 t -94.75 156.61 16.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.349 -0.844 . . . . 0.0 109.016 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.412 ' O ' ' CG1' ' A' ' 25' ' ' ILE . 45.3 pt -58.41 -20.5 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.925 . . . . 0.0 109.344 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -68.7 -43.61 75.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.115 -0.991 . . . . 0.0 109.186 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 28' ' ' LYS . 79.6 mm-40 -50.98 -49.72 59.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.098 -1.002 . . . . 0.0 110.082 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.468 ' O ' ' OG ' ' A' ' 29' ' ' SER . 19.6 pt -63.07 -43.79 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.044 -1.035 . . . . 0.0 109.632 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.456 ' N ' HG13 ' A' ' 25' ' ' ILE . 58.2 m -59.67 -44.22 93.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 109.202 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.628 ' O ' ' N ' ' A' ' 29' ' ' SER . 41.9 t30 -79.48 -61.64 1.94 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.174 -0.954 . . . . 0.0 108.849 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.507 ' O ' ' O ' ' A' ' 32' ' ' ASN . 36.0 tptt -44.31 -12.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.225 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.628 ' N ' ' O ' ' A' ' 27' ' ' ASN . 86.4 p -109.71 -38.31 5.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.076 -1.015 . . . . 0.0 109.436 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.3 m -60.12 -44.95 94.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.529 -0.732 . . . . 0.0 109.709 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.417 ' OD1' ' C ' ' A' ' 31' ' ' ASN . 45.9 t-20 -86.65 -58.94 2.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.295 -0.878 . . . . 0.0 109.519 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 32' ' ' ASN . 8.7 p-10 -107.8 94.28 4.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.426 -0.796 . . . . 0.0 109.553 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 33' ' ' GLN . 7.4 pt20 -71.99 93.76 1.41 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 109.42 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -151.08 -166.76 2.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.945 -1.097 . . . . 0.0 109.514 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.603 ' OD1' ' N ' ' A' ' 35' ' ' ASP . 0.4 OUTLIER -83.32 141.05 32.09 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.222 -0.924 . . . . 0.0 109.635 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.449 ' O ' ' N ' ' A' ' 122' ' ' VAL . 20.8 mm -80.2 122.14 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 79.5 t -115.68 127.85 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.114 -0.991 . . . . 0.0 110.604 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.505 ' O ' ' O ' ' A' ' 124' ' ' THR . 66.8 m -102.07 101.49 11.86 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.1 m -92.46 119.53 32.05 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.822 -1.174 . . . . 0.0 109.848 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.558 ' CG2' HG12 ' A' ' 125' ' ' VAL . 19.8 m -136.23 155.76 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -99.03 121.88 41.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 109.504 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.86 163.56 13.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.574 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.474 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 37.1 t60 -136.64 155.61 49.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.203 -0.936 . . . . 0.0 109.656 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -55.24 -26.47 39.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.325 -0.86 . . . . 0.0 109.711 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -101.46 -22.44 14.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.166 -0.959 . . . . 0.0 109.632 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.474 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 85.8 m-20 -75.08 137.49 41.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.419 -0.8 . . . . 0.0 109.942 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.8 mt -80.73 147.46 30.55 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.407 HG21 HD11 ' A' ' 99' ' ' LEU . 43.7 pt -122.12 144.26 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.144 -0.972 . . . . 0.0 110.294 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.9 -173.06 45.7 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.474 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 50.5 p90 -169.68 168.81 8.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.056 -1.261 . . . . 0.0 109.725 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -143.42 142.6 31.29 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.319 -0.863 . . . . 0.0 109.636 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 61.4 m -123.77 152.31 65.66 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 108.662 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.467 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.3 Cg_endo -51.7 150.98 15.71 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.431 2.087 . . . . 0.0 111.905 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.1 m -71.32 -13.2 61.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.459 -0.775 . . . . 0.0 110.726 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.491 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 80.2 m-20 -91.04 -1.04 57.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.867 -1.146 . . . . 0.0 110.214 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.467 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 16.5 m-85 -107.67 162.49 13.92 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.514 -0.741 . . . . 0.0 110.099 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.432 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 6.2 t -102.91 134.04 47.0 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.333 -0.855 . . . . 0.0 109.334 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 58' ' ' VAL . 3.5 m -90.45 115.25 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.092 -1.005 . . . . 0.0 110.389 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' A' ' 59' ' ' GLU . 15.8 mp0 -121.24 126.56 26.52 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.08 112.71 3.29 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.617 1.545 . . . . 0.0 112.265 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -94.05 -25.24 17.28 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.7 t0 -168.34 39.51 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 80.5 m -65.08 -153.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.579 -0.701 . . . . 0.0 109.729 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.474 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 3.9 p90 -111.26 -59.15 2.01 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.179 -0.95 . . . . 0.0 111.347 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.449 ' C ' ' O ' ' A' ' 64' ' ' PHE . 24.1 t -45.72 -73.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.682 -1.261 . . . . 0.0 108.757 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.436 ' N ' HG12 ' A' ' 65' ' ' VAL . 33.3 t -136.44 132.61 35.65 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -173.71 -178.67 1.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.908 -1.12 . . . . 0.0 110.446 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 7.6 m-85 -93.07 124.21 36.88 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -69.74 -175.03 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.07 -1.019 . . . . 0.0 109.869 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.8 mt -62.3 -23.66 66.86 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.29 -0.881 . . . . 0.0 108.905 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.6 p -81.92 -7.17 59.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 108.819 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.64 15.63 70.35 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -95.75 138.51 33.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.394 -1.062 . . . . 0.0 109.137 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -81.91 108.35 15.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.249 -0.907 . . . . 0.0 110.143 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -145.35 143.58 30.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 110.063 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.0 m-20 -64.54 149.59 48.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.913 -1.117 . . . . 0.0 109.512 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.63 HD11 ' HD3' ' A' ' 80' ' ' LYS . 13.9 tp -99.22 6.7 46.24 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.465 -0.772 . . . . 0.0 109.941 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 79' ' ' ASN . 17.8 pt-20 -69.38 -41.06 76.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.13 -0.981 . . . . 0.0 109.923 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 48.4 p-10 -62.58 -26.08 68.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.197 -0.939 . . . . 0.0 109.071 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.63 ' HD3' HD11 ' A' ' 77' ' ' LEU . 88.0 tttt -84.79 -46.29 11.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.45 -0.781 . . . . 0.0 109.442 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.606 HD23 HD21 ' A' ' 83' ' ' LEU . 41.0 tp -131.64 127.35 36.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.405 -0.809 . . . . 0.0 109.234 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -83.29 83.77 7.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.066 -1.021 . . . . 0.0 109.297 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.606 HD21 HD23 ' A' ' 81' ' ' LEU . 95.9 mt -75.73 146.71 39.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.888 . . . . 0.0 110.121 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.3 p -127.94 160.61 31.33 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.606 -0.684 . . . . 0.0 109.318 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.6 m120 54.72 50.78 15.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.278 -0.889 . . . . 0.0 109.546 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.2 mt -77.61 128.54 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 109.879 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.0 mm -118.92 119.19 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.489 -0.757 . . . . 0.0 109.229 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 85.4 mtp -123.44 108.03 12.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.214 -0.929 . . . . 0.0 109.806 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -114.19 101.75 9.49 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.411 -0.806 . . . . 0.0 108.873 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.472 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 95.4 m-70 -71.63 -36.22 70.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.995 -1.066 . . . . 0.0 110.592 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -60.91 -45.15 95.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.974 -1.079 . . . . 0.0 109.462 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -88.89 -5.21 58.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.953 . . . . 0.0 109.07 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.7 m-20 54.4 47.95 21.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.49 -0.756 . . . . 0.0 110.139 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.608 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 2.6 t -132.37 137.16 47.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.987 -1.071 . . . . 0.0 109.606 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.474 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 79.4 m-85 -126.68 138.88 53.47 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.402 -0.811 . . . . 0.0 109.977 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.608 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 71.4 m-85 -135.61 146.1 47.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.239 -0.913 . . . . 0.0 109.437 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.521 ' OG ' HD22 ' A' ' 83' ' ' LEU . 35.5 t -150.87 150.99 31.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.959 . . . . 0.0 109.242 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.418 ' HG2' HH11 ' A' ' 98' ' ' ARG . 60.3 mtt-85 -101.29 133.1 46.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.16 -0.962 . . . . 0.0 109.434 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 99' ' ' LEU . 38.5 mt -91.54 137.9 25.59 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.461 -0.774 . . . . 0.0 109.789 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.542 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 77.5 Cg_exo -45.68 177.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.876 1.717 . . . . 0.0 111.163 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.483 ' C ' ' HB1' ' A' ' 44' ' ' ALA . 99.9 p -89.36 -9.87 48.76 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.113 -0.992 . . . . 0.0 109.847 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.7 tp -133.68 128.15 34.39 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.208 -0.932 . . . . 0.0 110.254 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.3 mt -150.12 106.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.945 . . . . 0.0 108.677 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 96.3 p -107.78 0.33 22.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.088 -1.007 . . . . 0.0 109.772 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 127' ' ' ALA . 82.6 m-20 -84.64 154.54 22.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.038 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -102.38 31.5 4.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.493 -0.754 . . . . 0.0 109.12 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.441 ' CH2' HD22 ' A' ' 81' ' ' LEU . 16.5 p-90 -66.68 160.07 26.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.205 -0.934 . . . . 0.0 110.507 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -142.0 159.05 43.01 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.553 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 20.9 p90 -154.04 162.66 41.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.929 -1.107 . . . . 0.0 108.661 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 7.3 p90 -153.59 160.4 42.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.67 -1.269 . . . . 0.0 111.836 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 94.7 m -124.83 156.68 37.43 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 122' ' ' VAL . 44.0 t -127.9 138.91 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.867 -1.145 . . . . 0.0 111.792 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.1 m -120.11 130.77 54.79 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.2 p -168.93 174.84 6.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.322 -1.486 . . . . 0.0 111.601 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.491 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 52.4 mttm -152.72 168.1 26.79 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 117' ' ' ASN . 90.1 m-20 -58.54 148.34 28.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.835 -1.166 . . . . 0.0 108.845 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 66.2 t30 43.86 60.67 2.6 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.26 -0.9 . . . . 0.0 109.395 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 58.2 mm-40 -158.01 137.44 11.88 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.19 -0.944 . . . . 0.0 110.455 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -54.77 131.57 44.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.083 -1.011 . . . . 0.0 108.962 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -79.81 139.25 37.28 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.21 -0.931 . . . . 0.0 110.249 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.6 mt -111.26 124.43 52.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.644 -0.66 . . . . 0.0 109.389 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 112' ' ' VAL . 39.2 t -110.39 132.04 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.979 -1.076 . . . . 0.0 110.71 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.419 ' O ' ' CB ' ' A' ' 110' ' ' PHE . 26.4 t80 -110.43 123.0 49.06 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.505 ' O ' ' O ' ' A' ' 38' ' ' CYS . 6.6 t -137.88 143.73 41.01 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.005 -1.059 . . . . 0.0 112.145 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.558 HG12 ' CG2' ' A' ' 40' ' ' VAL . 2.8 m -136.71 159.52 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -133.16 150.64 52.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.071 -1.018 . . . . 0.0 110.31 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.4 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -78.45 162.03 26.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.9 t -103.63 135.29 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.054 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -69.46 125.12 25.75 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.583 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.61 176.02 43.51 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -115.85 132.47 56.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.493 -1.004 . . . . 0.0 109.246 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.512 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 36.9 t0 -110.21 109.18 19.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.595 -0.691 . . . . 0.0 109.333 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -88.17 -1.17 57.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.298 -0.876 . . . . 0.0 108.982 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.5 m -100.93 -18.64 16.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.515 -0.741 . . . . 0.0 110.577 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 12' ' ' GLU . 25.7 m -156.19 125.06 5.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.878 -1.139 . . . . 0.0 110.367 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 t -65.99 -27.0 67.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.413 -0.804 . . . . 0.0 108.957 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 58.7 mp0 -112.92 73.98 0.84 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.496 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 12.5 m -70.78 152.85 43.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.875 . . . . 0.0 110.225 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.93 -0.04 40.28 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.7 pt -125.9 -22.28 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.71 -0.619 . . . . 0.0 110.25 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -113.05 140.28 47.98 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.255 -0.903 . . . . 0.0 110.133 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.9 m -73.43 -17.08 61.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.603 -0.686 . . . . 0.0 110.691 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -132.87 144.04 49.92 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.998 -1.064 . . . . 0.0 110.563 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.512 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -160.7 171.32 36.81 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -122.93 158.95 29.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.423 -1.045 . . . . 0.0 109.666 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.4 t -96.22 151.71 19.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 0.0 109.058 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.7 pt -55.59 -33.08 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.347 -0.846 . . . . 0.0 109.372 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -65.25 -38.6 90.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.113 -0.992 . . . . 0.0 109.505 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.09 -41.78 94.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.814 . . . . 0.0 110.159 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.619 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 14.9 pt -85.63 -15.08 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.006 -1.059 . . . . 0.0 109.653 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.693 ' O ' ' C ' ' A' ' 27' ' ' ASN . 39.7 t -89.86 -78.05 0.38 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.175 -0.953 . . . . 0.0 109.169 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.693 ' C ' ' O ' ' A' ' 26' ' ' SER . 6.1 p30 -1.97 88.75 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 121.371 0.605 . . . . 0.0 109.541 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -77.21 22.28 0.22 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.489 -0.757 . . . . 0.0 109.455 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 30' ' ' SER . 40.6 t -90.17 -71.53 0.61 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.341 -0.849 . . . . 0.0 109.577 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 29' ' ' SER . 18.7 m -41.39 141.42 0.72 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.526 -0.733 . . . . 0.0 109.482 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -103.58 41.51 1.27 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.292 -0.88 . . . . 0.0 109.49 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -137.97 -22.91 1.05 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.966 . . . . 0.0 109.628 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.628 ' O ' ' N ' ' A' ' 35' ' ' ASP . 2.3 pt20 -57.08 -31.71 65.52 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.158 -0.964 . . . . 0.0 109.622 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.572 ' C ' ' O ' ' A' ' 33' ' ' GLN . 14.9 pt20 -28.15 -37.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.628 ' N ' ' O ' ' A' ' 33' ' ' GLN . 14.7 m-20 -125.05 107.97 11.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.683 -0.636 . . . . 0.0 110.15 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.9 mm -99.38 125.51 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.006 -1.059 . . . . 0.0 108.632 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.438 HG22 ' HB ' ' A' ' 122' ' ' VAL . 54.9 t -121.44 126.86 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.392 -0.818 . . . . 0.0 110.009 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.3 m -102.45 102.16 12.43 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 75.8 m -98.78 122.37 41.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.076 -1.015 . . . . 0.0 109.397 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.513 ' CG2' HG12 ' A' ' 125' ' ' VAL . 24.1 m -140.96 155.22 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.562 -0.711 . . . . 0.0 109.257 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -96.12 132.5 41.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.084 -1.01 . . . . 0.0 109.405 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.76 160.45 14.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.405 -0.81 . . . . 0.0 109.591 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.489 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 34.8 t60 -133.0 153.81 51.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.245 -0.909 . . . . 0.0 109.55 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 100' ' ' PRO . . . -54.01 -25.28 20.34 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.384 -0.822 . . . . 0.0 109.788 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -101.53 -26.06 13.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.704 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.489 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 76.5 m-20 -71.67 132.02 43.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.336 -0.852 . . . . 0.0 110.069 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.636 HD22 HH11 ' A' ' 98' ' ' ARG . 11.3 mt -77.28 145.89 37.19 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.422 HG21 HD11 ' A' ' 99' ' ' LEU . 44.9 pt -123.11 145.85 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.766 0.793 . . . . 0.0 110.479 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.48 -173.98 46.58 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -169.54 170.01 8.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.095 -1.239 . . . . 0.0 109.697 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -147.71 145.4 28.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.9 . . . . 0.0 109.907 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 92.6 m -124.83 151.65 68.61 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.6 Cg_endo -51.7 150.1 17.65 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.334 2.023 . . . . 0.0 112.044 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 m -69.68 -11.74 61.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.398 -0.813 . . . . 0.0 110.528 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -90.94 -2.67 57.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.023 -1.048 . . . . 0.0 110.223 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.434 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.4 m-85 -109.17 164.28 12.59 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.219 -0.925 . . . . 0.0 110.426 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.7 t -105.96 133.93 49.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.448 -0.783 . . . . 0.0 108.919 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 58' ' ' VAL . 3.1 m -89.8 118.92 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.032 -1.043 . . . . 0.0 110.364 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 112' ' ' VAL . 10.0 mt-10 -123.1 126.67 25.91 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.14 114.11 3.51 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.66 1.573 . . . . 0.0 112.12 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.505 ' O ' ' O ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -93.63 -24.14 18.01 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 110' ' ' PHE . 66.9 t0 -169.9 43.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.478 ' H ' ' CB ' ' A' ' 67' ' ' ALA . 97.3 m -67.55 -153.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.748 . . . . 0.0 109.844 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.492 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 3.8 p90 -110.1 -57.88 2.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.141 -0.975 . . . . 0.0 111.455 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 64' ' ' PHE . 24.9 t -46.76 -71.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.601 -1.312 . . . . 0.0 108.863 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.8 t -140.91 131.3 25.18 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.478 ' CB ' ' H ' ' A' ' 63' ' ' CYS . . . -170.76 175.74 4.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.975 -1.078 . . . . 0.0 110.425 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.533 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 2.5 m-85 -92.86 140.67 29.26 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -81.81 -170.35 2.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.835 -1.165 . . . . 0.0 109.829 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.554 ' N ' HD12 ' A' ' 70' ' ' LEU . 10.0 mp -66.42 -15.31 63.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.305 -0.872 . . . . 0.0 109.087 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 69.5 m -86.6 -7.94 57.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 108.883 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.7 20.9 64.93 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -106.98 138.26 43.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.273 -1.134 . . . . 0.0 109.114 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -65.62 124.32 22.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.257 -0.902 . . . . 0.0 109.754 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -143.71 165.09 28.61 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.396 -0.815 . . . . 0.0 109.704 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -106.51 137.83 43.8 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.353 -0.842 . . . . 0.0 109.371 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.8 tp -95.39 -11.03 28.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.192 -0.942 . . . . 0.0 109.988 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.497 ' CD ' ' N ' ' A' ' 79' ' ' ASN . 2.3 pp20? -61.35 -43.82 98.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.978 -1.076 . . . . 0.0 109.557 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 49.1 p30 -64.17 -20.43 66.0 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.096 -1.003 . . . . 0.0 108.856 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.54 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 84.7 tttt -88.95 -43.97 10.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.0 109.67 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.437 HD23 HD21 ' A' ' 83' ' ' LEU . 45.0 tp -133.35 123.24 25.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.423 -0.798 . . . . 0.0 109.305 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -79.3 85.25 5.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.117 -0.989 . . . . 0.0 109.409 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.542 HD22 ' OG ' ' A' ' 97' ' ' SER . 92.7 mt -74.23 147.03 42.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.322 -0.861 . . . . 0.0 110.036 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 47.3 p -127.42 161.23 29.18 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.527 -0.733 . . . . 0.0 109.339 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 53.58 51.16 15.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.172 -0.955 . . . . 0.0 109.553 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.1 mt -79.05 130.61 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.075 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.7 mm -118.62 119.09 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.509 -0.744 . . . . 0.0 109.117 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 83.0 mtp -121.42 103.78 9.2 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.257 -0.902 . . . . 0.0 109.731 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -113.52 101.45 9.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.425 -0.797 . . . . 0.0 109.085 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -76.46 -32.89 58.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.03 -1.044 . . . . 0.0 110.471 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -59.45 -47.07 86.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.011 -1.055 . . . . 0.0 109.579 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -89.53 2.96 53.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.184 -0.947 . . . . 0.0 109.044 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 50.78 46.58 25.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.543 -0.723 . . . . 0.0 109.904 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.544 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.7 t -131.5 135.31 46.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.027 -1.046 . . . . 0.0 109.427 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -128.23 140.07 52.1 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.421 -0.799 . . . . 0.0 109.977 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.544 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 70.8 m-85 -135.68 147.25 48.46 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.167 -0.958 . . . . 0.0 109.319 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.542 ' OG ' HD22 ' A' ' 83' ' ' LEU . 45.8 t -146.11 143.48 29.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.116 -0.99 . . . . 0.0 109.115 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.636 HH11 HD22 ' A' ' 47' ' ' LEU . 21.4 mmt180 -99.35 133.15 44.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.235 -0.916 . . . . 0.0 109.355 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 100' ' ' PRO . 88.4 mt -92.0 139.08 24.39 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.486 -0.759 . . . . 0.0 109.763 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.481 ' O ' ' O ' ' A' ' 44' ' ' ALA . 77.7 Cg_exo -45.87 176.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.867 1.711 . . . . 0.0 111.118 178.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.447 ' C ' ' HB1' ' A' ' 44' ' ' ALA . 6.2 m -86.03 -11.91 51.63 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.195 -0.941 . . . . 0.0 109.772 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.4 tp -138.66 130.5 27.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.107 -0.996 . . . . 0.0 110.536 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.8 mt -141.78 123.6 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.303 -0.873 . . . . 0.0 108.651 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.488 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 12.9 t -119.87 50.5 1.27 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.221 -0.924 . . . . 0.0 109.781 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.489 ' O ' ' OXT' ' A' ' 127' ' ' ALA . 87.8 m-20 -144.26 153.16 41.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.975 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -101.92 33.47 3.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.363 -0.836 . . . . 0.0 109.266 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.419 ' HB2' ' NZ ' ' A' ' 80' ' ' LYS . 15.1 p-90 -64.64 157.05 28.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.096 -1.002 . . . . 0.0 110.332 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -138.15 150.28 46.65 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.615 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 30.0 p90 -153.55 164.58 37.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.969 . . . . 0.0 108.785 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 11.8 p90 -155.11 161.83 41.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.803 -1.186 . . . . 0.0 111.783 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 98.7 m -126.09 157.15 38.76 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 122' ' ' VAL . 49.8 t -129.67 141.07 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.88 -1.137 . . . . 0.0 111.738 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 46.8 m -121.89 131.98 54.32 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 93.7 p -170.88 178.88 3.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.297 -1.502 . . . . 0.0 111.57 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.586 ' NZ ' ' OE1' ' A' ' 118' ' ' GLU . 26.1 mtmm -154.34 164.92 37.86 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.49 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 50.1 p30 -58.87 152.75 18.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.842 -1.161 . . . . 0.0 109.173 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.504 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 53.4 t-20 44.5 59.66 3.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.282 -0.886 . . . . 0.0 109.567 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.586 ' OE1' ' NZ ' ' A' ' 115' ' ' LYS . 41.2 mt-10 -164.97 145.44 7.32 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.158 -0.964 . . . . 0.0 110.241 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.619 ' NZ ' ' O ' ' A' ' 25' ' ' ILE . 51.0 mtmt -63.58 135.74 57.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.871 . . . . 0.0 108.729 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.591 ' HE2' ' H ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -84.3 146.43 27.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.075 -1.016 . . . . 0.0 110.42 -179.405 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 57.2 mt -111.58 124.23 51.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.184 -0.948 . . . . 0.0 109.287 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 112' ' ' VAL . 51.3 t -108.22 129.99 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.942 -1.099 . . . . 0.0 110.593 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -109.64 121.48 45.3 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.5 t -137.2 142.1 42.12 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.866 -1.146 . . . . 0.0 112.193 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.615 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.0 m -136.78 156.73 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -133.95 157.13 46.82 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.157 -0.965 . . . . 0.0 110.385 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.489 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.907 -1.044 . . . . 0.0 109.314 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.315 0.579 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -74.41 159.13 32.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.092 -1.005 . . . . 0.0 109.277 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.4 t -104.28 133.75 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.315 -0.866 . . . . 0.0 109.901 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -67.73 119.83 13.09 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.095 -1.003 . . . . 0.0 108.715 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.97 176.04 47.09 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.7 t -120.51 132.1 55.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.374 -1.074 . . . . 0.0 109.35 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.507 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 43.3 t0 -107.42 108.86 20.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.556 -0.715 . . . . 0.0 109.485 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -86.2 -0.92 56.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 108.929 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.3 m -101.81 -15.88 16.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.56 -0.712 . . . . 0.0 110.54 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 12' ' ' GLU . 5.9 m -158.54 127.67 5.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.883 -1.136 . . . . 0.0 110.258 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.514 ' OG ' ' OE1' ' A' ' 12' ' ' GLU . 64.6 p -68.16 -24.1 64.94 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.911 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 57.0 mp0 -114.58 74.05 0.86 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 23.5 p -71.33 153.87 42.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.464 -0.772 . . . . 0.0 110.241 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.46 0.82 37.45 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.1 pt -124.05 -25.65 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.628 -0.67 . . . . 0.0 110.219 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.48 ' O ' ' OG ' ' A' ' 13' ' ' SER . 71.4 m-85 -113.13 139.4 48.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.168 -0.957 . . . . 0.0 110.012 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.6 p -69.37 -16.46 63.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.719 . . . . 0.0 110.766 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -135.05 146.1 48.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.956 -1.09 . . . . 0.0 110.847 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.507 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -163.01 173.37 39.2 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -125.95 161.85 26.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.41 -1.053 . . . . 0.0 109.564 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 t -96.21 154.39 17.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.36 -0.837 . . . . 0.0 109.206 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.405 HG13 ' N ' ' A' ' 23' ' ' ASN . 40.4 pt -55.31 -33.91 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.271 -0.893 . . . . 0.0 109.329 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.431 ' OD1' ' OD1' ' A' ' 27' ' ' ASN . 37.9 t30 -66.14 -40.23 90.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.895 -1.128 . . . . 0.0 109.679 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -60.94 -45.49 94.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 0.0 110.283 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.4 pt -77.7 -15.45 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.104 -0.998 . . . . 0.0 109.587 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.704 ' O ' ' C ' ' A' ' 27' ' ' ASN . 20.6 p -93.6 -61.59 1.52 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.292 -0.88 . . . . 0.0 109.21 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.704 ' C ' ' O ' ' A' ' 26' ' ' SER . 99.0 m-20 0.21 84.06 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.454 ' HA ' HE22 ' A' ' 33' ' ' GLN . 63.9 pttt -63.92 22.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.573 -0.705 . . . . 0.0 109.745 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.641 ' H ' ' C ' ' A' ' 27' ' ' ASN . 87.3 p -103.5 -68.45 0.84 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.171 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.0 p -51.46 107.27 0.18 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.465 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -64.67 -37.19 86.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 0.0 109.761 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -58.02 -9.3 1.32 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.465 -0.772 . . . . 0.0 109.535 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.582 ' O ' ' N ' ' A' ' 35' ' ' ASP . 23.1 pt20 -58.07 -44.78 87.71 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.215 -0.928 . . . . 0.0 109.446 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.544 ' C ' ' O ' ' A' ' 33' ' ' GLN . 6.4 pt20 -31.45 -35.84 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.411 0.624 . . . . 0.0 109.749 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 33' ' ' GLN . 10.6 m-20 -119.63 102.26 8.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.376 -0.827 . . . . 0.0 110.181 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.438 ' CD1' ' O ' ' A' ' 33' ' ' GLN . 15.2 mm -97.56 121.64 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.999 -1.063 . . . . 0.0 108.337 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.6 t -117.86 126.5 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.362 -0.836 . . . . 0.0 110.383 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.427 ' O ' ' O ' ' A' ' 124' ' ' THR . 96.9 m -101.96 101.11 11.47 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.1 m -93.54 119.77 33.0 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.928 . . . . 0.0 109.624 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.592 ' CG2' HG12 ' A' ' 125' ' ' VAL . 14.6 m -139.88 139.48 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.498 -0.751 . . . . 0.0 109.238 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -82.22 127.41 33.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.117 -0.989 . . . . 0.0 109.301 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.01 154.79 17.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 109.45 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.439 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 45.8 t-80 -128.32 152.62 47.93 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.385 -0.822 . . . . 0.0 109.593 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.842 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -56.03 -25.61 45.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 109.766 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -97.14 -24.38 15.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 109.497 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 81.9 m-20 -77.35 136.86 38.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.465 -0.772 . . . . 0.0 109.888 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.1 mt -79.6 149.18 31.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.933 . . . . 0.0 108.595 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.471 HD13 HD21 ' A' ' 99' ' ' LEU . 22.1 pt -120.83 142.35 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.11 -0.994 . . . . 0.0 110.086 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.13 -173.27 45.79 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -172.79 172.12 4.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.081 -1.246 . . . . 0.0 109.864 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -146.02 144.55 30.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.271 -0.893 . . . . 0.0 109.861 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 47.1 m -125.24 153.99 71.88 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.127 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.452 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.66 146.96 25.3 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.647 2.232 . . . . 0.0 112.027 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.3 t -68.4 -13.16 62.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.462 -0.773 . . . . 0.0 110.71 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.47 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 80.0 m-20 -90.37 -0.61 57.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.942 -1.099 . . . . 0.0 110.213 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.452 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 18.8 m-85 -109.5 164.03 12.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.216 -0.928 . . . . 0.0 110.207 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.4 133.88 48.54 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.416 -0.802 . . . . 0.0 108.984 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 58' ' ' VAL . 3.2 m -91.47 112.95 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.994 -1.066 . . . . 0.0 110.508 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -121.42 129.53 25.19 Favored Pre-proline 0 N--CA 1.49 1.526 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.08 113.53 3.43 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.593 1.529 . . . . 0.0 112.243 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 25.5 t-80 -88.96 -24.81 22.33 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.1 t0 -170.17 37.32 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.415 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 79.6 m -60.78 -154.05 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.628 -0.67 . . . . 0.0 109.696 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.482 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 3.1 p90 -110.14 -57.81 2.15 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.12 -0.987 . . . . 0.0 111.206 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.459 HG23 ' CE2' ' A' ' 64' ' ' PHE . 6.2 t -46.68 -72.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.385 -1.447 . . . . 0.0 108.965 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.7 t -137.65 133.2 34.02 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.415 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.27 -178.75 2.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.986 -1.071 . . . . 0.0 110.483 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.517 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 6.3 m-85 -93.13 128.46 39.06 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -71.76 -173.69 1.03 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.076 -1.015 . . . . 0.0 109.724 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.67 -19.69 65.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.099 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.5 p -84.09 -9.17 58.81 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.365 -0.835 . . . . 0.0 108.92 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.97 19.69 58.94 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -105.2 140.59 38.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.319 -1.106 . . . . 0.0 109.075 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -74.12 123.0 23.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 110.167 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -155.31 132.2 10.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.93 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -61.76 146.18 50.2 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.171 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.473 HD11 ' CE ' ' A' ' 80' ' ' LYS . 6.9 tp -100.47 6.05 44.28 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.229 -0.919 . . . . 0.0 109.669 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.452 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.3 OUTLIER -72.57 -38.57 67.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.883 -1.136 . . . . 0.0 110.072 -179.178 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.94 -15.91 25.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.163 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.473 ' CE ' HD11 ' A' ' 77' ' ' LEU . 29.2 ttpt -102.79 -35.2 8.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 109.312 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.433 HD22 ' CH2' ' A' ' 107' ' ' TRP . 41.7 tp -131.9 123.36 27.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -82.0 83.72 7.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.919 -1.113 . . . . 0.0 109.248 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.3 mt -76.86 140.99 40.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.061 -1.024 . . . . 0.0 110.144 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.4 p -128.32 158.07 39.23 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.509 -0.744 . . . . 0.0 109.303 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 54.74 50.14 16.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 0.0 109.656 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.7 mt -78.48 132.63 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 109.818 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.5 mm -116.02 118.3 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.43 -0.794 . . . . 0.0 109.386 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 41.7 mtp -124.72 109.8 13.57 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.146 -0.971 . . . . 0.0 109.804 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.68 101.85 9.71 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.365 -0.835 . . . . 0.0 108.839 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.485 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 52.1 m170 -70.02 -38.63 75.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.022 -1.049 . . . . 0.0 110.628 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -60.53 -45.39 94.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.971 -1.081 . . . . 0.0 109.513 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -86.19 -6.11 59.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 0.0 109.135 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.485 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.6 m-20 54.72 47.89 21.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.388 -0.82 . . . . 0.0 110.237 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.593 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 1.9 t -133.87 139.45 46.21 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.983 -1.073 . . . . 0.0 109.409 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -128.05 140.13 52.14 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.49 -0.756 . . . . 0.0 110.055 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.593 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 73.5 m-85 -136.32 146.64 46.82 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.261 -0.9 . . . . 0.0 109.249 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 64.0 m -149.6 151.66 34.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.072 -1.018 . . . . 0.0 109.223 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 -101.35 132.52 46.87 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.038 -1.039 . . . . 0.0 109.341 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.471 HD21 HD13 ' A' ' 48' ' ' ILE . 86.4 mt -90.51 137.45 27.34 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.379 -0.826 . . . . 0.0 109.599 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.842 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 76.7 Cg_exo -46.24 163.89 0.1 OUTLIER 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.816 1.678 . . . . 0.0 111.296 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 93.4 p -73.68 -12.1 60.62 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.089 -1.007 . . . . 0.0 109.65 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.9 tp -137.31 130.27 30.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.086 -1.009 . . . . 0.0 110.609 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.2 mt -145.01 102.34 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.3 m -97.11 -6.51 34.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 0.0 109.847 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -83.69 154.74 23.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.999 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -105.55 33.35 3.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.35 -0.844 . . . . 0.0 109.241 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.433 ' CH2' HD22 ' A' ' 81' ' ' LEU . 23.6 p-90 -65.31 153.54 40.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.142 -0.974 . . . . 0.0 110.505 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -132.45 154.38 49.93 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.641 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 33.4 p90 -152.69 159.34 43.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.113 -0.992 . . . . 0.0 108.666 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.513 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 4.2 p90 -150.7 159.05 44.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.779 -1.2 . . . . 0.0 111.742 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 88.9 m -123.22 155.66 36.68 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 122' ' ' VAL . 41.9 t -129.97 141.97 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.759 -1.213 . . . . 0.0 111.768 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 76.3 m -120.49 131.39 54.7 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.9 p -169.56 171.84 7.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.272 -1.518 . . . . 0.0 111.653 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.47 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 51.9 mttm -148.59 165.23 31.88 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 54.4 p-10 -57.62 150.48 19.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.854 -1.154 . . . . 0.0 109.067 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 116' ' ' ASP . 64.3 t30 42.71 60.62 2.36 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.203 -0.935 . . . . 0.0 109.763 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 44.6 mt-10 -161.74 141.8 10.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.221 -0.924 . . . . 0.0 110.305 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.583 ' NZ ' ' O ' ' A' ' 26' ' ' SER . 99.1 mttt -54.58 147.07 14.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.161 -0.962 . . . . 0.0 108.953 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.424 ' H ' ' HG2' ' A' ' 120' ' ' LYS . 15.7 pttt -98.81 140.44 33.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.211 -0.93 . . . . 0.0 110.36 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.7 mt -111.27 124.51 52.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.567 -0.708 . . . . 0.0 109.251 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 112' ' ' VAL . 42.4 t -109.56 130.72 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.947 -1.095 . . . . 0.0 110.469 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -109.33 121.76 45.88 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 38' ' ' CYS . 7.2 t -136.97 141.81 42.6 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.927 -1.108 . . . . 0.0 112.123 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -135.74 159.1 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -123.58 142.91 50.58 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.129 -0.982 . . . . 0.0 110.389 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.319 179.748 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -83.98 151.76 24.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -0.855 . . . . 0.0 109.372 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.0 t -86.2 135.78 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.915 . . . . 0.0 110.031 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -71.05 129.51 39.15 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.571 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 168.11 -163.25 37.0 Favored Glycine 0 N--CA 1.483 1.798 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.98 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -129.08 135.09 48.44 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.461 -1.023 . . . . 0.0 109.779 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.446 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 39.5 t0 -114.51 109.41 18.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.447 -0.783 . . . . 0.0 109.302 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -89.23 3.26 52.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.161 -0.962 . . . . 0.0 108.807 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.6 m -98.21 -20.7 17.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.409 -0.807 . . . . 0.0 110.586 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 12' ' ' GLU . 17.2 m -156.65 126.64 6.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.881 -1.137 . . . . 0.0 110.263 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 t -59.08 -31.88 69.29 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.459 ' H ' HG22 ' A' ' 10' ' ' THR . 97.1 mt-10 -112.64 73.89 0.84 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -66.62 148.57 51.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.34 -0.85 . . . . 0.0 110.29 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.6 t -98.35 0.55 45.67 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.6 pt -123.86 -20.73 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.658 -0.651 . . . . 0.0 110.243 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.448 ' CZ ' ' N ' ' A' ' 50' ' ' PHE . 56.6 m-85 -119.59 137.81 53.62 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.304 -0.872 . . . . 0.0 109.999 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.1 t -65.99 -16.81 64.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.635 -0.666 . . . . 0.0 110.819 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -132.71 144.11 50.07 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.04 -1.038 . . . . 0.0 110.68 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.446 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -159.38 171.72 35.9 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -130.37 165.14 23.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.382 -1.07 . . . . 0.0 109.682 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.9 t -95.46 153.81 17.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.38 -0.825 . . . . 0.0 109.17 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.1 pt -57.5 -32.22 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.24 -0.913 . . . . 0.0 109.379 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.473 ' O ' ' OG ' ' A' ' 26' ' ' SER . 14.9 t-20 -65.94 -39.45 90.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.113 -0.992 . . . . 0.0 109.533 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -65.16 -39.77 93.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.404 -0.81 . . . . 0.0 110.147 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.3 pt -86.29 -13.6 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.969 . . . . 0.0 109.703 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' A' ' 23' ' ' ASN . 88.0 p -66.69 -134.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.932 . . . . 0.0 109.33 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -104.52 28.36 7.05 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.244 -0.91 . . . . 0.0 109.11 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 29' ' ' SER . 8.8 mptt -126.87 15.02 7.45 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.536 -0.727 . . . . 0.0 109.651 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.493 ' O ' ' C ' ' A' ' 30' ' ' SER . 16.8 m -40.99 143.39 0.38 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.499 -0.751 . . . . 0.0 109.406 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.493 ' C ' ' O ' ' A' ' 29' ' ' SER . 44.6 t -37.59 -81.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.473 -0.767 . . . . 0.0 109.676 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -143.21 -4.72 0.89 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.944 . . . . 0.0 109.69 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.529 ' O ' ' O ' ' A' ' 33' ' ' GLN . 98.9 m-20 -61.61 122.49 15.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.963 . . . . 0.0 109.385 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.529 ' O ' ' O ' ' A' ' 32' ' ' ASN . 3.7 pt20 -35.12 -95.91 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.864 -0.523 . . . . 0.0 109.816 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.427 ' H ' ' CG ' ' A' ' 33' ' ' GLN . 7.3 pt20 -139.67 34.0 2.01 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.781 -1.2 . . . . 0.0 109.213 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -134.42 106.17 6.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.408 -0.807 . . . . 0.0 109.721 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.1 mm -91.77 120.8 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 108.669 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.468 HG22 ' HB ' ' A' ' 122' ' ' VAL . 51.8 t -116.21 128.33 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.469 -0.77 . . . . 0.0 110.13 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 74.8 m -101.99 101.82 12.27 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.5 m -93.61 119.84 33.14 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.266 -0.896 . . . . 0.0 109.673 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.481 ' CG2' HG12 ' A' ' 125' ' ' VAL . 27.0 m -141.12 153.77 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.544 -0.723 . . . . 0.0 109.12 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -99.79 134.95 41.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.989 -1.069 . . . . 0.0 109.488 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.68 159.58 14.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.324 -0.86 . . . . 0.0 109.549 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.452 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 21.3 t-80 -133.11 150.88 52.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.908 . . . . 0.0 109.445 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.98 -23.95 5.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.256 -0.903 . . . . 0.0 109.805 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -104.03 -25.87 12.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -0.925 . . . . 0.0 109.732 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 84.6 m-20 -73.03 134.58 44.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.324 -0.86 . . . . 0.0 109.954 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -80.42 147.93 30.77 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.552 HD13 HD21 ' A' ' 99' ' ' LEU . 45.9 pt -120.34 142.31 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.219 -0.926 . . . . 0.0 110.128 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.58 -172.65 45.39 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.448 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 45.7 p90 -172.42 172.08 4.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.965 -1.314 . . . . 0.0 109.724 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -146.15 144.82 30.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.207 -0.933 . . . . 0.0 109.864 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 85.3 m -123.2 151.94 62.97 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.419 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.45 146.95 23.8 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.287 1.992 . . . . 0.0 111.929 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.3 t -68.47 -13.21 62.15 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.463 -0.773 . . . . 0.0 110.838 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -91.24 -1.48 57.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.935 -1.103 . . . . 0.0 110.324 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.419 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 20.0 m-85 -108.95 164.36 12.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.251 -0.906 . . . . 0.0 110.422 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.9 t -104.72 134.95 47.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.35 -0.844 . . . . 0.0 108.996 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.8 m -90.44 123.36 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.958 -1.089 . . . . 0.0 110.223 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 112' ' ' VAL . 26.3 mt-10 -127.81 126.22 23.82 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.06 114.32 3.57 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 121.688 1.592 . . . . 0.0 112.16 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 68' ' ' PHE . 7.3 t-160 -93.07 -24.84 18.17 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.6 t0 -170.21 39.76 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 98.6 m -63.02 -153.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.44 -0.788 . . . . 0.0 109.733 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.9 p90 -111.17 -56.42 2.37 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.246 -0.909 . . . . 0.0 111.359 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 66' ' ' SER . 16.2 t -48.51 -72.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.362 -1.461 . . . . 0.0 108.848 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.447 ' N ' HG12 ' A' ' 65' ' ' VAL . 33.3 t -138.89 131.29 28.58 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -173.42 -179.42 1.88 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.999 -1.063 . . . . 0.0 110.483 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.507 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 6.2 m-85 -93.45 127.65 39.18 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -73.95 -172.36 1.31 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.115 -0.99 . . . . 0.0 109.671 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.8 mt -63.62 -22.53 66.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 109.122 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.0 p -82.5 -7.41 59.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 108.875 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.93 18.47 67.53 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -101.48 140.72 35.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.253 -1.145 . . . . 0.0 108.989 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -80.6 115.9 20.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.297 -0.877 . . . . 0.0 110.133 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -152.65 139.64 19.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 109.767 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -63.3 148.56 47.94 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.156 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 77' ' ' LEU . 14.0 tp -97.59 7.94 45.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.306 -0.871 . . . . 0.0 109.817 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -68.65 -40.47 80.2 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.845 -1.159 . . . . 0.0 110.049 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 79' ' ' ASN . 52.0 t-20 -62.39 -33.99 75.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.019 -1.051 . . . . 0.0 109.108 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -74.42 -48.87 25.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.888 . . . . 0.0 109.56 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.47 HD11 ' HG2' ' A' ' 100' ' ' PRO . 48.5 tp -139.29 124.74 19.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.459 -0.776 . . . . 0.0 109.161 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -81.19 90.13 6.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.046 -1.033 . . . . 0.0 109.734 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.2 mt -75.26 149.96 38.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 109.972 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.9 p -127.24 159.97 32.72 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.469 -0.769 . . . . 0.0 109.203 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 m120 55.69 52.77 10.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.92 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -81.77 132.98 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.379 -0.826 . . . . 0.0 110.009 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.3 mm -122.48 122.65 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.521 -0.737 . . . . 0.0 109.21 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 91.0 mtp -122.24 102.91 8.41 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.154 -0.966 . . . . 0.0 109.757 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -111.98 100.62 9.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.304 -0.873 . . . . 0.0 109.037 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.491 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 76.3 m80 -73.28 -35.02 66.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.002 -1.061 . . . . 0.0 110.64 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -60.67 -46.59 89.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.009 -1.057 . . . . 0.0 109.646 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -88.48 -3.89 58.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.138 -0.976 . . . . 0.0 109.07 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 97.3 m-20 54.57 47.28 23.04 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 0.0 110.144 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.594 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 2.3 t -132.65 138.0 47.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.229 -0.919 . . . . 0.0 109.36 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -127.91 139.71 52.44 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.392 -0.818 . . . . 0.0 110.103 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.594 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 58.3 m-85 -136.2 146.88 47.3 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.279 -0.888 . . . . 0.0 109.245 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.4 t -151.46 152.92 33.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.978 . . . . 0.0 109.143 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -108.37 137.43 46.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.341 -0.849 . . . . 0.0 109.36 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.61 ' HB3' HD11 ' A' ' 103' ' ' ILE . 40.8 mt -93.24 141.1 23.57 Favored Pre-proline 0 N--CA 1.491 1.624 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.603 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.47 ' HG2' HD11 ' A' ' 81' ' ' LEU . 78.3 Cg_exo -46.54 159.49 0.29 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.781 1.654 . . . . 0.0 111.206 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.2 p -68.71 -16.52 63.84 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.254 -0.904 . . . . 0.0 109.772 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.2 tp -123.37 131.44 53.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.408 -0.808 . . . . 0.0 110.502 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.61 HD11 ' HB3' ' A' ' 99' ' ' LEU . 64.6 mt -143.07 126.03 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.4 m -139.16 52.99 1.75 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.955 -1.091 . . . . 0.0 109.782 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.519 ' O ' ' OXT' ' A' ' 127' ' ' ALA . 54.6 t0 -145.99 153.33 40.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.957 . . . . 0.0 110.026 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.491 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 99.0 m-20 -91.93 33.03 1.07 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.39 -0.819 . . . . 0.0 108.912 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.52 ' NE1' ' HB3' ' A' ' 127' ' ' ALA . 7.8 p-90 -64.57 154.33 36.53 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.135 -0.978 . . . . 0.0 110.494 -178.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.558 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 53.7 tttp -145.39 151.42 38.23 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.611 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 30.2 p90 -155.45 164.48 38.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.077 -1.014 . . . . 0.0 108.621 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.501 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 8.0 p90 -154.63 159.07 40.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.717 -1.239 . . . . 0.0 111.861 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 80.7 m -123.25 156.24 35.59 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.483 HG22 HG22 ' A' ' 122' ' ' VAL . 46.4 t -129.3 141.21 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 120.874 -1.141 . . . . 0.0 111.693 -178.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 35.1 m -122.25 131.73 54.07 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.0 p -172.12 179.04 2.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.243 -1.536 . . . . 0.0 111.565 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.468 ' HZ2' ' CB ' ' A' ' 115' ' ' LYS . 6.3 mtmp? -153.09 167.32 29.63 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 117' ' ' ASN . 99.9 m-20 -58.84 152.14 19.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.782 -1.199 . . . . 0.0 109.001 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.475 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 56.8 t-20 39.77 59.53 1.86 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.462 -0.774 . . . . 0.0 109.683 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 54.0 mm-40 -158.46 139.9 13.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.374 -0.829 . . . . 0.0 110.551 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -52.98 140.43 24.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 0.0 108.873 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -92.88 139.12 30.86 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.462 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.3 mt -110.04 122.77 48.35 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.483 HG22 HG22 ' A' ' 112' ' ' VAL . 43.6 t -107.25 129.47 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.049 -1.032 . . . . 0.0 110.625 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.412 ' CE1' ' HB3' ' A' ' 50' ' ' PHE . 21.5 t80 -106.95 119.07 38.35 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.558 ' OG1' ' NZ ' ' A' ' 108' ' ' LYS . 6.3 t -136.11 140.21 43.54 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.997 -1.064 . . . . 0.0 112.119 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.611 ' CG2' ' CE2' ' A' ' 109' ' ' PHE . 3.0 m -136.06 156.81 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -136.18 155.47 50.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.088 -1.007 . . . . 0.0 110.291 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.52 ' HB3' ' NE1' ' A' ' 107' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.355 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -138.53 157.4 46.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.904 . . . . 0.0 109.393 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.7 t -95.19 134.88 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.279 -0.888 . . . . 0.0 110.061 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -68.96 123.09 20.07 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.017 -1.052 . . . . 0.0 108.617 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.54 179.66 47.83 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.9 t -119.15 130.04 55.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.523 -0.986 . . . . 0.0 109.318 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.419 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 40.2 t0 -106.3 109.12 20.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.572 -0.705 . . . . 0.0 109.326 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -89.62 1.51 55.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.322 -0.861 . . . . 0.0 108.939 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.3 m -103.29 -17.03 15.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.477 -0.765 . . . . 0.0 110.514 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.552 HG22 ' H ' ' A' ' 12' ' ' GLU . 74.8 m -156.93 126.02 5.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.814 -1.179 . . . . 0.0 110.387 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.6 t -64.1 -28.19 69.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.37 -0.831 . . . . 0.0 108.937 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.552 ' H ' HG22 ' A' ' 10' ' ' THR . 79.2 mm-40 -112.68 73.77 0.83 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.1 t -68.15 150.43 48.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.806 . . . . 0.0 110.211 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.52 -0.08 41.34 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 pt -125.14 -22.03 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.712 -0.618 . . . . 0.0 110.312 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -114.19 141.47 47.48 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.279 -0.888 . . . . 0.0 110.156 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 m -74.98 -18.8 60.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.552 -0.718 . . . . 0.0 110.894 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.55 ' NZ ' ' CE1' ' A' ' 20' ' ' TYR . 61.5 tttm -129.43 140.22 51.39 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.018 -1.051 . . . . 0.0 110.577 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.419 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -155.98 164.88 32.49 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.55 ' CE1' ' NZ ' ' A' ' 18' ' ' LYS . 36.5 m-85 -118.28 155.18 31.04 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.446 -1.032 . . . . 0.0 109.745 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.7 t -94.17 152.08 18.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.443 -0.786 . . . . 0.0 109.024 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.4 pt -59.01 -28.27 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.761 -0.775 . . . . 0.0 109.478 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -69.72 -41.01 75.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.049 -1.032 . . . . 0.0 109.633 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -59.67 -45.92 90.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -0.89 . . . . 0.0 110.103 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 35.6 pt -67.17 -5.34 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.117 -0.989 . . . . 0.0 109.57 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.699 ' O ' ' N ' ' A' ' 28' ' ' LYS . 79.2 p -108.8 -36.47 6.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.261 -0.9 . . . . 0.0 109.231 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 29' ' ' SER . 98.8 m-20 -53.65 73.17 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 26' ' ' SER . 98.3 mttt -52.27 93.05 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.43 -0.794 . . . . 0.0 109.689 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -140.92 -85.55 0.19 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.938 . . . . 0.0 109.212 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.524 ' N ' ' OG ' ' A' ' 29' ' ' SER . 7.0 p -69.21 177.19 2.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.57 -0.706 . . . . 0.0 109.587 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 32' ' ' ASN . 56.8 p30 -51.46 -14.68 0.32 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.116 -0.99 . . . . 0.0 109.467 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.556 ' O ' HD11 ' A' ' 36' ' ' ILE . 91.3 m-20 -69.05 10.48 0.29 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.148 -0.97 . . . . 0.0 109.332 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.61 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 15.2 pt20 -91.44 -7.82 49.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.036 . . . . 0.0 109.568 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.479 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 15.3 pt20 -138.28 -33.1 0.69 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.338 -0.851 . . . . 0.0 109.802 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.479 ' OD1' ' O ' ' A' ' 34' ' ' GLN . 78.8 m-20 -136.59 113.71 10.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.446 -0.784 . . . . 0.0 109.559 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.556 HD11 ' O ' ' A' ' 32' ' ' ASN . 21.7 mm -92.72 120.1 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.061 -1.024 . . . . 0.0 108.58 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.4 t -115.33 124.48 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 110.147 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 71.3 m -102.64 101.97 12.14 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.6 m -95.81 121.13 37.21 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.164 -0.96 . . . . 0.0 109.693 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.443 ' CG2' HG12 ' A' ' 125' ' ' VAL . 26.8 m -141.04 153.91 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.578 -0.701 . . . . 0.0 109.218 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -97.99 133.96 41.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.008 -1.058 . . . . 0.0 109.37 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.81 160.57 14.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 0.0 109.641 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.446 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 32.2 t60 -135.28 151.88 50.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.327 -0.858 . . . . 0.0 109.487 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.571 ' HB1' ' HA ' ' A' ' 101' ' ' SER . . . -51.77 -25.23 7.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 109.635 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -101.48 -27.04 13.35 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.291 -0.881 . . . . 0.0 109.817 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.446 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 86.3 m-20 -73.64 134.4 43.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.298 -0.876 . . . . 0.0 109.989 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.523 HD21 ' CZ ' ' A' ' 98' ' ' ARG . 97.3 mt -79.92 148.31 31.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 108.545 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.485 HD13 HD21 ' A' ' 99' ' ' LEU . 9.5 pt -120.4 141.5 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.24 -0.913 . . . . 0.0 109.969 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' A' ' 95' ' ' PHE . . . 176.86 -173.28 46.18 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -171.66 173.05 4.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.001 -1.293 . . . . 0.0 109.791 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -146.05 144.78 30.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 0.0 109.892 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 80.0 m -123.79 152.45 65.96 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.429 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.53 148.33 20.77 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.28 1.987 . . . . 0.0 112.005 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.4 m -71.5 -12.96 61.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.431 -0.793 . . . . 0.0 110.647 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -91.84 1.9 56.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.016 -1.053 . . . . 0.0 110.119 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.446 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 18.1 m-85 -110.09 165.26 11.88 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.266 -0.896 . . . . 0.0 110.354 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.5 t -102.92 139.75 38.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 109.012 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.6 m -97.92 125.86 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.991 -1.068 . . . . 0.0 110.199 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -132.14 129.86 21.85 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.3 113.12 3.32 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.664 1.576 . . . . 0.0 112.095 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -92.01 -27.98 17.48 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 110' ' ' PHE . 54.3 t0 -166.81 38.42 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.587 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 79.0 m -62.85 -157.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.544 -0.722 . . . . 0.0 109.77 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 3.2 p90 -111.27 -49.07 3.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.226 -0.921 . . . . 0.0 111.629 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.409 HG23 ' CD2' ' A' ' 64' ' ' PHE . 53.6 t -59.22 -48.45 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.343 -1.473 . . . . 0.0 109.286 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.5 t -157.78 128.73 6.53 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.587 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.7 -178.93 1.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.092 -1.005 . . . . 0.0 110.499 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 9.9 m-85 -93.1 124.75 37.3 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -69.28 -174.91 0.71 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.011 . . . . 0.0 109.847 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.5 mt -62.92 -23.01 67.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.316 -0.865 . . . . 0.0 108.95 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.8 m -82.36 -6.34 59.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.327 -0.858 . . . . 0.0 108.761 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.18 19.88 63.88 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -101.71 138.95 38.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.318 -1.107 . . . . 0.0 109.101 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -82.46 110.25 17.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.21 -0.931 . . . . 0.0 109.964 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -147.01 141.91 26.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.499 -0.751 . . . . 0.0 110.011 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -59.86 144.02 49.78 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.274 -0.891 . . . . 0.0 109.32 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.571 HD11 ' HD2' ' A' ' 80' ' ' LYS . 14.3 tp -97.09 8.03 45.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.202 -0.936 . . . . 0.0 109.735 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -69.67 -38.74 77.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.179 -0.951 . . . . 0.0 110.065 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 41.7 p-10 -62.43 -32.85 73.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.125 -0.984 . . . . 0.0 109.217 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.571 ' HD2' HD11 ' A' ' 77' ' ' LEU . 37.3 ttmt -71.86 -50.79 26.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.345 -0.847 . . . . 0.0 109.663 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.595 HD22 ' CZ2' ' A' ' 107' ' ' TRP . 39.0 tp -140.74 128.2 21.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.479 -0.763 . . . . 0.0 109.166 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -81.05 87.73 6.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.035 -1.041 . . . . 0.0 109.487 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.7 mt -71.66 152.99 42.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 0.0 109.928 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.6 p -128.19 163.92 23.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.562 -0.711 . . . . 0.0 109.323 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 55.44 52.24 11.59 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.265 -0.897 . . . . 0.0 109.94 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.45 128.26 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.337 -0.852 . . . . 0.0 109.985 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.1 mm -123.47 122.44 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.554 -0.716 . . . . 0.0 109.136 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 83.2 mtp -123.59 104.81 9.26 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.197 -0.94 . . . . 0.0 109.793 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -113.37 101.85 9.78 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.342 -0.849 . . . . 0.0 109.013 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.487 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 96.6 m-70 -73.14 -36.14 66.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.97 -1.081 . . . . 0.0 110.652 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -60.21 -46.32 90.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.891 -1.131 . . . . 0.0 109.623 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -89.79 -5.09 57.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.172 -0.955 . . . . 0.0 109.032 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.487 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.6 m-20 54.66 47.66 22.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.551 -0.718 . . . . 0.0 110.25 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.586 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 2.5 t -131.94 135.8 46.88 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.21 -0.931 . . . . 0.0 109.291 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.416 ' O ' ' CA ' ' A' ' 49' ' ' GLY . 76.0 m-85 -126.63 139.28 53.29 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.388 -0.82 . . . . 0.0 109.951 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.586 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 72.3 m-85 -136.15 147.3 47.66 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.349 -0.844 . . . . 0.0 109.264 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.5 t -152.9 152.59 31.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.063 -1.023 . . . . 0.0 109.189 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.523 ' CZ ' HD21 ' A' ' 47' ' ' LEU . 9.0 mtt-85 -107.41 139.29 42.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.26 -0.9 . . . . 0.0 109.856 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.485 HD21 HD13 ' A' ' 48' ' ' ILE . 38.2 mt -94.88 141.47 23.35 Favored Pre-proline 0 N--CA 1.49 1.548 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.853 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.517 ' HG2' HD11 ' A' ' 81' ' ' LEU . 77.3 Cg_exo -45.9 179.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.912 1.741 . . . . 0.0 111.162 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.571 ' HA ' ' HB1' ' A' ' 44' ' ' ALA . 73.7 m -86.08 -14.17 45.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.088 -1.008 . . . . 0.0 110.001 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.7 tp -120.99 130.22 53.72 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.276 -0.89 . . . . 0.0 110.442 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.434 HD11 ' HB3' ' A' ' 99' ' ' LEU . 7.6 mt -150.23 102.38 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 84.2 p -115.49 -0.69 13.0 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.168 -0.957 . . . . 0.0 109.748 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 52.4 t0 -87.38 158.01 19.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.57 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 92.9 m-20 -99.42 32.2 2.86 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.451 -0.781 . . . . 0.0 109.071 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.595 ' CZ2' HD22 ' A' ' 81' ' ' LEU . 10.3 p-90 -65.97 157.18 31.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.145 -0.972 . . . . 0.0 110.509 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -146.4 157.96 43.83 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.568 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 39.6 p90 -155.68 163.54 39.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.155 -0.966 . . . . 0.0 108.718 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 62' ' ' ASP . 14.3 p90 -153.73 163.07 40.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.83 -1.169 . . . . 0.0 111.877 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 95.1 m -127.73 158.93 36.3 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 122' ' ' VAL . 44.0 t -130.44 143.34 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.93 -1.106 . . . . 0.0 111.856 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 86.1 m -124.8 132.92 53.3 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.0 p -171.49 179.14 2.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.306 -1.496 . . . . 0.0 111.669 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.575 ' NZ ' ' OE2' ' A' ' 118' ' ' GLU . 6.4 mtmp? -153.09 166.15 33.36 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.62 151.7 20.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.867 -1.146 . . . . 0.0 109.245 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.49 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 64.8 t30 44.7 61.2 2.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.219 -0.926 . . . . 0.0 109.667 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.575 ' OE2' ' NZ ' ' A' ' 115' ' ' LYS . 42.5 mt-10 -164.61 145.38 7.85 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.226 -0.921 . . . . 0.0 110.26 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.61 ' NZ ' ' O ' ' A' ' 33' ' ' GLN . 67.6 mttm -60.47 146.79 43.45 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.228 -0.92 . . . . 0.0 108.937 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -93.72 141.71 28.18 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.111 -0.993 . . . . 0.0 110.394 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.1 mt -108.84 121.0 44.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.313 -0.867 . . . . 0.0 108.899 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 112' ' ' VAL . 55.4 t -108.96 130.3 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.092 -1.005 . . . . 0.0 110.577 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -110.65 122.65 48.3 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.0 t -137.68 143.94 41.56 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.029 -1.044 . . . . 0.0 112.378 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.568 ' CG2' ' CE2' ' A' ' 109' ' ' PHE . 3.0 m -135.42 158.77 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -136.83 153.91 50.66 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.058 -1.026 . . . . 0.0 110.282 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.512 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.354 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.282 0.563 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -77.84 156.65 30.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.238 -0.914 . . . . 0.0 109.251 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.6 t -95.06 133.36 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.97 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.419 ' N ' ' HD2' ' A' ' 4' ' ' LYS . 13.6 mptt -70.59 125.18 26.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.104 -0.998 . . . . 0.0 108.663 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.21 -179.95 42.71 Favored Glycine 0 N--CA 1.484 1.844 0 C-N-CA 119.479 -1.343 . . . . 0.0 109.79 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.9 t -116.92 134.72 54.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.402 -1.057 . . . . 0.0 109.712 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.544 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 68.1 t0 -115.81 110.66 19.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.499 -0.751 . . . . 0.0 109.332 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -87.17 3.26 47.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.94 . . . . 0.0 108.916 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.4 m -102.96 -18.85 14.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.434 -0.791 . . . . 0.0 110.549 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 12' ' ' GLU . 10.4 m -157.42 127.52 6.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.887 -1.133 . . . . 0.0 110.289 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 21' ' ' SER . 37.3 m -66.49 -27.0 67.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.408 -0.807 . . . . 0.0 109.001 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.583 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 57.9 mp0 -113.81 74.87 0.89 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 15' ' ' ILE . 26.6 m -75.97 115.87 16.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.423 -0.798 . . . . 0.0 110.578 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.406 HG23 HG23 ' A' ' 15' ' ' ILE . 7.7 t -65.39 3.2 0.71 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.524 ' H ' ' C ' ' A' ' 13' ' ' SER . 15.1 pt -122.83 -36.57 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.712 -0.618 . . . . 0.0 110.333 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.416 ' CZ ' ' CE1' ' A' ' 96' ' ' TYR . 50.9 m-85 -108.21 137.11 46.75 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.185 -0.947 . . . . 0.0 109.816 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.2 t -68.28 -18.4 64.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.593 -0.692 . . . . 0.0 111.003 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -130.58 141.42 50.46 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.953 -1.092 . . . . 0.0 110.521 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.544 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -161.83 173.55 38.2 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -128.44 162.23 27.63 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.38 -1.07 . . . . 0.0 109.568 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.509 ' N ' ' OG ' ' A' ' 11' ' ' SER . 10.7 t -97.05 157.37 15.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.392 -0.817 . . . . 0.0 109.182 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.457 ' O ' ' OG ' ' A' ' 26' ' ' SER . 44.1 pt -57.97 -30.38 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.308 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -65.9 -40.42 91.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.153 -0.967 . . . . 0.0 109.59 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -66.11 -41.53 90.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 110.219 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.1 pt -86.85 -17.61 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.003 -1.061 . . . . 0.0 109.739 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.594 ' O ' ' N ' ' A' ' 28' ' ' LYS . 37.8 m -93.65 -73.27 0.57 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 0.0 109.342 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 29' ' ' SER . 58.7 t30 -50.36 87.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 0.0 109.147 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' A' ' 26' ' ' SER . 35.2 pttt -45.63 95.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.555 -0.715 . . . . 0.0 109.54 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 27' ' ' ASN . 20.3 m -157.17 21.42 0.3 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.335 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.5 t -78.23 155.43 30.31 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.881 -0.727 . . . . 0.0 109.929 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 32' ' ' ASN . 26.3 p-10 -52.03 -54.35 31.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.157 -0.964 . . . . 0.0 109.468 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.589 ' ND2' ' O ' ' A' ' 35' ' ' ASP . 25.1 p30 -71.94 177.29 4.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.168 -0.957 . . . . 0.0 109.341 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.509 ' C ' ' H ' ' A' ' 35' ' ' ASP . 21.0 pt20 -75.97 -148.42 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.595 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.603 ' H ' ' CD ' ' A' ' 34' ' ' GLN . 5.0 pm0 -69.65 40.0 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.471 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.589 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 86.3 m-20 -131.78 109.24 10.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.498 -0.751 . . . . 0.0 109.518 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.2 mm -97.31 124.49 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.995 -1.066 . . . . 0.0 108.775 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.486 HG22 ' HB ' ' A' ' 122' ' ' VAL . 50.0 t -121.03 129.62 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.303 -0.873 . . . . 0.0 110.157 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 124' ' ' THR . 84.5 m -101.26 100.12 10.59 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.8 m -95.53 120.64 36.13 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.089 -1.007 . . . . 0.0 109.412 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.61 HG22 HG12 ' A' ' 125' ' ' VAL . 3.1 m -139.05 159.44 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.526 -0.734 . . . . 0.0 109.176 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -97.77 123.71 41.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.151 -0.968 . . . . 0.0 109.594 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.441 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -90.55 155.03 19.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -0.87 . . . . 0.0 109.531 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.431 ' O ' HD12 ' A' ' 99' ' ' LEU . 35.4 t-80 -133.33 152.13 51.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -0.898 . . . . 0.0 109.553 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.751 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -57.34 -29.61 64.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.335 -0.853 . . . . 0.0 109.827 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -93.6 -26.89 16.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 109.725 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -76.68 135.6 39.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.523 -0.735 . . . . 0.0 110.043 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.1 mt -78.36 148.64 33.63 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.468 HD13 HD21 ' A' ' 99' ' ' LEU . 47.5 pt -122.36 144.83 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.331 -0.856 . . . . 0.0 110.308 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.5 -171.2 44.16 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -172.73 171.57 4.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.136 -1.214 . . . . 0.0 109.71 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -146.82 144.84 29.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 0.0 109.9 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 86.0 m -125.37 152.17 70.96 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.929 . . . . 0.0 108.54 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.472 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.4 Cg_endo -51.63 149.82 17.9 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.3 2.0 . . . . 0.0 111.944 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.0 m -70.84 -12.1 61.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -0.83 . . . . 0.0 110.682 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.448 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 82.4 m-20 -92.78 0.23 57.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.94 -1.1 . . . . 0.0 110.182 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.472 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 16.3 m-85 -108.28 164.2 12.53 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.202 -0.936 . . . . 0.0 110.364 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.9 m -103.85 128.08 51.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 109.087 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 58' ' ' VAL . 3.2 m -88.3 114.38 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.959 -1.088 . . . . 0.0 110.151 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -120.37 126.8 26.62 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.06 113.53 3.43 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 121.545 1.496 . . . . 0.0 112.106 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.491 ' O ' ' O ' ' A' ' 68' ' ' PHE . 2.8 t-80 -93.59 -23.63 18.23 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -172.26 51.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.67 ' H ' ' CB ' ' A' ' 67' ' ' ALA . 76.4 m -76.47 -151.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.63 -0.668 . . . . 0.0 109.799 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.49 ' CE2' HG23 ' A' ' 65' ' ' VAL . 6.5 p90 -110.18 -58.33 2.08 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.098 -1.001 . . . . 0.0 111.373 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.49 HG23 ' CE2' ' A' ' 64' ' ' PHE . 24.0 t -45.27 -70.35 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.627 -1.296 . . . . 0.0 108.809 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.4 t -145.58 129.36 17.23 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.67 ' CB ' ' H ' ' A' ' 63' ' ' CYS . . . -167.84 -179.78 4.38 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.373 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.534 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 4.3 m-85 -93.98 141.2 28.79 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.461 ' OD1' ' OE1' ' A' ' 75' ' ' GLU . 33.2 m120 -80.88 -169.7 2.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.955 -1.091 . . . . 0.0 109.652 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 70' ' ' LEU . 10.2 mp -67.91 -13.8 62.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 108.913 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.4 t -90.73 -7.14 53.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -0.856 . . . . 0.0 108.982 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.07 23.87 56.26 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -107.73 136.44 47.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.213 -1.169 . . . . 0.0 109.095 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -67.42 135.02 52.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.216 -0.927 . . . . 0.0 109.984 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.461 ' OE1' ' OD1' ' A' ' 69' ' ' ASN . 80.3 tt0 -155.42 166.0 34.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.437 -0.789 . . . . 0.0 109.548 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.458 ' N ' ' HG2' ' A' ' 75' ' ' GLU . 5.3 m120 -106.94 139.1 41.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.33 -0.856 . . . . 0.0 109.531 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.7 tp -95.79 -10.27 29.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.0 . . . . 0.0 110.027 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.481 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 20.5 pt-20 -62.67 -44.86 95.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.99 -1.069 . . . . 0.0 109.476 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.563 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 48.7 p30 -66.72 -22.09 66.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.138 -0.976 . . . . 0.0 108.94 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.563 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 52.6 tptt -86.74 -48.09 8.55 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.359 -0.838 . . . . 0.0 109.415 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.649 HD23 HD21 ' A' ' 83' ' ' LEU . 30.8 tp -122.89 129.95 52.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.412 -0.805 . . . . 0.0 109.174 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -78.66 82.68 4.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.032 -1.043 . . . . 0.0 109.244 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.649 HD21 HD23 ' A' ' 81' ' ' LEU . 88.8 mt -81.53 137.69 35.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.873 . . . . 0.0 110.112 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 48.1 p -127.44 163.31 24.36 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.513 -0.742 . . . . 0.0 109.278 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.5 m120 55.04 51.05 14.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.623 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.2 131.53 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.353 -0.842 . . . . 0.0 110.039 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.6 mm -121.85 121.17 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.503 -0.748 . . . . 0.0 109.277 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 79.6 mtp -123.73 107.4 11.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.21 -0.931 . . . . 0.0 109.785 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -112.57 101.27 9.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.374 -0.829 . . . . 0.0 109.082 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.448 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 76.4 m80 -71.55 -36.8 71.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.917 -1.114 . . . . 0.0 110.651 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -60.61 -45.74 92.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.022 -1.049 . . . . 0.0 109.557 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -87.91 -5.28 58.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.117 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 99.7 m-20 54.37 47.61 22.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.504 -0.747 . . . . 0.0 110.332 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.597 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 2.6 t -132.99 138.19 46.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.028 -1.045 . . . . 0.0 109.333 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -126.38 138.9 53.61 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.512 -0.742 . . . . 0.0 109.809 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.597 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 77.9 m-85 -135.41 146.15 48.0 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.115 -0.991 . . . . 0.0 109.336 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.5 p -153.03 155.69 37.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.097 -1.002 . . . . 0.0 108.986 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.425 ' HG2' HH11 ' A' ' 98' ' ' ARG . 59.2 mtt-85 -105.11 136.68 44.16 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.264 -0.897 . . . . 0.0 109.65 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.468 HD21 HD13 ' A' ' 48' ' ' ILE . 78.1 mt -91.83 138.41 24.91 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.459 -0.776 . . . . 0.0 109.706 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.751 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 76.4 Cg_exo -45.74 175.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.83 1.686 . . . . 0.0 111.305 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.6 m -83.92 -12.93 54.66 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.077 -1.014 . . . . 0.0 109.844 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.3 tp -134.13 130.0 36.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.131 -0.981 . . . . 0.0 110.511 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 91.3 mt -147.37 102.48 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.865 . . . . 0.0 108.806 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.3 m -104.1 -6.96 20.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.072 -1.017 . . . . 0.0 109.794 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 127' ' ' ALA . 78.6 m-20 -78.41 151.65 32.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 110.022 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -100.15 31.79 3.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.391 -0.818 . . . . 0.0 109.205 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.408 ' CH2' HD22 ' A' ' 81' ' ' LEU . 20.4 p-90 -65.4 159.88 23.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.117 -0.99 . . . . 0.0 110.465 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -142.23 156.97 45.34 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.643 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 36.4 p90 -154.08 158.62 40.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.088 -1.007 . . . . 0.0 108.692 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 18.5 p90 -150.66 156.33 41.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.804 -1.185 . . . . 0.0 111.937 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 96.5 m -121.78 156.19 33.71 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 122' ' ' VAL . 51.7 t -127.71 138.43 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.77 -1.206 . . . . 0.0 111.872 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 67.0 m -123.34 132.0 53.84 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 97.5 p -165.6 171.5 13.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.121 -1.612 . . . . 0.0 111.652 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.448 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 47.6 mtpt -136.87 158.58 44.14 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -60.29 143.21 53.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.933 -1.105 . . . . 0.0 108.813 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 59.6 t-20 49.82 62.63 2.55 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.395 -0.816 . . . . 0.0 109.09 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 63.3 mm-40 -165.11 149.66 9.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.177 -0.952 . . . . 0.0 110.71 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -55.18 136.92 48.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.251 -0.905 . . . . 0.0 108.974 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -88.41 140.41 29.5 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.18 -0.95 . . . . 0.0 110.322 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 70.8 mt -109.16 122.03 46.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.432 -0.793 . . . . 0.0 109.136 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 112' ' ' VAL . 47.2 t -111.02 131.36 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.075 -1.016 . . . . 0.0 110.492 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -107.58 118.59 37.12 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 38' ' ' CYS . 7.3 t -136.6 141.43 43.27 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.868 -1.145 . . . . 0.0 111.967 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.643 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 2.8 m -137.37 160.34 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -128.81 149.04 50.9 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.094 -1.004 . . . . 0.0 110.264 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.353 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -77.07 152.66 34.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.307 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.8 t -95.32 135.36 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.324 -0.86 . . . . 0.0 109.89 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -67.99 121.31 15.81 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.0 108.6 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.71 175.04 45.45 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.425 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 5.0 t -116.08 130.02 56.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.415 -1.05 . . . . 0.0 109.465 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.478 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 42.6 t0 -104.82 108.51 20.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.533 -0.729 . . . . 0.0 109.214 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -89.29 0.24 56.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.889 . . . . 0.0 108.93 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.4 m -102.33 -17.17 16.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.568 -0.707 . . . . 0.0 110.414 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.445 HG22 ' H ' ' A' ' 12' ' ' GLU . 8.0 m -156.87 126.7 6.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.801 -1.187 . . . . 0.0 110.229 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.2 p -64.06 -27.63 69.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 108.858 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.445 ' H ' HG22 ' A' ' 10' ' ' THR . 97.3 mt-10 -114.77 76.87 1.02 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 88.1 p -71.75 153.37 42.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.395 -0.815 . . . . 0.0 110.224 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.15 1.1 35.72 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.6 pt -123.61 -24.03 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.632 -0.667 . . . . 0.0 110.29 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.507 ' O ' ' OG ' ' A' ' 13' ' ' SER . 63.3 m-85 -114.91 140.87 48.63 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.093 -1.005 . . . . 0.0 110.093 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.1 p -69.04 -17.81 63.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.403 -0.811 . . . . 0.0 110.614 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -129.58 139.86 51.36 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.921 -1.112 . . . . 0.0 110.458 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.478 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -150.37 162.95 29.43 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.425 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 36.5 m-85 -127.14 159.21 34.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.371 -1.076 . . . . 0.0 109.568 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.9 t -89.76 149.89 22.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.366 -0.834 . . . . 0.0 109.145 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.2 pt -64.38 -30.03 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.216 -0.927 . . . . 0.0 109.58 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -70.63 -41.01 72.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.151 -0.968 . . . . 0.0 109.786 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.05 -45.65 92.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 110.247 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 26' ' ' SER . 15.3 pt -69.97 -42.82 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.11 -0.994 . . . . 0.0 109.585 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.61 ' O ' ' N ' ' A' ' 28' ' ' LYS . 4.4 t -66.33 -54.85 19.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.169 -0.957 . . . . 0.0 109.32 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.682 ' O ' ' C ' ' A' ' 28' ' ' LYS . 62.5 t30 -46.57 88.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.342 -0.849 . . . . 0.0 109.22 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.682 ' C ' ' O ' ' A' ' 27' ' ' ASN . 44.2 tptt -13.3 115.58 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 121.349 0.595 . . . . 0.0 109.663 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.554 ' OG ' HD11 ' A' ' 36' ' ' ILE . 74.5 m -46.96 123.5 5.31 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.467 -178.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 p -98.73 -8.12 26.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 109.316 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 56.1 p30 -104.7 -1.63 26.03 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.21 -0.931 . . . . 0.0 109.658 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.51 ' CG ' ' H ' ' A' ' 33' ' ' GLN . 66.5 t30 -162.56 -168.66 1.88 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.152 -0.967 . . . . 0.0 109.412 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.51 ' H ' ' CG ' ' A' ' 32' ' ' ASN . 18.5 pt20 -77.52 -172.46 2.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.611 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.491 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 13.8 pt20 -76.04 50.43 0.6 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.955 . . . . 0.0 109.575 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 34' ' ' GLN . 98.6 m-20 -141.68 116.77 9.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.393 -0.817 . . . . 0.0 109.521 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.554 HD11 ' OG ' ' A' ' 29' ' ' SER . 43.4 mm -93.64 126.85 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.928 -1.107 . . . . 0.0 108.726 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.453 HG22 ' HB ' ' A' ' 122' ' ' VAL . 56.1 t -123.29 129.17 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.364 -0.835 . . . . 0.0 110.31 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 85.1 m -102.08 101.61 11.98 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.4 m -97.03 122.31 39.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.057 -1.027 . . . . 0.0 109.649 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.619 ' CG2' HG12 ' A' ' 125' ' ' VAL . 19.0 m -138.91 158.02 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.437 -0.789 . . . . 0.0 109.079 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -97.06 119.95 36.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.135 -0.978 . . . . 0.0 109.517 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.41 156.43 17.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.362 -0.836 . . . . 0.0 109.592 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.413 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 39.9 t60 -131.26 152.37 50.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.829 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -56.02 -26.18 47.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.282 -0.886 . . . . 0.0 109.797 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -99.06 -24.75 14.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -0.95 . . . . 0.0 109.626 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 98.5 m-20 -74.67 137.17 42.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.512 -0.743 . . . . 0.0 110.002 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.9 mt -78.83 146.53 33.64 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 99' ' ' LEU . 45.4 pt -121.83 144.3 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.095 -1.003 . . . . 0.0 110.28 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.17 -173.46 46.26 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -171.18 170.94 5.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.038 -1.272 . . . . 0.0 109.794 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -147.04 145.44 29.68 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.343 -0.848 . . . . 0.0 109.864 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 86.4 m -125.22 151.4 69.45 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 108.815 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.48 154.1 9.3 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.43 2.086 . . . . 0.0 111.977 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.7 m -72.24 -10.5 59.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.496 -0.753 . . . . 0.0 110.711 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.536 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 78.7 m-20 -93.29 -3.68 53.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.95 -1.094 . . . . 0.0 110.245 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.476 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 15.4 m-85 -105.92 160.63 15.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.246 -0.909 . . . . 0.0 110.08 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -101.33 132.69 46.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.47 -0.768 . . . . 0.0 109.328 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.6 m -88.59 118.31 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.109 -0.994 . . . . 0.0 110.219 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -126.93 127.04 24.47 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.13 113.51 3.42 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 121.631 1.554 . . . . 0.0 112.131 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.484 ' O ' ' O ' ' A' ' 68' ' ' PHE . 9.6 t-160 -91.4 -25.57 19.29 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.475 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.3 t0 -169.48 38.94 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.422 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 81.8 m -62.56 -154.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.601 -0.687 . . . . 0.0 109.717 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.544 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 2.1 p90 -109.96 -59.28 1.95 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.061 -1.024 . . . . 0.0 111.359 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.464 ' C ' ' O ' ' A' ' 64' ' ' PHE . 25.3 t -44.75 -73.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.67 -1.269 . . . . 0.0 108.788 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.422 ' N ' HG12 ' A' ' 65' ' ' VAL . 43.0 t -138.2 131.13 29.84 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.422 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -171.98 179.1 2.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.876 -1.14 . . . . 0.0 110.458 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 5.2 m-85 -93.84 126.18 38.89 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -71.74 -170.79 0.59 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.976 -1.078 . . . . 0.0 109.823 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.548 ' N ' HD12 ' A' ' 70' ' ' LEU . 10.8 mp -65.07 -19.72 66.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.191 -0.943 . . . . 0.0 109.038 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.6 m -83.49 -7.97 59.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.343 -0.848 . . . . 0.0 108.843 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.5 19.15 66.9 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -103.79 137.05 42.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.342 -1.093 . . . . 0.0 109.139 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -76.38 113.85 14.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.279 -0.888 . . . . 0.0 110.073 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -144.56 131.56 20.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.333 -0.855 . . . . 0.0 110.04 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -59.98 145.18 47.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.145 -0.972 . . . . 0.0 109.303 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.3 tp -100.2 -0.9 37.82 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.588 -0.695 . . . . 0.0 110.088 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -67.03 -42.35 85.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.222 -0.924 . . . . 0.0 109.85 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -63.77 -21.94 66.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.995 . . . . 0.0 109.023 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -86.86 -46.82 9.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.46 -0.775 . . . . 0.0 109.342 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.542 HD23 HD21 ' A' ' 83' ' ' LEU . 38.8 tp -124.62 127.89 48.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.492 -0.755 . . . . 0.0 109.171 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -77.17 83.48 3.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.966 -1.084 . . . . 0.0 109.235 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.576 HD22 ' OG ' ' A' ' 97' ' ' SER . 83.1 mt -81.22 139.37 35.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.414 -0.804 . . . . 0.0 110.027 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.8 p -128.0 160.76 30.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.558 -0.714 . . . . 0.0 109.247 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 55.02 50.1 16.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.302 -0.874 . . . . 0.0 109.472 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.4 mt -78.91 131.97 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 110.093 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.3 mm -119.6 120.08 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.456 -0.778 . . . . 0.0 109.329 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 93.8 mtp -122.09 105.06 9.93 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.058 -1.026 . . . . 0.0 109.785 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -112.5 101.16 9.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.337 -0.852 . . . . 0.0 109.067 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -76.68 -31.72 57.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.217 -0.927 . . . . 0.0 110.49 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -59.97 -46.96 87.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.799 -1.188 . . . . 0.0 109.645 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -90.23 3.01 54.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.157 -0.965 . . . . 0.0 109.1 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 51.96 46.8 25.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.479 -0.763 . . . . 0.0 110.13 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.475 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 3.5 t -132.6 137.73 47.15 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.997 -1.064 . . . . 0.0 109.475 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -128.91 140.02 51.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.477 -0.764 . . . . 0.0 109.974 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.475 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 78.4 m-85 -135.14 146.71 49.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.154 -0.966 . . . . 0.0 109.477 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.576 ' OG ' HD22 ' A' ' 83' ' ' LEU . 32.4 t -149.82 149.39 30.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.024 -1.047 . . . . 0.0 109.157 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.412 ' HG2' HH11 ' A' ' 98' ' ' ARG . 60.3 mtt-85 -102.17 134.48 45.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.074 -1.016 . . . . 0.0 109.5 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 48' ' ' ILE . 87.5 mt -92.69 139.21 23.49 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.486 -0.759 . . . . 0.0 109.625 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.829 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 78.2 Cg_exo -45.81 170.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.851 1.701 . . . . 0.0 111.284 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.9 m -79.93 -12.24 59.74 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.098 -1.001 . . . . 0.0 109.778 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.3 tp -135.39 131.17 35.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.256 -0.902 . . . . 0.0 110.573 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 87.0 mt -147.54 102.27 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.8 t -99.73 -3.88 31.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.861 -1.149 . . . . 0.0 109.897 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 127' ' ' ALA . 84.7 m-20 -83.7 154.63 23.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.958 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -104.21 33.17 3.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.389 -0.819 . . . . 0.0 109.161 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 18.4 p-90 -65.33 152.06 44.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.932 . . . . 0.0 110.462 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -130.82 150.97 51.74 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.644 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 25.2 p90 -150.17 159.66 44.25 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.042 -1.036 . . . . 0.0 108.693 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.501 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 6.0 p90 -152.87 159.06 43.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.773 -1.205 . . . . 0.0 111.819 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 99.4 m -123.18 156.02 35.92 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.59 HG22 HG22 ' A' ' 122' ' ' VAL . 42.4 t -129.19 140.86 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.866 -1.147 . . . . 0.0 111.794 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 70.2 m -121.65 131.46 54.11 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.6 p -170.82 176.11 4.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.232 -1.542 . . . . 0.0 111.704 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.536 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 51.5 mttm -151.57 166.46 31.11 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 117' ' ' ASN . 98.6 m-20 -57.59 151.54 16.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.757 -1.214 . . . . 0.0 109.17 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 116' ' ' ASP . 66.7 t30 42.43 61.47 2.01 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.209 -0.932 . . . . 0.0 109.816 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 43.6 mt-10 -161.76 140.84 9.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.103 -0.998 . . . . 0.0 110.21 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.47 ' NZ ' ' OG ' ' A' ' 29' ' ' SER . 6.2 mmmt -55.02 138.75 43.17 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.171 -0.955 . . . . 0.0 109.326 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -87.35 139.93 30.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.302 -0.874 . . . . 0.0 110.387 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.3 mt -110.12 122.27 47.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.473 -0.767 . . . . 0.0 109.024 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.59 HG22 HG22 ' A' ' 112' ' ' VAL . 51.6 t -110.69 131.76 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.04 -1.038 . . . . 0.0 110.664 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.405 ' CZ ' ' CG1' ' A' ' 125' ' ' VAL . 23.9 t80 -110.22 122.53 47.87 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.0 t -137.54 142.45 41.4 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 119.059 -1.057 . . . . 0.0 111.969 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.644 ' CG2' ' CE2' ' A' ' 109' ' ' PHE . 3.0 m -137.53 154.52 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -122.87 147.6 46.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.201 -0.937 . . . . 0.0 110.366 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.329 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 mmtp -134.24 157.0 47.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.324 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.8 t -97.64 132.19 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.256 -0.903 . . . . 0.0 109.873 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -68.01 121.42 16.05 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.175 -0.953 . . . . 0.0 108.648 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.29 172.4 43.45 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.9 t -113.66 129.36 56.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.384 -1.068 . . . . 0.0 109.329 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.441 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 40.3 t0 -101.97 108.67 20.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.508 -0.745 . . . . 0.0 109.252 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.476 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 96.8 m-85 -89.75 -1.29 57.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.018 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.1 m -103.0 -16.0 15.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.594 -0.691 . . . . 0.0 110.511 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.569 HG22 ' H ' ' A' ' 12' ' ' GLU . 39.0 m -157.9 126.25 5.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.756 -1.215 . . . . 0.0 110.152 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.9 p -66.07 -26.01 67.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.97 . . . . 0.0 108.921 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.569 ' H ' HG22 ' A' ' 10' ' ' THR . 79.4 mm-40 -114.07 74.16 0.86 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.8 p -71.25 154.15 41.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 110.24 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.407 HG23 HG23 ' A' ' 15' ' ' ILE . 14.8 t -101.86 0.96 36.43 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.407 HG23 HG23 ' A' ' 14' ' ' THR . 5.5 pt -125.28 -26.47 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.643 -0.661 . . . . 0.0 110.243 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.405 ' CD2' HG13 ' A' ' 15' ' ' ILE . 72.3 m-85 -105.37 143.53 33.41 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.028 -1.045 . . . . 0.0 109.887 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.9 m -70.37 -18.09 63.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.542 -0.724 . . . . 0.0 110.765 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' NZ ' HG12 ' A' ' 40' ' ' VAL . 53.3 mtmt -144.33 156.52 44.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.75 -1.219 . . . . 0.0 110.775 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.441 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -158.78 169.24 35.09 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -117.6 151.66 36.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.199 -1.177 . . . . 0.0 109.646 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.1 t -94.45 156.45 16.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.348 -0.845 . . . . 0.0 109.069 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.4 pt -60.0 -24.05 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.104 -0.998 . . . . 0.0 109.554 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -77.23 -51.37 11.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.126 -0.983 . . . . 0.0 109.587 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -51.73 -40.26 59.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.003 . . . . 0.0 110.229 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.5 pt -78.88 -5.89 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.976 -1.078 . . . . 0.0 109.781 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.5 m -96.81 -65.31 0.97 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.189 -0.945 . . . . 0.0 109.549 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.663 ' O ' ' N ' ' A' ' 29' ' ' SER . 98.5 m-20 -109.48 -70.94 0.78 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.901 . . . . 0.0 109.342 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -57.9 69.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.825 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.663 ' N ' ' O ' ' A' ' 27' ' ' ASN . 66.9 m -116.05 85.04 2.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.842 . . . . 0.0 108.916 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.9 m -88.61 70.11 8.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.821 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.49 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 11.1 p30 -152.68 -51.25 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 0.0 109.673 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 31' ' ' ASN . 73.6 m-20 -166.12 176.64 7.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.336 -0.853 . . . . 0.0 109.62 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.479 ' O ' ' O ' ' A' ' 32' ' ' ASN . 22.5 pt20 -60.56 -129.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.962 . . . . 0.0 109.458 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.504 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 15.4 pt20 -71.1 43.05 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.001 -1.062 . . . . 0.0 109.232 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.504 ' OD1' ' O ' ' A' ' 34' ' ' GLN . 53.9 m-20 -136.71 116.51 13.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.404 -0.81 . . . . 0.0 109.666 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.7 mm -98.16 121.24 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.922 . . . . 0.0 108.72 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.0 t -117.07 127.83 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.153 -0.967 . . . . 0.0 110.182 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.476 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 96.7 m -102.45 100.62 10.76 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 65.6 m -94.4 120.24 34.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.016 -1.053 . . . . 0.0 109.645 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.453 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 27.5 m -141.3 156.11 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.161 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -98.11 133.96 41.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.171 -0.955 . . . . 0.0 109.445 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.439 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -102.0 150.35 23.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.052 -1.03 . . . . 0.0 109.63 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.519 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 29.8 t60 -120.0 152.52 37.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.363 -0.836 . . . . 0.0 109.551 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.34 -25.59 35.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 109.917 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -99.78 -21.63 15.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.118 -0.989 . . . . 0.0 109.714 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.519 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 81.4 m-20 -77.85 138.02 38.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.501 -0.749 . . . . 0.0 109.998 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.2 mt -79.39 148.9 31.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 108.703 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.404 HG21 HD11 ' A' ' 99' ' ' LEU . 42.6 pt -120.4 141.73 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.969 -1.082 . . . . 0.0 110.214 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.67 -178.3 47.96 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.43 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 55.2 p90 -164.0 170.08 17.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.118 -1.224 . . . . 0.0 109.736 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -144.08 142.87 30.87 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.354 -0.841 . . . . 0.0 109.772 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 82.4 m -122.79 151.83 61.34 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.445 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.46 145.75 27.71 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.289 1.993 . . . . 0.0 111.893 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.3 t -67.88 -14.57 63.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.464 -0.772 . . . . 0.0 110.624 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.587 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.4 m-20 -90.2 1.5 56.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.889 -1.132 . . . . 0.0 110.087 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.454 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 19.1 m-85 -111.11 166.75 10.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.6 m -103.6 139.98 38.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.398 -0.814 . . . . 0.0 109.315 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.7 m -97.55 120.35 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.94 -1.1 . . . . 0.0 110.311 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -127.19 126.68 24.29 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.0 113.81 3.49 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.732 1.622 . . . . 0.0 112.235 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -93.1 -24.8 18.15 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.7 t0 -168.89 36.26 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.412 ' O ' ' O ' ' A' ' 62' ' ' ASP . 88.7 m -59.44 -155.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.499 -0.751 . . . . 0.0 109.893 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.466 ' O ' ' C ' ' A' ' 65' ' ' VAL . 3.9 p90 -110.0 -59.07 1.98 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.953 -1.092 . . . . 0.0 111.246 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.483 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 36.6 t -43.95 -73.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.678 -1.264 . . . . 0.0 108.858 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.2 t -139.25 131.98 29.05 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -172.94 -178.48 1.83 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.879 -1.138 . . . . 0.0 110.457 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.502 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 6.6 m-85 -92.27 126.25 37.27 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -73.34 -172.49 1.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.136 -0.978 . . . . 0.0 109.763 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.522 ' N ' HD22 ' A' ' 70' ' ' LEU . 3.8 mm? -64.22 -22.16 66.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.33 -0.856 . . . . 0.0 109.102 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 89.4 p -82.57 -7.37 59.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.889 . . . . 0.0 108.83 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.69 17.95 66.97 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -100.43 139.68 35.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -1.18 . . . . 0.0 109.184 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -82.07 109.46 16.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.174 -0.954 . . . . 0.0 109.934 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -143.88 137.57 27.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.863 . . . . 0.0 110.004 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 77' ' ' LEU . 62.0 t-20 -60.12 145.85 45.31 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.171 -0.956 . . . . 0.0 109.403 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.512 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 14.0 tp -99.07 6.56 46.51 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.359 -0.838 . . . . 0.0 109.829 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.44 ' CD ' ' N ' ' A' ' 79' ' ' ASN . 2.3 pp20? -69.69 -40.33 76.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.104 -0.997 . . . . 0.0 109.896 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.605 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 43.4 p30 -63.37 -27.69 69.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.155 -0.966 . . . . 0.0 109.12 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.605 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 50.9 tptt -78.26 -50.44 11.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.458 -0.776 . . . . 0.0 109.343 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.538 HD11 ' HG2' ' A' ' 100' ' ' PRO . 38.0 tp -130.39 130.53 44.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.512 -0.742 . . . . 0.0 109.191 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -81.32 84.53 6.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.13 -0.981 . . . . 0.0 109.408 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 86.4 mt -76.67 143.68 39.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -0.828 . . . . 0.0 109.888 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.1 p -127.67 161.81 28.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.509 -0.745 . . . . 0.0 109.299 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 55.44 51.83 12.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -0.952 . . . . 0.0 109.652 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.4 mt -80.39 130.59 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.397 -0.815 . . . . 0.0 110.047 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.5 mm -118.68 120.26 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.447 -0.783 . . . . 0.0 109.139 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 84.2 mtp -121.15 101.26 7.54 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.082 -1.011 . . . . 0.0 109.834 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -110.29 100.22 9.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.264 -0.898 . . . . 0.0 108.896 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.479 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 93.0 m-70 -72.34 -36.49 68.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.971 -1.081 . . . . 0.0 110.655 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -60.4 -46.18 90.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.94 -1.1 . . . . 0.0 109.631 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -88.59 -4.98 58.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -0.923 . . . . 0.0 109.119 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.7 m-20 54.37 47.94 21.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.517 -0.739 . . . . 0.0 110.283 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.598 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 1.8 t -133.41 140.01 47.08 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.025 -1.047 . . . . 0.0 109.463 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 66.4 m-85 -129.04 140.03 51.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.463 -0.773 . . . . 0.0 109.959 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.598 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 82.1 m-85 -138.08 148.89 45.48 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.261 -0.899 . . . . 0.0 109.479 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.3 p -154.54 158.02 39.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.142 -0.974 . . . . 0.0 109.215 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -104.01 136.37 43.78 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.166 -0.959 . . . . 0.0 109.399 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 100' ' ' PRO . 36.4 mt -89.69 136.66 29.21 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 109.635 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.538 ' HG2' HD11 ' A' ' 81' ' ' LEU . 77.6 Cg_exo -45.75 177.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.863 1.708 . . . . 0.0 111.211 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 87.7 p -87.39 -15.3 38.23 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.064 -1.022 . . . . 0.0 109.839 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' A' ' 102' ' ' LEU . 52.2 tp -127.37 128.85 46.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.156 -0.965 . . . . 0.0 110.311 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.8 mt -150.22 107.77 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.206 -0.934 . . . . 0.0 108.676 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 81.5 p -118.44 -1.56 11.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.06 -1.025 . . . . 0.0 109.773 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 9.0 p30 -82.67 154.5 24.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.052 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -95.61 34.08 1.54 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.504 -0.748 . . . . 0.0 109.037 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.464 ' CZ3' ' CD1' ' A' ' 109' ' ' PHE . 10.0 p-90 -63.21 154.16 32.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 110.379 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -142.69 149.65 39.11 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.62 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 33.5 p90 -154.46 163.74 39.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.125 -0.984 . . . . 0.0 108.784 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 7.3 p90 -154.44 160.04 41.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.846 -1.159 . . . . 0.0 111.705 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 67.8 m -123.35 155.99 36.25 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.656 HG22 HG22 ' A' ' 122' ' ' VAL . 46.0 t -129.36 140.87 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.878 -1.139 . . . . 0.0 111.756 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 98.4 m -124.66 133.37 53.25 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 72.6 p -170.49 179.23 3.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.239 -1.538 . . . . 0.0 111.665 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.587 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 49.7 mtmt -151.61 162.59 40.73 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 117' ' ' ASN . 97.9 m-20 -57.81 152.19 16.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.816 -1.178 . . . . 0.0 109.173 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.53 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 57.3 t-20 45.24 61.33 2.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.104 -0.997 . . . . 0.0 109.681 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 38.0 mt-10 -166.15 146.69 6.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.141 -0.974 . . . . 0.0 110.174 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.38 139.32 57.73 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.133 -0.979 . . . . 0.0 109.021 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -85.95 142.09 29.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.169 -0.957 . . . . 0.0 110.326 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 68.6 mt -109.21 120.8 43.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.402 -0.812 . . . . 0.0 109.045 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.656 HG22 HG22 ' A' ' 112' ' ' VAL . 49.8 t -109.42 131.21 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 120.951 -1.093 . . . . 0.0 110.774 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -109.66 121.03 44.3 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.4 t -137.16 142.63 42.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.776 -1.202 . . . . 0.0 112.008 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.62 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 2.9 m -136.26 156.37 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -133.88 155.97 48.92 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.226 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.51 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.432 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -83.96 148.11 27.09 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.24 -0.913 . . . . 0.0 109.328 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.7 t -80.81 134.19 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.35 -0.844 . . . . 0.0 110.119 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -72.18 129.93 39.64 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.017 -1.052 . . . . 0.0 108.642 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.97 -154.35 24.29 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.378 -1.392 . . . . 0.0 109.914 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.4 t -133.93 131.64 39.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -1.111 . . . . 0.0 109.656 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.513 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 38.6 t0 -109.51 109.25 20.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.539 -0.726 . . . . 0.0 109.15 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.4 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 91.0 m-85 -89.78 3.38 53.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 108.819 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 91.9 m -100.54 -19.59 16.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.386 -0.821 . . . . 0.0 110.515 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.597 HG22 ' H ' ' A' ' 12' ' ' GLU . 32.6 m -157.75 127.49 6.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.791 -1.193 . . . . 0.0 110.535 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.1 p -64.17 -27.22 68.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.232 -0.917 . . . . 0.0 108.996 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.597 ' H ' HG22 ' A' ' 10' ' ' THR . 97.7 mt-10 -114.02 74.36 0.87 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.513 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 8.6 m -69.29 150.61 47.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.269 -0.894 . . . . 0.0 110.304 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.27 -1.05 34.62 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.9 pt -125.59 -10.35 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.676 -0.64 . . . . 0.0 110.491 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -125.7 141.0 52.23 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.201 -0.937 . . . . 0.0 110.191 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.8 t -69.18 -20.73 64.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.668 -0.645 . . . . 0.0 110.995 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -132.57 142.65 49.26 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.106 -0.997 . . . . 0.0 110.668 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.44 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -154.74 169.61 32.97 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -128.81 159.77 34.69 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.474 -1.015 . . . . 0.0 109.647 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.0 t -90.82 148.77 22.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.393 -0.817 . . . . 0.0 109.187 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 23' ' ' ASN . 39.4 pt -58.39 -33.38 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.12 -0.987 . . . . 0.0 109.476 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.481 ' O ' ' OD1' ' A' ' 27' ' ' ASN . 49.0 t-20 -65.86 -37.8 87.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 109.793 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -66.45 -41.23 89.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.611 -0.681 . . . . 0.0 110.464 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.401 HG12 ' H ' ' A' ' 25' ' ' ILE . 16.0 pt -83.1 -15.75 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.944 -1.097 . . . . 0.0 109.767 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 28' ' ' LYS . 53.2 p -89.46 -73.14 0.52 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.937 . . . . 0.0 109.287 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.569 ' N ' ' OG ' ' A' ' 26' ' ' SER . 48.5 p-10 -38.0 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.524 0.678 . . . . 0.0 109.206 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 26' ' ' SER . 59.1 pttt -90.99 49.23 1.61 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.468 -0.77 . . . . 0.0 109.775 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.0 m -157.28 18.11 0.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.415 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.9 t -75.42 -103.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.462 -0.773 . . . . 0.0 109.533 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.55 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 98.0 m-20 -110.34 -61.89 1.6 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.149 -0.969 . . . . 0.0 109.242 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -94.89 106.53 18.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.289 -0.882 . . . . 0.0 109.44 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.55 ' NE2' ' O ' ' A' ' 31' ' ' ASN . 1.2 pm0 -104.07 82.32 1.95 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.216 -0.928 . . . . 0.0 109.698 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.476 ' N ' ' NZ ' ' A' ' 119' ' ' LYS . 3.9 pt20 -162.34 -162.77 0.85 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -59.69 139.82 56.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.215 -0.928 . . . . 0.0 109.247 -179.193 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.0 mm -97.33 122.77 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.106 -0.996 . . . . 0.0 108.508 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.447 HG22 ' HB ' ' A' ' 122' ' ' VAL . 54.7 t -118.98 131.97 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.371 -0.831 . . . . 0.0 110.565 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.417 ' O ' ' O ' ' A' ' 124' ' ' THR . 89.0 m -102.1 102.65 13.15 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.5 m -93.07 119.97 32.87 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.081 -1.012 . . . . 0.0 109.574 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.586 ' CG2' HG12 ' A' ' 125' ' ' VAL . 11.8 m -140.33 141.03 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.656 -0.653 . . . . 0.0 109.344 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -87.02 129.89 34.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.078 -1.014 . . . . 0.0 109.452 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.434 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -98.58 159.64 14.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 109.504 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.48 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 24.9 t-80 -134.77 154.05 51.76 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.282 -0.886 . . . . 0.0 109.568 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.55 -26.48 32.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.373 -0.829 . . . . 0.0 109.762 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -99.49 -27.04 13.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.904 . . . . 0.0 109.866 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 83.9 m-20 -69.91 132.79 46.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.199 -0.938 . . . . 0.0 110.152 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.418 HD22 ' HD3' ' A' ' 98' ' ' ARG . 21.2 mt -77.81 145.09 36.57 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.549 HD13 HD21 ' A' ' 99' ' ' LEU . 21.7 pt -117.37 137.45 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.169 -0.957 . . . . 0.0 110.15 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.1 154.08 11.61 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -142.45 173.55 11.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.022 -1.281 . . . . 0.0 109.879 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -146.65 144.72 29.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.356 -0.84 . . . . 0.0 109.87 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 88.7 m -123.34 152.11 63.76 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.449 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.8 Cg_endo -51.55 151.52 14.02 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.321 2.014 . . . . 0.0 112.043 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.3 m -71.7 -13.62 61.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.456 -0.777 . . . . 0.0 110.59 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.609 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 82.4 m-20 -90.84 -1.34 57.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.961 -1.087 . . . . 0.0 110.196 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.449 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.3 m-85 -108.11 164.13 12.56 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.306 -0.871 . . . . 0.0 110.492 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.1 t -104.72 137.55 42.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.295 -0.878 . . . . 0.0 108.982 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.8 m -93.13 121.86 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.066 -1.021 . . . . 0.0 110.212 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.414 ' O ' ' O ' ' A' ' 112' ' ' VAL . 10.4 mt-10 -126.19 124.61 24.57 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.15 113.51 3.41 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.623 1.548 . . . . 0.0 112.097 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 68' ' ' PHE . 12.6 t-80 -93.51 -24.0 18.15 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 110' ' ' PHE . 68.0 t0 -171.0 48.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.668 ' H ' ' CB ' ' A' ' 67' ' ' ALA . 91.0 m -71.59 -154.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.518 -0.739 . . . . 0.0 109.774 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.474 ' CD2' HG23 ' A' ' 65' ' ' VAL . 3.6 p90 -112.17 -49.26 2.98 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.299 -0.876 . . . . 0.0 111.649 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.474 HG23 ' CD2' ' A' ' 64' ' ' PHE . 76.5 t -59.47 -48.27 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.291 -1.506 . . . . 0.0 109.43 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.3 t -161.16 130.8 4.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.668 ' CB ' ' H ' ' A' ' 63' ' ' CYS . . . -173.93 -178.49 1.54 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.129 -0.982 . . . . 0.0 110.414 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 6.1 m-85 -93.06 125.59 37.73 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -70.86 -173.92 0.86 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.107 -0.995 . . . . 0.0 109.871 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.526 ' N ' HD12 ' A' ' 70' ' ' LEU . 11.1 mp -64.45 -21.37 66.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.301 -0.874 . . . . 0.0 109.037 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.8 m -82.35 -8.27 59.63 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.306 -0.871 . . . . 0.0 108.943 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.35 17.72 63.91 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -104.91 145.02 30.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.327 -1.102 . . . . 0.0 109.213 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -83.63 117.8 23.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.486 -0.759 . . . . 0.0 110.149 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -149.73 136.36 19.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.836 . . . . 0.0 110.211 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -59.73 142.96 52.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.494 HD11 ' HD2' ' A' ' 80' ' ' LYS . 13.5 tp -95.45 7.07 47.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.227 -0.921 . . . . 0.0 109.775 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' A' ' 79' ' ' ASN . 0.3 OUTLIER -68.82 -39.9 79.79 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.269 -0.894 . . . . 0.0 109.991 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.448 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 91.3 m-20 -62.04 -36.03 80.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.017 . . . . 0.0 109.121 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.494 ' HD2' HD11 ' A' ' 77' ' ' LEU . 21.5 ttmt -72.53 -48.72 38.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.514 -0.741 . . . . 0.0 109.657 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.505 HD11 ' HG2' ' A' ' 100' ' ' PRO . 42.6 tp -148.79 120.84 8.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.468 -0.77 . . . . 0.0 108.997 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.48 113.1 19.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.968 . . . . 0.0 109.502 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.2 mt -90.5 159.27 16.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.857 . . . . 0.0 109.917 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 46.7 p -127.14 160.79 30.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.464 -0.773 . . . . 0.0 109.223 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.439 HD22 ' HG3' ' A' ' 98' ' ' ARG . 95.8 m-20 55.5 52.11 11.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -0.947 . . . . 0.0 109.814 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.2 mt -79.03 127.81 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.922 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.6 mm -122.18 121.51 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.49 -0.756 . . . . 0.0 109.174 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 86.6 mtp -121.84 103.18 8.67 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.222 -0.924 . . . . 0.0 109.569 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -112.24 100.76 9.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.377 -0.827 . . . . 0.0 109.033 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.476 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 77.5 m80 -71.18 -37.41 72.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.006 -1.059 . . . . 0.0 110.596 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -60.7 -46.03 91.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.972 -1.08 . . . . 0.0 109.704 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -88.71 -4.73 58.46 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.092 -1.005 . . . . 0.0 109.112 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.6 m-20 53.36 47.72 23.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.417 -0.802 . . . . 0.0 110.04 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.585 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.0 t -132.63 137.04 46.87 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.024 -1.047 . . . . 0.0 109.403 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -126.86 139.37 53.13 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.068 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.585 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 72.3 m-85 -136.42 146.31 46.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.27 -0.893 . . . . 0.0 109.259 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.9 m -151.18 151.53 32.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.175 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.439 ' HG3' HD22 ' A' ' 85' ' ' ASN . 7.5 mmm180 -102.32 131.87 48.65 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.351 -0.843 . . . . 0.0 109.576 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.549 HD21 HD13 ' A' ' 48' ' ' ILE . 92.6 mt -86.43 137.16 34.58 Favored Pre-proline 0 N--CA 1.489 1.479 0 C-N-CA 120.431 -0.508 . . . . 0.0 109.717 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.505 ' HG2' HD11 ' A' ' 81' ' ' LEU . 77.7 Cg_exo -45.86 -177.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.954 1.77 . . . . 0.0 111.204 178.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.6 t -88.88 -19.23 26.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.963 -1.085 . . . . 0.0 110.107 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.7 tp -124.42 128.47 49.08 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.283 -0.886 . . . . 0.0 110.516 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 78.5 mt -149.74 102.72 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 92.4 p -113.08 1.0 15.16 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.316 -0.865 . . . . 0.0 109.89 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.601 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 49.3 t0 -83.51 153.23 24.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 110.114 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.601 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 95.5 m-20 -96.23 33.36 1.77 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.453 -0.779 . . . . 0.0 108.938 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.516 ' CD1' ' OXT' ' A' ' 127' ' ' ALA . 11.9 p-90 -63.99 154.24 34.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 110.628 -178.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -140.06 150.13 43.99 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.637 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 32.5 p90 -154.5 161.86 41.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.096 -1.002 . . . . 0.0 108.595 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.42 ' O ' ' C ' ' A' ' 62' ' ' ASP . 13.3 p90 -153.58 158.44 41.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.738 -1.226 . . . . 0.0 111.906 -178.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 90.8 m -123.61 156.79 35.13 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 122' ' ' VAL . 50.7 t -127.91 137.66 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 120.96 -1.088 . . . . 0.0 111.736 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.2 m -119.22 130.52 55.52 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.0 p -171.54 178.73 3.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.41 -1.431 . . . . 0.0 111.577 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.609 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 49.3 mtmt -150.06 164.38 35.7 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 117' ' ' ASN . 88.3 m-20 -58.21 151.39 19.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.863 -1.148 . . . . 0.0 109.175 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.481 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 54.3 t-20 43.69 61.94 2.09 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.172 -0.955 . . . . 0.0 109.772 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.481 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 36.1 mt-10 -164.46 144.13 7.53 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.136 -0.978 . . . . 0.0 110.145 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.476 ' NZ ' ' N ' ' A' ' 34' ' ' GLN . 18.0 mmmt -55.1 135.26 49.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.326 -0.859 . . . . 0.0 109.216 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -85.27 140.97 30.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.165 -0.96 . . . . 0.0 110.327 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.7 mt -110.17 123.67 50.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.554 -0.716 . . . . 0.0 109.187 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 112' ' ' VAL . 46.7 t -108.69 130.05 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.032 -1.042 . . . . 0.0 110.387 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -108.03 118.68 37.38 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 38' ' ' CYS . 6.1 t -136.74 142.52 43.05 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.496 1.141 . . . . 0.0 112.109 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.637 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -137.05 160.23 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -131.03 147.83 52.68 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.263 -0.898 . . . . 0.0 110.409 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.516 ' OXT' ' CD1' ' A' ' 107' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.432 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 1' ' ' GLU . 56.8 mp0 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -141.55 149.84 41.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.879 . . . . 0.0 109.317 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.456 HG13 ' CB ' ' A' ' 47' ' ' LEU . 85.4 t -87.59 135.51 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.93 . . . . 0.0 110.117 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -66.55 124.53 23.06 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.662 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.97 166.93 34.71 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.2 t -107.04 129.89 54.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.455 -1.026 . . . . 0.0 109.192 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.473 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 35.6 t0 -108.49 109.28 20.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.529 -0.732 . . . . 0.0 109.461 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.416 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 86.2 m-85 -89.49 1.7 55.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 108.948 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.5 m -101.99 -18.36 15.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.516 -0.74 . . . . 0.0 110.62 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 12' ' ' GLU . 8.5 m -156.86 126.5 6.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.761 -1.212 . . . . 0.0 110.383 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.593 ' OG ' ' N ' ' A' ' 21' ' ' SER . 38.6 m -67.06 -26.38 66.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.443 -0.785 . . . . 0.0 109.138 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.447 ' H ' HG22 ' A' ' 10' ' ' THR . 79.6 mm-40 -113.59 73.91 0.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 20.7 p -71.73 153.27 42.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.385 -0.822 . . . . 0.0 110.221 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.38 -1.27 31.19 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.3 pt -125.67 -13.45 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.661 -0.649 . . . . 0.0 110.443 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.461 ' O ' ' OG ' ' A' ' 13' ' ' SER . 76.5 m-85 -121.63 137.13 54.87 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.283 -0.886 . . . . 0.0 109.925 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.8 t -68.12 -20.04 64.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.578 -0.701 . . . . 0.0 110.669 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -131.95 142.55 49.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.95 -1.094 . . . . 0.0 110.745 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.473 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -154.88 168.36 32.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -128.96 160.11 33.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.334 -1.098 . . . . 0.0 109.586 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.593 ' N ' ' OG ' ' A' ' 11' ' ' SER . 6.2 t -90.84 148.95 22.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 109.097 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.2 pt -58.43 -32.55 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.171 -0.956 . . . . 0.0 109.444 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -68.85 -40.31 79.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 0.0 109.74 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -61.45 -45.03 95.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 110.319 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 26' ' ' SER . 9.7 pt -68.77 -45.03 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.045 -1.034 . . . . 0.0 109.702 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.702 ' O ' ' C ' ' A' ' 27' ' ' ASN . 5.9 t -65.99 -49.26 68.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -0.844 . . . . 0.0 109.336 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.702 ' C ' ' O ' ' A' ' 26' ' ' SER . 5.7 t-20 -5.07 85.97 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.781 ' O ' ' N ' ' A' ' 30' ' ' SER . 2.0 mptm? -39.44 170.18 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.1 p -47.79 73.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.584 -0.698 . . . . 0.0 109.99 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.781 ' N ' ' O ' ' A' ' 28' ' ' LYS . 33.3 p -128.71 -39.9 1.59 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.431 -0.793 . . . . 0.0 109.373 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -119.38 -16.6 8.95 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.396 -0.815 . . . . 0.0 109.587 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.504 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 32.0 p30 -161.94 116.44 1.91 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 109.436 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -110.86 53.21 0.71 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.151 -0.968 . . . . 0.0 109.61 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -151.52 -169.05 3.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.076 -1.015 . . . . 0.0 109.462 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -73.65 141.64 46.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 109.484 -179.599 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.8 mm -88.19 122.66 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.948 . . . . 0.0 108.508 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -118.77 131.42 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.314 -0.867 . . . . 0.0 110.526 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 124' ' ' THR . 95.1 m -101.57 101.06 11.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.1 m -94.35 120.09 34.07 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.143 -0.973 . . . . 0.0 109.852 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.484 ' CG2' HG12 ' A' ' 125' ' ' VAL . 20.3 m -141.12 155.8 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.499 -0.751 . . . . 0.0 109.184 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -97.07 131.07 44.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.371 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.27 162.92 12.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.595 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.461 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 34.3 t-80 -132.59 148.97 52.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.307 -0.871 . . . . 0.0 109.454 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -52.48 -26.94 14.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 109.889 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -99.71 -23.15 15.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 109.786 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.461 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 92.1 m-20 -74.18 136.83 42.84 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.415 -0.803 . . . . 0.0 110.156 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.588 HD21 ' NE ' ' A' ' 98' ' ' ARG . 15.1 mt -75.52 143.37 42.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 108.826 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.0 pt -121.14 142.8 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.288 -0.883 . . . . 0.0 110.091 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.47 -175.39 47.21 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.484 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 48.9 p90 -164.12 169.01 18.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.059 -1.259 . . . . 0.0 109.639 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -146.03 144.14 29.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.762 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 84.1 m -125.58 152.17 71.51 Favored Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.52 151.3 14.26 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.273 1.982 . . . . 0.0 111.952 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.9 m -71.23 -11.01 60.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.379 -0.826 . . . . 0.0 110.673 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.618 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 83.6 m-20 -90.69 -1.71 57.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.938 -1.101 . . . . 0.0 110.092 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.434 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 20.5 m-85 -109.61 164.04 12.9 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.149 -0.97 . . . . 0.0 110.315 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 m -102.81 146.21 28.6 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.374 -0.829 . . . . 0.0 109.043 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.6 m -101.02 124.19 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.99 -1.069 . . . . 0.0 110.087 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -130.63 127.25 22.26 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.09 113.79 3.47 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.657 1.571 . . . . 0.0 112.146 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.495 ' O ' ' O ' ' A' ' 68' ' ' PHE . 27.1 t-80 -93.88 -26.4 16.91 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.7 t0 -168.26 38.35 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.459 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 81.8 m -62.75 -155.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.735 . . . . 0.0 109.836 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 4.8 p90 -107.95 -54.54 2.48 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.195 -0.941 . . . . 0.0 111.475 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.0 t -49.13 -71.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.67 -1.269 . . . . 0.0 108.728 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.7 t -142.4 131.36 23.04 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.459 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -168.94 -179.57 3.72 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.364 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.552 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 4.4 m-85 -94.61 145.1 25.06 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.431 HD21 ' HG2' ' A' ' 75' ' ' GLU . 99.6 m-20 -86.59 -172.89 4.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.93 -1.106 . . . . 0.0 109.695 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.0 mt -64.65 -15.37 61.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -0.881 . . . . 0.0 109.16 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.3 m -86.92 -6.42 58.78 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.361 -0.837 . . . . 0.0 108.948 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.34 20.47 69.36 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -107.55 142.46 37.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.291 -1.123 . . . . 0.0 109.207 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -66.05 131.66 46.74 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.212 -0.93 . . . . 0.0 109.899 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.431 ' HG2' HD21 ' A' ' 69' ' ' ASN . 30.7 tp10 -152.21 163.26 39.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.364 -0.835 . . . . 0.0 109.405 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -107.01 138.06 43.89 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.175 -0.953 . . . . 0.0 109.553 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.1 tp -88.03 -8.83 55.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.105 -0.997 . . . . 0.0 109.921 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.586 ' OE1' ' N ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -60.0 -45.99 90.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.869 -1.144 . . . . 0.0 109.532 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.592 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 28.7 p30 -63.8 -34.8 78.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.073 -1.017 . . . . 0.0 108.951 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.592 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 9.1 tppt? -69.91 -51.67 31.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 109.112 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.455 HD11 ' HG2' ' A' ' 100' ' ' PRO . 20.7 tp -151.76 121.42 6.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.448 -0.783 . . . . 0.0 108.958 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -78.17 113.78 16.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.018 -1.051 . . . . 0.0 109.573 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.72 162.3 17.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.412 -0.805 . . . . 0.0 109.974 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 70.4 p -129.55 162.0 29.21 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.349 -0.845 . . . . 0.0 109.331 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.1 m120 55.36 51.23 13.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 109.691 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.5 mt -81.13 131.44 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.327 -0.858 . . . . 0.0 110.264 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.3 mm -127.58 123.5 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.456 -0.777 . . . . 0.0 109.073 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 72.6 mtp -122.59 104.09 9.11 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.21 -0.932 . . . . 0.0 109.761 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -111.9 100.7 9.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.327 -0.858 . . . . 0.0 109.039 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.488 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 97.5 m-70 -72.32 -36.41 68.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.882 -1.136 . . . . 0.0 110.642 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -60.51 -46.16 91.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.999 -1.063 . . . . 0.0 109.528 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -88.91 -4.83 58.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.071 -1.018 . . . . 0.0 109.149 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.5 m-20 54.48 48.17 21.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.468 -0.77 . . . . 0.0 110.273 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.601 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.9 t -134.02 139.46 46.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.994 -1.066 . . . . 0.0 109.296 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.484 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 75.2 m-85 -128.4 140.33 51.9 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.483 -0.761 . . . . 0.0 110.071 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.601 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 72.0 m-85 -137.99 147.96 44.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.323 -0.861 . . . . 0.0 109.13 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.4 p -156.33 157.98 36.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.08 -1.012 . . . . 0.0 109.21 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.588 ' NE ' HD21 ' A' ' 47' ' ' LEU . 18.7 mmt180 -104.08 137.65 41.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.324 -0.86 . . . . 0.0 109.613 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.422 ' HB3' HD11 ' A' ' 103' ' ' ILE . 54.8 mt -87.81 137.5 31.74 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.65 -0.656 . . . . 0.0 109.62 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.493 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 77.5 Cg_exo -46.88 154.04 1.21 Allowed 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.745 1.63 . . . . 0.0 111.212 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 54.0 m -62.56 -36.86 84.01 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.118 -0.989 . . . . 0.0 109.93 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.4 tp -111.34 130.63 55.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.26 -0.9 . . . . 0.0 110.55 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.422 HD11 ' HB3' ' A' ' 99' ' ' LEU . 95.3 mt -145.71 103.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.401 -0.812 . . . . 0.0 108.857 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.459 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 7.1 m -111.18 53.58 0.7 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.179 -0.951 . . . . 0.0 109.647 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.479 ' O ' ' OXT' ' A' ' 127' ' ' ALA . 83.1 m-20 -144.86 156.5 44.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 110.029 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -102.89 33.06 3.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.426 -0.796 . . . . 0.0 109.09 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 19.3 p-90 -65.15 150.8 47.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.411 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -132.38 151.08 52.01 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.625 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 32.2 p90 -151.62 161.0 43.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.196 -0.94 . . . . 0.0 108.665 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 8.1 p90 -154.19 164.33 38.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.741 -1.225 . . . . 0.0 111.912 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 85.2 m -127.72 157.96 38.91 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.533 HG22 HG22 ' A' ' 122' ' ' VAL . 44.2 t -127.72 137.88 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.802 -1.186 . . . . 0.0 111.929 -178.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 70.9 m -119.24 130.04 55.25 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.7 p -169.29 179.33 3.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.281 -1.512 . . . . 0.0 111.658 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.618 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 42.2 mtmt -158.78 167.67 28.86 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 117' ' ' ASN . 54.1 p-10 -58.56 151.55 20.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.766 -1.209 . . . . 0.0 109.008 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.452 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 58.9 t-20 41.42 58.71 2.6 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.329 -0.857 . . . . 0.0 109.6 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 66.5 mm-40 -157.87 137.5 12.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.394 -0.817 . . . . 0.0 110.503 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -54.69 136.5 45.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.366 -0.834 . . . . 0.0 109.12 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.452 ' H ' ' HG2' ' A' ' 120' ' ' LYS . 4.4 pttm -85.36 139.08 31.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.217 -0.927 . . . . 0.0 110.49 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.9 mt -111.77 125.48 54.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.556 -0.715 . . . . 0.0 109.354 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.533 HG22 HG22 ' A' ' 112' ' ' VAL . 53.4 t -110.98 131.25 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.036 -1.04 . . . . 0.0 110.561 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -108.73 119.46 39.61 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 38' ' ' CYS . 6.8 t -136.83 141.52 42.86 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.957 -1.089 . . . . 0.0 111.989 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.625 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -136.41 156.55 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -127.13 151.01 49.22 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.179 -0.951 . . . . 0.0 110.265 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.479 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.365 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.364 0.602 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -77.46 150.12 34.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.155 -0.966 . . . . 0.0 109.242 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.438 HG13 ' HB2' ' A' ' 47' ' ' LEU . 84.6 t -91.66 135.63 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 110.267 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -69.55 123.2 20.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.9 -1.125 . . . . 0.0 108.543 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.76 174.87 46.07 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.656 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 7.7 t -114.8 128.19 56.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.441 -1.035 . . . . 0.0 109.292 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.442 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 51.8 t0 -106.05 109.05 20.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.505 -0.747 . . . . 0.0 109.359 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 97.6 m-85 -88.05 -0.12 56.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.226 -0.921 . . . . 0.0 108.961 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.5 m -101.47 -15.67 17.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.42 -0.8 . . . . 0.0 110.578 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 12' ' ' GLU . 6.5 m -159.89 129.24 5.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.88 -1.137 . . . . 0.0 110.316 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.501 ' OG ' ' OE1' ' A' ' 12' ' ' GLU . 78.2 p -70.76 -22.78 62.36 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.587 -0.845 . . . . 0.0 108.852 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.505 ' H ' HG22 ' A' ' 10' ' ' THR . 57.9 mp0 -114.16 74.12 0.86 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.442 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 6.4 m -70.77 151.32 44.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.371 -0.83 . . . . 0.0 110.241 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.0 -0.72 35.99 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.7 pt -125.91 -22.8 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.612 -0.68 . . . . 0.0 110.34 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -112.15 141.97 45.18 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.261 -0.9 . . . . 0.0 110.015 -178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.3 p -75.59 -21.14 58.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.519 -0.738 . . . . 0.0 110.958 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -118.66 127.89 54.0 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.138 -0.976 . . . . 0.0 110.449 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.94 153.84 20.69 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.656 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 20.4 m-85 -118.31 144.42 45.86 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.479 -1.013 . . . . 0.0 109.557 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.1 t -96.27 153.8 17.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 109.122 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.9 pt -48.2 -32.23 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.209 -0.932 . . . . 0.0 109.357 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -68.76 -47.55 65.95 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.9 -1.125 . . . . 0.0 109.707 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -51.12 -47.62 61.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.332 -0.855 . . . . 0.0 109.904 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.1 pt -67.12 -31.01 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.109 -0.995 . . . . 0.0 109.584 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 28' ' ' LYS . 68.3 p -82.39 -7.22 59.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 109.391 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' A' ' 29' ' ' SER . 65.8 t30 -68.05 54.04 0.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.364 -0.835 . . . . 0.0 108.959 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 26' ' ' SER . 22.6 pttp -75.93 37.61 0.15 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.272 -0.893 . . . . 0.0 109.772 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 27' ' ' ASN . 5.7 t -78.92 -65.49 0.99 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 109.621 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.0 m -56.5 -174.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.454 -0.779 . . . . 0.0 109.5 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.616 ' O ' ' N ' ' A' ' 33' ' ' GLN . 90.3 m-20 -60.49 -41.17 93.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.441 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 53.2 p-10 -59.3 71.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.261 -0.899 . . . . 0.0 109.203 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.628 ' C ' ' H ' ' A' ' 35' ' ' ASP . 10.9 pt20 -70.17 -113.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.119 -0.988 . . . . 0.0 109.631 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -65.4 22.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.187 -0.945 . . . . 0.0 109.546 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.628 ' H ' ' C ' ' A' ' 33' ' ' GLN . 33.5 m-20 -118.07 101.66 8.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -0.838 . . . . 0.0 109.482 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.6 mm -102.07 124.58 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.198 -0.938 . . . . 0.0 108.646 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' A' ' 122' ' ' VAL . 50.9 t -119.96 129.86 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.334 -0.854 . . . . 0.0 110.277 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.44 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 76.6 m -102.61 101.87 12.05 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.8 m -95.19 120.51 35.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.16 -0.962 . . . . 0.0 109.84 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.549 ' CG2' HG12 ' A' ' 125' ' ' VAL . 26.1 m -140.43 157.45 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.467 -0.771 . . . . 0.0 109.146 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -99.99 133.74 43.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.114 -0.991 . . . . 0.0 109.398 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.22 160.7 14.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 0.0 109.52 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.403 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 20.8 t60 -134.58 152.38 51.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.19 -27.57 35.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.363 -0.835 . . . . 0.0 109.823 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -99.05 -25.46 14.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.934 . . . . 0.0 109.647 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 97.1 m-20 -75.14 133.29 41.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.363 -0.836 . . . . 0.0 110.074 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.438 ' HB2' HG13 ' A' ' 3' ' ' VAL . 49.6 mt -77.94 148.41 34.51 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.48 HD13 HD21 ' A' ' 99' ' ' LEU . 13.2 pt -120.94 142.78 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.272 -0.892 . . . . 0.0 110.048 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 95' ' ' PHE . . . 176.78 -172.6 45.56 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.466 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 51.4 p90 -170.14 170.17 7.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -1.218 . . . . 0.0 109.79 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -145.06 143.43 30.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.289 -0.882 . . . . 0.0 109.703 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.2 m -125.57 154.28 72.75 Favored Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.419 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.8 Cg_endo -51.53 143.35 36.33 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.213 1.942 . . . . 0.0 111.991 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.1 t -67.28 -12.84 61.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.387 -0.821 . . . . 0.0 110.595 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -89.46 3.33 52.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.941 -1.1 . . . . 0.0 110.197 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.572 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 20.7 m-85 -113.29 167.73 10.32 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.157 -0.965 . . . . 0.0 110.324 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.8 t -103.35 138.47 40.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.328 -0.858 . . . . 0.0 108.903 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.4 m -97.29 118.05 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.987 -1.07 . . . . 0.0 110.386 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -126.76 129.53 24.03 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.97 114.34 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.628 1.552 . . . . 0.0 111.959 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.447 ' O ' ' O ' ' A' ' 68' ' ' PHE . 10.9 t-80 -87.76 -24.38 23.81 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.1 t0 -172.93 38.91 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.452 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 71.1 m -60.92 -152.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.549 -0.719 . . . . 0.0 109.762 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.445 ' O ' ' C ' ' A' ' 65' ' ' VAL . 3.9 p90 -109.42 -58.7 2.0 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.216 -0.928 . . . . 0.0 111.354 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 66' ' ' SER . 13.4 t -46.67 -74.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.436 -1.415 . . . . 0.0 108.927 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.513 ' N ' HG12 ' A' ' 65' ' ' VAL . 32.4 t -135.96 132.02 35.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.452 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.84 179.89 2.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.01 . . . . 0.0 110.459 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.517 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 4.4 m-85 -93.69 128.2 39.78 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -73.61 -176.51 2.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.953 -1.092 . . . . 0.0 109.844 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.59 -20.4 65.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.932 . . . . 0.0 109.035 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.5 m -83.92 -6.43 59.42 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.74 19.05 64.36 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -100.18 139.06 36.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -1.149 . . . . 0.0 109.019 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -85.4 108.77 18.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.205 -0.934 . . . . 0.0 109.994 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -146.06 140.48 26.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.435 -0.791 . . . . 0.0 109.91 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 -62.15 148.95 42.83 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.475 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.42 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 13.0 tp -96.51 7.53 46.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.209 -0.932 . . . . 0.0 109.724 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -69.07 -40.6 78.39 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.949 -1.094 . . . . 0.0 109.878 -179.583 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.501 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 95.2 m-20 -64.31 -38.85 92.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.173 -0.955 . . . . 0.0 109.122 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -67.81 -53.23 28.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.216 -0.927 . . . . 0.0 109.389 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.523 HD22 ' CZ2' ' A' ' 107' ' ' TRP . 35.7 tp -143.23 121.57 12.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.413 -0.805 . . . . 0.0 109.049 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -81.03 104.88 11.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 109.371 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.537 HD13 ' OG ' ' A' ' 97' ' ' SER . 91.9 mt -84.3 163.03 19.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 109.949 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 46.6 p -129.95 162.94 27.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.438 -0.789 . . . . 0.0 109.384 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 54.39 51.85 13.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.159 -0.963 . . . . 0.0 109.775 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -81.31 128.76 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 110.117 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.5 mm -125.91 123.67 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.528 -0.733 . . . . 0.0 109.206 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 91.3 mtp -123.45 104.93 9.38 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.164 -0.96 . . . . 0.0 109.829 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -110.19 100.24 9.17 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.382 -0.824 . . . . 0.0 109.014 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.509 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 98.7 m-70 -73.0 -34.75 66.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.978 -1.076 . . . . 0.0 110.643 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -61.58 -44.91 96.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.964 -1.085 . . . . 0.0 109.647 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -88.65 -4.72 58.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.955 . . . . 0.0 109.104 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.509 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 1.6 m-20 56.5 45.57 22.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.492 -0.755 . . . . 0.0 109.995 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.575 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.7 t -132.26 138.73 48.0 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.04 -1.037 . . . . 0.0 109.385 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.466 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 69.5 m-85 -127.62 139.74 52.54 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.406 -0.809 . . . . 0.0 109.986 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.615 ' CB ' HH12 ' A' ' 98' ' ' ARG . 82.5 m-85 -136.45 147.03 46.99 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.293 -0.879 . . . . 0.0 109.278 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.583 ' N ' ' NH1' ' A' ' 98' ' ' ARG . 38.2 t -153.41 150.72 29.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.114 -0.991 . . . . 0.0 109.357 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.615 HH12 ' CB ' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -105.88 139.27 40.69 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.222 -0.924 . . . . 0.0 109.541 -179.726 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.523 ' HB3' HD11 ' A' ' 103' ' ' ILE . 42.9 mt -93.65 142.38 25.06 Favored Pre-proline 0 N--CA 1.491 1.613 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.69 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.489 ' HG2' HD11 ' A' ' 81' ' ' LEU . 78.0 Cg_exo -46.83 157.47 0.52 Allowed 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.713 1.608 . . . . 0.0 111.226 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.1 t -67.27 -17.25 64.71 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.157 -0.965 . . . . 0.0 109.702 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 45.9 tp -122.2 130.84 53.57 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.281 -0.887 . . . . 0.0 110.555 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.523 HD11 ' HB3' ' A' ' 99' ' ' LEU . 24.2 mt -144.39 124.5 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.6 m -133.3 15.75 4.12 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.042 -1.036 . . . . 0.0 109.855 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -109.02 154.15 22.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.329 -0.857 . . . . 0.0 110.014 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -95.99 32.13 1.98 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.471 -0.768 . . . . 0.0 108.997 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.523 ' CZ2' HD22 ' A' ' 81' ' ' LEU . 18.2 p-90 -66.33 156.86 33.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.899 . . . . 0.0 110.636 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -143.78 155.42 44.15 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.632 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 38.3 p90 -151.88 161.46 42.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.208 -0.933 . . . . 0.0 108.785 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.519 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 5.5 p90 -152.24 161.17 43.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.77 -1.206 . . . . 0.0 111.813 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 91.7 m -127.97 157.45 40.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.616 HG22 HG22 ' A' ' 122' ' ' VAL . 43.8 t -130.22 142.22 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.836 -1.165 . . . . 0.0 111.712 -178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 75.1 m -119.86 131.1 55.17 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.4 p -170.8 179.06 3.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.215 -1.553 . . . . 0.0 111.616 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.464 ' HZ2' ' HB3' ' A' ' 115' ' ' LYS . 5.6 mtmp? -158.11 167.34 30.12 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 117' ' ' ASN . 91.3 m-20 -58.13 150.5 21.12 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.818 -1.176 . . . . 0.0 109.119 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.437 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 66.5 t30 44.38 59.99 3.03 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.172 -0.955 . . . . 0.0 109.809 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.572 ' OE1' ' CE2' ' A' ' 56' ' ' TYR . 49.7 mt-10 -162.06 140.77 9.3 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.18 -0.95 . . . . 0.0 110.21 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -56.63 144.47 31.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 109.209 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -93.54 141.0 28.96 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.123 -0.986 . . . . 0.0 110.315 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.416 HD13 ' CG ' ' A' ' 8' ' ' PHE . 75.0 mt -112.3 125.73 54.48 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.546 -0.721 . . . . 0.0 109.151 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.616 HG22 HG22 ' A' ' 112' ' ' VAL . 49.5 t -110.92 131.27 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.036 -1.04 . . . . 0.0 110.63 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -109.65 121.17 44.62 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.7 t -137.24 141.82 42.04 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.953 -1.092 . . . . 0.0 112.114 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.632 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.1 m -135.49 157.77 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -128.25 150.94 49.82 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.208 -0.932 . . . . 0.0 110.263 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.498 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.253 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -76.62 157.35 31.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.905 . . . . 0.0 109.272 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 66.9 t -99.31 133.84 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.306 -0.871 . . . . 0.0 109.831 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -67.48 122.91 19.0 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.134 -0.979 . . . . 0.0 108.544 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.82 162.99 26.58 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.7 t -103.5 135.25 45.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.477 -1.014 . . . . 0.0 110.084 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.509 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 67.7 t0 -111.98 109.43 19.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.371 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -87.4 -0.92 57.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 108.985 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.3 m -98.89 -17.67 18.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.645 -0.659 . . . . 0.0 110.505 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 12' ' ' GLU . 4.2 m -160.41 131.08 5.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.764 -1.21 . . . . 0.0 110.223 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.1 p -64.17 -26.18 68.41 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.697 -0.801 . . . . 0.0 108.851 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.438 ' H ' HG22 ' A' ' 10' ' ' THR . 98.4 mt-10 -114.37 102.12 9.8 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.517 ' C ' ' H ' ' A' ' 15' ' ' ILE . 23.6 m -102.8 113.28 26.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -0.803 . . . . 0.0 110.372 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.5 t -65.64 2.88 0.85 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.517 ' H ' ' C ' ' A' ' 13' ' ' SER . 6.8 pt -123.56 -32.6 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.482 -0.761 . . . . 0.0 110.325 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.5 ' CZ ' ' CE2' ' A' ' 96' ' ' TYR . 53.8 m-85 -113.07 146.76 38.58 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.954 -1.091 . . . . 0.0 109.854 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 m -79.85 -20.82 45.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.38 -0.825 . . . . 0.0 110.956 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -119.9 131.18 55.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.708 -1.245 . . . . 0.0 110.86 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.463 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -150.51 158.66 27.78 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -118.03 153.22 34.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.201 -1.176 . . . . 0.0 109.609 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.8 t -89.77 148.87 22.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.327 -0.858 . . . . 0.0 109.265 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.1 pt -55.33 -31.22 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.12 -0.987 . . . . 0.0 109.536 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -68.31 -41.38 80.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.131 -0.981 . . . . 0.0 109.616 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.597 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 96.3 mt-10 -56.85 -48.63 77.63 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.236 -0.915 . . . . 0.0 110.395 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.427 HG13 ' N ' ' A' ' 26' ' ' SER . 15.0 pt -62.58 -44.19 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.036 -1.04 . . . . 0.0 109.619 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.704 ' O ' ' N ' ' A' ' 28' ' ' LYS . 78.1 p -72.0 -33.85 68.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.296 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 29' ' ' SER . 62.5 t-20 -54.56 73.38 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.53 -0.731 . . . . 0.0 109.307 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 26' ' ' SER . 42.5 tttp -62.79 78.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.431 -0.793 . . . . 0.0 109.287 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 27' ' ' ASN . 44.2 t -129.43 -87.44 0.53 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.126 -0.984 . . . . 0.0 109.595 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.4 t -129.79 -52.75 1.15 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.397 -0.814 . . . . 0.0 109.636 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.489 ' O ' ' CG ' ' A' ' 32' ' ' ASN . 57.8 t30 -65.0 -6.57 8.9 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.196 -0.94 . . . . 0.0 109.465 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.597 ' ND2' ' O ' ' A' ' 24' ' ' GLU . 75.7 m-80 -161.4 119.46 2.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.339 -0.85 . . . . 0.0 109.605 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.547 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 9.3 pt20 -136.01 -52.42 0.73 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.108 -0.995 . . . . 0.0 109.538 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.484 ' H ' ' HG3' ' A' ' 33' ' ' GLN . 29.5 pt20 -155.2 -20.63 0.11 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.317 -0.864 . . . . 0.0 109.621 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -131.24 108.31 9.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.375 -0.828 . . . . 0.0 109.422 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.571 HD12 ' OD1' ' A' ' 32' ' ' ASN . 7.8 mm -95.7 118.44 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.102 -0.999 . . . . 0.0 108.714 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.7 t -114.9 127.73 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.1 -1.0 . . . . 0.0 110.268 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 81.3 m -102.51 102.49 12.77 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.6 m -95.07 120.19 34.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -0.981 . . . . 0.0 109.763 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.524 ' CG2' HG12 ' A' ' 125' ' ' VAL . 21.7 m -139.78 156.74 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.395 -0.816 . . . . 0.0 108.996 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.3 130.7 45.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.203 -0.936 . . . . 0.0 109.341 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.88 161.71 14.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 109.635 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -139.0 150.31 45.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 109.586 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.46 -25.2 50.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 109.818 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -98.98 -26.29 14.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.162 -0.961 . . . . 0.0 109.667 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -78.97 134.97 36.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.531 -0.73 . . . . 0.0 110.013 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.7 mt -78.13 149.88 33.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 108.554 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.492 ' CD1' HD21 ' A' ' 99' ' ' LEU . 24.0 pt -120.82 142.42 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.887 -1.133 . . . . 0.0 110.027 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.2 -170.66 43.34 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -172.9 171.17 4.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.063 -1.257 . . . . 0.0 109.684 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -146.42 145.01 30.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.317 -0.865 . . . . 0.0 109.866 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.6 m -125.03 152.26 70.2 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.435 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.33 145.58 27.13 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.328 2.019 . . . . 0.0 112.026 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.9 m -68.65 -11.97 60.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.428 -0.795 . . . . 0.0 110.606 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.596 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 79.4 m-20 -91.44 1.03 57.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.928 -1.107 . . . . 0.0 110.039 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.51 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 19.4 m-85 -111.59 166.53 11.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.919 -1.113 . . . . 0.0 110.162 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -104.53 131.26 52.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.302 -0.874 . . . . 0.0 109.339 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.6 m -89.14 121.12 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.006 -1.059 . . . . 0.0 110.203 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -125.81 129.15 24.41 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.21 114.42 3.55 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.664 1.576 . . . . 0.0 112.088 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.465 ' O ' ' O ' ' A' ' 68' ' ' PHE . 10.8 t-80 -92.93 -25.29 18.1 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.474 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.8 t0 -171.43 40.44 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.508 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 70.8 m -63.7 -152.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.604 -0.685 . . . . 0.0 109.84 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.6 p90 -110.95 -58.9 2.04 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.863 -1.148 . . . . 0.0 111.151 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.442 ' C ' ' O ' ' A' ' 64' ' ' PHE . 25.3 t -45.97 -70.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.442 -1.411 . . . . 0.0 108.897 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.3 t -140.44 130.76 25.16 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.508 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.22 178.48 2.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.926 -1.109 . . . . 0.0 110.425 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.519 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 6.5 m-85 -93.12 124.94 37.45 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -69.6 -176.36 1.01 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.936 -1.103 . . . . 0.0 109.759 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 17.5 mt -63.29 -21.73 66.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.857 . . . . 0.0 109.044 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.6 m -81.63 -5.81 58.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.352 -0.842 . . . . 0.0 108.858 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.41 19.94 65.38 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -105.25 141.56 36.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -1.145 . . . . 0.0 109.187 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -83.89 112.83 20.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.115 -0.99 . . . . 0.0 109.944 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -148.13 136.26 21.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.783 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -58.33 144.87 40.03 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.073 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.568 HD11 ' HD2' ' A' ' 80' ' ' LYS . 14.6 tp -97.12 7.4 46.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.186 -0.946 . . . . 0.0 109.691 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.46 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -69.7 -38.74 77.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 109.913 -179.374 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.586 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 49.3 p-10 -61.26 -31.15 70.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.164 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.586 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 37.4 ttmt -74.87 -48.37 25.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.374 -0.828 . . . . 0.0 109.392 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.552 HD22 ' CZ2' ' A' ' 107' ' ' TRP . 31.9 tp -136.74 127.27 26.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.38 -0.825 . . . . 0.0 109.205 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -74.68 85.44 2.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.119 -0.988 . . . . 0.0 109.12 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.0 mt -77.73 138.23 38.92 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.283 -0.885 . . . . 0.0 109.927 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.3 p -126.39 166.52 17.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.543 -0.723 . . . . 0.0 109.315 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 55.51 50.46 14.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.883 . . . . 0.0 109.559 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.89 130.86 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 0.0 110.094 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -120.72 120.3 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.349 -0.844 . . . . 0.0 109.201 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 81.5 mtp -122.53 104.72 9.55 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.987 -1.071 . . . . 0.0 109.98 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -108.52 99.35 8.75 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.248 -0.907 . . . . 0.0 108.805 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.477 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 97.4 m-70 -72.53 -36.89 68.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.985 -1.072 . . . . 0.0 110.686 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -60.54 -45.75 92.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.005 -1.059 . . . . 0.0 109.515 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -87.68 -4.83 58.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.142 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.3 m-20 54.93 47.46 22.17 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 110.348 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.562 ' OG1' ' CE1' ' A' ' 96' ' ' TYR . 2.6 t -134.66 141.94 46.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.956 -1.09 . . . . 0.0 109.387 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -129.44 140.34 51.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.42 -0.8 . . . . 0.0 110.01 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.562 ' CE1' ' OG1' ' A' ' 94' ' ' THR . 82.7 m-85 -135.38 146.14 48.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.23 -0.919 . . . . 0.0 109.483 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.4 m -151.43 153.27 34.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 109.231 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.4 mtt-85 -107.9 138.4 44.23 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.071 -1.018 . . . . 0.0 109.419 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.634 ' HB3' HD11 ' A' ' 103' ' ' ILE . 60.3 mt -96.0 141.17 22.78 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.828 . . . . 0.0 109.727 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.499 ' HG2' HD11 ' A' ' 81' ' ' LEU . 77.9 Cg_exo -45.64 178.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.901 1.734 . . . . 0.0 111.187 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.9 m -85.46 -11.73 53.59 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.035 -1.041 . . . . 0.0 109.689 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.3 tp -124.3 131.14 53.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.007 . . . . 0.0 110.54 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.634 HD11 ' HB3' ' A' ' 99' ' ' LEU . 41.3 mt -147.48 103.82 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 97.4 p -114.0 -0.41 14.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.028 -1.045 . . . . 0.0 109.748 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 0.4 OUTLIER -89.46 153.66 20.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 0.0 110.071 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -98.43 31.98 2.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.459 -0.776 . . . . 0.0 109.127 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.552 ' CZ2' HD22 ' A' ' 81' ' ' LEU . 16.1 p-90 -65.65 159.21 25.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -0.848 . . . . 0.0 110.493 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -146.7 156.82 43.47 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.57 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 43.5 p90 -153.47 163.67 39.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.085 -1.01 . . . . 0.0 108.9 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 6.8 p90 -152.71 163.04 40.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.672 -1.268 . . . . 0.0 111.681 -178.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 87.0 m -130.04 158.64 39.06 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 122' ' ' VAL . 42.9 t -130.74 143.36 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.66 -1.275 . . . . 0.0 111.774 -178.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 87.8 m -123.36 132.61 54.04 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.3 p -170.76 178.69 3.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.298 -1.501 . . . . 0.0 111.743 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.596 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 46.2 mtmt -154.06 165.55 35.82 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.6 150.89 21.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.78 -1.2 . . . . 0.0 109.123 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.527 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 61.8 t-20 46.47 61.27 2.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.266 -0.897 . . . . 0.0 109.52 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 44.4 mt-10 -165.1 145.43 7.16 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.956 -1.09 . . . . 0.0 110.127 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -60.66 147.73 40.98 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.204 -0.935 . . . . 0.0 109.003 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -93.26 140.8 29.14 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.066 -1.021 . . . . 0.0 110.355 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.2 mt -110.17 122.35 47.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.412 -0.805 . . . . 0.0 109.093 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 112' ' ' VAL . 48.7 t -109.96 130.79 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.938 -1.101 . . . . 0.0 110.833 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -109.57 121.46 45.24 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.0 t -137.37 142.15 41.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.666 -1.271 . . . . 0.0 112.029 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.57 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.1 m -135.09 158.04 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -137.12 157.88 45.71 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.89 -1.131 . . . . 0.0 110.128 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.408 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -74.76 157.98 34.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.167 -0.958 . . . . 0.0 109.198 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.525 HG22 HD12 ' A' ' 47' ' ' LEU . 53.4 t -103.3 132.81 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -0.893 . . . . 0.0 109.955 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -62.76 117.5 6.41 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.363 -0.935 . . . . 0.0 108.574 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.44 155.7 15.72 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.422 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 4.9 t -100.08 132.01 45.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.562 -0.963 . . . . 0.0 109.493 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.511 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 47.2 t0 -105.05 108.4 19.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.448 -0.783 . . . . 0.0 109.302 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -88.27 -0.99 57.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 108.854 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 m -101.19 -16.56 16.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.492 -0.755 . . . . 0.0 110.434 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.6 m -157.13 124.88 5.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.859 -1.15 . . . . 0.0 110.182 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.493 ' OG ' ' OE1' ' A' ' 12' ' ' GLU . 78.0 p -67.16 -26.9 66.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.369 -0.832 . . . . 0.0 108.98 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.496 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 57.5 mp0 -109.07 72.61 0.82 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 t -74.11 158.59 33.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.407 -0.808 . . . . 0.0 110.137 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.433 HG23 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -103.23 -48.7 3.94 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.131 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.433 ' H ' HG23 ' A' ' 14' ' ' THR . 24.0 pt -86.78 -12.92 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.574 -0.704 . . . . 0.0 110.16 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.417 ' CD2' HG13 ' A' ' 15' ' ' ILE . 68.0 m-85 -110.4 136.93 48.81 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.153 -0.967 . . . . 0.0 109.606 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 t -74.24 -26.7 60.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.431 -0.793 . . . . 0.0 111.157 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -123.3 134.51 54.05 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.07 -1.019 . . . . 0.0 110.787 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.511 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -144.47 156.13 26.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.422 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 22.5 m-85 -122.22 153.34 38.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.333 -1.098 . . . . 0.0 109.647 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 t -88.83 149.56 23.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.328 -0.857 . . . . 0.0 109.116 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.446 ' O ' ' OG ' ' A' ' 26' ' ' SER . 45.8 pt -58.55 -30.2 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.495 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -66.85 -40.65 87.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.929 . . . . 0.0 109.619 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.457 ' O ' ' CG ' ' A' ' 32' ' ' ASN . 76.5 mm-40 -64.44 -45.45 87.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.408 -0.808 . . . . 0.0 110.113 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.8 pt -80.57 -14.07 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.939 -1.101 . . . . 0.0 109.679 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 28' ' ' LYS . 49.2 m -96.01 -70.21 0.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 109.34 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 29' ' ' SER . 66.3 t30 -52.27 85.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 109.246 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 26' ' ' SER . 18.3 pttm -49.18 96.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.45 -0.781 . . . . 0.0 109.679 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 30' ' ' SER . 89.4 p -107.31 -100.54 0.36 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.08 -1.012 . . . . 0.0 109.74 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.581 ' C ' ' H ' ' A' ' 32' ' ' ASN . 78.3 p -125.61 -71.81 0.69 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.45 -0.781 . . . . 0.0 109.845 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -64.72 13.82 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.278 -0.889 . . . . 0.0 109.477 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.581 ' H ' ' C ' ' A' ' 30' ' ' SER . 15.6 p30 -169.12 81.84 0.13 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 0.0 109.604 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -138.96 -34.44 0.6 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.144 -0.973 . . . . 0.0 109.905 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.546 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 13.8 pt20 -117.09 -45.04 2.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.379 -0.826 . . . . 0.0 109.753 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.546 ' OD1' ' O ' ' A' ' 34' ' ' GLN . 1.8 m-20 -145.62 124.52 12.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.322 -0.861 . . . . 0.0 109.305 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.412 HD12 ' CB ' ' A' ' 32' ' ' ASN . 9.0 mm -90.29 122.71 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.135 -0.978 . . . . 0.0 108.439 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.4 t -121.06 126.5 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.0 110.337 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 96.8 m -103.16 102.47 12.46 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.8 m -94.85 120.77 35.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.13 -0.981 . . . . 0.0 109.848 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.518 ' CG2' HG12 ' A' ' 125' ' ' VAL . 27.3 m -139.82 156.73 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.364 -0.835 . . . . 0.0 109.013 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -100.16 131.84 45.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 109.415 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.449 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -97.07 158.09 15.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 109.57 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.428 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 31.5 t60 -134.05 153.25 51.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.207 -0.933 . . . . 0.0 109.53 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.24 -25.03 20.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.349 -0.844 . . . . 0.0 109.772 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -99.74 -25.93 14.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.068 -1.02 . . . . 0.0 109.662 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 77.8 m-20 -75.47 134.57 40.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.88 . . . . 0.0 110.034 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.525 HD12 HG22 ' A' ' 3' ' ' VAL . 83.1 mt -76.24 147.39 38.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 108.661 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.595 HD13 HD21 ' A' ' 99' ' ' LEU . 9.0 pt -116.93 136.57 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.159 -0.963 . . . . 0.0 109.847 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.26 -176.94 47.86 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.438 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 55.6 p90 -164.57 169.77 16.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.087 -1.243 . . . . 0.0 109.858 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -144.17 143.16 30.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.255 -0.903 . . . . 0.0 109.908 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 68.6 m -126.6 152.37 74.47 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.422 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.4 149.16 17.93 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.404 2.069 . . . . 0.0 112.122 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.4 p -71.73 -11.27 60.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.435 -0.791 . . . . 0.0 110.649 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -90.67 0.24 57.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.9 -1.125 . . . . 0.0 110.129 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.422 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 20.7 m-85 -110.36 165.99 11.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.199 -0.938 . . . . 0.0 110.252 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -102.87 133.45 47.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 0.0 109.107 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.1 m -91.13 123.53 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.969 -1.082 . . . . 0.0 110.335 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -130.68 129.16 22.64 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.05 113.53 3.44 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.71 1.607 . . . . 0.0 112.046 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.47 ' O ' ' O ' ' A' ' 68' ' ' PHE . 15.9 t-160 -91.06 -26.66 19.05 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.503 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.5 t0 -169.72 37.13 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.541 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 75.9 m -60.38 -155.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.472 -0.767 . . . . 0.0 109.724 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.471 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 3.3 p90 -111.47 -56.66 2.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.141 -0.974 . . . . 0.0 111.316 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.419 HG23 ' CE2' ' A' ' 64' ' ' PHE . 78.0 t -47.36 -54.7 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 120.479 -1.388 . . . . 0.0 109.062 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -158.08 129.8 6.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.541 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.01 -179.34 1.99 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.957 -1.09 . . . . 0.0 110.442 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 6.3 m-85 -93.16 123.58 36.53 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -70.66 -173.74 0.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 109.787 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.519 ' N ' HD12 ' A' ' 70' ' ' LEU . 10.3 mp -63.61 -21.49 66.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.272 -0.892 . . . . 0.0 109.018 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.7 m -82.44 -7.05 59.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.347 -0.846 . . . . 0.0 108.885 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.41 19.83 65.62 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -102.86 138.78 39.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.212 -1.169 . . . . 0.0 108.999 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -83.7 108.33 16.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 110.004 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -144.2 138.74 28.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.852 . . . . 0.0 109.85 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 77' ' ' LEU . 55.1 t-20 -59.78 145.55 44.87 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.298 -0.876 . . . . 0.0 108.954 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.54 HD11 ' HD2' ' A' ' 80' ' ' LYS . 13.4 tp -97.32 7.44 46.55 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.292 -0.88 . . . . 0.0 109.845 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.449 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -70.12 -37.99 75.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.065 -1.022 . . . . 0.0 110.058 -179.539 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -62.72 -32.73 73.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.044 -1.035 . . . . 0.0 109.156 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.54 ' HD2' HD11 ' A' ' 77' ' ' LEU . 23.4 ttmt -72.41 -50.21 28.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.853 . . . . 0.0 109.634 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.517 HD11 ' HG2' ' A' ' 100' ' ' PRO . 19.2 tp -139.3 128.81 24.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.487 -0.758 . . . . 0.0 109.074 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -78.99 88.28 4.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.988 . . . . 0.0 109.639 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.21 150.82 41.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.357 -0.839 . . . . 0.0 109.936 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.2 p -127.14 164.33 21.86 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.512 -0.742 . . . . 0.0 109.176 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.481 HD22 ' HG3' ' A' ' 98' ' ' ARG . 78.7 m-20 56.1 53.15 9.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 0.0 109.942 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.5 mt -79.68 125.17 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -0.825 . . . . 0.0 109.918 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -123.14 121.99 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.5 -0.75 . . . . 0.0 109.265 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 84.6 mtp -123.25 103.37 8.49 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.108 -0.995 . . . . 0.0 109.696 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -110.98 101.36 9.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.378 -0.826 . . . . 0.0 109.037 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.499 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 91.8 m-70 -72.96 -35.78 66.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.876 -1.14 . . . . 0.0 110.686 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -60.19 -45.91 91.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.942 -1.099 . . . . 0.0 109.572 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -89.87 -4.35 57.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.925 . . . . 0.0 109.064 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.499 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 97.7 m-20 54.52 47.91 21.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.424 -0.798 . . . . 0.0 110.167 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.574 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 2.5 t -133.35 138.64 46.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.171 -0.956 . . . . 0.0 109.451 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.438 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 65.2 m-85 -129.06 140.64 51.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.402 -0.811 . . . . 0.0 109.915 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.574 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 72.1 m-85 -137.74 148.89 46.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.45 -0.781 . . . . 0.0 109.383 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 63.8 m -152.49 155.1 36.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.092 -1.005 . . . . 0.0 109.172 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.489 ' CZ ' HD21 ' A' ' 47' ' ' LEU . 16.6 mmt180 -102.53 136.08 42.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.188 -0.945 . . . . 0.0 109.732 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.646 ' HB3' HD11 ' A' ' 103' ' ' ILE . 68.2 mt -89.92 136.78 28.72 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.803 -0.56 . . . . 0.0 109.699 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.517 ' HG2' HD11 ' A' ' 81' ' ' LEU . 77.9 Cg_exo -45.87 176.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 121.848 1.699 . . . . 0.0 111.188 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.2 m -85.63 -14.66 44.93 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.099 -1.0 . . . . 0.0 109.925 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 47.6 tp -121.04 130.43 53.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.189 -0.945 . . . . 0.0 110.523 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.646 HD11 ' HB3' ' A' ' 99' ' ' LEU . 43.9 mt -149.84 102.88 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.5 p -120.01 3.68 10.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.202 -0.936 . . . . 0.0 109.722 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.518 ' O ' ' OXT' ' A' ' 127' ' ' ALA . 27.9 t70 -93.72 158.97 15.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.97 . . . . 0.0 109.933 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -96.15 33.8 1.68 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.455 -0.778 . . . . 0.0 109.045 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 12.4 p-90 -65.21 154.27 38.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 110.635 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -145.86 155.46 42.91 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.602 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 42.0 p90 -154.35 162.63 41.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.133 -0.979 . . . . 0.0 108.753 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 6.1 p90 -152.79 162.32 41.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.69 -1.256 . . . . 0.0 111.833 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 95.2 m -127.63 157.66 39.64 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 122' ' ' VAL . 42.2 t -130.01 142.62 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.768 -1.208 . . . . 0.0 111.789 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 72.2 m -123.39 132.44 53.97 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.0 p -171.19 178.63 3.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.239 -1.538 . . . . 0.0 111.691 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.637 ' HZ2' ' CB ' ' A' ' 115' ' ' LYS . 7.3 mtmp? -153.41 164.75 37.61 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 117' ' ' ASN . 99.7 m-20 -57.76 152.28 15.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.771 -1.206 . . . . 0.0 109.195 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.515 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 66.8 t30 44.68 60.73 2.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.217 -0.927 . . . . 0.0 109.669 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.59 ' OE2' ' NZ ' ' A' ' 115' ' ' LYS . 36.8 mt-10 -165.37 145.71 6.97 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.136 -0.977 . . . . 0.0 110.178 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.404 ' HZ2' ' HA ' ' A' ' 28' ' ' LYS . 56.5 mtpt -63.67 136.2 57.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.25 -0.906 . . . . 0.0 109.038 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.408 ' CE ' ' OD1' ' A' ' 35' ' ' ASP . 52.8 pttt -85.26 146.12 27.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.226 -0.922 . . . . 0.0 110.406 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.1 mt -111.16 123.71 50.74 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.498 -0.751 . . . . 0.0 109.177 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 112' ' ' VAL . 46.0 t -109.03 130.34 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.022 -1.049 . . . . 0.0 110.617 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -110.69 122.62 48.24 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.9 t -137.84 143.28 40.9 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.835 -1.166 . . . . 0.0 112.208 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.602 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.1 m -134.75 156.9 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -134.79 155.58 50.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.982 -1.074 . . . . 0.0 110.272 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.518 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.086 -0.959 . . . . 0.0 109.393 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.339 0.59 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 mmtp -76.31 142.71 41.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.1 -1.0 . . . . 0.0 109.188 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.92 133.54 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.708 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.61 ' NZ ' ' OD2' ' A' ' 46' ' ' ASP . 2.0 mptm? -74.72 125.49 28.85 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.047 -1.033 . . . . 0.0 108.95 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.95 179.05 44.33 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.436 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 4.8 t -115.97 132.23 56.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.483 -1.01 . . . . 0.0 109.316 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.472 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 29.5 t70 -108.19 109.63 21.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.496 -0.752 . . . . 0.0 109.422 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 91.0 m-85 -89.83 0.05 57.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.227 -0.921 . . . . 0.0 108.857 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.0 m -101.88 -17.88 15.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.566 -0.709 . . . . 0.0 110.505 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 12' ' ' GLU . 6.8 m -156.87 125.22 5.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.878 -1.139 . . . . 0.0 110.249 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.0 p -66.85 -24.84 66.19 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.629 -0.829 . . . . 0.0 108.97 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.441 ' H ' HG22 ' A' ' 10' ' ' THR . 79.0 mm-40 -115.0 74.59 0.89 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.461 ' OG ' ' CG ' ' A' ' 7' ' ' ASP . 20.0 m -71.81 152.39 42.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.83 . . . . 0.0 110.398 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.77 0.29 38.54 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.8 pt -125.27 -23.83 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.646 -0.659 . . . . 0.0 110.292 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -111.78 140.99 45.96 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.243 -0.911 . . . . 0.0 109.92 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.1 p -72.54 -18.42 61.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.589 -0.694 . . . . 0.0 111.045 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -132.14 143.14 49.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.015 -1.053 . . . . 0.0 110.847 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.472 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -152.81 159.91 28.73 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.436 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 32.4 m-85 -118.52 156.24 29.44 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.442 -1.034 . . . . 0.0 109.594 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.3 t -96.66 158.45 15.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.37 -0.832 . . . . 0.0 109.148 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.5 pt -61.47 -22.71 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.153 -0.967 . . . . 0.0 109.35 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -80.01 -52.85 7.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.137 -0.977 . . . . 0.0 109.778 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.458 ' O ' ' OD1' ' A' ' 27' ' ' ASN . 79.8 mm-40 -51.7 -36.88 48.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.852 . . . . 0.0 110.004 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.5 pt -76.34 -13.03 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.978 -1.076 . . . . 0.0 109.598 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.771 ' O ' ' N ' ' A' ' 28' ' ' LYS . 31.8 t -104.23 -28.55 11.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.261 -0.899 . . . . 0.0 109.375 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 29' ' ' SER . 46.8 p30 -42.49 77.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.499 0.666 . . . . 0.0 109.431 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.771 ' N ' ' O ' ' A' ' 26' ' ' SER . 68.6 mttm -54.97 86.0 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.377 -0.827 . . . . 0.0 109.585 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 27' ' ' ASN . 5.6 p -143.25 -84.1 0.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.893 . . . . 0.0 109.235 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 84.5 p -69.39 -179.26 1.6 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.465 -0.772 . . . . 0.0 109.449 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.562 ' OD1' ' NE2' ' A' ' 34' ' ' GLN . 34.5 t30 -51.18 -17.14 0.6 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.115 -0.99 . . . . 0.0 109.454 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.429 ' O ' ' CD1' ' A' ' 36' ' ' ILE . 98.9 m-20 -65.6 4.94 0.49 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -0.863 . . . . 0.0 109.2 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 31' ' ' ASN . 20.4 pt20 -90.48 -12.38 37.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.944 -1.097 . . . . 0.0 109.573 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.562 ' NE2' ' OD1' ' A' ' 31' ' ' ASN . 29.5 pt20 -122.44 -34.75 3.22 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.517 -0.739 . . . . 0.0 109.672 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.539 ' OD2' ' CE ' ' A' ' 120' ' ' LYS . 1.4 m-20 -147.8 115.5 6.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.319 -0.863 . . . . 0.0 109.493 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.429 ' CD1' ' O ' ' A' ' 32' ' ' ASN . 20.2 mm -81.97 124.63 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.086 -1.009 . . . . 0.0 108.462 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.1 t -121.68 126.52 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.277 -0.889 . . . . 0.0 110.173 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.44 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 84.3 m -102.18 100.8 11.05 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.8 m -93.87 119.58 32.99 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.141 -0.974 . . . . 0.0 109.659 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.434 ' CG2' HG12 ' A' ' 125' ' ' VAL . 28.0 m -141.95 153.86 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.49 -0.756 . . . . 0.0 109.232 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.419 ' HD3' ' H ' ' A' ' 41' ' ' LYS . 1.3 mppt? -95.25 133.88 38.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.116 -0.99 . . . . 0.0 109.142 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.435 ' HB1' ' CG2' ' A' ' 48' ' ' ILE . . . -109.47 124.06 50.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.457 -0.777 . . . . 0.0 109.734 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.509 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 28.2 t60 -86.72 148.2 25.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.84 . . . . 0.0 109.542 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.907 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -50.17 -34.26 21.9 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.22 -0.925 . . . . 0.0 109.779 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -89.88 -17.63 27.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.273 -0.892 . . . . 0.0 109.423 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.61 ' OD2' ' NZ ' ' A' ' 4' ' ' LYS . 76.4 m-20 -75.7 136.83 40.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.432 -0.793 . . . . 0.0 110.07 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.3 mt -77.31 145.41 37.41 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.435 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 21.0 pt -121.32 143.21 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.264 -0.898 . . . . 0.0 110.191 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.21 -174.07 46.07 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.613 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 50.8 p90 -170.52 169.62 7.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -1.225 . . . . 0.0 109.831 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -146.17 144.54 30.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.306 -0.871 . . . . 0.0 109.861 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 40.8 m -125.01 153.93 71.29 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.424 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 9.0 Cg_endo -51.51 144.78 31.27 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.337 2.025 . . . . 0.0 112.167 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.6 t -68.3 -13.85 62.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.453 -0.779 . . . . 0.0 110.636 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.623 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.9 m-20 -89.95 1.73 55.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.89 -1.131 . . . . 0.0 110.039 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.424 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 18.9 m-85 -110.79 165.93 11.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.099 -1.001 . . . . 0.0 110.446 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.416 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 39.5 t -102.7 132.92 48.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.344 -0.847 . . . . 0.0 108.96 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.4 m -89.73 120.31 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.992 -1.067 . . . . 0.0 110.346 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 59' ' ' GLU . 35.0 mp0 -127.69 128.08 23.95 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.22 114.3 3.53 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.683 1.588 . . . . 0.0 112.106 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.493 ' O ' ' O ' ' A' ' 68' ' ' PHE . 9.3 t-80 -91.17 -25.33 19.61 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 63' ' ' CYS . 67.4 t0 -171.85 36.43 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.495 ' O ' ' O ' ' A' ' 62' ' ' ASP . 96.5 m -57.13 -155.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.548 -0.72 . . . . 0.0 109.651 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.459 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 4.0 p90 -108.77 -56.27 2.29 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.037 -1.04 . . . . 0.0 111.173 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.44 HG23 ' CE2' ' A' ' 64' ' ' PHE . 53.2 t -46.49 -73.42 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.479 -1.388 . . . . 0.0 108.865 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.2 t -140.21 130.71 25.47 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.424 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.19 -178.41 2.07 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.464 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 5.0 m-85 -93.82 128.84 40.28 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -76.45 -174.57 2.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.953 -1.092 . . . . 0.0 109.741 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.4 -20.55 65.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.275 -0.891 . . . . 0.0 109.21 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.9 m -83.38 -6.85 59.59 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.32 19.61 66.3 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -101.43 136.74 40.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -1.167 . . . . 0.0 109.145 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -84.94 112.98 21.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.122 -0.986 . . . . 0.0 110.097 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -150.12 141.55 23.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.41 -0.806 . . . . 0.0 109.983 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 77' ' ' LEU . 56.0 t-20 -61.61 146.71 48.07 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.4 -0.812 . . . . 0.0 109.215 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.539 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 6.6 tp -99.69 6.11 45.63 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.288 -0.882 . . . . 0.0 109.8 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.439 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.8 OUTLIER -75.52 -39.02 58.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.97 -1.081 . . . . 0.0 109.983 -179.449 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 56.5 p30 -59.26 -14.21 10.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.131 -0.981 . . . . 0.0 109.165 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 31.0 ttpt -107.0 -36.17 6.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.382 -0.824 . . . . 0.0 109.327 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.662 HD22 ' CH2' ' A' ' 107' ' ' TRP . 33.1 tp -123.92 129.5 51.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.42 -0.8 . . . . 0.0 109.339 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -73.31 83.46 1.4 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.039 -1.038 . . . . 0.0 109.285 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.572 ' CB ' HD11 ' A' ' 86' ' ' ILE . 24.3 mt -69.32 130.11 41.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.224 -0.923 . . . . 0.0 109.959 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.3 p -133.86 151.71 51.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.397 -0.814 . . . . 0.0 109.302 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 52.82 50.69 17.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.098 -1.001 . . . . 0.0 109.58 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.572 HD11 ' CB ' ' A' ' 83' ' ' LEU . 97.6 mt -78.73 130.37 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.327 -0.858 . . . . 0.0 110.085 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mm -117.85 118.84 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.473 -0.767 . . . . 0.0 109.276 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 81.0 mtp -124.17 108.09 11.92 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.286 -0.884 . . . . 0.0 109.822 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -113.93 102.17 9.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.362 -0.836 . . . . 0.0 109.05 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.501 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 70.2 m80 -72.33 -35.74 68.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.898 -1.126 . . . . 0.0 110.488 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -60.7 -44.86 96.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.874 -1.141 . . . . 0.0 109.457 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -89.41 -5.72 57.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.134 -0.979 . . . . 0.0 109.129 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.501 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.3 m-20 55.36 47.47 21.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.576 -0.702 . . . . 0.0 110.392 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.589 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 2.8 t -132.3 137.5 47.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.146 -0.971 . . . . 0.0 109.404 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.613 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 23.8 m-85 -127.28 139.41 52.92 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.372 -0.83 . . . . 0.0 109.818 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.589 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 81.2 m-85 -135.9 147.01 47.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.21 -0.932 . . . . 0.0 109.358 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.6 t -150.86 150.9 31.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.953 -1.092 . . . . 0.0 109.174 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.413 ' HG2' HH11 ' A' ' 98' ' ' ARG . 60.7 mtt-85 -101.68 134.41 44.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.044 -1.035 . . . . 0.0 109.476 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.4 HD11 HG21 ' A' ' 48' ' ' ILE . 94.7 mt -93.39 139.22 22.86 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.436 -0.79 . . . . 0.0 109.5 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.907 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 77.0 Cg_exo -46.36 163.22 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.853 1.702 . . . . 0.0 111.222 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 m -76.34 -10.15 59.19 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.1 -1.0 . . . . 0.0 109.696 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.8 tp -136.42 129.29 30.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.152 -0.968 . . . . 0.0 110.339 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 88.7 mt -145.69 106.92 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 108.893 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.3 p -100.53 -2.81 32.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.048 -1.032 . . . . 0.0 109.899 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -88.45 156.13 19.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.99 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -105.02 33.2 3.75 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.452 -0.78 . . . . 0.0 109.135 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.662 ' CH2' HD22 ' A' ' 81' ' ' LEU . 24.4 p-90 -65.77 161.53 20.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.141 -0.974 . . . . 0.0 110.625 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -143.54 160.68 40.19 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.622 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 36.4 p90 -155.09 160.65 41.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.17 -0.956 . . . . 0.0 108.674 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.518 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 5.0 p90 -151.67 159.93 43.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.778 -1.201 . . . . 0.0 111.892 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 96.7 m -125.0 156.5 38.01 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.635 HG22 HG22 ' A' ' 122' ' ' VAL . 44.8 t -130.58 143.65 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.839 -1.163 . . . . 0.0 111.764 -178.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 63.4 m -124.66 132.95 53.38 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.6 p -167.62 178.08 5.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.25 -1.531 . . . . 0.0 111.694 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.623 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 46.5 mtmt -155.31 165.04 37.88 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 117' ' ' ASN . 98.2 m-20 -58.69 150.95 22.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.827 -1.171 . . . . 0.0 109.116 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.492 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 64.5 t30 44.53 60.95 2.62 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.232 -0.917 . . . . 0.0 109.639 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 40.4 mt-10 -164.48 144.72 7.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.132 -0.98 . . . . 0.0 110.216 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.539 ' CE ' ' NZ ' ' A' ' 28' ' ' LYS . 69.7 mmtt -63.28 136.66 57.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.197 -0.939 . . . . 0.0 109.111 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.539 ' CE ' ' OD2' ' A' ' 35' ' ' ASP . 4.3 pttm -84.26 144.8 28.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.249 -0.907 . . . . 0.0 110.575 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 72.7 mt -110.92 123.67 50.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.583 -0.698 . . . . 0.0 109.181 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.635 HG22 HG22 ' A' ' 112' ' ' VAL . 45.3 t -109.9 130.94 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.01 -1.056 . . . . 0.0 110.679 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -110.37 122.53 47.92 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 38' ' ' CYS . 7.6 t -137.86 142.85 40.71 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.795 -1.191 . . . . 0.0 112.163 -178.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.622 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -136.12 158.18 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -124.01 145.21 49.35 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.106 -0.996 . . . . 0.0 110.415 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.279 179.792 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -76.18 162.96 27.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.139 -0.976 . . . . 0.0 109.294 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 69.4 t -106.12 134.32 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.162 -0.962 . . . . 0.0 110.042 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -70.47 124.04 23.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.065 -1.022 . . . . 0.0 108.371 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.18 164.79 30.39 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.471 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 4.4 t -107.59 138.04 44.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.621 -0.929 . . . . 0.0 109.386 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.445 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 67.3 t0 -114.81 109.01 17.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.446 -0.784 . . . . 0.0 109.36 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -86.32 -0.73 56.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 108.928 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.427 ' OG1' ' N ' ' A' ' 53' ' ' PRO . 17.1 m -99.66 -17.92 17.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.638 -0.663 . . . . 0.0 110.5 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.472 HG22 ' H ' ' A' ' 12' ' ' GLU . 9.3 m -158.24 127.64 5.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.769 -1.207 . . . . 0.0 110.263 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.7 p -62.5 -28.08 69.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -0.953 . . . . 0.0 108.973 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.472 ' H ' HG22 ' A' ' 10' ' ' THR . 97.8 mt-10 -109.24 108.4 18.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 15' ' ' ILE . 74.4 m -107.63 109.5 21.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 110.376 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 14' ' ' THR . 0.1 OUTLIER -66.84 2.58 1.35 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.489 ' H ' ' C ' ' A' ' 13' ' ' SER . 6.9 pt -124.48 -30.28 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.598 -0.689 . . . . 0.0 110.374 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.484 ' CZ ' ' CE2' ' A' ' 96' ' ' TYR . 54.5 m-85 -112.67 144.63 41.86 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.129 -0.982 . . . . 0.0 110.145 -179.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.0 p -75.11 -22.34 58.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.567 -0.708 . . . . 0.0 110.837 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -119.96 129.22 54.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.869 -1.144 . . . . 0.0 110.644 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -140.7 154.23 24.15 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.471 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 24.2 m-85 -124.06 154.61 39.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.354 -1.086 . . . . 0.0 109.53 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.1 t -91.25 152.91 20.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.367 -0.833 . . . . 0.0 109.206 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.9 pt -51.6 -33.47 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 120.955 -1.09 . . . . 0.0 109.484 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -69.86 -46.44 65.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 109.674 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -56.44 -47.02 79.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 110.199 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.456 HG13 ' N ' ' A' ' 26' ' ' SER . 32.8 pt -66.65 -40.34 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.082 -1.011 . . . . 0.0 109.46 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.456 ' N ' HG13 ' A' ' 25' ' ' ILE . 22.4 t -132.65 84.35 2.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.927 . . . . 0.0 109.316 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -86.52 124.17 32.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 109.396 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.47 ' HD2' ' H ' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -76.18 -14.93 60.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.437 -0.789 . . . . 0.0 109.582 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.463 ' O ' ' C ' ' A' ' 30' ' ' SER . 81.9 p -92.77 -77.1 0.45 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.203 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.463 ' C ' ' O ' ' A' ' 29' ' ' SER . 15.8 t -39.48 153.66 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.607 -0.683 . . . . 0.0 109.556 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.615 ' O ' ' N ' ' A' ' 33' ' ' GLN . 32.5 p-10 -97.04 -46.74 6.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.973 . . . . 0.0 109.503 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.536 ' C ' ' O ' ' A' ' 31' ' ' ASN . 24.1 p-10 -33.14 90.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.598 -0.689 . . . . 0.0 109.923 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.615 ' N ' ' O ' ' A' ' 31' ' ' ASN . 10.9 pt20 -137.46 117.13 13.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.159 -0.963 . . . . 0.0 109.211 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.568 ' CG ' ' H ' ' A' ' 35' ' ' ASP . 10.3 pt20 -169.18 -60.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.101 -0.999 . . . . 0.0 109.618 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.568 ' H ' ' CG ' ' A' ' 34' ' ' GLN . 3.7 m-20 -151.76 116.62 5.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.373 -0.829 . . . . 0.0 109.549 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mm -82.65 125.72 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.126 -0.984 . . . . 0.0 108.456 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.4 t -121.51 130.37 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.121 -0.987 . . . . 0.0 110.445 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.434 ' O ' ' O ' ' A' ' 124' ' ' THR . 61.1 m -101.79 101.39 11.86 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.8 m -94.08 119.18 32.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.848 -1.157 . . . . 0.0 109.649 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.558 ' CG2' HG12 ' A' ' 125' ' ' VAL . 19.7 m -139.4 156.54 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.475 -0.766 . . . . 0.0 109.118 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -99.05 131.59 44.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.929 . . . . 0.0 109.561 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.56 152.48 21.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.553 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.477 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 47.4 t-80 -124.1 153.53 41.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.358 -0.839 . . . . 0.0 109.515 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.61 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -56.05 -26.1 47.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.368 -0.832 . . . . 0.0 109.772 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -96.91 -23.67 16.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.954 . . . . 0.0 109.61 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.477 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 82.4 m-20 -78.96 136.74 37.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.948 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.9 mt -78.78 150.36 32.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 0.0 108.669 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.9 pt -121.66 143.55 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.06 -1.025 . . . . 0.0 110.111 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.5 -172.72 45.49 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -170.49 169.9 7.16 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.007 -1.29 . . . . 0.0 109.713 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -145.11 144.03 30.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.296 -0.878 . . . . 0.0 109.816 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 86.0 m -123.45 151.99 63.97 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.427 ' N ' ' OG1' ' A' ' 9' ' ' THR . 8.6 Cg_endo -51.59 144.41 33.19 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.363 2.042 . . . . 0.0 111.949 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -66.64 -13.82 61.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.52 -0.738 . . . . 0.0 110.535 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.605 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 82.3 m-20 -89.93 0.66 56.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.922 -1.111 . . . . 0.0 110.161 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.423 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.0 m-85 -110.97 165.73 11.62 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.267 -0.896 . . . . 0.0 110.187 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.7 m -102.28 140.46 36.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.388 -0.82 . . . . 0.0 109.294 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.8 m -97.21 118.42 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.002 -1.061 . . . . 0.0 110.369 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.446 ' OE1' ' N ' ' A' ' 59' ' ' GLU . 5.6 mp0 -125.09 126.77 25.18 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.17 114.39 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.658 1.572 . . . . 0.0 112.142 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -93.66 -24.32 17.92 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.894 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.2 t0 -170.94 40.07 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.451 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 88.5 m -63.97 -152.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.608 -0.682 . . . . 0.0 109.89 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.519 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 3.3 p90 -110.3 -58.19 2.11 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.118 -0.989 . . . . 0.0 111.252 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.447 ' C ' ' O ' ' A' ' 64' ' ' PHE . 27.6 t -45.82 -70.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.568 -1.332 . . . . 0.0 108.807 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.4 t -142.54 132.48 24.33 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.451 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -171.83 179.59 2.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.929 -1.107 . . . . 0.0 110.419 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 4.7 m-85 -93.76 140.44 29.66 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.437 HD21 ' HG2' ' A' ' 75' ' ' GLU . 99.8 m-20 -80.7 -171.12 2.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.895 -1.128 . . . . 0.0 109.9 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.2 mt -65.99 -15.8 63.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.353 -0.842 . . . . 0.0 109.134 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.441 ' OG ' ' NZ ' ' A' ' 73' ' ' LYS . 32.5 t -86.47 -7.15 58.65 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.322 -0.861 . . . . 0.0 108.878 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.57 20.2 66.81 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.441 ' NZ ' ' OG ' ' A' ' 71' ' ' SER . 64.6 mttp -107.28 140.47 40.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -1.147 . . . . 0.0 109.068 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -63.66 134.15 54.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.135 -0.978 . . . . 0.0 109.933 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.437 ' HG2' HD21 ' A' ' 69' ' ' ASN . 34.5 tp10 -154.19 163.81 39.53 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.313 -0.867 . . . . 0.0 109.446 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -107.35 138.79 42.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.251 -0.906 . . . . 0.0 109.52 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 tp -97.06 -16.01 20.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.079 -1.013 . . . . 0.0 109.828 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -61.1 -43.65 98.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.894 -1.129 . . . . 0.0 109.521 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -65.09 -13.51 58.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.042 -1.036 . . . . 0.0 108.887 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -100.41 -41.66 6.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.384 -0.823 . . . . 0.0 109.162 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.521 HD23 HD21 ' A' ' 83' ' ' LEU . 37.1 tp -125.83 126.39 44.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 109.133 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -81.03 83.83 6.63 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.081 -1.012 . . . . 0.0 109.378 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.521 HD21 HD23 ' A' ' 81' ' ' LEU . 89.1 mt -77.21 143.93 38.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.312 -0.868 . . . . 0.0 109.955 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.7 p -127.78 158.23 38.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.554 -0.716 . . . . 0.0 109.308 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.0 m120 55.22 51.54 13.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.95 . . . . 0.0 109.699 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.75 129.84 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 110.107 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.2 mm -118.22 118.8 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.447 -0.783 . . . . 0.0 109.271 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 80.2 mtp -120.52 103.34 9.08 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.28 -0.887 . . . . 0.0 109.74 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -110.6 99.63 8.57 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.252 -0.905 . . . . 0.0 109.041 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.482 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 61.8 m80 -72.3 -35.99 68.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.107 -0.996 . . . . 0.0 110.549 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -60.32 -45.02 94.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.912 -1.117 . . . . 0.0 109.516 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -89.5 -4.94 57.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 109.031 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.482 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.0 m-20 54.82 48.46 20.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.495 -0.753 . . . . 0.0 110.17 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.543 ' OG1' ' CE1' ' A' ' 96' ' ' TYR . 3.3 t -134.22 140.14 46.28 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.026 -1.046 . . . . 0.0 109.343 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -129.43 140.72 51.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.489 -0.757 . . . . 0.0 110.206 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.543 ' CE1' ' OG1' ' A' ' 94' ' ' THR . 83.6 m-85 -136.18 146.85 47.3 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.417 -0.802 . . . . 0.0 109.537 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.1 p -152.64 159.44 43.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.981 -1.074 . . . . 0.0 109.172 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 71.0 mtp180 -108.44 137.9 45.64 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.096 -1.003 . . . . 0.0 109.339 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 99' ' ' LEU . 46.3 mt -92.86 137.54 23.91 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.405 -0.809 . . . . 0.0 109.543 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.61 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 76.8 Cg_exo -45.86 170.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.836 1.69 . . . . 0.0 111.309 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.3 m -79.69 -10.61 59.81 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.101 -1.0 . . . . 0.0 109.754 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.6 tp -136.11 129.93 32.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.225 -0.922 . . . . 0.0 110.432 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.6 mt -147.37 102.37 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.235 -0.916 . . . . 0.0 108.643 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.7 m -102.83 -6.91 22.04 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.017 -1.052 . . . . 0.0 109.8 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 127' ' ' ALA . 84.7 m-20 -81.42 154.36 26.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.169 -0.957 . . . . 0.0 110.013 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -103.51 33.74 3.24 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.417 -0.802 . . . . 0.0 109.091 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.453 ' CH2' HD22 ' A' ' 81' ' ' LEU . 23.5 p-90 -64.98 152.66 42.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 110.452 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.24 153.96 51.09 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.639 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 30.6 p90 -152.4 162.35 41.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.999 -1.063 . . . . 0.0 108.698 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.491 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 8.2 p90 -154.1 160.77 42.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.729 -1.232 . . . . 0.0 111.792 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 97.5 m -125.61 156.45 39.16 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.587 HG22 HG22 ' A' ' 122' ' ' VAL . 42.8 t -128.45 139.1 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.881 -1.137 . . . . 0.0 111.79 -178.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 93.5 m -122.15 131.87 54.17 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.5 p -170.2 178.55 3.79 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.176 -1.578 . . . . 0.0 111.663 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.605 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 50.0 mtmt -151.7 163.38 39.25 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -58.55 151.25 20.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.775 -1.203 . . . . 0.0 109.078 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.52 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 60.5 t-20 46.35 61.19 2.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.228 -0.92 . . . . 0.0 109.47 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 37.3 mt-10 -165.73 146.3 6.79 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.127 -0.983 . . . . 0.0 110.233 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -61.84 134.75 57.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.168 -0.958 . . . . 0.0 109.089 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -81.57 143.31 32.08 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.118 -0.989 . . . . 0.0 110.328 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 58.7 mt -110.75 122.87 48.89 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.587 HG22 HG22 ' A' ' 112' ' ' VAL . 52.6 t -110.07 131.14 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.883 -1.135 . . . . 0.0 110.79 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -109.0 120.52 42.79 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 38' ' ' CYS . 7.2 t -137.08 141.25 42.37 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.933 -1.105 . . . . 0.0 111.892 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.639 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -135.92 159.47 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -124.9 146.68 49.21 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.161 -0.962 . . . . 0.0 110.423 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.31 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.258 0.551 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -76.99 152.77 35.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.935 . . . . 0.0 109.201 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.2 t -93.91 133.05 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 109.983 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.548 ' NZ ' ' OD2' ' A' ' 46' ' ' ASP . 96.7 mttt -72.85 127.18 31.8 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.735 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.77 166.18 32.26 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.442 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 5.2 t -104.96 131.9 51.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.422 -1.046 . . . . 0.0 109.471 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -110.88 109.44 19.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.494 -0.754 . . . . 0.0 109.424 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.413 ' CD1' HD13 ' A' ' 121' ' ' LEU . 92.9 m-85 -87.17 1.1 54.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 108.942 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.4 m -105.24 -17.17 14.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.561 -0.712 . . . . 0.0 110.461 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.9 m -153.7 121.23 5.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.823 -1.173 . . . . 0.0 110.311 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.6 p -62.87 -29.79 71.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 108.911 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -109.98 73.02 0.82 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.491 ' HB2' ' H ' ' A' ' 16' ' ' PHE . 19.8 p -71.9 111.84 7.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.261 -0.899 . . . . 0.0 110.315 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.0 t -69.4 2.86 2.65 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.433 ' H ' ' C ' ' A' ' 13' ' ' SER . 4.8 pt -123.61 -32.24 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.711 -0.618 . . . . 0.0 110.394 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.491 ' H ' ' HB2' ' A' ' 13' ' ' SER . 86.6 m-85 -106.6 145.67 31.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.212 -0.93 . . . . 0.0 109.812 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.1 m -71.34 -25.29 62.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.511 -0.743 . . . . 0.0 110.886 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -125.19 136.03 53.18 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.925 -1.109 . . . . 0.0 110.52 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -142.89 158.33 27.1 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.442 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 22.6 m-85 -123.53 152.69 41.52 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.346 -1.091 . . . . 0.0 109.648 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.3 t -99.69 162.53 12.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.0 109.049 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.9 pt -56.23 -19.0 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.103 -0.998 . . . . 0.0 109.4 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.413 ' OD1' ' C ' ' A' ' 23' ' ' ASN . 46.5 t-20 -86.0 -54.75 4.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.187 -0.946 . . . . 0.0 109.402 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -46.34 -40.72 12.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.916 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 32' ' ' ASN . 39.5 pt -61.87 -25.58 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.019 -1.05 . . . . 0.0 109.518 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 27' ' ' ASN . 2.9 t -90.35 -106.65 0.09 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.161 -0.962 . . . . 0.0 108.927 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.542 ' N ' ' OG ' ' A' ' 26' ' ' SER . 97.6 m-20 -84.21 121.64 27.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.184 -0.948 . . . . 0.0 108.735 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -142.01 -71.44 0.34 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.195 -0.94 . . . . 0.0 109.83 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 t -159.59 -76.56 0.07 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.047 -1.033 . . . . 0.0 109.09 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.558 ' C ' ' H ' ' A' ' 32' ' ' ASN . 5.1 p -71.22 -166.81 0.19 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.545 ' C ' ' H ' ' A' ' 33' ' ' GLN . 95.1 m-20 -67.45 34.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.714 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.558 ' H ' ' C ' ' A' ' 30' ' ' SER . 99.3 m-20 -65.4 11.22 0.07 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.154 -0.966 . . . . 0.0 109.439 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' A' ' 31' ' ' ASN . 29.8 pt20 -94.14 -6.9 43.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.916 -1.115 . . . . 0.0 109.5 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.485 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 14.0 pt20 -136.44 -34.6 0.77 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.113 -0.992 . . . . 0.0 109.695 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 34' ' ' GLN . 74.6 m-20 -136.58 114.6 11.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.42 -0.8 . . . . 0.0 109.45 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.1 mm -93.97 118.86 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.898 -1.126 . . . . 0.0 108.446 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.2 t -114.36 124.89 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.348 -0.845 . . . . 0.0 110.213 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 83.1 m -102.26 101.92 12.26 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.8 m -97.4 121.96 39.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.072 -1.017 . . . . 0.0 109.588 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.413 ' CG2' HG12 ' A' ' 125' ' ' VAL . 24.1 m -139.38 155.5 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.408 -0.807 . . . . 0.0 109.024 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -95.94 123.76 39.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.324 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.542 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -87.99 161.99 17.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.7 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -139.99 148.4 41.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.908 . . . . 0.0 109.6 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.635 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -55.71 -24.2 33.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.362 -0.837 . . . . 0.0 109.745 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.485 ' OD1' ' O ' ' A' ' 45' ' ' ASN . 63.1 t-20 -98.96 -27.72 13.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.05 -1.031 . . . . 0.0 109.704 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.548 ' OD2' ' NZ ' ' A' ' 4' ' ' LYS . 88.3 m-20 -77.41 137.12 38.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.531 -0.731 . . . . 0.0 110.099 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.6 mt -78.23 148.28 34.03 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.431 HD13 HD21 ' A' ' 99' ' ' LEU . 47.2 pt -121.59 143.3 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.06 -1.025 . . . . 0.0 110.126 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.22 -176.14 47.22 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 50.5 p90 -164.9 170.37 15.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.126 -1.22 . . . . 0.0 109.75 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -148.33 146.08 28.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 109.936 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.4 m -126.21 152.17 73.16 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.3 Cg_endo -51.44 153.53 10.14 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.322 2.014 . . . . 0.0 111.867 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.5 m -72.5 -10.64 60.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.449 -0.782 . . . . 0.0 110.7 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.599 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.9 m-20 -92.4 -2.26 56.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.993 -1.067 . . . . 0.0 110.173 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.434 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 18.6 m-85 -108.69 164.58 12.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.158 -0.964 . . . . 0.0 110.346 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 t -105.11 135.13 47.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.331 -0.855 . . . . 0.0 109.119 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 58' ' ' VAL . 3.0 m -92.6 119.87 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.993 -1.067 . . . . 0.0 110.316 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -123.36 126.4 25.88 Favored Pre-proline 0 N--CA 1.489 1.522 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.13 114.25 3.54 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.721 1.614 . . . . 0.0 112.144 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 68' ' ' PHE . 16.5 t-80 -93.71 -24.26 17.91 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.0 t0 -170.18 40.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.453 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 89.1 m -63.6 -154.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.524 -0.735 . . . . 0.0 109.887 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 4.3 p90 -110.56 -57.28 2.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.122 -0.986 . . . . 0.0 111.388 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 64' ' ' PHE . 34.7 t -46.12 -59.12 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.562 -1.336 . . . . 0.0 108.963 -179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.1 t -156.85 133.86 10.36 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.453 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.0 -178.14 2.07 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.396 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 4.3 m-85 -93.63 143.25 26.48 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . 0.456 ' OD1' ' OE1' ' A' ' 75' ' ' GLU . 28.7 m120 -84.77 -169.2 2.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.112 -0.993 . . . . 0.0 109.828 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.568 ' N ' HD12 ' A' ' 70' ' ' LEU . 10.2 mp -66.85 -15.32 63.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.362 -0.836 . . . . 0.0 108.936 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.8 p -89.62 -8.35 52.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.916 . . . . 0.0 108.693 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.25 22.25 57.29 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -107.16 138.9 42.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.278 -1.13 . . . . 0.0 109.126 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -67.97 136.42 53.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.419 -0.8 . . . . 0.0 109.988 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.456 ' OE1' ' OD1' ' A' ' 69' ' ' ASN . 68.1 tt0 -155.33 165.84 35.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 109.594 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.416 ' N ' ' HG2' ' A' ' 75' ' ' GLU . 4.1 m120 -103.93 135.6 45.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.448 -0.782 . . . . 0.0 109.452 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.7 tp -97.61 -10.04 25.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.115 -0.99 . . . . 0.0 109.98 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -60.28 -44.57 95.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.944 -1.097 . . . . 0.0 109.638 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -64.83 -21.8 66.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.101 -1.0 . . . . 0.0 108.927 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -81.0 -48.42 12.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.437 -0.79 . . . . 0.0 109.283 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.673 HD23 HD21 ' A' ' 83' ' ' LEU . 44.0 tp -127.06 128.69 46.68 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.522 -0.737 . . . . 0.0 109.111 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -73.91 83.96 1.71 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.031 -1.043 . . . . 0.0 109.198 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.673 HD21 HD23 ' A' ' 81' ' ' LEU . 92.6 mt -80.37 135.25 36.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -0.828 . . . . 0.0 110.026 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.9 p -126.78 162.21 26.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.601 -0.687 . . . . 0.0 109.201 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.403 HD22 ' HD2' ' A' ' 98' ' ' ARG . 97.7 m-20 54.82 50.95 14.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 109.574 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.53 131.33 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.331 -0.856 . . . . 0.0 110.124 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -119.49 120.01 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.461 -0.774 . . . . 0.0 109.246 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 71.9 mtp -122.51 105.33 10.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.111 -0.993 . . . . 0.0 109.745 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -110.81 100.79 9.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.367 -0.833 . . . . 0.0 109.0 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.453 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 95.5 m-70 -73.25 -34.61 65.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.964 -1.085 . . . . 0.0 110.583 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -60.47 -45.8 92.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.862 -1.149 . . . . 0.0 109.63 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -89.64 -3.89 58.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.129 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 97.5 m-20 55.06 48.07 20.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.585 -0.697 . . . . 0.0 110.326 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.597 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 1.9 t -133.43 138.89 46.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.99 -1.068 . . . . 0.0 109.458 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 75.3 m-85 -126.93 139.06 53.34 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.323 -0.861 . . . . 0.0 109.93 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.597 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 73.4 m-85 -135.39 146.23 48.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.257 -0.902 . . . . 0.0 109.427 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 53.9 m -150.05 151.95 34.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.094 -1.004 . . . . 0.0 109.189 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.423 ' HG2' HH11 ' A' ' 98' ' ' ARG . 59.0 mtt-85 -103.55 135.64 44.76 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.062 -1.024 . . . . 0.0 109.415 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.542 HD11 ' HB1' ' A' ' 42' ' ' ALA . 67.8 mt -89.81 137.18 28.53 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.478 -0.764 . . . . 0.0 109.607 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.635 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 76.9 Cg_exo -46.39 162.09 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.777 1.651 . . . . 0.0 111.329 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.0 m -71.36 -17.43 62.43 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.115 -0.991 . . . . 0.0 109.713 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.2 tp -132.46 130.71 40.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.236 -0.915 . . . . 0.0 110.39 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.449 HD11 ' HB3' ' A' ' 99' ' ' LEU . 96.7 mt -142.78 125.56 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.321 -0.862 . . . . 0.0 108.713 178.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.9 p -131.5 54.28 1.93 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.041 -1.037 . . . . 0.0 109.755 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.603 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 7.1 t0 -145.24 151.06 37.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 109.954 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.603 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 99.8 m-20 -91.33 33.66 0.98 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.492 -0.755 . . . . 0.0 109.039 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.589 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 12.8 p-90 -64.86 150.19 48.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.167 -0.958 . . . . 0.0 110.514 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.6 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 12.9 tttp -139.85 151.95 46.09 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.637 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 32.1 p90 -156.07 162.61 40.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.028 -1.045 . . . . 0.0 108.72 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.464 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 10.1 p90 -153.89 158.62 41.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.679 -1.263 . . . . 0.0 111.785 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 98.1 m -123.15 156.49 34.94 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 122' ' ' VAL . 46.5 t -128.5 139.19 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 120.955 -1.09 . . . . 0.0 111.678 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 23.2 m -122.14 131.61 54.05 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 71.6 p -172.01 179.18 2.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.325 -1.484 . . . . 0.0 111.573 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.599 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 49.8 mtmt -150.72 163.17 39.21 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 117' ' ' ASN . 55.2 p-10 -58.13 154.38 13.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.751 -1.218 . . . . 0.0 109.214 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.508 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 66.3 t30 43.43 60.33 2.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.208 -0.932 . . . . 0.0 109.641 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 36.8 mt-10 -165.31 146.01 7.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.14 -0.975 . . . . 0.0 110.205 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.472 ' NZ ' ' O ' ' A' ' 33' ' ' GLN . 67.3 mttm -57.41 144.27 37.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.232 -0.918 . . . . 0.0 108.904 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -91.9 139.74 30.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.175 -0.953 . . . . 0.0 110.382 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.413 HD13 ' CD1' ' A' ' 8' ' ' PHE . 26.5 mt -108.04 120.43 42.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.374 -0.828 . . . . 0.0 109.043 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 112' ' ' VAL . 49.9 t -109.01 129.88 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.968 -1.083 . . . . 0.0 110.493 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -108.27 120.42 42.33 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.6 ' OG1' ' NZ ' ' A' ' 108' ' ' LYS . 12.9 t -136.26 140.93 43.82 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.889 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.637 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.1 m -134.88 156.47 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -129.97 150.5 51.22 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.158 -0.964 . . . . 0.0 110.3 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.519 ' HB3' ' NE1' ' A' ' 107' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.277 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -74.59 160.78 30.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.147 -0.971 . . . . 0.0 109.301 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 51.7 t -104.48 130.82 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.236 -0.915 . . . . 0.0 109.904 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.461 ' N ' ' CD ' ' A' ' 4' ' ' LYS . 3.6 mptp? -68.54 122.96 19.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.159 -0.963 . . . . 0.0 108.791 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.52 175.39 44.71 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -116.11 130.78 56.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.453 -1.028 . . . . 0.0 109.479 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.512 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 40.5 t0 -108.23 109.47 20.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.447 -0.783 . . . . 0.0 109.269 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.47 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 91.8 m-85 -88.29 0.89 55.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.151 -0.968 . . . . 0.0 108.977 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.2 m -102.12 -17.02 16.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.592 -0.692 . . . . 0.0 110.685 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.608 HG22 ' H ' ' A' ' 12' ' ' GLU . 69.4 m -158.08 128.38 6.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.868 -1.145 . . . . 0.0 110.292 -179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.581 ' OG ' ' N ' ' A' ' 21' ' ' SER . 13.7 m -68.11 -25.45 65.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.895 . . . . 0.0 108.934 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.608 ' H ' HG22 ' A' ' 10' ' ' THR . 77.6 mt-10 -114.35 74.28 0.87 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 108.928 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.512 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 7.8 m -70.01 151.94 44.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 110.248 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -100.03 -0.08 39.91 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.8 pt -125.25 -25.01 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.7 -0.625 . . . . 0.0 110.176 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -111.58 139.64 46.85 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.033 -1.042 . . . . 0.0 109.912 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.2 m -71.85 -18.09 62.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.555 -0.716 . . . . 0.0 110.649 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -131.22 142.13 50.13 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.789 -1.194 . . . . 0.0 110.636 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.447 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -162.33 166.35 36.45 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.443 ' C ' ' OG ' ' A' ' 11' ' ' SER . 70.8 m-85 -125.65 168.24 14.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.316 -1.108 . . . . 0.0 109.586 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.581 ' N ' ' OG ' ' A' ' 11' ' ' SER . 4.9 t -103.4 164.69 11.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.466 -0.771 . . . . 0.0 109.072 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 26' ' ' SER . 44.9 pt -62.3 -20.82 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.078 -1.014 . . . . 0.0 109.512 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' A' ' 23' ' ' ASN . 49.0 t-20 -59.86 -35.41 74.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.342 -0.849 . . . . 0.0 109.338 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -69.01 -36.89 78.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.402 -0.811 . . . . 0.0 110.068 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 26' ' ' SER . 2.4 pt -100.48 -3.8 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.834 -1.166 . . . . 0.0 109.432 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 22' ' ' ILE . 48.9 m -54.31 -166.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.135 -0.978 . . . . 0.0 109.345 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.47 ' OD1' ' NZ ' ' A' ' 119' ' ' LYS . 89.8 m-20 -114.62 2.93 14.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.21 -0.931 . . . . 0.0 109.275 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -60.49 -98.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.522 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.3 t -144.45 69.85 1.27 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.108 -0.995 . . . . 0.0 109.183 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.7 p -73.62 139.74 45.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.37 -0.831 . . . . 0.0 109.616 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -67.05 -52.41 42.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.146 -0.971 . . . . 0.0 109.823 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.562 ' O ' ' O ' ' A' ' 33' ' ' GLN . 99.2 m-20 -65.7 121.38 14.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.019 -1.05 . . . . 0.0 109.605 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.713 ' C ' ' H ' ' A' ' 35' ' ' ASP . 2.8 pt20 -46.91 -178.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.512 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -58.62 16.48 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.483 -1.386 . . . . 0.0 109.961 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.713 ' H ' ' C ' ' A' ' 33' ' ' GLN . 97.4 m-20 -118.1 101.56 8.33 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.45 -0.781 . . . . 0.0 109.328 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.7 mm -102.2 126.13 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.037 -1.039 . . . . 0.0 108.895 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.486 HG22 ' HB ' ' A' ' 122' ' ' VAL . 53.1 t -120.97 129.84 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.061 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.47 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 91.1 m -100.8 99.56 10.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.0 m -95.87 121.07 37.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.933 -1.104 . . . . 0.0 109.489 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.452 ' CG2' HG12 ' A' ' 125' ' ' VAL . 22.8 m -141.34 155.84 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.401 -0.812 . . . . 0.0 109.246 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -96.08 129.52 43.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.945 . . . . 0.0 109.387 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.491 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -100.02 154.53 18.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.304 -0.872 . . . . 0.0 109.626 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.48 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 32.4 t-80 -126.56 151.84 47.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.336 -0.852 . . . . 0.0 109.558 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.544 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -55.17 -25.11 30.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.883 . . . . 0.0 109.789 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -98.99 -24.97 14.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.926 . . . . 0.0 109.655 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 85.5 m-20 -74.4 135.66 42.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.428 -0.795 . . . . 0.0 110.161 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.404 ' HB3' HH21 ' A' ' 98' ' ' ARG . 69.7 mt -76.86 145.59 38.26 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.542 HD13 HD21 ' A' ' 99' ' ' LEU . 39.1 pt -120.17 141.92 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.019 -1.05 . . . . 0.0 110.392 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.29 -174.57 46.83 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -170.16 169.95 7.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.049 -1.265 . . . . 0.0 109.739 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -146.96 145.03 29.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.315 -0.865 . . . . 0.0 109.762 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.7 m -124.49 153.4 69.43 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.258 -0.902 . . . . 0.0 108.626 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.45 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.51 147.69 22.31 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.307 2.004 . . . . 0.0 111.98 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.1 t -68.1 -13.84 62.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.465 -0.772 . . . . 0.0 110.621 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.634 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.7 m-20 -89.71 -0.77 57.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.834 -1.166 . . . . 0.0 110.224 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.45 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.5 m-85 -109.63 164.8 12.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.961 . . . . 0.0 110.186 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 m -105.24 135.51 46.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.387 -0.821 . . . . 0.0 109.298 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.8 m -90.16 118.4 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.074 -1.016 . . . . 0.0 110.393 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -123.84 127.84 25.31 Favored Pre-proline 0 N--CA 1.491 1.609 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.29 114.04 3.47 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.662 1.574 . . . . 0.0 112.16 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 68' ' ' PHE . 12.1 t-80 -91.22 -25.41 19.53 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.3 t0 -172.7 39.27 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.458 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 77.0 m -60.87 -153.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.538 -0.726 . . . . 0.0 109.842 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 4.3 p90 -108.97 -56.1 2.32 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.004 -1.06 . . . . 0.0 111.256 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 66' ' ' SER . 13.1 t -48.79 -74.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.559 -1.338 . . . . 0.0 108.876 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.507 ' N ' HG12 ' A' ' 65' ' ' VAL . 27.6 t -137.16 131.2 32.22 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.458 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.11 179.92 2.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.992 -1.068 . . . . 0.0 110.428 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 5.4 m-85 -93.46 130.31 39.33 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -76.63 -174.03 2.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.931 -1.106 . . . . 0.0 109.904 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.4 mt -64.27 -20.85 66.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 109.103 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.7 p -83.42 -6.36 59.44 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.12 19.74 66.45 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -100.82 139.14 36.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.233 -1.157 . . . . 0.0 109.193 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -84.38 112.38 20.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.928 . . . . 0.0 110.08 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -150.57 140.99 22.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.355 -0.841 . . . . 0.0 109.964 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -63.24 149.46 45.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.114 -0.991 . . . . 0.0 109.49 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 77' ' ' LEU . 14.7 tp -96.55 7.39 46.66 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.359 -0.838 . . . . 0.0 109.691 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -69.02 -40.39 78.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.053 -1.029 . . . . 0.0 109.952 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.607 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 51.5 p-10 -61.95 -31.44 71.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 0.0 109.106 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.607 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 29.1 tptp -75.56 -48.17 23.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.514 -0.741 . . . . 0.0 109.255 178.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.465 HD11 ' HG2' ' A' ' 100' ' ' PRO . 15.6 tp -149.13 123.67 9.74 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -80.46 99.54 8.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.054 -1.029 . . . . 0.0 109.644 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.2 mt -76.08 158.97 31.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.435 -0.79 . . . . 0.0 109.784 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.2 p -129.51 160.17 34.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.264 -0.898 . . . . 0.0 109.346 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 54.59 51.29 14.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.072 -1.018 . . . . 0.0 109.723 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.9 mt -80.74 130.79 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.331 -0.856 . . . . 0.0 109.996 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.9 mm -123.06 121.82 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.516 -0.74 . . . . 0.0 109.192 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 87.1 mtp -121.87 104.14 9.34 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.021 -1.05 . . . . 0.0 109.884 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -112.07 100.76 9.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.296 -0.878 . . . . 0.0 108.904 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.48 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 93.5 m-70 -72.88 -35.94 67.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.873 -1.142 . . . . 0.0 110.657 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -60.4 -46.55 89.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.964 -1.085 . . . . 0.0 109.434 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -88.13 -4.92 58.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 0.0 109.107 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.48 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.3 m-20 54.71 47.72 21.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.522 -0.736 . . . . 0.0 110.173 178.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.584 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 4.8 t -132.62 137.87 47.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.009 -1.057 . . . . 0.0 109.359 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -126.89 139.24 53.22 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.385 -0.822 . . . . 0.0 109.979 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.584 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 80.4 m-85 -136.24 146.79 47.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.162 -0.961 . . . . 0.0 109.569 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.548 ' C ' ' CZ ' ' A' ' 98' ' ' ARG . 20.0 p -154.28 153.18 31.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.199 -0.938 . . . . 0.0 109.167 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.548 ' CZ ' ' C ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -100.64 137.01 39.61 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.112 -0.993 . . . . 0.0 109.687 -179.729 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.542 HD21 HD13 ' A' ' 48' ' ' ILE . 63.8 mt -88.84 134.74 33.06 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.467 -0.771 . . . . 0.0 109.518 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.586 ' HD2' HD11 ' A' ' 103' ' ' ILE . 78.1 Cg_exo -46.48 155.78 0.68 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.68 1.586 . . . . 0.0 111.32 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.5 t -63.98 -43.36 95.96 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.172 -0.955 . . . . 0.0 109.862 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.7 tp -105.18 126.25 51.87 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.163 -0.961 . . . . 0.0 110.209 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.586 HD11 ' HD2' ' A' ' 100' ' ' PRO . 91.9 mt -151.33 104.06 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.134 -0.979 . . . . 0.0 108.847 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 90.7 p -108.25 0.9 21.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.967 . . . . 0.0 109.757 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -79.93 151.6 30.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 109.994 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -98.85 32.6 2.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.462 -0.774 . . . . 0.0 108.969 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 19.7 p-90 -65.89 158.41 28.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 110.587 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.3 157.46 44.79 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.63 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 35.8 p90 -155.31 160.47 40.78 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.939 -1.101 . . . . 0.0 108.769 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.529 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 5.6 p90 -151.49 158.99 44.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.664 -1.273 . . . . 0.0 111.766 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 90.0 m -124.62 156.3 37.71 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 122' ' ' VAL . 41.7 t -129.64 141.66 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.89 -1.132 . . . . 0.0 111.72 -178.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 91.4 m -120.37 131.44 54.84 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.8 p -168.38 178.86 4.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.264 -1.523 . . . . 0.0 111.643 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.634 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 42.5 mtmt -159.11 167.94 27.91 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.508 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 48.5 p30 -58.72 151.44 21.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.823 -1.173 . . . . 0.0 109.009 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.47 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 60.1 t-20 40.89 58.91 2.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.237 -0.914 . . . . 0.0 109.385 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 54.5 mm-40 -157.57 137.54 12.45 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.089 -1.007 . . . . 0.0 110.521 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.47 ' NZ ' ' OD1' ' A' ' 27' ' ' ASN . 64.1 mttp -54.3 140.89 31.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.059 -1.025 . . . . 0.0 109.141 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -89.11 138.75 31.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.189 -0.944 . . . . 0.0 110.307 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.5 mt -111.24 123.11 49.55 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 112' ' ' VAL . 39.4 t -108.58 130.45 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.878 -1.139 . . . . 0.0 110.621 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -108.91 119.76 40.5 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.6 t -137.14 143.51 42.52 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.876 -1.14 . . . . 0.0 111.946 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.63 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.4 m -136.79 159.55 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 126' ' ' GLU . 57.2 mp0 -128.51 147.83 50.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.055 -1.028 . . . . 0.0 110.217 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.299 179.762 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -80.39 160.03 25.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.19 -0.944 . . . . 0.0 109.327 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 77.5 t -97.76 134.84 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.262 -0.899 . . . . 0.0 110.079 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.418 ' N ' ' HD2' ' A' ' 4' ' ' LYS . 14.2 mptt -68.89 125.91 28.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.949 -1.095 . . . . 0.0 108.618 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.82 -170.95 44.12 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.461 -1.352 . . . . 0.0 109.736 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.7 t -126.49 132.66 51.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -1.087 . . . . 0.0 109.612 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.453 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 51.6 t0 -107.86 108.71 20.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.557 -0.714 . . . . 0.0 109.283 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -88.28 1.23 55.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 108.756 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 83.0 m -102.28 -16.97 16.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.503 -0.748 . . . . 0.0 110.477 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.627 HG22 ' H ' ' A' ' 12' ' ' GLU . 48.6 m -158.08 127.37 5.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.884 -1.135 . . . . 0.0 110.409 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 t -65.2 -26.01 67.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 108.826 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.627 ' H ' HG22 ' A' ' 10' ' ' THR . 76.8 mm-40 -114.33 74.06 0.85 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -69.91 150.8 46.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 110.37 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.89 0.89 39.29 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.425 HD12 ' CE2' ' A' ' 16' ' ' PHE . 6.9 pt -123.91 -23.63 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.666 -0.647 . . . . 0.0 110.184 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.425 ' CE2' HD12 ' A' ' 15' ' ' ILE . 58.6 m-85 -115.26 136.85 52.67 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.304 -0.873 . . . . 0.0 110.023 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.1 t -67.28 -17.79 64.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.571 -0.706 . . . . 0.0 110.864 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -129.95 140.97 50.84 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.039 -1.038 . . . . 0.0 110.523 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.453 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -154.43 161.16 29.99 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -119.37 155.6 31.63 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.481 -1.011 . . . . 0.0 109.636 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.3 t -90.59 152.16 21.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.806 . . . . 0.0 109.09 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.4 pt -54.52 -33.13 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -0.934 . . . . 0.0 109.376 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -68.31 -44.34 75.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.038 -1.039 . . . . 0.0 109.859 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -56.38 -42.69 78.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 110.101 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.6 pt -80.65 -15.77 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.87 -1.144 . . . . 0.0 109.598 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -148.26 70.95 1.15 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.569 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.485 ' O ' ' C ' ' A' ' 28' ' ' LYS . 10.0 p30 -104.13 136.87 42.94 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.286 -0.884 . . . . 0.0 109.448 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 27' ' ' ASN . 99.3 mttt -39.35 -42.94 1.11 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.458 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.7 t -98.4 131.78 44.4 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.103 -0.998 . . . . 0.0 108.724 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.1 t -105.15 121.73 44.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.047 -1.033 . . . . 0.0 109.873 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.493 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 61.2 t-20 -98.83 16.14 23.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.931 . . . . 0.0 109.203 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.405 ' CG ' ' H ' ' A' ' 33' ' ' GLN . 66.1 t30 -168.95 -178.55 3.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.917 . . . . 0.0 109.756 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.405 ' H ' ' CG ' ' A' ' 32' ' ' ASN . 18.1 pt20 -60.01 158.26 11.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 109.002 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.475 ' CG ' ' N ' ' A' ' 35' ' ' ASP . 11.7 pt20 -63.4 -41.72 98.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.032 -1.043 . . . . 0.0 109.444 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 35' ' ' ASP . 0.7 OUTLIER -54.25 130.87 40.24 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.293 -0.879 . . . . 0.0 109.148 -179.312 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.5 mm -100.46 120.72 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.089 -1.007 . . . . 0.0 108.481 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.6 t -115.98 127.05 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.345 -0.847 . . . . 0.0 110.482 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.42 ' O ' ' O ' ' A' ' 124' ' ' THR . 97.5 m -102.62 101.43 11.57 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.2 m -94.22 120.69 34.84 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.055 -1.028 . . . . 0.0 109.58 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.553 ' CG2' HG12 ' A' ' 125' ' ' VAL . 15.9 m -141.36 149.34 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.528 -0.733 . . . . 0.0 109.349 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -90.52 130.65 36.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.971 -1.081 . . . . 0.0 109.24 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.25 151.27 22.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.906 . . . . 0.0 109.288 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.494 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 38.2 t-80 -122.92 152.63 40.63 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.322 -0.861 . . . . 0.0 109.483 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.838 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -55.69 -25.73 41.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.409 -0.807 . . . . 0.0 109.762 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -98.81 -25.72 14.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 0.0 109.764 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.494 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 86.3 m-20 -73.37 135.51 44.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.361 -0.837 . . . . 0.0 110.026 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 75.3 mt -77.21 145.87 37.35 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.414 HG21 HD11 ' A' ' 99' ' ' LEU . 46.1 pt -123.05 145.04 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.204 -0.935 . . . . 0.0 110.207 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.52 -172.52 45.28 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 49.9 p90 -171.3 170.11 6.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.075 -1.25 . . . . 0.0 109.785 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -146.38 144.67 29.9 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.243 -0.911 . . . . 0.0 109.79 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 70.4 m -123.0 153.15 64.08 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.424 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 9.3 Cg_endo -51.81 145.06 32.86 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.292 1.995 . . . . 0.0 112.138 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 t -68.02 -14.83 63.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.481 -0.762 . . . . 0.0 110.628 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -89.6 1.64 55.72 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.931 -1.106 . . . . 0.0 110.233 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.438 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 19.0 m-85 -110.55 166.43 11.0 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.398 -0.814 . . . . 0.0 110.482 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.431 ' OG ' ' OE2' ' A' ' 59' ' ' GLU . 35.2 t -103.01 133.88 47.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -0.837 . . . . 0.0 108.828 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.1 m -91.05 124.49 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.042 -1.037 . . . . 0.0 110.198 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.431 ' OE2' ' OG ' ' A' ' 57' ' ' SER . 10.5 mp0 -131.28 125.82 21.08 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.07 114.47 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.644 1.562 . . . . 0.0 112.047 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.497 ' O ' ' O ' ' A' ' 68' ' ' PHE . 17.3 t-80 -91.57 -23.26 19.96 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.2 t0 -173.5 39.15 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.425 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 81.5 m -60.34 -152.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.577 -0.702 . . . . 0.0 109.533 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.502 ' N ' ' CD1' ' A' ' 64' ' ' PHE . 3.3 p90 -110.88 -58.03 2.15 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.245 -0.909 . . . . 0.0 111.318 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 64' ' ' PHE . 23.5 t -45.95 -72.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.298 -1.501 . . . . 0.0 108.893 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.426 ' N ' HG12 ' A' ' 65' ' ' VAL . 38.4 t -139.98 130.31 25.31 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.425 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.24 -178.79 1.8 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.121 -0.987 . . . . 0.0 110.524 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 4.2 m-85 -93.55 123.45 36.87 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -71.9 -175.84 1.54 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.044 -1.035 . . . . 0.0 109.754 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.6 mt -62.79 -22.86 66.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.181 -0.95 . . . . 0.0 109.112 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.6 t -79.85 -7.36 58.67 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.333 -0.855 . . . . 0.0 108.857 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.69 18.4 68.24 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -101.41 138.63 38.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -1.156 . . . . 0.0 109.072 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -86.08 110.12 19.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.202 -0.936 . . . . 0.0 110.165 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -146.72 143.35 28.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.364 -0.835 . . . . 0.0 109.914 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -64.65 149.64 48.61 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.503 -0.879 . . . . 0.0 109.51 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 13.1 tp -98.8 4.94 47.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.234 -0.916 . . . . 0.0 109.945 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 79' ' ' ASN . 17.7 pt-20 -68.23 -41.31 81.42 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.038 -1.039 . . . . 0.0 110.013 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.593 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 43.4 p30 -64.46 -27.67 69.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.09 -1.006 . . . . 0.0 109.138 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.593 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 28.9 tptp -83.5 -47.73 11.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 109.361 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.582 HD23 HD21 ' A' ' 83' ' ' LEU . 43.3 tp -125.94 126.68 44.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.44 -0.787 . . . . 0.0 109.299 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -77.86 83.62 4.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.134 -0.979 . . . . 0.0 109.277 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.582 HD21 HD23 ' A' ' 81' ' ' LEU . 92.3 mt -82.6 136.04 34.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.393 -0.817 . . . . 0.0 110.083 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.3 p -126.16 160.79 29.24 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.418 ' HB2' ' NE ' ' A' ' 98' ' ' ARG . 26.5 m120 55.59 50.8 13.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.455 -0.778 . . . . 0.0 109.666 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.2 mt -78.33 131.53 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.997 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.2 mm -117.94 118.68 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.374 -0.829 . . . . 0.0 109.258 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 93.8 mtp -124.98 110.65 14.47 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.276 -0.89 . . . . 0.0 109.883 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -114.07 101.13 8.94 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.364 -0.835 . . . . 0.0 108.907 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.458 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 74.2 m80 -71.04 -36.74 72.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.079 -1.013 . . . . 0.0 110.677 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -60.14 -45.78 91.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.998 -1.064 . . . . 0.0 109.66 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -88.61 -5.23 58.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.161 -0.962 . . . . 0.0 109.152 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.3 m-20 54.72 48.28 20.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.573 -0.704 . . . . 0.0 110.338 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.603 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 2.9 t -132.38 137.04 47.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.013 -1.055 . . . . 0.0 109.313 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.563 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 47.1 m-85 -125.2 138.34 54.13 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.338 -0.851 . . . . 0.0 109.735 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TYR . . . . . 0.603 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 81.3 m-85 -136.07 146.19 46.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.217 -0.927 . . . . 0.0 109.154 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 83.8 p -154.96 155.91 35.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.932 . . . . 0.0 109.015 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.614 ' CB ' HH11 ' A' ' 98' ' ' ARG . 0.0 OUTLIER -107.81 139.56 42.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.162 -0.961 . . . . 0.0 109.934 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 100' ' ' PRO . 94.6 mt -96.6 142.31 24.36 Favored Pre-proline 0 C--N 1.297 -1.685 0 O-C-N 121.65 -0.656 . . . . 0.0 109.756 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.838 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 76.4 Cg_exo -45.56 177.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.779 1.653 . . . . 0.0 111.263 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 96.9 p -85.32 -9.23 57.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.022 -1.049 . . . . 0.0 109.747 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.2 tp -139.0 130.66 27.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.229 -0.919 . . . . 0.0 110.778 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.2 mt -147.37 102.57 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.225 -0.922 . . . . 0.0 108.885 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 97.1 p -100.0 -3.05 32.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.056 -1.027 . . . . 0.0 109.819 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 127' ' ' ALA . 84.4 m-20 -82.11 151.05 27.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.853 . . . . 0.0 110.165 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -99.22 31.34 3.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.525 -0.734 . . . . 0.0 109.126 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.431 ' CH2' HD22 ' A' ' 81' ' ' LEU . 18.8 p-90 -66.59 159.95 26.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 110.627 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -144.24 158.83 43.51 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PHE . . . . . 0.539 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 25.5 p90 -152.13 161.96 41.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.942 -1.098 . . . . 0.0 108.655 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.521 ' N ' ' CD1' ' A' ' 110' ' ' PHE . 7.3 p90 -152.56 158.48 42.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.794 -1.191 . . . . 0.0 111.746 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 84.9 m -124.74 156.55 37.49 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.588 HG22 HG22 ' A' ' 122' ' ' VAL . 44.4 t -129.73 140.51 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.893 -1.129 . . . . 0.0 111.829 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 72.2 m -124.16 133.18 53.63 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.2 p -169.56 178.25 4.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.27 -1.518 . . . . 0.0 111.647 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.546 ' NZ ' ' OE2' ' A' ' 118' ' ' GLU . 6.1 mtmp? -153.59 163.29 40.23 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 178.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 117' ' ' ASN . 99.3 m-20 -58.22 153.22 15.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.851 -1.156 . . . . 0.0 109.109 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.506 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 66.7 t30 44.04 59.4 3.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.167 -0.958 . . . . 0.0 109.555 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.546 ' OE2' ' NZ ' ' A' ' 115' ' ' LYS . 41.6 mt-10 -165.23 145.96 7.24 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.189 -0.944 . . . . 0.0 110.164 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.2 134.07 52.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.115 -0.991 . . . . 0.0 109.003 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -83.37 147.86 27.65 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.038 -1.039 . . . . 0.0 110.337 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.6 mt -111.04 124.45 52.2 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.588 HG22 HG22 ' A' ' 112' ' ' VAL . 42.2 t -108.83 130.22 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.998 -1.064 . . . . 0.0 110.388 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -109.52 121.23 44.74 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.42 ' O ' ' O ' ' A' ' 38' ' ' CYS . 5.3 t -137.33 142.89 41.83 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.468 1.127 . . . . 0.0 112.323 -178.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.553 HG12 ' CG2' ' A' ' 40' ' ' VAL . 3.1 m -138.39 158.7 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.546 ' CD ' ' N ' ' A' ' 127' ' ' ALA . 12.4 tm-20 -134.34 155.7 49.79 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.185 -0.947 . . . . 0.0 110.317 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.546 ' N ' ' CD ' ' A' ' 126' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.386 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 70.4 t -98.22 130.78 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.333 -0.854 . . . . 0.0 109.871 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -71.07 121.94 19.16 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.201 -0.937 . . . . 0.0 108.483 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.2 164.86 31.04 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.403 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 7.2 t -105.71 133.34 50.61 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.396 -1.061 . . . . 0.0 109.862 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.512 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 39.8 t0 -110.92 109.39 19.52 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.211 -0.931 . . . . 0.0 109.462 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.426 ' CG ' HD13 ' A' ' 121' ' ' LEU . 84.2 m-85 -87.0 3.75 44.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.135 -0.978 . . . . 0.0 108.872 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.4 m -109.83 -16.61 13.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.473 -0.767 . . . . 0.0 110.623 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.5 m -151.14 117.24 5.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.804 -1.185 . . . . 0.0 110.186 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.7 m -59.93 -32.22 70.57 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -111.49 75.48 0.92 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.512 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 1.3 m -74.18 115.11 13.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.354 -0.842 . . . . 0.0 110.365 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.9 t -67.75 3.25 1.51 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.478 ' H ' ' C ' ' A' ' 13' ' ' SER . 8.0 pt -124.02 -40.8 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.473 -0.767 . . . . 0.0 110.184 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.445 ' CE2' HD12 ' A' ' 15' ' ' ILE . 85.4 m-85 -100.32 142.08 32.28 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.919 -1.113 . . . . 0.0 109.806 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.6 t -72.24 -23.79 61.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.414 -0.804 . . . . 0.0 110.915 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -119.2 129.78 55.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.715 -1.24 . . . . 0.0 110.417 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -141.41 154.73 24.82 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.403 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 33.0 m-85 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.252 -1.146 . . . . 0.0 109.575 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.2 mm . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.515 HG22 ' HB ' ' A' ' 122' ' ' VAL . 49.0 t -119.3 129.42 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.062 -1.024 . . . . 0.0 110.25 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 74.4 m -102.77 101.91 12.02 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.0 m -94.12 120.63 34.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -0.958 . . . . 0.0 109.722 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.59 HG22 HG12 ' A' ' 125' ' ' VAL . 3.1 m -138.58 158.58 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.42 -0.8 . . . . 0.0 109.041 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -100.85 122.45 43.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -0.895 . . . . 0.0 109.509 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.49 164.41 13.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -0.847 . . . . 0.0 109.546 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.436 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 26.0 t60 -138.1 153.07 49.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 0.0 109.715 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 100' ' ' PRO . . . -54.63 -26.29 32.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 0.0 109.783 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -100.99 -24.77 14.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.148 -0.97 . . . . 0.0 109.572 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 98.0 m-20 -72.77 138.5 46.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.827 . . . . 0.0 109.893 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.538 HD22 ' CZ ' ' A' ' 98' ' ' ARG . 98.3 mt -80.31 144.88 32.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 108.741 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.9 pt -122.12 143.85 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.927 -1.108 . . . . 0.0 110.014 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.04 -175.82 47.69 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.464 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 50.2 p90 -167.71 169.49 11.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.024 -1.28 . . . . 0.0 109.751 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -148.43 146.38 28.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.955 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 63.1 m -126.33 152.21 73.52 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.21 153.93 8.75 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.449 2.099 . . . . 0.0 111.923 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.8 p -72.64 -10.99 60.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.709 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.514 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 80.8 m-20 -92.02 -3.31 55.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.937 -1.102 . . . . 0.0 110.083 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.476 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 15.8 m-85 -106.61 161.44 14.63 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.9 -1.125 . . . . 0.0 110.168 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.424 ' HG ' ' HZ3' ' A' ' 115' ' ' LYS . 7.1 m -99.89 138.39 37.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.363 -0.835 . . . . 0.0 109.389 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.8 m -94.38 117.08 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.977 -1.077 . . . . 0.0 110.454 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -126.18 127.67 24.61 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.97 111.11 3.03 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.614 1.543 . . . . 0.0 112.224 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -90.96 -26.99 18.99 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.461 ' HB3' ' H ' ' A' ' 110' ' ' PHE . 68.3 t0 -166.37 42.22 0.06 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.594 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 84.5 m -67.74 -157.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 109.836 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.9 p90 -112.16 -49.53 2.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.874 -1.141 . . . . 0.0 111.425 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 55.7 t -58.41 -48.75 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.495 -1.378 . . . . 0.0 108.922 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.1 t -156.84 128.94 7.32 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.594 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.62 -178.16 1.57 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.872 -1.142 . . . . 0.0 110.475 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 9.2 m-85 -94.14 127.54 40.03 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -70.16 -175.77 1.03 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.964 -1.085 . . . . 0.0 109.879 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.8 mt -61.95 -24.35 66.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.337 -0.852 . . . . 0.0 108.968 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 67.1 m -82.43 -5.07 58.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.316 -0.865 . . . . 0.0 108.804 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.41 19.03 65.13 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -100.23 141.41 33.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -1.136 . . . . 0.0 109.145 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -82.69 110.35 17.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.149 -0.969 . . . . 0.0 110.016 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -146.1 140.95 27.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.328 -0.857 . . . . 0.0 109.56 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -61.25 145.92 49.61 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.3 tp -96.61 5.89 49.83 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.175 -0.953 . . . . 0.0 109.892 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.463 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.3 OUTLIER -70.73 -41.66 71.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.1 -1.0 . . . . 0.0 109.789 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.415 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 41.0 t30 -59.8 -27.22 66.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.146 -0.971 . . . . 0.0 109.037 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -82.15 -45.46 15.1 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.246 -0.909 . . . . 0.0 109.353 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.548 HD22 ' CZ2' ' A' ' 107' ' ' TRP . 51.0 tp -139.13 133.64 31.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.431 -0.793 . . . . 0.0 109.187 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.65 86.09 7.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.079 -1.013 . . . . 0.0 109.433 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.432 HD21 HD23 ' A' ' 81' ' ' LEU . 96.4 mt -73.37 148.33 43.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.898 . . . . 0.0 109.842 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.1 p -127.29 162.74 25.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.409 -0.807 . . . . 0.0 109.391 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 54.32 51.88 13.51 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.062 -1.023 . . . . 0.0 109.529 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -80.2 131.07 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.353 -0.842 . . . . 0.0 110.093 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.8 mm -123.87 122.42 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.434 -0.791 . . . . 0.0 109.238 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 87.9 mtp -123.48 107.79 11.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.953 -1.092 . . . . 0.0 110.019 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -114.7 101.49 9.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.21 -0.931 . . . . 0.0 108.983 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.469 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 95.9 m-70 -73.27 -34.69 65.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.052 -1.03 . . . . 0.0 110.645 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -60.34 -45.7 92.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.896 -1.127 . . . . 0.0 109.61 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -89.43 -4.71 57.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.087 -1.008 . . . . 0.0 109.053 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 96.7 m-20 55.39 47.8 20.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 110.151 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.573 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.3 t -132.33 136.45 46.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.98 -1.075 . . . . 0.0 109.516 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.464 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 79.3 m-85 -126.29 139.53 53.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.019 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.573 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 80.1 m-85 -135.03 146.45 49.0 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.199 -0.938 . . . . 0.0 109.434 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.586 ' C ' ' HE ' ' A' ' 98' ' ' ARG . 39.7 t -145.74 144.95 30.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.095 -1.003 . . . . 0.0 109.212 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.586 ' HE ' ' C ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -100.46 128.75 46.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.072 -1.017 . . . . 0.0 109.435 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.523 ' O ' ' O ' ' A' ' 100' ' ' PRO . 94.8 mt -89.86 138.27 27.91 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.25 -0.906 . . . . 0.0 109.636 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 99' ' ' LEU . 75.7 Cg_exo -46.17 -177.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.896 1.731 . . . . 0.0 110.984 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 95.3 p -90.45 -8.35 50.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.968 -1.082 . . . . 0.0 109.748 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.7 tp -135.49 129.76 33.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.125 -0.984 . . . . 0.0 110.445 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.1 mt -150.92 108.3 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.367 -0.833 . . . . 0.0 108.838 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 99.8 p -110.41 0.11 17.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.124 -0.985 . . . . 0.0 109.678 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 127' ' ' ALA . 73.7 m-20 -82.57 152.79 25.81 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.062 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -99.15 32.5 2.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.375 -0.828 . . . . 0.0 109.082 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.548 ' CZ2' HD22 ' A' ' 81' ' ' LEU . 17.7 p-90 -65.88 151.09 47.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 110.553 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -134.91 156.3 49.2 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.627 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 36.9 p90 -156.06 158.13 37.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.079 -1.013 . . . . 0.0 108.954 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.461 ' H ' ' HB3' ' A' ' 62' ' ' ASP . 17.5 p90 -151.83 156.27 39.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.756 -1.215 . . . . 0.0 111.588 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 90.7 m -121.38 158.51 28.14 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 76.7 t -132.8 150.15 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.612 -1.305 . . . . 0.0 111.684 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.5 m -127.88 134.12 49.37 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.8 p -167.58 176.83 6.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.336 -1.478 . . . . 0.0 111.743 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.514 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 50.0 mttm -155.86 168.35 27.48 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 117' ' ' ASN . 90.8 m-20 -57.67 148.29 24.98 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.917 -1.114 . . . . 0.0 109.331 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.487 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 65.9 t30 40.9 60.93 1.84 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.264 -0.897 . . . . 0.0 109.771 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 48.9 mm-40 -157.31 136.67 12.01 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.978 -1.076 . . . . 0.0 110.187 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -56.33 133.44 52.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.262 -0.899 . . . . 0.0 109.019 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 120' ' ' LYS . 23.6 pttm -85.28 143.28 28.8 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.114 -0.991 . . . . 0.0 110.404 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.426 HD13 ' CG ' ' A' ' 8' ' ' PHE . 68.4 mt -111.33 124.33 52.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.446 -0.784 . . . . 0.0 109.154 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.515 ' HB ' HG22 ' A' ' 37' ' ' VAL . 46.4 t -109.45 130.98 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.986 -1.071 . . . . 0.0 110.711 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -109.98 120.62 43.04 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.4 t -137.05 143.95 42.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.475 -1.391 . . . . 0.0 112.008 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.627 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 2.9 m -136.53 159.94 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -134.31 150.11 50.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.836 -1.165 . . . . 0.0 110.13 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.338 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.6 t -88.16 136.39 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.372 -0.83 . . . . 0.0 110.36 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -68.84 125.22 25.92 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.054 -1.029 . . . . 0.0 108.615 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.81 179.11 45.18 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -118.56 132.4 56.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.619 -0.93 . . . . 0.0 109.369 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.483 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 36.0 t0 -109.07 109.07 19.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.542 -0.724 . . . . 0.0 109.272 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.458 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 78.0 m-85 -88.76 -0.54 57.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.171 -0.956 . . . . 0.0 108.912 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.0 m -98.55 -18.18 18.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.468 -0.77 . . . . 0.0 110.537 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.612 HG22 ' H ' ' A' ' 12' ' ' GLU . 65.0 m -158.2 127.07 5.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.836 -1.165 . . . . 0.0 110.361 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.1 p -64.59 -26.6 68.47 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.611 -0.836 . . . . 0.0 108.985 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.612 ' H ' HG22 ' A' ' 10' ' ' THR . 78.9 mm-40 -113.04 73.89 0.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.501 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 95.0 p -69.67 151.39 45.94 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.226 -0.921 . . . . 0.0 110.159 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 t -101.25 0.85 38.14 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 pt -124.76 -20.86 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.672 -0.643 . . . . 0.0 110.496 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.501 ' O ' ' OG ' ' A' ' 13' ' ' SER . 57.4 m-85 -115.93 144.52 43.94 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.401 -0.812 . . . . 0.0 110.325 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.0 m -72.28 -17.58 61.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.502 -0.749 . . . . 0.0 110.542 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -135.0 145.53 48.18 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.96 -1.088 . . . . 0.0 110.762 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.483 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -159.53 173.37 36.29 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.394 -1.062 . . . . 0.0 109.614 -179.845 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.9 mm . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.533 HG22 ' HB ' ' A' ' 122' ' ' VAL . 47.2 t -120.78 130.21 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.411 -0.806 . . . . 0.0 110.42 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.458 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 89.6 m -101.05 100.67 11.29 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 58.5 m -96.06 120.73 36.86 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.182 -0.949 . . . . 0.0 109.513 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.2 m -141.66 153.51 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.492 -0.755 . . . . 0.0 109.306 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -94.03 132.75 38.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.005 -1.059 . . . . 0.0 109.149 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.437 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -102.02 146.78 27.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.22 -0.925 . . . . 0.0 109.626 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.475 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 21.0 t-80 -116.43 150.73 37.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.429 -0.794 . . . . 0.0 109.507 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.667 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -55.99 -25.38 43.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.415 -0.803 . . . . 0.0 109.883 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.554 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 30.5 p30 -98.22 -22.99 15.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 109.684 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.554 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 82.2 m-20 -76.4 136.78 39.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.449 -0.782 . . . . 0.0 110.165 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.47 146.5 38.48 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.492 HD13 HD21 ' A' ' 99' ' ' LEU . 38.3 pt -120.4 141.89 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.113 -0.992 . . . . 0.0 110.307 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.93 -173.75 46.25 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -170.18 169.55 7.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.11 -1.229 . . . . 0.0 109.685 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -144.74 143.64 30.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.235 -0.916 . . . . 0.0 110.015 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 90.1 m -124.0 151.87 65.83 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.432 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.74 147.53 24.34 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.337 2.025 . . . . 0.0 111.976 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.1 m -70.6 -12.1 61.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.424 -0.798 . . . . 0.0 110.545 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.608 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.8 m-20 -91.6 0.49 57.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.051 -1.031 . . . . 0.0 110.084 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.4 m-85 -109.86 165.73 11.48 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.124 -0.985 . . . . 0.0 110.353 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -103.65 130.76 51.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.34 -0.85 . . . . 0.0 109.05 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.8 m -89.5 118.74 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.004 -1.06 . . . . 0.0 110.104 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -124.73 126.78 25.31 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.13 114.57 3.6 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.777 1.651 . . . . 0.0 112.051 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.491 ' O ' ' O ' ' A' ' 68' ' ' PHE . 17.0 t-80 -93.56 -24.0 18.11 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.8 t0 -170.19 40.59 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.485 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 89.9 m -64.28 -154.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.422 -0.799 . . . . 0.0 109.887 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.6 p90 -109.29 -58.69 2.0 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.155 -0.966 . . . . 0.0 111.483 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 64' ' ' PHE . 31.2 t -46.05 -70.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.58 -1.325 . . . . 0.0 108.804 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.2 t -141.38 132.45 26.23 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.485 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -170.97 175.86 4.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.97 -1.081 . . . . 0.0 110.464 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.1 m-85 -92.39 142.36 27.53 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -83.26 -170.86 3.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.879 -1.138 . . . . 0.0 109.895 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 70' ' ' LEU . 10.3 mp -66.56 -15.03 63.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.325 -0.86 . . . . 0.0 108.98 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 65.7 m -86.55 -8.61 57.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.38 -0.825 . . . . 0.0 108.806 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.93 20.07 64.01 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -106.73 139.84 40.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.318 -1.107 . . . . 0.0 109.246 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -66.78 125.68 26.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.28 -0.888 . . . . 0.0 109.844 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -145.47 165.26 29.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.408 -0.808 . . . . 0.0 109.644 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.442 ' ND2' ' CD ' ' A' ' 78' ' ' GLU . 37.8 t-20 -105.96 136.94 44.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.337 -0.852 . . . . 0.0 109.472 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 tp -93.26 -8.28 42.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 0.0 110.194 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.488 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 20.7 pt-20 -58.94 -46.63 87.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.044 -1.035 . . . . 0.0 109.523 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.488 ' N ' ' CG ' ' A' ' 78' ' ' GLU . 92.5 m-20 -64.87 -34.52 78.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 108.972 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -69.24 -52.41 27.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.499 -0.751 . . . . 0.0 109.61 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.565 HD23 HD21 ' A' ' 83' ' ' LEU . 31.5 tp -129.13 126.51 39.45 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -76.63 108.54 9.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.015 -1.053 . . . . 0.0 109.018 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.565 HD21 HD23 ' A' ' 81' ' ' LEU . 95.3 mt -105.18 137.86 42.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 110.088 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.9 p -124.46 162.69 23.4 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.493 -0.754 . . . . 0.0 109.287 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.6 ' O ' ' NH1' ' A' ' 98' ' ' ARG . 98.9 m-20 55.0 51.46 13.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.573 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -78.92 130.62 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.185 -0.947 . . . . 0.0 110.152 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.5 mm -120.19 119.79 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.482 -0.761 . . . . 0.0 109.225 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 78.8 mtp -124.56 109.59 13.41 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.295 -0.878 . . . . 0.0 109.835 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -111.73 100.74 9.18 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.38 -0.825 . . . . 0.0 108.938 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.486 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 97.1 m-70 -71.76 -36.48 70.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.859 -1.15 . . . . 0.0 110.632 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -61.13 -46.76 89.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.963 -1.085 . . . . 0.0 109.556 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -87.17 -4.96 59.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.07 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.4 m-20 54.93 47.32 22.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.556 -0.715 . . . . 0.0 110.209 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.592 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 3.3 t -133.84 139.73 46.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.03 -1.043 . . . . 0.0 109.325 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 49.5 m-85 -128.52 140.14 51.96 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.429 -0.794 . . . . 0.0 109.982 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.592 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 67.2 m-85 -138.23 148.7 45.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.289 -0.882 . . . . 0.0 109.16 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.703 ' N ' ' NH2' ' A' ' 98' ' ' ARG . 57.6 m -157.3 159.4 37.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.099 -1.001 . . . . 0.0 109.336 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.703 ' NH2' ' N ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -103.59 139.72 38.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.236 -0.915 . . . . 0.0 109.679 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.492 HD21 HD13 ' A' ' 48' ' ' ILE . 47.4 mt -91.98 138.54 24.64 Favored Pre-proline 0 C--N 1.304 -1.396 0 O-C-N 121.619 -0.676 . . . . 0.0 109.597 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.667 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 75.7 Cg_exo -46.93 158.28 0.44 Allowed 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.734 1.622 . . . . 0.0 111.265 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.6 t -69.6 -17.98 63.58 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.179 -0.95 . . . . 0.0 109.916 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 102' ' ' LEU . 44.9 tp -125.41 129.32 49.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.258 -0.901 . . . . 0.0 110.639 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 83.1 mt -149.29 102.86 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.3 m -113.25 3.1 15.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.352 -0.842 . . . . 0.0 109.834 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 53.2 t0 -89.28 155.28 19.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.976 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.584 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 98.9 m-20 -96.54 34.15 1.69 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.417 -0.802 . . . . 0.0 108.914 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.468 ' CZ3' ' CD1' ' A' ' 109' ' ' PHE . 13.0 p-90 -62.69 154.06 30.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.165 -0.959 . . . . 0.0 110.42 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.603 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 21.2 tttp -141.07 149.13 41.24 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.641 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 29.2 p90 -155.09 163.31 40.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.188 -0.945 . . . . 0.0 108.731 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 10.7 p90 -154.84 160.06 40.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.86 -1.15 . . . . 0.0 111.872 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 75.1 m -122.92 155.43 36.73 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 122' ' ' VAL . 44.4 t -128.78 139.05 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.848 -1.158 . . . . 0.0 111.933 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 96.4 m -122.9 131.94 53.96 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 62.9 p -171.54 178.7 3.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.306 -1.496 . . . . 0.0 111.608 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.608 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 50.6 mtmt -150.7 163.62 38.1 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 55.4 p-10 -59.44 154.27 17.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.907 -1.121 . . . . 0.0 109.114 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.511 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 64.7 t30 44.26 59.69 3.13 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.211 -0.931 . . . . 0.0 109.642 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 38.8 mt-10 -165.28 146.19 7.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.256 -0.902 . . . . 0.0 110.154 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -58.03 142.16 47.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 109.193 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -88.95 140.09 29.79 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.077 -1.015 . . . . 0.0 110.414 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 86.6 mt -108.89 120.8 43.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.417 -0.802 . . . . 0.0 108.965 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 112' ' ' VAL . 48.6 t -109.36 130.1 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.049 -1.032 . . . . 0.0 110.54 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -107.81 118.62 37.23 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.603 ' OG1' ' NZ ' ' A' ' 108' ' ' LYS . 7.3 t -136.94 141.88 42.65 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.918 -1.114 . . . . 0.0 112.3 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.3 m -134.55 158.48 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -132.31 152.66 51.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.229 -0.919 . . . . 0.0 110.278 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.333 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.2 t -96.55 133.17 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 109.795 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.8 mmtp -69.86 122.11 18.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.126 -0.984 . . . . 0.0 108.706 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.3 176.41 46.22 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.543 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 4.7 t -116.28 128.54 55.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.471 -1.017 . . . . 0.0 109.296 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.452 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 54.4 t0 -103.45 111.18 23.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.59 -0.694 . . . . 0.0 109.375 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -91.59 -0.88 57.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.186 -0.947 . . . . 0.0 108.826 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.5 m -103.72 -16.67 15.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.486 -0.759 . . . . 0.0 110.632 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 12' ' ' GLU . 23.3 m -156.35 125.02 5.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.883 -1.136 . . . . 0.0 110.278 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.505 ' OG ' ' OE1' ' A' ' 12' ' ' GLU . 74.0 p -65.47 -26.36 67.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.184 -0.948 . . . . 0.0 108.981 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.516 ' H ' HG22 ' A' ' 10' ' ' THR . 55.5 mp0 -113.67 72.96 0.8 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.2 t -67.7 150.62 48.46 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.134 -0.979 . . . . 0.0 110.352 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.77 0.6 41.99 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.411 HD12 ' OH ' ' A' ' 96' ' ' TYR . 24.2 pt -125.04 -27.19 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.749 -0.594 . . . . 0.0 110.199 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -110.27 133.74 52.95 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.041 -1.037 . . . . 0.0 109.87 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.9 t -67.95 -18.53 64.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.641 -0.662 . . . . 0.0 110.858 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -125.09 136.73 53.94 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.027 -1.046 . . . . 0.0 110.67 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.452 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -146.86 158.81 27.84 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.543 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 21.4 m-85 . . . . . 0 N--CA 1.495 1.795 0 O-C-N 121.323 -1.104 . . . . 0.0 109.589 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.449 ' O ' ' N ' ' A' ' 122' ' ' VAL . 20.8 mm . . . . . 0 N--CA 1.492 1.635 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 79.5 t -115.68 127.85 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.114 -0.991 . . . . 0.0 110.604 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.505 ' O ' ' O ' ' A' ' 124' ' ' THR . 66.8 m -102.07 101.49 11.86 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.1 m -92.46 119.53 32.05 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.822 -1.174 . . . . 0.0 109.848 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.558 ' CG2' HG12 ' A' ' 125' ' ' VAL . 19.8 m -136.23 155.76 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -99.03 121.88 41.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 109.504 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.86 163.56 13.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.574 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.474 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 37.1 t60 -136.64 155.61 49.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.203 -0.936 . . . . 0.0 109.656 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -55.24 -26.47 39.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.325 -0.86 . . . . 0.0 109.711 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -101.46 -22.44 14.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.166 -0.959 . . . . 0.0 109.632 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.474 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 85.8 m-20 -75.08 137.49 41.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.419 -0.8 . . . . 0.0 109.942 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.8 mt -80.73 147.46 30.55 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.407 HG21 HD11 ' A' ' 99' ' ' LEU . 43.7 pt -122.12 144.26 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.144 -0.972 . . . . 0.0 110.294 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.9 -173.06 45.7 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.474 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 50.5 p90 -169.68 168.81 8.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.056 -1.261 . . . . 0.0 109.725 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -143.42 142.6 31.29 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.319 -0.863 . . . . 0.0 109.636 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 61.4 m -123.77 152.31 65.66 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 108.662 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.467 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.3 Cg_endo -51.7 150.98 15.71 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.431 2.087 . . . . 0.0 111.905 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.1 m -71.32 -13.2 61.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.459 -0.775 . . . . 0.0 110.726 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.491 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 80.2 m-20 -91.04 -1.04 57.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.867 -1.146 . . . . 0.0 110.214 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.467 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 16.5 m-85 -107.67 162.49 13.92 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.514 -0.741 . . . . 0.0 110.099 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.432 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 6.2 t -102.91 134.04 47.0 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.333 -0.855 . . . . 0.0 109.334 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 58' ' ' VAL . 3.5 m -90.45 115.25 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.092 -1.005 . . . . 0.0 110.389 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.492 ' N ' ' OE1' ' A' ' 59' ' ' GLU . 15.8 mp0 -121.24 126.56 26.52 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.08 112.71 3.29 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.617 1.545 . . . . 0.0 112.265 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -94.05 -25.24 17.28 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.7 t0 -168.34 39.51 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 80.5 m -65.08 -153.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.579 -0.701 . . . . 0.0 109.729 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.9 p90 -111.26 -59.15 2.01 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.179 -0.95 . . . . 0.0 111.347 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.449 ' C ' ' O ' ' A' ' 64' ' ' PHE . 24.1 t -45.72 -73.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.682 -1.261 . . . . 0.0 108.757 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.436 ' N ' HG12 ' A' ' 65' ' ' VAL . 33.3 t -136.44 132.61 35.65 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -173.71 -178.67 1.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.908 -1.12 . . . . 0.0 110.446 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 7.6 m-85 -93.07 124.21 36.88 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -69.74 -175.03 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.07 -1.019 . . . . 0.0 109.869 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.8 mt -62.3 -23.66 66.86 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.29 -0.881 . . . . 0.0 108.905 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.6 p -81.92 -7.17 59.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 108.819 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.64 15.63 70.35 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -95.75 138.51 33.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.394 -1.062 . . . . 0.0 109.137 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -81.91 108.35 15.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.249 -0.907 . . . . 0.0 110.143 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -145.35 143.58 30.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 110.063 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.0 m-20 -64.54 149.59 48.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.913 -1.117 . . . . 0.0 109.512 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.63 HD11 ' HD3' ' A' ' 80' ' ' LYS . 13.9 tp -99.22 6.7 46.24 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.465 -0.772 . . . . 0.0 109.941 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 79' ' ' ASN . 17.8 pt-20 -69.38 -41.06 76.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.13 -0.981 . . . . 0.0 109.923 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 48.4 p-10 -62.58 -26.08 68.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.197 -0.939 . . . . 0.0 109.071 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.63 ' HD3' HD11 ' A' ' 77' ' ' LEU . 88.0 tttt -84.79 -46.29 11.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.45 -0.781 . . . . 0.0 109.442 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.606 HD23 HD21 ' A' ' 83' ' ' LEU . 41.0 tp -131.64 127.35 36.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.405 -0.809 . . . . 0.0 109.234 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -83.29 83.77 7.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.066 -1.021 . . . . 0.0 109.297 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.606 HD21 HD23 ' A' ' 81' ' ' LEU . 95.9 mt -75.73 146.71 39.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.888 . . . . 0.0 110.121 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.3 p -127.94 160.61 31.33 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.606 -0.684 . . . . 0.0 109.318 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.716 HD22 ' HE ' ' A' ' 98' ' ' ARG . 96.8 m-20 54.72 50.78 15.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.278 -0.889 . . . . 0.0 109.546 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.2 mt -77.61 128.54 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 109.879 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.0 mm -118.92 119.19 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.489 -0.757 . . . . 0.0 109.229 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 85.4 mtp -123.44 108.03 12.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.214 -0.929 . . . . 0.0 109.806 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -114.19 101.75 9.49 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.411 -0.806 . . . . 0.0 108.873 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.472 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 95.4 m-70 -71.63 -36.22 70.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.995 -1.066 . . . . 0.0 110.592 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -60.91 -45.15 95.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.974 -1.079 . . . . 0.0 109.462 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -88.89 -5.21 58.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.953 . . . . 0.0 109.07 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.7 m-20 54.4 47.95 21.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.49 -0.756 . . . . 0.0 110.139 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.608 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 2.6 t -132.37 137.16 47.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.987 -1.071 . . . . 0.0 109.606 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.474 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 79.4 m-85 -126.68 138.88 53.47 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.402 -0.811 . . . . 0.0 109.977 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.608 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 71.4 m-85 -135.61 146.1 47.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.239 -0.913 . . . . 0.0 109.437 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.521 ' OG ' HD22 ' A' ' 83' ' ' LEU . 35.5 t -150.87 150.99 31.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.959 . . . . 0.0 109.242 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.716 ' HE ' HD22 ' A' ' 85' ' ' ASN . 60.3 mtt-85 -101.29 133.1 46.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.16 -0.962 . . . . 0.0 109.434 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 99' ' ' LEU . 38.5 mt -91.54 137.9 25.59 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.461 -0.774 . . . . 0.0 109.789 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.542 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 77.5 Cg_exo -45.68 177.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.876 1.717 . . . . 0.0 111.163 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.483 ' C ' ' HB1' ' A' ' 44' ' ' ALA . 99.9 p -89.36 -9.87 48.76 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.113 -0.992 . . . . 0.0 109.847 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.7 tp -133.68 128.15 34.39 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.208 -0.932 . . . . 0.0 110.254 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.3 mt -150.12 106.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.945 . . . . 0.0 108.677 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 96.3 p -107.78 0.33 22.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.088 -1.007 . . . . 0.0 109.772 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 127' ' ' ALA . 82.6 m-20 -84.64 154.54 22.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.038 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -102.38 31.5 4.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.493 -0.754 . . . . 0.0 109.12 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.441 ' CH2' HD22 ' A' ' 81' ' ' LEU . 16.5 p-90 -66.68 160.07 26.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.205 -0.934 . . . . 0.0 110.507 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -142.0 159.05 43.01 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.553 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 20.9 p90 -154.04 162.66 41.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.929 -1.107 . . . . 0.0 108.661 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 7.3 p90 -153.59 160.4 42.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.67 -1.269 . . . . 0.0 111.836 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 94.7 m -124.83 156.68 37.43 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 122' ' ' VAL . 44.0 t -127.9 138.91 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.867 -1.145 . . . . 0.0 111.792 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.1 m -120.11 130.77 54.79 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.2 p -168.93 174.84 6.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.322 -1.486 . . . . 0.0 111.601 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.491 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 52.4 mttm -152.72 168.1 26.79 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 117' ' ' ASN . 90.1 m-20 -58.54 148.34 28.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.835 -1.166 . . . . 0.0 108.845 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 66.2 t30 43.86 60.67 2.6 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.26 -0.9 . . . . 0.0 109.395 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 58.2 mm-40 -158.01 137.44 11.88 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.19 -0.944 . . . . 0.0 110.455 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -54.77 131.57 44.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.083 -1.011 . . . . 0.0 108.962 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -79.81 139.25 37.28 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.21 -0.931 . . . . 0.0 110.249 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.6 mt -111.26 124.43 52.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.644 -0.66 . . . . 0.0 109.389 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 112' ' ' VAL . 39.2 t -110.39 132.04 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.979 -1.076 . . . . 0.0 110.71 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.419 ' O ' ' CB ' ' A' ' 110' ' ' PHE . 26.4 t80 -110.43 123.0 49.06 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.505 ' O ' ' O ' ' A' ' 38' ' ' CYS . 6.6 t -137.88 143.73 41.01 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.005 -1.059 . . . . 0.0 112.145 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.558 HG12 ' CG2' ' A' ' 40' ' ' VAL . 2.8 m -136.71 159.52 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -133.16 150.64 52.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.071 -1.018 . . . . 0.0 110.31 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.4 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.9 t -103.63 135.29 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.054 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -69.46 125.12 25.75 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.583 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.61 176.02 43.51 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -115.85 132.47 56.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.493 -1.004 . . . . 0.0 109.246 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.512 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 36.9 t0 -110.21 109.18 19.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.595 -0.691 . . . . 0.0 109.333 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -88.17 -1.17 57.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.298 -0.876 . . . . 0.0 108.982 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.5 m -100.93 -18.64 16.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.515 -0.741 . . . . 0.0 110.577 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 12' ' ' GLU . 25.7 m -156.19 125.06 5.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.878 -1.139 . . . . 0.0 110.367 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 t -65.99 -27.0 67.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.413 -0.804 . . . . 0.0 108.957 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 58.7 mp0 -112.92 73.98 0.84 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.496 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 12.5 m -70.78 152.85 43.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.875 . . . . 0.0 110.225 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.93 -0.04 40.28 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.7 pt -125.9 -22.28 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.71 -0.619 . . . . 0.0 110.25 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -113.05 140.28 47.98 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.255 -0.903 . . . . 0.0 110.133 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.9 m -73.43 -17.08 61.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.603 -0.686 . . . . 0.0 110.691 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -132.87 144.04 49.92 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.998 -1.064 . . . . 0.0 110.563 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.512 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -160.7 171.32 36.81 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.423 -1.045 . . . . 0.0 109.666 179.935 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.9 mm . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.438 HG22 ' HB ' ' A' ' 122' ' ' VAL . 54.9 t -121.44 126.86 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.392 -0.818 . . . . 0.0 110.009 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.3 m -102.45 102.16 12.43 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 75.8 m -98.78 122.37 41.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.076 -1.015 . . . . 0.0 109.397 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.513 ' CG2' HG12 ' A' ' 125' ' ' VAL . 24.1 m -140.96 155.22 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.562 -0.711 . . . . 0.0 109.257 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -96.12 132.5 41.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.084 -1.01 . . . . 0.0 109.405 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.76 160.45 14.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.405 -0.81 . . . . 0.0 109.591 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.489 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 34.8 t60 -133.0 153.81 51.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.245 -0.909 . . . . 0.0 109.55 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 100' ' ' PRO . . . -54.01 -25.28 20.34 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.384 -0.822 . . . . 0.0 109.788 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -101.53 -26.06 13.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.704 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.489 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 76.5 m-20 -71.67 132.02 43.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.336 -0.852 . . . . 0.0 110.069 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.636 HD22 HH11 ' A' ' 98' ' ' ARG . 11.3 mt -77.28 145.89 37.19 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.422 HG21 HD11 ' A' ' 99' ' ' LEU . 44.9 pt -123.11 145.85 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.766 0.793 . . . . 0.0 110.479 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.48 -173.98 46.58 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -169.54 170.01 8.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.095 -1.239 . . . . 0.0 109.697 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -147.71 145.4 28.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.9 . . . . 0.0 109.907 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 92.6 m -124.83 151.65 68.61 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.6 Cg_endo -51.7 150.1 17.65 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.334 2.023 . . . . 0.0 112.044 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 m -69.68 -11.74 61.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.398 -0.813 . . . . 0.0 110.528 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -90.94 -2.67 57.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.023 -1.048 . . . . 0.0 110.223 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.434 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.4 m-85 -109.17 164.28 12.59 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.219 -0.925 . . . . 0.0 110.426 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.7 t -105.96 133.93 49.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.448 -0.783 . . . . 0.0 108.919 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 58' ' ' VAL . 3.1 m -89.8 118.92 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.032 -1.043 . . . . 0.0 110.364 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 112' ' ' VAL . 10.0 mt-10 -123.1 126.67 25.91 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.14 114.11 3.51 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.66 1.573 . . . . 0.0 112.12 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.505 ' O ' ' O ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -93.63 -24.14 18.01 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 110' ' ' PHE . 66.9 t0 -169.9 43.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.478 ' H ' ' CB ' ' A' ' 67' ' ' ALA . 97.3 m -67.55 -153.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.748 . . . . 0.0 109.844 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.8 p90 -110.1 -57.88 2.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.141 -0.975 . . . . 0.0 111.455 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 64' ' ' PHE . 24.9 t -46.76 -71.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.601 -1.312 . . . . 0.0 108.863 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.8 t -140.91 131.3 25.18 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.478 ' CB ' ' H ' ' A' ' 63' ' ' CYS . . . -170.76 175.74 4.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.975 -1.078 . . . . 0.0 110.425 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 2.5 m-85 -92.86 140.67 29.26 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -81.81 -170.35 2.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.835 -1.165 . . . . 0.0 109.829 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 70' ' ' LEU . 10.0 mp -66.42 -15.31 63.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.305 -0.872 . . . . 0.0 109.087 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 69.5 m -86.6 -7.94 57.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 108.883 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.7 20.9 64.93 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -106.98 138.26 43.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.273 -1.134 . . . . 0.0 109.114 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -65.62 124.32 22.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.257 -0.902 . . . . 0.0 109.754 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -143.71 165.09 28.61 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.396 -0.815 . . . . 0.0 109.704 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -106.51 137.83 43.8 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.353 -0.842 . . . . 0.0 109.371 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.8 tp -95.39 -11.03 28.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.192 -0.942 . . . . 0.0 109.988 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.497 ' CD ' ' N ' ' A' ' 79' ' ' ASN . 2.3 pp20? -61.35 -43.82 98.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.978 -1.076 . . . . 0.0 109.557 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 49.1 p30 -64.17 -20.43 66.0 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.096 -1.003 . . . . 0.0 108.856 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.54 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 84.7 tttt -88.95 -43.97 10.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.0 109.67 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.437 HD23 HD21 ' A' ' 83' ' ' LEU . 45.0 tp -133.35 123.24 25.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.423 -0.798 . . . . 0.0 109.305 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -79.3 85.25 5.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.117 -0.989 . . . . 0.0 109.409 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.542 HD22 ' OG ' ' A' ' 97' ' ' SER . 92.7 mt -74.23 147.03 42.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.322 -0.861 . . . . 0.0 110.036 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 47.3 p -127.42 161.23 29.18 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.527 -0.733 . . . . 0.0 109.339 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 53.58 51.16 15.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.172 -0.955 . . . . 0.0 109.553 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.1 mt -79.05 130.61 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.075 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.7 mm -118.62 119.09 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.509 -0.744 . . . . 0.0 109.117 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 83.0 mtp -121.42 103.78 9.2 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.257 -0.902 . . . . 0.0 109.731 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -113.52 101.45 9.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.425 -0.797 . . . . 0.0 109.085 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -76.46 -32.89 58.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.03 -1.044 . . . . 0.0 110.471 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -59.45 -47.07 86.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.011 -1.055 . . . . 0.0 109.579 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -89.53 2.96 53.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.184 -0.947 . . . . 0.0 109.044 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 50.78 46.58 25.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.543 -0.723 . . . . 0.0 109.904 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.544 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.7 t -131.5 135.31 46.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.027 -1.046 . . . . 0.0 109.427 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -128.23 140.07 52.1 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.421 -0.799 . . . . 0.0 109.977 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.544 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 70.8 m-85 -135.68 147.25 48.46 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.167 -0.958 . . . . 0.0 109.319 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.542 ' OG ' HD22 ' A' ' 83' ' ' LEU . 45.8 t -146.11 143.48 29.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.116 -0.99 . . . . 0.0 109.115 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.636 HH11 HD22 ' A' ' 47' ' ' LEU . 21.4 mmt180 -99.35 133.15 44.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.235 -0.916 . . . . 0.0 109.355 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 100' ' ' PRO . 88.4 mt -92.0 139.08 24.39 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.486 -0.759 . . . . 0.0 109.763 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.481 ' O ' ' O ' ' A' ' 44' ' ' ALA . 77.7 Cg_exo -45.87 176.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.867 1.711 . . . . 0.0 111.118 178.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.447 ' C ' ' HB1' ' A' ' 44' ' ' ALA . 6.2 m -86.03 -11.91 51.63 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.195 -0.941 . . . . 0.0 109.772 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.4 tp -138.66 130.5 27.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.107 -0.996 . . . . 0.0 110.536 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.8 mt -141.78 123.6 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.303 -0.873 . . . . 0.0 108.651 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.488 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 12.9 t -119.87 50.5 1.27 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.221 -0.924 . . . . 0.0 109.781 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.489 ' O ' ' OXT' ' A' ' 127' ' ' ALA . 87.8 m-20 -144.26 153.16 41.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.975 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -101.92 33.47 3.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.363 -0.836 . . . . 0.0 109.266 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.419 ' HB2' ' NZ ' ' A' ' 80' ' ' LYS . 15.1 p-90 -64.64 157.05 28.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.096 -1.002 . . . . 0.0 110.332 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -138.15 150.28 46.65 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.615 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 30.0 p90 -153.55 164.58 37.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.969 . . . . 0.0 108.785 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 11.8 p90 -155.11 161.83 41.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.803 -1.186 . . . . 0.0 111.783 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 98.7 m -126.09 157.15 38.76 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 122' ' ' VAL . 49.8 t -129.67 141.07 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.88 -1.137 . . . . 0.0 111.738 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 46.8 m -121.89 131.98 54.32 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 93.7 p -170.88 178.88 3.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.297 -1.502 . . . . 0.0 111.57 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.586 ' NZ ' ' OE1' ' A' ' 118' ' ' GLU . 26.1 mtmm -154.34 164.92 37.86 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.49 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 50.1 p30 -58.87 152.75 18.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.842 -1.161 . . . . 0.0 109.173 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.504 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 53.4 t-20 44.5 59.66 3.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.282 -0.886 . . . . 0.0 109.567 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.586 ' OE1' ' NZ ' ' A' ' 115' ' ' LYS . 41.2 mt-10 -164.97 145.44 7.32 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.158 -0.964 . . . . 0.0 110.241 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -63.58 135.74 57.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.871 . . . . 0.0 108.729 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.591 ' HE2' ' H ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -84.3 146.43 27.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.075 -1.016 . . . . 0.0 110.42 -179.405 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 57.2 mt -111.58 124.23 51.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.184 -0.948 . . . . 0.0 109.287 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 112' ' ' VAL . 51.3 t -108.22 129.99 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.942 -1.099 . . . . 0.0 110.593 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -109.64 121.48 45.3 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.5 t -137.2 142.1 42.12 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.866 -1.146 . . . . 0.0 112.193 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.615 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.0 m -136.78 156.73 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -133.95 157.13 46.82 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.157 -0.965 . . . . 0.0 110.385 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.489 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.907 -1.044 . . . . 0.0 109.314 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.4 t -104.28 133.75 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.315 -0.866 . . . . 0.0 109.901 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -67.73 119.83 13.09 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.095 -1.003 . . . . 0.0 108.715 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.97 176.04 47.09 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.7 t -120.51 132.1 55.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.374 -1.074 . . . . 0.0 109.35 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.507 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 43.3 t0 -107.42 108.86 20.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.556 -0.715 . . . . 0.0 109.485 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -86.2 -0.92 56.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 108.929 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.3 m -101.81 -15.88 16.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.56 -0.712 . . . . 0.0 110.54 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 12' ' ' GLU . 5.9 m -158.54 127.67 5.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.883 -1.136 . . . . 0.0 110.258 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.514 ' OG ' ' OE1' ' A' ' 12' ' ' GLU . 64.6 p -68.16 -24.1 64.94 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.911 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 57.0 mp0 -114.58 74.05 0.86 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 23.5 p -71.33 153.87 42.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.464 -0.772 . . . . 0.0 110.241 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.46 0.82 37.45 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.1 pt -124.05 -25.65 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.628 -0.67 . . . . 0.0 110.219 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.48 ' O ' ' OG ' ' A' ' 13' ' ' SER . 71.4 m-85 -113.13 139.4 48.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.168 -0.957 . . . . 0.0 110.012 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.6 p -69.37 -16.46 63.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.719 . . . . 0.0 110.766 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -135.05 146.1 48.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.956 -1.09 . . . . 0.0 110.847 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.507 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -163.01 173.37 39.2 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 . . . . . 0 N--CA 1.494 1.765 0 O-C-N 121.41 -1.053 . . . . 0.0 109.564 -179.809 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.2 mm . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.6 t -117.86 126.5 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.362 -0.836 . . . . 0.0 110.383 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.427 ' O ' ' O ' ' A' ' 124' ' ' THR . 96.9 m -101.96 101.11 11.47 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.1 m -93.54 119.77 33.0 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.928 . . . . 0.0 109.624 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.592 ' CG2' HG12 ' A' ' 125' ' ' VAL . 14.6 m -139.88 139.48 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.498 -0.751 . . . . 0.0 109.238 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -82.22 127.41 33.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.117 -0.989 . . . . 0.0 109.301 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.01 154.79 17.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 109.45 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.439 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 45.8 t-80 -128.32 152.62 47.93 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.385 -0.822 . . . . 0.0 109.593 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.842 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -56.03 -25.61 45.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 109.766 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -97.14 -24.38 15.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 109.497 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 81.9 m-20 -77.35 136.86 38.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.465 -0.772 . . . . 0.0 109.888 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.1 mt -79.6 149.18 31.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.933 . . . . 0.0 108.595 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.471 HD13 HD21 ' A' ' 99' ' ' LEU . 22.1 pt -120.83 142.35 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.11 -0.994 . . . . 0.0 110.086 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.13 -173.27 45.79 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -172.79 172.12 4.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.081 -1.246 . . . . 0.0 109.864 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -146.02 144.55 30.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.271 -0.893 . . . . 0.0 109.861 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 47.1 m -125.24 153.99 71.88 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.127 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.452 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.66 146.96 25.3 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.647 2.232 . . . . 0.0 112.027 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.3 t -68.4 -13.16 62.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.462 -0.773 . . . . 0.0 110.71 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.47 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 80.0 m-20 -90.37 -0.61 57.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.942 -1.099 . . . . 0.0 110.213 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.452 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 18.8 m-85 -109.5 164.03 12.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.216 -0.928 . . . . 0.0 110.207 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.4 133.88 48.54 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.416 -0.802 . . . . 0.0 108.984 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 58' ' ' VAL . 3.2 m -91.47 112.95 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.994 -1.066 . . . . 0.0 110.508 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -121.42 129.53 25.19 Favored Pre-proline 0 N--CA 1.49 1.526 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.08 113.53 3.43 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.593 1.529 . . . . 0.0 112.243 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -88.96 -24.81 22.33 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.1 t0 -170.17 37.32 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.415 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 79.6 m -60.78 -154.05 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.628 -0.67 . . . . 0.0 109.696 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.1 p90 -110.14 -57.81 2.15 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.12 -0.987 . . . . 0.0 111.206 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.459 HG23 ' CE2' ' A' ' 64' ' ' PHE . 6.2 t -46.68 -72.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.385 -1.447 . . . . 0.0 108.965 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.7 t -137.65 133.2 34.02 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.415 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.27 -178.75 2.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.986 -1.071 . . . . 0.0 110.483 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 6.3 m-85 -93.13 128.46 39.06 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -71.76 -173.69 1.03 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.076 -1.015 . . . . 0.0 109.724 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.67 -19.69 65.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.099 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.5 p -84.09 -9.17 58.81 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.365 -0.835 . . . . 0.0 108.92 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.97 19.69 58.94 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -105.2 140.59 38.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.319 -1.106 . . . . 0.0 109.075 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -74.12 123.0 23.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 110.167 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -155.31 132.2 10.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.93 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -61.76 146.18 50.2 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.171 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.473 HD11 ' CE ' ' A' ' 80' ' ' LYS . 6.9 tp -100.47 6.05 44.28 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.229 -0.919 . . . . 0.0 109.669 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.452 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.3 OUTLIER -72.57 -38.57 67.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.883 -1.136 . . . . 0.0 110.072 -179.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.94 -15.91 25.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.163 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.473 ' CE ' HD11 ' A' ' 77' ' ' LEU . 29.2 ttpt -102.79 -35.2 8.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 109.312 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.433 HD22 ' CH2' ' A' ' 107' ' ' TRP . 41.7 tp -131.9 123.36 27.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -82.0 83.72 7.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.919 -1.113 . . . . 0.0 109.248 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.3 mt -76.86 140.99 40.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.061 -1.024 . . . . 0.0 110.144 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.4 p -128.32 158.07 39.23 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.509 -0.744 . . . . 0.0 109.303 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 54.74 50.14 16.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 0.0 109.656 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.7 mt -78.48 132.63 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 109.818 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.5 mm -116.02 118.3 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.43 -0.794 . . . . 0.0 109.386 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 41.7 mtp -124.72 109.8 13.57 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.146 -0.971 . . . . 0.0 109.804 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.68 101.85 9.71 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.365 -0.835 . . . . 0.0 108.839 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.485 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 52.1 m170 -70.02 -38.63 75.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.022 -1.049 . . . . 0.0 110.628 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -60.53 -45.39 94.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.971 -1.081 . . . . 0.0 109.513 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -86.19 -6.11 59.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 0.0 109.135 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.485 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.6 m-20 54.72 47.89 21.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.388 -0.82 . . . . 0.0 110.237 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.593 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 1.9 t -133.87 139.45 46.21 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.983 -1.073 . . . . 0.0 109.409 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -128.05 140.13 52.14 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.49 -0.756 . . . . 0.0 110.055 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.593 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 73.5 m-85 -136.32 146.64 46.82 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.261 -0.9 . . . . 0.0 109.249 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 64.0 m -149.6 151.66 34.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.072 -1.018 . . . . 0.0 109.223 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 -101.35 132.52 46.87 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.038 -1.039 . . . . 0.0 109.341 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.471 HD21 HD13 ' A' ' 48' ' ' ILE . 86.4 mt -90.51 137.45 27.34 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.379 -0.826 . . . . 0.0 109.599 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.842 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 76.7 Cg_exo -46.24 163.89 0.1 OUTLIER 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.816 1.678 . . . . 0.0 111.296 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 93.4 p -73.68 -12.1 60.62 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.089 -1.007 . . . . 0.0 109.65 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.9 tp -137.31 130.27 30.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.086 -1.009 . . . . 0.0 110.609 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.2 mt -145.01 102.34 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.3 m -97.11 -6.51 34.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 0.0 109.847 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -83.69 154.74 23.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.999 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -105.55 33.35 3.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.35 -0.844 . . . . 0.0 109.241 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.433 ' CH2' HD22 ' A' ' 81' ' ' LEU . 23.6 p-90 -65.31 153.54 40.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.142 -0.974 . . . . 0.0 110.505 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -132.45 154.38 49.93 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.641 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 33.4 p90 -152.69 159.34 43.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.113 -0.992 . . . . 0.0 108.666 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 4.2 p90 -150.7 159.05 44.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.779 -1.2 . . . . 0.0 111.742 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 88.9 m -123.22 155.66 36.68 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 122' ' ' VAL . 41.9 t -129.97 141.97 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.759 -1.213 . . . . 0.0 111.768 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 76.3 m -120.49 131.39 54.7 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.9 p -169.56 171.84 7.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.272 -1.518 . . . . 0.0 111.653 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.47 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 51.9 mttm -148.59 165.23 31.88 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 54.4 p-10 -57.62 150.48 19.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.854 -1.154 . . . . 0.0 109.067 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 116' ' ' ASP . 64.3 t30 42.71 60.62 2.36 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.203 -0.935 . . . . 0.0 109.763 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 44.6 mt-10 -161.74 141.8 10.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.221 -0.924 . . . . 0.0 110.305 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -54.58 147.07 14.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.161 -0.962 . . . . 0.0 108.953 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.424 ' H ' ' HG2' ' A' ' 120' ' ' LYS . 15.7 pttt -98.81 140.44 33.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.211 -0.93 . . . . 0.0 110.36 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.7 mt -111.27 124.51 52.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.567 -0.708 . . . . 0.0 109.251 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 112' ' ' VAL . 42.4 t -109.56 130.72 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.947 -1.095 . . . . 0.0 110.469 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -109.33 121.76 45.88 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 38' ' ' CYS . 7.2 t -136.97 141.81 42.6 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.927 -1.108 . . . . 0.0 112.123 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -135.74 159.1 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -123.58 142.91 50.58 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.129 -0.982 . . . . 0.0 110.389 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.319 179.748 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.6 mttp . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.0 t -86.2 135.78 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.915 . . . . 0.0 110.031 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -71.05 129.51 39.15 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.571 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 168.11 -163.25 37.0 Favored Glycine 0 N--CA 1.483 1.798 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.98 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -129.08 135.09 48.44 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.461 -1.023 . . . . 0.0 109.779 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.446 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 39.5 t0 -114.51 109.41 18.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.447 -0.783 . . . . 0.0 109.302 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -89.23 3.26 52.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.161 -0.962 . . . . 0.0 108.807 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.6 m -98.21 -20.7 17.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.409 -0.807 . . . . 0.0 110.586 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 12' ' ' GLU . 17.2 m -156.65 126.64 6.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.881 -1.137 . . . . 0.0 110.263 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 t -59.08 -31.88 69.29 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.459 ' H ' HG22 ' A' ' 10' ' ' THR . 97.1 mt-10 -112.64 73.89 0.84 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -66.62 148.57 51.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.34 -0.85 . . . . 0.0 110.29 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.6 t -98.35 0.55 45.67 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.6 pt -123.86 -20.73 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.658 -0.651 . . . . 0.0 110.243 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.448 ' CZ ' ' N ' ' A' ' 50' ' ' PHE . 56.6 m-85 -119.59 137.81 53.62 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.304 -0.872 . . . . 0.0 109.999 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.1 t -65.99 -16.81 64.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.635 -0.666 . . . . 0.0 110.819 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -132.71 144.11 50.07 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.04 -1.038 . . . . 0.0 110.68 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.446 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -159.38 171.72 35.9 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.382 -1.07 . . . . 0.0 109.682 179.954 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.1 mm . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 108.669 -0.864 . . . . 0.0 108.669 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.468 HG22 ' HB ' ' A' ' 122' ' ' VAL . 51.8 t -116.21 128.33 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.469 -0.77 . . . . 0.0 110.13 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 74.8 m -101.99 101.82 12.27 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.5 m -93.61 119.84 33.14 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.266 -0.896 . . . . 0.0 109.673 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.481 ' CG2' HG12 ' A' ' 125' ' ' VAL . 27.0 m -141.12 153.77 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.544 -0.723 . . . . 0.0 109.12 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -99.79 134.95 41.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.989 -1.069 . . . . 0.0 109.488 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.68 159.58 14.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.324 -0.86 . . . . 0.0 109.549 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.452 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 21.3 t-80 -133.11 150.88 52.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.908 . . . . 0.0 109.445 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.98 -23.95 5.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.256 -0.903 . . . . 0.0 109.805 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -104.03 -25.87 12.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -0.925 . . . . 0.0 109.732 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 84.6 m-20 -73.03 134.58 44.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.324 -0.86 . . . . 0.0 109.954 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -80.42 147.93 30.77 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.552 HD13 HD21 ' A' ' 99' ' ' LEU . 45.9 pt -120.34 142.31 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.219 -0.926 . . . . 0.0 110.128 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.58 -172.65 45.39 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.448 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 45.7 p90 -172.42 172.08 4.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.965 -1.314 . . . . 0.0 109.724 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -146.15 144.82 30.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.207 -0.933 . . . . 0.0 109.864 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 85.3 m -123.2 151.94 62.97 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.419 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.45 146.95 23.8 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.287 1.992 . . . . 0.0 111.929 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.3 t -68.47 -13.21 62.15 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.463 -0.773 . . . . 0.0 110.838 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -91.24 -1.48 57.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.935 -1.103 . . . . 0.0 110.324 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.419 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 20.0 m-85 -108.95 164.36 12.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.251 -0.906 . . . . 0.0 110.422 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.9 t -104.72 134.95 47.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.35 -0.844 . . . . 0.0 108.996 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.8 m -90.44 123.36 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.958 -1.089 . . . . 0.0 110.223 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 112' ' ' VAL . 26.3 mt-10 -127.81 126.22 23.82 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.06 114.32 3.57 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 121.688 1.592 . . . . 0.0 112.16 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 68' ' ' PHE . 7.3 t-160 -93.07 -24.84 18.17 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.6 t0 -170.21 39.76 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 98.6 m -63.02 -153.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.44 -0.788 . . . . 0.0 109.733 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.9 p90 -111.17 -56.42 2.37 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.246 -0.909 . . . . 0.0 111.359 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 66' ' ' SER . 16.2 t -48.51 -72.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.362 -1.461 . . . . 0.0 108.848 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.447 ' N ' HG12 ' A' ' 65' ' ' VAL . 33.3 t -138.89 131.29 28.58 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -173.42 -179.42 1.88 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.999 -1.063 . . . . 0.0 110.483 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 6.2 m-85 -93.45 127.65 39.18 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -73.95 -172.36 1.31 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.115 -0.99 . . . . 0.0 109.671 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.8 mt -63.62 -22.53 66.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 109.122 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.0 p -82.5 -7.41 59.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 108.875 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.93 18.47 67.53 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -101.48 140.72 35.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.253 -1.145 . . . . 0.0 108.989 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -80.6 115.9 20.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.297 -0.877 . . . . 0.0 110.133 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -152.65 139.64 19.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 109.767 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -63.3 148.56 47.94 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.156 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 77' ' ' LEU . 14.0 tp -97.59 7.94 45.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.306 -0.871 . . . . 0.0 109.817 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -68.65 -40.47 80.2 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.845 -1.159 . . . . 0.0 110.049 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 79' ' ' ASN . 52.0 t-20 -62.39 -33.99 75.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.019 -1.051 . . . . 0.0 109.108 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -74.42 -48.87 25.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.888 . . . . 0.0 109.56 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.47 HD11 ' HG2' ' A' ' 100' ' ' PRO . 48.5 tp -139.29 124.74 19.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.459 -0.776 . . . . 0.0 109.161 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -81.19 90.13 6.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.046 -1.033 . . . . 0.0 109.734 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.2 mt -75.26 149.96 38.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 109.972 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.9 p -127.24 159.97 32.72 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.469 -0.769 . . . . 0.0 109.203 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.756 HD22 HH11 ' A' ' 98' ' ' ARG . 82.3 m-20 55.69 52.77 10.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.92 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -81.77 132.98 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.379 -0.826 . . . . 0.0 110.009 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.3 mm -122.48 122.65 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.521 -0.737 . . . . 0.0 109.21 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 91.0 mtp -122.24 102.91 8.41 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.154 -0.966 . . . . 0.0 109.757 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -111.98 100.62 9.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.304 -0.873 . . . . 0.0 109.037 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.491 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 76.3 m80 -73.28 -35.02 66.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.002 -1.061 . . . . 0.0 110.64 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -60.67 -46.59 89.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.009 -1.057 . . . . 0.0 109.646 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -88.48 -3.89 58.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.138 -0.976 . . . . 0.0 109.07 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 97.3 m-20 54.57 47.28 23.04 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 0.0 110.144 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.594 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 2.3 t -132.65 138.0 47.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.229 -0.919 . . . . 0.0 109.36 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -127.91 139.71 52.44 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.392 -0.818 . . . . 0.0 110.103 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.594 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 58.3 m-85 -136.2 146.88 47.3 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.279 -0.888 . . . . 0.0 109.245 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.4 t -151.46 152.92 33.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.978 . . . . 0.0 109.143 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.756 HH11 HD22 ' A' ' 85' ' ' ASN . 53.9 mtp180 -108.37 137.43 46.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.341 -0.849 . . . . 0.0 109.36 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.61 ' HB3' HD11 ' A' ' 103' ' ' ILE . 40.8 mt -93.24 141.1 23.57 Favored Pre-proline 0 N--CA 1.491 1.624 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.603 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.47 ' HG2' HD11 ' A' ' 81' ' ' LEU . 78.3 Cg_exo -46.54 159.49 0.29 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.781 1.654 . . . . 0.0 111.206 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.2 p -68.71 -16.52 63.84 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.254 -0.904 . . . . 0.0 109.772 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.2 tp -123.37 131.44 53.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.408 -0.808 . . . . 0.0 110.502 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.61 HD11 ' HB3' ' A' ' 99' ' ' LEU . 64.6 mt -143.07 126.03 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.4 m -139.16 52.99 1.75 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.955 -1.091 . . . . 0.0 109.782 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.519 ' O ' ' OXT' ' A' ' 127' ' ' ALA . 54.6 t0 -145.99 153.33 40.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.957 . . . . 0.0 110.026 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.491 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 99.0 m-20 -91.93 33.03 1.07 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.39 -0.819 . . . . 0.0 108.912 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.52 ' NE1' ' HB3' ' A' ' 127' ' ' ALA . 7.8 p-90 -64.57 154.33 36.53 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.135 -0.978 . . . . 0.0 110.494 -178.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.52 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 53.7 tttp -145.39 151.42 38.23 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.611 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 30.2 p90 -155.45 164.48 38.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.077 -1.014 . . . . 0.0 108.621 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 8.0 p90 -154.63 159.07 40.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.717 -1.239 . . . . 0.0 111.861 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 80.7 m -123.25 156.24 35.59 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.483 HG22 HG22 ' A' ' 122' ' ' VAL . 46.4 t -129.3 141.21 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 120.874 -1.141 . . . . 0.0 111.693 -178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 35.1 m -122.25 131.73 54.07 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.0 p -172.12 179.04 2.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.243 -1.536 . . . . 0.0 111.565 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.468 ' CB ' ' HZ2' ' A' ' 115' ' ' LYS . 6.3 mtmp? -153.09 167.32 29.63 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 117' ' ' ASN . 99.9 m-20 -58.84 152.14 19.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.782 -1.199 . . . . 0.0 109.001 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.475 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 56.8 t-20 39.77 59.53 1.86 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.462 -0.774 . . . . 0.0 109.683 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 54.0 mm-40 -158.46 139.9 13.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.374 -0.829 . . . . 0.0 110.551 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -52.98 140.43 24.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 0.0 108.873 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -92.88 139.12 30.86 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.462 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.3 mt -110.04 122.77 48.35 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.483 HG22 HG22 ' A' ' 112' ' ' VAL . 43.6 t -107.25 129.47 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.049 -1.032 . . . . 0.0 110.625 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.412 ' CE1' ' HB3' ' A' ' 50' ' ' PHE . 21.5 t80 -106.95 119.07 38.35 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.52 ' OG1' ' NZ ' ' A' ' 108' ' ' LYS . 6.3 t -136.11 140.21 43.54 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.997 -1.064 . . . . 0.0 112.119 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.611 ' CG2' ' CE2' ' A' ' 109' ' ' PHE . 3.0 m -136.06 156.81 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -136.18 155.47 50.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.088 -1.007 . . . . 0.0 110.291 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.52 ' HB3' ' NE1' ' A' ' 107' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.355 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.7 t -95.19 134.88 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.279 -0.888 . . . . 0.0 110.061 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -68.96 123.09 20.07 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.017 -1.052 . . . . 0.0 108.617 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.54 179.66 47.83 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.9 t -119.15 130.04 55.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.523 -0.986 . . . . 0.0 109.318 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.419 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 40.2 t0 -106.3 109.12 20.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.572 -0.705 . . . . 0.0 109.326 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -89.62 1.51 55.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.322 -0.861 . . . . 0.0 108.939 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.3 m -103.29 -17.03 15.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.477 -0.765 . . . . 0.0 110.514 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.552 HG22 ' H ' ' A' ' 12' ' ' GLU . 74.8 m -156.93 126.02 5.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.814 -1.179 . . . . 0.0 110.387 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.6 t -64.1 -28.19 69.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.37 -0.831 . . . . 0.0 108.937 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.552 ' H ' HG22 ' A' ' 10' ' ' THR . 79.2 mm-40 -112.68 73.77 0.83 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.1 t -68.15 150.43 48.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.806 . . . . 0.0 110.211 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.52 -0.08 41.34 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 pt -125.14 -22.03 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.712 -0.618 . . . . 0.0 110.312 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -114.19 141.47 47.48 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.279 -0.888 . . . . 0.0 110.156 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 m -74.98 -18.8 60.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.552 -0.718 . . . . 0.0 110.894 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.55 ' NZ ' ' CE1' ' A' ' 20' ' ' TYR . 61.5 tttm -129.43 140.22 51.39 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.018 -1.051 . . . . 0.0 110.577 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.419 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -155.98 164.88 32.49 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.55 ' CE1' ' NZ ' ' A' ' 18' ' ' LYS . 36.5 m-85 . . . . . 0 N--CA 1.495 1.795 0 O-C-N 121.446 -1.032 . . . . 0.0 109.745 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.7 mm . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.4 t -115.33 124.48 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 110.147 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 71.3 m -102.64 101.97 12.14 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.6 m -95.81 121.13 37.21 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.164 -0.96 . . . . 0.0 109.693 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.443 ' CG2' HG12 ' A' ' 125' ' ' VAL . 26.8 m -141.04 153.91 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.578 -0.701 . . . . 0.0 109.218 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -97.99 133.96 41.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.008 -1.058 . . . . 0.0 109.37 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.81 160.57 14.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 0.0 109.641 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.446 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 32.2 t60 -135.28 151.88 50.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.327 -0.858 . . . . 0.0 109.487 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.571 ' HB1' ' HA ' ' A' ' 101' ' ' SER . . . -51.77 -25.23 7.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 109.635 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -101.48 -27.04 13.35 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.291 -0.881 . . . . 0.0 109.817 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.446 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 86.3 m-20 -73.64 134.4 43.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.298 -0.876 . . . . 0.0 109.989 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.523 HD21 ' CZ ' ' A' ' 98' ' ' ARG . 97.3 mt -79.92 148.31 31.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 108.545 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.485 HD13 HD21 ' A' ' 99' ' ' LEU . 9.5 pt -120.4 141.5 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.24 -0.913 . . . . 0.0 109.969 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' A' ' 95' ' ' PHE . . . 176.86 -173.28 46.18 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -171.66 173.05 4.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.001 -1.293 . . . . 0.0 109.791 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -146.05 144.78 30.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 0.0 109.892 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 80.0 m -123.79 152.45 65.96 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.429 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.53 148.33 20.77 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.28 1.987 . . . . 0.0 112.005 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.4 m -71.5 -12.96 61.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.431 -0.793 . . . . 0.0 110.647 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -91.84 1.9 56.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.016 -1.053 . . . . 0.0 110.119 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.446 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 18.1 m-85 -110.09 165.26 11.88 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.266 -0.896 . . . . 0.0 110.354 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.5 t -102.92 139.75 38.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 109.012 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.6 m -97.92 125.86 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.991 -1.068 . . . . 0.0 110.199 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -132.14 129.86 21.85 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.3 113.12 3.32 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.664 1.576 . . . . 0.0 112.095 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -92.01 -27.98 17.48 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 110' ' ' PHE . 54.3 t0 -166.81 38.42 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.587 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 79.0 m -62.85 -157.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.544 -0.722 . . . . 0.0 109.77 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.2 p90 -111.27 -49.07 3.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.226 -0.921 . . . . 0.0 111.629 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.409 HG23 ' CD2' ' A' ' 64' ' ' PHE . 53.6 t -59.22 -48.45 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.343 -1.473 . . . . 0.0 109.286 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.5 t -157.78 128.73 6.53 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.587 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.7 -178.93 1.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.092 -1.005 . . . . 0.0 110.499 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 9.9 m-85 -93.1 124.75 37.3 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -69.28 -174.91 0.71 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.011 . . . . 0.0 109.847 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.5 mt -62.92 -23.01 67.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.316 -0.865 . . . . 0.0 108.95 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.8 m -82.36 -6.34 59.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.327 -0.858 . . . . 0.0 108.761 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.18 19.88 63.88 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -101.71 138.95 38.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.318 -1.107 . . . . 0.0 109.101 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -82.46 110.25 17.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.21 -0.931 . . . . 0.0 109.964 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -147.01 141.91 26.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.499 -0.751 . . . . 0.0 110.011 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -59.86 144.02 49.78 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.274 -0.891 . . . . 0.0 109.32 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.571 HD11 ' HD2' ' A' ' 80' ' ' LYS . 14.3 tp -97.09 8.03 45.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.202 -0.936 . . . . 0.0 109.735 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -69.67 -38.74 77.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.179 -0.951 . . . . 0.0 110.065 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 41.7 p-10 -62.43 -32.85 73.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.125 -0.984 . . . . 0.0 109.217 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.571 ' HD2' HD11 ' A' ' 77' ' ' LEU . 37.3 ttmt -71.86 -50.79 26.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.345 -0.847 . . . . 0.0 109.663 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.595 HD22 ' CZ2' ' A' ' 107' ' ' TRP . 39.0 tp -140.74 128.2 21.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.479 -0.763 . . . . 0.0 109.166 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -81.05 87.73 6.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.035 -1.041 . . . . 0.0 109.487 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.7 mt -71.66 152.99 42.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 0.0 109.928 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.6 p -128.19 163.92 23.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.562 -0.711 . . . . 0.0 109.323 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 55.44 52.24 11.59 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.265 -0.897 . . . . 0.0 109.94 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.45 128.26 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.337 -0.852 . . . . 0.0 109.985 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.1 mm -123.47 122.44 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.554 -0.716 . . . . 0.0 109.136 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 83.2 mtp -123.59 104.81 9.26 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.197 -0.94 . . . . 0.0 109.793 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -113.37 101.85 9.78 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.342 -0.849 . . . . 0.0 109.013 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.487 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 96.6 m-70 -73.14 -36.14 66.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.97 -1.081 . . . . 0.0 110.652 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -60.21 -46.32 90.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.891 -1.131 . . . . 0.0 109.623 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -89.79 -5.09 57.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.172 -0.955 . . . . 0.0 109.032 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.487 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.6 m-20 54.66 47.66 22.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.551 -0.718 . . . . 0.0 110.25 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.586 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 2.5 t -131.94 135.8 46.88 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.21 -0.931 . . . . 0.0 109.291 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.416 ' O ' ' CA ' ' A' ' 49' ' ' GLY . 76.0 m-85 -126.63 139.28 53.29 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.388 -0.82 . . . . 0.0 109.951 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.586 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 72.3 m-85 -136.15 147.3 47.66 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.349 -0.844 . . . . 0.0 109.264 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.5 t -152.9 152.59 31.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.063 -1.023 . . . . 0.0 109.189 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.523 ' CZ ' HD21 ' A' ' 47' ' ' LEU . 9.0 mtt-85 -107.41 139.29 42.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.26 -0.9 . . . . 0.0 109.856 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.485 HD21 HD13 ' A' ' 48' ' ' ILE . 38.2 mt -94.88 141.47 23.35 Favored Pre-proline 0 N--CA 1.49 1.548 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.853 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.517 ' HG2' HD11 ' A' ' 81' ' ' LEU . 77.3 Cg_exo -45.9 179.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.912 1.741 . . . . 0.0 111.162 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.571 ' HA ' ' HB1' ' A' ' 44' ' ' ALA . 73.7 m -86.08 -14.17 45.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.088 -1.008 . . . . 0.0 110.001 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.7 tp -120.99 130.22 53.72 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.276 -0.89 . . . . 0.0 110.442 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.434 HD11 ' HB3' ' A' ' 99' ' ' LEU . 7.6 mt -150.23 102.38 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 84.2 p -115.49 -0.69 13.0 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.168 -0.957 . . . . 0.0 109.748 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 52.4 t0 -87.38 158.01 19.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.57 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 92.9 m-20 -99.42 32.2 2.86 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.451 -0.781 . . . . 0.0 109.071 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.595 ' CZ2' HD22 ' A' ' 81' ' ' LEU . 10.3 p-90 -65.97 157.18 31.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.145 -0.972 . . . . 0.0 110.509 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -146.4 157.96 43.83 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.568 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 39.6 p90 -155.68 163.54 39.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.155 -0.966 . . . . 0.0 108.718 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 62' ' ' ASP . 14.3 p90 -153.73 163.07 40.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.83 -1.169 . . . . 0.0 111.877 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 95.1 m -127.73 158.93 36.3 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 122' ' ' VAL . 44.0 t -130.44 143.34 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.93 -1.106 . . . . 0.0 111.856 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 86.1 m -124.8 132.92 53.3 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.0 p -171.49 179.14 2.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.306 -1.496 . . . . 0.0 111.669 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.575 ' NZ ' ' OE2' ' A' ' 118' ' ' GLU . 6.4 mtmp? -153.09 166.15 33.36 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.62 151.7 20.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.867 -1.146 . . . . 0.0 109.245 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.49 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 64.8 t30 44.7 61.2 2.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.219 -0.926 . . . . 0.0 109.667 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.575 ' OE2' ' NZ ' ' A' ' 115' ' ' LYS . 42.5 mt-10 -164.61 145.38 7.85 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.226 -0.921 . . . . 0.0 110.26 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -60.47 146.79 43.45 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.228 -0.92 . . . . 0.0 108.937 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -93.72 141.71 28.18 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.111 -0.993 . . . . 0.0 110.394 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.1 mt -108.84 121.0 44.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.313 -0.867 . . . . 0.0 108.899 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 112' ' ' VAL . 55.4 t -108.96 130.3 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.092 -1.005 . . . . 0.0 110.577 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -110.65 122.65 48.3 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.0 t -137.68 143.94 41.56 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.029 -1.044 . . . . 0.0 112.378 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.568 ' CG2' ' CE2' ' A' ' 109' ' ' PHE . 3.0 m -135.42 158.77 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -136.83 153.91 50.66 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.058 -1.026 . . . . 0.0 110.282 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.512 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.354 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.6 t -95.06 133.36 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.97 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.419 ' HD2' ' N ' ' A' ' 4' ' ' LYS . 13.6 mptt -70.59 125.18 26.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.104 -0.998 . . . . 0.0 108.663 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.21 -179.95 42.71 Favored Glycine 0 N--CA 1.484 1.844 0 C-N-CA 119.479 -1.343 . . . . 0.0 109.79 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.9 t -116.92 134.72 54.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.402 -1.057 . . . . 0.0 109.712 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.544 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 68.1 t0 -115.81 110.66 19.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.499 -0.751 . . . . 0.0 109.332 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -87.17 3.26 47.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.94 . . . . 0.0 108.916 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.4 m -102.96 -18.85 14.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.434 -0.791 . . . . 0.0 110.549 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 12' ' ' GLU . 10.4 m -157.42 127.52 6.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.887 -1.133 . . . . 0.0 110.289 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.3 m -66.49 -27.0 67.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.408 -0.807 . . . . 0.0 109.001 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.583 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 57.9 mp0 -113.81 74.87 0.89 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 15' ' ' ILE . 26.6 m -75.97 115.87 16.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.423 -0.798 . . . . 0.0 110.578 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.406 HG23 HG23 ' A' ' 15' ' ' ILE . 7.7 t -65.39 3.2 0.71 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.524 ' H ' ' C ' ' A' ' 13' ' ' SER . 15.1 pt -122.83 -36.57 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.712 -0.618 . . . . 0.0 110.333 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.416 ' CZ ' ' CE1' ' A' ' 96' ' ' TYR . 50.9 m-85 -108.21 137.11 46.75 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.185 -0.947 . . . . 0.0 109.816 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.2 t -68.28 -18.4 64.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.593 -0.692 . . . . 0.0 111.003 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -130.58 141.42 50.46 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.953 -1.092 . . . . 0.0 110.521 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.544 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -161.83 173.55 38.2 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.38 -1.07 . . . . 0.0 109.568 -179.859 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.2 mm . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.486 HG22 ' HB ' ' A' ' 122' ' ' VAL . 50.0 t -121.03 129.62 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.303 -0.873 . . . . 0.0 110.157 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 124' ' ' THR . 84.5 m -101.26 100.12 10.59 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.8 m -95.53 120.64 36.13 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.089 -1.007 . . . . 0.0 109.412 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.61 HG22 HG12 ' A' ' 125' ' ' VAL . 3.1 m -139.05 159.44 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.526 -0.734 . . . . 0.0 109.176 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -97.77 123.71 41.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.151 -0.968 . . . . 0.0 109.594 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.441 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -90.55 155.03 19.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -0.87 . . . . 0.0 109.531 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.431 ' O ' HD12 ' A' ' 99' ' ' LEU . 35.4 t-80 -133.33 152.13 51.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -0.898 . . . . 0.0 109.553 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.751 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -57.34 -29.61 64.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.335 -0.853 . . . . 0.0 109.827 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -93.6 -26.89 16.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 109.725 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -76.68 135.6 39.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.523 -0.735 . . . . 0.0 110.043 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.1 mt -78.36 148.64 33.63 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.468 HD13 HD21 ' A' ' 99' ' ' LEU . 47.5 pt -122.36 144.83 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.331 -0.856 . . . . 0.0 110.308 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.5 -171.2 44.16 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -172.73 171.57 4.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.136 -1.214 . . . . 0.0 109.71 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -146.82 144.84 29.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 0.0 109.9 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 86.0 m -125.37 152.17 70.96 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.929 . . . . 0.0 108.54 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.472 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.4 Cg_endo -51.63 149.82 17.9 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.3 2.0 . . . . 0.0 111.944 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.0 m -70.84 -12.1 61.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -0.83 . . . . 0.0 110.682 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.448 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 82.4 m-20 -92.78 0.23 57.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.94 -1.1 . . . . 0.0 110.182 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.472 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 16.3 m-85 -108.28 164.2 12.53 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.202 -0.936 . . . . 0.0 110.364 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.9 m -103.85 128.08 51.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 109.087 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 58' ' ' VAL . 3.2 m -88.3 114.38 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.959 -1.088 . . . . 0.0 110.151 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -120.37 126.8 26.62 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.06 113.53 3.43 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 121.545 1.496 . . . . 0.0 112.106 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.491 ' O ' ' O ' ' A' ' 68' ' ' PHE . 2.8 t-80 -93.59 -23.63 18.23 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -172.26 51.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.67 ' H ' ' CB ' ' A' ' 67' ' ' ALA . 76.4 m -76.47 -151.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.63 -0.668 . . . . 0.0 109.799 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.49 ' CE2' HG23 ' A' ' 65' ' ' VAL . 6.5 p90 -110.18 -58.33 2.08 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.098 -1.001 . . . . 0.0 111.373 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.49 HG23 ' CE2' ' A' ' 64' ' ' PHE . 24.0 t -45.27 -70.35 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.627 -1.296 . . . . 0.0 108.809 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.4 t -145.58 129.36 17.23 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.67 ' CB ' ' H ' ' A' ' 63' ' ' CYS . . . -167.84 -179.78 4.38 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.373 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.3 m-85 -93.98 141.2 28.79 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.698 HD21 ' CB ' ' A' ' 75' ' ' GLU . 75.8 m-20 -80.88 -169.7 2.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.955 -1.091 . . . . 0.0 109.652 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 70' ' ' LEU . 10.2 mp -67.91 -13.8 62.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 108.913 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.4 t -90.73 -7.14 53.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -0.856 . . . . 0.0 108.982 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.07 23.87 56.26 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -107.73 136.44 47.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.213 -1.169 . . . . 0.0 109.095 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -67.42 135.02 52.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.216 -0.927 . . . . 0.0 109.984 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.698 ' CB ' HD21 ' A' ' 69' ' ' ASN . 80.3 tt0 -155.42 166.0 34.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.437 -0.789 . . . . 0.0 109.548 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.458 ' N ' ' HG2' ' A' ' 75' ' ' GLU . 5.3 m120 -106.94 139.1 41.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.33 -0.856 . . . . 0.0 109.531 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.7 tp -95.79 -10.27 29.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.0 . . . . 0.0 110.027 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.481 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 20.5 pt-20 -62.67 -44.86 95.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.99 -1.069 . . . . 0.0 109.476 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.563 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 48.7 p30 -66.72 -22.09 66.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.138 -0.976 . . . . 0.0 108.94 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.563 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 52.6 tptt -86.74 -48.09 8.55 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.359 -0.838 . . . . 0.0 109.415 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.649 HD23 HD21 ' A' ' 83' ' ' LEU . 30.8 tp -122.89 129.95 52.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.412 -0.805 . . . . 0.0 109.174 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -78.66 82.68 4.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.032 -1.043 . . . . 0.0 109.244 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.649 HD21 HD23 ' A' ' 81' ' ' LEU . 88.8 mt -81.53 137.69 35.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.873 . . . . 0.0 110.112 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 48.1 p -127.44 163.31 24.36 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.513 -0.742 . . . . 0.0 109.278 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.557 HD22 ' HE ' ' A' ' 98' ' ' ARG . 97.8 m-20 55.04 51.05 14.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.623 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.2 131.53 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.353 -0.842 . . . . 0.0 110.039 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.6 mm -121.85 121.17 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.503 -0.748 . . . . 0.0 109.277 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 79.6 mtp -123.73 107.4 11.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.21 -0.931 . . . . 0.0 109.785 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -112.57 101.27 9.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.374 -0.829 . . . . 0.0 109.082 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.448 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 76.4 m80 -71.55 -36.8 71.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.917 -1.114 . . . . 0.0 110.651 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -60.61 -45.74 92.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.022 -1.049 . . . . 0.0 109.557 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -87.91 -5.28 58.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.117 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 99.7 m-20 54.37 47.61 22.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.504 -0.747 . . . . 0.0 110.332 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.597 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 2.6 t -132.99 138.19 46.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.028 -1.045 . . . . 0.0 109.333 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -126.38 138.9 53.61 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.512 -0.742 . . . . 0.0 109.809 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.597 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 77.9 m-85 -135.41 146.15 48.0 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.115 -0.991 . . . . 0.0 109.336 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.5 p -153.03 155.69 37.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.097 -1.002 . . . . 0.0 108.986 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.557 ' HE ' HD22 ' A' ' 85' ' ' ASN . 59.2 mtt-85 -105.11 136.68 44.16 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.264 -0.897 . . . . 0.0 109.65 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.468 HD21 HD13 ' A' ' 48' ' ' ILE . 78.1 mt -91.83 138.41 24.91 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.459 -0.776 . . . . 0.0 109.706 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.751 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 76.4 Cg_exo -45.74 175.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.83 1.686 . . . . 0.0 111.305 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.6 m -83.92 -12.93 54.66 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.077 -1.014 . . . . 0.0 109.844 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.3 tp -134.13 130.0 36.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.131 -0.981 . . . . 0.0 110.511 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 91.3 mt -147.37 102.48 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.865 . . . . 0.0 108.806 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.3 m -104.1 -6.96 20.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.072 -1.017 . . . . 0.0 109.794 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 127' ' ' ALA . 78.6 m-20 -78.41 151.65 32.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 110.022 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -100.15 31.79 3.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.391 -0.818 . . . . 0.0 109.205 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.408 ' CH2' HD22 ' A' ' 81' ' ' LEU . 20.4 p-90 -65.4 159.88 23.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.117 -0.99 . . . . 0.0 110.465 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -142.23 156.97 45.34 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.643 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 36.4 p90 -154.08 158.62 40.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.088 -1.007 . . . . 0.0 108.692 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 18.5 p90 -150.66 156.33 41.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.804 -1.185 . . . . 0.0 111.937 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 96.5 m -121.78 156.19 33.71 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 122' ' ' VAL . 51.7 t -127.71 138.43 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.77 -1.206 . . . . 0.0 111.872 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 67.0 m -123.34 132.0 53.84 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 97.5 p -165.6 171.5 13.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.121 -1.612 . . . . 0.0 111.652 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.448 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 47.6 mtpt -136.87 158.58 44.14 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -60.29 143.21 53.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.933 -1.105 . . . . 0.0 108.813 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 59.6 t-20 49.82 62.63 2.55 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.395 -0.816 . . . . 0.0 109.09 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 63.3 mm-40 -165.11 149.66 9.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.177 -0.952 . . . . 0.0 110.71 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -55.18 136.92 48.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.251 -0.905 . . . . 0.0 108.974 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -88.41 140.41 29.5 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.18 -0.95 . . . . 0.0 110.322 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 70.8 mt -109.16 122.03 46.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.432 -0.793 . . . . 0.0 109.136 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 112' ' ' VAL . 47.2 t -111.02 131.36 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.075 -1.016 . . . . 0.0 110.492 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -107.58 118.59 37.12 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 38' ' ' CYS . 7.3 t -136.6 141.43 43.27 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.868 -1.145 . . . . 0.0 111.967 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.643 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 2.8 m -137.37 160.34 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -128.81 149.04 50.9 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.094 -1.004 . . . . 0.0 110.264 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.353 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.8 t -95.32 135.36 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.324 -0.86 . . . . 0.0 109.89 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -67.99 121.31 15.81 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.0 108.6 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.71 175.04 45.45 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.425 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 5.0 t -116.08 130.02 56.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.415 -1.05 . . . . 0.0 109.465 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.478 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 42.6 t0 -104.82 108.51 20.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.533 -0.729 . . . . 0.0 109.214 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -89.29 0.24 56.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.889 . . . . 0.0 108.93 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.4 m -102.33 -17.17 16.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.568 -0.707 . . . . 0.0 110.414 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.445 HG22 ' H ' ' A' ' 12' ' ' GLU . 8.0 m -156.87 126.7 6.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.801 -1.187 . . . . 0.0 110.229 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.2 p -64.06 -27.63 69.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 108.858 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.445 ' H ' HG22 ' A' ' 10' ' ' THR . 97.3 mt-10 -114.77 76.87 1.02 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 88.1 p -71.75 153.37 42.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.395 -0.815 . . . . 0.0 110.224 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.15 1.1 35.72 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.6 pt -123.61 -24.03 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.632 -0.667 . . . . 0.0 110.29 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.507 ' O ' ' OG ' ' A' ' 13' ' ' SER . 63.3 m-85 -114.91 140.87 48.63 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.093 -1.005 . . . . 0.0 110.093 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.1 p -69.04 -17.81 63.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.403 -0.811 . . . . 0.0 110.614 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -129.58 139.86 51.36 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.921 -1.112 . . . . 0.0 110.458 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.478 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -150.37 162.95 29.43 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.425 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 36.5 m-85 . . . . . 0 N--CA 1.494 1.727 0 O-C-N 121.371 -1.076 . . . . 0.0 109.568 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 mm . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.453 HG22 ' HB ' ' A' ' 122' ' ' VAL . 56.1 t -123.29 129.17 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.364 -0.835 . . . . 0.0 110.31 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 85.1 m -102.08 101.61 11.98 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.4 m -97.03 122.31 39.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.057 -1.027 . . . . 0.0 109.649 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.619 ' CG2' HG12 ' A' ' 125' ' ' VAL . 19.0 m -138.91 158.02 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.437 -0.789 . . . . 0.0 109.079 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -97.06 119.95 36.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.135 -0.978 . . . . 0.0 109.517 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.41 156.43 17.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.362 -0.836 . . . . 0.0 109.592 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.413 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 39.9 t60 -131.26 152.37 50.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.829 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -56.02 -26.18 47.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.282 -0.886 . . . . 0.0 109.797 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -99.06 -24.75 14.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -0.95 . . . . 0.0 109.626 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 98.5 m-20 -74.67 137.17 42.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.512 -0.743 . . . . 0.0 110.002 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.9 mt -78.83 146.53 33.64 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 99' ' ' LEU . 45.4 pt -121.83 144.3 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.095 -1.003 . . . . 0.0 110.28 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.17 -173.46 46.26 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -171.18 170.94 5.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.038 -1.272 . . . . 0.0 109.794 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -147.04 145.44 29.68 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.343 -0.848 . . . . 0.0 109.864 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 86.4 m -125.22 151.4 69.45 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 108.815 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.48 154.1 9.3 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.43 2.086 . . . . 0.0 111.977 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.7 m -72.24 -10.5 59.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.496 -0.753 . . . . 0.0 110.711 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.536 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 78.7 m-20 -93.29 -3.68 53.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.95 -1.094 . . . . 0.0 110.245 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.476 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 15.4 m-85 -105.92 160.63 15.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.246 -0.909 . . . . 0.0 110.08 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -101.33 132.69 46.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.47 -0.768 . . . . 0.0 109.328 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.6 m -88.59 118.31 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.109 -0.994 . . . . 0.0 110.219 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -126.93 127.04 24.47 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.13 113.51 3.42 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 121.631 1.554 . . . . 0.0 112.131 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.484 ' O ' ' O ' ' A' ' 68' ' ' PHE . 9.6 t-160 -91.4 -25.57 19.29 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.475 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.3 t0 -169.48 38.94 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.422 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 81.8 m -62.56 -154.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.601 -0.687 . . . . 0.0 109.717 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.1 p90 -109.96 -59.28 1.95 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.061 -1.024 . . . . 0.0 111.359 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.464 ' C ' ' O ' ' A' ' 64' ' ' PHE . 25.3 t -44.75 -73.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.67 -1.269 . . . . 0.0 108.788 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.422 ' N ' HG12 ' A' ' 65' ' ' VAL . 43.0 t -138.2 131.13 29.84 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.422 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -171.98 179.1 2.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.876 -1.14 . . . . 0.0 110.458 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 5.2 m-85 -93.84 126.18 38.89 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -71.74 -170.79 0.59 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.976 -1.078 . . . . 0.0 109.823 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.548 HD12 ' N ' ' A' ' 70' ' ' LEU . 10.8 mp -65.07 -19.72 66.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.191 -0.943 . . . . 0.0 109.038 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.6 m -83.49 -7.97 59.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.343 -0.848 . . . . 0.0 108.843 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.5 19.15 66.9 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -103.79 137.05 42.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.342 -1.093 . . . . 0.0 109.139 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -76.38 113.85 14.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.279 -0.888 . . . . 0.0 110.073 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -144.56 131.56 20.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.333 -0.855 . . . . 0.0 110.04 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -59.98 145.18 47.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.145 -0.972 . . . . 0.0 109.303 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.3 tp -100.2 -0.9 37.82 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.588 -0.695 . . . . 0.0 110.088 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -67.03 -42.35 85.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.222 -0.924 . . . . 0.0 109.85 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -63.77 -21.94 66.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.995 . . . . 0.0 109.023 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -86.86 -46.82 9.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.46 -0.775 . . . . 0.0 109.342 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.542 HD23 HD21 ' A' ' 83' ' ' LEU . 38.8 tp -124.62 127.89 48.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.492 -0.755 . . . . 0.0 109.171 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -77.17 83.48 3.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.966 -1.084 . . . . 0.0 109.235 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.576 HD22 ' OG ' ' A' ' 97' ' ' SER . 83.1 mt -81.22 139.37 35.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.414 -0.804 . . . . 0.0 110.027 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.8 p -128.0 160.76 30.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.558 -0.714 . . . . 0.0 109.247 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 55.02 50.1 16.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.302 -0.874 . . . . 0.0 109.472 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.4 mt -78.91 131.97 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 110.093 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.3 mm -119.6 120.08 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.456 -0.778 . . . . 0.0 109.329 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 93.8 mtp -122.09 105.06 9.93 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.058 -1.026 . . . . 0.0 109.785 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -112.5 101.16 9.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.337 -0.852 . . . . 0.0 109.067 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -76.68 -31.72 57.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.217 -0.927 . . . . 0.0 110.49 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -59.97 -46.96 87.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.799 -1.188 . . . . 0.0 109.645 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -90.23 3.01 54.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.157 -0.965 . . . . 0.0 109.1 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 51.96 46.8 25.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.479 -0.763 . . . . 0.0 110.13 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.475 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 3.5 t -132.6 137.73 47.15 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.997 -1.064 . . . . 0.0 109.475 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -128.91 140.02 51.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.477 -0.764 . . . . 0.0 109.974 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.475 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 78.4 m-85 -135.14 146.71 49.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.154 -0.966 . . . . 0.0 109.477 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.576 ' OG ' HD22 ' A' ' 83' ' ' LEU . 32.4 t -149.82 149.39 30.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.024 -1.047 . . . . 0.0 109.157 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.412 HH11 ' HG2' ' A' ' 98' ' ' ARG . 60.3 mtt-85 -102.17 134.48 45.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.074 -1.016 . . . . 0.0 109.5 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 48' ' ' ILE . 87.5 mt -92.69 139.21 23.49 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.486 -0.759 . . . . 0.0 109.625 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.829 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 78.2 Cg_exo -45.81 170.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.851 1.701 . . . . 0.0 111.284 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.9 m -79.93 -12.24 59.74 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.098 -1.001 . . . . 0.0 109.778 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.3 tp -135.39 131.17 35.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.256 -0.902 . . . . 0.0 110.573 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 87.0 mt -147.54 102.27 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.8 t -99.73 -3.88 31.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.861 -1.149 . . . . 0.0 109.897 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 127' ' ' ALA . 84.7 m-20 -83.7 154.63 23.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.958 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -104.21 33.17 3.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.389 -0.819 . . . . 0.0 109.161 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 18.4 p-90 -65.33 152.06 44.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.932 . . . . 0.0 110.462 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -130.82 150.97 51.74 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.644 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 25.2 p90 -150.17 159.66 44.25 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.042 -1.036 . . . . 0.0 108.693 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 6.0 p90 -152.87 159.06 43.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.773 -1.205 . . . . 0.0 111.819 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 99.4 m -123.18 156.02 35.92 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.59 HG22 HG22 ' A' ' 122' ' ' VAL . 42.4 t -129.19 140.86 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.866 -1.147 . . . . 0.0 111.794 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 70.2 m -121.65 131.46 54.11 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.6 p -170.82 176.11 4.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.232 -1.542 . . . . 0.0 111.704 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.536 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 51.5 mttm -151.57 166.46 31.11 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 117' ' ' ASN . 98.6 m-20 -57.59 151.54 16.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.757 -1.214 . . . . 0.0 109.17 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 116' ' ' ASP . 66.7 t30 42.43 61.47 2.01 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.209 -0.932 . . . . 0.0 109.816 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 43.6 mt-10 -161.76 140.84 9.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.103 -0.998 . . . . 0.0 110.21 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 6.2 mmmt -55.02 138.75 43.17 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.171 -0.955 . . . . 0.0 109.326 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -87.35 139.93 30.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.302 -0.874 . . . . 0.0 110.387 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.3 mt -110.12 122.27 47.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.473 -0.767 . . . . 0.0 109.024 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.59 HG22 HG22 ' A' ' 112' ' ' VAL . 51.6 t -110.69 131.76 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.04 -1.038 . . . . 0.0 110.664 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.405 ' CZ ' ' CG1' ' A' ' 125' ' ' VAL . 23.9 t80 -110.22 122.53 47.87 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.0 t -137.54 142.45 41.4 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 119.059 -1.057 . . . . 0.0 111.969 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.644 ' CG2' ' CE2' ' A' ' 109' ' ' PHE . 3.0 m -137.53 154.52 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -122.87 147.6 46.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.201 -0.937 . . . . 0.0 110.366 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.329 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 mmtp . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.8 t -97.64 132.19 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.256 -0.903 . . . . 0.0 109.873 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -68.01 121.42 16.05 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.175 -0.953 . . . . 0.0 108.648 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.29 172.4 43.45 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.9 t -113.66 129.36 56.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.384 -1.068 . . . . 0.0 109.329 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.441 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 40.3 t0 -101.97 108.67 20.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.508 -0.745 . . . . 0.0 109.252 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.476 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 96.8 m-85 -89.75 -1.29 57.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.018 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.1 m -103.0 -16.0 15.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.594 -0.691 . . . . 0.0 110.511 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.569 HG22 ' H ' ' A' ' 12' ' ' GLU . 39.0 m -157.9 126.25 5.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.756 -1.215 . . . . 0.0 110.152 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.9 p -66.07 -26.01 67.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.97 . . . . 0.0 108.921 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.569 ' H ' HG22 ' A' ' 10' ' ' THR . 79.4 mm-40 -114.07 74.16 0.86 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.8 p -71.25 154.15 41.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 110.24 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.407 HG23 HG23 ' A' ' 15' ' ' ILE . 14.8 t -101.86 0.96 36.43 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.407 HG23 HG23 ' A' ' 14' ' ' THR . 5.5 pt -125.28 -26.47 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.643 -0.661 . . . . 0.0 110.243 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.405 ' CD2' HG13 ' A' ' 15' ' ' ILE . 72.3 m-85 -105.37 143.53 33.41 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.028 -1.045 . . . . 0.0 109.887 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.9 m -70.37 -18.09 63.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.542 -0.724 . . . . 0.0 110.765 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' NZ ' HG12 ' A' ' 40' ' ' VAL . 53.3 mtmt -144.33 156.52 44.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.75 -1.219 . . . . 0.0 110.775 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.441 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -158.78 169.24 35.09 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.199 -1.177 . . . . 0.0 109.646 -179.754 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.7 mm . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.0 t -117.07 127.83 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.153 -0.967 . . . . 0.0 110.182 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.476 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 96.7 m -102.45 100.62 10.76 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 65.6 m -94.4 120.24 34.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.016 -1.053 . . . . 0.0 109.645 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.453 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 27.5 m -141.3 156.11 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.161 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -98.11 133.96 41.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.171 -0.955 . . . . 0.0 109.445 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.439 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -102.0 150.35 23.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.052 -1.03 . . . . 0.0 109.63 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.519 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 29.8 t60 -120.0 152.52 37.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.363 -0.836 . . . . 0.0 109.551 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.34 -25.59 35.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 109.917 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -99.78 -21.63 15.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.118 -0.989 . . . . 0.0 109.714 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.519 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 81.4 m-20 -77.85 138.02 38.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.501 -0.749 . . . . 0.0 109.998 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.2 mt -79.39 148.9 31.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 108.703 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.404 HG21 HD11 ' A' ' 99' ' ' LEU . 42.6 pt -120.4 141.73 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.969 -1.082 . . . . 0.0 110.214 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.67 -178.3 47.96 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.43 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 55.2 p90 -164.0 170.08 17.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.118 -1.224 . . . . 0.0 109.736 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -144.08 142.87 30.87 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.354 -0.841 . . . . 0.0 109.772 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 82.4 m -122.79 151.83 61.34 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.445 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.46 145.75 27.71 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.289 1.993 . . . . 0.0 111.893 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.3 t -67.88 -14.57 63.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.464 -0.772 . . . . 0.0 110.624 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.587 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.4 m-20 -90.2 1.5 56.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.889 -1.132 . . . . 0.0 110.087 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.454 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 19.1 m-85 -111.11 166.75 10.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.6 m -103.6 139.98 38.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.398 -0.814 . . . . 0.0 109.315 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.7 m -97.55 120.35 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.94 -1.1 . . . . 0.0 110.311 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -127.19 126.68 24.29 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.0 113.81 3.49 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.732 1.622 . . . . 0.0 112.235 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -93.1 -24.8 18.15 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.7 t0 -168.89 36.26 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.412 ' O ' ' O ' ' A' ' 62' ' ' ASP . 88.7 m -59.44 -155.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.499 -0.751 . . . . 0.0 109.893 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.466 ' O ' ' C ' ' A' ' 65' ' ' VAL . 3.9 p90 -110.0 -59.07 1.98 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.953 -1.092 . . . . 0.0 111.246 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.483 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 36.6 t -43.95 -73.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.678 -1.264 . . . . 0.0 108.858 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.2 t -139.25 131.98 29.05 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -172.94 -178.48 1.83 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.879 -1.138 . . . . 0.0 110.457 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 6.6 m-85 -92.27 126.25 37.27 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -73.34 -172.49 1.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.136 -0.978 . . . . 0.0 109.763 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.522 HD22 ' N ' ' A' ' 70' ' ' LEU . 3.8 mm? -64.22 -22.16 66.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.33 -0.856 . . . . 0.0 109.102 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 89.4 p -82.57 -7.37 59.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.889 . . . . 0.0 108.83 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.69 17.95 66.97 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -100.43 139.68 35.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -1.18 . . . . 0.0 109.184 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -82.07 109.46 16.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.174 -0.954 . . . . 0.0 109.934 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -143.88 137.57 27.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.863 . . . . 0.0 110.004 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 77' ' ' LEU . 62.0 t-20 -60.12 145.85 45.31 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.171 -0.956 . . . . 0.0 109.403 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.512 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 14.0 tp -99.07 6.56 46.51 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.359 -0.838 . . . . 0.0 109.829 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.44 ' CD ' ' N ' ' A' ' 79' ' ' ASN . 2.3 pp20? -69.69 -40.33 76.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.104 -0.997 . . . . 0.0 109.896 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.605 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 43.4 p30 -63.37 -27.69 69.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.155 -0.966 . . . . 0.0 109.12 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.605 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 50.9 tptt -78.26 -50.44 11.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.458 -0.776 . . . . 0.0 109.343 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.538 HD11 ' HG2' ' A' ' 100' ' ' PRO . 38.0 tp -130.39 130.53 44.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.512 -0.742 . . . . 0.0 109.191 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -81.32 84.53 6.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.13 -0.981 . . . . 0.0 109.408 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 86.4 mt -76.67 143.68 39.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -0.828 . . . . 0.0 109.888 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.1 p -127.67 161.81 28.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.509 -0.745 . . . . 0.0 109.299 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.506 ' ND2' HH11 ' A' ' 98' ' ' ARG . 10.9 m-20 55.44 51.83 12.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -0.952 . . . . 0.0 109.652 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.4 mt -80.39 130.59 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.397 -0.815 . . . . 0.0 110.047 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.5 mm -118.68 120.26 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.447 -0.783 . . . . 0.0 109.139 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 84.2 mtp -121.15 101.26 7.54 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.082 -1.011 . . . . 0.0 109.834 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -110.29 100.22 9.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.264 -0.898 . . . . 0.0 108.896 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.479 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 93.0 m-70 -72.34 -36.49 68.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.971 -1.081 . . . . 0.0 110.655 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -60.4 -46.18 90.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.94 -1.1 . . . . 0.0 109.631 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -88.59 -4.98 58.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -0.923 . . . . 0.0 109.119 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.7 m-20 54.37 47.94 21.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.517 -0.739 . . . . 0.0 110.283 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.598 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 1.8 t -133.41 140.01 47.08 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.025 -1.047 . . . . 0.0 109.463 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 66.4 m-85 -129.04 140.03 51.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.463 -0.773 . . . . 0.0 109.959 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.598 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 82.1 m-85 -138.08 148.89 45.48 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.261 -0.899 . . . . 0.0 109.479 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.3 p -154.54 158.02 39.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.142 -0.974 . . . . 0.0 109.215 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.506 HH11 ' ND2' ' A' ' 85' ' ' ASN . 68.6 mtp180 -104.01 136.37 43.78 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.166 -0.959 . . . . 0.0 109.399 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 100' ' ' PRO . 36.4 mt -89.69 136.66 29.21 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 109.635 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.538 ' HG2' HD11 ' A' ' 81' ' ' LEU . 77.6 Cg_exo -45.75 177.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.863 1.708 . . . . 0.0 111.211 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 87.7 p -87.39 -15.3 38.23 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.064 -1.022 . . . . 0.0 109.839 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' A' ' 102' ' ' LEU . 52.2 tp -127.37 128.85 46.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.156 -0.965 . . . . 0.0 110.311 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.8 mt -150.22 107.77 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.206 -0.934 . . . . 0.0 108.676 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 81.5 p -118.44 -1.56 11.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.06 -1.025 . . . . 0.0 109.773 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 9.0 p30 -82.67 154.5 24.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.052 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -95.61 34.08 1.54 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.504 -0.748 . . . . 0.0 109.037 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.464 ' CZ3' ' CD1' ' A' ' 109' ' ' PHE . 10.0 p-90 -63.21 154.16 32.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 110.379 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -142.69 149.65 39.11 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.62 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 33.5 p90 -154.46 163.74 39.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.125 -0.984 . . . . 0.0 108.784 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 7.3 p90 -154.44 160.04 41.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.846 -1.159 . . . . 0.0 111.705 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 67.8 m -123.35 155.99 36.25 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.656 HG22 HG22 ' A' ' 122' ' ' VAL . 46.0 t -129.36 140.87 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.878 -1.139 . . . . 0.0 111.756 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 98.4 m -124.66 133.37 53.25 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 72.6 p -170.49 179.23 3.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.239 -1.538 . . . . 0.0 111.665 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.587 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 49.7 mtmt -151.61 162.59 40.73 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 117' ' ' ASN . 97.9 m-20 -57.81 152.19 16.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.816 -1.178 . . . . 0.0 109.173 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.53 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 57.3 t-20 45.24 61.33 2.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.104 -0.997 . . . . 0.0 109.681 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 38.0 mt-10 -166.15 146.69 6.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.141 -0.974 . . . . 0.0 110.174 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.38 139.32 57.73 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.133 -0.979 . . . . 0.0 109.021 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -85.95 142.09 29.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.169 -0.957 . . . . 0.0 110.326 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 68.6 mt -109.21 120.8 43.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.402 -0.812 . . . . 0.0 109.045 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.656 HG22 HG22 ' A' ' 112' ' ' VAL . 49.8 t -109.42 131.21 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 120.951 -1.093 . . . . 0.0 110.774 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -109.66 121.03 44.3 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.4 t -137.16 142.63 42.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.776 -1.202 . . . . 0.0 112.008 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.62 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 2.9 m -136.26 156.37 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -133.88 155.97 48.92 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.226 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.51 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.432 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.3 mttp . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.7 t -80.81 134.19 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.35 -0.844 . . . . 0.0 110.119 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -72.18 129.93 39.64 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.017 -1.052 . . . . 0.0 108.642 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.97 -154.35 24.29 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.378 -1.392 . . . . 0.0 109.914 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.4 t -133.93 131.64 39.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -1.111 . . . . 0.0 109.656 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.513 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 38.6 t0 -109.51 109.25 20.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.539 -0.726 . . . . 0.0 109.15 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.4 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 91.0 m-85 -89.78 3.38 53.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 108.819 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 91.9 m -100.54 -19.59 16.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.386 -0.821 . . . . 0.0 110.515 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.597 HG22 ' H ' ' A' ' 12' ' ' GLU . 32.6 m -157.75 127.49 6.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.791 -1.193 . . . . 0.0 110.535 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.1 p -64.17 -27.22 68.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.232 -0.917 . . . . 0.0 108.996 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.597 ' H ' HG22 ' A' ' 10' ' ' THR . 97.7 mt-10 -114.02 74.36 0.87 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.513 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 8.6 m -69.29 150.61 47.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.269 -0.894 . . . . 0.0 110.304 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.27 -1.05 34.62 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.9 pt -125.59 -10.35 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.676 -0.64 . . . . 0.0 110.491 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -125.7 141.0 52.23 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.201 -0.937 . . . . 0.0 110.191 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.8 t -69.18 -20.73 64.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.668 -0.645 . . . . 0.0 110.995 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -132.57 142.65 49.26 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.106 -0.997 . . . . 0.0 110.668 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.44 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -154.74 169.61 32.97 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.474 -1.015 . . . . 0.0 109.647 -179.963 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.0 mm . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.447 HG22 ' HB ' ' A' ' 122' ' ' VAL . 54.7 t -118.98 131.97 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.371 -0.831 . . . . 0.0 110.565 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.417 ' O ' ' O ' ' A' ' 124' ' ' THR . 89.0 m -102.1 102.65 13.15 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.5 m -93.07 119.97 32.87 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.081 -1.012 . . . . 0.0 109.574 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.586 ' CG2' HG12 ' A' ' 125' ' ' VAL . 11.8 m -140.33 141.03 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.656 -0.653 . . . . 0.0 109.344 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -87.02 129.89 34.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.078 -1.014 . . . . 0.0 109.452 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.434 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -98.58 159.64 14.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 109.504 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.48 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 26.1 t60 -134.77 154.05 51.76 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.282 -0.886 . . . . 0.0 109.568 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.55 -26.48 32.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.373 -0.829 . . . . 0.0 109.762 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -99.49 -27.04 13.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.904 . . . . 0.0 109.866 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 83.9 m-20 -69.91 132.79 46.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.199 -0.938 . . . . 0.0 110.152 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.418 HD22 ' HD3' ' A' ' 98' ' ' ARG . 21.2 mt -77.81 145.09 36.57 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.549 HD13 HD21 ' A' ' 99' ' ' LEU . 21.7 pt -117.37 137.45 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.169 -0.957 . . . . 0.0 110.15 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.1 154.08 11.61 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -142.45 173.55 11.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.022 -1.281 . . . . 0.0 109.879 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -146.65 144.72 29.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.356 -0.84 . . . . 0.0 109.87 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 88.7 m -123.34 152.11 63.76 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.449 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.8 Cg_endo -51.55 151.52 14.02 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.321 2.014 . . . . 0.0 112.043 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.3 m -71.7 -13.62 61.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.456 -0.777 . . . . 0.0 110.59 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.609 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 82.4 m-20 -90.84 -1.34 57.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.961 -1.087 . . . . 0.0 110.196 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.449 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.3 m-85 -108.11 164.13 12.56 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.306 -0.871 . . . . 0.0 110.492 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.1 t -104.72 137.55 42.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.295 -0.878 . . . . 0.0 108.982 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.8 m -93.13 121.86 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.066 -1.021 . . . . 0.0 110.212 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.414 ' O ' ' O ' ' A' ' 112' ' ' VAL . 10.4 mt-10 -126.19 124.61 24.57 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.15 113.51 3.41 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.623 1.548 . . . . 0.0 112.097 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 68' ' ' PHE . 12.6 t-80 -93.51 -24.0 18.15 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 110' ' ' PHE . 68.0 t0 -171.0 48.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.668 ' H ' ' CB ' ' A' ' 67' ' ' ALA . 91.0 m -71.59 -154.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.518 -0.739 . . . . 0.0 109.774 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.474 ' CD2' HG23 ' A' ' 65' ' ' VAL . 3.6 p90 -112.17 -49.26 2.98 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.299 -0.876 . . . . 0.0 111.649 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.474 HG23 ' CD2' ' A' ' 64' ' ' PHE . 76.5 t -59.47 -48.27 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.291 -1.506 . . . . 0.0 109.43 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.3 t -161.16 130.8 4.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.668 ' CB ' ' H ' ' A' ' 63' ' ' CYS . . . -173.93 -178.49 1.54 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.129 -0.982 . . . . 0.0 110.414 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 6.1 m-85 -93.06 125.59 37.73 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -70.86 -173.92 0.86 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.107 -0.995 . . . . 0.0 109.871 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 70' ' ' LEU . 11.1 mp -64.45 -21.37 66.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.301 -0.874 . . . . 0.0 109.037 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.8 m -82.35 -8.27 59.63 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.306 -0.871 . . . . 0.0 108.943 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.35 17.72 63.91 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -104.91 145.02 30.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.327 -1.102 . . . . 0.0 109.213 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -83.63 117.8 23.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.486 -0.759 . . . . 0.0 110.149 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -149.73 136.36 19.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.836 . . . . 0.0 110.211 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -59.73 142.96 52.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.494 HD11 ' HD2' ' A' ' 80' ' ' LYS . 13.5 tp -95.45 7.07 47.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.227 -0.921 . . . . 0.0 109.775 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' A' ' 79' ' ' ASN . 0.3 OUTLIER -68.82 -39.9 79.79 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.269 -0.894 . . . . 0.0 109.991 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.448 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 91.3 m-20 -62.04 -36.03 80.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.017 . . . . 0.0 109.121 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.494 ' HD2' HD11 ' A' ' 77' ' ' LEU . 21.5 ttmt -72.53 -48.72 38.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.514 -0.741 . . . . 0.0 109.657 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.505 HD11 ' HG2' ' A' ' 100' ' ' PRO . 42.6 tp -148.79 120.84 8.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.468 -0.77 . . . . 0.0 108.997 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.48 113.1 19.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.968 . . . . 0.0 109.502 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.2 mt -90.5 159.27 16.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.857 . . . . 0.0 109.917 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 46.7 p -127.14 160.79 30.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.464 -0.773 . . . . 0.0 109.223 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.439 HD22 ' HG3' ' A' ' 98' ' ' ARG . 95.8 m-20 55.5 52.11 11.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -0.947 . . . . 0.0 109.814 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.2 mt -79.03 127.81 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.922 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.6 mm -122.18 121.51 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.49 -0.756 . . . . 0.0 109.174 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 86.6 mtp -121.84 103.18 8.67 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.222 -0.924 . . . . 0.0 109.569 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -112.24 100.76 9.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.377 -0.827 . . . . 0.0 109.033 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.476 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 77.5 m80 -71.18 -37.41 72.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.006 -1.059 . . . . 0.0 110.596 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -60.7 -46.03 91.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.972 -1.08 . . . . 0.0 109.704 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -88.71 -4.73 58.46 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.092 -1.005 . . . . 0.0 109.112 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.6 m-20 53.36 47.72 23.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.417 -0.802 . . . . 0.0 110.04 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.585 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.0 t -132.63 137.04 46.87 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.024 -1.047 . . . . 0.0 109.403 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -126.86 139.37 53.13 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.068 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.585 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 72.3 m-85 -136.42 146.31 46.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.27 -0.893 . . . . 0.0 109.259 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.9 m -151.18 151.53 32.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.175 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.439 ' HG3' HD22 ' A' ' 85' ' ' ASN . 7.5 mmm180 -102.32 131.87 48.65 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.351 -0.843 . . . . 0.0 109.576 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.549 HD21 HD13 ' A' ' 48' ' ' ILE . 92.6 mt -86.43 137.16 34.58 Favored Pre-proline 0 N--CA 1.489 1.479 0 C-N-CA 120.431 -0.508 . . . . 0.0 109.717 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.505 ' HG2' HD11 ' A' ' 81' ' ' LEU . 77.7 Cg_exo -45.86 -177.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.954 1.77 . . . . 0.0 111.204 178.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.6 t -88.88 -19.23 26.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.963 -1.085 . . . . 0.0 110.107 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.7 tp -124.42 128.47 49.08 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.283 -0.886 . . . . 0.0 110.516 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 78.5 mt -149.74 102.72 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 92.4 p -113.08 1.0 15.16 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.316 -0.865 . . . . 0.0 109.89 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.601 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 49.3 t0 -83.51 153.23 24.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 110.114 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.601 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 95.5 m-20 -96.23 33.36 1.77 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.453 -0.779 . . . . 0.0 108.938 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.516 ' CD1' ' OXT' ' A' ' 127' ' ' ALA . 11.9 p-90 -63.99 154.24 34.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 110.628 -178.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -140.06 150.13 43.99 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.637 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 32.5 p90 -154.5 161.86 41.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.096 -1.002 . . . . 0.0 108.595 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.42 ' O ' ' C ' ' A' ' 62' ' ' ASP . 13.3 p90 -153.58 158.44 41.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.738 -1.226 . . . . 0.0 111.906 -178.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 90.8 m -123.61 156.79 35.13 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 122' ' ' VAL . 50.7 t -127.91 137.66 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 120.96 -1.088 . . . . 0.0 111.736 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.2 m -119.22 130.52 55.52 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.0 p -171.54 178.73 3.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.41 -1.431 . . . . 0.0 111.577 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.609 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 49.3 mtmt -150.06 164.38 35.7 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 117' ' ' ASN . 88.3 m-20 -58.21 151.39 19.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.863 -1.148 . . . . 0.0 109.175 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.481 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 54.3 t-20 43.69 61.94 2.09 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.172 -0.955 . . . . 0.0 109.772 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.481 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 36.1 mt-10 -164.46 144.13 7.53 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.136 -0.978 . . . . 0.0 110.145 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.0 mmmt -55.1 135.26 49.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.326 -0.859 . . . . 0.0 109.216 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -85.27 140.97 30.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.165 -0.96 . . . . 0.0 110.327 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.7 mt -110.17 123.67 50.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.554 -0.716 . . . . 0.0 109.187 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 112' ' ' VAL . 46.7 t -108.69 130.05 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.032 -1.042 . . . . 0.0 110.387 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -108.03 118.68 37.38 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 38' ' ' CYS . 6.1 t -136.74 142.52 43.05 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.496 1.141 . . . . 0.0 112.109 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.637 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -137.05 160.23 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -131.03 147.83 52.68 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.263 -0.898 . . . . 0.0 110.409 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.516 ' OXT' ' CD1' ' A' ' 107' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.432 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.456 HG13 ' CB ' ' A' ' 47' ' ' LEU . 85.4 t -87.59 135.51 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.93 . . . . 0.0 110.117 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -66.55 124.53 23.06 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.662 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.97 166.93 34.71 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.2 t -107.04 129.89 54.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.455 -1.026 . . . . 0.0 109.192 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.473 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 35.6 t0 -108.49 109.28 20.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.529 -0.732 . . . . 0.0 109.461 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.416 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 86.2 m-85 -89.49 1.7 55.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 108.948 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.5 m -101.99 -18.36 15.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.516 -0.74 . . . . 0.0 110.62 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 12' ' ' GLU . 8.5 m -156.86 126.5 6.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.761 -1.212 . . . . 0.0 110.383 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.6 m -67.06 -26.38 66.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.443 -0.785 . . . . 0.0 109.138 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.447 ' H ' HG22 ' A' ' 10' ' ' THR . 79.6 mm-40 -113.59 73.91 0.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 20.7 p -71.73 153.27 42.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.385 -0.822 . . . . 0.0 110.221 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.38 -1.27 31.19 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.3 pt -125.67 -13.45 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.661 -0.649 . . . . 0.0 110.443 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.461 ' O ' ' OG ' ' A' ' 13' ' ' SER . 76.5 m-85 -121.63 137.13 54.87 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.283 -0.886 . . . . 0.0 109.925 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.8 t -68.12 -20.04 64.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.578 -0.701 . . . . 0.0 110.669 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -131.95 142.55 49.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.95 -1.094 . . . . 0.0 110.745 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.473 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -154.88 168.36 32.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 . . . . . 0 N--CA 1.493 1.709 0 O-C-N 121.334 -1.098 . . . . 0.0 109.586 179.867 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.8 mm . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -118.77 131.42 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.314 -0.867 . . . . 0.0 110.526 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 124' ' ' THR . 95.1 m -101.57 101.06 11.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.1 m -94.35 120.09 34.07 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.143 -0.973 . . . . 0.0 109.852 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.484 ' CG2' HG12 ' A' ' 125' ' ' VAL . 20.3 m -141.12 155.8 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.499 -0.751 . . . . 0.0 109.184 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -97.07 131.07 44.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.371 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.27 162.92 12.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.595 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.461 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 34.3 t-80 -132.59 148.97 52.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.307 -0.871 . . . . 0.0 109.454 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -52.48 -26.94 14.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 109.889 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -99.71 -23.15 15.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 109.786 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.461 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 92.1 m-20 -74.18 136.83 42.84 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.415 -0.803 . . . . 0.0 110.156 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.588 HD21 ' NE ' ' A' ' 98' ' ' ARG . 15.1 mt -75.52 143.37 42.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 108.826 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.0 pt -121.14 142.8 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.288 -0.883 . . . . 0.0 110.091 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.47 -175.39 47.21 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.484 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 48.9 p90 -164.12 169.01 18.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.059 -1.259 . . . . 0.0 109.639 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -146.03 144.14 29.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.762 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 84.1 m -125.58 152.17 71.51 Favored Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.52 151.3 14.26 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.273 1.982 . . . . 0.0 111.952 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.9 m -71.23 -11.01 60.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.379 -0.826 . . . . 0.0 110.673 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.618 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 83.6 m-20 -90.69 -1.71 57.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.938 -1.101 . . . . 0.0 110.092 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.434 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 20.5 m-85 -109.61 164.04 12.9 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.149 -0.97 . . . . 0.0 110.315 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 m -102.81 146.21 28.6 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.374 -0.829 . . . . 0.0 109.043 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.6 m -101.02 124.19 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.99 -1.069 . . . . 0.0 110.087 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -130.63 127.25 22.26 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.09 113.79 3.47 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.657 1.571 . . . . 0.0 112.146 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.495 ' O ' ' O ' ' A' ' 68' ' ' PHE . 27.1 t-80 -93.88 -26.4 16.91 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.7 t0 -168.26 38.35 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.459 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 81.8 m -62.75 -155.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.735 . . . . 0.0 109.836 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 4.8 p90 -107.95 -54.54 2.48 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.195 -0.941 . . . . 0.0 111.475 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.0 t -49.13 -71.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.67 -1.269 . . . . 0.0 108.728 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.7 t -142.4 131.36 23.04 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.459 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -168.94 -179.57 3.72 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.364 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.4 m-85 -94.61 145.1 25.06 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.431 HD21 ' HG2' ' A' ' 75' ' ' GLU . 99.6 m-20 -86.59 -172.89 4.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.93 -1.106 . . . . 0.0 109.695 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.0 mt -64.65 -15.37 61.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -0.881 . . . . 0.0 109.16 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.3 m -86.92 -6.42 58.78 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.361 -0.837 . . . . 0.0 108.948 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.34 20.47 69.36 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -107.55 142.46 37.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.291 -1.123 . . . . 0.0 109.207 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -66.05 131.66 46.74 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.212 -0.93 . . . . 0.0 109.899 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.431 ' HG2' HD21 ' A' ' 69' ' ' ASN . 30.7 tp10 -152.21 163.26 39.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.364 -0.835 . . . . 0.0 109.405 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -107.01 138.06 43.89 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.175 -0.953 . . . . 0.0 109.553 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.1 tp -88.03 -8.83 55.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.105 -0.997 . . . . 0.0 109.921 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.586 ' OE1' ' N ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -60.0 -45.99 90.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.869 -1.144 . . . . 0.0 109.532 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.592 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 28.7 p30 -63.8 -34.8 78.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.073 -1.017 . . . . 0.0 108.951 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.592 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 9.1 tppt? -69.91 -51.67 31.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 109.112 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.455 HD11 ' HG2' ' A' ' 100' ' ' PRO . 20.7 tp -151.76 121.42 6.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.448 -0.783 . . . . 0.0 108.958 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -78.17 113.78 16.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.018 -1.051 . . . . 0.0 109.573 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.72 162.3 17.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.412 -0.805 . . . . 0.0 109.974 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 70.4 p -129.55 162.0 29.21 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.349 -0.845 . . . . 0.0 109.331 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.474 HD22 ' HG3' ' A' ' 98' ' ' ARG . 73.6 m-80 55.36 51.23 13.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 109.691 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.5 mt -81.13 131.44 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.327 -0.858 . . . . 0.0 110.264 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.3 mm -127.58 123.5 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.456 -0.777 . . . . 0.0 109.073 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 72.6 mtp -122.59 104.09 9.11 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.21 -0.932 . . . . 0.0 109.761 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -111.9 100.7 9.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.327 -0.858 . . . . 0.0 109.039 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.488 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 97.5 m-70 -72.32 -36.41 68.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.882 -1.136 . . . . 0.0 110.642 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -60.51 -46.16 91.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.999 -1.063 . . . . 0.0 109.528 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -88.91 -4.83 58.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.071 -1.018 . . . . 0.0 109.149 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.5 m-20 54.48 48.17 21.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.468 -0.77 . . . . 0.0 110.273 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.601 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.9 t -134.02 139.46 46.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.994 -1.066 . . . . 0.0 109.296 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.484 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 75.2 m-85 -128.4 140.33 51.9 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.483 -0.761 . . . . 0.0 110.071 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.601 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 72.0 m-85 -137.99 147.96 44.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.323 -0.861 . . . . 0.0 109.13 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.4 p -156.33 157.98 36.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.08 -1.012 . . . . 0.0 109.21 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.588 ' NE ' HD21 ' A' ' 47' ' ' LEU . 18.7 mmt180 -104.08 137.65 41.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.324 -0.86 . . . . 0.0 109.613 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.422 ' HB3' HD11 ' A' ' 103' ' ' ILE . 54.8 mt -87.81 137.5 31.74 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.65 -0.656 . . . . 0.0 109.62 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.493 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 77.5 Cg_exo -46.88 154.04 1.21 Allowed 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.745 1.63 . . . . 0.0 111.212 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 54.0 m -62.56 -36.86 84.01 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.118 -0.989 . . . . 0.0 109.93 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.4 tp -111.34 130.63 55.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.26 -0.9 . . . . 0.0 110.55 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.422 HD11 ' HB3' ' A' ' 99' ' ' LEU . 95.3 mt -145.71 103.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.401 -0.812 . . . . 0.0 108.857 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.459 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 7.1 m -111.18 53.58 0.7 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.179 -0.951 . . . . 0.0 109.647 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.479 ' O ' ' OXT' ' A' ' 127' ' ' ALA . 83.1 m-20 -144.86 156.5 44.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 110.029 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -102.89 33.06 3.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.426 -0.796 . . . . 0.0 109.09 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 19.3 p-90 -65.15 150.8 47.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.411 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -132.38 151.08 52.01 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.625 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 32.2 p90 -151.62 161.0 43.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.196 -0.94 . . . . 0.0 108.665 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 8.1 p90 -154.19 164.33 38.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.741 -1.225 . . . . 0.0 111.912 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 85.2 m -127.72 157.96 38.91 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.533 HG22 HG22 ' A' ' 122' ' ' VAL . 44.2 t -127.72 137.88 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.802 -1.186 . . . . 0.0 111.929 -178.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 70.9 m -119.24 130.04 55.25 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.7 p -169.29 179.33 3.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.281 -1.512 . . . . 0.0 111.658 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.618 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 42.2 mtmt -158.78 167.67 28.86 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 117' ' ' ASN . 54.1 p-10 -58.56 151.55 20.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.766 -1.209 . . . . 0.0 109.008 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.452 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 58.9 t-20 41.42 58.71 2.6 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.329 -0.857 . . . . 0.0 109.6 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 66.5 mm-40 -157.87 137.5 12.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.394 -0.817 . . . . 0.0 110.503 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -54.69 136.5 45.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.366 -0.834 . . . . 0.0 109.12 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.452 ' H ' ' HG2' ' A' ' 120' ' ' LYS . 4.4 pttm -85.36 139.08 31.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.217 -0.927 . . . . 0.0 110.49 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.9 mt -111.77 125.48 54.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.556 -0.715 . . . . 0.0 109.354 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.533 HG22 HG22 ' A' ' 112' ' ' VAL . 53.4 t -110.98 131.25 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.036 -1.04 . . . . 0.0 110.561 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -108.73 119.46 39.61 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 38' ' ' CYS . 6.8 t -136.83 141.52 42.86 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.957 -1.089 . . . . 0.0 111.989 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.625 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -136.41 156.55 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -127.13 151.01 49.22 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.179 -0.951 . . . . 0.0 110.265 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.479 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.365 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.3 mttp . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.438 HG13 ' HB2' ' A' ' 47' ' ' LEU . 84.6 t -91.66 135.63 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 110.267 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -69.55 123.2 20.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.9 -1.125 . . . . 0.0 108.543 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.76 174.87 46.07 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.656 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 7.7 t -114.8 128.19 56.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.441 -1.035 . . . . 0.0 109.292 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.442 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 51.8 t0 -106.05 109.05 20.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.505 -0.747 . . . . 0.0 109.359 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 97.6 m-85 -88.05 -0.12 56.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.226 -0.921 . . . . 0.0 108.961 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.5 m -101.47 -15.67 17.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.42 -0.8 . . . . 0.0 110.578 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 12' ' ' GLU . 6.5 m -159.89 129.24 5.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.88 -1.137 . . . . 0.0 110.316 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.501 ' OG ' ' OE1' ' A' ' 12' ' ' GLU . 78.2 p -70.76 -22.78 62.36 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.587 -0.845 . . . . 0.0 108.852 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.505 ' H ' HG22 ' A' ' 10' ' ' THR . 57.9 mp0 -114.16 74.12 0.86 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.442 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 6.4 m -70.77 151.32 44.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.371 -0.83 . . . . 0.0 110.241 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.0 -0.72 35.99 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.7 pt -125.91 -22.8 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.612 -0.68 . . . . 0.0 110.34 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -112.15 141.97 45.18 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.261 -0.9 . . . . 0.0 110.015 -178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.3 p -75.59 -21.14 58.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.519 -0.738 . . . . 0.0 110.958 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -118.66 127.89 54.0 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.138 -0.976 . . . . 0.0 110.449 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.94 153.84 20.69 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.656 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 20.4 m-85 . . . . . 0 N--CA 1.495 1.783 0 O-C-N 121.479 -1.013 . . . . 0.0 109.557 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.6 mm . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' A' ' 122' ' ' VAL . 50.9 t -119.96 129.86 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.334 -0.854 . . . . 0.0 110.277 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.44 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 76.6 m -102.61 101.87 12.05 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.8 m -95.19 120.51 35.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.16 -0.962 . . . . 0.0 109.84 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.549 ' CG2' HG12 ' A' ' 125' ' ' VAL . 26.1 m -140.43 157.45 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.467 -0.771 . . . . 0.0 109.146 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -99.99 133.74 43.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.114 -0.991 . . . . 0.0 109.398 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.22 160.7 14.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 0.0 109.52 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.403 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 20.8 t60 -134.58 152.38 51.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.19 -27.57 35.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.363 -0.835 . . . . 0.0 109.823 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -99.05 -25.46 14.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.934 . . . . 0.0 109.647 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 97.1 m-20 -75.14 133.29 41.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.363 -0.836 . . . . 0.0 110.074 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.438 ' HB2' HG13 ' A' ' 3' ' ' VAL . 49.6 mt -77.94 148.41 34.51 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.48 HD13 HD21 ' A' ' 99' ' ' LEU . 13.2 pt -120.94 142.78 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.272 -0.892 . . . . 0.0 110.048 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 95' ' ' PHE . . . 176.78 -172.6 45.56 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.466 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 51.4 p90 -170.14 170.17 7.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -1.218 . . . . 0.0 109.79 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -145.06 143.43 30.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.289 -0.882 . . . . 0.0 109.703 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.2 m -125.57 154.28 72.75 Favored Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.419 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.8 Cg_endo -51.53 143.35 36.33 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.213 1.942 . . . . 0.0 111.991 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.1 t -67.28 -12.84 61.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.387 -0.821 . . . . 0.0 110.595 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -89.46 3.33 52.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.941 -1.1 . . . . 0.0 110.197 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.572 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 20.7 m-85 -113.29 167.73 10.32 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.157 -0.965 . . . . 0.0 110.324 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.8 t -103.35 138.47 40.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.328 -0.858 . . . . 0.0 108.903 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.4 m -97.29 118.05 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.987 -1.07 . . . . 0.0 110.386 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -126.76 129.53 24.03 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.97 114.34 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.628 1.552 . . . . 0.0 111.959 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.447 ' O ' ' O ' ' A' ' 68' ' ' PHE . 10.9 t-80 -87.76 -24.38 23.81 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.1 t0 -172.93 38.91 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.452 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 71.1 m -60.92 -152.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.549 -0.719 . . . . 0.0 109.762 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.445 ' O ' ' C ' ' A' ' 65' ' ' VAL . 3.9 p90 -109.42 -58.7 2.0 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.216 -0.928 . . . . 0.0 111.354 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 66' ' ' SER . 13.4 t -46.67 -74.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.436 -1.415 . . . . 0.0 108.927 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.513 ' N ' HG12 ' A' ' 65' ' ' VAL . 32.4 t -135.96 132.02 35.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.452 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.84 179.89 2.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.01 . . . . 0.0 110.459 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.4 m-85 -93.69 128.2 39.78 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -73.61 -176.51 2.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.953 -1.092 . . . . 0.0 109.844 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.59 -20.4 65.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.932 . . . . 0.0 109.035 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.5 m -83.92 -6.43 59.42 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.74 19.05 64.36 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -100.18 139.06 36.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -1.149 . . . . 0.0 109.019 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -85.4 108.77 18.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.205 -0.934 . . . . 0.0 109.994 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -146.06 140.48 26.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.435 -0.791 . . . . 0.0 109.91 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 -62.15 148.95 42.83 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.475 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.42 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 13.0 tp -96.51 7.53 46.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.209 -0.932 . . . . 0.0 109.724 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -69.07 -40.6 78.39 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.949 -1.094 . . . . 0.0 109.878 -179.583 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.501 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 95.2 m-20 -64.31 -38.85 92.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.173 -0.955 . . . . 0.0 109.122 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -67.81 -53.23 28.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.216 -0.927 . . . . 0.0 109.389 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.523 HD22 ' CZ2' ' A' ' 107' ' ' TRP . 35.7 tp -143.23 121.57 12.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.413 -0.805 . . . . 0.0 109.049 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -81.03 104.88 11.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 109.371 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.537 HD13 ' OG ' ' A' ' 97' ' ' SER . 91.9 mt -84.3 163.03 19.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 109.949 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 46.6 p -129.95 162.94 27.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.438 -0.789 . . . . 0.0 109.384 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 54.39 51.85 13.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.159 -0.963 . . . . 0.0 109.775 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -81.31 128.76 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 110.117 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.5 mm -125.91 123.67 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.528 -0.733 . . . . 0.0 109.206 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 91.3 mtp -123.45 104.93 9.38 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.164 -0.96 . . . . 0.0 109.829 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -110.19 100.24 9.17 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.382 -0.824 . . . . 0.0 109.014 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.509 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 98.7 m-70 -73.0 -34.75 66.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.978 -1.076 . . . . 0.0 110.643 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -61.58 -44.91 96.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.964 -1.085 . . . . 0.0 109.647 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -88.65 -4.72 58.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.955 . . . . 0.0 109.104 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.509 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 1.6 m-20 56.5 45.57 22.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.492 -0.755 . . . . 0.0 109.995 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.575 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.7 t -132.26 138.73 48.0 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.04 -1.037 . . . . 0.0 109.385 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.466 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 69.5 m-85 -127.62 139.74 52.54 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.406 -0.809 . . . . 0.0 109.986 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.615 ' CB ' HH12 ' A' ' 98' ' ' ARG . 82.5 m-85 -136.45 147.03 46.99 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.293 -0.879 . . . . 0.0 109.278 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.583 ' N ' ' NH1' ' A' ' 98' ' ' ARG . 38.2 t -153.41 150.72 29.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.114 -0.991 . . . . 0.0 109.357 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.615 HH12 ' CB ' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -105.88 139.27 40.69 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.222 -0.924 . . . . 0.0 109.541 -179.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.523 ' HB3' HD11 ' A' ' 103' ' ' ILE . 42.9 mt -93.65 142.38 25.06 Favored Pre-proline 0 N--CA 1.491 1.613 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.69 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.489 ' HG2' HD11 ' A' ' 81' ' ' LEU . 78.0 Cg_exo -46.83 157.47 0.52 Allowed 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.713 1.608 . . . . 0.0 111.226 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.1 t -67.27 -17.25 64.71 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.157 -0.965 . . . . 0.0 109.702 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 45.9 tp -122.2 130.84 53.57 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.281 -0.887 . . . . 0.0 110.555 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.523 HD11 ' HB3' ' A' ' 99' ' ' LEU . 24.2 mt -144.39 124.5 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.6 m -133.3 15.75 4.12 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.042 -1.036 . . . . 0.0 109.855 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -109.02 154.15 22.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.329 -0.857 . . . . 0.0 110.014 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -95.99 32.13 1.98 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.471 -0.768 . . . . 0.0 108.997 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.523 ' CZ2' HD22 ' A' ' 81' ' ' LEU . 18.2 p-90 -66.33 156.86 33.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.899 . . . . 0.0 110.636 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -143.78 155.42 44.15 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.632 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 38.3 p90 -151.88 161.46 42.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.208 -0.933 . . . . 0.0 108.785 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 5.5 p90 -152.24 161.17 43.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.77 -1.206 . . . . 0.0 111.813 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 91.7 m -127.97 157.45 40.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.616 HG22 HG22 ' A' ' 122' ' ' VAL . 43.8 t -130.22 142.22 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.836 -1.165 . . . . 0.0 111.712 -178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 75.1 m -119.86 131.1 55.17 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.4 p -170.8 179.06 3.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.215 -1.553 . . . . 0.0 111.616 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.464 ' HZ2' ' HB3' ' A' ' 115' ' ' LYS . 5.6 mtmp? -158.11 167.34 30.12 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 117' ' ' ASN . 91.3 m-20 -58.13 150.5 21.12 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.818 -1.176 . . . . 0.0 109.119 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.437 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 66.5 t30 44.38 59.99 3.03 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.172 -0.955 . . . . 0.0 109.809 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.572 ' OE1' ' CE2' ' A' ' 56' ' ' TYR . 49.7 mt-10 -162.06 140.77 9.3 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.18 -0.95 . . . . 0.0 110.21 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -56.63 144.47 31.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 109.209 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -93.54 141.0 28.96 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.123 -0.986 . . . . 0.0 110.315 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.416 HD13 ' CG ' ' A' ' 8' ' ' PHE . 75.0 mt -112.3 125.73 54.48 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.546 -0.721 . . . . 0.0 109.151 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.616 HG22 HG22 ' A' ' 112' ' ' VAL . 49.5 t -110.92 131.27 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.036 -1.04 . . . . 0.0 110.63 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -109.65 121.17 44.62 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.7 t -137.24 141.82 42.04 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.953 -1.092 . . . . 0.0 112.114 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.632 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.1 m -135.49 157.77 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -128.25 150.94 49.82 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.208 -0.932 . . . . 0.0 110.263 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.498 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.253 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.4 mttt . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 66.9 t -99.31 133.84 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.306 -0.871 . . . . 0.0 109.831 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -67.48 122.91 19.0 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.134 -0.979 . . . . 0.0 108.544 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.82 162.99 26.58 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.7 t -103.5 135.25 45.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.477 -1.014 . . . . 0.0 110.084 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.509 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 67.7 t0 -111.98 109.43 19.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.371 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -87.4 -0.92 57.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 108.985 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.3 m -98.89 -17.67 18.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.645 -0.659 . . . . 0.0 110.505 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 12' ' ' GLU . 4.2 m -160.41 131.08 5.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.764 -1.21 . . . . 0.0 110.223 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.1 p -64.17 -26.18 68.41 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.697 -0.801 . . . . 0.0 108.851 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.438 ' H ' HG22 ' A' ' 10' ' ' THR . 98.4 mt-10 -114.37 102.12 9.8 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.517 ' C ' ' H ' ' A' ' 15' ' ' ILE . 23.6 m -102.8 113.28 26.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -0.803 . . . . 0.0 110.372 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.5 t -65.64 2.88 0.85 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.517 ' H ' ' C ' ' A' ' 13' ' ' SER . 6.8 pt -123.56 -32.6 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.482 -0.761 . . . . 0.0 110.325 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.5 ' CZ ' ' CE2' ' A' ' 96' ' ' TYR . 53.8 m-85 -113.07 146.76 38.58 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.954 -1.091 . . . . 0.0 109.854 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 m -79.85 -20.82 45.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.38 -0.825 . . . . 0.0 110.956 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -119.9 131.18 55.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.708 -1.245 . . . . 0.0 110.86 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.463 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -150.51 158.66 27.78 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.201 -1.176 . . . . 0.0 109.609 -179.927 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.8 mm . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.7 t -114.9 127.73 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.1 -1.0 . . . . 0.0 110.268 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 81.3 m -102.51 102.49 12.77 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.6 m -95.07 120.19 34.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -0.981 . . . . 0.0 109.763 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.524 ' CG2' HG12 ' A' ' 125' ' ' VAL . 21.7 m -139.78 156.74 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.395 -0.816 . . . . 0.0 108.996 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.3 130.7 45.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.203 -0.936 . . . . 0.0 109.341 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.88 161.71 14.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 109.635 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -139.0 150.31 45.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 109.586 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.46 -25.2 50.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 109.818 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -98.98 -26.29 14.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.162 -0.961 . . . . 0.0 109.667 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -78.97 134.97 36.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.531 -0.73 . . . . 0.0 110.013 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.7 mt -78.13 149.88 33.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 108.554 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.492 ' CD1' HD21 ' A' ' 99' ' ' LEU . 24.0 pt -120.82 142.42 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.887 -1.133 . . . . 0.0 110.027 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.2 -170.66 43.34 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -172.9 171.17 4.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.063 -1.257 . . . . 0.0 109.684 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -146.42 145.01 30.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.317 -0.865 . . . . 0.0 109.866 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.6 m -125.03 152.26 70.2 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.435 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.33 145.58 27.13 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.328 2.019 . . . . 0.0 112.026 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.9 m -68.65 -11.97 60.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.428 -0.795 . . . . 0.0 110.606 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.596 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 79.4 m-20 -91.44 1.03 57.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.928 -1.107 . . . . 0.0 110.039 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.51 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 19.4 m-85 -111.59 166.53 11.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.919 -1.113 . . . . 0.0 110.162 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -104.53 131.26 52.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.302 -0.874 . . . . 0.0 109.339 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.6 m -89.14 121.12 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.006 -1.059 . . . . 0.0 110.203 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -125.81 129.15 24.41 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.21 114.42 3.55 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.664 1.576 . . . . 0.0 112.088 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.465 ' O ' ' O ' ' A' ' 68' ' ' PHE . 10.8 t-80 -92.93 -25.29 18.1 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.474 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.8 t0 -171.43 40.44 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.508 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 70.8 m -63.7 -152.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.604 -0.685 . . . . 0.0 109.84 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.6 p90 -110.95 -58.9 2.04 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.863 -1.148 . . . . 0.0 111.151 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.442 ' C ' ' O ' ' A' ' 64' ' ' PHE . 25.3 t -45.97 -70.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.442 -1.411 . . . . 0.0 108.897 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.3 t -140.44 130.76 25.16 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.508 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.22 178.48 2.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.926 -1.109 . . . . 0.0 110.425 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 6.5 m-85 -93.12 124.94 37.45 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -69.6 -176.36 1.01 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.936 -1.103 . . . . 0.0 109.759 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 17.5 mt -63.29 -21.73 66.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.857 . . . . 0.0 109.044 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.6 m -81.63 -5.81 58.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.352 -0.842 . . . . 0.0 108.858 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.41 19.94 65.38 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -105.25 141.56 36.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -1.145 . . . . 0.0 109.187 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -83.89 112.83 20.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.115 -0.99 . . . . 0.0 109.944 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -148.13 136.26 21.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.783 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -58.33 144.87 40.03 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.073 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.568 HD11 ' HD2' ' A' ' 80' ' ' LYS . 14.6 tp -97.12 7.4 46.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.186 -0.946 . . . . 0.0 109.691 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.46 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -69.7 -38.74 77.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 109.913 -179.374 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.586 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 49.3 p-10 -61.26 -31.15 70.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.164 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.586 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 37.4 ttmt -74.87 -48.37 25.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.374 -0.828 . . . . 0.0 109.392 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.552 HD22 ' CZ2' ' A' ' 107' ' ' TRP . 31.9 tp -136.74 127.27 26.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.38 -0.825 . . . . 0.0 109.205 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -74.68 85.44 2.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.119 -0.988 . . . . 0.0 109.12 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.0 mt -77.73 138.23 38.92 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.283 -0.885 . . . . 0.0 109.927 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.3 p -126.39 166.52 17.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.543 -0.723 . . . . 0.0 109.315 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 55.51 50.46 14.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.883 . . . . 0.0 109.559 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.89 130.86 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 0.0 110.094 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -120.72 120.3 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.349 -0.844 . . . . 0.0 109.201 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 81.5 mtp -122.53 104.72 9.55 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.987 -1.071 . . . . 0.0 109.98 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -108.52 99.35 8.75 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.248 -0.907 . . . . 0.0 108.805 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.477 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 97.4 m-70 -72.53 -36.89 68.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.985 -1.072 . . . . 0.0 110.686 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -60.54 -45.75 92.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.005 -1.059 . . . . 0.0 109.515 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -87.68 -4.83 58.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.142 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.3 m-20 54.93 47.46 22.17 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 110.348 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.562 ' OG1' ' CE1' ' A' ' 96' ' ' TYR . 2.6 t -134.66 141.94 46.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.956 -1.09 . . . . 0.0 109.387 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -129.44 140.34 51.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.42 -0.8 . . . . 0.0 110.01 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.562 ' CE1' ' OG1' ' A' ' 94' ' ' THR . 82.7 m-85 -135.38 146.14 48.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.23 -0.919 . . . . 0.0 109.483 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.4 m -151.43 153.27 34.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 109.231 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.4 mtt-85 -107.9 138.4 44.23 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.071 -1.018 . . . . 0.0 109.419 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.634 ' HB3' HD11 ' A' ' 103' ' ' ILE . 60.3 mt -96.0 141.17 22.78 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.828 . . . . 0.0 109.727 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.499 ' HG2' HD11 ' A' ' 81' ' ' LEU . 77.9 Cg_exo -45.64 178.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.901 1.734 . . . . 0.0 111.187 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.9 m -85.46 -11.73 53.59 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.035 -1.041 . . . . 0.0 109.689 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.3 tp -124.3 131.14 53.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.007 . . . . 0.0 110.54 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.634 HD11 ' HB3' ' A' ' 99' ' ' LEU . 41.3 mt -147.48 103.82 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 97.4 p -114.0 -0.41 14.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.028 -1.045 . . . . 0.0 109.748 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 0.4 OUTLIER -89.46 153.66 20.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 0.0 110.071 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -98.43 31.98 2.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.459 -0.776 . . . . 0.0 109.127 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.552 ' CZ2' HD22 ' A' ' 81' ' ' LEU . 16.1 p-90 -65.65 159.21 25.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -0.848 . . . . 0.0 110.493 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -146.7 156.82 43.47 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.57 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 43.5 p90 -153.47 163.67 39.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.085 -1.01 . . . . 0.0 108.9 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 6.8 p90 -152.71 163.04 40.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.672 -1.268 . . . . 0.0 111.681 -178.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 87.0 m -130.04 158.64 39.06 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 122' ' ' VAL . 42.9 t -130.74 143.36 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.66 -1.275 . . . . 0.0 111.774 -178.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 87.8 m -123.36 132.61 54.04 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.3 p -170.76 178.69 3.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.298 -1.501 . . . . 0.0 111.743 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.596 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 46.2 mtmt -154.06 165.55 35.82 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.6 150.89 21.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.78 -1.2 . . . . 0.0 109.123 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.527 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 61.8 t-20 46.47 61.27 2.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.266 -0.897 . . . . 0.0 109.52 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 44.4 mt-10 -165.1 145.43 7.16 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.956 -1.09 . . . . 0.0 110.127 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -60.66 147.73 40.98 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.204 -0.935 . . . . 0.0 109.003 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -93.26 140.8 29.14 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.066 -1.021 . . . . 0.0 110.355 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.2 mt -110.17 122.35 47.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.412 -0.805 . . . . 0.0 109.093 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 112' ' ' VAL . 48.7 t -109.96 130.79 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.938 -1.101 . . . . 0.0 110.833 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -109.57 121.46 45.24 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.0 t -137.37 142.15 41.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.666 -1.271 . . . . 0.0 112.029 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.57 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.1 m -135.09 158.04 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -137.12 157.88 45.71 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.89 -1.131 . . . . 0.0 110.128 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.408 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.525 HG22 HD12 ' A' ' 47' ' ' LEU . 53.4 t -103.3 132.81 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -0.893 . . . . 0.0 109.955 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -62.76 117.5 6.41 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.363 -0.935 . . . . 0.0 108.574 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.44 155.7 15.72 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.422 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 4.9 t -100.08 132.01 45.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.562 -0.963 . . . . 0.0 109.493 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.511 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 47.2 t0 -105.05 108.4 19.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.448 -0.783 . . . . 0.0 109.302 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -88.27 -0.99 57.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 108.854 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 m -101.19 -16.56 16.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.492 -0.755 . . . . 0.0 110.434 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.6 m -157.13 124.88 5.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.859 -1.15 . . . . 0.0 110.182 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.493 ' OG ' ' OE1' ' A' ' 12' ' ' GLU . 78.0 p -67.16 -26.9 66.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.369 -0.832 . . . . 0.0 108.98 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.496 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 57.5 mp0 -109.07 72.61 0.82 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 t -74.11 158.59 33.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.407 -0.808 . . . . 0.0 110.137 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.433 HG23 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -103.23 -48.7 3.94 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.131 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.433 ' H ' HG23 ' A' ' 14' ' ' THR . 24.0 pt -86.78 -12.92 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.574 -0.704 . . . . 0.0 110.16 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.417 ' CD2' HG13 ' A' ' 15' ' ' ILE . 68.0 m-85 -110.4 136.93 48.81 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.153 -0.967 . . . . 0.0 109.606 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 t -74.24 -26.7 60.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.431 -0.793 . . . . 0.0 111.157 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -123.3 134.51 54.05 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.07 -1.019 . . . . 0.0 110.787 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.511 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -144.47 156.13 26.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.422 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 22.5 m-85 . . . . . 0 N--CA 1.494 1.75 0 O-C-N 121.333 -1.098 . . . . 0.0 109.647 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.0 mm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.4 t -121.06 126.5 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.0 110.337 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 96.8 m -103.16 102.47 12.46 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.8 m -94.85 120.77 35.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.13 -0.981 . . . . 0.0 109.848 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.518 ' CG2' HG12 ' A' ' 125' ' ' VAL . 27.3 m -139.82 156.73 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.364 -0.835 . . . . 0.0 109.013 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -100.16 131.84 45.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 109.415 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.449 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -97.07 158.09 15.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 109.57 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.428 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 31.5 t60 -134.05 153.25 51.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.207 -0.933 . . . . 0.0 109.53 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.24 -25.03 20.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.349 -0.844 . . . . 0.0 109.772 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -99.74 -25.93 14.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.068 -1.02 . . . . 0.0 109.662 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 77.8 m-20 -75.47 134.57 40.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.88 . . . . 0.0 110.034 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.525 HD12 HG22 ' A' ' 3' ' ' VAL . 83.1 mt -76.24 147.39 38.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 108.661 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.595 HD13 HD21 ' A' ' 99' ' ' LEU . 9.0 pt -116.93 136.57 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.159 -0.963 . . . . 0.0 109.847 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.26 -176.94 47.86 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.438 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 55.6 p90 -164.57 169.77 16.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.087 -1.243 . . . . 0.0 109.858 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -144.17 143.16 30.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.255 -0.903 . . . . 0.0 109.908 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 68.6 m -126.6 152.37 74.47 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.422 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.4 149.16 17.93 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.404 2.069 . . . . 0.0 112.122 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.4 p -71.73 -11.27 60.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.435 -0.791 . . . . 0.0 110.649 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -90.67 0.24 57.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.9 -1.125 . . . . 0.0 110.129 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.422 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 20.7 m-85 -110.36 165.99 11.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.199 -0.938 . . . . 0.0 110.252 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -102.87 133.45 47.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 0.0 109.107 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.1 m -91.13 123.53 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.969 -1.082 . . . . 0.0 110.335 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -130.68 129.16 22.64 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.05 113.53 3.44 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.71 1.607 . . . . 0.0 112.046 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.47 ' O ' ' O ' ' A' ' 68' ' ' PHE . 15.9 t-160 -91.06 -26.66 19.05 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.503 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.5 t0 -169.72 37.13 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.541 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 75.9 m -60.38 -155.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.472 -0.767 . . . . 0.0 109.724 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.3 p90 -111.47 -56.66 2.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.141 -0.974 . . . . 0.0 111.316 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.419 HG23 ' CE2' ' A' ' 64' ' ' PHE . 78.0 t -47.36 -54.7 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 120.479 -1.388 . . . . 0.0 109.062 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -158.08 129.8 6.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.541 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.01 -179.34 1.99 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.957 -1.09 . . . . 0.0 110.442 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 6.3 m-85 -93.16 123.58 36.53 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -70.66 -173.74 0.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 109.787 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 70' ' ' LEU . 10.3 mp -63.61 -21.49 66.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.272 -0.892 . . . . 0.0 109.018 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.7 m -82.44 -7.05 59.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.347 -0.846 . . . . 0.0 108.885 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.41 19.83 65.62 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -102.86 138.78 39.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.212 -1.169 . . . . 0.0 108.999 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -83.7 108.33 16.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 110.004 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -144.2 138.74 28.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.852 . . . . 0.0 109.85 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 77' ' ' LEU . 55.1 t-20 -59.78 145.55 44.87 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.298 -0.876 . . . . 0.0 108.954 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.54 HD11 ' HD2' ' A' ' 80' ' ' LYS . 13.4 tp -97.32 7.44 46.55 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.292 -0.88 . . . . 0.0 109.845 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.449 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -70.12 -37.99 75.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.065 -1.022 . . . . 0.0 110.058 -179.539 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -62.72 -32.73 73.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.044 -1.035 . . . . 0.0 109.156 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.54 ' HD2' HD11 ' A' ' 77' ' ' LEU . 23.4 ttmt -72.41 -50.21 28.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.853 . . . . 0.0 109.634 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.517 HD11 ' HG2' ' A' ' 100' ' ' PRO . 19.2 tp -139.3 128.81 24.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.487 -0.758 . . . . 0.0 109.074 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -78.99 88.28 4.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.988 . . . . 0.0 109.639 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.21 150.82 41.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.357 -0.839 . . . . 0.0 109.936 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.2 p -127.14 164.33 21.86 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.512 -0.742 . . . . 0.0 109.176 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.481 HD22 ' HG3' ' A' ' 98' ' ' ARG . 78.7 m-20 56.1 53.15 9.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 0.0 109.942 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.5 mt -79.68 125.17 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -0.825 . . . . 0.0 109.918 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -123.14 121.99 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.5 -0.75 . . . . 0.0 109.265 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 84.6 mtp -123.25 103.37 8.49 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.108 -0.995 . . . . 0.0 109.696 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -110.98 101.36 9.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.378 -0.826 . . . . 0.0 109.037 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.499 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 91.8 m-70 -72.96 -35.78 66.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.876 -1.14 . . . . 0.0 110.686 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -60.19 -45.91 91.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.942 -1.099 . . . . 0.0 109.572 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -89.87 -4.35 57.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.925 . . . . 0.0 109.064 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.499 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 97.7 m-20 54.52 47.91 21.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.424 -0.798 . . . . 0.0 110.167 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.574 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 2.5 t -133.35 138.64 46.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.171 -0.956 . . . . 0.0 109.451 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.438 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 65.2 m-85 -129.06 140.64 51.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.402 -0.811 . . . . 0.0 109.915 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.574 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 72.1 m-85 -137.74 148.89 46.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.45 -0.781 . . . . 0.0 109.383 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 63.8 m -152.49 155.1 36.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.092 -1.005 . . . . 0.0 109.172 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.489 ' CZ ' HD21 ' A' ' 47' ' ' LEU . 16.6 mmt180 -102.53 136.08 42.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.188 -0.945 . . . . 0.0 109.732 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.646 ' HB3' HD11 ' A' ' 103' ' ' ILE . 68.2 mt -89.92 136.78 28.72 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.803 -0.56 . . . . 0.0 109.699 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.517 ' HG2' HD11 ' A' ' 81' ' ' LEU . 77.9 Cg_exo -45.87 176.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 121.848 1.699 . . . . 0.0 111.188 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.2 m -85.63 -14.66 44.93 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.099 -1.0 . . . . 0.0 109.925 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 47.6 tp -121.04 130.43 53.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.189 -0.945 . . . . 0.0 110.523 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.646 HD11 ' HB3' ' A' ' 99' ' ' LEU . 43.9 mt -149.84 102.88 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.5 p -120.01 3.68 10.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.202 -0.936 . . . . 0.0 109.722 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.518 ' O ' ' OXT' ' A' ' 127' ' ' ALA . 27.9 t70 -93.72 158.97 15.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.97 . . . . 0.0 109.933 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -96.15 33.8 1.68 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.455 -0.778 . . . . 0.0 109.045 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 12.4 p-90 -65.21 154.27 38.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 110.635 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -145.86 155.46 42.91 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.602 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 42.0 p90 -154.35 162.63 41.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.133 -0.979 . . . . 0.0 108.753 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 6.1 p90 -152.79 162.32 41.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.69 -1.256 . . . . 0.0 111.833 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 95.2 m -127.63 157.66 39.64 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 122' ' ' VAL . 42.2 t -130.01 142.62 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.768 -1.208 . . . . 0.0 111.789 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 72.2 m -123.39 132.44 53.97 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.0 p -171.19 178.63 3.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.239 -1.538 . . . . 0.0 111.691 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.637 ' CB ' ' HZ2' ' A' ' 115' ' ' LYS . 7.3 mtmp? -153.41 164.75 37.61 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 117' ' ' ASN . 99.7 m-20 -57.76 152.28 15.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.771 -1.206 . . . . 0.0 109.195 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.515 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 66.8 t30 44.68 60.73 2.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.217 -0.927 . . . . 0.0 109.669 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.59 ' OE2' ' NZ ' ' A' ' 115' ' ' LYS . 36.8 mt-10 -165.37 145.71 6.97 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.136 -0.977 . . . . 0.0 110.178 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -63.67 136.2 57.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.25 -0.906 . . . . 0.0 109.038 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -85.26 146.12 27.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.226 -0.922 . . . . 0.0 110.406 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.1 mt -111.16 123.71 50.74 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.498 -0.751 . . . . 0.0 109.177 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 112' ' ' VAL . 46.0 t -109.03 130.34 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.022 -1.049 . . . . 0.0 110.617 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -110.69 122.62 48.24 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.9 t -137.84 143.28 40.9 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.835 -1.166 . . . . 0.0 112.208 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.602 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.1 m -134.75 156.9 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -134.79 155.58 50.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.982 -1.074 . . . . 0.0 110.272 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.518 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.086 -0.959 . . . . 0.0 109.393 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 mmtp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.92 133.54 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.708 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.61 ' NZ ' ' OD2' ' A' ' 46' ' ' ASP . 2.0 mptm? -74.72 125.49 28.85 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.047 -1.033 . . . . 0.0 108.95 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.95 179.05 44.33 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.436 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 4.8 t -115.97 132.23 56.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.483 -1.01 . . . . 0.0 109.316 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.472 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 29.5 t70 -108.19 109.63 21.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.496 -0.752 . . . . 0.0 109.422 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 91.0 m-85 -89.83 0.05 57.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.227 -0.921 . . . . 0.0 108.857 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.0 m -101.88 -17.88 15.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.566 -0.709 . . . . 0.0 110.505 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 12' ' ' GLU . 6.8 m -156.87 125.22 5.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.878 -1.139 . . . . 0.0 110.249 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.0 p -66.85 -24.84 66.19 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.629 -0.829 . . . . 0.0 108.97 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.441 ' H ' HG22 ' A' ' 10' ' ' THR . 79.0 mm-40 -115.0 74.59 0.89 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.461 ' OG ' ' CG ' ' A' ' 7' ' ' ASP . 20.0 m -71.81 152.39 42.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.83 . . . . 0.0 110.398 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.77 0.29 38.54 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.8 pt -125.27 -23.83 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.646 -0.659 . . . . 0.0 110.292 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -111.78 140.99 45.96 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.243 -0.911 . . . . 0.0 109.92 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.1 p -72.54 -18.42 61.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.589 -0.694 . . . . 0.0 111.045 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -132.14 143.14 49.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.015 -1.053 . . . . 0.0 110.847 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.472 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -152.81 159.91 28.73 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.436 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 32.4 m-85 . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.442 -1.034 . . . . 0.0 109.594 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.2 mm . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.1 t -121.68 126.52 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.277 -0.889 . . . . 0.0 110.173 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.44 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 84.3 m -102.18 100.8 11.05 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.8 m -93.87 119.58 32.99 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.141 -0.974 . . . . 0.0 109.659 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.434 ' CG2' HG12 ' A' ' 125' ' ' VAL . 28.0 m -141.95 153.86 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.49 -0.756 . . . . 0.0 109.232 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.419 ' H ' ' HD3' ' A' ' 41' ' ' LYS . 1.3 mppt? -95.25 133.88 38.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.116 -0.99 . . . . 0.0 109.142 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.435 ' HB1' ' CG2' ' A' ' 48' ' ' ILE . . . -109.47 124.06 50.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.457 -0.777 . . . . 0.0 109.734 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.509 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 28.2 t60 -86.72 148.2 25.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.84 . . . . 0.0 109.542 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.907 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -50.17 -34.26 21.9 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.22 -0.925 . . . . 0.0 109.779 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -89.88 -17.63 27.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.273 -0.892 . . . . 0.0 109.423 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.61 ' OD2' ' NZ ' ' A' ' 4' ' ' LYS . 76.4 m-20 -75.7 136.83 40.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.432 -0.793 . . . . 0.0 110.07 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.3 mt -77.31 145.41 37.41 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.435 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 21.0 pt -121.32 143.21 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.264 -0.898 . . . . 0.0 110.191 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.21 -174.07 46.07 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.613 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 50.8 p90 -170.52 169.62 7.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -1.225 . . . . 0.0 109.831 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -146.17 144.54 30.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.306 -0.871 . . . . 0.0 109.861 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 40.8 m -125.01 153.93 71.29 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.424 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 9.0 Cg_endo -51.51 144.78 31.27 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.337 2.025 . . . . 0.0 112.167 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.6 t -68.3 -13.85 62.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.453 -0.779 . . . . 0.0 110.636 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.623 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.9 m-20 -89.95 1.73 55.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.89 -1.131 . . . . 0.0 110.039 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.424 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 18.9 m-85 -110.79 165.93 11.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.099 -1.001 . . . . 0.0 110.446 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.416 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 39.5 t -102.7 132.92 48.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.344 -0.847 . . . . 0.0 108.96 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.4 m -89.73 120.31 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.992 -1.067 . . . . 0.0 110.346 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 59' ' ' GLU . 35.0 mp0 -127.69 128.08 23.95 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.22 114.3 3.53 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.683 1.588 . . . . 0.0 112.106 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.493 ' O ' ' O ' ' A' ' 68' ' ' PHE . 9.3 t-80 -91.17 -25.33 19.61 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 63' ' ' CYS . 67.4 t0 -171.85 36.43 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.495 ' O ' ' O ' ' A' ' 62' ' ' ASP . 96.5 m -57.13 -155.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.548 -0.72 . . . . 0.0 109.651 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 4.0 p90 -108.77 -56.27 2.29 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.037 -1.04 . . . . 0.0 111.173 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.44 HG23 ' CE2' ' A' ' 64' ' ' PHE . 53.2 t -46.49 -73.42 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.479 -1.388 . . . . 0.0 108.865 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.2 t -140.21 130.71 25.47 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.424 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.19 -178.41 2.07 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.464 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 5.0 m-85 -93.82 128.84 40.28 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -76.45 -174.57 2.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.953 -1.092 . . . . 0.0 109.741 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.4 -20.55 65.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.275 -0.891 . . . . 0.0 109.21 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.9 m -83.38 -6.85 59.59 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.32 19.61 66.3 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -101.43 136.74 40.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -1.167 . . . . 0.0 109.145 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -84.94 112.98 21.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.122 -0.986 . . . . 0.0 110.097 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -150.12 141.55 23.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.41 -0.806 . . . . 0.0 109.983 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 77' ' ' LEU . 56.0 t-20 -61.61 146.71 48.07 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.4 -0.812 . . . . 0.0 109.215 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.539 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 6.6 tp -99.69 6.11 45.63 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.288 -0.882 . . . . 0.0 109.8 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.439 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.8 OUTLIER -75.52 -39.02 58.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.97 -1.081 . . . . 0.0 109.983 -179.449 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 56.5 p30 -59.26 -14.21 10.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.131 -0.981 . . . . 0.0 109.165 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 31.0 ttpt -107.0 -36.17 6.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.382 -0.824 . . . . 0.0 109.327 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.662 HD22 ' CH2' ' A' ' 107' ' ' TRP . 33.1 tp -123.92 129.5 51.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.42 -0.8 . . . . 0.0 109.339 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -73.31 83.46 1.4 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.039 -1.038 . . . . 0.0 109.285 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.572 ' CB ' HD11 ' A' ' 86' ' ' ILE . 24.3 mt -69.32 130.11 41.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.224 -0.923 . . . . 0.0 109.959 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.3 p -133.86 151.71 51.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.397 -0.814 . . . . 0.0 109.302 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 52.82 50.69 17.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.098 -1.001 . . . . 0.0 109.58 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.572 HD11 ' CB ' ' A' ' 83' ' ' LEU . 97.6 mt -78.73 130.37 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.327 -0.858 . . . . 0.0 110.085 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mm -117.85 118.84 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.473 -0.767 . . . . 0.0 109.276 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 81.0 mtp -124.17 108.09 11.92 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.286 -0.884 . . . . 0.0 109.822 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -113.93 102.17 9.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.362 -0.836 . . . . 0.0 109.05 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.501 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 70.2 m80 -72.33 -35.74 68.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.898 -1.126 . . . . 0.0 110.488 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -60.7 -44.86 96.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.874 -1.141 . . . . 0.0 109.457 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -89.41 -5.72 57.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.134 -0.979 . . . . 0.0 109.129 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.501 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.3 m-20 55.36 47.47 21.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.576 -0.702 . . . . 0.0 110.392 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.589 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 2.8 t -132.3 137.5 47.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.146 -0.971 . . . . 0.0 109.404 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.613 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 23.8 m-85 -127.28 139.41 52.92 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.372 -0.83 . . . . 0.0 109.818 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.589 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 81.2 m-85 -135.9 147.01 47.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.21 -0.932 . . . . 0.0 109.358 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.6 t -150.86 150.9 31.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.953 -1.092 . . . . 0.0 109.174 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.413 HH11 ' HG2' ' A' ' 98' ' ' ARG . 60.7 mtt-85 -101.68 134.41 44.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.044 -1.035 . . . . 0.0 109.476 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.4 HD11 HG21 ' A' ' 48' ' ' ILE . 94.7 mt -93.39 139.22 22.86 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.436 -0.79 . . . . 0.0 109.5 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.907 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 77.0 Cg_exo -46.36 163.22 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.853 1.702 . . . . 0.0 111.222 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 m -76.34 -10.15 59.19 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.1 -1.0 . . . . 0.0 109.696 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.8 tp -136.42 129.29 30.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.152 -0.968 . . . . 0.0 110.339 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 88.7 mt -145.69 106.92 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 108.893 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.3 p -100.53 -2.81 32.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.048 -1.032 . . . . 0.0 109.899 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -88.45 156.13 19.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.99 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -105.02 33.2 3.75 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.452 -0.78 . . . . 0.0 109.135 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.662 ' CH2' HD22 ' A' ' 81' ' ' LEU . 24.4 p-90 -65.77 161.53 20.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.141 -0.974 . . . . 0.0 110.625 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -143.54 160.68 40.19 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.622 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 36.4 p90 -155.09 160.65 41.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.17 -0.956 . . . . 0.0 108.674 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.518 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 5.0 p90 -151.67 159.93 43.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.778 -1.201 . . . . 0.0 111.892 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 96.7 m -125.0 156.5 38.01 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.635 HG22 HG22 ' A' ' 122' ' ' VAL . 44.8 t -130.58 143.65 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.839 -1.163 . . . . 0.0 111.764 -178.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 63.4 m -124.66 132.95 53.38 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.6 p -167.62 178.08 5.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.25 -1.531 . . . . 0.0 111.694 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.623 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 46.5 mtmt -155.31 165.04 37.88 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 117' ' ' ASN . 98.2 m-20 -58.69 150.95 22.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.827 -1.171 . . . . 0.0 109.116 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.492 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 64.5 t30 44.53 60.95 2.62 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.232 -0.917 . . . . 0.0 109.639 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 40.4 mt-10 -164.48 144.72 7.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.132 -0.98 . . . . 0.0 110.216 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 69.7 mmtt -63.28 136.66 57.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.197 -0.939 . . . . 0.0 109.111 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.432 ' HG2' ' H ' ' A' ' 120' ' ' LYS . 4.3 pttm -84.26 144.8 28.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.249 -0.907 . . . . 0.0 110.575 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 72.7 mt -110.92 123.67 50.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.583 -0.698 . . . . 0.0 109.181 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.635 HG22 HG22 ' A' ' 112' ' ' VAL . 45.3 t -109.9 130.94 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.01 -1.056 . . . . 0.0 110.679 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -110.37 122.53 47.92 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 38' ' ' CYS . 7.6 t -137.86 142.85 40.71 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.795 -1.191 . . . . 0.0 112.163 -178.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.622 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -136.12 158.18 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -124.01 145.21 49.35 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.106 -0.996 . . . . 0.0 110.415 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.279 179.792 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 69.4 t -106.12 134.32 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.162 -0.962 . . . . 0.0 110.042 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -70.47 124.04 23.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.065 -1.022 . . . . 0.0 108.371 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.18 164.79 30.39 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.471 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 4.4 t -107.59 138.04 44.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.621 -0.929 . . . . 0.0 109.386 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.445 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 67.3 t0 -114.81 109.01 17.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.446 -0.784 . . . . 0.0 109.36 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -86.32 -0.73 56.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 108.928 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.427 ' OG1' ' N ' ' A' ' 53' ' ' PRO . 17.1 m -99.66 -17.92 17.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.638 -0.663 . . . . 0.0 110.5 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.472 HG22 ' H ' ' A' ' 12' ' ' GLU . 9.3 m -158.24 127.64 5.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.769 -1.207 . . . . 0.0 110.263 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.7 p -62.5 -28.08 69.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -0.953 . . . . 0.0 108.973 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.472 ' H ' HG22 ' A' ' 10' ' ' THR . 97.8 mt-10 -109.24 108.4 18.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 15' ' ' ILE . 74.4 m -107.63 109.5 21.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 110.376 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 14' ' ' THR . 0.1 OUTLIER -66.84 2.58 1.35 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.489 ' H ' ' C ' ' A' ' 13' ' ' SER . 6.9 pt -124.48 -30.28 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.598 -0.689 . . . . 0.0 110.374 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.484 ' CZ ' ' CE2' ' A' ' 96' ' ' TYR . 54.5 m-85 -112.67 144.63 41.86 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.129 -0.982 . . . . 0.0 110.145 -179.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.0 p -75.11 -22.34 58.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.567 -0.708 . . . . 0.0 110.837 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -119.96 129.22 54.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.869 -1.144 . . . . 0.0 110.644 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -140.7 154.23 24.15 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.471 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 24.2 m-85 . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.354 -1.086 . . . . 0.0 109.53 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mm . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.4 t -121.51 130.37 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.121 -0.987 . . . . 0.0 110.445 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.434 ' O ' ' O ' ' A' ' 124' ' ' THR . 61.1 m -101.79 101.39 11.86 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.8 m -94.08 119.18 32.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.848 -1.157 . . . . 0.0 109.649 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.558 ' CG2' HG12 ' A' ' 125' ' ' VAL . 19.7 m -139.4 156.54 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.475 -0.766 . . . . 0.0 109.118 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -99.05 131.59 44.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.929 . . . . 0.0 109.561 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.56 152.48 21.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.553 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.477 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 47.4 t-80 -124.1 153.53 41.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.358 -0.839 . . . . 0.0 109.515 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.61 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -56.05 -26.1 47.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.368 -0.832 . . . . 0.0 109.772 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -96.91 -23.67 16.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.954 . . . . 0.0 109.61 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.477 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 82.4 m-20 -78.96 136.74 37.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.948 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.9 mt -78.78 150.36 32.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 0.0 108.669 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.9 pt -121.66 143.55 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.06 -1.025 . . . . 0.0 110.111 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.5 -172.72 45.49 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -170.49 169.9 7.16 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.007 -1.29 . . . . 0.0 109.713 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -145.11 144.03 30.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.296 -0.878 . . . . 0.0 109.816 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 86.0 m -123.45 151.99 63.97 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.427 ' N ' ' OG1' ' A' ' 9' ' ' THR . 8.6 Cg_endo -51.59 144.41 33.19 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.363 2.042 . . . . 0.0 111.949 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -66.64 -13.82 61.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.52 -0.738 . . . . 0.0 110.535 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.605 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 82.3 m-20 -89.93 0.66 56.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.922 -1.111 . . . . 0.0 110.161 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.423 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.0 m-85 -110.97 165.73 11.62 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.267 -0.896 . . . . 0.0 110.187 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.7 m -102.28 140.46 36.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.388 -0.82 . . . . 0.0 109.294 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.8 m -97.21 118.42 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.002 -1.061 . . . . 0.0 110.369 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.446 ' N ' ' OE1' ' A' ' 59' ' ' GLU . 5.6 mp0 -125.09 126.77 25.18 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.17 114.39 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.658 1.572 . . . . 0.0 112.142 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -93.66 -24.32 17.92 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.2 t0 -170.94 40.07 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.451 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 88.5 m -63.97 -152.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.608 -0.682 . . . . 0.0 109.89 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.3 p90 -110.3 -58.19 2.11 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.118 -0.989 . . . . 0.0 111.252 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.447 ' C ' ' O ' ' A' ' 64' ' ' PHE . 27.6 t -45.82 -70.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.568 -1.332 . . . . 0.0 108.807 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.4 t -142.54 132.48 24.33 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.451 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -171.83 179.59 2.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.929 -1.107 . . . . 0.0 110.419 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.7 m-85 -93.76 140.44 29.66 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.437 HD21 ' HG2' ' A' ' 75' ' ' GLU . 99.8 m-20 -80.7 -171.12 2.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.895 -1.128 . . . . 0.0 109.9 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.2 mt -65.99 -15.8 63.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.353 -0.842 . . . . 0.0 109.134 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.441 ' OG ' ' NZ ' ' A' ' 73' ' ' LYS . 32.5 t -86.47 -7.15 58.65 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.322 -0.861 . . . . 0.0 108.878 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.57 20.2 66.81 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.441 ' NZ ' ' OG ' ' A' ' 71' ' ' SER . 64.6 mttp -107.28 140.47 40.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -1.147 . . . . 0.0 109.068 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -63.66 134.15 54.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.135 -0.978 . . . . 0.0 109.933 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.437 ' HG2' HD21 ' A' ' 69' ' ' ASN . 34.5 tp10 -154.19 163.81 39.53 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.313 -0.867 . . . . 0.0 109.446 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -107.35 138.79 42.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.251 -0.906 . . . . 0.0 109.52 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 tp -97.06 -16.01 20.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.079 -1.013 . . . . 0.0 109.828 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -61.1 -43.65 98.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.894 -1.129 . . . . 0.0 109.521 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -65.09 -13.51 58.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.042 -1.036 . . . . 0.0 108.887 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -100.41 -41.66 6.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.384 -0.823 . . . . 0.0 109.162 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.521 HD23 HD21 ' A' ' 83' ' ' LEU . 37.1 tp -125.83 126.39 44.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 109.133 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -81.03 83.83 6.63 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.081 -1.012 . . . . 0.0 109.378 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.521 HD21 HD23 ' A' ' 81' ' ' LEU . 89.1 mt -77.21 143.93 38.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.312 -0.868 . . . . 0.0 109.955 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.7 p -127.78 158.23 38.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.554 -0.716 . . . . 0.0 109.308 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.862 HD22 HH11 ' A' ' 98' ' ' ARG . 88.4 m-20 55.22 51.54 13.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.95 . . . . 0.0 109.699 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.75 129.84 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 110.107 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.2 mm -118.22 118.8 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.447 -0.783 . . . . 0.0 109.271 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 80.2 mtp -120.52 103.34 9.08 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.28 -0.887 . . . . 0.0 109.74 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -110.6 99.63 8.57 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.252 -0.905 . . . . 0.0 109.041 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.482 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 61.8 m80 -72.3 -35.99 68.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.107 -0.996 . . . . 0.0 110.549 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -60.32 -45.02 94.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.912 -1.117 . . . . 0.0 109.516 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -89.5 -4.94 57.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 109.031 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.482 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.0 m-20 54.82 48.46 20.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.495 -0.753 . . . . 0.0 110.17 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.543 ' OG1' ' CE1' ' A' ' 96' ' ' TYR . 3.3 t -134.22 140.14 46.28 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.026 -1.046 . . . . 0.0 109.343 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -129.43 140.72 51.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.489 -0.757 . . . . 0.0 110.206 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.543 ' CE1' ' OG1' ' A' ' 94' ' ' THR . 83.6 m-85 -136.18 146.85 47.3 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.417 -0.802 . . . . 0.0 109.537 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.1 p -152.64 159.44 43.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.981 -1.074 . . . . 0.0 109.172 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.862 HH11 HD22 ' A' ' 85' ' ' ASN . 71.0 mtp180 -108.44 137.9 45.64 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.096 -1.003 . . . . 0.0 109.339 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 99' ' ' LEU . 46.3 mt -92.86 137.54 23.91 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.405 -0.809 . . . . 0.0 109.543 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.61 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 76.8 Cg_exo -45.86 170.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.836 1.69 . . . . 0.0 111.309 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.3 m -79.69 -10.61 59.81 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.101 -1.0 . . . . 0.0 109.754 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.6 tp -136.11 129.93 32.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.225 -0.922 . . . . 0.0 110.432 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.6 mt -147.37 102.37 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.235 -0.916 . . . . 0.0 108.643 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.7 m -102.83 -6.91 22.04 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.017 -1.052 . . . . 0.0 109.8 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 127' ' ' ALA . 84.7 m-20 -81.42 154.36 26.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.169 -0.957 . . . . 0.0 110.013 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -103.51 33.74 3.24 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.417 -0.802 . . . . 0.0 109.091 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.453 ' CH2' HD22 ' A' ' 81' ' ' LEU . 23.5 p-90 -64.98 152.66 42.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 110.452 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.24 153.96 51.09 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.639 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 30.6 p90 -152.4 162.35 41.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.999 -1.063 . . . . 0.0 108.698 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 8.2 p90 -154.1 160.77 42.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.729 -1.232 . . . . 0.0 111.792 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 97.5 m -125.61 156.45 39.16 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.587 HG22 HG22 ' A' ' 122' ' ' VAL . 42.8 t -128.45 139.1 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.881 -1.137 . . . . 0.0 111.79 -178.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 93.5 m -122.15 131.87 54.17 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.5 p -170.2 178.55 3.79 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.176 -1.578 . . . . 0.0 111.663 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.605 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 50.0 mtmt -151.7 163.38 39.25 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -58.55 151.25 20.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.775 -1.203 . . . . 0.0 109.078 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.52 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 60.5 t-20 46.35 61.19 2.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.228 -0.92 . . . . 0.0 109.47 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 37.3 mt-10 -165.73 146.3 6.79 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.127 -0.983 . . . . 0.0 110.233 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -61.84 134.75 57.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.168 -0.958 . . . . 0.0 109.089 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -81.57 143.31 32.08 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.118 -0.989 . . . . 0.0 110.328 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 58.7 mt -110.75 122.87 48.89 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.587 HG22 HG22 ' A' ' 112' ' ' VAL . 52.6 t -110.07 131.14 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.883 -1.135 . . . . 0.0 110.79 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -109.0 120.52 42.79 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 38' ' ' CYS . 7.2 t -137.08 141.25 42.37 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.933 -1.105 . . . . 0.0 111.892 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.639 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -135.92 159.47 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -124.9 146.68 49.21 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.161 -0.962 . . . . 0.0 110.423 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.31 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.2 t -93.91 133.05 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 109.983 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.548 ' NZ ' ' OD2' ' A' ' 46' ' ' ASP . 96.7 mttt -72.85 127.18 31.8 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.735 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.77 166.18 32.26 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.442 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 5.2 t -104.96 131.9 51.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.422 -1.046 . . . . 0.0 109.471 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -110.88 109.44 19.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.494 -0.754 . . . . 0.0 109.424 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.413 ' CD1' HD13 ' A' ' 121' ' ' LEU . 92.9 m-85 -87.17 1.1 54.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 108.942 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.4 m -105.24 -17.17 14.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.561 -0.712 . . . . 0.0 110.461 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.9 m -153.7 121.23 5.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.823 -1.173 . . . . 0.0 110.311 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.6 p -62.87 -29.79 71.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 108.911 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -109.98 73.02 0.82 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.491 ' HB2' ' H ' ' A' ' 16' ' ' PHE . 19.8 p -71.9 111.84 7.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.261 -0.899 . . . . 0.0 110.315 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.0 t -69.4 2.86 2.65 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.433 ' H ' ' C ' ' A' ' 13' ' ' SER . 4.8 pt -123.61 -32.24 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.711 -0.618 . . . . 0.0 110.394 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.491 ' H ' ' HB2' ' A' ' 13' ' ' SER . 86.6 m-85 -106.6 145.67 31.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.212 -0.93 . . . . 0.0 109.812 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.1 m -71.34 -25.29 62.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.511 -0.743 . . . . 0.0 110.886 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -125.19 136.03 53.18 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.925 -1.109 . . . . 0.0 110.52 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -142.89 158.33 27.1 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.442 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 22.6 m-85 . . . . . 0 N--CA 1.495 1.792 0 O-C-N 121.346 -1.091 . . . . 0.0 109.648 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.1 mm . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.2 t -114.36 124.89 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.348 -0.845 . . . . 0.0 110.213 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 83.1 m -102.26 101.92 12.26 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.8 m -97.4 121.96 39.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.072 -1.017 . . . . 0.0 109.588 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.413 ' CG2' HG12 ' A' ' 125' ' ' VAL . 24.1 m -139.38 155.5 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.408 -0.807 . . . . 0.0 109.024 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -95.94 123.76 39.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.324 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.542 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -87.99 161.99 17.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.7 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -139.99 148.4 41.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.908 . . . . 0.0 109.6 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.635 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -55.71 -24.2 33.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.362 -0.837 . . . . 0.0 109.745 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.485 ' OD1' ' O ' ' A' ' 45' ' ' ASN . 63.1 t-20 -98.96 -27.72 13.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.05 -1.031 . . . . 0.0 109.704 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.548 ' OD2' ' NZ ' ' A' ' 4' ' ' LYS . 88.3 m-20 -77.41 137.12 38.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.531 -0.731 . . . . 0.0 110.099 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.6 mt -78.23 148.28 34.03 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.431 HD13 HD21 ' A' ' 99' ' ' LEU . 47.2 pt -121.59 143.3 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.06 -1.025 . . . . 0.0 110.126 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.22 -176.14 47.22 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 50.5 p90 -164.9 170.37 15.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.126 -1.22 . . . . 0.0 109.75 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -148.33 146.08 28.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 109.936 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.4 m -126.21 152.17 73.16 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.3 Cg_endo -51.44 153.53 10.14 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.322 2.014 . . . . 0.0 111.867 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.5 m -72.5 -10.64 60.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.449 -0.782 . . . . 0.0 110.7 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.599 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.9 m-20 -92.4 -2.26 56.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.993 -1.067 . . . . 0.0 110.173 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.434 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 18.6 m-85 -108.69 164.58 12.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.158 -0.964 . . . . 0.0 110.346 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 t -105.11 135.13 47.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.331 -0.855 . . . . 0.0 109.119 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 58' ' ' VAL . 3.0 m -92.6 119.87 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.993 -1.067 . . . . 0.0 110.316 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -123.36 126.4 25.88 Favored Pre-proline 0 N--CA 1.489 1.522 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.13 114.25 3.54 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.721 1.614 . . . . 0.0 112.144 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 68' ' ' PHE . 16.5 t-80 -93.71 -24.26 17.91 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.0 t0 -170.18 40.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.453 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 89.1 m -63.6 -154.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.524 -0.735 . . . . 0.0 109.887 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 4.3 p90 -110.56 -57.28 2.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.122 -0.986 . . . . 0.0 111.388 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 64' ' ' PHE . 34.7 t -46.12 -59.12 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.562 -1.336 . . . . 0.0 108.963 -179.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.1 t -156.85 133.86 10.36 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.453 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.0 -178.14 2.07 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.396 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.3 m-85 -93.63 143.25 26.48 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . 0.719 HD21 ' CB ' ' A' ' 75' ' ' GLU . 82.9 m-20 -84.77 -169.2 2.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.112 -0.993 . . . . 0.0 109.828 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.568 HD12 ' N ' ' A' ' 70' ' ' LEU . 10.2 mp -66.85 -15.32 63.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.362 -0.836 . . . . 0.0 108.936 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.8 p -89.62 -8.35 52.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.916 . . . . 0.0 108.693 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.25 22.25 57.29 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -107.16 138.9 42.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.278 -1.13 . . . . 0.0 109.126 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -67.97 136.42 53.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.419 -0.8 . . . . 0.0 109.988 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.719 ' CB ' HD21 ' A' ' 69' ' ' ASN . 68.1 tt0 -155.33 165.84 35.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 109.594 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.416 ' N ' ' HG2' ' A' ' 75' ' ' GLU . 4.1 m120 -103.93 135.6 45.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.448 -0.782 . . . . 0.0 109.452 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.7 tp -97.61 -10.04 25.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.115 -0.99 . . . . 0.0 109.98 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -60.28 -44.57 95.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.944 -1.097 . . . . 0.0 109.638 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -64.83 -21.8 66.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.101 -1.0 . . . . 0.0 108.927 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -81.0 -48.42 12.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.437 -0.79 . . . . 0.0 109.283 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.673 HD23 HD21 ' A' ' 83' ' ' LEU . 44.0 tp -127.06 128.69 46.68 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.522 -0.737 . . . . 0.0 109.111 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -73.91 83.96 1.71 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.031 -1.043 . . . . 0.0 109.198 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.673 HD21 HD23 ' A' ' 81' ' ' LEU . 92.6 mt -80.37 135.25 36.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -0.828 . . . . 0.0 110.026 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.9 p -126.78 162.21 26.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.601 -0.687 . . . . 0.0 109.201 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.403 HD22 ' HD2' ' A' ' 98' ' ' ARG . 97.7 m-20 54.82 50.95 14.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 109.574 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.53 131.33 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.331 -0.856 . . . . 0.0 110.124 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -119.49 120.01 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.461 -0.774 . . . . 0.0 109.246 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 71.9 mtp -122.51 105.33 10.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.111 -0.993 . . . . 0.0 109.745 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -110.81 100.79 9.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.367 -0.833 . . . . 0.0 109.0 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.453 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 95.5 m-70 -73.25 -34.61 65.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.964 -1.085 . . . . 0.0 110.583 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -60.47 -45.8 92.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.862 -1.149 . . . . 0.0 109.63 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -89.64 -3.89 58.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.129 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 97.5 m-20 55.06 48.07 20.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.585 -0.697 . . . . 0.0 110.326 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.597 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 1.9 t -133.43 138.89 46.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.99 -1.068 . . . . 0.0 109.458 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 75.3 m-85 -126.93 139.06 53.34 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.323 -0.861 . . . . 0.0 109.93 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.597 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 73.4 m-85 -135.39 146.23 48.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.257 -0.902 . . . . 0.0 109.427 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 53.9 m -150.05 151.95 34.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.094 -1.004 . . . . 0.0 109.189 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.423 HH11 ' HG2' ' A' ' 98' ' ' ARG . 59.0 mtt-85 -103.55 135.64 44.76 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.062 -1.024 . . . . 0.0 109.415 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.542 HD11 ' HB1' ' A' ' 42' ' ' ALA . 67.8 mt -89.81 137.18 28.53 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.478 -0.764 . . . . 0.0 109.607 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.635 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 76.9 Cg_exo -46.39 162.09 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.777 1.651 . . . . 0.0 111.329 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.0 m -71.36 -17.43 62.43 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.115 -0.991 . . . . 0.0 109.713 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.2 tp -132.46 130.71 40.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.236 -0.915 . . . . 0.0 110.39 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.449 HD11 ' HB3' ' A' ' 99' ' ' LEU . 96.7 mt -142.78 125.56 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.321 -0.862 . . . . 0.0 108.713 178.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.9 p -131.5 54.28 1.93 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.041 -1.037 . . . . 0.0 109.755 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.603 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 7.1 t0 -145.24 151.06 37.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 109.954 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.603 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 99.8 m-20 -91.33 33.66 0.98 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.492 -0.755 . . . . 0.0 109.039 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.589 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 12.8 p-90 -64.86 150.19 48.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.167 -0.958 . . . . 0.0 110.514 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.6 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 12.9 tttp -139.85 151.95 46.09 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.637 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 32.1 p90 -156.07 162.61 40.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.028 -1.045 . . . . 0.0 108.72 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 10.1 p90 -153.89 158.62 41.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.679 -1.263 . . . . 0.0 111.785 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 98.1 m -123.15 156.49 34.94 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 122' ' ' VAL . 46.5 t -128.5 139.19 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 120.955 -1.09 . . . . 0.0 111.678 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 23.2 m -122.14 131.61 54.05 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 71.6 p -172.01 179.18 2.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.325 -1.484 . . . . 0.0 111.573 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.599 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 49.8 mtmt -150.72 163.17 39.21 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 117' ' ' ASN . 55.2 p-10 -58.13 154.38 13.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.751 -1.218 . . . . 0.0 109.214 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.508 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 66.3 t30 43.43 60.33 2.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.208 -0.932 . . . . 0.0 109.641 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 36.8 mt-10 -165.31 146.01 7.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.14 -0.975 . . . . 0.0 110.205 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -57.41 144.27 37.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.232 -0.918 . . . . 0.0 108.904 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -91.9 139.74 30.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.175 -0.953 . . . . 0.0 110.382 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.413 HD13 ' CD1' ' A' ' 8' ' ' PHE . 26.5 mt -108.04 120.43 42.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.374 -0.828 . . . . 0.0 109.043 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 112' ' ' VAL . 49.9 t -109.01 129.88 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.968 -1.083 . . . . 0.0 110.493 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -108.27 120.42 42.33 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.6 ' OG1' ' NZ ' ' A' ' 108' ' ' LYS . 12.9 t -136.26 140.93 43.82 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.889 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.637 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.1 m -134.88 156.47 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -129.97 150.5 51.22 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.158 -0.964 . . . . 0.0 110.3 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.519 ' HB3' ' NE1' ' A' ' 107' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.277 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 51.7 t -104.48 130.82 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.236 -0.915 . . . . 0.0 109.904 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.461 ' N ' ' CD ' ' A' ' 4' ' ' LYS . 3.6 mptp? -68.54 122.96 19.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.159 -0.963 . . . . 0.0 108.791 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.52 175.39 44.71 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -116.11 130.78 56.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.453 -1.028 . . . . 0.0 109.479 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.512 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 40.5 t0 -108.23 109.47 20.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.447 -0.783 . . . . 0.0 109.269 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.47 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 91.8 m-85 -88.29 0.89 55.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.151 -0.968 . . . . 0.0 108.977 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.2 m -102.12 -17.02 16.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.592 -0.692 . . . . 0.0 110.685 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.608 HG22 ' H ' ' A' ' 12' ' ' GLU . 69.4 m -158.08 128.38 6.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.868 -1.145 . . . . 0.0 110.292 -179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.443 ' OG ' ' C ' ' A' ' 20' ' ' TYR . 13.7 m -68.11 -25.45 65.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.895 . . . . 0.0 108.934 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.608 ' H ' HG22 ' A' ' 10' ' ' THR . 77.6 mt-10 -114.35 74.28 0.87 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 108.928 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.512 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 7.8 m -70.01 151.94 44.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 110.248 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -100.03 -0.08 39.91 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.8 pt -125.25 -25.01 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.7 -0.625 . . . . 0.0 110.176 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -111.58 139.64 46.85 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.033 -1.042 . . . . 0.0 109.912 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.2 m -71.85 -18.09 62.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.555 -0.716 . . . . 0.0 110.649 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -131.22 142.13 50.13 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.789 -1.194 . . . . 0.0 110.636 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.447 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -162.33 166.35 36.45 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.443 ' C ' ' OG ' ' A' ' 11' ' ' SER . 70.8 m-85 . . . . . 0 N--CA 1.495 1.779 0 O-C-N 121.316 -1.108 . . . . 0.0 109.586 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.7 mm . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.486 HG22 ' HB ' ' A' ' 122' ' ' VAL . 53.1 t -120.97 129.84 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.061 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.47 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 91.1 m -100.8 99.56 10.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.0 m -95.87 121.07 37.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.933 -1.104 . . . . 0.0 109.489 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.452 ' CG2' HG12 ' A' ' 125' ' ' VAL . 22.8 m -141.34 155.84 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.401 -0.812 . . . . 0.0 109.246 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -96.08 129.52 43.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.945 . . . . 0.0 109.387 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.491 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -100.02 154.53 18.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.304 -0.872 . . . . 0.0 109.626 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.48 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 32.4 t-80 -126.56 151.84 47.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.336 -0.852 . . . . 0.0 109.558 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.544 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -55.17 -25.11 30.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.883 . . . . 0.0 109.789 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -98.99 -24.97 14.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.926 . . . . 0.0 109.655 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 85.5 m-20 -74.4 135.66 42.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.428 -0.795 . . . . 0.0 110.161 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.404 ' HB3' HH21 ' A' ' 98' ' ' ARG . 69.7 mt -76.86 145.59 38.26 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.542 HD13 HD21 ' A' ' 99' ' ' LEU . 39.1 pt -120.17 141.92 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.019 -1.05 . . . . 0.0 110.392 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.29 -174.57 46.83 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -170.16 169.95 7.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.049 -1.265 . . . . 0.0 109.739 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -146.96 145.03 29.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.315 -0.865 . . . . 0.0 109.762 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.7 m -124.49 153.4 69.43 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.258 -0.902 . . . . 0.0 108.626 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.45 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.51 147.69 22.31 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.307 2.004 . . . . 0.0 111.98 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.1 t -68.1 -13.84 62.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.465 -0.772 . . . . 0.0 110.621 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.634 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.7 m-20 -89.71 -0.77 57.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.834 -1.166 . . . . 0.0 110.224 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.45 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.5 m-85 -109.63 164.8 12.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.961 . . . . 0.0 110.186 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 m -105.24 135.51 46.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.387 -0.821 . . . . 0.0 109.298 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.8 m -90.16 118.4 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.074 -1.016 . . . . 0.0 110.393 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -123.84 127.84 25.31 Favored Pre-proline 0 N--CA 1.491 1.609 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.29 114.04 3.47 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.662 1.574 . . . . 0.0 112.16 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 68' ' ' PHE . 12.1 t-80 -91.22 -25.41 19.53 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.3 t0 -172.7 39.27 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.458 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 77.0 m -60.87 -153.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.538 -0.726 . . . . 0.0 109.842 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 4.3 p90 -108.97 -56.1 2.32 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.004 -1.06 . . . . 0.0 111.256 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 66' ' ' SER . 13.1 t -48.79 -74.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.559 -1.338 . . . . 0.0 108.876 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.507 ' N ' HG12 ' A' ' 65' ' ' VAL . 27.6 t -137.16 131.2 32.22 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.458 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.11 179.92 2.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.992 -1.068 . . . . 0.0 110.428 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 5.4 m-85 -93.46 130.31 39.33 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -76.63 -174.03 2.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.931 -1.106 . . . . 0.0 109.904 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.4 mt -64.27 -20.85 66.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 109.103 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.7 p -83.42 -6.36 59.44 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.12 19.74 66.45 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -100.82 139.14 36.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.233 -1.157 . . . . 0.0 109.193 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -84.38 112.38 20.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.928 . . . . 0.0 110.08 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -150.57 140.99 22.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.355 -0.841 . . . . 0.0 109.964 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -63.24 149.46 45.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.114 -0.991 . . . . 0.0 109.49 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 77' ' ' LEU . 14.7 tp -96.55 7.39 46.66 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.359 -0.838 . . . . 0.0 109.691 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -69.02 -40.39 78.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.053 -1.029 . . . . 0.0 109.952 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.607 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 51.5 p-10 -61.95 -31.44 71.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 0.0 109.106 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.607 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 29.1 tptp -75.56 -48.17 23.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.514 -0.741 . . . . 0.0 109.255 178.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.465 HD11 ' HG2' ' A' ' 100' ' ' PRO . 15.6 tp -149.13 123.67 9.74 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -80.46 99.54 8.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.054 -1.029 . . . . 0.0 109.644 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.2 mt -76.08 158.97 31.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.435 -0.79 . . . . 0.0 109.784 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.2 p -129.51 160.17 34.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.264 -0.898 . . . . 0.0 109.346 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 54.59 51.29 14.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.072 -1.018 . . . . 0.0 109.723 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.9 mt -80.74 130.79 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.331 -0.856 . . . . 0.0 109.996 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.9 mm -123.06 121.82 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.516 -0.74 . . . . 0.0 109.192 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 87.1 mtp -121.87 104.14 9.34 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.021 -1.05 . . . . 0.0 109.884 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -112.07 100.76 9.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.296 -0.878 . . . . 0.0 108.904 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.48 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 93.5 m-70 -72.88 -35.94 67.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.873 -1.142 . . . . 0.0 110.657 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -60.4 -46.55 89.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.964 -1.085 . . . . 0.0 109.434 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -88.13 -4.92 58.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 0.0 109.107 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.48 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.3 m-20 54.71 47.72 21.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.522 -0.736 . . . . 0.0 110.173 178.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.584 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 4.8 t -132.62 137.87 47.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.009 -1.057 . . . . 0.0 109.359 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -126.89 139.24 53.22 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.385 -0.822 . . . . 0.0 109.979 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.584 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 80.4 m-85 -136.24 146.79 47.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.162 -0.961 . . . . 0.0 109.569 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.548 ' C ' ' CZ ' ' A' ' 98' ' ' ARG . 20.0 p -154.28 153.18 31.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.199 -0.938 . . . . 0.0 109.167 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.548 ' CZ ' ' C ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -100.64 137.01 39.61 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.112 -0.993 . . . . 0.0 109.687 -179.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.542 HD21 HD13 ' A' ' 48' ' ' ILE . 63.8 mt -88.84 134.74 33.06 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.467 -0.771 . . . . 0.0 109.518 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.586 ' HD2' HD11 ' A' ' 103' ' ' ILE . 78.1 Cg_exo -46.48 155.78 0.68 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.68 1.586 . . . . 0.0 111.32 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.5 t -63.98 -43.36 95.96 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.172 -0.955 . . . . 0.0 109.862 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.7 tp -105.18 126.25 51.87 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.163 -0.961 . . . . 0.0 110.209 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.586 HD11 ' HD2' ' A' ' 100' ' ' PRO . 91.9 mt -151.33 104.06 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.134 -0.979 . . . . 0.0 108.847 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 90.7 p -108.25 0.9 21.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.967 . . . . 0.0 109.757 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -79.93 151.6 30.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 109.994 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -98.85 32.6 2.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.462 -0.774 . . . . 0.0 108.969 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 19.7 p-90 -65.89 158.41 28.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 110.587 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.3 157.46 44.79 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.63 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 35.8 p90 -155.31 160.47 40.78 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.939 -1.101 . . . . 0.0 108.769 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 5.6 p90 -151.49 158.99 44.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.664 -1.273 . . . . 0.0 111.766 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 90.0 m -124.62 156.3 37.71 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 122' ' ' VAL . 41.7 t -129.64 141.66 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.89 -1.132 . . . . 0.0 111.72 -178.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 91.4 m -120.37 131.44 54.84 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.8 p -168.38 178.86 4.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.264 -1.523 . . . . 0.0 111.643 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.634 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 42.5 mtmt -159.11 167.94 27.91 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.508 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 48.5 p30 -58.72 151.44 21.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.823 -1.173 . . . . 0.0 109.009 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.47 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 60.1 t-20 40.89 58.91 2.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.237 -0.914 . . . . 0.0 109.385 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 54.5 mm-40 -157.57 137.54 12.45 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.089 -1.007 . . . . 0.0 110.521 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -54.3 140.89 31.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.059 -1.025 . . . . 0.0 109.141 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -89.11 138.75 31.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.189 -0.944 . . . . 0.0 110.307 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.5 mt -111.24 123.11 49.55 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 112' ' ' VAL . 39.4 t -108.58 130.45 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.878 -1.139 . . . . 0.0 110.621 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -108.91 119.76 40.5 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.6 t -137.14 143.51 42.52 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.876 -1.14 . . . . 0.0 111.946 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.63 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.4 m -136.79 159.55 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 126' ' ' GLU . 57.2 mp0 -128.51 147.83 50.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.055 -1.028 . . . . 0.0 110.217 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.299 179.762 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 77.5 t -97.76 134.84 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.262 -0.899 . . . . 0.0 110.079 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 4' ' ' LYS . 14.2 mptt -68.89 125.91 28.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.949 -1.095 . . . . 0.0 108.618 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.82 -170.95 44.12 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.461 -1.352 . . . . 0.0 109.736 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.7 t -126.49 132.66 51.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -1.087 . . . . 0.0 109.612 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.453 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 51.6 t0 -107.86 108.71 20.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.557 -0.714 . . . . 0.0 109.283 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -88.28 1.23 55.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 108.756 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 83.0 m -102.28 -16.97 16.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.503 -0.748 . . . . 0.0 110.477 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.627 HG22 ' H ' ' A' ' 12' ' ' GLU . 48.6 m -158.08 127.37 5.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.884 -1.135 . . . . 0.0 110.409 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 t -65.2 -26.01 67.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 108.826 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.627 ' H ' HG22 ' A' ' 10' ' ' THR . 76.8 mm-40 -114.33 74.06 0.85 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -69.91 150.8 46.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 110.37 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.89 0.89 39.29 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.425 HD12 ' CE2' ' A' ' 16' ' ' PHE . 6.9 pt -123.91 -23.63 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.666 -0.647 . . . . 0.0 110.184 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.425 ' CE2' HD12 ' A' ' 15' ' ' ILE . 58.6 m-85 -115.26 136.85 52.67 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.304 -0.873 . . . . 0.0 110.023 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.1 t -67.28 -17.79 64.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.571 -0.706 . . . . 0.0 110.864 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -129.95 140.97 50.84 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.039 -1.038 . . . . 0.0 110.523 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.453 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -154.43 161.16 29.99 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 . . . . . 0 N--CA 1.495 1.782 0 O-C-N 121.481 -1.011 . . . . 0.0 109.636 -179.794 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.5 mm . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.6 t -115.98 127.05 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.345 -0.847 . . . . 0.0 110.482 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.42 ' O ' ' O ' ' A' ' 124' ' ' THR . 97.5 m -102.62 101.43 11.57 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.2 m -94.22 120.69 34.84 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.055 -1.028 . . . . 0.0 109.58 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.553 ' CG2' HG12 ' A' ' 125' ' ' VAL . 15.9 m -141.36 149.34 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.528 -0.733 . . . . 0.0 109.349 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -90.52 130.65 36.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.971 -1.081 . . . . 0.0 109.24 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.25 151.27 22.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.906 . . . . 0.0 109.288 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.494 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 38.2 t-80 -122.92 152.63 40.63 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.322 -0.861 . . . . 0.0 109.483 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.838 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -55.69 -25.73 41.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.409 -0.807 . . . . 0.0 109.762 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -98.81 -25.72 14.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 0.0 109.764 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.494 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 86.3 m-20 -73.37 135.51 44.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.361 -0.837 . . . . 0.0 110.026 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 75.3 mt -77.21 145.87 37.35 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.414 HG21 HD11 ' A' ' 99' ' ' LEU . 46.1 pt -123.05 145.04 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.204 -0.935 . . . . 0.0 110.207 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.52 -172.52 45.28 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 49.9 p90 -171.3 170.11 6.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.075 -1.25 . . . . 0.0 109.785 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -146.38 144.67 29.9 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.243 -0.911 . . . . 0.0 109.79 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 70.4 m -123.0 153.15 64.08 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.424 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 9.3 Cg_endo -51.81 145.06 32.86 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.292 1.995 . . . . 0.0 112.138 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 t -68.02 -14.83 63.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.481 -0.762 . . . . 0.0 110.628 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -89.6 1.64 55.72 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.931 -1.106 . . . . 0.0 110.233 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.438 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 19.0 m-85 -110.55 166.43 11.0 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.398 -0.814 . . . . 0.0 110.482 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.431 ' OG ' ' OE2' ' A' ' 59' ' ' GLU . 35.2 t -103.01 133.88 47.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -0.837 . . . . 0.0 108.828 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.1 m -91.05 124.49 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.042 -1.037 . . . . 0.0 110.198 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.431 ' OE2' ' OG ' ' A' ' 57' ' ' SER . 10.5 mp0 -131.28 125.82 21.08 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.07 114.47 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.644 1.562 . . . . 0.0 112.047 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.497 ' O ' ' O ' ' A' ' 68' ' ' PHE . 17.3 t-80 -91.57 -23.26 19.96 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.2 t0 -173.5 39.15 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.425 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 81.5 m -60.34 -152.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.577 -0.702 . . . . 0.0 109.533 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.3 p90 -110.88 -58.03 2.15 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.245 -0.909 . . . . 0.0 111.318 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 64' ' ' PHE . 23.5 t -45.95 -72.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.298 -1.501 . . . . 0.0 108.893 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.426 ' N ' HG12 ' A' ' 65' ' ' VAL . 38.4 t -139.98 130.31 25.31 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.425 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.24 -178.79 1.8 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.121 -0.987 . . . . 0.0 110.524 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.2 m-85 -93.55 123.45 36.87 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -71.9 -175.84 1.54 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.044 -1.035 . . . . 0.0 109.754 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.6 mt -62.79 -22.86 66.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.181 -0.95 . . . . 0.0 109.112 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.6 t -79.85 -7.36 58.67 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.333 -0.855 . . . . 0.0 108.857 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.69 18.4 68.24 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -101.41 138.63 38.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -1.156 . . . . 0.0 109.072 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -86.08 110.12 19.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.202 -0.936 . . . . 0.0 110.165 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -146.72 143.35 28.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.364 -0.835 . . . . 0.0 109.914 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -64.65 149.64 48.61 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.503 -0.879 . . . . 0.0 109.51 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 13.1 tp -98.8 4.94 47.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.234 -0.916 . . . . 0.0 109.945 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 79' ' ' ASN . 17.7 pt-20 -68.23 -41.31 81.42 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.038 -1.039 . . . . 0.0 110.013 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.593 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 43.4 p30 -64.46 -27.67 69.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.09 -1.006 . . . . 0.0 109.138 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.593 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 28.9 tptp -83.5 -47.73 11.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 109.361 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.582 HD23 HD21 ' A' ' 83' ' ' LEU . 43.3 tp -125.94 126.68 44.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.44 -0.787 . . . . 0.0 109.299 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -77.86 83.62 4.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.134 -0.979 . . . . 0.0 109.277 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.582 HD21 HD23 ' A' ' 81' ' ' LEU . 92.3 mt -82.6 136.04 34.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.393 -0.817 . . . . 0.0 110.083 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.3 p -126.16 160.79 29.24 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.603 HD22 ' CZ ' ' A' ' 98' ' ' ARG . 84.0 m-20 55.59 50.8 13.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.455 -0.778 . . . . 0.0 109.666 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.2 mt -78.33 131.53 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.997 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.2 mm -117.94 118.68 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.374 -0.829 . . . . 0.0 109.258 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 93.8 mtp -124.98 110.65 14.47 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.276 -0.89 . . . . 0.0 109.883 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -114.07 101.13 8.94 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.364 -0.835 . . . . 0.0 108.907 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.458 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 74.2 m80 -71.04 -36.74 72.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.079 -1.013 . . . . 0.0 110.677 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -60.14 -45.78 91.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.998 -1.064 . . . . 0.0 109.66 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -88.61 -5.23 58.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.161 -0.962 . . . . 0.0 109.152 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.3 m-20 54.72 48.28 20.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.573 -0.704 . . . . 0.0 110.338 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.603 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 2.9 t -132.38 137.04 47.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.013 -1.055 . . . . 0.0 109.313 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.563 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 47.1 m-85 -125.2 138.34 54.13 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.338 -0.851 . . . . 0.0 109.735 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' TYR . . . . . 0.603 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 81.3 m-85 -136.07 146.19 46.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.217 -0.927 . . . . 0.0 109.154 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 83.8 p -154.96 155.91 35.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.932 . . . . 0.0 109.015 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.614 HH11 ' CB ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -107.81 139.56 42.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.162 -0.961 . . . . 0.0 109.934 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 100' ' ' PRO . 94.6 mt -96.6 142.31 24.36 Favored Pre-proline 0 C--N 1.297 -1.685 0 O-C-N 121.65 -0.656 . . . . 0.0 109.756 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.838 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 76.4 Cg_exo -45.56 177.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.779 1.653 . . . . 0.0 111.263 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 96.9 p -85.32 -9.23 57.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.022 -1.049 . . . . 0.0 109.747 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.2 tp -139.0 130.66 27.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.229 -0.919 . . . . 0.0 110.778 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.2 mt -147.37 102.57 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.225 -0.922 . . . . 0.0 108.885 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 97.1 p -100.0 -3.05 32.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.056 -1.027 . . . . 0.0 109.819 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 127' ' ' ALA . 84.4 m-20 -82.11 151.05 27.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.853 . . . . 0.0 110.165 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -99.22 31.34 3.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.525 -0.734 . . . . 0.0 109.126 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.431 ' CH2' HD22 ' A' ' 81' ' ' LEU . 18.8 p-90 -66.59 159.95 26.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 110.627 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -144.24 158.83 43.51 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PHE . . . . . 0.539 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 25.5 p90 -152.13 161.96 41.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.942 -1.098 . . . . 0.0 108.655 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 7.3 p90 -152.56 158.48 42.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.794 -1.191 . . . . 0.0 111.746 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 84.9 m -124.74 156.55 37.49 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.588 HG22 HG22 ' A' ' 122' ' ' VAL . 44.4 t -129.73 140.51 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.893 -1.129 . . . . 0.0 111.829 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 72.2 m -124.16 133.18 53.63 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.2 p -169.56 178.25 4.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.27 -1.518 . . . . 0.0 111.647 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.546 ' NZ ' ' OE2' ' A' ' 118' ' ' GLU . 6.1 mtmp? -153.59 163.29 40.23 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 178.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 117' ' ' ASN . 99.3 m-20 -58.22 153.22 15.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.851 -1.156 . . . . 0.0 109.109 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.506 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 66.7 t30 44.04 59.4 3.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.167 -0.958 . . . . 0.0 109.555 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.546 ' OE2' ' NZ ' ' A' ' 115' ' ' LYS . 41.6 mt-10 -165.23 145.96 7.24 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.189 -0.944 . . . . 0.0 110.164 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.2 134.07 52.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.115 -0.991 . . . . 0.0 109.003 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -83.37 147.86 27.65 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.038 -1.039 . . . . 0.0 110.337 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.6 mt -111.04 124.45 52.2 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.588 HG22 HG22 ' A' ' 112' ' ' VAL . 42.2 t -108.83 130.22 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.998 -1.064 . . . . 0.0 110.388 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -109.52 121.23 44.74 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.42 ' O ' ' O ' ' A' ' 38' ' ' CYS . 5.3 t -137.33 142.89 41.83 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.468 1.127 . . . . 0.0 112.323 -178.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.553 HG12 ' CG2' ' A' ' 40' ' ' VAL . 3.1 m -138.39 158.7 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.546 ' CD ' ' N ' ' A' ' 127' ' ' ALA . 12.4 tm-20 -134.34 155.7 49.79 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.185 -0.947 . . . . 0.0 110.317 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.546 ' N ' ' CD ' ' A' ' 126' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.386 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -73.09 156.41 38.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.155 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 70.4 t -98.22 130.78 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.333 -0.854 . . . . 0.0 109.871 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -71.07 121.94 19.16 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.201 -0.937 . . . . 0.0 108.483 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.2 164.86 31.04 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.403 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 7.2 t -105.71 133.34 50.61 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.396 -1.061 . . . . 0.0 109.862 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.512 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 39.8 t0 -110.92 109.39 19.52 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.211 -0.931 . . . . 0.0 109.462 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.426 ' CG ' HD13 ' A' ' 121' ' ' LEU . 84.2 m-85 -87.0 3.75 44.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.135 -0.978 . . . . 0.0 108.872 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.4 m -109.83 -16.61 13.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.473 -0.767 . . . . 0.0 110.623 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 36.5 m -151.14 117.24 5.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.804 -1.185 . . . . 0.0 110.186 -179.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.7 m -59.93 -32.22 70.57 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -111.49 75.48 0.92 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.512 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 1.3 m -74.18 115.11 13.3 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.354 -0.842 . . . . 0.0 110.365 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.9 t -67.75 3.25 1.51 Allowed 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.478 ' H ' ' C ' ' A' ' 13' ' ' SER . 8.0 pt -124.02 -40.8 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.473 -0.767 . . . . 0.0 110.184 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.445 ' CE2' HD12 ' A' ' 15' ' ' ILE . 85.4 m-85 -100.32 142.08 32.28 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.919 -1.113 . . . . 0.0 109.806 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.6 t -72.24 -23.79 61.28 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.414 -0.804 . . . . 0.0 110.915 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -119.2 129.78 55.15 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.715 -1.24 . . . . 0.0 110.417 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -141.41 154.73 24.82 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.403 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 33.0 m-85 -123.58 155.71 37.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -1.146 . . . . 0.0 109.575 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.8 t -94.81 157.44 15.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 0.0 109.127 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.8 pt -61.25 -23.67 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.101 -0.999 . . . . 0.0 109.481 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -79.47 -52.69 7.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 109.654 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -49.68 -39.55 37.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.361 -0.837 . . . . 0.0 109.969 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.4 pt -70.25 -12.64 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.919 -1.113 . . . . 0.0 109.526 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 54.2 p -101.96 -23.64 14.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.209 -0.932 . . . . 0.0 109.478 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.514 ' O ' ' N ' ' A' ' 29' ' ' SER . 56.3 t-20 -125.61 -78.97 0.6 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.246 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -66.34 66.98 0.05 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.513 -0.742 . . . . 0.0 109.434 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 27' ' ' ASN . 12.8 m -61.64 179.02 0.27 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 109.282 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.688 ' CB ' ' H ' ' A' ' 37' ' ' VAL . 16.1 m -72.18 -82.38 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.507 -0.746 . . . . 0.0 109.84 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -116.69 -59.05 2.01 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.195 -0.94 . . . . 0.0 109.573 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.413 HD22 ' HB2' ' A' ' 35' ' ' ASP . 89.0 m-20 -63.39 -150.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.489 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.465 ' HG3' ' H ' ' A' ' 34' ' ' GLN . 9.9 pt20 -102.96 -49.98 3.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.17 -0.956 . . . . 0.0 109.579 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.557 ' CG ' ' N ' ' A' ' 35' ' ' ASP . 11.0 pt20 -108.0 -47.0 3.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.061 -1.025 . . . . 0.0 109.429 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.557 ' N ' ' CG ' ' A' ' 34' ' ' GLN . 0.7 OUTLIER -50.23 117.85 2.62 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.308 -0.87 . . . . 0.0 109.259 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.2 mm -98.59 122.15 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.135 -0.978 . . . . 0.0 108.821 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.688 ' H ' ' CB ' ' A' ' 30' ' ' SER . 49.0 t -119.3 129.42 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.062 -1.024 . . . . 0.0 110.25 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 74.4 m -102.77 101.91 12.02 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.0 m -94.12 120.63 34.64 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -0.958 . . . . 0.0 109.722 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.59 HG22 HG12 ' A' ' 125' ' ' VAL . 3.1 m -138.58 158.58 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.42 -0.8 . . . . 0.0 109.041 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -100.85 122.45 43.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -0.895 . . . . 0.0 109.509 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -93.49 164.41 13.2 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -0.847 . . . . 0.0 109.546 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.436 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 26.0 t60 -138.1 153.07 49.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.158 -0.964 . . . . 0.0 109.715 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 100' ' ' PRO . . . -54.63 -26.29 32.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.283 -0.886 . . . . 0.0 109.783 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -100.99 -24.77 14.27 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.148 -0.97 . . . . 0.0 109.572 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.436 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 98.0 m-20 -72.77 138.5 46.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.827 . . . . 0.0 109.893 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.538 HD22 ' CZ ' ' A' ' 98' ' ' ARG . 98.3 mt -80.31 144.88 32.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 108.741 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 18.9 pt -122.12 143.85 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.927 -1.108 . . . . 0.0 110.014 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.04 -175.82 47.69 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.464 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 50.2 p90 -167.71 169.49 11.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.024 -1.28 . . . . 0.0 109.751 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -148.43 146.38 28.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.955 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 63.1 m -126.33 152.21 73.52 Favored Pre-proline 0 N--CA 1.493 1.706 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.21 153.93 8.75 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.449 2.099 . . . . 0.0 111.923 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 90.8 p -72.64 -10.99 60.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.709 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.514 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 80.8 m-20 -92.02 -3.31 55.99 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.937 -1.102 . . . . 0.0 110.083 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.476 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 15.8 m-85 -106.61 161.44 14.63 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.9 -1.125 . . . . 0.0 110.168 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.424 ' HG ' ' HZ3' ' A' ' 115' ' ' LYS . 7.1 m -99.89 138.39 37.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.363 -0.835 . . . . 0.0 109.389 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.8 m -94.38 117.08 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.977 -1.077 . . . . 0.0 110.454 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -126.18 127.67 24.61 Favored Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.97 111.11 3.03 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.614 1.543 . . . . 0.0 112.224 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -90.96 -26.99 18.99 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.461 ' HB3' ' H ' ' A' ' 110' ' ' PHE . 68.3 t0 -166.37 42.22 0.06 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.594 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 84.5 m -67.74 -157.02 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.537 -0.727 . . . . 0.0 109.836 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.541 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 1.9 p90 -112.16 -49.53 2.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.874 -1.141 . . . . 0.0 111.425 -178.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 55.7 t -58.41 -48.75 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.495 -1.378 . . . . 0.0 108.922 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.1 t -156.84 128.94 7.32 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.594 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.62 -178.16 1.57 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.872 -1.142 . . . . 0.0 110.475 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 9.2 m-85 -94.14 127.54 40.03 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -70.16 -175.77 1.03 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.964 -1.085 . . . . 0.0 109.879 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 59.8 mt -61.95 -24.35 66.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.337 -0.852 . . . . 0.0 108.968 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 67.1 m -82.43 -5.07 58.44 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.316 -0.865 . . . . 0.0 108.804 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.41 19.03 65.13 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -100.23 141.41 33.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -1.136 . . . . 0.0 109.145 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -82.69 110.35 17.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.149 -0.969 . . . . 0.0 110.016 -179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -146.1 140.95 27.1 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.328 -0.857 . . . . 0.0 109.56 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -61.25 145.92 49.61 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.3 tp -96.61 5.89 49.83 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.175 -0.953 . . . . 0.0 109.892 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.463 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.3 OUTLIER -70.73 -41.66 71.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.1 -1.0 . . . . 0.0 109.789 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.415 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 41.0 t30 -59.8 -27.22 66.4 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.146 -0.971 . . . . 0.0 109.037 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -82.15 -45.46 15.1 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.246 -0.909 . . . . 0.0 109.353 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.548 HD22 ' CZ2' ' A' ' 107' ' ' TRP . 51.0 tp -139.13 133.64 31.77 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.431 -0.793 . . . . 0.0 109.187 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.65 86.09 7.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.079 -1.013 . . . . 0.0 109.433 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.432 HD21 HD23 ' A' ' 81' ' ' LEU . 96.4 mt -73.37 148.33 43.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.898 . . . . 0.0 109.842 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 58.1 p -127.29 162.74 25.52 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.409 -0.807 . . . . 0.0 109.391 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 54.32 51.88 13.51 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.062 -1.023 . . . . 0.0 109.529 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -80.2 131.07 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.353 -0.842 . . . . 0.0 110.093 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.8 mm -123.87 122.42 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.434 -0.791 . . . . 0.0 109.238 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 87.9 mtp -123.48 107.79 11.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.953 -1.092 . . . . 0.0 110.019 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -114.7 101.49 9.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.21 -0.931 . . . . 0.0 108.983 179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.469 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 95.9 m-70 -73.27 -34.69 65.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.052 -1.03 . . . . 0.0 110.645 -179.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -60.34 -45.7 92.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.896 -1.127 . . . . 0.0 109.61 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -89.43 -4.71 57.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.087 -1.008 . . . . 0.0 109.053 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 96.7 m-20 55.39 47.8 20.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 0.0 110.151 179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.573 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.3 t -132.33 136.45 46.88 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.98 -1.075 . . . . 0.0 109.516 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.464 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 79.3 m-85 -126.29 139.53 53.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.26 -0.9 . . . . 0.0 110.019 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.573 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 80.1 m-85 -135.03 146.45 49.0 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.199 -0.938 . . . . 0.0 109.434 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.586 ' C ' ' HE ' ' A' ' 98' ' ' ARG . 39.7 t -145.74 144.95 30.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.095 -1.003 . . . . 0.0 109.212 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.586 ' HE ' ' C ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -100.46 128.75 46.44 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.072 -1.017 . . . . 0.0 109.435 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.523 ' O ' ' O ' ' A' ' 100' ' ' PRO . 94.8 mt -89.86 138.27 27.91 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.25 -0.906 . . . . 0.0 109.636 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.523 ' O ' ' O ' ' A' ' 99' ' ' LEU . 75.7 Cg_exo -46.17 -177.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 121.896 1.731 . . . . 0.0 110.984 177.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 95.3 p -90.45 -8.35 50.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.968 -1.082 . . . . 0.0 109.748 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.7 tp -135.49 129.76 33.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.125 -0.984 . . . . 0.0 110.445 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 48.1 mt -150.92 108.3 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.367 -0.833 . . . . 0.0 108.838 178.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 99.8 p -110.41 0.11 17.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.124 -0.985 . . . . 0.0 109.678 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 127' ' ' ALA . 73.7 m-20 -82.57 152.79 25.81 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.2 -0.937 . . . . 0.0 110.062 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -99.15 32.5 2.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.375 -0.828 . . . . 0.0 109.082 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.548 ' CZ2' HD22 ' A' ' 81' ' ' LEU . 17.7 p-90 -65.88 151.09 47.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 110.553 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -134.91 156.3 49.2 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.627 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 36.9 p90 -156.06 158.13 37.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.079 -1.013 . . . . 0.0 108.954 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.461 ' H ' ' HB3' ' A' ' 62' ' ' ASP . 17.5 p90 -151.83 156.27 39.85 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.756 -1.215 . . . . 0.0 111.588 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 90.7 m -121.38 158.51 28.14 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 76.7 t -132.8 150.15 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.612 -1.305 . . . . 0.0 111.684 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.5 m -127.88 134.12 49.37 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.8 p -167.58 176.83 6.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.336 -1.478 . . . . 0.0 111.743 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.514 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 50.0 mttm -155.86 168.35 27.48 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.455 ' O ' ' C ' ' A' ' 117' ' ' ASN . 90.8 m-20 -57.67 148.29 24.98 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.917 -1.114 . . . . 0.0 109.331 179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.487 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 65.9 t30 40.9 60.93 1.84 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.264 -0.897 . . . . 0.0 109.771 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 48.9 mm-40 -157.31 136.67 12.01 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.978 -1.076 . . . . 0.0 110.187 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -56.33 133.44 52.78 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.262 -0.899 . . . . 0.0 109.019 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.548 ' NZ ' ' OD1' ' A' ' 35' ' ' ASP . 23.6 pttm -85.28 143.28 28.8 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.114 -0.991 . . . . 0.0 110.404 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.426 HD13 ' CG ' ' A' ' 8' ' ' PHE . 68.4 mt -111.33 124.33 52.03 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.446 -0.784 . . . . 0.0 109.154 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.515 ' HB ' HG22 ' A' ' 37' ' ' VAL . 46.4 t -109.45 130.98 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.986 -1.071 . . . . 0.0 110.711 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -109.98 120.62 43.04 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.4 t -137.05 143.95 42.93 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.475 -1.391 . . . . 0.0 112.008 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.627 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 2.9 m -136.53 159.94 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -134.31 150.11 50.94 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.836 -1.165 . . . . 0.0 110.13 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.487 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.338 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -142.1 152.23 43.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.359 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 91.6 t -88.16 136.39 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.372 -0.83 . . . . 0.0 110.36 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -68.84 125.22 25.92 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.054 -1.029 . . . . 0.0 108.615 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.81 179.11 45.18 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -118.56 132.4 56.21 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.619 -0.93 . . . . 0.0 109.369 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.483 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 36.0 t0 -109.07 109.07 19.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.542 -0.724 . . . . 0.0 109.272 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.458 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 78.0 m-85 -88.76 -0.54 57.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.171 -0.956 . . . . 0.0 108.912 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.0 m -98.55 -18.18 18.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.468 -0.77 . . . . 0.0 110.537 -178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.612 HG22 ' H ' ' A' ' 12' ' ' GLU . 65.0 m -158.2 127.07 5.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.836 -1.165 . . . . 0.0 110.361 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.1 p -64.59 -26.6 68.47 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.611 -0.836 . . . . 0.0 108.985 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.612 ' H ' HG22 ' A' ' 10' ' ' THR . 78.9 mm-40 -113.04 73.89 0.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.501 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 95.0 p -69.67 151.39 45.94 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.226 -0.921 . . . . 0.0 110.159 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.7 t -101.25 0.85 38.14 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.1 pt -124.76 -20.86 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.672 -0.643 . . . . 0.0 110.496 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.501 ' O ' ' OG ' ' A' ' 13' ' ' SER . 57.4 m-85 -115.93 144.52 43.94 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.401 -0.812 . . . . 0.0 110.325 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.0 m -72.28 -17.58 61.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.502 -0.749 . . . . 0.0 110.542 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -135.0 145.53 48.18 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.96 -1.088 . . . . 0.0 110.762 -179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.483 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -159.53 173.37 36.29 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -131.47 164.22 26.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.394 -1.062 . . . . 0.0 109.614 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.6 t -95.43 151.8 18.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.321 -0.862 . . . . 0.0 109.122 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.458 ' O ' ' CB ' ' A' ' 26' ' ' SER . 42.9 pt -59.69 -31.92 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.41 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.8 t-20 -65.95 -39.18 90.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.913 . . . . 0.0 109.561 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.61 -43.4 89.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.42 -0.8 . . . . 0.0 110.229 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.5 pt -86.09 -19.29 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.0 -1.063 . . . . 0.0 109.704 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.68 ' O ' ' C ' ' A' ' 27' ' ' ASN . 48.0 t -85.11 -76.96 0.3 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.236 -0.915 . . . . 0.0 109.224 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.68 ' C ' ' O ' ' A' ' 26' ' ' SER . 63.6 t30 0.47 96.51 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 CA-C-O 121.337 0.589 . . . . 0.0 109.445 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 30' ' ' SER . 44.1 mmtm -66.13 34.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.56 -0.712 . . . . 0.0 109.741 -178.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.605 ' O ' ' N ' ' A' ' 31' ' ' ASN . 44.3 t -63.11 70.78 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.507 -0.746 . . . . 0.0 109.282 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 28' ' ' LYS . 15.1 m -36.89 -26.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.304 0.573 . . . . 0.0 109.621 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.605 ' N ' ' O ' ' A' ' 29' ' ' SER . 99.0 m-20 -68.58 33.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.561 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.546 ' H ' ' C ' ' A' ' 30' ' ' SER . 51.6 t-20 -155.61 120.25 4.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.085 -1.009 . . . . 0.0 109.286 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.498 ' C ' ' O ' ' A' ' 32' ' ' ASN . 11.6 pt20 -35.06 121.72 0.55 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.542 0.687 . . . . 0.0 109.691 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.405 ' HG2' ' H ' ' A' ' 34' ' ' GLN . 8.8 pt20 -72.33 38.91 0.08 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.216 -0.928 . . . . 0.0 109.413 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.479 ' H ' ' C ' ' A' ' 33' ' ' GLN . 88.9 m-20 -130.72 108.2 9.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.718 -0.614 . . . . 0.0 109.689 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.9 mm -99.29 125.04 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.108 -0.995 . . . . 0.0 108.591 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.533 HG22 ' HB ' ' A' ' 122' ' ' VAL . 47.2 t -120.78 130.21 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.411 -0.806 . . . . 0.0 110.42 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.458 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 89.6 m -101.05 100.67 11.29 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 58.5 m -96.06 120.73 36.86 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.182 -0.949 . . . . 0.0 109.513 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 24.2 m -141.66 153.51 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.492 -0.755 . . . . 0.0 109.306 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -94.03 132.75 38.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.005 -1.059 . . . . 0.0 109.149 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.437 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -102.02 146.78 27.42 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.22 -0.925 . . . . 0.0 109.626 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.475 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 21.0 t-80 -116.43 150.73 37.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.429 -0.794 . . . . 0.0 109.507 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.667 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -55.99 -25.38 43.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.415 -0.803 . . . . 0.0 109.883 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.554 ' OD1' ' N ' ' A' ' 46' ' ' ASP . 30.5 p30 -98.22 -22.99 15.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.189 -0.944 . . . . 0.0 109.684 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.554 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 82.2 m-20 -76.4 136.78 39.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.449 -0.782 . . . . 0.0 110.165 -179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 95.1 mt -76.47 146.5 38.48 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.492 HD13 HD21 ' A' ' 99' ' ' LEU . 38.3 pt -120.4 141.89 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.113 -0.992 . . . . 0.0 110.307 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.93 -173.75 46.25 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -170.18 169.55 7.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.11 -1.229 . . . . 0.0 109.685 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -144.74 143.64 30.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.235 -0.916 . . . . 0.0 110.015 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 90.1 m -124.0 151.87 65.83 Favored Pre-proline 0 N--CA 1.489 1.505 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.432 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.74 147.53 24.34 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.337 2.025 . . . . 0.0 111.976 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.1 m -70.6 -12.1 61.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.424 -0.798 . . . . 0.0 110.545 -179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.608 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.8 m-20 -91.6 0.49 57.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.051 -1.031 . . . . 0.0 110.084 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.4 m-85 -109.86 165.73 11.48 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.124 -0.985 . . . . 0.0 110.353 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -103.65 130.76 51.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.34 -0.85 . . . . 0.0 109.05 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.8 m -89.5 118.74 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.004 -1.06 . . . . 0.0 110.104 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -124.73 126.78 25.31 Favored Pre-proline 0 N--CA 1.491 1.589 0 N-CA-C 108.023 -1.102 . . . . 0.0 108.023 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.13 114.57 3.6 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.777 1.651 . . . . 0.0 112.051 -179.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.491 ' O ' ' O ' ' A' ' 68' ' ' PHE . 17.0 t-80 -93.56 -24.0 18.11 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.406 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.8 t0 -170.19 40.59 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.485 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 89.9 m -64.28 -154.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.422 -0.799 . . . . 0.0 109.887 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.6 p90 -109.29 -58.69 2.0 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.155 -0.966 . . . . 0.0 111.483 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 64' ' ' PHE . 31.2 t -46.05 -70.57 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 120.58 -1.325 . . . . 0.0 108.804 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 36.2 t -141.38 132.45 26.23 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.485 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -170.97 175.86 4.25 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.97 -1.081 . . . . 0.0 110.464 -179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.1 m-85 -92.39 142.36 27.53 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -83.26 -170.86 3.25 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.879 -1.138 . . . . 0.0 109.895 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.558 HD12 ' N ' ' A' ' 70' ' ' LEU . 10.3 mp -66.56 -15.03 63.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.325 -0.86 . . . . 0.0 108.98 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 65.7 m -86.55 -8.61 57.39 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.38 -0.825 . . . . 0.0 108.806 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.93 20.07 64.01 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -106.73 139.84 40.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.318 -1.107 . . . . 0.0 109.246 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -66.78 125.68 26.64 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.28 -0.888 . . . . 0.0 109.844 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -145.47 165.26 29.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.408 -0.808 . . . . 0.0 109.644 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.442 ' ND2' ' CD ' ' A' ' 78' ' ' GLU . 37.8 t-20 -105.96 136.94 44.73 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.337 -0.852 . . . . 0.0 109.472 179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 tp -93.26 -8.28 42.66 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 0.0 110.194 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.488 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 20.7 pt-20 -58.94 -46.63 87.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.044 -1.035 . . . . 0.0 109.523 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.488 ' N ' ' CG ' ' A' ' 78' ' ' GLU . 92.5 m-20 -64.87 -34.52 78.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.158 -0.964 . . . . 0.0 108.972 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.4 tptt -69.24 -52.41 27.92 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.499 -0.751 . . . . 0.0 109.61 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.565 HD23 HD21 ' A' ' 83' ' ' LEU . 31.5 tp -129.13 126.51 39.45 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -76.63 108.54 9.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.015 -1.053 . . . . 0.0 109.018 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.565 HD21 HD23 ' A' ' 81' ' ' LEU . 95.3 mt -105.18 137.86 42.29 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.417 -0.802 . . . . 0.0 110.088 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.9 p -124.46 162.69 23.4 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.493 -0.754 . . . . 0.0 109.287 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.6 ' O ' ' NH1' ' A' ' 98' ' ' ARG . 98.9 m-20 55.0 51.46 13.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 109.573 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -78.92 130.62 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.185 -0.947 . . . . 0.0 110.152 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.5 mm -120.19 119.79 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.482 -0.761 . . . . 0.0 109.225 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 78.8 mtp -124.56 109.59 13.41 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.295 -0.878 . . . . 0.0 109.835 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -111.73 100.74 9.18 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.38 -0.825 . . . . 0.0 108.938 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.486 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 97.1 m-70 -71.76 -36.48 70.4 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.859 -1.15 . . . . 0.0 110.632 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -61.13 -46.76 89.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.963 -1.085 . . . . 0.0 109.556 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -87.17 -4.96 59.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.233 -0.917 . . . . 0.0 109.07 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.4 m-20 54.93 47.32 22.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.556 -0.715 . . . . 0.0 110.209 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.592 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 3.3 t -133.84 139.73 46.43 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.03 -1.043 . . . . 0.0 109.325 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 95' ' ' PHE . 49.5 m-85 -128.52 140.14 51.96 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.429 -0.794 . . . . 0.0 109.982 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.592 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 67.2 m-85 -138.23 148.7 45.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.289 -0.882 . . . . 0.0 109.16 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.703 ' N ' ' NH2' ' A' ' 98' ' ' ARG . 57.6 m -157.3 159.4 37.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.099 -1.001 . . . . 0.0 109.336 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.703 ' NH2' ' N ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -103.59 139.72 38.51 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.236 -0.915 . . . . 0.0 109.679 179.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.492 HD21 HD13 ' A' ' 48' ' ' ILE . 47.4 mt -91.98 138.54 24.64 Favored Pre-proline 0 C--N 1.304 -1.396 0 O-C-N 121.619 -0.676 . . . . 0.0 109.597 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.667 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 75.7 Cg_exo -46.93 158.28 0.44 Allowed 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.734 1.622 . . . . 0.0 111.265 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.6 t -69.6 -17.98 63.58 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.179 -0.95 . . . . 0.0 109.916 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.4 ' HA ' HD12 ' A' ' 102' ' ' LEU . 44.9 tp -125.41 129.32 49.63 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.258 -0.901 . . . . 0.0 110.639 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 83.1 mt -149.29 102.86 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 178.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.3 m -113.25 3.1 15.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.352 -0.842 . . . . 0.0 109.834 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.584 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 53.2 t0 -89.28 155.28 19.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -0.906 . . . . 0.0 109.976 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.584 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 98.9 m-20 -96.54 34.15 1.69 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.417 -0.802 . . . . 0.0 108.914 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.468 ' CZ3' ' CD1' ' A' ' 109' ' ' PHE . 13.0 p-90 -62.69 154.06 30.54 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.165 -0.959 . . . . 0.0 110.42 -178.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.603 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 21.2 tttp -141.07 149.13 41.24 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.641 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 29.2 p90 -155.09 163.31 40.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.188 -0.945 . . . . 0.0 108.731 178.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.424 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 10.7 p90 -154.84 160.06 40.97 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.86 -1.15 . . . . 0.0 111.872 -178.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 75.1 m -122.92 155.43 36.73 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 122' ' ' VAL . 44.4 t -128.78 139.05 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.848 -1.158 . . . . 0.0 111.933 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 96.4 m -122.9 131.94 53.96 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 62.9 p -171.54 178.7 3.09 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.306 -1.496 . . . . 0.0 111.608 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.608 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 50.6 mtmt -150.7 163.62 38.1 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.417 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 55.4 p-10 -59.44 154.27 17.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.907 -1.121 . . . . 0.0 109.114 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.511 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 64.7 t30 44.26 59.69 3.13 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.211 -0.931 . . . . 0.0 109.642 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.511 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 38.8 mt-10 -165.28 146.19 7.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.256 -0.902 . . . . 0.0 110.154 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.587 ' NZ ' ' O ' ' A' ' 27' ' ' ASN . 98.8 mttt -58.03 142.16 47.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 109.193 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -88.95 140.09 29.79 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.077 -1.015 . . . . 0.0 110.414 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 86.6 mt -108.89 120.8 43.59 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.417 -0.802 . . . . 0.0 108.965 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 112' ' ' VAL . 48.6 t -109.36 130.1 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.049 -1.032 . . . . 0.0 110.54 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -107.81 118.62 37.23 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.603 ' OG1' ' NZ ' ' A' ' 108' ' ' LYS . 7.3 t -136.94 141.88 42.65 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.918 -1.114 . . . . 0.0 112.3 -178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.3 m -134.55 158.48 41.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -132.31 152.66 51.3 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.229 -0.919 . . . . 0.0 110.278 -179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.333 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.486 ' OE1' ' N ' ' A' ' 1' ' ' GLU . 57.2 mp0 . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -75.29 155.12 36.99 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.231 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 87.2 t -96.55 133.17 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.239 -0.913 . . . . 0.0 109.795 -179.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.8 mmtp -69.86 122.11 18.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.126 -0.984 . . . . 0.0 108.706 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.3 176.41 46.22 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.543 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 4.7 t -116.28 128.54 55.66 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.471 -1.017 . . . . 0.0 109.296 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.452 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 54.4 t0 -103.45 111.18 23.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.59 -0.694 . . . . 0.0 109.375 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -91.59 -0.88 57.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.186 -0.947 . . . . 0.0 108.826 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.5 m -103.72 -16.67 15.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.486 -0.759 . . . . 0.0 110.632 -178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.516 HG22 ' H ' ' A' ' 12' ' ' GLU . 23.3 m -156.35 125.02 5.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.883 -1.136 . . . . 0.0 110.278 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.505 ' OG ' ' OE1' ' A' ' 12' ' ' GLU . 74.0 p -65.47 -26.36 67.9 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.184 -0.948 . . . . 0.0 108.981 179.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.516 ' H ' HG22 ' A' ' 10' ' ' THR . 55.5 mp0 -113.67 72.96 0.8 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 23.2 t -67.7 150.62 48.46 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.134 -0.979 . . . . 0.0 110.352 -179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.77 0.6 41.99 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.411 HD12 ' OH ' ' A' ' 96' ' ' TYR . 24.2 pt -125.04 -27.19 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.749 -0.594 . . . . 0.0 110.199 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -110.27 133.74 52.95 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.041 -1.037 . . . . 0.0 109.87 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.9 t -67.95 -18.53 64.78 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.641 -0.662 . . . . 0.0 110.858 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.4 mmtp -125.09 136.73 53.94 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.027 -1.046 . . . . 0.0 110.67 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.452 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -146.86 158.81 27.84 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.543 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 21.4 m-85 -116.81 150.4 38.41 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.323 -1.104 . . . . 0.0 109.589 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.0 t -94.75 156.61 16.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.349 -0.844 . . . . 0.0 109.016 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.412 ' O ' ' CG1' ' A' ' 25' ' ' ILE . 45.3 pt -58.41 -20.5 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.219 -0.925 . . . . 0.0 109.344 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.6 t30 -68.7 -43.61 75.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.115 -0.991 . . . . 0.0 109.186 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' A' ' 28' ' ' LYS . 79.6 mm-40 -50.98 -49.72 59.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.098 -1.002 . . . . 0.0 110.082 -178.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.468 ' O ' ' OG ' ' A' ' 29' ' ' SER . 19.6 pt -63.07 -43.79 99.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.044 -1.035 . . . . 0.0 109.632 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.456 ' N ' HG13 ' A' ' 25' ' ' ILE . 58.2 m -59.67 -44.22 93.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.851 . . . . 0.0 109.202 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.628 ' O ' ' N ' ' A' ' 29' ' ' SER . 41.9 t30 -79.48 -61.64 1.94 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.174 -0.954 . . . . 0.0 108.849 179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.507 ' O ' ' O ' ' A' ' 32' ' ' ASN . 36.0 tptt -44.31 -12.87 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 120.028 -0.669 . . . . 0.0 109.225 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.628 ' N ' ' O ' ' A' ' 27' ' ' ASN . 86.4 p -109.71 -38.31 5.43 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.076 -1.015 . . . . 0.0 109.436 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.3 m -60.12 -44.95 94.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.529 -0.732 . . . . 0.0 109.709 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.417 ' OD1' ' C ' ' A' ' 31' ' ' ASN . 45.9 t-20 -86.65 -58.94 2.42 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.295 -0.878 . . . . 0.0 109.519 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.508 ' OD1' ' N ' ' A' ' 32' ' ' ASN . 8.7 p-10 -107.8 94.28 4.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.426 -0.796 . . . . 0.0 109.553 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 33' ' ' GLN . 7.4 pt20 -71.99 93.76 1.41 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 109.42 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -151.08 -166.76 2.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.945 -1.097 . . . . 0.0 109.514 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.603 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 0.4 OUTLIER -83.32 141.05 32.09 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.222 -0.924 . . . . 0.0 109.635 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.449 ' O ' ' N ' ' A' ' 122' ' ' VAL . 20.8 mm -80.2 122.14 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 79.5 t -115.68 127.85 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.114 -0.991 . . . . 0.0 110.604 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.505 ' O ' ' O ' ' A' ' 124' ' ' THR . 66.8 m -102.07 101.49 11.86 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.1 m -92.46 119.53 32.05 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.822 -1.174 . . . . 0.0 109.848 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.558 ' CG2' HG12 ' A' ' 125' ' ' VAL . 19.8 m -136.23 155.76 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -99.03 121.88 41.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.188 -0.945 . . . . 0.0 109.504 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.86 163.56 13.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.574 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.474 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 37.1 t60 -136.64 155.61 49.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.203 -0.936 . . . . 0.0 109.656 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.542 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -55.24 -26.47 39.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.325 -0.86 . . . . 0.0 109.711 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -101.46 -22.44 14.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.166 -0.959 . . . . 0.0 109.632 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.474 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 85.8 m-20 -75.08 137.49 41.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.419 -0.8 . . . . 0.0 109.942 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.8 mt -80.73 147.46 30.55 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.407 HG21 HD11 ' A' ' 99' ' ' LEU . 43.7 pt -122.12 144.26 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.144 -0.972 . . . . 0.0 110.294 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.9 -173.06 45.7 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.474 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 50.5 p90 -169.68 168.81 8.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.056 -1.261 . . . . 0.0 109.725 179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -143.42 142.6 31.29 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.319 -0.863 . . . . 0.0 109.636 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 61.4 m -123.77 152.31 65.66 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.305 -0.872 . . . . 0.0 108.662 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.467 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.3 Cg_endo -51.7 150.98 15.71 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.431 2.087 . . . . 0.0 111.905 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.1 m -71.32 -13.2 61.8 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.459 -0.775 . . . . 0.0 110.726 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.491 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 80.2 m-20 -91.04 -1.04 57.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.867 -1.146 . . . . 0.0 110.214 -179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.467 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 16.5 m-85 -107.67 162.49 13.92 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.514 -0.741 . . . . 0.0 110.099 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.432 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 6.2 t -102.91 134.04 47.0 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.333 -0.855 . . . . 0.0 109.334 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 58' ' ' VAL . 3.5 m -90.45 115.25 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.092 -1.005 . . . . 0.0 110.389 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.492 ' N ' ' OE1' ' A' ' 59' ' ' GLU . 15.8 mp0 -121.24 126.56 26.52 Favored Pre-proline 0 N--CA 1.49 1.563 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.08 112.71 3.29 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 121.617 1.545 . . . . 0.0 112.265 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -94.05 -25.24 17.28 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.7 t0 -168.34 39.51 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 80.5 m -65.08 -153.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.579 -0.701 . . . . 0.0 109.729 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.9 p90 -111.26 -59.15 2.01 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.179 -0.95 . . . . 0.0 111.347 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.449 ' C ' ' O ' ' A' ' 64' ' ' PHE . 24.1 t -45.72 -73.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.682 -1.261 . . . . 0.0 108.757 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.436 ' N ' HG12 ' A' ' 65' ' ' VAL . 33.3 t -136.44 132.61 35.65 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -173.71 -178.67 1.64 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.908 -1.12 . . . . 0.0 110.446 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 7.6 m-85 -93.07 124.21 36.88 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -69.74 -175.03 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.07 -1.019 . . . . 0.0 109.869 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 58.8 mt -62.3 -23.66 66.86 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.29 -0.881 . . . . 0.0 108.905 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.6 p -81.92 -7.17 59.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 108.819 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.64 15.63 70.35 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -95.75 138.51 33.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.394 -1.062 . . . . 0.0 109.137 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -81.91 108.35 15.35 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.249 -0.907 . . . . 0.0 110.143 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -145.35 143.58 30.22 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 110.063 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.0 m-20 -64.54 149.59 48.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.913 -1.117 . . . . 0.0 109.512 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.63 HD11 ' HD3' ' A' ' 80' ' ' LYS . 13.9 tp -99.22 6.7 46.24 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.465 -0.772 . . . . 0.0 109.941 -179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 79' ' ' ASN . 17.8 pt-20 -69.38 -41.06 76.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.13 -0.981 . . . . 0.0 109.923 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 48.4 p-10 -62.58 -26.08 68.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.197 -0.939 . . . . 0.0 109.071 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.63 ' HD3' HD11 ' A' ' 77' ' ' LEU . 88.0 tttt -84.79 -46.29 11.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.45 -0.781 . . . . 0.0 109.442 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.606 HD23 HD21 ' A' ' 83' ' ' LEU . 41.0 tp -131.64 127.35 36.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.405 -0.809 . . . . 0.0 109.234 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -83.29 83.77 7.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.066 -1.021 . . . . 0.0 109.297 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.606 HD21 HD23 ' A' ' 81' ' ' LEU . 95.9 mt -75.73 146.71 39.9 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.888 . . . . 0.0 110.121 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 50.3 p -127.94 160.61 31.33 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.606 -0.684 . . . . 0.0 109.318 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.716 HD22 ' HE ' ' A' ' 98' ' ' ARG . 96.8 m-20 54.72 50.78 15.06 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.278 -0.889 . . . . 0.0 109.546 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.2 mt -77.61 128.54 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.27 -0.894 . . . . 0.0 109.879 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.0 mm -118.92 119.19 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.489 -0.757 . . . . 0.0 109.229 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 85.4 mtp -123.44 108.03 12.24 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.214 -0.929 . . . . 0.0 109.806 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -114.19 101.75 9.49 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.411 -0.806 . . . . 0.0 108.873 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.472 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 95.4 m-70 -71.63 -36.22 70.66 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.995 -1.066 . . . . 0.0 110.592 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -60.91 -45.15 95.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.974 -1.079 . . . . 0.0 109.462 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -88.89 -5.21 58.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.953 . . . . 0.0 109.07 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.7 m-20 54.4 47.95 21.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.49 -0.756 . . . . 0.0 110.139 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.608 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 2.6 t -132.37 137.16 47.26 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.987 -1.071 . . . . 0.0 109.606 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.474 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 79.4 m-85 -126.68 138.88 53.47 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.402 -0.811 . . . . 0.0 109.977 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.608 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 71.4 m-85 -135.61 146.1 47.56 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.239 -0.913 . . . . 0.0 109.437 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.521 ' OG ' HD22 ' A' ' 83' ' ' LEU . 35.5 t -150.87 150.99 31.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.959 . . . . 0.0 109.242 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.716 ' HE ' HD22 ' A' ' 85' ' ' ASN . 60.3 mtt-85 -101.29 133.1 46.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.16 -0.962 . . . . 0.0 109.434 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 99' ' ' LEU . 38.5 mt -91.54 137.9 25.59 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.461 -0.774 . . . . 0.0 109.789 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.542 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 77.5 Cg_exo -45.68 177.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.306 0 C-N-CA 121.876 1.717 . . . . 0.0 111.163 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.483 ' C ' ' HB1' ' A' ' 44' ' ' ALA . 99.9 p -89.36 -9.87 48.76 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.113 -0.992 . . . . 0.0 109.847 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.7 tp -133.68 128.15 34.39 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.208 -0.932 . . . . 0.0 110.254 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 68.3 mt -150.12 106.41 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.189 -0.945 . . . . 0.0 108.677 178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 96.3 p -107.78 0.33 22.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.088 -1.007 . . . . 0.0 109.772 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.478 ' O ' ' O ' ' A' ' 127' ' ' ALA . 82.6 m-20 -84.64 154.54 22.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.038 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -102.38 31.5 4.0 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.493 -0.754 . . . . 0.0 109.12 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.441 ' CH2' HD22 ' A' ' 81' ' ' LEU . 16.5 p-90 -66.68 160.07 26.37 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.205 -0.934 . . . . 0.0 110.507 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -142.0 159.05 43.01 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.553 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 20.9 p90 -154.04 162.66 41.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.929 -1.107 . . . . 0.0 108.661 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 7.3 p90 -153.59 160.4 42.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.67 -1.269 . . . . 0.0 111.836 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 94.7 m -124.83 156.68 37.43 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 122' ' ' VAL . 44.0 t -127.9 138.91 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.867 -1.145 . . . . 0.0 111.792 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 78.1 m -120.11 130.77 54.79 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.2 p -168.93 174.84 6.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.322 -1.486 . . . . 0.0 111.601 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.491 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 52.4 mttm -152.72 168.1 26.79 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 117' ' ' ASN . 90.1 m-20 -58.54 148.34 28.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.835 -1.166 . . . . 0.0 108.845 179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 66.2 t30 43.86 60.67 2.6 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.26 -0.9 . . . . 0.0 109.395 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 58.2 mm-40 -158.01 137.44 11.88 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.19 -0.944 . . . . 0.0 110.455 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -54.77 131.57 44.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.083 -1.011 . . . . 0.0 108.962 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.5 ptpt -79.81 139.25 37.28 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.21 -0.931 . . . . 0.0 110.249 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 81.6 mt -111.26 124.43 52.2 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.644 -0.66 . . . . 0.0 109.389 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 112' ' ' VAL . 39.2 t -110.39 132.04 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.979 -1.076 . . . . 0.0 110.71 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.419 ' O ' ' CB ' ' A' ' 110' ' ' PHE . 26.4 t80 -110.43 123.0 49.06 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.505 ' O ' ' O ' ' A' ' 38' ' ' CYS . 6.6 t -137.88 143.73 41.01 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.005 -1.059 . . . . 0.0 112.145 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.558 HG12 ' CG2' ' A' ' 40' ' ' VAL . 2.8 m -136.71 159.52 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 177.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -133.16 150.64 52.01 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.071 -1.018 . . . . 0.0 110.31 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.478 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.4 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -78.45 162.03 26.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.289 -0.882 . . . . 0.0 109.465 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 55.9 t -103.63 135.29 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.231 -0.918 . . . . 0.0 110.054 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -69.46 125.12 25.75 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.583 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.61 176.02 43.51 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -115.85 132.47 56.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.493 -1.004 . . . . 0.0 109.246 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.512 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 36.9 t0 -110.21 109.18 19.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.595 -0.691 . . . . 0.0 109.333 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -88.17 -1.17 57.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.298 -0.876 . . . . 0.0 108.982 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.5 m -100.93 -18.64 16.25 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.515 -0.741 . . . . 0.0 110.577 -178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 12' ' ' GLU . 25.7 m -156.19 125.06 5.99 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.878 -1.139 . . . . 0.0 110.367 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.7 t -65.99 -27.0 67.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.413 -0.804 . . . . 0.0 108.957 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 58.7 mp0 -112.92 73.98 0.84 Allowed 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.496 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 12.5 m -70.78 152.85 43.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.299 -0.875 . . . . 0.0 110.225 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.93 -0.04 40.28 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.7 pt -125.9 -22.28 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.71 -0.619 . . . . 0.0 110.25 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -113.05 140.28 47.98 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.255 -0.903 . . . . 0.0 110.133 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.9 m -73.43 -17.08 61.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.603 -0.686 . . . . 0.0 110.691 -179.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -132.87 144.04 49.92 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.998 -1.064 . . . . 0.0 110.563 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.512 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -160.7 171.32 36.81 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -122.93 158.95 29.28 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.423 -1.045 . . . . 0.0 109.666 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.4 t -96.22 151.71 19.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 0.0 109.058 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.7 pt -55.59 -33.08 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.347 -0.846 . . . . 0.0 109.372 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -65.25 -38.6 90.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.113 -0.992 . . . . 0.0 109.505 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.09 -41.78 94.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.814 . . . . 0.0 110.159 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.619 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 14.9 pt -85.63 -15.08 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.006 -1.059 . . . . 0.0 109.653 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.693 ' O ' ' C ' ' A' ' 27' ' ' ASN . 39.7 t -89.86 -78.05 0.38 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.175 -0.953 . . . . 0.0 109.169 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.693 ' C ' ' O ' ' A' ' 26' ' ' SER . 6.1 p30 -1.97 88.75 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 121.371 0.605 . . . . 0.0 109.541 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -77.21 22.28 0.22 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.489 -0.757 . . . . 0.0 109.455 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 30' ' ' SER . 40.6 t -90.17 -71.53 0.61 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.341 -0.849 . . . . 0.0 109.577 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 29' ' ' SER . 18.7 m -41.39 141.42 0.72 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.526 -0.733 . . . . 0.0 109.482 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -103.58 41.51 1.27 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.292 -0.88 . . . . 0.0 109.49 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -137.97 -22.91 1.05 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.155 -0.966 . . . . 0.0 109.628 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.628 ' O ' ' N ' ' A' ' 35' ' ' ASP . 2.3 pt20 -57.08 -31.71 65.52 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.158 -0.964 . . . . 0.0 109.622 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.572 ' C ' ' O ' ' A' ' 33' ' ' GLN . 14.9 pt20 -28.15 -37.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.628 ' N ' ' O ' ' A' ' 33' ' ' GLN . 14.7 m-20 -125.05 107.97 11.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.683 -0.636 . . . . 0.0 110.15 179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.9 mm -99.38 125.51 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.006 -1.059 . . . . 0.0 108.632 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.438 HG22 ' HB ' ' A' ' 122' ' ' VAL . 54.9 t -121.44 126.86 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.392 -0.818 . . . . 0.0 110.009 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 73.3 m -102.45 102.16 12.43 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 75.8 m -98.78 122.37 41.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.076 -1.015 . . . . 0.0 109.397 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.513 ' CG2' HG12 ' A' ' 125' ' ' VAL . 24.1 m -140.96 155.22 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.562 -0.711 . . . . 0.0 109.257 179.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -96.12 132.5 41.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.084 -1.01 . . . . 0.0 109.405 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.76 160.45 14.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.405 -0.81 . . . . 0.0 109.591 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.489 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 34.8 t60 -133.0 153.81 51.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.245 -0.909 . . . . 0.0 109.55 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 100' ' ' PRO . . . -54.01 -25.28 20.34 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.384 -0.822 . . . . 0.0 109.788 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -101.53 -26.06 13.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.704 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.489 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 76.5 m-20 -71.67 132.02 43.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.336 -0.852 . . . . 0.0 110.069 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.636 HD22 HH11 ' A' ' 98' ' ' ARG . 11.3 mt -77.28 145.89 37.19 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.422 HG21 HD11 ' A' ' 99' ' ' LEU . 44.9 pt -123.11 145.85 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.766 0.793 . . . . 0.0 110.479 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.48 -173.98 46.58 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -169.54 170.01 8.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.095 -1.239 . . . . 0.0 109.697 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -147.71 145.4 28.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.9 . . . . 0.0 109.907 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 92.6 m -124.83 151.65 68.61 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.6 Cg_endo -51.7 150.1 17.65 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.334 2.023 . . . . 0.0 112.044 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.6 m -69.68 -11.74 61.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.398 -0.813 . . . . 0.0 110.528 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -90.94 -2.67 57.69 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.023 -1.048 . . . . 0.0 110.223 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.434 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.4 m-85 -109.17 164.28 12.59 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.219 -0.925 . . . . 0.0 110.426 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.7 t -105.96 133.93 49.89 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.448 -0.783 . . . . 0.0 108.919 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 58' ' ' VAL . 3.1 m -89.8 118.92 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.032 -1.043 . . . . 0.0 110.364 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 112' ' ' VAL . 10.0 mt-10 -123.1 126.67 25.91 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.14 114.11 3.51 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.66 1.573 . . . . 0.0 112.12 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.505 ' O ' ' O ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -93.63 -24.14 18.01 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 110' ' ' PHE . 66.9 t0 -169.9 43.11 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.478 ' H ' ' CB ' ' A' ' 67' ' ' ALA . 97.3 m -67.55 -153.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.748 . . . . 0.0 109.844 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.492 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.8 p90 -110.1 -57.88 2.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.141 -0.975 . . . . 0.0 111.455 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.436 ' C ' ' O ' ' A' ' 64' ' ' PHE . 24.9 t -46.76 -71.39 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 120.601 -1.312 . . . . 0.0 108.863 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.8 t -140.91 131.3 25.18 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.478 ' CB ' ' H ' ' A' ' 63' ' ' CYS . . . -170.76 175.74 4.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.975 -1.078 . . . . 0.0 110.425 -179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 2.5 m-85 -92.86 140.67 29.26 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -81.81 -170.35 2.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.835 -1.165 . . . . 0.0 109.829 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 70' ' ' LEU . 10.0 mp -66.42 -15.31 63.21 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.305 -0.872 . . . . 0.0 109.087 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 69.5 m -86.6 -7.94 57.91 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.283 -0.886 . . . . 0.0 108.883 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.7 20.9 64.93 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -106.98 138.26 43.49 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.273 -1.134 . . . . 0.0 109.114 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -65.62 124.32 22.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.257 -0.902 . . . . 0.0 109.754 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -143.71 165.09 28.61 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.396 -0.815 . . . . 0.0 109.704 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -106.51 137.83 43.8 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.353 -0.842 . . . . 0.0 109.371 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.8 tp -95.39 -11.03 28.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.192 -0.942 . . . . 0.0 109.988 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.497 ' CD ' ' N ' ' A' ' 79' ' ' ASN . 2.3 pp20? -61.35 -43.82 98.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.978 -1.076 . . . . 0.0 109.557 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.54 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 49.1 p30 -64.17 -20.43 66.0 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.096 -1.003 . . . . 0.0 108.856 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.54 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 84.7 tttt -88.95 -43.97 10.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.348 -0.845 . . . . 0.0 109.67 179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.437 HD23 HD21 ' A' ' 83' ' ' LEU . 45.0 tp -133.35 123.24 25.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.423 -0.798 . . . . 0.0 109.305 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -79.3 85.25 5.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.117 -0.989 . . . . 0.0 109.409 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.542 HD22 ' OG ' ' A' ' 97' ' ' SER . 92.7 mt -74.23 147.03 42.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.322 -0.861 . . . . 0.0 110.036 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 47.3 p -127.42 161.23 29.18 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.527 -0.733 . . . . 0.0 109.339 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 53.58 51.16 15.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.172 -0.955 . . . . 0.0 109.553 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.1 mt -79.05 130.61 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 0.0 110.075 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.7 mm -118.62 119.09 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.509 -0.744 . . . . 0.0 109.117 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 83.0 mtp -121.42 103.78 9.2 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.257 -0.902 . . . . 0.0 109.731 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -113.52 101.45 9.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.425 -0.797 . . . . 0.0 109.085 179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -76.46 -32.89 58.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.03 -1.044 . . . . 0.0 110.471 -179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -59.45 -47.07 86.88 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.011 -1.055 . . . . 0.0 109.579 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -89.53 2.96 53.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.184 -0.947 . . . . 0.0 109.044 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 50.78 46.58 25.79 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.543 -0.723 . . . . 0.0 109.904 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.544 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.7 t -131.5 135.31 46.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.027 -1.046 . . . . 0.0 109.427 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -128.23 140.07 52.1 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.421 -0.799 . . . . 0.0 109.977 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.544 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 70.8 m-85 -135.68 147.25 48.46 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.167 -0.958 . . . . 0.0 109.319 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.542 ' OG ' HD22 ' A' ' 83' ' ' LEU . 45.8 t -146.11 143.48 29.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.116 -0.99 . . . . 0.0 109.115 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.636 HH11 HD22 ' A' ' 47' ' ' LEU . 21.4 mmt180 -99.35 133.15 44.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.235 -0.916 . . . . 0.0 109.355 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 100' ' ' PRO . 88.4 mt -92.0 139.08 24.39 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.486 -0.759 . . . . 0.0 109.763 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.481 ' O ' ' O ' ' A' ' 44' ' ' ALA . 77.7 Cg_exo -45.87 176.01 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 121.867 1.711 . . . . 0.0 111.118 178.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.447 ' C ' ' HB1' ' A' ' 44' ' ' ALA . 6.2 m -86.03 -11.91 51.63 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.195 -0.941 . . . . 0.0 109.772 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.4 tp -138.66 130.5 27.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.107 -0.996 . . . . 0.0 110.536 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.8 mt -141.78 123.6 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.303 -0.873 . . . . 0.0 108.651 178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.488 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 12.9 t -119.87 50.5 1.27 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.221 -0.924 . . . . 0.0 109.781 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.489 ' O ' ' OXT' ' A' ' 127' ' ' ALA . 87.8 m-20 -144.26 153.16 41.76 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.199 -0.938 . . . . 0.0 109.975 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -101.92 33.47 3.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.363 -0.836 . . . . 0.0 109.266 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.419 ' HB2' ' NZ ' ' A' ' 80' ' ' LYS . 15.1 p-90 -64.64 157.05 28.18 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.096 -1.002 . . . . 0.0 110.332 -178.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -138.15 150.28 46.65 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.615 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 30.0 p90 -153.55 164.58 37.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.969 . . . . 0.0 108.785 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 11.8 p90 -155.11 161.83 41.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.803 -1.186 . . . . 0.0 111.783 -179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 98.7 m -126.09 157.15 38.76 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 122' ' ' VAL . 49.8 t -129.67 141.07 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.88 -1.137 . . . . 0.0 111.738 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 46.8 m -121.89 131.98 54.32 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 177.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 93.7 p -170.88 178.88 3.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.297 -1.502 . . . . 0.0 111.57 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.586 ' NZ ' ' OE1' ' A' ' 118' ' ' GLU . 26.1 mtmm -154.34 164.92 37.86 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.49 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 50.1 p30 -58.87 152.75 18.63 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.842 -1.161 . . . . 0.0 109.173 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.504 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 53.4 t-20 44.5 59.66 3.21 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.282 -0.886 . . . . 0.0 109.567 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.586 ' OE1' ' NZ ' ' A' ' 115' ' ' LYS . 41.2 mt-10 -164.97 145.44 7.32 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.158 -0.964 . . . . 0.0 110.241 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.619 ' NZ ' ' O ' ' A' ' 25' ' ' ILE . 51.0 mtmt -63.58 135.74 57.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.307 -0.871 . . . . 0.0 108.729 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.591 ' HE2' ' H ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -84.3 146.43 27.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.075 -1.016 . . . . 0.0 110.42 -179.405 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 57.2 mt -111.58 124.23 51.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.184 -0.948 . . . . 0.0 109.287 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.572 HG22 HG22 ' A' ' 112' ' ' VAL . 51.3 t -108.22 129.99 61.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.942 -1.099 . . . . 0.0 110.593 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -109.64 121.48 45.3 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.5 t -137.2 142.1 42.12 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.866 -1.146 . . . . 0.0 112.193 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.615 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.0 m -136.78 156.73 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 177.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -133.95 157.13 46.82 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.157 -0.965 . . . . 0.0 110.385 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.489 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.907 -1.044 . . . . 0.0 109.314 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.315 0.579 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -74.41 159.13 32.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.092 -1.005 . . . . 0.0 109.277 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.4 t -104.28 133.75 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.315 -0.866 . . . . 0.0 109.901 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -67.73 119.83 13.09 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.095 -1.003 . . . . 0.0 108.715 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.97 176.04 47.09 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.7 t -120.51 132.1 55.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.374 -1.074 . . . . 0.0 109.35 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.507 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 43.3 t0 -107.42 108.86 20.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.556 -0.715 . . . . 0.0 109.485 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -86.2 -0.92 56.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.199 -0.938 . . . . 0.0 108.929 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.3 m -101.81 -15.88 16.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.56 -0.712 . . . . 0.0 110.54 -178.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 12' ' ' GLU . 5.9 m -158.54 127.67 5.59 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.883 -1.136 . . . . 0.0 110.258 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.514 ' OG ' ' OE1' ' A' ' 12' ' ' GLU . 64.6 p -68.16 -24.1 64.94 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.911 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.518 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 57.0 mp0 -114.58 74.05 0.86 Allowed 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 23.5 p -71.33 153.87 42.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.464 -0.772 . . . . 0.0 110.241 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.46 0.82 37.45 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.1 pt -124.05 -25.65 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.628 -0.67 . . . . 0.0 110.219 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.48 ' O ' ' OG ' ' A' ' 13' ' ' SER . 71.4 m-85 -113.13 139.4 48.76 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.168 -0.957 . . . . 0.0 110.012 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.6 p -69.37 -16.46 63.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.55 -0.719 . . . . 0.0 110.766 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -135.05 146.1 48.64 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.956 -1.09 . . . . 0.0 110.847 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.507 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -163.01 173.37 39.2 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -125.95 161.85 26.56 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.41 -1.053 . . . . 0.0 109.564 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.0 t -96.21 154.39 17.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.36 -0.837 . . . . 0.0 109.206 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.405 HG13 ' N ' ' A' ' 23' ' ' ASN . 40.4 pt -55.31 -33.91 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.271 -0.893 . . . . 0.0 109.329 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.431 ' OD1' ' OD1' ' A' ' 27' ' ' ASN . 37.9 t30 -66.14 -40.23 90.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.895 -1.128 . . . . 0.0 109.679 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -60.94 -45.49 94.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 0.0 110.283 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.4 pt -77.7 -15.45 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.104 -0.998 . . . . 0.0 109.587 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.704 ' O ' ' C ' ' A' ' 27' ' ' ASN . 20.6 p -93.6 -61.59 1.52 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.292 -0.88 . . . . 0.0 109.21 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.704 ' C ' ' O ' ' A' ' 26' ' ' SER . 99.0 m-20 0.21 84.06 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.331 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.454 ' HA ' HE22 ' A' ' 33' ' ' GLN . 63.9 pttt -63.92 22.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.573 -0.705 . . . . 0.0 109.745 -178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.641 ' H ' ' C ' ' A' ' 27' ' ' ASN . 87.3 p -103.5 -68.45 0.84 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.171 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 90.0 p -51.46 107.27 0.18 Allowed 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.465 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -64.67 -37.19 86.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.177 -0.952 . . . . 0.0 109.761 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -58.02 -9.3 1.32 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.465 -0.772 . . . . 0.0 109.535 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.582 ' O ' ' N ' ' A' ' 35' ' ' ASP . 23.1 pt20 -58.07 -44.78 87.71 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.215 -0.928 . . . . 0.0 109.446 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.544 ' C ' ' O ' ' A' ' 33' ' ' GLN . 6.4 pt20 -31.45 -35.84 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.411 0.624 . . . . 0.0 109.749 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.582 ' N ' ' O ' ' A' ' 33' ' ' GLN . 10.6 m-20 -119.63 102.26 8.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.376 -0.827 . . . . 0.0 110.181 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.438 ' CD1' ' O ' ' A' ' 33' ' ' GLN . 15.2 mm -97.56 121.64 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.999 -1.063 . . . . 0.0 108.337 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.6 t -117.86 126.5 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.362 -0.836 . . . . 0.0 110.383 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.427 ' O ' ' O ' ' A' ' 124' ' ' THR . 96.9 m -101.96 101.11 11.47 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.1 m -93.54 119.77 33.0 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.216 -0.928 . . . . 0.0 109.624 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.592 ' CG2' HG12 ' A' ' 125' ' ' VAL . 14.6 m -139.88 139.48 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.498 -0.751 . . . . 0.0 109.238 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -82.22 127.41 33.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.117 -0.989 . . . . 0.0 109.301 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.01 154.79 17.46 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 109.45 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.439 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 45.8 t-80 -128.32 152.62 47.93 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.385 -0.822 . . . . 0.0 109.593 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.842 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -56.03 -25.61 45.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 109.766 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -97.14 -24.38 15.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 0.0 109.497 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.439 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 81.9 m-20 -77.35 136.86 38.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.465 -0.772 . . . . 0.0 109.888 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 98.1 mt -79.6 149.18 31.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.933 . . . . 0.0 108.595 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.471 HD13 HD21 ' A' ' 99' ' ' LEU . 22.1 pt -120.83 142.35 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.11 -0.994 . . . . 0.0 110.086 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.13 -173.27 45.79 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -172.79 172.12 4.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.081 -1.246 . . . . 0.0 109.864 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -146.02 144.55 30.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.271 -0.893 . . . . 0.0 109.861 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 47.1 m -125.24 153.99 71.88 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.343 -0.848 . . . . 0.0 109.127 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.452 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.66 146.96 25.3 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.647 2.232 . . . . 0.0 112.027 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.3 t -68.4 -13.16 62.09 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.462 -0.773 . . . . 0.0 110.71 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.47 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 80.0 m-20 -90.37 -0.61 57.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.942 -1.099 . . . . 0.0 110.213 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.452 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 18.8 m-85 -109.5 164.03 12.88 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.216 -0.928 . . . . 0.0 110.207 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.4 133.88 48.54 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.416 -0.802 . . . . 0.0 108.984 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 58' ' ' VAL . 3.2 m -91.47 112.95 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.994 -1.066 . . . . 0.0 110.508 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.4 mm-40 -121.42 129.53 25.19 Favored Pre-proline 0 N--CA 1.49 1.526 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.08 113.53 3.43 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.593 1.529 . . . . 0.0 112.243 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -88.96 -24.81 22.33 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.478 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.1 t0 -170.17 37.32 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.415 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 79.6 m -60.78 -154.05 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.628 -0.67 . . . . 0.0 109.696 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.482 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.1 p90 -110.14 -57.81 2.15 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.12 -0.987 . . . . 0.0 111.206 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.459 HG23 ' CE2' ' A' ' 64' ' ' PHE . 6.2 t -46.68 -72.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.385 -1.447 . . . . 0.0 108.965 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.7 t -137.65 133.2 34.02 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.415 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.27 -178.75 2.12 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.986 -1.071 . . . . 0.0 110.483 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 6.3 m-85 -93.13 128.46 39.06 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -71.76 -173.69 1.03 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.076 -1.015 . . . . 0.0 109.724 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 93.0 mt -63.67 -19.69 65.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.287 -0.883 . . . . 0.0 109.099 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 91.5 p -84.09 -9.17 58.81 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.365 -0.835 . . . . 0.0 108.92 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.97 19.69 58.94 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -105.2 140.59 38.12 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.319 -1.106 . . . . 0.0 109.075 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -74.12 123.0 23.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 110.167 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -155.31 132.2 10.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.348 -0.845 . . . . 0.0 109.93 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -61.76 146.18 50.2 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.171 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.473 HD11 ' CE ' ' A' ' 80' ' ' LYS . 6.9 tp -100.47 6.05 44.28 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.229 -0.919 . . . . 0.0 109.669 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.452 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.3 OUTLIER -72.57 -38.57 67.87 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.883 -1.136 . . . . 0.0 110.072 -179.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -59.94 -15.91 25.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.201 -0.937 . . . . 0.0 109.163 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.473 ' CE ' HD11 ' A' ' 77' ' ' LEU . 29.2 ttpt -102.79 -35.2 8.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 109.312 179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.433 HD22 ' CH2' ' A' ' 107' ' ' TRP . 41.7 tp -131.9 123.36 27.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.444 -0.785 . . . . 0.0 109.346 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.3 ptpt -82.0 83.72 7.18 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.919 -1.113 . . . . 0.0 109.248 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 90.3 mt -76.86 140.99 40.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.061 -1.024 . . . . 0.0 110.144 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 69.4 p -128.32 158.07 39.23 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.509 -0.744 . . . . 0.0 109.303 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 54.74 50.14 16.43 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 0.0 109.656 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 93.7 mt -78.48 132.63 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 109.818 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 11.5 mm -116.02 118.3 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.43 -0.794 . . . . 0.0 109.386 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 41.7 mtp -124.72 109.8 13.57 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.146 -0.971 . . . . 0.0 109.804 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -113.68 101.85 9.71 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.365 -0.835 . . . . 0.0 108.839 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.485 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 52.1 m170 -70.02 -38.63 75.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.022 -1.049 . . . . 0.0 110.628 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -60.53 -45.39 94.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.971 -1.081 . . . . 0.0 109.513 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -86.19 -6.11 59.05 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 0.0 109.135 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.485 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.6 m-20 54.72 47.89 21.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.388 -0.82 . . . . 0.0 110.237 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.593 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 1.9 t -133.87 139.45 46.21 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.983 -1.073 . . . . 0.0 109.409 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -128.05 140.13 52.14 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.49 -0.756 . . . . 0.0 110.055 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.593 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 73.5 m-85 -136.32 146.64 46.82 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.261 -0.9 . . . . 0.0 109.249 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 64.0 m -149.6 151.66 34.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.072 -1.018 . . . . 0.0 109.223 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 -101.35 132.52 46.87 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.038 -1.039 . . . . 0.0 109.341 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.471 HD21 HD13 ' A' ' 48' ' ' ILE . 86.4 mt -90.51 137.45 27.34 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.379 -0.826 . . . . 0.0 109.599 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.842 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 76.7 Cg_exo -46.24 163.89 0.1 OUTLIER 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 121.816 1.678 . . . . 0.0 111.296 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 93.4 p -73.68 -12.1 60.62 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.089 -1.007 . . . . 0.0 109.65 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.9 tp -137.31 130.27 30.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.086 -1.009 . . . . 0.0 110.609 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.2 mt -145.01 102.34 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.3 m -97.11 -6.51 34.88 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.105 -0.997 . . . . 0.0 109.847 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -83.69 154.74 23.5 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.999 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -105.55 33.35 3.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.35 -0.844 . . . . 0.0 109.241 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.433 ' CH2' HD22 ' A' ' 81' ' ' LEU . 23.6 p-90 -65.31 153.54 40.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.142 -0.974 . . . . 0.0 110.505 -178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 11.1 mttm -132.45 154.38 49.93 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.641 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 33.4 p90 -152.69 159.34 43.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.113 -0.992 . . . . 0.0 108.666 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.513 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 4.2 p90 -150.7 159.05 44.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.779 -1.2 . . . . 0.0 111.742 -178.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 88.9 m -123.22 155.66 36.68 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 122' ' ' VAL . 41.9 t -129.97 141.97 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.759 -1.213 . . . . 0.0 111.768 -178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 76.3 m -120.49 131.39 54.7 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.9 p -169.56 171.84 7.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.272 -1.518 . . . . 0.0 111.653 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.47 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 51.9 mttm -148.59 165.23 31.88 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.435 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 54.4 p-10 -57.62 150.48 19.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.854 -1.154 . . . . 0.0 109.067 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 116' ' ' ASP . 64.3 t30 42.71 60.62 2.36 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.203 -0.935 . . . . 0.0 109.763 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 44.6 mt-10 -161.74 141.8 10.36 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.221 -0.924 . . . . 0.0 110.305 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.583 ' NZ ' ' O ' ' A' ' 26' ' ' SER . 99.1 mttt -54.58 147.07 14.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.161 -0.962 . . . . 0.0 108.953 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.424 ' H ' ' HG2' ' A' ' 120' ' ' LYS . 15.7 pttt -98.81 140.44 33.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.211 -0.93 . . . . 0.0 110.36 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 61.7 mt -111.27 124.51 52.37 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.567 -0.708 . . . . 0.0 109.251 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 112' ' ' VAL . 42.4 t -109.56 130.72 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.947 -1.095 . . . . 0.0 110.469 -179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -109.33 121.76 45.88 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 38' ' ' CYS . 7.2 t -136.97 141.81 42.6 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.927 -1.108 . . . . 0.0 112.123 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.641 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -135.74 159.1 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -123.58 142.91 50.58 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.129 -0.982 . . . . 0.0 110.389 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.319 179.748 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -83.98 151.76 24.84 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.332 -0.855 . . . . 0.0 109.372 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.0 t -86.2 135.78 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.915 . . . . 0.0 110.031 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -71.05 129.51 39.15 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.571 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 168.11 -163.25 37.0 Favored Glycine 0 N--CA 1.483 1.798 0 C-N-CA 119.41 -1.376 . . . . 0.0 109.98 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -129.08 135.09 48.44 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.461 -1.023 . . . . 0.0 109.779 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.446 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 39.5 t0 -114.51 109.41 18.24 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.447 -0.783 . . . . 0.0 109.302 179.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -89.23 3.26 52.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.161 -0.962 . . . . 0.0 108.807 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.6 m -98.21 -20.7 17.11 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.409 -0.807 . . . . 0.0 110.586 -178.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 12' ' ' GLU . 17.2 m -156.65 126.64 6.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.881 -1.137 . . . . 0.0 110.263 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 t -59.08 -31.88 69.29 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.459 ' H ' HG22 ' A' ' 10' ' ' THR . 97.1 mt-10 -112.64 73.89 0.84 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 47.2 t -66.62 148.57 51.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.34 -0.85 . . . . 0.0 110.29 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.6 t -98.35 0.55 45.67 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.6 pt -123.86 -20.73 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.658 -0.651 . . . . 0.0 110.243 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.448 ' CZ ' ' N ' ' A' ' 50' ' ' PHE . 56.6 m-85 -119.59 137.81 53.62 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.304 -0.872 . . . . 0.0 109.999 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.1 t -65.99 -16.81 64.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.635 -0.666 . . . . 0.0 110.819 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -132.71 144.11 50.07 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.04 -1.038 . . . . 0.0 110.68 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.446 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -159.38 171.72 35.9 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -130.37 165.14 23.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.382 -1.07 . . . . 0.0 109.682 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.9 t -95.46 153.81 17.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.38 -0.825 . . . . 0.0 109.17 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.1 pt -57.5 -32.22 41.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.24 -0.913 . . . . 0.0 109.379 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.473 ' O ' ' OG ' ' A' ' 26' ' ' SER . 14.9 t-20 -65.94 -39.45 90.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.113 -0.992 . . . . 0.0 109.533 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -65.16 -39.77 93.41 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.404 -0.81 . . . . 0.0 110.147 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.3 pt -86.29 -13.6 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.15 -0.969 . . . . 0.0 109.703 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' A' ' 23' ' ' ASN . 88.0 p -66.69 -134.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.932 . . . . 0.0 109.33 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -104.52 28.36 7.05 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.244 -0.91 . . . . 0.0 109.11 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' A' ' 29' ' ' SER . 8.8 mptt -126.87 15.02 7.45 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.536 -0.727 . . . . 0.0 109.651 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.493 ' O ' ' C ' ' A' ' 30' ' ' SER . 16.8 m -40.99 143.39 0.38 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.499 -0.751 . . . . 0.0 109.406 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.493 ' C ' ' O ' ' A' ' 29' ' ' SER . 44.6 t -37.59 -81.74 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.473 -0.767 . . . . 0.0 109.676 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 55.1 p30 -143.21 -4.72 0.89 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.189 -0.944 . . . . 0.0 109.69 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.529 ' O ' ' O ' ' A' ' 33' ' ' GLN . 98.9 m-20 -61.61 122.49 15.42 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.16 -0.963 . . . . 0.0 109.385 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.529 ' O ' ' O ' ' A' ' 32' ' ' ASN . 0.4 OUTLIER -35.12 -95.91 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.864 -0.523 . . . . 0.0 109.816 -179.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.431 ' HG2' HE21 ' A' ' 33' ' ' GLN . 7.3 pt20 -139.67 34.0 2.01 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 120.781 -1.2 . . . . 0.0 109.213 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -134.42 106.17 6.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.408 -0.807 . . . . 0.0 109.721 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.1 mm -91.77 120.8 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.118 -0.989 . . . . 0.0 108.669 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.468 HG22 ' HB ' ' A' ' 122' ' ' VAL . 51.8 t -116.21 128.33 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.469 -0.77 . . . . 0.0 110.13 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 74.8 m -101.99 101.82 12.27 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.5 m -93.61 119.84 33.14 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.266 -0.896 . . . . 0.0 109.673 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.481 ' CG2' HG12 ' A' ' 125' ' ' VAL . 27.0 m -141.12 153.77 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.544 -0.723 . . . . 0.0 109.12 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -99.79 134.95 41.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.989 -1.069 . . . . 0.0 109.488 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.68 159.58 14.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.324 -0.86 . . . . 0.0 109.549 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.452 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 21.3 t-80 -133.11 150.88 52.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.246 -0.908 . . . . 0.0 109.445 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.98 -23.95 5.85 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.256 -0.903 . . . . 0.0 109.805 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -104.03 -25.87 12.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.22 -0.925 . . . . 0.0 109.732 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.452 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 84.6 m-20 -73.03 134.58 44.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.324 -0.86 . . . . 0.0 109.954 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 86.1 mt -80.42 147.93 30.77 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.552 HD13 HD21 ' A' ' 99' ' ' LEU . 45.9 pt -120.34 142.31 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.219 -0.926 . . . . 0.0 110.128 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.58 -172.65 45.39 Favored Glycine 0 N--CA 1.498 2.798 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.448 ' N ' ' CZ ' ' A' ' 16' ' ' PHE . 45.7 p90 -172.42 172.08 4.5 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.965 -1.314 . . . . 0.0 109.724 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -146.15 144.82 30.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.207 -0.933 . . . . 0.0 109.864 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 85.3 m -123.2 151.94 62.97 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.419 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.45 146.95 23.8 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.287 1.992 . . . . 0.0 111.929 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.3 t -68.47 -13.21 62.15 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.463 -0.773 . . . . 0.0 110.838 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -91.24 -1.48 57.67 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.935 -1.103 . . . . 0.0 110.324 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.419 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 20.0 m-85 -108.95 164.36 12.47 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.251 -0.906 . . . . 0.0 110.422 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.9 t -104.72 134.95 47.0 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.35 -0.844 . . . . 0.0 108.996 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.562 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.8 m -90.44 123.36 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.958 -1.089 . . . . 0.0 110.223 -179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.42 ' O ' ' O ' ' A' ' 112' ' ' VAL . 26.3 mt-10 -127.81 126.22 23.82 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.06 114.32 3.57 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 121.688 1.592 . . . . 0.0 112.16 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.412 ' O ' ' O ' ' A' ' 68' ' ' PHE . 7.3 t-160 -93.07 -24.84 18.17 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.6 t0 -170.21 39.76 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 98.6 m -63.02 -153.87 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.44 -0.788 . . . . 0.0 109.733 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.9 p90 -111.17 -56.42 2.37 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.246 -0.909 . . . . 0.0 111.359 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 66' ' ' SER . 16.2 t -48.51 -72.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.362 -1.461 . . . . 0.0 108.848 -179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.447 ' N ' HG12 ' A' ' 65' ' ' VAL . 33.3 t -138.89 131.29 28.58 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -173.42 -179.42 1.88 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.999 -1.063 . . . . 0.0 110.483 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 6.2 m-85 -93.45 127.65 39.18 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -73.95 -172.36 1.31 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.115 -0.99 . . . . 0.0 109.671 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 47.8 mt -63.62 -22.53 66.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 109.122 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.0 p -82.5 -7.41 59.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 108.875 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.93 18.47 67.53 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -101.48 140.72 35.39 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.253 -1.145 . . . . 0.0 108.989 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -80.6 115.9 20.35 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.297 -0.877 . . . . 0.0 110.133 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -152.65 139.64 19.15 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.308 -0.87 . . . . 0.0 109.767 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 40.8 m-20 -63.3 148.56 47.94 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.156 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 77' ' ' LEU . 14.0 tp -97.59 7.94 45.55 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.306 -0.871 . . . . 0.0 109.817 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -68.65 -40.47 80.2 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.845 -1.159 . . . . 0.0 110.049 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 79' ' ' ASN . 52.0 t-20 -62.39 -33.99 75.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.019 -1.051 . . . . 0.0 109.108 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -74.42 -48.87 25.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.888 . . . . 0.0 109.56 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.47 HD11 ' HG2' ' A' ' 100' ' ' PRO . 48.5 tp -139.29 124.74 19.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.459 -0.776 . . . . 0.0 109.161 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -81.19 90.13 6.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.046 -1.033 . . . . 0.0 109.734 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.2 mt -75.26 149.96 38.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 109.972 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 63.9 p -127.24 159.97 32.72 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.469 -0.769 . . . . 0.0 109.203 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.756 HD22 HH11 ' A' ' 98' ' ' ARG . 82.3 m-20 55.69 52.77 10.43 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -0.91 . . . . 0.0 109.92 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -81.77 132.98 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.379 -0.826 . . . . 0.0 110.009 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.3 mm -122.48 122.65 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.521 -0.737 . . . . 0.0 109.21 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 91.0 mtp -122.24 102.91 8.41 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.154 -0.966 . . . . 0.0 109.757 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -111.98 100.62 9.03 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.304 -0.873 . . . . 0.0 109.037 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.491 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 76.3 m80 -73.28 -35.02 66.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.002 -1.061 . . . . 0.0 110.64 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -60.67 -46.59 89.75 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.009 -1.057 . . . . 0.0 109.646 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -88.48 -3.89 58.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.138 -0.976 . . . . 0.0 109.07 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 97.3 m-20 54.57 47.28 23.04 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.385 -0.822 . . . . 0.0 110.144 178.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.594 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 2.3 t -132.65 138.0 47.18 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.229 -0.919 . . . . 0.0 109.36 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -127.91 139.71 52.44 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.392 -0.818 . . . . 0.0 110.103 -179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.594 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 58.3 m-85 -136.2 146.88 47.3 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.279 -0.888 . . . . 0.0 109.245 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 29.4 t -151.46 152.92 33.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.136 -0.978 . . . . 0.0 109.143 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.756 HH11 HD22 ' A' ' 85' ' ' ASN . 53.9 mtp180 -108.37 137.43 46.35 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.341 -0.849 . . . . 0.0 109.36 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.61 ' HB3' HD11 ' A' ' 103' ' ' ILE . 40.8 mt -93.24 141.1 23.57 Favored Pre-proline 0 N--CA 1.491 1.624 0 C-N-CA 120.381 -0.528 . . . . 0.0 109.603 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.47 ' HG2' HD11 ' A' ' 81' ' ' LEU . 78.3 Cg_exo -46.54 159.49 0.29 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 121.781 1.654 . . . . 0.0 111.206 178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.2 p -68.71 -16.52 63.84 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.254 -0.904 . . . . 0.0 109.772 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.2 tp -123.37 131.44 53.65 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.408 -0.808 . . . . 0.0 110.502 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.61 HD11 ' HB3' ' A' ' 99' ' ' LEU . 64.6 mt -143.07 126.03 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.4 m -139.16 52.99 1.75 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.955 -1.091 . . . . 0.0 109.782 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.519 ' O ' ' OXT' ' A' ' 127' ' ' ALA . 54.6 t0 -145.99 153.33 40.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.957 . . . . 0.0 110.026 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.491 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 99.0 m-20 -91.93 33.03 1.07 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.39 -0.819 . . . . 0.0 108.912 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.52 ' NE1' ' HB3' ' A' ' 127' ' ' ALA . 7.8 p-90 -64.57 154.33 36.53 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.135 -0.978 . . . . 0.0 110.494 -178.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.558 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 53.7 tttp -145.39 151.42 38.23 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.611 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 30.2 p90 -155.45 164.48 38.64 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.077 -1.014 . . . . 0.0 108.621 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 8.0 p90 -154.63 159.07 40.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.717 -1.239 . . . . 0.0 111.861 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 80.7 m -123.25 156.24 35.59 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.483 HG22 HG22 ' A' ' 122' ' ' VAL . 46.4 t -129.3 141.21 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 O-C-N 120.874 -1.141 . . . . 0.0 111.693 -178.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 35.1 m -122.25 131.73 54.07 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.0 p -172.12 179.04 2.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.243 -1.536 . . . . 0.0 111.565 -178.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.468 ' CB ' ' HZ2' ' A' ' 115' ' ' LYS . 6.3 mtmp? -153.09 167.32 29.63 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 117' ' ' ASN . 99.9 m-20 -58.84 152.14 19.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.782 -1.199 . . . . 0.0 109.001 179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.475 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 56.8 t-20 39.77 59.53 1.86 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.462 -0.774 . . . . 0.0 109.683 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 54.0 mm-40 -158.46 139.9 13.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.374 -0.829 . . . . 0.0 110.551 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -52.98 140.43 24.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.33 -0.856 . . . . 0.0 108.873 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.1 ptmt -92.88 139.12 30.86 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.462 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 59.3 mt -110.04 122.77 48.35 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.483 HG22 HG22 ' A' ' 112' ' ' VAL . 43.6 t -107.25 129.47 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.049 -1.032 . . . . 0.0 110.625 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.412 ' CE1' ' HB3' ' A' ' 50' ' ' PHE . 21.5 t80 -106.95 119.07 38.35 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 178.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.558 ' OG1' ' NZ ' ' A' ' 108' ' ' LYS . 6.3 t -136.11 140.21 43.54 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.997 -1.064 . . . . 0.0 112.119 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.611 ' CG2' ' CE2' ' A' ' 109' ' ' PHE . 3.0 m -136.06 156.81 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 177.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -136.18 155.47 50.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.088 -1.007 . . . . 0.0 110.291 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.52 ' HB3' ' NE1' ' A' ' 107' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.355 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -138.53 157.4 46.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.253 -0.904 . . . . 0.0 109.393 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.7 t -95.19 134.88 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.279 -0.888 . . . . 0.0 110.061 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -68.96 123.09 20.07 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.017 -1.052 . . . . 0.0 108.617 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.54 179.66 47.83 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.9 t -119.15 130.04 55.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.523 -0.986 . . . . 0.0 109.318 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.419 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 40.2 t0 -106.3 109.12 20.95 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.572 -0.705 . . . . 0.0 109.326 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -89.62 1.51 55.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.322 -0.861 . . . . 0.0 108.939 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.3 m -103.29 -17.03 15.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.477 -0.765 . . . . 0.0 110.514 -178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.552 HG22 ' H ' ' A' ' 12' ' ' GLU . 74.8 m -156.93 126.02 5.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.814 -1.179 . . . . 0.0 110.387 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.6 t -64.1 -28.19 69.61 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.37 -0.831 . . . . 0.0 108.937 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.552 ' H ' HG22 ' A' ' 10' ' ' THR . 79.2 mm-40 -112.68 73.77 0.83 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 39.1 t -68.15 150.43 48.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.806 . . . . 0.0 110.211 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.52 -0.08 41.34 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 17.9 pt -125.14 -22.03 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.712 -0.618 . . . . 0.0 110.312 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -114.19 141.47 47.48 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.279 -0.888 . . . . 0.0 110.156 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 m -74.98 -18.8 60.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.552 -0.718 . . . . 0.0 110.894 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.55 ' NZ ' ' CE1' ' A' ' 20' ' ' TYR . 61.5 tttm -129.43 140.22 51.39 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.018 -1.051 . . . . 0.0 110.577 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.419 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -155.98 164.88 32.49 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.55 ' CE1' ' NZ ' ' A' ' 18' ' ' LYS . 36.5 m-85 -118.28 155.18 31.04 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.446 -1.032 . . . . 0.0 109.745 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.7 t -94.17 152.08 18.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.443 -0.786 . . . . 0.0 109.024 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.4 pt -59.01 -28.27 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.761 -0.775 . . . . 0.0 109.478 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -69.72 -41.01 75.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.049 -1.032 . . . . 0.0 109.633 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -59.67 -45.92 90.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -0.89 . . . . 0.0 110.103 -178.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 35.6 pt -67.17 -5.34 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.117 -0.989 . . . . 0.0 109.57 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.699 ' O ' ' N ' ' A' ' 28' ' ' LYS . 79.2 p -108.8 -36.47 6.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.261 -0.9 . . . . 0.0 109.231 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.45 ' O ' ' N ' ' A' ' 29' ' ' SER . 98.8 m-20 -53.65 73.17 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 26' ' ' SER . 98.3 mttt -52.27 93.05 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.43 -0.794 . . . . 0.0 109.689 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -140.92 -85.55 0.19 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.938 . . . . 0.0 109.212 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.524 ' N ' ' OG ' ' A' ' 29' ' ' SER . 7.0 p -69.21 177.19 2.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.57 -0.706 . . . . 0.0 109.587 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 32' ' ' ASN . 56.8 p30 -51.46 -14.68 0.32 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.116 -0.99 . . . . 0.0 109.467 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.556 ' O ' HD11 ' A' ' 36' ' ' ILE . 91.3 m-20 -69.05 10.48 0.29 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.148 -0.97 . . . . 0.0 109.332 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.61 ' O ' ' NZ ' ' A' ' 119' ' ' LYS . 15.2 pt20 -91.44 -7.82 49.56 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.036 . . . . 0.0 109.568 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.479 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 15.3 pt20 -138.28 -33.1 0.69 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.338 -0.851 . . . . 0.0 109.802 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.479 ' OD1' ' O ' ' A' ' 34' ' ' GLN . 78.8 m-20 -136.59 113.71 10.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.446 -0.784 . . . . 0.0 109.559 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.556 HD11 ' O ' ' A' ' 32' ' ' ASN . 21.7 mm -92.72 120.1 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.061 -1.024 . . . . 0.0 108.58 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 52.4 t -115.33 124.48 71.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.425 -0.797 . . . . 0.0 110.147 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 71.3 m -102.64 101.97 12.14 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.6 m -95.81 121.13 37.21 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.164 -0.96 . . . . 0.0 109.693 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.443 ' CG2' HG12 ' A' ' 125' ' ' VAL . 26.8 m -141.04 153.91 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.578 -0.701 . . . . 0.0 109.218 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -97.99 133.96 41.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.008 -1.058 . . . . 0.0 109.37 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -98.81 160.57 14.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.298 -0.876 . . . . 0.0 109.641 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.446 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 32.2 t60 -135.28 151.88 50.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.327 -0.858 . . . . 0.0 109.487 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.571 ' HB1' ' HA ' ' A' ' 101' ' ' SER . . . -51.77 -25.23 7.14 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.238 -0.914 . . . . 0.0 109.635 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -101.48 -27.04 13.35 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.291 -0.881 . . . . 0.0 109.817 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.446 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 86.3 m-20 -73.64 134.4 43.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.298 -0.876 . . . . 0.0 109.989 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.523 HD21 ' CZ ' ' A' ' 98' ' ' ARG . 97.3 mt -79.92 148.31 31.31 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 108.545 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.485 HD13 HD21 ' A' ' 99' ' ' LEU . 9.5 pt -120.4 141.5 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.24 -0.913 . . . . 0.0 109.969 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.416 ' CA ' ' O ' ' A' ' 95' ' ' PHE . . . 176.86 -173.28 46.18 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -171.66 173.05 4.76 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.001 -1.293 . . . . 0.0 109.791 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -146.05 144.78 30.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.308 -0.87 . . . . 0.0 109.892 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 80.0 m -123.79 152.45 65.96 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.429 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.53 148.33 20.77 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.28 1.987 . . . . 0.0 112.005 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.4 m -71.5 -12.96 61.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.431 -0.793 . . . . 0.0 110.647 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -91.84 1.9 56.87 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.016 -1.053 . . . . 0.0 110.119 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.446 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 18.1 m-85 -110.09 165.26 11.88 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.266 -0.896 . . . . 0.0 110.354 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.5 t -102.92 139.75 38.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.289 -0.882 . . . . 0.0 109.012 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.6 m -97.92 125.86 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.991 -1.068 . . . . 0.0 110.199 -179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -132.14 129.86 21.85 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -78.3 113.12 3.32 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.664 1.576 . . . . 0.0 112.095 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -92.01 -27.98 17.48 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.415 ' HB2' ' CZ ' ' A' ' 110' ' ' PHE . 54.3 t0 -166.81 38.42 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.587 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 79.0 m -62.85 -157.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.544 -0.722 . . . . 0.0 109.77 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.2 p90 -111.27 -49.07 3.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.226 -0.921 . . . . 0.0 111.629 -178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.409 HG23 ' CD2' ' A' ' 64' ' ' PHE . 53.6 t -59.22 -48.45 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 120.343 -1.473 . . . . 0.0 109.286 -178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.5 t -157.78 128.73 6.53 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.587 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.7 -178.93 1.69 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.092 -1.005 . . . . 0.0 110.499 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 9.9 m-85 -93.1 124.75 37.3 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -69.28 -174.91 0.71 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.011 . . . . 0.0 109.847 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 54.5 mt -62.92 -23.01 67.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.316 -0.865 . . . . 0.0 108.95 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.8 m -82.36 -6.34 59.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.327 -0.858 . . . . 0.0 108.761 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.18 19.88 63.88 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -101.71 138.95 38.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.318 -1.107 . . . . 0.0 109.101 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -82.46 110.25 17.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.21 -0.931 . . . . 0.0 109.964 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -147.01 141.91 26.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.499 -0.751 . . . . 0.0 110.011 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -59.86 144.02 49.78 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.274 -0.891 . . . . 0.0 109.32 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.571 HD11 ' HD2' ' A' ' 80' ' ' LYS . 14.3 tp -97.09 8.03 45.36 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.202 -0.936 . . . . 0.0 109.735 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -69.67 -38.74 77.19 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.179 -0.951 . . . . 0.0 110.065 -179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.555 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 41.7 p-10 -62.43 -32.85 73.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.125 -0.984 . . . . 0.0 109.217 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.571 ' HD2' HD11 ' A' ' 77' ' ' LEU . 37.3 ttmt -71.86 -50.79 26.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.345 -0.847 . . . . 0.0 109.663 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.595 HD22 ' CZ2' ' A' ' 107' ' ' TRP . 39.0 tp -140.74 128.2 21.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.479 -0.763 . . . . 0.0 109.166 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -81.05 87.73 6.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.035 -1.041 . . . . 0.0 109.487 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 94.7 mt -71.66 152.99 42.38 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.28 -0.888 . . . . 0.0 109.928 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 44.6 p -128.19 163.92 23.64 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.562 -0.711 . . . . 0.0 109.323 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 55.44 52.24 11.59 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.265 -0.897 . . . . 0.0 109.94 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.45 128.26 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.337 -0.852 . . . . 0.0 109.985 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.1 mm -123.47 122.44 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.554 -0.716 . . . . 0.0 109.136 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 83.2 mtp -123.59 104.81 9.26 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.197 -0.94 . . . . 0.0 109.793 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -113.37 101.85 9.78 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.342 -0.849 . . . . 0.0 109.013 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.487 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 96.6 m-70 -73.14 -36.14 66.63 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.97 -1.081 . . . . 0.0 110.652 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -60.21 -46.32 90.15 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.891 -1.131 . . . . 0.0 109.623 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -89.79 -5.09 57.26 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.172 -0.955 . . . . 0.0 109.032 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.487 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.6 m-20 54.66 47.66 22.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.551 -0.718 . . . . 0.0 110.25 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.586 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 2.5 t -131.94 135.8 46.88 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.21 -0.931 . . . . 0.0 109.291 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.416 ' O ' ' CA ' ' A' ' 49' ' ' GLY . 76.0 m-85 -126.63 139.28 53.29 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.388 -0.82 . . . . 0.0 109.951 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.586 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 72.3 m-85 -136.15 147.3 47.66 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.349 -0.844 . . . . 0.0 109.264 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.5 t -152.9 152.59 31.68 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.063 -1.023 . . . . 0.0 109.189 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.523 ' CZ ' HD21 ' A' ' 47' ' ' LEU . 9.0 mtt-85 -107.41 139.29 42.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.26 -0.9 . . . . 0.0 109.856 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.485 HD21 HD13 ' A' ' 48' ' ' ILE . 38.2 mt -94.88 141.47 23.35 Favored Pre-proline 0 N--CA 1.49 1.548 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.853 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.517 ' HG2' HD11 ' A' ' 81' ' ' LEU . 77.3 Cg_exo -45.9 179.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.214 0 C-N-CA 121.912 1.741 . . . . 0.0 111.162 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.571 ' HA ' ' HB1' ' A' ' 44' ' ' ALA . 73.7 m -86.08 -14.17 45.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.088 -1.008 . . . . 0.0 110.001 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 55.7 tp -120.99 130.22 53.72 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.276 -0.89 . . . . 0.0 110.442 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.434 HD11 ' HB3' ' A' ' 99' ' ' LEU . 7.6 mt -150.23 102.38 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 84.2 p -115.49 -0.69 13.0 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.168 -0.957 . . . . 0.0 109.748 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.57 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 52.4 t0 -87.38 158.01 19.11 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.226 -0.921 . . . . 0.0 110.081 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.57 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 92.9 m-20 -99.42 32.2 2.86 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.451 -0.781 . . . . 0.0 109.071 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.595 ' CZ2' HD22 ' A' ' 81' ' ' LEU . 10.3 p-90 -65.97 157.18 31.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.145 -0.972 . . . . 0.0 110.509 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -146.4 157.96 43.83 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.568 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 39.6 p90 -155.68 163.54 39.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.155 -0.966 . . . . 0.0 108.718 179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 62' ' ' ASP . 14.3 p90 -153.73 163.07 40.64 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.83 -1.169 . . . . 0.0 111.877 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 95.1 m -127.73 158.93 36.3 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 122' ' ' VAL . 44.0 t -130.44 143.34 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.93 -1.106 . . . . 0.0 111.856 -178.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 86.1 m -124.8 132.92 53.3 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.0 p -171.49 179.14 2.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.306 -1.496 . . . . 0.0 111.669 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.575 ' NZ ' ' OE2' ' A' ' 118' ' ' GLU . 6.4 mtmp? -153.09 166.15 33.36 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.62 151.7 20.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.867 -1.146 . . . . 0.0 109.245 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.49 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 64.8 t30 44.7 61.2 2.55 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.219 -0.926 . . . . 0.0 109.667 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.575 ' OE2' ' NZ ' ' A' ' 115' ' ' LYS . 42.5 mt-10 -164.61 145.38 7.85 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.226 -0.921 . . . . 0.0 110.26 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.61 ' NZ ' ' O ' ' A' ' 33' ' ' GLN . 67.6 mttm -60.47 146.79 43.45 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.228 -0.92 . . . . 0.0 108.937 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.0 ptpt -93.72 141.71 28.18 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.111 -0.993 . . . . 0.0 110.394 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 52.1 mt -108.84 121.0 44.16 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.313 -0.867 . . . . 0.0 108.899 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 112' ' ' VAL . 55.4 t -108.96 130.3 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.092 -1.005 . . . . 0.0 110.577 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -110.65 122.65 48.3 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.0 t -137.68 143.94 41.56 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.029 -1.044 . . . . 0.0 112.378 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.568 ' CG2' ' CE2' ' A' ' 109' ' ' PHE . 3.0 m -135.42 158.77 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -136.83 153.91 50.66 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.058 -1.026 . . . . 0.0 110.282 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.512 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.354 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.282 0.563 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -77.84 156.65 30.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.238 -0.914 . . . . 0.0 109.251 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.6 t -95.06 133.36 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.196 -0.94 . . . . 0.0 109.97 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.419 ' HD2' ' N ' ' A' ' 4' ' ' LYS . 13.6 mptt -70.59 125.18 26.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.104 -0.998 . . . . 0.0 108.663 178.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.21 -179.95 42.71 Favored Glycine 0 N--CA 1.484 1.844 0 C-N-CA 119.479 -1.343 . . . . 0.0 109.79 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.9 t -116.92 134.72 54.4 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.402 -1.057 . . . . 0.0 109.712 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.544 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 68.1 t0 -115.81 110.66 19.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.499 -0.751 . . . . 0.0 109.332 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -87.17 3.26 47.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.195 -0.94 . . . . 0.0 108.916 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 99.4 m -102.96 -18.85 14.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.434 -0.791 . . . . 0.0 110.549 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 12' ' ' GLU . 10.4 m -157.42 127.52 6.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.887 -1.133 . . . . 0.0 110.289 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 21' ' ' SER . 37.3 m -66.49 -27.0 67.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.408 -0.807 . . . . 0.0 109.001 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.583 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 57.9 mp0 -113.81 74.87 0.89 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.524 ' C ' ' H ' ' A' ' 15' ' ' ILE . 26.6 m -75.97 115.87 16.1 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.423 -0.798 . . . . 0.0 110.578 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.406 HG23 HG23 ' A' ' 15' ' ' ILE . 7.7 t -65.39 3.2 0.71 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.524 ' H ' ' C ' ' A' ' 13' ' ' SER . 15.1 pt -122.83 -36.57 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.712 -0.618 . . . . 0.0 110.333 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.416 ' CZ ' ' CE1' ' A' ' 96' ' ' TYR . 50.9 m-85 -108.21 137.11 46.75 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.185 -0.947 . . . . 0.0 109.816 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.2 t -68.28 -18.4 64.52 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.593 -0.692 . . . . 0.0 111.003 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -130.58 141.42 50.46 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.953 -1.092 . . . . 0.0 110.521 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.544 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -161.83 173.55 38.2 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -128.44 162.23 27.63 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.38 -1.07 . . . . 0.0 109.568 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.509 ' N ' ' OG ' ' A' ' 11' ' ' SER . 10.7 t -97.05 157.37 15.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.392 -0.817 . . . . 0.0 109.182 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.457 ' O ' ' OG ' ' A' ' 26' ' ' SER . 44.1 pt -57.97 -30.38 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.308 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -65.9 -40.42 91.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.153 -0.967 . . . . 0.0 109.59 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -66.11 -41.53 90.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 110.219 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.1 pt -86.85 -17.61 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.003 -1.061 . . . . 0.0 109.739 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.594 ' O ' ' N ' ' A' ' 28' ' ' LYS . 37.8 m -93.65 -73.27 0.57 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 0.0 109.342 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.489 ' O ' ' N ' ' A' ' 29' ' ' SER . 58.7 t30 -50.36 87.06 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 0.0 109.147 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.594 ' N ' ' O ' ' A' ' 26' ' ' SER . 35.2 pttt -45.63 95.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.555 -0.715 . . . . 0.0 109.54 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 27' ' ' ASN . 20.3 m -157.17 21.42 0.3 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.143 -0.973 . . . . 0.0 109.335 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 40.5 t -78.23 155.43 30.31 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.881 -0.727 . . . . 0.0 109.929 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 32' ' ' ASN . 26.3 p-10 -52.03 -54.35 31.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.157 -0.964 . . . . 0.0 109.468 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.589 ' ND2' ' O ' ' A' ' 35' ' ' ASP . 25.1 p30 -71.94 177.29 4.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.168 -0.957 . . . . 0.0 109.341 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.509 ' C ' ' H ' ' A' ' 35' ' ' ASP . 21.0 pt20 -75.97 -148.42 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 109.595 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.774 ' H ' ' NE2' ' A' ' 34' ' ' GLN . 0.0 OUTLIER -69.65 40.0 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.258 -0.901 . . . . 0.0 109.471 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.589 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 86.3 m-20 -131.78 109.24 10.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.498 -0.751 . . . . 0.0 109.518 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.2 mm -97.31 124.49 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.995 -1.066 . . . . 0.0 108.775 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.486 HG22 ' HB ' ' A' ' 122' ' ' VAL . 50.0 t -121.03 129.62 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.303 -0.873 . . . . 0.0 110.157 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.454 ' O ' ' O ' ' A' ' 124' ' ' THR . 84.5 m -101.26 100.12 10.59 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.8 m -95.53 120.64 36.13 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.089 -1.007 . . . . 0.0 109.412 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.61 HG22 HG12 ' A' ' 125' ' ' VAL . 3.1 m -139.05 159.44 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.526 -0.734 . . . . 0.0 109.176 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -97.77 123.71 41.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.151 -0.968 . . . . 0.0 109.594 179.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.441 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -90.55 155.03 19.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.309 -0.87 . . . . 0.0 109.531 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.431 ' O ' HD12 ' A' ' 99' ' ' LEU . 35.4 t-80 -133.33 152.13 51.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.264 -0.898 . . . . 0.0 109.553 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.751 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -57.34 -29.61 64.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.335 -0.853 . . . . 0.0 109.827 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -93.6 -26.89 16.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 109.725 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -76.68 135.6 39.1 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.523 -0.735 . . . . 0.0 110.043 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.1 mt -78.36 148.64 33.63 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.468 HD13 HD21 ' A' ' 99' ' ' LEU . 47.5 pt -122.36 144.83 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.331 -0.856 . . . . 0.0 110.308 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.5 -171.2 44.16 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -172.73 171.57 4.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.136 -1.214 . . . . 0.0 109.71 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -146.82 144.84 29.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.204 -0.935 . . . . 0.0 109.9 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 86.0 m -125.37 152.17 70.96 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.213 -0.929 . . . . 0.0 108.54 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.472 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.4 Cg_endo -51.63 149.82 17.9 Favored 'Trans proline' 0 N--CA 1.494 1.525 0 C-N-CA 122.3 2.0 . . . . 0.0 111.944 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.0 m -70.84 -12.1 61.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -0.83 . . . . 0.0 110.682 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.448 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 82.4 m-20 -92.78 0.23 57.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.94 -1.1 . . . . 0.0 110.182 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.472 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 16.3 m-85 -108.28 164.2 12.53 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.202 -0.936 . . . . 0.0 110.364 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.9 m -103.85 128.08 51.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 109.087 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.687 HG23 ' O ' ' A' ' 58' ' ' VAL . 3.2 m -88.3 114.38 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 120.959 -1.088 . . . . 0.0 110.151 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -120.37 126.8 26.62 Favored Pre-proline 0 N--CA 1.49 1.542 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.06 113.53 3.43 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 121.545 1.496 . . . . 0.0 112.106 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.491 ' O ' ' O ' ' A' ' 68' ' ' PHE . 2.8 t-80 -93.59 -23.63 18.23 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -172.26 51.2 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.67 ' H ' ' CB ' ' A' ' 67' ' ' ALA . 76.4 m -76.47 -151.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.63 -0.668 . . . . 0.0 109.799 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.49 ' CE2' HG23 ' A' ' 65' ' ' VAL . 6.5 p90 -110.18 -58.33 2.08 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.098 -1.001 . . . . 0.0 111.373 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.49 HG23 ' CE2' ' A' ' 64' ' ' PHE . 24.0 t -45.27 -70.35 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.627 -1.296 . . . . 0.0 108.809 -179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.4 t -145.58 129.36 17.23 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.67 ' CB ' ' H ' ' A' ' 63' ' ' CYS . . . -167.84 -179.78 4.38 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.373 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.534 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.3 m-85 -93.98 141.2 28.79 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.698 HD21 ' CB ' ' A' ' 75' ' ' GLU . 75.8 m-20 -80.88 -169.7 2.33 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.955 -1.091 . . . . 0.0 109.652 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.529 HD12 ' N ' ' A' ' 70' ' ' LEU . 10.2 mp -67.91 -13.8 62.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.319 -0.863 . . . . 0.0 108.913 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.4 t -90.73 -7.14 53.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.33 -0.856 . . . . 0.0 108.982 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.07 23.87 56.26 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -107.73 136.44 47.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.213 -1.169 . . . . 0.0 109.095 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -67.42 135.02 52.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.216 -0.927 . . . . 0.0 109.984 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.698 ' CB ' HD21 ' A' ' 69' ' ' ASN . 80.3 tt0 -155.42 166.0 34.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.437 -0.789 . . . . 0.0 109.548 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.458 ' N ' ' HG2' ' A' ' 75' ' ' GLU . 5.3 m120 -106.94 139.1 41.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.33 -0.856 . . . . 0.0 109.531 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.7 tp -95.79 -10.27 29.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.099 -1.0 . . . . 0.0 110.027 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.481 ' CG ' ' N ' ' A' ' 79' ' ' ASN . 20.5 pt-20 -62.67 -44.86 95.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.99 -1.069 . . . . 0.0 109.476 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.563 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 48.7 p30 -66.72 -22.09 66.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.138 -0.976 . . . . 0.0 108.94 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.563 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 52.6 tptt -86.74 -48.09 8.55 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.359 -0.838 . . . . 0.0 109.415 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.649 HD23 HD21 ' A' ' 83' ' ' LEU . 30.8 tp -122.89 129.95 52.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.412 -0.805 . . . . 0.0 109.174 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -78.66 82.68 4.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.032 -1.043 . . . . 0.0 109.244 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.649 HD21 HD23 ' A' ' 81' ' ' LEU . 88.8 mt -81.53 137.69 35.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.873 . . . . 0.0 110.112 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 48.1 p -127.44 163.31 24.36 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.513 -0.742 . . . . 0.0 109.278 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.557 HD22 ' HE ' ' A' ' 98' ' ' ARG . 97.8 m-20 55.04 51.05 14.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.271 -0.893 . . . . 0.0 109.623 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.2 131.53 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.353 -0.842 . . . . 0.0 110.039 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.6 mm -121.85 121.17 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.503 -0.748 . . . . 0.0 109.277 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 79.6 mtp -123.73 107.4 11.41 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.21 -0.931 . . . . 0.0 109.785 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -112.57 101.27 9.42 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.374 -0.829 . . . . 0.0 109.082 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.448 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 76.4 m80 -71.55 -36.8 71.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.917 -1.114 . . . . 0.0 110.651 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -60.61 -45.74 92.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.022 -1.049 . . . . 0.0 109.557 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -87.91 -5.28 58.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -0.923 . . . . 0.0 109.117 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 99.7 m-20 54.37 47.61 22.53 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.504 -0.747 . . . . 0.0 110.332 178.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.597 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 2.6 t -132.99 138.19 46.77 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.028 -1.045 . . . . 0.0 109.333 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -126.38 138.9 53.61 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.512 -0.742 . . . . 0.0 109.809 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.597 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 77.9 m-85 -135.41 146.15 48.0 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.115 -0.991 . . . . 0.0 109.336 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.5 p -153.03 155.69 37.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.097 -1.002 . . . . 0.0 108.986 178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.557 ' HE ' HD22 ' A' ' 85' ' ' ASN . 59.2 mtt-85 -105.11 136.68 44.16 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.264 -0.897 . . . . 0.0 109.65 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.468 HD21 HD13 ' A' ' 48' ' ' ILE . 78.1 mt -91.83 138.41 24.91 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.459 -0.776 . . . . 0.0 109.706 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.751 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 76.4 Cg_exo -45.74 175.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.83 1.686 . . . . 0.0 111.305 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.6 m -83.92 -12.93 54.66 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.077 -1.014 . . . . 0.0 109.844 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.3 tp -134.13 130.0 36.71 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.131 -0.981 . . . . 0.0 110.511 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 91.3 mt -147.37 102.48 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.317 -0.865 . . . . 0.0 108.806 179.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 57.3 m -104.1 -6.96 20.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.072 -1.017 . . . . 0.0 109.794 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.425 ' O ' ' O ' ' A' ' 127' ' ' ALA . 78.6 m-20 -78.41 151.65 32.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 110.022 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -100.15 31.79 3.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.391 -0.818 . . . . 0.0 109.205 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.408 ' CH2' HD22 ' A' ' 81' ' ' LEU . 20.4 p-90 -65.4 159.88 23.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.117 -0.99 . . . . 0.0 110.465 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -142.23 156.97 45.34 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.643 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 36.4 p90 -154.08 158.62 40.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.088 -1.007 . . . . 0.0 108.692 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 18.5 p90 -150.66 156.33 41.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.804 -1.185 . . . . 0.0 111.937 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 96.5 m -121.78 156.19 33.71 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 122' ' ' VAL . 51.7 t -127.71 138.43 54.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.77 -1.206 . . . . 0.0 111.872 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 67.0 m -123.34 132.0 53.84 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 97.5 p -165.6 171.5 13.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.121 -1.612 . . . . 0.0 111.652 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.448 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 47.6 mtpt -136.87 158.58 44.14 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -60.29 143.21 53.36 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.933 -1.105 . . . . 0.0 108.813 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 59.6 t-20 49.82 62.63 2.55 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.395 -0.816 . . . . 0.0 109.09 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 63.3 mm-40 -165.11 149.66 9.0 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.177 -0.952 . . . . 0.0 110.71 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -55.18 136.92 48.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.251 -0.905 . . . . 0.0 108.974 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -88.41 140.41 29.5 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.18 -0.95 . . . . 0.0 110.322 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 70.8 mt -109.16 122.03 46.42 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.432 -0.793 . . . . 0.0 109.136 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 112' ' ' VAL . 47.2 t -111.02 131.36 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.075 -1.016 . . . . 0.0 110.492 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -107.58 118.59 37.12 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.454 ' O ' ' O ' ' A' ' 38' ' ' CYS . 7.3 t -136.6 141.43 43.27 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.868 -1.145 . . . . 0.0 111.967 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.643 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 2.8 m -137.37 160.34 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -128.81 149.04 50.9 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.094 -1.004 . . . . 0.0 110.264 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.425 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.353 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -77.07 152.66 34.94 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -0.916 . . . . 0.0 109.307 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.8 t -95.32 135.36 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.324 -0.86 . . . . 0.0 109.89 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -67.99 121.31 15.81 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.0 108.6 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 178.71 175.04 45.45 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.425 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 5.0 t -116.08 130.02 56.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.415 -1.05 . . . . 0.0 109.465 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.478 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 42.6 t0 -104.82 108.51 20.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.533 -0.729 . . . . 0.0 109.214 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -89.29 0.24 56.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.277 -0.889 . . . . 0.0 108.93 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.4 m -102.33 -17.17 16.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.568 -0.707 . . . . 0.0 110.414 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.445 HG22 ' H ' ' A' ' 12' ' ' GLU . 8.0 m -156.87 126.7 6.27 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.801 -1.187 . . . . 0.0 110.229 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.2 p -64.06 -27.63 69.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 0.0 108.858 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.445 ' H ' HG22 ' A' ' 10' ' ' THR . 97.3 mt-10 -114.77 76.87 1.02 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.507 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 88.1 p -71.75 153.37 42.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.395 -0.815 . . . . 0.0 110.224 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.15 1.1 35.72 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.6 pt -123.61 -24.03 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.632 -0.667 . . . . 0.0 110.29 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.507 ' O ' ' OG ' ' A' ' 13' ' ' SER . 63.3 m-85 -114.91 140.87 48.63 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.093 -1.005 . . . . 0.0 110.093 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.1 p -69.04 -17.81 63.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.403 -0.811 . . . . 0.0 110.614 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -129.58 139.86 51.36 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.921 -1.112 . . . . 0.0 110.458 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.478 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -150.37 162.95 29.43 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.425 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 36.5 m-85 -127.14 159.21 34.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.371 -1.076 . . . . 0.0 109.568 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.9 t -89.76 149.89 22.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.366 -0.834 . . . . 0.0 109.145 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.2 pt -64.38 -30.03 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.216 -0.927 . . . . 0.0 109.58 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -70.63 -41.01 72.75 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.151 -0.968 . . . . 0.0 109.786 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.05 -45.65 92.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 110.247 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 26' ' ' SER . 15.3 pt -69.97 -42.82 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.11 -0.994 . . . . 0.0 109.585 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.61 ' O ' ' N ' ' A' ' 28' ' ' LYS . 4.4 t -66.33 -54.85 19.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.169 -0.957 . . . . 0.0 109.32 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.682 ' O ' ' C ' ' A' ' 28' ' ' LYS . 62.5 t30 -46.57 88.98 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.342 -0.849 . . . . 0.0 109.22 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.682 ' C ' ' O ' ' A' ' 27' ' ' ASN . 44.2 tptt -13.3 115.58 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 121.349 0.595 . . . . 0.0 109.663 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.554 ' OG ' HD11 ' A' ' 36' ' ' ILE . 74.5 m -46.96 123.5 5.31 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.467 -178.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 p -98.73 -8.12 26.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.38 -0.825 . . . . 0.0 109.316 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 56.1 p30 -104.7 -1.63 26.03 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.21 -0.931 . . . . 0.0 109.658 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.51 ' CG ' ' H ' ' A' ' 33' ' ' GLN . 66.5 t30 -162.56 -168.66 1.88 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.152 -0.967 . . . . 0.0 109.412 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.51 ' H ' ' CG ' ' A' ' 32' ' ' ASN . 18.5 pt20 -77.52 -172.46 2.55 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.611 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.491 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 13.8 pt20 -76.04 50.43 0.6 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.955 . . . . 0.0 109.575 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 34' ' ' GLN . 98.6 m-20 -141.68 116.77 9.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.393 -0.817 . . . . 0.0 109.521 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.554 HD11 ' OG ' ' A' ' 29' ' ' SER . 43.4 mm -93.64 126.85 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.928 -1.107 . . . . 0.0 108.726 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.453 HG22 ' HB ' ' A' ' 122' ' ' VAL . 56.1 t -123.29 129.17 75.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.364 -0.835 . . . . 0.0 110.31 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 85.1 m -102.08 101.61 11.98 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 54.4 m -97.03 122.31 39.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.057 -1.027 . . . . 0.0 109.649 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.619 ' CG2' HG12 ' A' ' 125' ' ' VAL . 19.0 m -138.91 158.02 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.437 -0.789 . . . . 0.0 109.079 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -97.06 119.95 36.49 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.135 -0.978 . . . . 0.0 109.517 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.41 156.43 17.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.362 -0.836 . . . . 0.0 109.592 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.413 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 39.9 t60 -131.26 152.37 50.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.236 -0.915 . . . . 0.0 109.583 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.829 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -56.02 -26.18 47.66 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.282 -0.886 . . . . 0.0 109.797 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -99.06 -24.75 14.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.181 -0.95 . . . . 0.0 109.626 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.413 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 98.5 m-20 -74.67 137.17 42.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.512 -0.743 . . . . 0.0 110.002 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 83.9 mt -78.83 146.53 33.64 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 99' ' ' LEU . 45.4 pt -121.83 144.3 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.095 -1.003 . . . . 0.0 110.28 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.17 -173.46 46.26 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -171.18 170.94 5.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.038 -1.272 . . . . 0.0 109.794 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -147.04 145.44 29.68 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.343 -0.848 . . . . 0.0 109.864 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 86.4 m -125.22 151.4 69.45 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 108.815 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.48 154.1 9.3 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.43 2.086 . . . . 0.0 111.977 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.7 m -72.24 -10.5 59.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.496 -0.753 . . . . 0.0 110.711 -179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.536 ' O ' ' CE ' ' A' ' 115' ' ' LYS . 78.7 m-20 -93.29 -3.68 53.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.95 -1.094 . . . . 0.0 110.245 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.476 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 15.4 m-85 -105.92 160.63 15.11 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.246 -0.909 . . . . 0.0 110.08 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -101.33 132.69 46.75 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.47 -0.768 . . . . 0.0 109.328 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.6 m -88.59 118.31 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.109 -0.994 . . . . 0.0 110.219 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -126.93 127.04 24.47 Favored Pre-proline 0 N--CA 1.49 1.552 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.13 113.51 3.42 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 121.631 1.554 . . . . 0.0 112.131 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.484 ' O ' ' O ' ' A' ' 68' ' ' PHE . 9.6 t-160 -91.4 -25.57 19.29 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.475 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.3 t0 -169.48 38.94 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.422 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 81.8 m -62.56 -154.69 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.601 -0.687 . . . . 0.0 109.717 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 2.1 p90 -109.96 -59.28 1.95 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.061 -1.024 . . . . 0.0 111.359 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.464 ' C ' ' O ' ' A' ' 64' ' ' PHE . 25.3 t -44.75 -73.71 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 120.67 -1.269 . . . . 0.0 108.788 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.422 ' N ' HG12 ' A' ' 65' ' ' VAL . 43.0 t -138.2 131.13 29.84 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.422 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -171.98 179.1 2.78 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.876 -1.14 . . . . 0.0 110.458 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 5.2 m-85 -93.84 126.18 38.89 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -71.74 -170.79 0.59 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.976 -1.078 . . . . 0.0 109.823 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.548 HD12 ' N ' ' A' ' 70' ' ' LEU . 10.8 mp -65.07 -19.72 66.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.191 -0.943 . . . . 0.0 109.038 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.6 m -83.49 -7.97 59.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.343 -0.848 . . . . 0.0 108.843 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.5 19.15 66.9 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -103.79 137.05 42.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.342 -1.093 . . . . 0.0 109.139 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -76.38 113.85 14.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.279 -0.888 . . . . 0.0 110.073 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -144.56 131.56 20.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.333 -0.855 . . . . 0.0 110.04 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -59.98 145.18 47.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.145 -0.972 . . . . 0.0 109.303 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.3 tp -100.2 -0.9 37.82 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.588 -0.695 . . . . 0.0 110.088 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -67.03 -42.35 85.0 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.222 -0.924 . . . . 0.0 109.85 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -63.77 -21.94 66.66 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.995 . . . . 0.0 109.023 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -86.86 -46.82 9.57 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.46 -0.775 . . . . 0.0 109.342 179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.542 HD23 HD21 ' A' ' 83' ' ' LEU . 38.8 tp -124.62 127.89 48.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.492 -0.755 . . . . 0.0 109.171 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -77.17 83.48 3.65 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.966 -1.084 . . . . 0.0 109.235 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.576 HD22 ' OG ' ' A' ' 97' ' ' SER . 83.1 mt -81.22 139.37 35.55 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.414 -0.804 . . . . 0.0 110.027 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.8 p -128.0 160.76 30.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.558 -0.714 . . . . 0.0 109.247 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 55.02 50.1 16.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.302 -0.874 . . . . 0.0 109.472 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.4 mt -78.91 131.97 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 110.093 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.3 mm -119.6 120.08 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.456 -0.778 . . . . 0.0 109.329 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 93.8 mtp -122.09 105.06 9.93 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.058 -1.026 . . . . 0.0 109.785 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -112.5 101.16 9.33 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.337 -0.852 . . . . 0.0 109.067 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -76.68 -31.72 57.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.217 -0.927 . . . . 0.0 110.49 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -59.97 -46.96 87.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.799 -1.188 . . . . 0.0 109.645 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -90.23 3.01 54.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.157 -0.965 . . . . 0.0 109.1 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 51.96 46.8 25.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.479 -0.763 . . . . 0.0 110.13 179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.475 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 3.5 t -132.6 137.73 47.15 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.997 -1.064 . . . . 0.0 109.475 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -128.91 140.02 51.86 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.477 -0.764 . . . . 0.0 109.974 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.475 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 78.4 m-85 -135.14 146.71 49.05 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.154 -0.966 . . . . 0.0 109.477 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.576 ' OG ' HD22 ' A' ' 83' ' ' LEU . 32.4 t -149.82 149.39 30.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.024 -1.047 . . . . 0.0 109.157 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.412 HH11 ' HG2' ' A' ' 98' ' ' ARG . 60.3 mtt-85 -102.17 134.48 45.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.074 -1.016 . . . . 0.0 109.5 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 48' ' ' ILE . 87.5 mt -92.69 139.21 23.49 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.486 -0.759 . . . . 0.0 109.625 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.829 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 78.2 Cg_exo -45.81 170.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.851 1.701 . . . . 0.0 111.284 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.9 m -79.93 -12.24 59.74 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.098 -1.001 . . . . 0.0 109.778 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.3 tp -135.39 131.17 35.99 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.256 -0.902 . . . . 0.0 110.573 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 87.0 mt -147.54 102.27 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.8 t -99.73 -3.88 31.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.861 -1.149 . . . . 0.0 109.897 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 127' ' ' ALA . 84.7 m-20 -83.7 154.63 23.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -0.919 . . . . 0.0 109.958 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -104.21 33.17 3.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.389 -0.819 . . . . 0.0 109.161 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 18.4 p-90 -65.33 152.06 44.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.208 -0.932 . . . . 0.0 110.462 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -130.82 150.97 51.74 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.644 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 25.2 p90 -150.17 159.66 44.25 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.042 -1.036 . . . . 0.0 108.693 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 6.0 p90 -152.87 159.06 43.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.773 -1.205 . . . . 0.0 111.819 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 99.4 m -123.18 156.02 35.92 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.59 HG22 HG22 ' A' ' 122' ' ' VAL . 42.4 t -129.19 140.86 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.866 -1.147 . . . . 0.0 111.794 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 70.2 m -121.65 131.46 54.11 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.6 p -170.82 176.11 4.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.232 -1.542 . . . . 0.0 111.704 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.536 ' CE ' ' O ' ' A' ' 55' ' ' ASN . 51.5 mttm -151.57 166.46 31.11 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 117' ' ' ASN . 98.6 m-20 -57.59 151.54 16.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.757 -1.214 . . . . 0.0 109.17 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 116' ' ' ASP . 66.7 t30 42.43 61.47 2.01 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.209 -0.932 . . . . 0.0 109.816 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.414 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 43.6 mt-10 -161.76 140.84 9.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.103 -0.998 . . . . 0.0 110.21 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.47 ' NZ ' ' OG ' ' A' ' 29' ' ' SER . 6.2 mmmt -55.02 138.75 43.17 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.171 -0.955 . . . . 0.0 109.326 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -87.35 139.93 30.05 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.302 -0.874 . . . . 0.0 110.387 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.3 mt -110.12 122.27 47.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.473 -0.767 . . . . 0.0 109.024 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.59 HG22 HG22 ' A' ' 112' ' ' VAL . 51.6 t -110.69 131.76 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.04 -1.038 . . . . 0.0 110.664 -179.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.405 ' CZ ' ' CG1' ' A' ' 125' ' ' VAL . 23.9 t80 -110.22 122.53 47.87 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 7.0 t -137.54 142.45 41.4 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 119.059 -1.057 . . . . 0.0 111.969 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.644 ' CG2' ' CE2' ' A' ' 109' ' ' PHE . 3.0 m -137.53 154.52 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -122.87 147.6 46.39 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.201 -0.937 . . . . 0.0 110.366 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.329 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 mmtp -134.24 157.0 47.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 0.0 109.324 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 63.8 t -97.64 132.19 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.256 -0.903 . . . . 0.0 109.873 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -68.01 121.42 16.05 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.175 -0.953 . . . . 0.0 108.648 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.29 172.4 43.45 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.9 t -113.66 129.36 56.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.384 -1.068 . . . . 0.0 109.329 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.441 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 40.3 t0 -101.97 108.67 20.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.508 -0.745 . . . . 0.0 109.252 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.476 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 96.8 m-85 -89.75 -1.29 57.97 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.259 -0.901 . . . . 0.0 109.018 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.1 m -103.0 -16.0 15.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.594 -0.691 . . . . 0.0 110.511 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.569 HG22 ' H ' ' A' ' 12' ' ' GLU . 39.0 m -157.9 126.25 5.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.756 -1.215 . . . . 0.0 110.152 -179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 77.9 p -66.07 -26.01 67.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.97 . . . . 0.0 108.921 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.569 ' H ' HG22 ' A' ' 10' ' ' THR . 79.4 mm-40 -114.07 74.16 0.86 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 11.8 p -71.25 154.15 41.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.295 -0.878 . . . . 0.0 110.24 -179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.407 HG23 HG23 ' A' ' 15' ' ' ILE . 14.8 t -101.86 0.96 36.43 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.407 HG23 HG23 ' A' ' 14' ' ' THR . 5.5 pt -125.28 -26.47 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.643 -0.661 . . . . 0.0 110.243 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.405 ' CD2' HG13 ' A' ' 15' ' ' ILE . 72.3 m-85 -105.37 143.53 33.41 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.028 -1.045 . . . . 0.0 109.887 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.9 m -70.37 -18.09 63.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.542 -0.724 . . . . 0.0 110.765 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' NZ ' HG12 ' A' ' 40' ' ' VAL . 53.3 mtmt -144.33 156.52 44.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.75 -1.219 . . . . 0.0 110.775 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.441 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -158.78 169.24 35.09 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -117.6 151.66 36.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.199 -1.177 . . . . 0.0 109.646 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.1 t -94.45 156.45 16.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.348 -0.845 . . . . 0.0 109.069 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 46.4 pt -60.0 -24.05 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.104 -0.998 . . . . 0.0 109.554 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -77.23 -51.37 11.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.126 -0.983 . . . . 0.0 109.587 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -51.73 -40.26 59.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.003 . . . . 0.0 110.229 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 45.5 pt -78.88 -5.89 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.976 -1.078 . . . . 0.0 109.781 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.5 m -96.81 -65.31 0.97 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.189 -0.945 . . . . 0.0 109.549 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.663 ' O ' ' N ' ' A' ' 29' ' ' SER . 98.5 m-20 -109.48 -70.94 0.78 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.258 -0.901 . . . . 0.0 109.342 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -57.9 69.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 120.085 -0.646 . . . . 0.0 109.825 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.663 ' N ' ' O ' ' A' ' 27' ' ' ASN . 66.9 m -116.05 85.04 2.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.842 . . . . 0.0 108.916 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.9 m -88.61 70.11 8.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.821 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.49 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 11.1 p30 -152.68 -51.25 0.11 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.378 -0.826 . . . . 0.0 109.673 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.49 ' OD1' ' O ' ' A' ' 31' ' ' ASN . 73.6 m-20 -166.12 176.64 7.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.336 -0.853 . . . . 0.0 109.62 179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.479 ' O ' ' O ' ' A' ' 32' ' ' ASN . 3.9 pt20 -60.56 -129.42 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.962 . . . . 0.0 109.458 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.504 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 15.4 pt20 -71.1 43.05 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.001 -1.062 . . . . 0.0 109.232 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.504 ' OD1' ' O ' ' A' ' 34' ' ' GLN . 53.9 m-20 -136.71 116.51 13.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.404 -0.81 . . . . 0.0 109.666 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.7 mm -98.16 121.24 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.922 . . . . 0.0 108.72 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.0 t -117.07 127.83 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.153 -0.967 . . . . 0.0 110.182 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.476 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 96.7 m -102.45 100.62 10.76 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 65.6 m -94.4 120.24 34.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.016 -1.053 . . . . 0.0 109.645 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.453 HG12 ' NZ ' ' A' ' 18' ' ' LYS . 27.5 m -141.3 156.11 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.348 -0.845 . . . . 0.0 109.161 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -98.11 133.96 41.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.171 -0.955 . . . . 0.0 109.445 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.439 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -102.0 150.35 23.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.052 -1.03 . . . . 0.0 109.63 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.519 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 29.8 t60 -120.0 152.52 37.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.363 -0.836 . . . . 0.0 109.551 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.34 -25.59 35.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.328 -0.858 . . . . 0.0 109.917 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -99.78 -21.63 15.69 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.118 -0.989 . . . . 0.0 109.714 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.519 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 81.4 m-20 -77.85 138.02 38.71 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.501 -0.749 . . . . 0.0 109.998 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 93.2 mt -79.39 148.9 31.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.253 -0.904 . . . . 0.0 108.703 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.404 HG21 HD11 ' A' ' 99' ' ' LEU . 42.6 pt -120.4 141.73 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.969 -1.082 . . . . 0.0 110.214 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.67 -178.3 47.96 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.43 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 55.2 p90 -164.0 170.08 17.1 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.118 -1.224 . . . . 0.0 109.736 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -144.08 142.87 30.87 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.354 -0.841 . . . . 0.0 109.772 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 82.4 m -122.79 151.83 61.34 Favored Pre-proline 0 N--CA 1.491 1.606 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.445 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.46 145.75 27.71 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.289 1.993 . . . . 0.0 111.893 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.3 t -67.88 -14.57 63.06 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.464 -0.772 . . . . 0.0 110.624 -179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.587 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.4 m-20 -90.2 1.5 56.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.889 -1.132 . . . . 0.0 110.087 -179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.454 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 19.1 m-85 -111.11 166.75 10.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.172 -0.955 . . . . 0.0 110.138 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.6 m -103.6 139.98 38.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.398 -0.814 . . . . 0.0 109.315 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.7 m -97.55 120.35 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.94 -1.1 . . . . 0.0 110.311 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -127.19 126.68 24.29 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -78.0 113.81 3.49 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.732 1.622 . . . . 0.0 112.235 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -93.1 -24.8 18.15 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.7 t0 -168.89 36.26 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.412 ' O ' ' O ' ' A' ' 62' ' ' ASP . 88.7 m -59.44 -155.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.499 -0.751 . . . . 0.0 109.893 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.466 ' O ' ' C ' ' A' ' 65' ' ' VAL . 3.9 p90 -110.0 -59.07 1.98 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.953 -1.092 . . . . 0.0 111.246 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.483 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 36.6 t -43.95 -73.83 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.678 -1.264 . . . . 0.0 108.858 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 40.2 t -139.25 131.98 29.05 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -172.94 -178.48 1.83 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.879 -1.138 . . . . 0.0 110.457 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 6.6 m-85 -92.27 126.25 37.27 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -73.34 -172.49 1.16 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.136 -0.978 . . . . 0.0 109.763 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.522 HD22 ' N ' ' A' ' 70' ' ' LEU . 3.8 mm? -64.22 -22.16 66.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.33 -0.856 . . . . 0.0 109.102 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 89.4 p -82.57 -7.37 59.65 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.889 . . . . 0.0 108.83 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.69 17.95 66.97 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -100.43 139.68 35.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -1.18 . . . . 0.0 109.184 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -82.07 109.46 16.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.174 -0.954 . . . . 0.0 109.934 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -143.88 137.57 27.98 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.32 -0.863 . . . . 0.0 110.004 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.512 ' OD1' ' N ' ' A' ' 77' ' ' LEU . 62.0 t-20 -60.12 145.85 45.31 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.171 -0.956 . . . . 0.0 109.403 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.512 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 14.0 tp -99.07 6.56 46.51 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.359 -0.838 . . . . 0.0 109.829 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.44 ' CD ' ' N ' ' A' ' 79' ' ' ASN . 2.3 pp20? -69.69 -40.33 76.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.104 -0.997 . . . . 0.0 109.896 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.605 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 43.4 p30 -63.37 -27.69 69.48 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.155 -0.966 . . . . 0.0 109.12 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.605 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 50.9 tptt -78.26 -50.44 11.86 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.458 -0.776 . . . . 0.0 109.343 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.538 HD11 ' HG2' ' A' ' 100' ' ' PRO . 38.0 tp -130.39 130.53 44.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.512 -0.742 . . . . 0.0 109.191 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -81.32 84.53 6.61 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.13 -0.981 . . . . 0.0 109.408 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 86.4 mt -76.67 143.68 39.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -0.828 . . . . 0.0 109.888 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 43.1 p -127.67 161.81 28.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.509 -0.745 . . . . 0.0 109.299 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.506 ' ND2' HH11 ' A' ' 98' ' ' ARG . 10.9 m-20 55.44 51.83 12.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.178 -0.952 . . . . 0.0 109.652 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.4 mt -80.39 130.59 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.397 -0.815 . . . . 0.0 110.047 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.5 mm -118.68 120.26 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.447 -0.783 . . . . 0.0 109.139 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 84.2 mtp -121.15 101.26 7.54 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.082 -1.011 . . . . 0.0 109.834 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -110.29 100.22 9.13 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.264 -0.898 . . . . 0.0 108.896 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.479 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 93.0 m-70 -72.34 -36.49 68.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.971 -1.081 . . . . 0.0 110.655 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -60.4 -46.18 90.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.94 -1.1 . . . . 0.0 109.631 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -88.59 -4.98 58.46 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.223 -0.923 . . . . 0.0 109.119 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.479 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.7 m-20 54.37 47.94 21.8 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.517 -0.739 . . . . 0.0 110.283 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.598 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 1.8 t -133.41 140.01 47.08 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.025 -1.047 . . . . 0.0 109.463 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 66.4 m-85 -129.04 140.03 51.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.463 -0.773 . . . . 0.0 109.959 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.598 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 82.1 m-85 -138.08 148.89 45.48 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.261 -0.899 . . . . 0.0 109.479 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 13.3 p -154.54 158.02 39.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.142 -0.974 . . . . 0.0 109.215 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.506 HH11 ' ND2' ' A' ' 85' ' ' ASN . 68.6 mtp180 -104.01 136.37 43.78 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.166 -0.959 . . . . 0.0 109.399 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.466 ' O ' ' O ' ' A' ' 100' ' ' PRO . 36.4 mt -89.69 136.66 29.21 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.224 -0.922 . . . . 0.0 109.635 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.538 ' HG2' HD11 ' A' ' 81' ' ' LEU . 77.6 Cg_exo -45.75 177.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.863 1.708 . . . . 0.0 111.211 178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 87.7 p -87.39 -15.3 38.23 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.064 -1.022 . . . . 0.0 109.839 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' A' ' 102' ' ' LEU . 52.2 tp -127.37 128.85 46.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.156 -0.965 . . . . 0.0 110.311 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 72.8 mt -150.22 107.77 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.206 -0.934 . . . . 0.0 108.676 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 81.5 p -118.44 -1.56 11.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.06 -1.025 . . . . 0.0 109.773 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.545 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 9.0 p30 -82.67 154.5 24.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 110.052 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -95.61 34.08 1.54 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.504 -0.748 . . . . 0.0 109.037 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.464 ' CZ3' ' CD1' ' A' ' 109' ' ' PHE . 10.0 p-90 -63.21 154.16 32.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.191 -0.943 . . . . 0.0 110.379 -178.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -142.69 149.65 39.11 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.62 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 33.5 p90 -154.46 163.74 39.72 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.125 -0.984 . . . . 0.0 108.784 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 7.3 p90 -154.44 160.04 41.4 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.846 -1.159 . . . . 0.0 111.705 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 67.8 m -123.35 155.99 36.25 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.656 HG22 HG22 ' A' ' 122' ' ' VAL . 46.0 t -129.36 140.87 48.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 120.878 -1.139 . . . . 0.0 111.756 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 98.4 m -124.66 133.37 53.25 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 177.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 72.6 p -170.49 179.23 3.41 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.239 -1.538 . . . . 0.0 111.665 -178.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.587 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 49.7 mtmt -151.61 162.59 40.73 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 117' ' ' ASN . 97.9 m-20 -57.81 152.19 16.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.816 -1.178 . . . . 0.0 109.173 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.53 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 57.3 t-20 45.24 61.33 2.6 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.104 -0.997 . . . . 0.0 109.681 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.53 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 38.0 mt-10 -166.15 146.69 6.44 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.141 -0.974 . . . . 0.0 110.174 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -60.38 139.32 57.73 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.133 -0.979 . . . . 0.0 109.021 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -85.95 142.09 29.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.169 -0.957 . . . . 0.0 110.326 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 68.6 mt -109.21 120.8 43.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.402 -0.812 . . . . 0.0 109.045 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.656 HG22 HG22 ' A' ' 112' ' ' VAL . 49.8 t -109.42 131.21 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 120.951 -1.093 . . . . 0.0 110.774 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -109.66 121.03 44.3 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.4 t -137.16 142.63 42.2 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.776 -1.202 . . . . 0.0 112.008 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.62 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 2.9 m -136.26 156.37 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 177.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -133.88 155.97 48.92 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.94 -1.1 . . . . 0.0 110.226 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.51 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.432 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -83.96 148.11 27.09 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.24 -0.913 . . . . 0.0 109.328 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 73.7 t -80.81 134.19 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.35 -0.844 . . . . 0.0 110.119 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -72.18 129.93 39.64 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.017 -1.052 . . . . 0.0 108.642 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.97 -154.35 24.29 Favored Glycine 0 N--CA 1.485 1.939 0 C-N-CA 119.378 -1.392 . . . . 0.0 109.914 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.4 t -133.93 131.64 39.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.311 -1.111 . . . . 0.0 109.656 -179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.513 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 38.6 t0 -109.51 109.25 20.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.539 -0.726 . . . . 0.0 109.15 179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.4 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 91.0 m-85 -89.78 3.38 53.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.196 -0.94 . . . . 0.0 108.819 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 91.9 m -100.54 -19.59 16.1 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.386 -0.821 . . . . 0.0 110.515 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.597 HG22 ' H ' ' A' ' 12' ' ' GLU . 32.6 m -157.75 127.49 6.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.791 -1.193 . . . . 0.0 110.535 -179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.1 p -64.17 -27.22 68.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.232 -0.917 . . . . 0.0 108.996 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.597 ' H ' HG22 ' A' ' 10' ' ' THR . 97.7 mt-10 -114.02 74.36 0.87 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.513 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 8.6 m -69.29 150.61 47.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.269 -0.894 . . . . 0.0 110.304 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -101.27 -1.05 34.62 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.9 pt -125.59 -10.35 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.676 -0.64 . . . . 0.0 110.491 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -125.7 141.0 52.23 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.201 -0.937 . . . . 0.0 110.191 -179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.8 t -69.18 -20.73 64.0 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.668 -0.645 . . . . 0.0 110.995 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -132.57 142.65 49.26 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.106 -0.997 . . . . 0.0 110.668 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.44 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -154.74 169.61 32.97 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 31.9 m-85 -128.81 159.77 34.69 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.474 -1.015 . . . . 0.0 109.647 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.0 t -90.82 148.77 22.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.393 -0.817 . . . . 0.0 109.187 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 23' ' ' ASN . 39.4 pt -58.39 -33.38 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.12 -0.987 . . . . 0.0 109.476 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.481 ' O ' ' OD1' ' A' ' 27' ' ' ASN . 49.0 t-20 -65.86 -37.8 87.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.911 . . . . 0.0 109.793 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -66.45 -41.23 89.4 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.611 -0.681 . . . . 0.0 110.464 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.401 HG12 ' H ' ' A' ' 25' ' ' ILE . 16.0 pt -83.1 -15.75 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.944 -1.097 . . . . 0.0 109.767 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.598 ' O ' ' N ' ' A' ' 28' ' ' LYS . 53.2 p -89.46 -73.14 0.52 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.2 -0.937 . . . . 0.0 109.287 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.569 ' N ' ' OG ' ' A' ' 26' ' ' SER . 48.5 p-10 -38.0 91.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 CA-C-O 121.524 0.678 . . . . 0.0 109.206 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.598 ' N ' ' O ' ' A' ' 26' ' ' SER . 59.1 pttt -90.99 49.23 1.61 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.468 -0.77 . . . . 0.0 109.775 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.0 m -157.28 18.11 0.28 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.415 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 34.9 t -75.42 -103.48 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.462 -0.773 . . . . 0.0 109.533 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.55 ' O ' ' NE2' ' A' ' 33' ' ' GLN . 98.0 m-20 -110.34 -61.89 1.6 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.149 -0.969 . . . . 0.0 109.242 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.59 HD21 HE21 ' A' ' 34' ' ' GLN . 59.0 t30 -94.89 106.53 18.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.289 -0.882 . . . . 0.0 109.44 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.55 ' NE2' ' O ' ' A' ' 31' ' ' ASN . 1.2 pm0 -104.07 82.32 1.95 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.216 -0.928 . . . . 0.0 109.698 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.59 HE21 HD21 ' A' ' 32' ' ' ASN . 17.3 pt20 -162.34 -162.77 0.85 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.23 -0.919 . . . . 0.0 109.487 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.544 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -59.69 139.82 56.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.215 -0.928 . . . . 0.0 109.247 -179.193 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.0 mm -97.33 122.77 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.106 -0.996 . . . . 0.0 108.508 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.447 HG22 ' HB ' ' A' ' 122' ' ' VAL . 54.7 t -118.98 131.97 70.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.371 -0.831 . . . . 0.0 110.565 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.417 ' O ' ' O ' ' A' ' 124' ' ' THR . 89.0 m -102.1 102.65 13.15 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 94.5 m -93.07 119.97 32.87 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.081 -1.012 . . . . 0.0 109.574 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.586 ' CG2' HG12 ' A' ' 125' ' ' VAL . 11.8 m -140.33 141.03 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.656 -0.653 . . . . 0.0 109.344 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -87.02 129.89 34.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.078 -1.014 . . . . 0.0 109.452 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.434 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -98.58 159.64 14.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 109.504 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.48 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 26.1 t60 -134.77 154.05 51.76 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.282 -0.886 . . . . 0.0 109.568 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.55 -26.48 32.3 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.373 -0.829 . . . . 0.0 109.762 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -99.49 -27.04 13.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.253 -0.904 . . . . 0.0 109.866 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 83.9 m-20 -69.91 132.79 46.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.199 -0.938 . . . . 0.0 110.152 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.418 HD22 ' HD3' ' A' ' 98' ' ' ARG . 21.2 mt -77.81 145.09 36.57 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.549 HD13 HD21 ' A' ' 99' ' ' LEU . 21.7 pt -117.37 137.45 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.169 -0.957 . . . . 0.0 110.15 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.1 154.08 11.61 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -142.45 173.55 11.43 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.022 -1.281 . . . . 0.0 109.879 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 49.5 tttp -146.65 144.72 29.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.356 -0.84 . . . . 0.0 109.87 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 88.7 m -123.34 152.11 63.76 Favored Pre-proline 0 N--CA 1.489 1.48 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.449 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.8 Cg_endo -51.55 151.52 14.02 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 122.321 2.014 . . . . 0.0 112.043 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.3 m -71.7 -13.62 61.78 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.456 -0.777 . . . . 0.0 110.59 -179.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.609 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 82.4 m-20 -90.84 -1.34 57.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.961 -1.087 . . . . 0.0 110.196 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.449 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.3 m-85 -108.11 164.13 12.56 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.306 -0.871 . . . . 0.0 110.492 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 40.1 t -104.72 137.55 42.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.295 -0.878 . . . . 0.0 108.982 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.8 m -93.13 121.86 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.066 -1.021 . . . . 0.0 110.212 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.414 ' O ' ' O ' ' A' ' 112' ' ' VAL . 10.4 mt-10 -126.19 124.61 24.57 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.15 113.51 3.41 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.623 1.548 . . . . 0.0 112.097 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 68' ' ' PHE . 12.6 t-80 -93.51 -24.0 18.15 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 110' ' ' PHE . 68.0 t0 -171.0 48.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.668 ' H ' ' CB ' ' A' ' 67' ' ' ALA . 91.0 m -71.59 -154.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.518 -0.739 . . . . 0.0 109.774 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.474 ' CD2' HG23 ' A' ' 65' ' ' VAL . 3.6 p90 -112.17 -49.26 2.98 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.299 -0.876 . . . . 0.0 111.649 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.474 HG23 ' CD2' ' A' ' 64' ' ' PHE . 76.5 t -59.47 -48.27 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.291 -1.506 . . . . 0.0 109.43 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.3 t -161.16 130.8 4.82 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.668 ' CB ' ' H ' ' A' ' 63' ' ' CYS . . . -173.93 -178.49 1.54 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.129 -0.982 . . . . 0.0 110.414 -179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 6.1 m-85 -93.06 125.59 37.73 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.399 -0.964 . . . . 0.0 108.399 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -70.86 -173.92 0.86 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.107 -0.995 . . . . 0.0 109.871 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.526 HD12 ' N ' ' A' ' 70' ' ' LEU . 11.1 mp -64.45 -21.37 66.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.301 -0.874 . . . . 0.0 109.037 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 49.8 m -82.35 -8.27 59.63 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.306 -0.871 . . . . 0.0 108.943 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 84.35 17.72 63.91 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -104.91 145.02 30.99 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.327 -1.102 . . . . 0.0 109.213 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 59.9 t-20 -83.63 117.8 23.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.486 -0.759 . . . . 0.0 110.149 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -149.73 136.36 19.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.363 -0.836 . . . . 0.0 110.211 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -59.73 142.96 52.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.494 HD11 ' HD2' ' A' ' 80' ' ' LYS . 13.5 tp -95.45 7.07 47.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.227 -0.921 . . . . 0.0 109.775 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' A' ' 79' ' ' ASN . 0.3 OUTLIER -68.82 -39.9 79.79 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.269 -0.894 . . . . 0.0 109.991 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.448 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 91.3 m-20 -62.04 -36.03 80.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.017 . . . . 0.0 109.121 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.494 ' HD2' HD11 ' A' ' 77' ' ' LEU . 21.5 ttmt -72.53 -48.72 38.08 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.514 -0.741 . . . . 0.0 109.657 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.505 HD11 ' HG2' ' A' ' 100' ' ' PRO . 42.6 tp -148.79 120.84 8.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.468 -0.77 . . . . 0.0 108.997 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.48 113.1 19.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.15 -0.968 . . . . 0.0 109.502 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 97.2 mt -90.5 159.27 16.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.857 . . . . 0.0 109.917 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 46.7 p -127.14 160.79 30.14 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.464 -0.773 . . . . 0.0 109.223 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.439 HD22 ' HG3' ' A' ' 98' ' ' ARG . 95.8 m-20 55.5 52.11 11.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -0.947 . . . . 0.0 109.814 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.2 mt -79.03 127.81 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.922 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.6 mm -122.18 121.51 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 121.49 -0.756 . . . . 0.0 109.174 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 86.6 mtp -121.84 103.18 8.67 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.222 -0.924 . . . . 0.0 109.569 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -112.24 100.76 9.07 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.377 -0.827 . . . . 0.0 109.033 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.476 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 77.5 m80 -71.18 -37.41 72.17 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.006 -1.059 . . . . 0.0 110.596 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -60.7 -46.03 91.92 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.972 -1.08 . . . . 0.0 109.704 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -88.71 -4.73 58.46 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.092 -1.005 . . . . 0.0 109.112 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.476 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.6 m-20 53.36 47.72 23.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.417 -0.802 . . . . 0.0 110.04 178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.585 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.0 t -132.63 137.04 46.87 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.024 -1.047 . . . . 0.0 109.403 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -126.86 139.37 53.13 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.068 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.585 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 72.3 m-85 -136.42 146.31 46.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.27 -0.893 . . . . 0.0 109.259 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.9 m -151.18 151.53 32.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 109.175 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.439 ' HG3' HD22 ' A' ' 85' ' ' ASN . 7.5 mmm180 -102.32 131.87 48.65 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.351 -0.843 . . . . 0.0 109.576 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.549 HD21 HD13 ' A' ' 48' ' ' ILE . 92.6 mt -86.43 137.16 34.58 Favored Pre-proline 0 N--CA 1.489 1.479 0 C-N-CA 120.431 -0.508 . . . . 0.0 109.717 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.505 ' HG2' HD11 ' A' ' 81' ' ' LEU . 77.7 Cg_exo -45.86 -177.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.315 -1.212 0 C-N-CA 121.954 1.77 . . . . 0.0 111.204 178.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 14.6 t -88.88 -19.23 26.12 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.963 -1.085 . . . . 0.0 110.107 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 50.7 tp -124.42 128.47 49.08 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.283 -0.886 . . . . 0.0 110.516 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 78.5 mt -149.74 102.72 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 92.4 p -113.08 1.0 15.16 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.316 -0.865 . . . . 0.0 109.89 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.601 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 49.3 t0 -83.51 153.23 24.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 110.114 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.601 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 95.5 m-20 -96.23 33.36 1.77 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.453 -0.779 . . . . 0.0 108.938 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.516 ' CD1' ' OXT' ' A' ' 127' ' ' ALA . 11.9 p-90 -63.99 154.24 34.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.197 -0.939 . . . . 0.0 110.628 -178.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -140.06 150.13 43.99 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.637 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 32.5 p90 -154.5 161.86 41.45 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.096 -1.002 . . . . 0.0 108.595 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.42 ' O ' ' C ' ' A' ' 62' ' ' ASP . 13.3 p90 -153.58 158.44 41.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.738 -1.226 . . . . 0.0 111.906 -178.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 90.8 m -123.61 156.79 35.13 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 122' ' ' VAL . 50.7 t -127.91 137.66 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 120.96 -1.088 . . . . 0.0 111.736 -178.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.2 m -119.22 130.52 55.52 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.0 p -171.54 178.73 3.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.41 -1.431 . . . . 0.0 111.577 -178.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.609 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 49.3 mtmt -150.06 164.38 35.7 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.401 ' O ' ' C ' ' A' ' 117' ' ' ASN . 88.3 m-20 -58.21 151.39 19.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.863 -1.148 . . . . 0.0 109.175 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.481 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 54.3 t-20 43.69 61.94 2.09 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.172 -0.955 . . . . 0.0 109.772 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.481 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 36.1 mt-10 -164.46 144.13 7.53 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.136 -0.978 . . . . 0.0 110.145 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.476 ' NZ ' ' N ' ' A' ' 34' ' ' GLN . 18.0 mmmt -55.1 135.26 49.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.326 -0.859 . . . . 0.0 109.216 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.3 ptpt -85.27 140.97 30.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.165 -0.96 . . . . 0.0 110.327 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.7 mt -110.17 123.67 50.18 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.554 -0.716 . . . . 0.0 109.187 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 112' ' ' VAL . 46.7 t -108.69 130.05 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.032 -1.042 . . . . 0.0 110.387 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 63.2 t80 -108.03 118.68 37.38 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.417 ' O ' ' O ' ' A' ' 38' ' ' CYS . 6.1 t -136.74 142.52 43.05 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.496 1.141 . . . . 0.0 112.109 -178.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.637 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -137.05 160.23 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -131.03 147.83 52.68 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.263 -0.898 . . . . 0.0 110.409 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.516 ' OXT' ' CD1' ' A' ' 107' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.432 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 1' ' ' GLU . 56.8 mp0 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.4 mtpp -141.55 149.84 41.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -0.879 . . . . 0.0 109.317 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.456 HG13 ' CB ' ' A' ' 47' ' ' LEU . 85.4 t -87.59 135.51 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.93 . . . . 0.0 110.117 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -66.55 124.53 23.06 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.14 -1.024 . . . . 0.0 108.662 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 176.97 166.93 34.71 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.2 t -107.04 129.89 54.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.455 -1.026 . . . . 0.0 109.192 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.473 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 35.6 t0 -108.49 109.28 20.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.529 -0.732 . . . . 0.0 109.461 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.416 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 86.2 m-85 -89.49 1.7 55.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 108.948 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.5 m -101.99 -18.36 15.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.516 -0.74 . . . . 0.0 110.62 -178.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 12' ' ' GLU . 8.5 m -156.86 126.5 6.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.761 -1.212 . . . . 0.0 110.383 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.593 ' OG ' ' N ' ' A' ' 21' ' ' SER . 38.6 m -67.06 -26.38 66.72 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.443 -0.785 . . . . 0.0 109.138 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.447 ' H ' HG22 ' A' ' 10' ' ' THR . 79.6 mm-40 -113.59 73.91 0.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 16' ' ' PHE . 20.7 p -71.73 153.27 42.12 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.385 -0.822 . . . . 0.0 110.221 -179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.38 -1.27 31.19 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.3 pt -125.67 -13.45 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.661 -0.649 . . . . 0.0 110.443 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.461 ' O ' ' OG ' ' A' ' 13' ' ' SER . 76.5 m-85 -121.63 137.13 54.87 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.283 -0.886 . . . . 0.0 109.925 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 34.8 t -68.12 -20.04 64.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.578 -0.701 . . . . 0.0 110.669 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -131.95 142.55 49.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.95 -1.094 . . . . 0.0 110.745 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.473 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -154.88 168.36 32.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -128.96 160.11 33.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.334 -1.098 . . . . 0.0 109.586 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.593 ' N ' ' OG ' ' A' ' 11' ' ' SER . 6.2 t -90.84 148.95 22.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 109.097 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.2 pt -58.43 -32.55 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.171 -0.956 . . . . 0.0 109.444 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -68.85 -40.31 79.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -0.98 . . . . 0.0 109.74 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -61.45 -45.03 95.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 110.319 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 26' ' ' SER . 9.7 pt -68.77 -45.03 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.045 -1.034 . . . . 0.0 109.702 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.702 ' O ' ' C ' ' A' ' 27' ' ' ASN . 5.9 t -65.99 -49.26 68.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.35 -0.844 . . . . 0.0 109.336 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.702 ' C ' ' O ' ' A' ' 26' ' ' SER . 46.9 t30 -5.07 85.97 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.781 ' O ' ' N ' ' A' ' 30' ' ' SER . 2.0 mptm? -39.44 170.18 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.1 p -47.79 73.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.584 -0.698 . . . . 0.0 109.99 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.781 ' N ' ' O ' ' A' ' 28' ' ' LYS . 33.3 p -128.71 -39.9 1.59 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.431 -0.793 . . . . 0.0 109.373 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.449 ' HB3' HD22 ' A' ' 27' ' ' ASN . 62.1 t30 -119.38 -16.6 8.95 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.396 -0.815 . . . . 0.0 109.587 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.504 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 32.0 p30 -161.94 116.44 1.91 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 109.436 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -110.86 53.21 0.71 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.151 -0.968 . . . . 0.0 109.61 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -151.52 -169.05 3.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.076 -1.015 . . . . 0.0 109.462 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.613 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 0.5 OUTLIER -73.65 141.64 46.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.286 -0.884 . . . . 0.0 109.484 -179.599 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.8 mm -88.19 122.66 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.948 . . . . 0.0 108.508 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -118.77 131.42 71.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.314 -0.867 . . . . 0.0 110.526 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 124' ' ' THR . 95.1 m -101.57 101.06 11.55 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 85.1 m -94.35 120.09 34.07 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.143 -0.973 . . . . 0.0 109.852 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.484 ' CG2' HG12 ' A' ' 125' ' ' VAL . 20.3 m -141.12 155.8 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.499 -0.751 . . . . 0.0 109.184 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -97.07 131.07 44.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.184 -0.948 . . . . 0.0 109.371 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -100.27 162.92 12.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.343 -0.848 . . . . 0.0 109.595 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.461 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 34.3 t-80 -132.59 148.97 52.37 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.307 -0.871 . . . . 0.0 109.454 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -52.48 -26.94 14.29 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 109.889 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -99.71 -23.15 15.11 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.19 -0.944 . . . . 0.0 109.786 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.461 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 92.1 m-20 -74.18 136.83 42.84 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.415 -0.803 . . . . 0.0 110.156 -179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.588 HD21 ' NE ' ' A' ' 98' ' ' ARG . 15.1 mt -75.52 143.37 42.54 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 108.826 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 46.0 pt -121.14 142.8 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.288 -0.883 . . . . 0.0 110.091 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.47 -175.39 47.21 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.484 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 48.9 p90 -164.12 169.01 18.37 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.059 -1.259 . . . . 0.0 109.639 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.2 tttp -146.03 144.14 29.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.762 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 84.1 m -125.58 152.17 71.51 Favored Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.52 151.3 14.26 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 122.273 1.982 . . . . 0.0 111.952 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.9 m -71.23 -11.01 60.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.379 -0.826 . . . . 0.0 110.673 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.618 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 83.6 m-20 -90.69 -1.71 57.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.938 -1.101 . . . . 0.0 110.092 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.434 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 20.5 m-85 -109.61 164.04 12.9 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.149 -0.97 . . . . 0.0 110.315 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.4 m -102.81 146.21 28.6 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.374 -0.829 . . . . 0.0 109.043 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.6 m -101.02 124.19 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.99 -1.069 . . . . 0.0 110.087 -179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -130.63 127.25 22.26 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.09 113.79 3.47 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 121.657 1.571 . . . . 0.0 112.146 -179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.495 ' O ' ' O ' ' A' ' 68' ' ' PHE . 27.1 t-80 -93.88 -26.4 16.91 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.437 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.7 t0 -168.26 38.35 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.459 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 81.8 m -62.75 -155.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.525 -0.735 . . . . 0.0 109.836 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 4.8 p90 -107.95 -54.54 2.48 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.195 -0.941 . . . . 0.0 111.475 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 30.0 t -49.13 -71.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.67 -1.269 . . . . 0.0 108.728 -179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 46.7 t -142.4 131.36 23.04 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.459 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -168.94 -179.57 3.72 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.364 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.4 m-85 -94.61 145.1 25.06 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.431 HD21 ' HG2' ' A' ' 75' ' ' GLU . 99.6 m-20 -86.59 -172.89 4.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.93 -1.106 . . . . 0.0 109.695 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 77.0 mt -64.65 -15.37 61.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -0.881 . . . . 0.0 109.16 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.3 m -86.92 -6.42 58.78 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.361 -0.837 . . . . 0.0 108.948 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 79.34 20.47 69.36 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.4 mmmt -107.55 142.46 37.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.291 -1.123 . . . . 0.0 109.207 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -66.05 131.66 46.74 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.212 -0.93 . . . . 0.0 109.899 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.431 ' HG2' HD21 ' A' ' 69' ' ' ASN . 30.7 tp10 -152.21 163.26 39.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.364 -0.835 . . . . 0.0 109.405 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -107.01 138.06 43.89 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.175 -0.953 . . . . 0.0 109.553 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.1 tp -88.03 -8.83 55.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.105 -0.997 . . . . 0.0 109.921 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.586 ' OE1' ' N ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -60.0 -45.99 90.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.869 -1.144 . . . . 0.0 109.532 -179.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.592 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 28.7 p30 -63.8 -34.8 78.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.073 -1.017 . . . . 0.0 108.951 179.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.592 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 9.1 tppt? -69.91 -51.67 31.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.222 -0.924 . . . . 0.0 109.112 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.455 HD11 ' HG2' ' A' ' 100' ' ' PRO . 20.7 tp -151.76 121.42 6.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.448 -0.783 . . . . 0.0 108.958 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -78.17 113.78 16.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.018 -1.051 . . . . 0.0 109.573 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 92.1 mt -87.72 162.3 17.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.412 -0.805 . . . . 0.0 109.974 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 70.4 p -129.55 162.0 29.21 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.349 -0.845 . . . . 0.0 109.331 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.474 HD22 ' HG3' ' A' ' 98' ' ' ARG . 73.6 m-80 55.36 51.23 13.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.0 109.691 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.5 mt -81.13 131.44 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.327 -0.858 . . . . 0.0 110.264 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.3 mm -127.58 123.5 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.456 -0.777 . . . . 0.0 109.073 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 72.6 mtp -122.59 104.09 9.11 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.21 -0.932 . . . . 0.0 109.761 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -111.9 100.7 9.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.327 -0.858 . . . . 0.0 109.039 179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.488 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 97.5 m-70 -72.32 -36.41 68.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.882 -1.136 . . . . 0.0 110.642 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -60.51 -46.16 91.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.999 -1.063 . . . . 0.0 109.528 -179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -88.91 -4.83 58.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.071 -1.018 . . . . 0.0 109.149 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.5 m-20 54.48 48.17 21.13 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.468 -0.77 . . . . 0.0 110.273 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.601 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.9 t -134.02 139.46 46.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.994 -1.066 . . . . 0.0 109.296 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.484 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 75.2 m-85 -128.4 140.33 51.9 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.483 -0.761 . . . . 0.0 110.071 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.601 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 72.0 m-85 -137.99 147.96 44.72 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.323 -0.861 . . . . 0.0 109.13 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 12.4 p -156.33 157.98 36.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.08 -1.012 . . . . 0.0 109.21 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.588 ' NE ' HD21 ' A' ' 47' ' ' LEU . 18.7 mmt180 -104.08 137.65 41.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.324 -0.86 . . . . 0.0 109.613 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.422 ' HB3' HD11 ' A' ' 103' ' ' ILE . 54.8 mt -87.81 137.5 31.74 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.65 -0.656 . . . . 0.0 109.62 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.493 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 77.5 Cg_exo -46.88 154.04 1.21 Allowed 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 121.745 1.63 . . . . 0.0 111.212 178.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 54.0 m -62.56 -36.86 84.01 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.118 -0.989 . . . . 0.0 109.93 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.4 tp -111.34 130.63 55.62 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.26 -0.9 . . . . 0.0 110.55 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.422 HD11 ' HB3' ' A' ' 99' ' ' LEU . 95.3 mt -145.71 103.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.401 -0.812 . . . . 0.0 108.857 179.079 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.459 ' O ' ' OD1' ' A' ' 105' ' ' ASP . 7.1 m -111.18 53.58 0.7 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.179 -0.951 . . . . 0.0 109.647 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.479 ' O ' ' OXT' ' A' ' 127' ' ' ALA . 83.1 m-20 -144.86 156.5 44.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 110.029 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -102.89 33.06 3.38 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.426 -0.796 . . . . 0.0 109.09 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 19.3 p-90 -65.15 150.8 47.54 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.22 -0.925 . . . . 0.0 110.411 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -132.38 151.08 52.01 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.625 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 32.2 p90 -151.62 161.0 43.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.196 -0.94 . . . . 0.0 108.665 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 8.1 p90 -154.19 164.33 38.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.741 -1.225 . . . . 0.0 111.912 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 85.2 m -127.72 157.96 38.91 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.533 HG22 HG22 ' A' ' 122' ' ' VAL . 44.2 t -127.72 137.88 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.802 -1.186 . . . . 0.0 111.929 -178.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 70.9 m -119.24 130.04 55.25 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 177.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 39.7 p -169.29 179.33 3.97 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.281 -1.512 . . . . 0.0 111.658 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.618 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 42.2 mtmt -158.78 167.67 28.86 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 117' ' ' ASN . 54.1 p-10 -58.56 151.55 20.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.766 -1.209 . . . . 0.0 109.008 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.452 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 58.9 t-20 41.42 58.71 2.6 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.329 -0.857 . . . . 0.0 109.6 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 66.5 mm-40 -157.87 137.5 12.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.394 -0.817 . . . . 0.0 110.503 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -54.69 136.5 45.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.366 -0.834 . . . . 0.0 109.12 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.452 ' H ' ' HG2' ' A' ' 120' ' ' LYS . 4.4 pttm -85.36 139.08 31.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.217 -0.927 . . . . 0.0 110.49 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 87.9 mt -111.77 125.48 54.04 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.556 -0.715 . . . . 0.0 109.354 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.533 HG22 HG22 ' A' ' 112' ' ' VAL . 53.4 t -110.98 131.25 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.036 -1.04 . . . . 0.0 110.561 -179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -108.73 119.46 39.61 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.465 ' O ' ' O ' ' A' ' 38' ' ' CYS . 6.8 t -136.83 141.52 42.86 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.957 -1.089 . . . . 0.0 111.989 -178.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.625 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -136.41 156.55 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -127.13 151.01 49.22 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.179 -0.951 . . . . 0.0 110.265 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.479 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.365 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.364 0.602 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -77.46 150.12 34.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.155 -0.966 . . . . 0.0 109.242 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.438 HG13 ' HB2' ' A' ' 47' ' ' LEU . 84.6 t -91.66 135.63 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -0.916 . . . . 0.0 110.267 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -69.55 123.2 20.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.9 -1.125 . . . . 0.0 108.543 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.76 174.87 46.07 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.656 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 7.7 t -114.8 128.19 56.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.441 -1.035 . . . . 0.0 109.292 179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.442 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 51.8 t0 -106.05 109.05 20.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.505 -0.747 . . . . 0.0 109.359 179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 97.6 m-85 -88.05 -0.12 56.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.226 -0.921 . . . . 0.0 108.961 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.5 m -101.47 -15.67 17.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.42 -0.8 . . . . 0.0 110.578 -178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 12' ' ' GLU . 6.5 m -159.89 129.24 5.21 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.88 -1.137 . . . . 0.0 110.316 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.501 ' OG ' ' OE1' ' A' ' 12' ' ' GLU . 78.2 p -70.76 -22.78 62.36 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.587 -0.845 . . . . 0.0 108.852 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.505 ' H ' HG22 ' A' ' 10' ' ' THR . 57.9 mp0 -114.16 74.12 0.86 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.442 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 6.4 m -70.77 151.32 44.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.371 -0.83 . . . . 0.0 110.241 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.0 -0.72 35.99 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.7 pt -125.91 -22.8 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.612 -0.68 . . . . 0.0 110.34 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -112.15 141.97 45.18 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.261 -0.9 . . . . 0.0 110.015 -178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.3 p -75.59 -21.14 58.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.519 -0.738 . . . . 0.0 110.958 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -118.66 127.89 54.0 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.138 -0.976 . . . . 0.0 110.449 -179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.94 153.84 20.69 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.656 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 20.4 m-85 -118.31 144.42 45.86 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.479 -1.013 . . . . 0.0 109.557 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.1 t -96.27 153.8 17.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.316 -0.865 . . . . 0.0 109.122 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.9 pt -48.2 -32.23 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.209 -0.932 . . . . 0.0 109.357 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -68.76 -47.55 65.95 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.9 -1.125 . . . . 0.0 109.707 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -51.12 -47.62 61.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.332 -0.855 . . . . 0.0 109.904 -179.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.1 pt -67.12 -31.01 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.109 -0.995 . . . . 0.0 109.584 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.497 ' O ' ' N ' ' A' ' 28' ' ' LYS . 68.3 p -82.39 -7.22 59.63 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 109.391 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.411 ' C ' ' H ' ' A' ' 29' ' ' SER . 65.8 t30 -68.05 54.04 0.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.364 -0.835 . . . . 0.0 108.959 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 26' ' ' SER . 22.6 pttp -75.93 37.61 0.15 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.272 -0.893 . . . . 0.0 109.772 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 27' ' ' ASN . 5.7 t -78.92 -65.49 0.99 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 109.621 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 45.0 m -56.5 -174.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.454 -0.779 . . . . 0.0 109.5 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.616 ' O ' ' N ' ' A' ' 33' ' ' GLN . 90.3 m-20 -60.49 -41.17 93.71 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.27 -0.894 . . . . 0.0 109.427 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.441 ' O ' ' OD1' ' A' ' 32' ' ' ASN . 53.2 p-10 -59.3 71.84 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.261 -0.899 . . . . 0.0 109.203 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.628 ' C ' ' H ' ' A' ' 35' ' ' ASP . 10.9 pt20 -70.17 -113.26 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.119 -0.988 . . . . 0.0 109.631 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -65.4 22.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.187 -0.945 . . . . 0.0 109.546 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.628 ' H ' ' C ' ' A' ' 33' ' ' GLN . 33.5 m-20 -118.07 101.66 8.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -0.838 . . . . 0.0 109.482 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.6 mm -102.07 124.58 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.198 -0.938 . . . . 0.0 108.646 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' A' ' 122' ' ' VAL . 50.9 t -119.96 129.86 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.334 -0.854 . . . . 0.0 110.277 -179.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.44 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 76.6 m -102.61 101.87 12.05 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.8 m -95.19 120.51 35.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.16 -0.962 . . . . 0.0 109.84 -179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.549 ' CG2' HG12 ' A' ' 125' ' ' VAL . 26.1 m -140.43 157.45 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.467 -0.771 . . . . 0.0 109.146 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -99.99 133.74 43.93 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.114 -0.991 . . . . 0.0 109.398 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -99.22 160.7 14.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.274 -0.891 . . . . 0.0 109.52 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.403 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 20.8 t60 -134.58 152.38 51.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.19 -27.57 35.01 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.363 -0.835 . . . . 0.0 109.823 -179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -99.05 -25.46 14.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.205 -0.934 . . . . 0.0 109.647 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.403 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 97.1 m-20 -75.14 133.29 41.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.363 -0.836 . . . . 0.0 110.074 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.438 ' HB2' HG13 ' A' ' 3' ' ' VAL . 49.6 mt -77.94 148.41 34.51 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.48 HD13 HD21 ' A' ' 99' ' ' LEU . 13.2 pt -120.94 142.78 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.272 -0.892 . . . . 0.0 110.048 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 95' ' ' PHE . . . 176.78 -172.6 45.56 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.466 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 51.4 p90 -170.14 170.17 7.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -1.218 . . . . 0.0 109.79 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 35.7 ttmt -145.06 143.43 30.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.289 -0.882 . . . . 0.0 109.703 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.2 m -125.57 154.28 72.75 Favored Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.419 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.8 Cg_endo -51.53 143.35 36.33 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.213 1.942 . . . . 0.0 111.991 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.1 t -67.28 -12.84 61.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.387 -0.821 . . . . 0.0 110.595 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -89.46 3.33 52.7 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.941 -1.1 . . . . 0.0 110.197 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.572 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 20.7 m-85 -113.29 167.73 10.32 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.157 -0.965 . . . . 0.0 110.324 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.8 t -103.35 138.47 40.06 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.328 -0.858 . . . . 0.0 108.903 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.4 m -97.29 118.05 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.987 -1.07 . . . . 0.0 110.386 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -126.76 129.53 24.03 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.97 114.34 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.628 1.552 . . . . 0.0 111.959 -179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.447 ' O ' ' O ' ' A' ' 68' ' ' PHE . 10.9 t-80 -87.76 -24.38 23.81 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.439 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.1 t0 -172.93 38.91 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.452 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 71.1 m -60.92 -152.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.549 -0.719 . . . . 0.0 109.762 -179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.445 ' O ' ' C ' ' A' ' 65' ' ' VAL . 3.9 p90 -109.42 -58.7 2.0 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.216 -0.928 . . . . 0.0 111.354 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.513 HG12 ' N ' ' A' ' 66' ' ' SER . 13.4 t -46.67 -74.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.436 -1.415 . . . . 0.0 108.927 -179.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.513 ' N ' HG12 ' A' ' 65' ' ' VAL . 32.4 t -135.96 132.02 35.86 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.452 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.84 179.89 2.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.01 . . . . 0.0 110.459 -179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.517 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.4 m-85 -93.69 128.2 39.78 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -73.61 -176.51 2.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.953 -1.092 . . . . 0.0 109.844 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 49.5 mt -63.59 -20.4 65.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.21 -0.932 . . . . 0.0 109.035 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 66.5 m -83.92 -6.43 59.42 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 82.74 19.05 64.36 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -100.18 139.06 36.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -1.149 . . . . 0.0 109.019 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 -85.4 108.77 18.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.205 -0.934 . . . . 0.0 109.994 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -146.06 140.48 26.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.435 -0.791 . . . . 0.0 109.91 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 42.8 m-20 -62.15 148.95 42.83 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.475 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.42 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 13.0 tp -96.51 7.53 46.29 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.209 -0.932 . . . . 0.0 109.724 -179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER -69.07 -40.6 78.39 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.949 -1.094 . . . . 0.0 109.878 -179.583 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.501 ' N ' ' OE1' ' A' ' 78' ' ' GLU . 95.2 m-20 -64.31 -38.85 92.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.173 -0.955 . . . . 0.0 109.122 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -67.81 -53.23 28.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.216 -0.927 . . . . 0.0 109.389 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.523 HD22 ' CZ2' ' A' ' 107' ' ' TRP . 35.7 tp -143.23 121.57 12.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.413 -0.805 . . . . 0.0 109.049 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -81.03 104.88 11.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.192 -0.943 . . . . 0.0 109.371 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.537 HD13 ' OG ' ' A' ' 97' ' ' SER . 91.9 mt -84.3 163.03 19.87 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.369 -0.832 . . . . 0.0 109.949 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 46.6 p -129.95 162.94 27.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.438 -0.789 . . . . 0.0 109.384 179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 54.39 51.85 13.5 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.159 -0.963 . . . . 0.0 109.775 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -81.31 128.76 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.246 -0.909 . . . . 0.0 110.117 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 47.5 mm -125.91 123.67 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.528 -0.733 . . . . 0.0 109.206 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 91.3 mtp -123.45 104.93 9.38 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.164 -0.96 . . . . 0.0 109.829 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -110.19 100.24 9.17 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.382 -0.824 . . . . 0.0 109.014 179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.509 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 98.7 m-70 -73.0 -34.75 66.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.978 -1.076 . . . . 0.0 110.643 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -61.58 -44.91 96.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.964 -1.085 . . . . 0.0 109.647 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -88.65 -4.72 58.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.955 . . . . 0.0 109.104 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.509 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 1.6 m-20 56.5 45.57 22.21 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.492 -0.755 . . . . 0.0 109.995 178.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.575 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 3.7 t -132.26 138.73 48.0 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.04 -1.037 . . . . 0.0 109.385 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.466 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 69.5 m-85 -127.62 139.74 52.54 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.406 -0.809 . . . . 0.0 109.986 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.615 ' CB ' HH12 ' A' ' 98' ' ' ARG . 82.5 m-85 -136.45 147.03 46.99 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.293 -0.879 . . . . 0.0 109.278 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.583 ' N ' ' NH1' ' A' ' 98' ' ' ARG . 38.2 t -153.41 150.72 29.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.114 -0.991 . . . . 0.0 109.357 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.615 HH12 ' CB ' ' A' ' 96' ' ' TYR . 0.0 OUTLIER -105.88 139.27 40.69 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.222 -0.924 . . . . 0.0 109.541 -179.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.523 ' HB3' HD11 ' A' ' 103' ' ' ILE . 42.9 mt -93.65 142.38 25.06 Favored Pre-proline 0 N--CA 1.491 1.613 0 C-N-CA 120.279 -0.568 . . . . 0.0 109.69 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.489 ' HG2' HD11 ' A' ' 81' ' ' LEU . 78.0 Cg_exo -46.83 157.47 0.52 Allowed 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.713 1.608 . . . . 0.0 111.226 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.1 t -67.27 -17.25 64.71 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.157 -0.965 . . . . 0.0 109.702 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 45.9 tp -122.2 130.84 53.57 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.281 -0.887 . . . . 0.0 110.555 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.523 HD11 ' HB3' ' A' ' 99' ' ' LEU . 24.2 mt -144.39 124.5 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 10.6 m -133.3 15.75 4.12 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.042 -1.036 . . . . 0.0 109.855 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 0.3 OUTLIER -109.02 154.15 22.61 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.329 -0.857 . . . . 0.0 110.014 -179.763 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -95.99 32.13 1.98 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.471 -0.768 . . . . 0.0 108.997 179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.523 ' CZ2' HD22 ' A' ' 81' ' ' LEU . 18.2 p-90 -66.33 156.86 33.24 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.899 . . . . 0.0 110.636 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -143.78 155.42 44.15 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.632 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 38.3 p90 -151.88 161.46 42.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.208 -0.933 . . . . 0.0 108.785 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 5.5 p90 -152.24 161.17 43.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.77 -1.206 . . . . 0.0 111.813 -178.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 91.7 m -127.97 157.45 40.57 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.616 HG22 HG22 ' A' ' 122' ' ' VAL . 43.8 t -130.22 142.22 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 120.836 -1.165 . . . . 0.0 111.712 -178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 75.1 m -119.86 131.1 55.17 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.4 p -170.8 179.06 3.31 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.215 -1.553 . . . . 0.0 111.616 -178.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.464 ' HZ2' ' HB3' ' A' ' 115' ' ' LYS . 5.6 mtmp? -158.11 167.34 30.12 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.4 ' O ' ' C ' ' A' ' 117' ' ' ASN . 91.3 m-20 -58.13 150.5 21.12 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.818 -1.176 . . . . 0.0 109.119 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.437 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 66.5 t30 44.38 59.99 3.03 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.172 -0.955 . . . . 0.0 109.809 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.572 ' OE1' ' CE2' ' A' ' 56' ' ' TYR . 49.7 mt-10 -162.06 140.77 9.3 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.18 -0.95 . . . . 0.0 110.21 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -56.63 144.47 31.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 109.209 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -93.54 141.0 28.96 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.123 -0.986 . . . . 0.0 110.315 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.416 HD13 ' CG ' ' A' ' 8' ' ' PHE . 75.0 mt -112.3 125.73 54.48 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.546 -0.721 . . . . 0.0 109.151 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.616 HG22 HG22 ' A' ' 112' ' ' VAL . 49.5 t -110.92 131.27 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.036 -1.04 . . . . 0.0 110.63 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -109.65 121.17 44.62 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.7 t -137.24 141.82 42.04 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.953 -1.092 . . . . 0.0 112.114 -178.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.632 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.1 m -135.49 157.77 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -128.25 150.94 49.82 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.208 -0.932 . . . . 0.0 110.263 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.498 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.942 -1.028 . . . . 0.0 109.253 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -76.62 157.35 31.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.905 . . . . 0.0 109.272 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 66.9 t -99.31 133.84 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.306 -0.871 . . . . 0.0 109.831 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -67.48 122.91 19.0 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.134 -0.979 . . . . 0.0 108.544 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.82 162.99 26.58 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.7 t -103.5 135.25 45.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.477 -1.014 . . . . 0.0 110.084 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.509 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 67.7 t0 -111.98 109.43 19.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.371 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -87.4 -0.92 57.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 108.985 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.3 m -98.89 -17.67 18.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.645 -0.659 . . . . 0.0 110.505 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 12' ' ' GLU . 4.2 m -160.41 131.08 5.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.764 -1.21 . . . . 0.0 110.223 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.1 p -64.17 -26.18 68.41 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.697 -0.801 . . . . 0.0 108.851 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.438 ' H ' HG22 ' A' ' 10' ' ' THR . 98.4 mt-10 -114.37 102.12 9.8 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.517 ' C ' ' H ' ' A' ' 15' ' ' ILE . 23.6 m -102.8 113.28 26.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.416 -0.803 . . . . 0.0 110.372 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.5 t -65.64 2.88 0.85 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.517 ' H ' ' C ' ' A' ' 13' ' ' SER . 6.8 pt -123.56 -32.6 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.482 -0.761 . . . . 0.0 110.325 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.5 ' CZ ' ' CE2' ' A' ' 96' ' ' TYR . 53.8 m-85 -113.07 146.76 38.58 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.954 -1.091 . . . . 0.0 109.854 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 m -79.85 -20.82 45.06 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.38 -0.825 . . . . 0.0 110.956 -179.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -119.9 131.18 55.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.708 -1.245 . . . . 0.0 110.86 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.463 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -150.51 158.66 27.78 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -118.03 153.22 34.06 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.201 -1.176 . . . . 0.0 109.609 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 6.8 t -89.77 148.87 22.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.327 -0.858 . . . . 0.0 109.265 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.1 pt -55.33 -31.22 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.12 -0.987 . . . . 0.0 109.536 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 46.1 t30 -68.31 -41.38 80.97 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.131 -0.981 . . . . 0.0 109.616 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.597 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 96.3 mt-10 -56.85 -48.63 77.63 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.236 -0.915 . . . . 0.0 110.395 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.427 HG13 ' N ' ' A' ' 26' ' ' SER . 15.0 pt -62.58 -44.19 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.036 -1.04 . . . . 0.0 109.619 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.704 ' O ' ' N ' ' A' ' 28' ' ' LYS . 78.1 p -72.0 -33.85 68.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.296 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.474 ' O ' ' N ' ' A' ' 29' ' ' SER . 62.5 t-20 -54.56 73.38 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.53 -0.731 . . . . 0.0 109.307 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.704 ' N ' ' O ' ' A' ' 26' ' ' SER . 42.5 tttp -62.79 78.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.431 -0.793 . . . . 0.0 109.287 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 27' ' ' ASN . 44.2 t -129.43 -87.44 0.53 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.126 -0.984 . . . . 0.0 109.595 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.4 t -129.79 -52.75 1.15 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.397 -0.814 . . . . 0.0 109.636 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.489 ' O ' ' CG ' ' A' ' 32' ' ' ASN . 57.8 t30 -65.0 -6.57 8.9 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.196 -0.94 . . . . 0.0 109.465 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.597 ' ND2' ' O ' ' A' ' 24' ' ' GLU . 75.7 m-80 -161.4 119.46 2.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.339 -0.85 . . . . 0.0 109.605 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.547 ' O ' ' NZ ' ' A' ' 28' ' ' LYS . 9.3 pt20 -136.01 -52.42 0.73 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.108 -0.995 . . . . 0.0 109.538 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.484 ' H ' ' HG3' ' A' ' 33' ' ' GLN . 29.5 pt20 -155.2 -20.63 0.11 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.317 -0.864 . . . . 0.0 109.621 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -131.24 108.31 9.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.375 -0.828 . . . . 0.0 109.422 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.571 HD12 ' OD1' ' A' ' 32' ' ' ASN . 7.8 mm -95.7 118.44 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.102 -0.999 . . . . 0.0 108.714 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.7 t -114.9 127.73 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.1 -1.0 . . . . 0.0 110.268 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 81.3 m -102.51 102.49 12.77 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 98.6 m -95.07 120.19 34.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -0.981 . . . . 0.0 109.763 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.524 ' CG2' HG12 ' A' ' 125' ' ' VAL . 21.7 m -139.78 156.74 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.395 -0.816 . . . . 0.0 108.996 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -99.3 130.7 45.61 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.203 -0.936 . . . . 0.0 109.341 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -91.88 161.71 14.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 109.635 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -139.0 150.31 45.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.21 -0.931 . . . . 0.0 109.586 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.46 -25.2 50.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -0.843 . . . . 0.0 109.818 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -98.98 -26.29 14.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.162 -0.961 . . . . 0.0 109.667 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -78.97 134.97 36.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.531 -0.73 . . . . 0.0 110.013 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 90.7 mt -78.13 149.88 33.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.241 -0.912 . . . . 0.0 108.554 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.492 ' CD1' HD21 ' A' ' 99' ' ' LEU . 24.0 pt -120.82 142.42 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.887 -1.133 . . . . 0.0 110.027 -179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.2 -170.66 43.34 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -172.9 171.17 4.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.063 -1.257 . . . . 0.0 109.684 179.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -146.42 145.01 30.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.317 -0.865 . . . . 0.0 109.866 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.6 m -125.03 152.26 70.2 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.435 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.33 145.58 27.13 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.328 2.019 . . . . 0.0 112.026 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.9 m -68.65 -11.97 60.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.428 -0.795 . . . . 0.0 110.606 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.596 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 79.4 m-20 -91.44 1.03 57.42 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.928 -1.107 . . . . 0.0 110.039 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.51 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 19.4 m-85 -111.59 166.53 11.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.919 -1.113 . . . . 0.0 110.162 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -104.53 131.26 52.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.302 -0.874 . . . . 0.0 109.339 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.6 m -89.14 121.12 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.006 -1.059 . . . . 0.0 110.203 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -125.81 129.15 24.41 Favored Pre-proline 0 N--CA 1.492 1.646 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.21 114.42 3.55 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.664 1.576 . . . . 0.0 112.088 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.465 ' O ' ' O ' ' A' ' 68' ' ' PHE . 10.8 t-80 -92.93 -25.29 18.1 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.474 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.8 t0 -171.43 40.44 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.508 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 70.8 m -63.7 -152.66 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.604 -0.685 . . . . 0.0 109.84 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.6 p90 -110.95 -58.9 2.04 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.863 -1.148 . . . . 0.0 111.151 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.442 ' C ' ' O ' ' A' ' 64' ' ' PHE . 25.3 t -45.97 -70.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 120.442 -1.411 . . . . 0.0 108.897 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.3 t -140.44 130.76 25.16 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.508 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.22 178.48 2.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.926 -1.109 . . . . 0.0 110.425 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 6.5 m-85 -93.12 124.94 37.45 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -69.6 -176.36 1.01 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.936 -1.103 . . . . 0.0 109.759 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 17.5 mt -63.29 -21.73 66.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.328 -0.857 . . . . 0.0 109.044 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.6 m -81.63 -5.81 58.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.352 -0.842 . . . . 0.0 108.858 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.41 19.94 65.38 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -105.25 141.56 36.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.254 -1.145 . . . . 0.0 109.187 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -83.89 112.83 20.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.115 -0.99 . . . . 0.0 109.944 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -148.13 136.26 21.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.329 -0.857 . . . . 0.0 109.783 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -58.33 144.87 40.03 Favored 'General case' 0 N--CA 1.499 1.983 0 C-N-CA 119.829 -0.748 . . . . 0.0 109.073 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.568 HD11 ' HD2' ' A' ' 80' ' ' LYS . 14.6 tp -97.12 7.4 46.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.186 -0.946 . . . . 0.0 109.691 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.46 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -69.7 -38.74 77.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 109.913 -179.374 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.586 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 49.3 p-10 -61.26 -31.15 70.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.164 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.586 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 37.4 ttmt -74.87 -48.37 25.27 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.374 -0.828 . . . . 0.0 109.392 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.552 HD22 ' CZ2' ' A' ' 107' ' ' TRP . 31.9 tp -136.74 127.27 26.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.38 -0.825 . . . . 0.0 109.205 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -74.68 85.44 2.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.119 -0.988 . . . . 0.0 109.12 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 49.0 mt -77.73 138.23 38.92 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.283 -0.885 . . . . 0.0 109.927 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 41.3 p -126.39 166.52 17.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.543 -0.723 . . . . 0.0 109.315 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 55.51 50.46 14.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.883 . . . . 0.0 109.559 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.89 130.86 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.358 -0.839 . . . . 0.0 110.094 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.6 mm -120.72 120.3 62.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.349 -0.844 . . . . 0.0 109.201 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 81.5 mtp -122.53 104.72 9.55 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.987 -1.071 . . . . 0.0 109.98 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -108.52 99.35 8.75 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.248 -0.907 . . . . 0.0 108.805 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.477 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 97.4 m-70 -72.53 -36.89 68.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.985 -1.072 . . . . 0.0 110.686 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -60.54 -45.75 92.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.005 -1.059 . . . . 0.0 109.515 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -87.68 -4.83 58.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.142 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.477 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.3 m-20 54.93 47.46 22.17 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.494 -0.754 . . . . 0.0 110.348 178.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.562 ' OG1' ' CE1' ' A' ' 96' ' ' TYR . 2.6 t -134.66 141.94 46.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.956 -1.09 . . . . 0.0 109.387 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -129.44 140.34 51.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.42 -0.8 . . . . 0.0 110.01 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.562 ' CE1' ' OG1' ' A' ' 94' ' ' THR . 82.7 m-85 -135.38 146.14 48.04 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.23 -0.919 . . . . 0.0 109.483 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 48.4 m -151.43 153.27 34.35 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.082 -1.011 . . . . 0.0 109.231 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 15.4 mtt-85 -107.9 138.4 44.23 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.071 -1.018 . . . . 0.0 109.419 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.634 ' HB3' HD11 ' A' ' 103' ' ' ILE . 60.3 mt -96.0 141.17 22.78 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.828 . . . . 0.0 109.727 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.499 ' HG2' HD11 ' A' ' 81' ' ' LEU . 77.9 Cg_exo -45.64 178.17 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 121.901 1.734 . . . . 0.0 111.187 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 67.9 m -85.46 -11.73 53.59 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.035 -1.041 . . . . 0.0 109.689 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.3 tp -124.3 131.14 53.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.007 . . . . 0.0 110.54 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.634 HD11 ' HB3' ' A' ' 99' ' ' LEU . 41.3 mt -147.48 103.82 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 97.4 p -114.0 -0.41 14.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.028 -1.045 . . . . 0.0 109.748 -179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 105' ' ' ASP . 0.4 OUTLIER -89.46 153.66 20.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 0.0 110.071 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -98.43 31.98 2.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.459 -0.776 . . . . 0.0 109.127 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.552 ' CZ2' HD22 ' A' ' 81' ' ' LEU . 16.1 p-90 -65.65 159.21 25.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -0.848 . . . . 0.0 110.493 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.4 pttm -146.7 156.82 43.47 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.57 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 43.5 p90 -153.47 163.67 39.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.085 -1.01 . . . . 0.0 108.9 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 6.8 p90 -152.71 163.04 40.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.672 -1.268 . . . . 0.0 111.681 -178.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 87.0 m -130.04 158.64 39.06 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 122' ' ' VAL . 42.9 t -130.74 143.36 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.66 -1.275 . . . . 0.0 111.774 -178.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 87.8 m -123.36 132.61 54.04 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 46.3 p -170.76 178.69 3.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.298 -1.501 . . . . 0.0 111.743 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.596 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 46.2 mtmt -154.06 165.55 35.82 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.6 150.89 21.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.78 -1.2 . . . . 0.0 109.123 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.527 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 61.8 t-20 46.47 61.27 2.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.266 -0.897 . . . . 0.0 109.52 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 44.4 mt-10 -165.1 145.43 7.16 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.956 -1.09 . . . . 0.0 110.127 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -60.66 147.73 40.98 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.204 -0.935 . . . . 0.0 109.003 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -93.26 140.8 29.14 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.066 -1.021 . . . . 0.0 110.355 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 42.2 mt -110.17 122.35 47.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.412 -0.805 . . . . 0.0 109.093 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 112' ' ' VAL . 48.7 t -109.96 130.79 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.938 -1.101 . . . . 0.0 110.833 -179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -109.57 121.46 45.24 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.0 t -137.37 142.15 41.75 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.666 -1.271 . . . . 0.0 112.029 -178.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.57 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.1 m -135.09 158.04 40.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -137.12 157.88 45.71 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.89 -1.131 . . . . 0.0 110.128 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.504 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.408 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -74.76 157.98 34.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.167 -0.958 . . . . 0.0 109.198 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.525 HG22 HD12 ' A' ' 47' ' ' LEU . 53.4 t -103.3 132.81 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -0.893 . . . . 0.0 109.955 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.1 mmtp -62.76 117.5 6.41 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.363 -0.935 . . . . 0.0 108.574 179.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 179.44 155.7 15.72 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.422 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 4.9 t -100.08 132.01 45.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.562 -0.963 . . . . 0.0 109.493 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.511 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 47.2 t0 -105.05 108.4 19.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.448 -0.783 . . . . 0.0 109.302 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -88.27 -0.99 57.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.304 -0.872 . . . . 0.0 108.854 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.5 m -101.19 -16.56 16.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.492 -0.755 . . . . 0.0 110.434 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.6 m -157.13 124.88 5.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.859 -1.15 . . . . 0.0 110.182 -179.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.493 ' OG ' ' OE1' ' A' ' 12' ' ' GLU . 78.0 p -67.16 -26.9 66.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.369 -0.832 . . . . 0.0 108.98 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.496 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 57.5 mp0 -109.07 72.61 0.82 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.9 t -74.11 158.59 33.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.407 -0.808 . . . . 0.0 110.137 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.433 HG23 ' H ' ' A' ' 15' ' ' ILE . 0.0 OUTLIER -103.23 -48.7 3.94 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.131 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.433 ' H ' HG23 ' A' ' 14' ' ' THR . 24.0 pt -86.78 -12.92 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.574 -0.704 . . . . 0.0 110.16 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.417 ' CD2' HG13 ' A' ' 15' ' ' ILE . 68.0 m-85 -110.4 136.93 48.81 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.153 -0.967 . . . . 0.0 109.606 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 t -74.24 -26.7 60.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.431 -0.793 . . . . 0.0 111.157 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -123.3 134.51 54.05 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.07 -1.019 . . . . 0.0 110.787 -178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.511 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -144.47 156.13 26.66 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.422 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 22.5 m-85 -122.22 153.34 38.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.333 -1.098 . . . . 0.0 109.647 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.2 t -88.83 149.56 23.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.328 -0.857 . . . . 0.0 109.116 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.446 ' O ' ' OG ' ' A' ' 26' ' ' SER . 45.8 pt -58.55 -30.2 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.495 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.0 t30 -66.85 -40.65 87.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.929 . . . . 0.0 109.619 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.457 ' O ' ' CG ' ' A' ' 32' ' ' ASN . 76.5 mm-40 -64.44 -45.45 87.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.408 -0.808 . . . . 0.0 110.113 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 25.8 pt -80.57 -14.07 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.939 -1.101 . . . . 0.0 109.679 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 28' ' ' LYS . 49.2 m -96.01 -70.21 0.72 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 109.34 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.427 ' O ' ' N ' ' A' ' 29' ' ' SER . 66.3 t30 -52.27 85.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.0 109.246 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.589 ' N ' ' O ' ' A' ' 26' ' ' SER . 18.3 pttm -49.18 96.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.45 -0.781 . . . . 0.0 109.679 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.519 ' OG ' ' N ' ' A' ' 30' ' ' SER . 89.4 p -107.31 -100.54 0.36 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.08 -1.012 . . . . 0.0 109.74 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.581 ' C ' ' H ' ' A' ' 32' ' ' ASN . 78.3 p -125.61 -71.81 0.69 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.45 -0.781 . . . . 0.0 109.845 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -64.72 13.82 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.278 -0.889 . . . . 0.0 109.477 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.581 ' H ' ' C ' ' A' ' 30' ' ' SER . 15.6 p30 -169.12 81.84 0.13 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 0.0 109.604 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -138.96 -34.44 0.6 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.144 -0.973 . . . . 0.0 109.905 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.546 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 13.8 pt20 -117.09 -45.04 2.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.379 -0.826 . . . . 0.0 109.753 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.546 ' OD1' ' O ' ' A' ' 34' ' ' GLN . 1.8 m-20 -145.62 124.52 12.72 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.322 -0.861 . . . . 0.0 109.305 -179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.412 HD12 ' CB ' ' A' ' 32' ' ' ASN . 9.0 mm -90.29 122.71 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.135 -0.978 . . . . 0.0 108.439 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 88.4 t -121.06 126.5 75.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.0 110.337 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 96.8 m -103.16 102.47 12.46 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.8 m -94.85 120.77 35.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.13 -0.981 . . . . 0.0 109.848 -179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.518 ' CG2' HG12 ' A' ' 125' ' ' VAL . 27.3 m -139.82 156.73 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.364 -0.835 . . . . 0.0 109.013 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -100.16 131.84 45.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.086 -1.009 . . . . 0.0 109.415 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.449 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -97.07 158.09 15.6 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.296 -0.877 . . . . 0.0 109.57 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.428 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 31.5 t60 -134.05 153.25 51.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.207 -0.933 . . . . 0.0 109.53 -179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.24 -25.03 20.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.349 -0.844 . . . . 0.0 109.772 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -99.74 -25.93 14.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.068 -1.02 . . . . 0.0 109.662 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.428 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 77.8 m-20 -75.47 134.57 40.8 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.291 -0.88 . . . . 0.0 110.034 -179.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.525 HD12 HG22 ' A' ' 3' ' ' VAL . 83.1 mt -76.24 147.39 38.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.138 -0.976 . . . . 0.0 108.661 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.595 HD13 HD21 ' A' ' 99' ' ' LEU . 9.0 pt -116.93 136.57 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.159 -0.963 . . . . 0.0 109.847 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.26 -176.94 47.86 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.438 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 55.6 p90 -164.57 169.77 16.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.087 -1.243 . . . . 0.0 109.858 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -144.17 143.16 30.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.255 -0.903 . . . . 0.0 109.908 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 68.6 m -126.6 152.37 74.47 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.422 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.7 Cg_endo -51.4 149.16 17.93 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.404 2.069 . . . . 0.0 112.122 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 92.4 p -71.73 -11.27 60.74 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.435 -0.791 . . . . 0.0 110.649 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -90.67 0.24 57.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.9 -1.125 . . . . 0.0 110.129 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.422 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 20.7 m-85 -110.36 165.99 11.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.199 -0.938 . . . . 0.0 110.252 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 t -102.87 133.45 47.93 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.357 -0.839 . . . . 0.0 109.107 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.1 m -91.13 123.53 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.969 -1.082 . . . . 0.0 110.335 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -130.68 129.16 22.64 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.05 113.53 3.44 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 121.71 1.607 . . . . 0.0 112.046 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.47 ' O ' ' O ' ' A' ' 68' ' ' PHE . 15.9 t-160 -91.06 -26.66 19.05 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.503 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 67.5 t0 -169.72 37.13 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.541 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 75.9 m -60.38 -155.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.472 -0.767 . . . . 0.0 109.724 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.3 p90 -111.47 -56.66 2.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.141 -0.974 . . . . 0.0 111.316 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.419 HG23 ' CE2' ' A' ' 64' ' ' PHE . 78.0 t -47.36 -54.7 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 120.479 -1.388 . . . . 0.0 109.062 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -158.08 129.8 6.8 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.541 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.01 -179.34 1.99 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.957 -1.09 . . . . 0.0 110.442 -179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 6.3 m-85 -93.16 123.58 36.53 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -70.66 -173.74 0.8 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.137 -0.977 . . . . 0.0 109.787 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 70' ' ' LEU . 10.3 mp -63.61 -21.49 66.39 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.272 -0.892 . . . . 0.0 109.018 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 61.7 m -82.44 -7.05 59.64 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.347 -0.846 . . . . 0.0 108.885 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.41 19.83 65.62 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -102.86 138.78 39.29 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.212 -1.169 . . . . 0.0 108.999 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -83.7 108.33 16.7 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 0.0 110.004 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -144.2 138.74 28.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -0.852 . . . . 0.0 109.85 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.467 ' OD1' ' N ' ' A' ' 77' ' ' LEU . 55.1 t-20 -59.78 145.55 44.87 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.298 -0.876 . . . . 0.0 108.954 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.54 HD11 ' HD2' ' A' ' 80' ' ' LYS . 13.4 tp -97.32 7.44 46.55 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.292 -0.88 . . . . 0.0 109.845 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.449 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.2 OUTLIER -70.12 -37.99 75.47 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.065 -1.022 . . . . 0.0 110.058 -179.539 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -62.72 -32.73 73.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.044 -1.035 . . . . 0.0 109.156 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.54 ' HD2' HD11 ' A' ' 77' ' ' LEU . 23.4 ttmt -72.41 -50.21 28.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.853 . . . . 0.0 109.634 179.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.517 HD11 ' HG2' ' A' ' 100' ' ' PRO . 19.2 tp -139.3 128.81 24.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.487 -0.758 . . . . 0.0 109.074 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -78.99 88.28 4.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.12 -0.988 . . . . 0.0 109.639 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.21 150.82 41.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.357 -0.839 . . . . 0.0 109.936 -179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 62.2 p -127.14 164.33 21.86 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.512 -0.742 . . . . 0.0 109.176 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.481 HD22 ' HG3' ' A' ' 98' ' ' ARG . 78.7 m-20 56.1 53.15 9.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.276 -0.89 . . . . 0.0 109.942 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.5 mt -79.68 125.17 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -0.825 . . . . 0.0 109.918 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.7 mm -123.14 121.99 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.5 -0.75 . . . . 0.0 109.265 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 84.6 mtp -123.25 103.37 8.49 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.108 -0.995 . . . . 0.0 109.696 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -110.98 101.36 9.93 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.378 -0.826 . . . . 0.0 109.037 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.499 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 91.8 m-70 -72.96 -35.78 66.99 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.876 -1.14 . . . . 0.0 110.686 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -60.19 -45.91 91.52 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.942 -1.099 . . . . 0.0 109.572 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -89.87 -4.35 57.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.925 . . . . 0.0 109.064 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.499 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 97.7 m-20 54.52 47.91 21.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.424 -0.798 . . . . 0.0 110.167 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.574 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 2.5 t -133.35 138.64 46.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.171 -0.956 . . . . 0.0 109.451 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.438 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 65.2 m-85 -129.06 140.64 51.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.402 -0.811 . . . . 0.0 109.915 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.574 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 72.1 m-85 -137.74 148.89 46.0 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.45 -0.781 . . . . 0.0 109.383 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 63.8 m -152.49 155.1 36.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.092 -1.005 . . . . 0.0 109.172 179.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.489 ' CZ ' HD21 ' A' ' 47' ' ' LEU . 16.6 mmt180 -102.53 136.08 42.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.188 -0.945 . . . . 0.0 109.732 179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.646 ' HB3' HD11 ' A' ' 103' ' ' ILE . 68.2 mt -89.92 136.78 28.72 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.803 -0.56 . . . . 0.0 109.699 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.517 ' HG2' HD11 ' A' ' 81' ' ' LEU . 77.9 Cg_exo -45.87 176.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 121.848 1.699 . . . . 0.0 111.188 178.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.2 m -85.63 -14.66 44.93 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.099 -1.0 . . . . 0.0 109.925 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 47.6 tp -121.04 130.43 53.78 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.189 -0.945 . . . . 0.0 110.523 -179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.646 HD11 ' HB3' ' A' ' 99' ' ' LEU . 43.9 mt -149.84 102.88 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.5 p -120.01 3.68 10.97 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.202 -0.936 . . . . 0.0 109.722 -179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.518 ' O ' ' OXT' ' A' ' 127' ' ' ALA . 27.9 t70 -93.72 158.97 15.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.149 -0.97 . . . . 0.0 109.933 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -96.15 33.8 1.68 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.455 -0.778 . . . . 0.0 109.045 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 12.4 p-90 -65.21 154.27 38.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.186 -0.946 . . . . 0.0 110.635 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -145.86 155.46 42.91 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.602 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 42.0 p90 -154.35 162.63 41.06 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.133 -0.979 . . . . 0.0 108.753 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 6.1 p90 -152.79 162.32 41.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.69 -1.256 . . . . 0.0 111.833 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 95.2 m -127.63 157.66 39.64 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 122' ' ' VAL . 42.2 t -130.01 142.62 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 O-C-N 120.768 -1.208 . . . . 0.0 111.789 -178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 72.2 m -123.39 132.44 53.97 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 177.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.0 p -171.19 178.63 3.26 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.239 -1.538 . . . . 0.0 111.691 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.637 ' CB ' ' HZ2' ' A' ' 115' ' ' LYS . 7.3 mtmp? -153.41 164.75 37.61 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.409 ' O ' ' C ' ' A' ' 117' ' ' ASN . 99.7 m-20 -57.76 152.28 15.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.771 -1.206 . . . . 0.0 109.195 179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.515 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 66.8 t30 44.68 60.73 2.75 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.217 -0.927 . . . . 0.0 109.669 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.59 ' OE2' ' NZ ' ' A' ' 115' ' ' LYS . 36.8 mt-10 -165.37 145.71 6.97 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.136 -0.977 . . . . 0.0 110.178 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.404 ' HZ2' ' HA ' ' A' ' 28' ' ' LYS . 56.5 mtpt -63.67 136.2 57.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.25 -0.906 . . . . 0.0 109.038 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.408 ' CE ' ' OD1' ' A' ' 35' ' ' ASP . 52.8 pttt -85.26 146.12 27.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.226 -0.922 . . . . 0.0 110.406 -179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 56.1 mt -111.16 123.71 50.74 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.498 -0.751 . . . . 0.0 109.177 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.589 HG22 HG22 ' A' ' 112' ' ' VAL . 46.0 t -109.03 130.34 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.022 -1.049 . . . . 0.0 110.617 -179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -110.69 122.62 48.24 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 6.9 t -137.84 143.28 40.9 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.835 -1.166 . . . . 0.0 112.208 -178.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.602 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.1 m -134.75 156.9 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -134.79 155.58 50.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.982 -1.074 . . . . 0.0 110.272 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.518 ' OXT' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.086 -0.959 . . . . 0.0 109.393 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.339 0.59 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 22.7 mmtp -76.31 142.71 41.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.1 -1.0 . . . . 0.0 109.188 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 44.0 t -80.92 133.54 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.708 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.61 ' NZ ' ' OD2' ' A' ' 46' ' ' ASP . 2.0 mptm? -74.72 125.49 28.85 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.047 -1.033 . . . . 0.0 108.95 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.95 179.05 44.33 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.436 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 4.8 t -115.97 132.23 56.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.483 -1.01 . . . . 0.0 109.316 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.472 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 29.5 t70 -108.19 109.63 21.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.496 -0.752 . . . . 0.0 109.422 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.44 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 91.0 m-85 -89.83 0.05 57.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.227 -0.921 . . . . 0.0 108.857 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.0 m -101.88 -17.88 15.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.566 -0.709 . . . . 0.0 110.505 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 12' ' ' GLU . 6.8 m -156.87 125.22 5.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.878 -1.139 . . . . 0.0 110.249 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.0 p -66.85 -24.84 66.19 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.629 -0.829 . . . . 0.0 108.97 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.441 ' H ' HG22 ' A' ' 10' ' ' THR . 79.0 mm-40 -115.0 74.59 0.89 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.461 ' OG ' ' CG ' ' A' ' 7' ' ' ASP . 20.0 m -71.81 152.39 42.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.83 . . . . 0.0 110.398 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.77 0.29 38.54 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.8 pt -125.27 -23.83 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.646 -0.659 . . . . 0.0 110.292 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -111.78 140.99 45.96 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.243 -0.911 . . . . 0.0 109.92 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.1 p -72.54 -18.42 61.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.589 -0.694 . . . . 0.0 111.045 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -132.14 143.14 49.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.015 -1.053 . . . . 0.0 110.847 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.472 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -152.81 159.91 28.73 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.436 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 32.4 m-85 -118.52 156.24 29.44 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.442 -1.034 . . . . 0.0 109.594 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.3 t -96.66 158.45 15.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.37 -0.832 . . . . 0.0 109.148 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.5 pt -61.47 -22.71 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.153 -0.967 . . . . 0.0 109.35 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -80.01 -52.85 7.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.137 -0.977 . . . . 0.0 109.778 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.458 ' O ' ' OD1' ' A' ' 27' ' ' ASN . 79.8 mm-40 -51.7 -36.88 48.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.336 -0.852 . . . . 0.0 110.004 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.5 pt -76.34 -13.03 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.978 -1.076 . . . . 0.0 109.598 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.771 ' O ' ' N ' ' A' ' 28' ' ' LYS . 31.8 t -104.23 -28.55 11.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.261 -0.899 . . . . 0.0 109.375 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 29' ' ' SER . 46.8 p30 -42.49 77.92 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.499 0.666 . . . . 0.0 109.431 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.771 ' N ' ' O ' ' A' ' 26' ' ' SER . 68.6 mttm -54.97 86.0 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.377 -0.827 . . . . 0.0 109.585 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 27' ' ' ASN . 5.6 p -143.25 -84.1 0.16 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.893 . . . . 0.0 109.235 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 84.5 p -69.39 -179.26 1.6 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.465 -0.772 . . . . 0.0 109.449 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.562 ' OD1' ' NE2' ' A' ' 34' ' ' GLN . 34.5 t30 -51.18 -17.14 0.6 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.115 -0.99 . . . . 0.0 109.454 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.429 ' O ' ' CD1' ' A' ' 36' ' ' ILE . 98.9 m-20 -65.6 4.94 0.49 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.32 -0.863 . . . . 0.0 109.2 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 31' ' ' ASN . 20.4 pt20 -90.48 -12.38 37.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.944 -1.097 . . . . 0.0 109.573 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.562 ' NE2' ' OD1' ' A' ' 31' ' ' ASN . 29.5 pt20 -122.44 -34.75 3.22 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.517 -0.739 . . . . 0.0 109.672 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.539 ' OD2' ' CE ' ' A' ' 120' ' ' LYS . 1.4 m-20 -147.8 115.5 6.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.319 -0.863 . . . . 0.0 109.493 -179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.429 ' CD1' ' O ' ' A' ' 32' ' ' ASN . 20.2 mm -81.97 124.63 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.086 -1.009 . . . . 0.0 108.462 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 54.1 t -121.68 126.52 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.277 -0.889 . . . . 0.0 110.173 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.44 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 84.3 m -102.18 100.8 11.05 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 95.8 m -93.87 119.58 32.99 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.141 -0.974 . . . . 0.0 109.659 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.434 ' CG2' HG12 ' A' ' 125' ' ' VAL . 28.0 m -141.95 153.86 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.49 -0.756 . . . . 0.0 109.232 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.419 ' H ' ' HD3' ' A' ' 41' ' ' LYS . 1.3 mppt? -95.25 133.88 38.64 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.116 -0.99 . . . . 0.0 109.142 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.435 ' HB1' ' CG2' ' A' ' 48' ' ' ILE . . . -109.47 124.06 50.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.457 -0.777 . . . . 0.0 109.734 -179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.509 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 28.2 t60 -86.72 148.2 25.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.355 -0.84 . . . . 0.0 109.542 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.907 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -50.17 -34.26 21.9 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.22 -0.925 . . . . 0.0 109.779 -179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -89.88 -17.63 27.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.273 -0.892 . . . . 0.0 109.423 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.61 ' OD2' ' NZ ' ' A' ' 4' ' ' LYS . 76.4 m-20 -75.7 136.83 40.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.432 -0.793 . . . . 0.0 110.07 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 79.3 mt -77.31 145.41 37.41 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.435 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 21.0 pt -121.32 143.21 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.264 -0.898 . . . . 0.0 110.191 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 179.21 -174.07 46.07 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.613 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 50.8 p90 -170.52 169.62 7.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -1.225 . . . . 0.0 109.831 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -146.17 144.54 30.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.306 -0.871 . . . . 0.0 109.861 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 40.8 m -125.01 153.93 71.29 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.424 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 9.0 Cg_endo -51.51 144.78 31.27 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.337 2.025 . . . . 0.0 112.167 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.6 t -68.3 -13.85 62.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.453 -0.779 . . . . 0.0 110.636 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.623 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.9 m-20 -89.95 1.73 55.92 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.89 -1.131 . . . . 0.0 110.039 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.424 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 18.9 m-85 -110.79 165.93 11.43 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.099 -1.001 . . . . 0.0 110.446 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.416 ' O ' ' OE1' ' A' ' 59' ' ' GLU . 39.5 t -102.7 132.92 48.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.344 -0.847 . . . . 0.0 108.96 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.4 m -89.73 120.31 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 120.992 -1.067 . . . . 0.0 110.346 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 59' ' ' GLU . 35.0 mp0 -127.69 128.08 23.95 Favored Pre-proline 0 N--CA 1.489 1.491 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.22 114.3 3.53 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.683 1.588 . . . . 0.0 112.106 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.493 ' O ' ' O ' ' A' ' 68' ' ' PHE . 9.3 t-80 -91.17 -25.33 19.61 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 63' ' ' CYS . 67.4 t0 -171.85 36.43 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.495 ' O ' ' O ' ' A' ' 62' ' ' ASP . 96.5 m -57.13 -155.45 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.548 -0.72 . . . . 0.0 109.651 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 4.0 p90 -108.77 -56.27 2.29 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.037 -1.04 . . . . 0.0 111.173 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.44 HG23 ' CE2' ' A' ' 64' ' ' PHE . 53.2 t -46.49 -73.42 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.479 -1.388 . . . . 0.0 108.865 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.2 t -140.21 130.71 25.47 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.424 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.19 -178.41 2.07 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.464 -178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 5.0 m-85 -93.82 128.84 40.28 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -76.45 -174.57 2.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.953 -1.092 . . . . 0.0 109.741 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 72.8 mt -63.4 -20.55 65.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.275 -0.891 . . . . 0.0 109.21 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.9 m -83.38 -6.85 59.59 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.32 19.61 66.3 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -101.43 136.74 40.77 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.216 -1.167 . . . . 0.0 109.145 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -84.94 112.98 21.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.122 -0.986 . . . . 0.0 110.097 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -150.12 141.55 23.36 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.41 -0.806 . . . . 0.0 109.983 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 77' ' ' LEU . 56.0 t-20 -61.61 146.71 48.07 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.4 -0.812 . . . . 0.0 109.215 -179.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.539 ' N ' ' OD1' ' A' ' 76' ' ' ASN . 6.6 tp -99.69 6.11 45.63 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.288 -0.882 . . . . 0.0 109.8 -179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.439 ' OE1' ' C ' ' A' ' 78' ' ' GLU . 0.8 OUTLIER -75.52 -39.02 58.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.97 -1.081 . . . . 0.0 109.983 -179.449 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 56.5 p30 -59.26 -14.21 10.36 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.131 -0.981 . . . . 0.0 109.165 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 31.0 ttpt -107.0 -36.17 6.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.382 -0.824 . . . . 0.0 109.327 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.662 HD22 ' CH2' ' A' ' 107' ' ' TRP . 33.1 tp -123.92 129.5 51.08 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.42 -0.8 . . . . 0.0 109.339 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -73.31 83.46 1.4 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.039 -1.038 . . . . 0.0 109.285 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.572 ' CB ' HD11 ' A' ' 86' ' ' ILE . 24.3 mt -69.32 130.11 41.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.224 -0.923 . . . . 0.0 109.959 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 82.3 p -133.86 151.71 51.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.397 -0.814 . . . . 0.0 109.302 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 52.82 50.69 17.49 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.098 -1.001 . . . . 0.0 109.58 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.572 HD11 ' CB ' ' A' ' 83' ' ' LEU . 97.6 mt -78.73 130.37 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.327 -0.858 . . . . 0.0 110.085 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.9 mm -117.85 118.84 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.473 -0.767 . . . . 0.0 109.276 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 81.0 mtp -124.17 108.09 11.92 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.286 -0.884 . . . . 0.0 109.822 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -113.93 102.17 9.94 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.362 -0.836 . . . . 0.0 109.05 179.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.501 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 70.2 m80 -72.33 -35.74 68.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.898 -1.126 . . . . 0.0 110.488 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -60.7 -44.86 96.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.874 -1.141 . . . . 0.0 109.457 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -89.41 -5.72 57.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.134 -0.979 . . . . 0.0 109.129 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.501 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.3 m-20 55.36 47.47 21.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.576 -0.702 . . . . 0.0 110.392 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.589 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 2.8 t -132.3 137.5 47.48 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.146 -0.971 . . . . 0.0 109.404 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.613 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 23.8 m-85 -127.28 139.41 52.92 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.372 -0.83 . . . . 0.0 109.818 -179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.589 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 81.2 m-85 -135.9 147.01 47.97 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.21 -0.932 . . . . 0.0 109.358 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.6 t -150.86 150.9 31.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.953 -1.092 . . . . 0.0 109.174 179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.413 HH11 ' HG2' ' A' ' 98' ' ' ARG . 60.7 mtt-85 -101.68 134.41 44.86 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.044 -1.035 . . . . 0.0 109.476 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.4 HD11 HG21 ' A' ' 48' ' ' ILE . 94.7 mt -93.39 139.22 22.86 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.436 -0.79 . . . . 0.0 109.5 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.907 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 77.0 Cg_exo -46.36 163.22 0.11 Allowed 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 121.853 1.702 . . . . 0.0 111.222 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 m -76.34 -10.15 59.19 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.1 -1.0 . . . . 0.0 109.696 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.8 tp -136.42 129.29 30.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.152 -0.968 . . . . 0.0 110.339 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 88.7 mt -145.69 106.92 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 108.893 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 95.3 p -100.53 -2.81 32.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.048 -1.032 . . . . 0.0 109.899 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -88.45 156.13 19.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.257 -0.902 . . . . 0.0 109.99 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -105.02 33.2 3.75 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.452 -0.78 . . . . 0.0 109.135 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.662 ' CH2' HD22 ' A' ' 81' ' ' LEU . 24.4 p-90 -65.77 161.53 20.67 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.141 -0.974 . . . . 0.0 110.625 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -143.54 160.68 40.19 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.622 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 36.4 p90 -155.09 160.65 41.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.17 -0.956 . . . . 0.0 108.674 179.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.518 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 5.0 p90 -151.67 159.93 43.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.778 -1.201 . . . . 0.0 111.892 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 96.7 m -125.0 156.5 38.01 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.635 HG22 HG22 ' A' ' 122' ' ' VAL . 44.8 t -130.58 143.65 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.839 -1.163 . . . . 0.0 111.764 -178.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 63.4 m -124.66 132.95 53.38 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 177.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.6 p -167.62 178.08 5.54 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.25 -1.531 . . . . 0.0 111.694 -178.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.623 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 46.5 mtmt -155.31 165.04 37.88 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 117' ' ' ASN . 98.2 m-20 -58.69 150.95 22.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.827 -1.171 . . . . 0.0 109.116 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.492 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 64.5 t30 44.53 60.95 2.62 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.232 -0.917 . . . . 0.0 109.639 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.492 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 40.4 mt-10 -164.48 144.72 7.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.132 -0.98 . . . . 0.0 110.216 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.539 ' CE ' ' NZ ' ' A' ' 28' ' ' LYS . 69.7 mmtt -63.28 136.66 57.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.197 -0.939 . . . . 0.0 109.111 179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.539 ' CE ' ' OD2' ' A' ' 35' ' ' ASP . 4.3 pttm -84.26 144.8 28.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.249 -0.907 . . . . 0.0 110.575 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 72.7 mt -110.92 123.67 50.59 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.583 -0.698 . . . . 0.0 109.181 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.635 HG22 HG22 ' A' ' 112' ' ' VAL . 45.3 t -109.9 130.94 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.01 -1.056 . . . . 0.0 110.679 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -110.37 122.53 47.92 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.438 ' O ' ' O ' ' A' ' 38' ' ' CYS . 7.6 t -137.86 142.85 40.71 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.795 -1.191 . . . . 0.0 112.163 -178.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.622 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -136.12 158.18 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 177.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -124.01 145.21 49.35 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.106 -0.996 . . . . 0.0 110.415 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.279 179.792 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -76.18 162.96 27.54 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.139 -0.976 . . . . 0.0 109.294 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 69.4 t -106.12 134.32 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.162 -0.962 . . . . 0.0 110.042 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -70.47 124.04 23.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.065 -1.022 . . . . 0.0 108.371 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.18 164.79 30.39 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.471 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 4.4 t -107.59 138.04 44.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.621 -0.929 . . . . 0.0 109.386 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.445 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 67.3 t0 -114.81 109.01 17.51 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.446 -0.784 . . . . 0.0 109.36 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -86.32 -0.73 56.53 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 108.928 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.427 ' OG1' ' N ' ' A' ' 53' ' ' PRO . 17.1 m -99.66 -17.92 17.54 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.638 -0.663 . . . . 0.0 110.5 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.472 HG22 ' H ' ' A' ' 12' ' ' GLU . 9.3 m -158.24 127.64 5.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.769 -1.207 . . . . 0.0 110.263 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 78.7 p -62.5 -28.08 69.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.174 -0.953 . . . . 0.0 108.973 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.472 ' H ' HG22 ' A' ' 10' ' ' THR . 97.8 mt-10 -109.24 108.4 18.99 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 15' ' ' ILE . 74.4 m -107.63 109.5 21.15 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.869 . . . . 0.0 110.376 -179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 14' ' ' THR . 0.1 OUTLIER -66.84 2.58 1.35 Allowed 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.972 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.489 ' H ' ' C ' ' A' ' 13' ' ' SER . 6.9 pt -124.48 -30.28 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.598 -0.689 . . . . 0.0 110.374 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.484 ' CZ ' ' CE2' ' A' ' 96' ' ' TYR . 54.5 m-85 -112.67 144.63 41.86 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.129 -0.982 . . . . 0.0 110.145 -179.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.0 p -75.11 -22.34 58.3 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.567 -0.708 . . . . 0.0 110.837 -179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.0 tptt -119.96 129.22 54.2 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.869 -1.144 . . . . 0.0 110.644 -179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -140.7 154.23 24.15 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.471 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 24.2 m-85 -124.06 154.61 39.68 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.354 -1.086 . . . . 0.0 109.53 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.1 t -91.25 152.91 20.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.367 -0.833 . . . . 0.0 109.206 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.9 pt -51.6 -33.47 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 120.955 -1.09 . . . . 0.0 109.484 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -69.86 -46.44 65.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 109.674 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -56.44 -47.02 79.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 110.199 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.456 HG13 ' N ' ' A' ' 26' ' ' SER . 32.8 pt -66.65 -40.34 85.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.082 -1.011 . . . . 0.0 109.46 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.456 ' N ' HG13 ' A' ' 25' ' ' ILE . 22.4 t -132.65 84.35 2.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.927 . . . . 0.0 109.316 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -86.52 124.17 32.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.196 -0.94 . . . . 0.0 109.396 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.47 ' H ' ' HD2' ' A' ' 28' ' ' LYS . 0.0 OUTLIER -76.18 -14.93 60.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.437 -0.789 . . . . 0.0 109.582 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.463 ' O ' ' C ' ' A' ' 30' ' ' SER . 81.9 p -92.77 -77.1 0.45 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 109.203 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.463 ' C ' ' O ' ' A' ' 29' ' ' SER . 15.8 t -39.48 153.66 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.607 -0.683 . . . . 0.0 109.556 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.615 ' O ' ' N ' ' A' ' 33' ' ' GLN . 32.5 p-10 -97.04 -46.74 6.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.144 -0.973 . . . . 0.0 109.503 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.536 ' C ' ' O ' ' A' ' 31' ' ' ASN . 24.1 p-10 -33.14 90.53 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.598 -0.689 . . . . 0.0 109.923 -179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.615 ' N ' ' O ' ' A' ' 31' ' ' ASN . 10.9 pt20 -137.46 117.13 13.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.159 -0.963 . . . . 0.0 109.211 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.568 ' CG ' ' H ' ' A' ' 35' ' ' ASP . 10.3 pt20 -169.18 -60.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.101 -0.999 . . . . 0.0 109.618 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.568 ' H ' ' CG ' ' A' ' 34' ' ' GLN . 3.7 m-20 -151.76 116.62 5.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.373 -0.829 . . . . 0.0 109.549 -179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mm -82.65 125.72 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.126 -0.984 . . . . 0.0 108.456 179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.4 t -121.51 130.37 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.121 -0.987 . . . . 0.0 110.445 -179.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.434 ' O ' ' O ' ' A' ' 124' ' ' THR . 61.1 m -101.79 101.39 11.86 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 92.8 m -94.08 119.18 32.58 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.848 -1.157 . . . . 0.0 109.649 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.558 ' CG2' HG12 ' A' ' 125' ' ' VAL . 19.7 m -139.4 156.54 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.475 -0.766 . . . . 0.0 109.118 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -99.05 131.59 44.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.929 . . . . 0.0 109.561 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.56 152.48 21.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.302 -0.874 . . . . 0.0 109.553 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.477 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 47.4 t-80 -124.1 153.53 41.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.358 -0.839 . . . . 0.0 109.515 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.61 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -56.05 -26.1 47.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.368 -0.832 . . . . 0.0 109.772 -179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -96.91 -23.67 16.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.954 . . . . 0.0 109.61 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.477 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 82.4 m-20 -78.96 136.74 37.33 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.473 -0.767 . . . . 0.0 109.948 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 96.9 mt -78.78 150.36 32.4 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 0.0 108.669 178.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 37.9 pt -121.66 143.55 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.06 -1.025 . . . . 0.0 110.111 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.5 -172.72 45.49 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 50.7 p90 -170.49 169.9 7.16 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.007 -1.29 . . . . 0.0 109.713 179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -145.11 144.03 30.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.296 -0.878 . . . . 0.0 109.816 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 86.0 m -123.45 151.99 63.97 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.427 ' N ' ' OG1' ' A' ' 9' ' ' THR . 8.6 Cg_endo -51.59 144.41 33.19 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 122.363 2.042 . . . . 0.0 111.949 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.8 t -66.64 -13.82 61.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.52 -0.738 . . . . 0.0 110.535 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.605 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 82.3 m-20 -89.93 0.66 56.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.922 -1.111 . . . . 0.0 110.161 -179.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.423 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.0 m-85 -110.97 165.73 11.62 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.267 -0.896 . . . . 0.0 110.187 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.7 m -102.28 140.46 36.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.388 -0.82 . . . . 0.0 109.294 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.8 m -97.21 118.42 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.002 -1.061 . . . . 0.0 110.369 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.446 ' N ' ' OE1' ' A' ' 59' ' ' GLU . 5.6 mp0 -125.09 126.77 25.18 Favored Pre-proline 0 N--CA 1.489 1.517 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.17 114.39 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 121.658 1.572 . . . . 0.0 112.142 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -93.66 -24.32 17.92 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.466 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.2 t0 -170.94 40.07 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.451 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 88.5 m -63.97 -152.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.608 -0.682 . . . . 0.0 109.89 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.3 p90 -110.3 -58.19 2.11 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.118 -0.989 . . . . 0.0 111.252 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.447 ' C ' ' O ' ' A' ' 64' ' ' PHE . 27.6 t -45.82 -70.74 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.568 -1.332 . . . . 0.0 108.807 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.4 t -142.54 132.48 24.33 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.451 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -171.83 179.59 2.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.929 -1.107 . . . . 0.0 110.419 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.7 m-85 -93.76 140.44 29.66 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.437 HD21 ' HG2' ' A' ' 75' ' ' GLU . 99.8 m-20 -80.7 -171.12 2.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.895 -1.128 . . . . 0.0 109.9 -179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 38.2 mt -65.99 -15.8 63.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.353 -0.842 . . . . 0.0 109.134 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.441 ' OG ' ' NZ ' ' A' ' 73' ' ' LYS . 32.5 t -86.47 -7.15 58.65 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.322 -0.861 . . . . 0.0 108.878 179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 80.57 20.2 66.81 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.441 ' NZ ' ' OG ' ' A' ' 71' ' ' SER . 64.6 mttp -107.28 140.47 40.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.25 -1.147 . . . . 0.0 109.068 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -63.66 134.15 54.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.135 -0.978 . . . . 0.0 109.933 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.437 ' HG2' HD21 ' A' ' 69' ' ' ASN . 34.5 tp10 -154.19 163.81 39.53 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.313 -0.867 . . . . 0.0 109.446 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -107.35 138.79 42.89 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.251 -0.906 . . . . 0.0 109.52 179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 tp -97.06 -16.01 20.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.079 -1.013 . . . . 0.0 109.828 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -61.1 -43.65 98.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.894 -1.129 . . . . 0.0 109.521 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -65.09 -13.51 58.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.042 -1.036 . . . . 0.0 108.887 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -100.41 -41.66 6.93 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.384 -0.823 . . . . 0.0 109.162 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.521 HD23 HD21 ' A' ' 83' ' ' LEU . 37.1 tp -125.83 126.39 44.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.307 -0.871 . . . . 0.0 109.133 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -81.03 83.83 6.63 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.081 -1.012 . . . . 0.0 109.378 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.521 HD21 HD23 ' A' ' 81' ' ' LEU . 89.1 mt -77.21 143.93 38.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.312 -0.868 . . . . 0.0 109.955 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.7 p -127.78 158.23 38.24 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.554 -0.716 . . . . 0.0 109.308 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.862 HD22 HH11 ' A' ' 98' ' ' ARG . 88.4 m-20 55.22 51.54 13.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.179 -0.95 . . . . 0.0 109.699 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.6 mt -78.75 129.84 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.23 -0.919 . . . . 0.0 110.107 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.2 mm -118.22 118.8 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.447 -0.783 . . . . 0.0 109.271 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 80.2 mtp -120.52 103.34 9.08 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.28 -0.887 . . . . 0.0 109.74 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -110.6 99.63 8.57 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.252 -0.905 . . . . 0.0 109.041 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.482 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 61.8 m80 -72.3 -35.99 68.82 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.107 -0.996 . . . . 0.0 110.549 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 86.5 t80 -60.32 -45.02 94.88 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.912 -1.117 . . . . 0.0 109.516 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -89.5 -4.94 57.71 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 109.031 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.482 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.0 m-20 54.82 48.46 20.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.495 -0.753 . . . . 0.0 110.17 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.543 ' OG1' ' CE1' ' A' ' 96' ' ' TYR . 3.3 t -134.22 140.14 46.28 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.026 -1.046 . . . . 0.0 109.343 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -129.43 140.72 51.23 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.489 -0.757 . . . . 0.0 110.206 -179.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.543 ' CE1' ' OG1' ' A' ' 94' ' ' THR . 83.6 m-85 -136.18 146.85 47.3 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.417 -0.802 . . . . 0.0 109.537 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 15.1 p -152.64 159.44 43.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.981 -1.074 . . . . 0.0 109.172 179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.862 HH11 HD22 ' A' ' 85' ' ' ASN . 71.0 mtp180 -108.44 137.9 45.64 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.096 -1.003 . . . . 0.0 109.339 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 99' ' ' LEU . 46.3 mt -92.86 137.54 23.91 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.405 -0.809 . . . . 0.0 109.543 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.61 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 76.8 Cg_exo -45.86 170.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.836 1.69 . . . . 0.0 111.309 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.3 m -79.69 -10.61 59.81 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.101 -1.0 . . . . 0.0 109.754 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 52.6 tp -136.11 129.93 32.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.225 -0.922 . . . . 0.0 110.432 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.6 mt -147.37 102.37 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.235 -0.916 . . . . 0.0 108.643 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 68.7 m -102.83 -6.91 22.04 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.017 -1.052 . . . . 0.0 109.8 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 127' ' ' ALA . 84.7 m-20 -81.42 154.36 26.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.169 -0.957 . . . . 0.0 110.013 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -103.51 33.74 3.24 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.417 -0.802 . . . . 0.0 109.091 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.453 ' CH2' HD22 ' A' ' 81' ' ' LEU . 23.5 p-90 -64.98 152.66 42.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 110.452 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.24 153.96 51.09 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.639 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 30.6 p90 -152.4 162.35 41.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.999 -1.063 . . . . 0.0 108.698 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 8.2 p90 -154.1 160.77 42.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.729 -1.232 . . . . 0.0 111.792 -178.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 97.5 m -125.61 156.45 39.16 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 178.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.587 HG22 HG22 ' A' ' 122' ' ' VAL . 42.8 t -128.45 139.1 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.881 -1.137 . . . . 0.0 111.79 -178.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 93.5 m -122.15 131.87 54.17 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.5 p -170.2 178.55 3.79 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.176 -1.578 . . . . 0.0 111.663 -178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.605 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 50.0 mtmt -151.7 163.38 39.25 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 178.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -58.55 151.25 20.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.775 -1.203 . . . . 0.0 109.078 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.52 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 60.5 t-20 46.35 61.19 2.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.228 -0.92 . . . . 0.0 109.47 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.52 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 37.3 mt-10 -165.73 146.3 6.79 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.127 -0.983 . . . . 0.0 110.233 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -61.84 134.75 57.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.168 -0.958 . . . . 0.0 109.089 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -81.57 143.31 32.08 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.118 -0.989 . . . . 0.0 110.328 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 58.7 mt -110.75 122.87 48.89 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.587 HG22 HG22 ' A' ' 112' ' ' VAL . 52.6 t -110.07 131.14 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.883 -1.135 . . . . 0.0 110.79 -179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -109.0 120.52 42.79 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.434 ' O ' ' O ' ' A' ' 38' ' ' CYS . 7.2 t -137.08 141.25 42.37 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.933 -1.105 . . . . 0.0 111.892 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.639 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.2 m -135.92 159.47 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -124.9 146.68 49.21 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.161 -0.962 . . . . 0.0 110.423 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.068 -0.968 . . . . 0.0 109.31 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.258 0.551 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -76.99 152.77 35.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.935 . . . . 0.0 109.201 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.2 t -93.91 133.05 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.939 . . . . 0.0 109.983 -179.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.548 ' NZ ' ' OD2' ' A' ' 46' ' ' ASP . 96.7 mttt -72.85 127.18 31.8 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.418 -0.913 . . . . 0.0 108.735 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.77 166.18 32.26 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.442 ' SG ' ' CE1' ' A' ' 20' ' ' TYR . 5.2 t -104.96 131.9 51.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.422 -1.046 . . . . 0.0 109.471 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -110.88 109.44 19.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.494 -0.754 . . . . 0.0 109.424 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.413 ' CD1' HD13 ' A' ' 121' ' ' LEU . 92.9 m-85 -87.17 1.1 54.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.284 -0.885 . . . . 0.0 108.942 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.4 m -105.24 -17.17 14.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.561 -0.712 . . . . 0.0 110.461 -178.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.9 m -153.7 121.23 5.88 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.823 -1.173 . . . . 0.0 110.311 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 94.6 p -62.87 -29.79 71.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.209 -0.932 . . . . 0.0 108.911 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 26.4 mm-40 -109.98 73.02 0.82 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.491 ' HB2' ' H ' ' A' ' 16' ' ' PHE . 19.8 p -71.9 111.84 7.49 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.261 -0.899 . . . . 0.0 110.315 -178.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.0 t -69.4 2.86 2.65 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.433 ' H ' ' C ' ' A' ' 13' ' ' SER . 4.8 pt -123.61 -32.24 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.711 -0.618 . . . . 0.0 110.394 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.491 ' H ' ' HB2' ' A' ' 13' ' ' SER . 86.6 m-85 -106.6 145.67 31.63 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.212 -0.93 . . . . 0.0 109.812 -179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.1 m -71.34 -25.29 62.33 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.511 -0.743 . . . . 0.0 110.886 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -125.19 136.03 53.18 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.925 -1.109 . . . . 0.0 110.52 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -142.89 158.33 27.1 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.359 -1.497 . . . . 0.0 109.359 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.442 ' CE1' ' SG ' ' A' ' 6' ' ' CYS . 22.6 m-85 -123.53 152.69 41.52 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.346 -1.091 . . . . 0.0 109.648 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.3 t -99.69 162.53 12.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.312 -0.867 . . . . 0.0 109.049 179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.9 pt -56.23 -19.0 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.103 -0.998 . . . . 0.0 109.4 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.413 ' OD1' ' C ' ' A' ' 23' ' ' ASN . 46.5 t-20 -86.0 -54.75 4.3 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.187 -0.946 . . . . 0.0 109.402 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -46.34 -40.72 12.3 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.916 -178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 32' ' ' ASN . 39.5 pt -61.87 -25.58 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.019 -1.05 . . . . 0.0 109.518 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 27' ' ' ASN . 2.9 t -90.35 -106.65 0.09 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.161 -0.962 . . . . 0.0 108.927 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.542 ' N ' ' OG ' ' A' ' 26' ' ' SER . 97.6 m-20 -84.21 121.64 27.75 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.184 -0.948 . . . . 0.0 108.735 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -142.01 -71.44 0.34 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.195 -0.94 . . . . 0.0 109.83 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.4 t -159.59 -76.56 0.07 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.047 -1.033 . . . . 0.0 109.09 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.558 ' C ' ' H ' ' A' ' 32' ' ' ASN . 5.1 p -71.22 -166.81 0.19 Allowed 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.545 ' C ' ' H ' ' A' ' 33' ' ' GLN . 95.1 m-20 -67.45 34.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.291 -0.881 . . . . 0.0 109.714 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.558 ' H ' ' C ' ' A' ' 30' ' ' SER . 99.3 m-20 -65.4 11.22 0.07 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.154 -0.966 . . . . 0.0 109.439 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.545 ' H ' ' C ' ' A' ' 31' ' ' ASN . 29.8 pt20 -94.14 -6.9 43.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.916 -1.115 . . . . 0.0 109.5 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.485 ' O ' ' OD1' ' A' ' 35' ' ' ASP . 14.0 pt20 -136.44 -34.6 0.77 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.113 -0.992 . . . . 0.0 109.695 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 34' ' ' GLN . 74.6 m-20 -136.58 114.6 11.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.42 -0.8 . . . . 0.0 109.45 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.1 mm -93.97 118.86 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.898 -1.126 . . . . 0.0 108.446 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 66.2 t -114.36 124.89 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.348 -0.845 . . . . 0.0 110.213 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 83.1 m -102.26 101.92 12.26 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.8 m -97.4 121.96 39.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.072 -1.017 . . . . 0.0 109.588 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.413 ' CG2' HG12 ' A' ' 125' ' ' VAL . 24.1 m -139.38 155.5 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.408 -0.807 . . . . 0.0 109.024 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 51.0 tttp -95.94 123.76 39.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.252 -0.905 . . . . 0.0 109.324 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.542 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -87.99 161.99 17.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.7 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -139.99 148.4 41.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.908 . . . . 0.0 109.6 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.635 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -55.71 -24.2 33.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.362 -0.837 . . . . 0.0 109.745 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.485 ' OD1' ' O ' ' A' ' 45' ' ' ASN . 63.1 t-20 -98.96 -27.72 13.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.05 -1.031 . . . . 0.0 109.704 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.548 ' OD2' ' NZ ' ' A' ' 4' ' ' LYS . 88.3 m-20 -77.41 137.12 38.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.531 -0.731 . . . . 0.0 110.099 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 82.6 mt -78.23 148.28 34.03 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.431 HD13 HD21 ' A' ' 99' ' ' LEU . 47.2 pt -121.59 143.3 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.06 -1.025 . . . . 0.0 110.126 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 175.22 -176.14 47.22 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.448 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 50.5 p90 -164.9 170.37 15.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.126 -1.22 . . . . 0.0 109.75 179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -148.33 146.08 28.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.283 -0.886 . . . . 0.0 109.936 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.4 m -126.21 152.17 73.16 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.3 Cg_endo -51.44 153.53 10.14 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.322 2.014 . . . . 0.0 111.867 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 12.5 m -72.5 -10.64 60.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.449 -0.782 . . . . 0.0 110.7 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.599 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.9 m-20 -92.4 -2.26 56.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.993 -1.067 . . . . 0.0 110.173 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.434 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 18.6 m-85 -108.69 164.58 12.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.158 -0.964 . . . . 0.0 110.346 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.2 t -105.11 135.13 47.03 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.331 -0.855 . . . . 0.0 109.119 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 58' ' ' VAL . 3.0 m -92.6 119.87 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.993 -1.067 . . . . 0.0 110.316 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -123.36 126.4 25.88 Favored Pre-proline 0 N--CA 1.489 1.522 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.13 114.25 3.54 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 121.721 1.614 . . . . 0.0 112.144 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 68' ' ' PHE . 16.5 t-80 -93.71 -24.26 17.91 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.0 t0 -170.18 40.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.453 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 89.1 m -63.6 -154.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.524 -0.735 . . . . 0.0 109.887 -179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 4.3 p90 -110.56 -57.28 2.24 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.122 -0.986 . . . . 0.0 111.388 -178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 64' ' ' PHE . 34.7 t -46.12 -59.12 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 120.562 -1.336 . . . . 0.0 108.963 -179.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.1 t -156.85 133.86 10.36 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.453 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -172.0 -178.14 2.07 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.396 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.3 m-85 -93.63 143.25 26.48 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.719 HD21 ' CB ' ' A' ' 75' ' ' GLU . 82.9 m-20 -84.77 -169.2 2.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.112 -0.993 . . . . 0.0 109.828 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.568 HD12 ' N ' ' A' ' 70' ' ' LEU . 10.2 mp -66.85 -15.32 63.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.362 -0.836 . . . . 0.0 108.936 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 90.8 p -89.62 -8.35 52.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.235 -0.916 . . . . 0.0 108.693 179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.25 22.25 57.29 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -107.16 138.9 42.48 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.278 -1.13 . . . . 0.0 109.126 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -67.97 136.42 53.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.419 -0.8 . . . . 0.0 109.988 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.719 ' CB ' HD21 ' A' ' 69' ' ' ASN . 68.1 tt0 -155.33 165.84 35.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 109.594 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.416 ' N ' ' HG2' ' A' ' 75' ' ' GLU . 4.1 m120 -103.93 135.6 45.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.448 -0.782 . . . . 0.0 109.452 179.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.7 tp -97.61 -10.04 25.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.115 -0.99 . . . . 0.0 109.98 -179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -60.28 -44.57 95.23 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.944 -1.097 . . . . 0.0 109.638 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -64.83 -21.8 66.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.101 -1.0 . . . . 0.0 108.927 179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -81.0 -48.42 12.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.437 -0.79 . . . . 0.0 109.283 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.673 HD23 HD21 ' A' ' 83' ' ' LEU . 44.0 tp -127.06 128.69 46.68 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.522 -0.737 . . . . 0.0 109.111 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -73.91 83.96 1.71 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.031 -1.043 . . . . 0.0 109.198 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.673 HD21 HD23 ' A' ' 81' ' ' LEU . 92.6 mt -80.37 135.25 36.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -0.828 . . . . 0.0 110.026 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 61.9 p -126.78 162.21 26.37 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.601 -0.687 . . . . 0.0 109.201 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.403 HD22 ' HD2' ' A' ' 98' ' ' ARG . 97.7 m-20 54.82 50.95 14.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 109.574 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.7 mt -79.53 131.33 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.331 -0.856 . . . . 0.0 110.124 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 45.4 mm -119.49 120.01 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.461 -0.774 . . . . 0.0 109.246 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 71.9 mtp -122.51 105.33 10.04 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.111 -0.993 . . . . 0.0 109.745 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -110.81 100.79 9.47 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.367 -0.833 . . . . 0.0 109.0 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.453 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 95.5 m-70 -73.25 -34.61 65.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.964 -1.085 . . . . 0.0 110.583 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -60.47 -45.8 92.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.862 -1.149 . . . . 0.0 109.63 -179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -89.64 -3.89 58.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.266 -0.896 . . . . 0.0 109.129 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.453 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 97.5 m-20 55.06 48.07 20.57 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.585 -0.697 . . . . 0.0 110.326 178.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.597 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 1.9 t -133.43 138.89 46.43 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.99 -1.068 . . . . 0.0 109.458 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.448 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 75.3 m-85 -126.93 139.06 53.34 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.323 -0.861 . . . . 0.0 109.93 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.597 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 73.4 m-85 -135.39 146.23 48.11 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.257 -0.902 . . . . 0.0 109.427 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 53.9 m -150.05 151.95 34.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.094 -1.004 . . . . 0.0 109.189 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.423 HH11 ' HG2' ' A' ' 98' ' ' ARG . 59.0 mtt-85 -103.55 135.64 44.76 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.062 -1.024 . . . . 0.0 109.415 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.542 HD11 ' HB1' ' A' ' 42' ' ' ALA . 67.8 mt -89.81 137.18 28.53 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.478 -0.764 . . . . 0.0 109.607 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.635 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 76.9 Cg_exo -46.39 162.09 0.15 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.777 1.651 . . . . 0.0 111.329 178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.0 m -71.36 -17.43 62.43 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.115 -0.991 . . . . 0.0 109.713 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.2 tp -132.46 130.71 40.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.236 -0.915 . . . . 0.0 110.39 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.449 HD11 ' HB3' ' A' ' 99' ' ' LEU . 96.7 mt -142.78 125.56 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.321 -0.862 . . . . 0.0 108.713 178.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 29.9 p -131.5 54.28 1.93 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.041 -1.037 . . . . 0.0 109.755 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.603 ' OD1' ' N ' ' A' ' 106' ' ' ASN . 7.1 t0 -145.24 151.06 37.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.197 -0.939 . . . . 0.0 109.954 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.603 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 99.8 m-20 -91.33 33.66 0.98 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.492 -0.755 . . . . 0.0 109.039 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.589 ' N ' ' OD1' ' A' ' 105' ' ' ASP . 12.8 p-90 -64.86 150.19 48.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.167 -0.958 . . . . 0.0 110.514 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.6 ' NZ ' ' OG1' ' A' ' 124' ' ' THR . 12.9 tttp -139.85 151.95 46.09 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.637 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 32.1 p90 -156.07 162.61 40.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.028 -1.045 . . . . 0.0 108.72 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.464 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 10.1 p90 -153.89 158.62 41.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.679 -1.263 . . . . 0.0 111.785 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 98.1 m -123.15 156.49 34.94 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 122' ' ' VAL . 46.5 t -128.5 139.19 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 120.955 -1.09 . . . . 0.0 111.678 -178.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 23.2 m -122.14 131.61 54.05 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 177.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 71.6 p -172.01 179.18 2.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.325 -1.484 . . . . 0.0 111.573 -178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.599 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 49.8 mtmt -150.72 163.17 39.21 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 117' ' ' ASN . 55.2 p-10 -58.13 154.38 13.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.751 -1.218 . . . . 0.0 109.214 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.508 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 66.3 t30 43.43 60.33 2.64 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.208 -0.932 . . . . 0.0 109.641 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 117' ' ' ASN . 36.8 mt-10 -165.31 146.01 7.17 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.14 -0.975 . . . . 0.0 110.205 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.472 ' NZ ' ' O ' ' A' ' 33' ' ' GLN . 67.3 mttm -57.41 144.27 37.05 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.232 -0.918 . . . . 0.0 108.904 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.1 ptpt -91.9 139.74 30.36 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.175 -0.953 . . . . 0.0 110.382 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.413 HD13 ' CD1' ' A' ' 8' ' ' PHE . 26.5 mt -108.04 120.43 42.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.374 -0.828 . . . . 0.0 109.043 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 112' ' ' VAL . 49.9 t -109.01 129.88 62.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.968 -1.083 . . . . 0.0 110.493 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -108.27 120.42 42.33 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.6 ' OG1' ' NZ ' ' A' ' 108' ' ' LYS . 12.9 t -136.26 140.93 43.82 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.889 -178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.637 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.1 m -134.88 156.47 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -129.97 150.5 51.22 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.158 -0.964 . . . . 0.0 110.3 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.519 ' HB3' ' NE1' ' A' ' 107' ' ' TRP . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.277 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -74.59 160.78 30.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.147 -0.971 . . . . 0.0 109.301 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 51.7 t -104.48 130.82 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.236 -0.915 . . . . 0.0 109.904 -179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.461 ' N ' ' CD ' ' A' ' 4' ' ' LYS . 3.6 mptp? -68.54 122.96 19.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.159 -0.963 . . . . 0.0 108.791 179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 177.52 175.39 44.71 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.6 t -116.11 130.78 56.96 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.453 -1.028 . . . . 0.0 109.479 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.512 ' CB ' ' OG ' ' A' ' 13' ' ' SER . 40.5 t0 -108.23 109.47 20.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.447 -0.783 . . . . 0.0 109.269 179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.47 ' CZ ' ' SG ' ' A' ' 38' ' ' CYS . 91.8 m-85 -88.29 0.89 55.62 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.151 -0.968 . . . . 0.0 108.977 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.2 m -102.12 -17.02 16.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.592 -0.692 . . . . 0.0 110.685 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.608 HG22 ' H ' ' A' ' 12' ' ' GLU . 69.4 m -158.08 128.38 6.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.868 -1.145 . . . . 0.0 110.292 -179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.581 ' OG ' ' N ' ' A' ' 21' ' ' SER . 13.7 m -68.11 -25.45 65.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.269 -0.895 . . . . 0.0 108.934 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.608 ' H ' HG22 ' A' ' 10' ' ' THR . 77.6 mt-10 -114.35 74.28 0.87 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.367 -0.833 . . . . 0.0 108.928 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.512 ' OG ' ' CB ' ' A' ' 7' ' ' ASP . 7.8 m -70.01 151.94 44.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -0.907 . . . . 0.0 110.248 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.407 HG22 ' H ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -100.03 -0.08 39.91 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.8 pt -125.25 -25.01 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.7 -0.625 . . . . 0.0 110.176 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -111.58 139.64 46.85 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.033 -1.042 . . . . 0.0 109.912 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.2 m -71.85 -18.09 62.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.555 -0.716 . . . . 0.0 110.649 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -131.22 142.13 50.13 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.789 -1.194 . . . . 0.0 110.636 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.447 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -162.33 166.35 36.45 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.443 ' C ' ' OG ' ' A' ' 11' ' ' SER . 70.8 m-85 -125.65 168.24 14.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.316 -1.108 . . . . 0.0 109.586 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.581 ' N ' ' OG ' ' A' ' 11' ' ' SER . 4.9 t -103.4 164.69 11.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.466 -0.771 . . . . 0.0 109.072 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 26' ' ' SER . 44.9 pt -62.3 -20.82 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.078 -1.014 . . . . 0.0 109.512 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' A' ' 23' ' ' ASN . 49.0 t-20 -59.86 -35.41 74.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.342 -0.849 . . . . 0.0 109.338 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -69.01 -36.89 78.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.402 -0.811 . . . . 0.0 110.068 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.482 ' O ' ' O ' ' A' ' 26' ' ' SER . 2.4 pt -100.48 -3.8 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 120.834 -1.166 . . . . 0.0 109.432 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 22' ' ' ILE . 48.9 m -54.31 -166.75 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.135 -0.978 . . . . 0.0 109.345 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.47 ' OD1' ' NZ ' ' A' ' 119' ' ' LYS . 89.8 m-20 -114.62 2.93 14.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.21 -0.931 . . . . 0.0 109.275 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -60.49 -98.73 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.522 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.3 t -144.45 69.85 1.27 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.108 -0.995 . . . . 0.0 109.183 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.7 p -73.62 139.74 45.7 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.37 -0.831 . . . . 0.0 109.616 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -67.05 -52.41 42.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.146 -0.971 . . . . 0.0 109.823 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.562 ' O ' ' O ' ' A' ' 33' ' ' GLN . 99.2 m-20 -65.7 121.38 14.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.019 -1.05 . . . . 0.0 109.605 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.713 ' C ' ' H ' ' A' ' 35' ' ' ASP . 2.8 pt20 -46.91 -178.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.512 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -58.62 16.48 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.483 -1.386 . . . . 0.0 109.961 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.713 ' H ' ' C ' ' A' ' 33' ' ' GLN . 97.4 m-20 -118.1 101.56 8.33 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.45 -0.781 . . . . 0.0 109.328 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.7 mm -102.2 126.13 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.037 -1.039 . . . . 0.0 108.895 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.486 HG22 ' HB ' ' A' ' 122' ' ' VAL . 53.1 t -120.97 129.84 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 110.061 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.47 ' SG ' ' CZ ' ' A' ' 8' ' ' PHE . 91.1 m -100.8 99.56 10.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 76.0 m -95.87 121.07 37.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.933 -1.104 . . . . 0.0 109.489 -179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.452 ' CG2' HG12 ' A' ' 125' ' ' VAL . 22.8 m -141.34 155.84 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.401 -0.812 . . . . 0.0 109.246 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.6 mtmp? -96.08 129.52 43.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.187 -0.945 . . . . 0.0 109.387 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.491 ' HB1' HD11 ' A' ' 99' ' ' LEU . . . -100.02 154.53 18.32 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.304 -0.872 . . . . 0.0 109.626 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.48 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 32.4 t-80 -126.56 151.84 47.38 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.336 -0.852 . . . . 0.0 109.558 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.544 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -55.17 -25.11 30.26 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.883 . . . . 0.0 109.789 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -98.99 -24.97 14.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.926 . . . . 0.0 109.655 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 85.5 m-20 -74.4 135.66 42.39 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.428 -0.795 . . . . 0.0 110.161 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.404 ' HB3' HH21 ' A' ' 98' ' ' ARG . 69.7 mt -76.86 145.59 38.26 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.542 HD13 HD21 ' A' ' 99' ' ' LEU . 39.1 pt -120.17 141.92 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.019 -1.05 . . . . 0.0 110.392 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 178.29 -174.57 46.83 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -170.16 169.95 7.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.049 -1.265 . . . . 0.0 109.739 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 62.0 tttm -146.96 145.03 29.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.315 -0.865 . . . . 0.0 109.762 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 66.7 m -124.49 153.4 69.43 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.258 -0.902 . . . . 0.0 108.626 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.45 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 8.5 Cg_endo -51.51 147.69 22.31 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.307 2.004 . . . . 0.0 111.98 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.1 t -68.1 -13.84 62.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.465 -0.772 . . . . 0.0 110.621 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.634 ' O ' ' NZ ' ' A' ' 115' ' ' LYS . 81.7 m-20 -89.71 -0.77 57.74 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.834 -1.166 . . . . 0.0 110.224 -179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.45 ' CD1' ' HG2' ' A' ' 53' ' ' PRO . 19.5 m-85 -109.63 164.8 12.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.162 -0.961 . . . . 0.0 110.186 179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.3 m -105.24 135.51 46.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.387 -0.821 . . . . 0.0 109.298 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.8 m -90.16 118.4 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.074 -1.016 . . . . 0.0 110.393 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -123.84 127.84 25.31 Favored Pre-proline 0 N--CA 1.491 1.609 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.29 114.04 3.47 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.662 1.574 . . . . 0.0 112.16 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 68' ' ' PHE . 12.1 t-80 -91.22 -25.41 19.53 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.471 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.3 t0 -172.7 39.27 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.458 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 77.0 m -60.87 -153.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.538 -0.726 . . . . 0.0 109.842 -179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.412 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 4.3 p90 -108.97 -56.1 2.32 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.004 -1.06 . . . . 0.0 111.256 -179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.507 HG12 ' N ' ' A' ' 66' ' ' SER . 13.1 t -48.79 -74.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.559 -1.338 . . . . 0.0 108.876 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.507 ' N ' HG12 ' A' ' 65' ' ' VAL . 27.6 t -137.16 131.2 32.22 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.458 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.11 179.92 2.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.992 -1.068 . . . . 0.0 110.428 -179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 5.4 m-85 -93.46 130.31 39.33 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -76.63 -174.03 2.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.931 -1.106 . . . . 0.0 109.904 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 67.4 mt -64.27 -20.85 66.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -0.841 . . . . 0.0 109.103 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.7 p -83.42 -6.36 59.44 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.12 19.74 66.45 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -100.82 139.14 36.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.233 -1.157 . . . . 0.0 109.193 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -84.38 112.38 20.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.216 -0.928 . . . . 0.0 110.08 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -150.57 140.99 22.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.355 -0.841 . . . . 0.0 109.964 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -63.24 149.46 45.47 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.114 -0.991 . . . . 0.0 109.49 -179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 77' ' ' LEU . 14.7 tp -96.55 7.39 46.66 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.359 -0.838 . . . . 0.0 109.691 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -69.02 -40.39 78.7 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.053 -1.029 . . . . 0.0 109.952 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.607 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 51.5 p-10 -61.95 -31.44 71.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.129 -0.982 . . . . 0.0 109.106 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.607 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 29.1 tptp -75.56 -48.17 23.56 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.514 -0.741 . . . . 0.0 109.255 178.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.465 HD11 ' HG2' ' A' ' 100' ' ' PRO . 15.6 tp -149.13 123.67 9.74 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -80.46 99.54 8.06 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.054 -1.029 . . . . 0.0 109.644 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 95.2 mt -76.08 158.97 31.23 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.435 -0.79 . . . . 0.0 109.784 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.2 p -129.51 160.17 34.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.264 -0.898 . . . . 0.0 109.346 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 54.59 51.29 14.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.072 -1.018 . . . . 0.0 109.723 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 96.9 mt -80.74 130.79 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.331 -0.856 . . . . 0.0 109.996 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.9 mm -123.06 121.82 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.516 -0.74 . . . . 0.0 109.192 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 87.1 mtp -121.87 104.14 9.34 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.021 -1.05 . . . . 0.0 109.884 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -112.07 100.76 9.12 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.296 -0.878 . . . . 0.0 108.904 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.48 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 93.5 m-70 -72.88 -35.94 67.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.873 -1.142 . . . . 0.0 110.657 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -60.4 -46.55 89.57 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.964 -1.085 . . . . 0.0 109.434 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -88.13 -4.92 58.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.137 -0.977 . . . . 0.0 109.107 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.48 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.3 m-20 54.71 47.72 21.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.522 -0.736 . . . . 0.0 110.173 178.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.584 ' OG1' ' CE2' ' A' ' 96' ' ' TYR . 4.8 t -132.62 137.87 47.18 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.009 -1.057 . . . . 0.0 109.359 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -126.89 139.24 53.22 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.385 -0.822 . . . . 0.0 109.979 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.584 ' CE2' ' OG1' ' A' ' 94' ' ' THR . 80.4 m-85 -136.24 146.79 47.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.162 -0.961 . . . . 0.0 109.569 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.548 ' C ' ' CZ ' ' A' ' 98' ' ' ARG . 20.0 p -154.28 153.18 31.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.199 -0.938 . . . . 0.0 109.167 178.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.548 ' CZ ' ' C ' ' A' ' 97' ' ' SER . 0.0 OUTLIER -100.64 137.01 39.61 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.112 -0.993 . . . . 0.0 109.687 -179.729 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.542 HD21 HD13 ' A' ' 48' ' ' ILE . 63.8 mt -88.84 134.74 33.06 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.467 -0.771 . . . . 0.0 109.518 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.586 ' HD2' HD11 ' A' ' 103' ' ' ILE . 78.1 Cg_exo -46.48 155.78 0.68 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 121.68 1.586 . . . . 0.0 111.32 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.5 t -63.98 -43.36 95.96 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.172 -0.955 . . . . 0.0 109.862 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 41.7 tp -105.18 126.25 51.87 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.163 -0.961 . . . . 0.0 110.209 -178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.586 HD11 ' HD2' ' A' ' 100' ' ' PRO . 91.9 mt -151.33 104.06 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.134 -0.979 . . . . 0.0 108.847 179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 90.7 p -108.25 0.9 21.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.152 -0.967 . . . . 0.0 109.757 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -79.93 151.6 30.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.186 -0.946 . . . . 0.0 109.994 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -98.85 32.6 2.57 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.462 -0.774 . . . . 0.0 108.969 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . . . . . . . . . 19.7 p-90 -65.89 158.41 28.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 110.587 -178.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.3 157.46 44.79 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.63 ' CE1' ' CG2' ' A' ' 125' ' ' VAL . 35.8 p90 -155.31 160.47 40.78 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.939 -1.101 . . . . 0.0 108.769 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 5.6 p90 -151.49 158.99 44.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.664 -1.273 . . . . 0.0 111.766 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 90.0 m -124.62 156.3 37.71 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 122' ' ' VAL . 41.7 t -129.64 141.66 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.89 -1.132 . . . . 0.0 111.72 -178.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 91.4 m -120.37 131.44 54.84 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 177.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.8 p -168.38 178.86 4.68 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.264 -1.523 . . . . 0.0 111.643 -178.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.634 ' NZ ' ' O ' ' A' ' 55' ' ' ASN . 42.5 mtmt -159.11 167.94 27.91 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.508 ' O ' ' OD1' ' A' ' 116' ' ' ASP . 48.5 p30 -58.72 151.44 21.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.823 -1.173 . . . . 0.0 109.009 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.47 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 60.1 t-20 40.89 58.91 2.36 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.237 -0.914 . . . . 0.0 109.385 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 117' ' ' ASN . 54.5 mm-40 -157.57 137.54 12.45 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.089 -1.007 . . . . 0.0 110.521 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.47 ' NZ ' ' OD1' ' A' ' 27' ' ' ASN . 64.1 mttp -54.3 140.89 31.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.059 -1.025 . . . . 0.0 109.141 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -89.11 138.75 31.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.189 -0.944 . . . . 0.0 110.307 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 64.5 mt -111.24 123.11 49.55 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.565 HG22 HG22 ' A' ' 112' ' ' VAL . 39.4 t -108.58 130.45 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.878 -1.139 . . . . 0.0 110.621 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -108.91 119.76 40.5 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.6 t -137.14 143.51 42.52 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.876 -1.14 . . . . 0.0 111.946 -178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.63 ' CG2' ' CE1' ' A' ' 109' ' ' PHE . 3.4 m -136.79 159.55 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 126' ' ' GLU . 57.2 mp0 -128.51 147.83 50.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.055 -1.028 . . . . 0.0 110.217 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.299 179.762 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -80.39 160.03 25.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.19 -0.944 . . . . 0.0 109.327 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 77.5 t -97.76 134.84 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.262 -0.899 . . . . 0.0 110.079 -179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 4' ' ' LYS . 14.2 mptt -68.89 125.91 28.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.949 -1.095 . . . . 0.0 108.618 179.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.82 -170.95 44.12 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.461 -1.352 . . . . 0.0 109.736 -179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 4.7 t -126.49 132.66 51.36 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.352 -1.087 . . . . 0.0 109.612 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.453 ' H ' ' HA2' ' A' ' 19' ' ' GLY . 51.6 t0 -107.86 108.71 20.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.557 -0.714 . . . . 0.0 109.283 179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -88.28 1.23 55.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.0 108.756 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 83.0 m -102.28 -16.97 16.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.503 -0.748 . . . . 0.0 110.477 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.627 HG22 ' H ' ' A' ' 12' ' ' GLU . 48.6 m -158.08 127.37 5.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.884 -1.135 . . . . 0.0 110.409 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.8 t -65.2 -26.01 67.95 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 108.826 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.627 ' H ' HG22 ' A' ' 10' ' ' THR . 76.8 mm-40 -114.33 74.06 0.85 Allowed 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.0 t -69.91 150.8 46.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.0 110.37 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.89 0.89 39.29 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.425 HD12 ' CE2' ' A' ' 16' ' ' PHE . 6.9 pt -123.91 -23.63 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.666 -0.647 . . . . 0.0 110.184 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.425 ' CE2' HD12 ' A' ' 15' ' ' ILE . 58.6 m-85 -115.26 136.85 52.67 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.304 -0.873 . . . . 0.0 110.023 -179.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.1 t -67.28 -17.79 64.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.571 -0.706 . . . . 0.0 110.864 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -129.95 140.97 50.84 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.039 -1.038 . . . . 0.0 110.523 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.453 ' HA2' ' H ' ' A' ' 7' ' ' ASP . . . -154.43 161.16 29.99 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -119.37 155.6 31.63 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.481 -1.011 . . . . 0.0 109.636 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 47.3 t -90.59 152.16 21.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.806 . . . . 0.0 109.09 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.4 pt -54.52 -33.13 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -0.934 . . . . 0.0 109.376 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -68.31 -44.34 75.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.038 -1.039 . . . . 0.0 109.859 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -56.38 -42.69 78.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.244 -0.91 . . . . 0.0 110.101 -179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 41.6 pt -80.65 -15.77 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.87 -1.144 . . . . 0.0 109.598 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.1 m -148.26 70.95 1.15 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.569 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.485 ' O ' ' C ' ' A' ' 28' ' ' LYS . 10.0 p30 -104.13 136.87 42.94 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.286 -0.884 . . . . 0.0 109.448 179.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.485 ' C ' ' O ' ' A' ' 27' ' ' ASN . 99.3 mttt -39.35 -42.94 1.11 Allowed 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.751 -0.78 . . . . 0.0 109.458 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.7 t -98.4 131.78 44.4 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.103 -0.998 . . . . 0.0 108.724 179.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.1 t -105.15 121.73 44.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.047 -1.033 . . . . 0.0 109.873 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.493 ' OD1' ' O ' ' A' ' 31' ' ' ASN . 61.2 t-20 -98.83 16.14 23.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.931 . . . . 0.0 109.203 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.405 ' CG ' ' H ' ' A' ' 33' ' ' GLN . 66.1 t30 -168.95 -178.55 3.34 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.234 -0.917 . . . . 0.0 109.756 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.405 ' H ' ' CG ' ' A' ' 32' ' ' ASN . 16.9 pt20 -60.01 158.26 11.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.187 -0.946 . . . . 0.0 109.002 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.475 ' CG ' ' N ' ' A' ' 35' ' ' ASP . 11.7 pt20 -63.4 -41.72 98.74 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.032 -1.043 . . . . 0.0 109.444 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 35' ' ' ASP . 0.7 OUTLIER -54.25 130.87 40.24 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.293 -0.879 . . . . 0.0 109.148 -179.312 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.5 mm -100.46 120.72 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.089 -1.007 . . . . 0.0 108.481 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 51.6 t -115.98 127.05 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.345 -0.847 . . . . 0.0 110.482 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.42 ' O ' ' O ' ' A' ' 124' ' ' THR . 97.5 m -102.62 101.43 11.57 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 99.2 m -94.22 120.69 34.84 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.055 -1.028 . . . . 0.0 109.58 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.553 ' CG2' HG12 ' A' ' 125' ' ' VAL . 15.9 m -141.36 149.34 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.528 -0.733 . . . . 0.0 109.349 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -90.52 130.65 36.55 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.971 -1.081 . . . . 0.0 109.24 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.25 151.27 22.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.906 . . . . 0.0 109.288 -179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.494 ' H ' ' HB2' ' A' ' 46' ' ' ASP . 38.2 t-80 -122.92 152.63 40.63 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.322 -0.861 . . . . 0.0 109.483 -179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.838 ' HB1' ' O ' ' A' ' 100' ' ' PRO . . . -55.69 -25.73 41.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.409 -0.807 . . . . 0.0 109.762 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -98.81 -25.72 14.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.118 -0.989 . . . . 0.0 109.764 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.494 ' HB2' ' H ' ' A' ' 43' ' ' HIS . 86.3 m-20 -73.37 135.51 44.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.361 -0.837 . . . . 0.0 110.026 -179.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 75.3 mt -77.21 145.87 37.35 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.414 HG21 HD11 ' A' ' 99' ' ' LEU . 46.1 pt -123.05 145.04 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.204 -0.935 . . . . 0.0 110.207 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 177.52 -172.52 45.28 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 95' ' ' PHE . 49.9 p90 -171.3 170.11 6.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.075 -1.25 . . . . 0.0 109.785 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -146.38 144.67 29.9 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.243 -0.911 . . . . 0.0 109.79 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 70.4 m -123.0 153.15 64.08 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.424 ' HG2' ' CD1' ' A' ' 56' ' ' TYR . 9.3 Cg_endo -51.81 145.06 32.86 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.292 1.995 . . . . 0.0 112.138 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.9 t -68.02 -14.83 63.28 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.481 -0.762 . . . . 0.0 110.628 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -89.6 1.64 55.72 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.931 -1.106 . . . . 0.0 110.233 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.438 ' CE2' ' OE1' ' A' ' 118' ' ' GLU . 19.0 m-85 -110.55 166.43 11.0 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.398 -0.814 . . . . 0.0 110.482 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.431 ' OG ' ' OE2' ' A' ' 59' ' ' GLU . 35.2 t -103.01 133.88 47.39 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -0.837 . . . . 0.0 108.828 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 58' ' ' VAL . 2.1 m -91.05 124.49 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.042 -1.037 . . . . 0.0 110.198 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.431 ' OE2' ' OG ' ' A' ' 57' ' ' SER . 10.5 mp0 -131.28 125.82 21.08 Favored Pre-proline 0 N--CA 1.49 1.541 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.07 114.47 3.59 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 121.644 1.562 . . . . 0.0 112.047 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.497 ' O ' ' O ' ' A' ' 68' ' ' PHE . 17.3 t-80 -91.57 -23.26 19.96 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 62' ' ' ASP . 68.2 t0 -173.5 39.15 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.425 ' N ' ' CB ' ' A' ' 67' ' ' ALA . 81.5 m -60.34 -152.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.577 -0.702 . . . . 0.0 109.533 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.502 ' CD1' ' N ' ' A' ' 64' ' ' PHE . 3.3 p90 -110.88 -58.03 2.15 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.245 -0.909 . . . . 0.0 111.318 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.453 ' C ' ' O ' ' A' ' 64' ' ' PHE . 23.5 t -45.95 -72.77 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 120.298 -1.501 . . . . 0.0 108.893 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.426 ' N ' HG12 ' A' ' 65' ' ' VAL . 38.4 t -139.98 130.31 25.31 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.425 ' CB ' ' N ' ' A' ' 63' ' ' CYS . . . -173.24 -178.79 1.8 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.121 -0.987 . . . . 0.0 110.524 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 68' ' ' PHE . 4.2 m-85 -93.55 123.45 36.87 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -71.9 -175.84 1.54 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.044 -1.035 . . . . 0.0 109.754 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 46.6 mt -62.79 -22.86 66.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.181 -0.95 . . . . 0.0 109.112 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.6 t -79.85 -7.36 58.67 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.333 -0.855 . . . . 0.0 108.857 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.69 18.4 68.24 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -101.41 138.63 38.17 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -1.156 . . . . 0.0 109.072 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -86.08 110.12 19.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.202 -0.936 . . . . 0.0 110.165 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -146.72 143.35 28.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.364 -0.835 . . . . 0.0 109.914 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.4 m-20 -64.65 149.64 48.61 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 119.503 -0.879 . . . . 0.0 109.51 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.435 ' CB ' ' O ' ' A' ' 64' ' ' PHE . 13.1 tp -98.8 4.94 47.72 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.234 -0.916 . . . . 0.0 109.945 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 79' ' ' ASN . 17.7 pt-20 -68.23 -41.31 81.42 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.038 -1.039 . . . . 0.0 110.013 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.593 ' OD1' ' N ' ' A' ' 80' ' ' LYS . 43.4 p30 -64.46 -27.67 69.14 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.09 -1.006 . . . . 0.0 109.138 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.593 ' N ' ' OD1' ' A' ' 79' ' ' ASN . 28.9 tptp -83.5 -47.73 11.04 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.316 -0.865 . . . . 0.0 109.361 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.582 HD23 HD21 ' A' ' 83' ' ' LEU . 43.3 tp -125.94 126.68 44.76 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.44 -0.787 . . . . 0.0 109.299 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -77.86 83.62 4.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.134 -0.979 . . . . 0.0 109.277 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.582 HD21 HD23 ' A' ' 81' ' ' LEU . 92.3 mt -82.6 136.04 34.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.393 -0.817 . . . . 0.0 110.083 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 45.3 p -126.16 160.79 29.24 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.603 HD22 ' CZ ' ' A' ' 98' ' ' ARG . 84.0 m-20 55.59 50.8 13.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.455 -0.778 . . . . 0.0 109.666 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 97.2 mt -78.33 131.53 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.3 -0.875 . . . . 0.0 109.997 -179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 46.2 mm -117.94 118.68 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.374 -0.829 . . . . 0.0 109.258 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 93.8 mtp -124.98 110.65 14.47 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.276 -0.89 . . . . 0.0 109.883 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -114.07 101.13 8.94 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.364 -0.835 . . . . 0.0 108.907 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.458 ' O ' ' OD1' ' A' ' 93' ' ' ASN . 74.2 m80 -71.04 -36.74 72.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.079 -1.013 . . . . 0.0 110.677 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -60.14 -45.78 91.86 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.998 -1.064 . . . . 0.0 109.66 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -88.61 -5.23 58.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.161 -0.962 . . . . 0.0 109.152 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 90' ' ' HIS . 98.3 m-20 54.72 48.28 20.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.573 -0.704 . . . . 0.0 110.338 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.603 ' OG1' ' CZ ' ' A' ' 96' ' ' TYR . 2.9 t -132.38 137.04 47.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.013 -1.055 . . . . 0.0 109.313 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.563 ' CD1' ' CZ ' ' A' ' 50' ' ' PHE . 47.1 m-85 -125.2 138.34 54.13 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.338 -0.851 . . . . 0.0 109.735 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TYR . . . . . 0.603 ' CZ ' ' OG1' ' A' ' 94' ' ' THR . 81.3 m-85 -136.07 146.19 46.8 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.217 -0.927 . . . . 0.0 109.154 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 83.8 p -154.96 155.91 35.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.932 . . . . 0.0 109.015 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.614 HH11 ' CB ' ' A' ' 98' ' ' ARG . 0.0 OUTLIER -107.81 139.56 42.21 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.162 -0.961 . . . . 0.0 109.934 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 100' ' ' PRO . 94.6 mt -96.6 142.31 24.36 Favored Pre-proline 0 C--N 1.297 -1.685 0 O-C-N 121.65 -0.656 . . . . 0.0 109.756 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.838 ' O ' ' HB1' ' A' ' 44' ' ' ALA . 76.4 Cg_exo -45.56 177.02 0.01 OUTLIER 'Trans proline' 0 N--CA 1.488 1.197 0 C-N-CA 121.779 1.653 . . . . 0.0 111.263 178.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 96.9 p -85.32 -9.23 57.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.022 -1.049 . . . . 0.0 109.747 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.2 tp -139.0 130.66 27.39 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.229 -0.919 . . . . 0.0 110.778 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 74.2 mt -147.37 102.57 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.225 -0.922 . . . . 0.0 108.885 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 97.1 p -100.0 -3.05 32.95 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.056 -1.027 . . . . 0.0 109.819 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.491 ' O ' ' O ' ' A' ' 127' ' ' ALA . 84.4 m-20 -82.11 151.05 27.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.336 -0.853 . . . . 0.0 110.165 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -99.22 31.34 3.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.525 -0.734 . . . . 0.0 109.126 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.431 ' CH2' HD22 ' A' ' 81' ' ' LEU . 18.8 p-90 -66.59 159.95 26.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 0.0 110.627 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -144.24 158.83 43.51 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PHE . . . . . 0.539 ' CE2' ' CG2' ' A' ' 125' ' ' VAL . 25.5 p90 -152.13 161.96 41.84 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.942 -1.098 . . . . 0.0 108.655 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 110' ' ' PHE . 7.3 p90 -152.56 158.48 42.56 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.794 -1.191 . . . . 0.0 111.746 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' CYS . . . . . . . . . . . . . 84.9 m -124.74 156.55 37.49 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.588 HG22 HG22 ' A' ' 122' ' ' VAL . 44.4 t -129.73 140.51 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.893 -1.129 . . . . 0.0 111.829 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 72.2 m -124.16 133.18 53.63 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.2 p -169.56 178.25 4.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.27 -1.518 . . . . 0.0 111.647 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.546 ' NZ ' ' OE2' ' A' ' 118' ' ' GLU . 6.1 mtmp? -153.59 163.29 40.23 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 178.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' A' ' 117' ' ' ASN . 99.3 m-20 -58.22 153.22 15.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.851 -1.156 . . . . 0.0 109.109 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.506 ' O ' ' CG ' ' A' ' 118' ' ' GLU . 66.7 t30 44.04 59.4 3.2 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.167 -0.958 . . . . 0.0 109.555 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.546 ' OE2' ' NZ ' ' A' ' 115' ' ' LYS . 41.6 mt-10 -165.23 145.96 7.24 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.189 -0.944 . . . . 0.0 110.164 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.2 134.07 52.9 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.115 -0.991 . . . . 0.0 109.003 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -83.37 147.86 27.65 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.038 -1.039 . . . . 0.0 110.337 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 65.6 mt -111.04 124.45 52.2 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.588 HG22 HG22 ' A' ' 112' ' ' VAL . 42.2 t -108.83 130.22 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.998 -1.064 . . . . 0.0 110.388 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -109.52 121.23 44.74 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.42 ' O ' ' O ' ' A' ' 38' ' ' CYS . 5.3 t -137.33 142.89 41.83 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 122.468 1.127 . . . . 0.0 112.323 -178.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.553 HG12 ' CG2' ' A' ' 40' ' ' VAL . 3.1 m -138.39 158.7 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.546 ' CD ' ' N ' ' A' ' 127' ' ' ALA . 12.4 tm-20 -134.34 155.7 49.79 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.185 -0.947 . . . . 0.0 110.317 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.546 ' N ' ' CD ' ' A' ' 126' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.062 -0.97 . . . . 0.0 109.386 179.823 . . . . . . . . 1 1 . 1 stop_ save_